disease_type,disease_name,primary_site,submitter_id,age_at_diagnosis,gender,year_of_birth,race,days_to_collection,sample_type,percent_neutrophil_infiltration,percent_monocyte_infiltration,percent_normal_cells,percent_tumor_nuclei,percent_lymphocyte_infiltration,percent_stromal_cells,percent_tumor_cells,sample_id,bcr_patient_barcode,stage
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-A7Q1,22454.0,female,1952,asian,158,Primary Tumor,5.0,10.0,0.0,80.0,80.0,20.0,70.0,TCGA-FA-A7Q1-01A,TCGA-FA-A7Q1,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3408,28171.0,female,1927,white,None,Primary Tumor,None,None,0.0,85.0,3.0,10.0,80.0,TCGA-18-3408-01A,TCGA-18-3408,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HR,27629.0,female,1936,white,513,Primary Tumor,0.0,0.0,0.0,92.0,0.0,5.0,85.0,TCGA-NC-A5HR-01A,TCGA-NC-A5HR,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8437,15475.0,female,1964,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8437-01A,TCGA-KN-8437,1.0
UVM,Uveal Melanoma,Eye,TCGA-V3-A9ZY,19894.0,male,1959,white,4,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V3-A9ZY-01A,TCGA-V3-A9ZY,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-68-8251,28739.0,male,1934,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,75.0,TCGA-68-8251-01A,TCGA-68-8251,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A85I,24408.0,male,1947,white,135,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-EB-A85I-01A,TCGA-EB-A85I,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5473,28826.0,male,1927,white,None,Primary Tumor,0.0,0.0,2.0,80.0,5.0,18.0,60.0,TCGA-22-5473-01A,TCGA-22-5473,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A4BY,24445.0,male,1946,white,67,Primary Tumor,0.0,0.0,5.0,90.0,0.0,10.0,85.0,TCGA-56-A4BY-01A,TCGA-56-A4BY,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8339,24545.0,male,1939,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KL-8339-01A,TCGA-KL-8339,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4533,28001.0,female,1925,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,20.0,60.0,TCGA-33-4533-01A,TCGA-33-4533,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A53A,25662.0,male,1942,black or african american,161,Primary Tumor,0.0,1.0,0.0,100.0,1.0,10.0,90.0,TCGA-98-A53A-01A,TCGA-98-A53A,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2787,21124.0,male,1947,not reported,None,Primary Tumor,None,None,0.0,75.0,None,5.0,93.0,TCGA-66-2787-01A,TCGA-66-2787,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2793,25111.0,male,1940,not reported,None,Primary Tumor,None,None,15.0,70.0,None,5.0,78.0,TCGA-66-2793-01A,TCGA-66-2793,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A4OZ,15337.0,female,1971,white,118,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-EB-A4OZ-01A,TCGA-EB-A4OZ,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-6798,20837.0,male,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,70.0,TCGA-85-6798-01A,TCGA-85-6798,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5479,23563.0,male,1940,white,None,Primary Tumor,None,None,0.0,65.0,30.0,25.0,60.0,TCGA-22-5479-01A,TCGA-22-5479,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5022,27856.0,male,1929,white,None,Primary Tumor,2.0,2.0,0.0,65.0,20.0,10.0,80.0,TCGA-39-5022-01A,TCGA-39-5022,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-52-7810,22241.0,female,1948,white,None,Primary Tumor,None,None,20.0,70.0,None,0.0,80.0,TCGA-52-7810-01A,TCGA-52-7810,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KI,24966.0,male,1944,not reported,518,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KI-01A,TCGA-VD-A8KI,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-WE-A8K4,31308.0,male,1928,white,203,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-WE-A8K4-01A,TCGA-WE-A8K4,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A3XE,28148.0,female,1935,white,113,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-EB-A3XE-01A,TCGA-EB-A3XE,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A5DS,26355.0,female,1940,white,70,Primary Tumor,0.0,0.0,5.0,70.0,0.0,20.0,70.0,TCGA-56-A5DS-01A,TCGA-56-A5DS,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9U3,28474.0,female,1928,white,3124,Primary Tumor,0.0,2.0,0.0,95.0,95.0,5.0,95.0,TCGA-GS-A9U3-01A,TCGA-GS-A9U3,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8436,22997.0,male,1947,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8436-01A,TCGA-KN-8436,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-A46J,23653.0,male,1942,white,2176,Primary Tumor,1.0,2.0,5.0,60.0,4.0,50.0,25.0,TCGA-58-A46J-01A,TCGA-58-A46J,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A5ES,28092.0,female,1936,white,89,Primary Tumor,0.0,0.0,0.0,96.0,0.0,1.0,99.0,TCGA-BF-A5ES-01A,TCGA-BF-A5ES,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-8392,25710.0,male,1940,white,None,Primary Tumor,None,15.0,7.0,70.0,5.0,8.0,70.0,TCGA-58-8392-01A,TCGA-58-8392,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-D9-A4Z3,26812.0,female,1939,white,16,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-D9-A4Z3-01A,TCGA-D9-A4Z3,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GR-A4D4,20888.0,female,1953,white,868,Primary Tumor,0.0,2.0,5.0,90.0,5.0,5.0,85.0,TCGA-GR-A4D4-01A,TCGA-GR-A4D4,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8130,25260.0,male,1931,not reported,None,Primary Tumor,None,None,0.0,65.0,None,20.0,80.0,TCGA-77-8130-01A,TCGA-77-8130,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-79-5596,None,male,None,not reported,None,Primary Tumor,None,None,0.0,70.0,10.0,30.0,58.0,TCGA-79-5596-01A,TCGA-79-5596,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A41B,27998.0,female,1936,white,119,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-EB-A41B-01A,TCGA-EB-A41B,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A5UM,17867.0,female,1964,white,92,Primary Tumor,0.0,0.0,40.0,75.0,2.0,0.0,60.0,TCGA-EB-A5UM-01A,TCGA-EB-A5UM,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5474,27271.0,male,1931,white,None,Primary Tumor,1.0,1.0,0.0,71.0,20.0,0.0,92.0,TCGA-22-5474-01A,TCGA-22-5474,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A51B,19645.0,male,1959,white,100,Primary Tumor,0.0,1.0,15.0,75.0,3.0,0.0,85.0,TCGA-EB-A51B-01A,TCGA-EB-A51B,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A5SE,26965.0,male,1939,white,170,Primary Tumor,0.0,0.0,20.0,90.0,0.0,0.0,80.0,TCGA-EB-A5SE-01A,TCGA-EB-A5SE,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5232,27633.0,female,1931,black or african american,None,Primary Tumor,None,None,3.0,80.0,None,5.0,89.0,TCGA-34-5232-01A,TCGA-34-5232,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-6175,23228.0,female,1947,white,None,Primary Tumor,None,None,20.0,70.0,None,25.0,52.0,TCGA-85-6175-01A,TCGA-85-6175,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-52-7812,24887.0,male,1941,white,None,Primary Tumor,2.0,5.0,14.0,70.0,15.0,0.0,85.0,TCGA-52-7812-01A,TCGA-52-7812,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NK-A5CR,28126.0,male,1930,not reported,1961,Primary Tumor,0.0,5.0,10.0,60.0,5.0,30.0,50.0,TCGA-NK-A5CR-01A,TCGA-NK-A5CR,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PQ,21550.0,male,None,black or african american,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-UZ-A9PQ-01A,TCGA-UZ-A9PQ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SI,26719.0,female,1933,asian,2855,Primary Tumor,4.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-XF-A9SI-01A,TCGA-XF-A9SI,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A8O7,19063.0,male,1961,asian,97,Primary Tumor,3.0,1.0,0.0,90.0,8.0,15.0,82.0,TCGA-E7-A8O7-01A,TCGA-E7-A8O7,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-8311,22220.0,male,1952,white,None,Primary Tumor,None,None,None,90.0,None,None,None,TCGA-A4-8311-01A,TCGA-A4-8311,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A8OC,32872,male,None,white,None,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-UY-A8OC-01A,TCGA-UY-A8OC,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J8,18498.0,male,1957,white,2427,Primary Tumor,0.0,2.0,0.0,95.0,2.0,3.0,95.0,TCGA-2Z-A9J8-01A,TCGA-2Z-A9J8,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN4,28302.0,female,1930,white,2457,Primary Tumor,2.0,2.0,0.0,70.0,22.0,50.0,45.0,TCGA-XF-AAN4-01A,TCGA-XF-AAN4,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4726,25194.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,30.0,70.0,TCGA-CN-4726-01A,TCGA-CN-4726,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IA-A83T,29430.0,male,1925,white,2997,Primary Tumor,0.0,5.0,0.0,75.0,1.0,0.0,100.0,TCGA-IA-A83T-01A,TCGA-IA-A83T,
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4735,19107.0,male,1958,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,89.0,TCGA-CN-4735-01A,TCGA-CN-4735,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-Y8-A895,27139.0,male,1939,white,36,Primary Tumor,1.0,4.0,0.0,80.0,2.0,20.0,80.0,TCGA-Y8-A895-01A,TCGA-Y8-A895,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NM,30936.0,female,1920,white,3478,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-L5-A8NM-01A,TCGA-L5-A8NM,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6DA,15004.0,female,1971,white,366,Primary Tumor,1.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-BA-A6DA-01A,TCGA-BA-A6DA,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-A8YH,19051.0,male,1961,black or african american,125,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-B9-A8YH-01A,TCGA-B9-A8YH,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5878,29010.0,female,1926,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BQ-5878-01A,TCGA-BQ-5878,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FJ-A3ZE,23866.0,male,1947,white,42,Primary Tumor,2.0,1.0,0.0,85.0,4.0,14.0,85.0,TCGA-FJ-A3ZE-01A,TCGA-FJ-A3ZE,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J6,22265.0,male,1949,white,1703,Primary Tumor,0.0,3.0,0.0,94.0,2.0,5.0,80.0,TCGA-2Z-A9J6-01A,TCGA-2Z-A9J6,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5360,25034.0,male,1940,white,None,Primary Tumor,None,None,20.0,70.0,None,15.0,65.0,TCGA-CN-5360-01A,TCGA-CN-5360,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-5558,23984.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,83.0,TCGA-BA-5558-01A,TCGA-BA-5558,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NA-A4QX,22264.0,female,1949,white,1325,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-NA-A4QX-01A,TCGA-NA-A4QX,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A42C,23584.0,male,1947,white,274,Primary Tumor,0.0,0.0,0.0,92.0,1.0,28.0,70.0,TCGA-BT-A42C-01A,TCGA-BT-A42C,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7996,22559.0,female,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-A4-7996-01A,TCGA-A4-7996,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6DI,22857.0,male,1950,black or african american,414,Primary Tumor,1.0,0.0,15.0,75.0,3.0,0.0,85.0,TCGA-BA-A6DI-01A,TCGA-BA-A6DI,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E5-A4U1,26305.0,male,1939,not reported,504,Primary Tumor,0.0,0.0,5.0,90.0,0.0,5.0,90.0,TCGA-E5-A4U1-01A,TCGA-E5-A4U1,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OH,26180.0,male,1941,white,203,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,75.0,TCGA-L5-A4OH-01A,TCGA-L5-A4OH,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6218,19096.0,female,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CQ-6218-01A,TCGA-CQ-6218,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A55Z,24017.0,male,1946,black or african american,356,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-MH-A55Z-01A,TCGA-MH-A55Z,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5971,22279.0,male,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CV-5971-01A,TCGA-CV-5971,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-T2-A6X2,30013.0,male,1929,white,880,Primary Tumor,0.0,0.0,0.0,65.0,4.0,0.0,100.0,TCGA-T2-A6X2-01A,TCGA-T2-A6X2,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9RE,28622.0,female,1932,white,1364,Primary Tumor,2.0,0.0,0.0,85.0,8.0,35.0,55.0,TCGA-ZF-A9RE-01A,TCGA-ZF-A9RE,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-4P-AA8J,24222.0,male,1947,black or african american,120,Primary Tumor,0.0,0.0,0.0,70.0,10.0,40.0,60.0,TCGA-4P-AA8J-01A,TCGA-4P-AA8J,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4CD,25497.0,male,1942,white,442,Primary Tumor,2.0,2.0,0.0,60.0,8.0,50.0,33.0,TCGA-CQ-A4CD-01A,TCGA-CQ-A4CD,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A47Y,20432.0,male,1957,asian,130,Primary Tumor,0.0,0.0,0.0,99.0,0.0,5.0,95.0,TCGA-CF-A47Y-01A,TCGA-CF-A47Y,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-AATP,27049.0,male,1938,white,594,Primary Tumor,5.0,2.0,0.0,80.0,3.0,20.0,80.0,TCGA-GU-AATP-01A,TCGA-GU-AATP,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MT-A51X,10976.0,male,1982,white,77,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-MT-A51X-01A,TCGA-MT-A51X,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA87,26430.0,male,1938,black or african american,1159,Primary Tumor,0.0,0.0,0.0,90.0,7.0,43.0,50.0,TCGA-4Z-AA87-01A,TCGA-4Z-AA87,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JR,20932.0,male,1955,white,434,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-2Z-A9JR-01A,TCGA-2Z-A9JR,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A6MF,13867.0,male,1976,asian,114,Primary Tumor,0.0,2.0,5.0,90.0,2.0,5.0,90.0,TCGA-E7-A6MF-01A,TCGA-E7-A6MF,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6IF,22463.0,male,1952,white,55,Primary Tumor,0.0,0.0,55.0,60.0,4.0,0.0,45.0,TCGA-QK-A6IF-01A,TCGA-QK-A6IF,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7395,29527.0,female,1929,white,None,Primary Tumor,0.0,0.0,0.0,61.0,35.0,0.0,100.0,TCGA-CR-7395-01A,TCGA-CR-7395,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EO,18123.0,male,1964,white,284,Primary Tumor,3.0,3.0,0.0,70.0,25.0,35.0,50.0,TCGA-VR-A8EO-01A,TCGA-VR-A8EO,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4C7,32194.0,male,1922,white,866,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-CQ-A4C7-01A,TCGA-CQ-A4C7,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NF-A5CP,32871.0,female,1917,white,1980,Primary Tumor,20.0,20.0,0.0,90.0,40.0,10.0,90.0,TCGA-NF-A5CP-01A,TCGA-NF-A5CP,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R2,27537.0,male,1938,white,307,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ZF-A9R2-01A,TCGA-ZF-A9R2,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-F9-A7Q0,13523.0,female,1976,asian,90,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-F9-A7Q0-01A,TCGA-F9-A7Q0,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6228,25942.0,female,1938,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CQ-6228-01A,TCGA-CQ-6228,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA4U,25682.0,male,1938,white,1842,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-ZF-AA4U-01A,TCGA-ZF-AA4U,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A2EF,18467.0,male,1957,white,1485,Primary Tumor,0.0,3.0,0.0,75.0,4.0,25.0,60.0,TCGA-G2-A2EF-01A,TCGA-G2-A2EF,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A9PE,31755.0,male,None,white,None,Primary Tumor,5.0,1.0,0.0,75.0,2.0,23.0,75.0,TCGA-UY-A9PE-01A,TCGA-UY-A9PE,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N7-A4Y8,26650.0,female,1938,white,1057,Primary Tumor,0.0,0.0,0.0,100.0,0.0,5.0,85.0,TCGA-N7-A4Y8-01A,TCGA-N7-A4Y8,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4728,20660.0,male,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,70.0,TCGA-CN-4728-01A,TCGA-CN-4728,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A5KF,24528.0,male,1945,asian,107,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-E7-A5KF-01A,TCGA-E7-A5KF,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9Q0,21915.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-UZ-A9Q0-01A,TCGA-UZ-A9Q0,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SZ,29100.0,male,1928,white,2352,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-XF-A9SZ-01A,TCGA-XF-A9SZ,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7100,24183.0,male,1935,white,None,Primary Tumor,None,None,0.0,75.0,None,18.0,77.0,TCGA-CV-7100-01A,TCGA-CV-7100,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5440,19197.0,male,1950,white,None,Primary Tumor,None,None,0.0,70.0,None,40.0,60.0,TCGA-CV-5440-01A,TCGA-CV-5440,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7051,27120.0,male,1933,white,None,Primary Tumor,0.0,1.0,0.0,90.0,1.0,0.0,100.0,TCGA-BQ-7051-01A,TCGA-BQ-7051,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7415,22062.0,male,1935,white,None,Primary Tumor,0.0,0.0,0.0,75.0,5.0,0.0,100.0,TCGA-CV-7415-01A,TCGA-CV-7415,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-A5DU,16779.0,female,1967,white,44,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-A4-A5DU-01A,TCGA-A4-A5DU,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-F9-A7VF,27446.0,female,1938,white,66,Primary Tumor,4.0,8.0,0.0,80.0,8.0,20.0,70.0,TCGA-F9-A7VF-01A,TCGA-F9-A7VF,1.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NF-A4WU,21901.0,female,1952,white,629,Primary Tumor,40.0,20.0,0.0,80.0,20.0,20.0,80.0,TCGA-NF-A4WU-01A,TCGA-NF-A4WU,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A6EO,16185.0,male,1969,white,120,Primary Tumor,0.0,0.0,20.0,75.0,10.0,0.0,80.0,TCGA-D6-A6EO-01A,TCGA-D6-A6EO,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-7063,21723.0,female,1949,white,None,Primary Tumor,0.0,0.0,0.0,60.0,38.0,10.0,90.0,TCGA-CQ-7063-01A,TCGA-CQ-7063,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A6B2,25625.0,male,1942,white,472,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-DK-A6B2-01A,TCGA-DK-A6B2,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4733,22561.0,male,1949,white,None,Primary Tumor,5.0,0.0,0.0,40.0,50.0,10.0,90.0,TCGA-CN-4733-01A,TCGA-CN-4733,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5881,25481.0,male,1937,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,93.0,TCGA-BQ-5881-01A,TCGA-BQ-5881,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A6EP,22674.0,male,1951,white,107,Primary Tumor,0.0,0.0,0.0,75.0,7.0,0.0,97.0,TCGA-D6-A6EP-01A,TCGA-D6-A6EP,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-AA3J,25469.0,male,1944,black or african american,15,Primary Tumor,4.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-QK-AA3J-01A,TCGA-QK-AA3J,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A641,17454.0,male,1965,white,346,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-CN-A641-01A,TCGA-CN-A641,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-F9-A97G,29156.0,male,1934,asian,134,Primary Tumor,0.0,0.0,15.0,70.0,0.0,30.0,55.0,TCGA-F9-A97G-01A,TCGA-F9-A97G,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OE,29591.0,male,1930,white,308,Primary Tumor,0.0,0.0,10.0,70.0,7.0,20.0,70.0,TCGA-L5-A4OE-01A,TCGA-L5-A4OE,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N9-A4Q1,25791.0,female,1935,black or african american,2779,Primary Tumor,5.0,15.0,5.0,80.0,70.0,5.0,80.0,TCGA-N9-A4Q1-01A,TCGA-N9-A4Q1,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9RN,24795.0,female,1943,white,1184,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-ZF-A9RN-01A,TCGA-ZF-A9RN,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7369,21897.0,male,1949,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,75.0,TCGA-CR-7369-01A,TCGA-CR-7369,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5334,32024.0,male,1921,white,None,Primary Tumor,None,None,None,80.0,10.0,4.0,96.0,TCGA-CQ-5334-01A,TCGA-CQ-5334,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A6MD,24180.0,male,1946,white,221,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-E7-A6MD-01A,TCGA-E7-A6MD,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49O,17237.0,male,1964,asian,605,Primary Tumor,2.0,2.0,0.0,75.0,3.0,23.0,75.0,TCGA-LN-A49O-01A,TCGA-LN-A49O,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5882,20042.0,male,1953,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BQ-5882-01A,TCGA-BQ-5882,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5879,11862.0,female,1973,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,80.0,TCGA-BQ-5879-01A,TCGA-BQ-5879,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49P,26189.0,male,1940,asian,548,Primary Tumor,2.0,2.0,0.0,75.0,4.0,24.0,75.0,TCGA-LN-A49P-01A,TCGA-LN-A49P,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-KQ-A41N,26837.0,male,1938,black or african american,555,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-KQ-A41N-01A,TCGA-KQ-A41N,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6017,20358.0,male,1955,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-CN-6017-01A,TCGA-CN-6017,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-A5NF,21524.0,male,None,not reported,None,Primary Tumor,3.0,2.0,0.0,70.0,4.0,30.0,70.0,TCGA-HE-A5NF-01A,TCGA-HE-A5NF,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A55W,18573.0,male,1961,black or african american,672,Primary Tumor,0.0,3.0,0.0,80.0,1.0,0.0,100.0,TCGA-MH-A55W-01A,TCGA-MH-A55W,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NW,20194.0,male,1946,white,4395,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-L5-A8NW-01A,TCGA-L5-A8NW,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SJ,30362.0,male,1921,white,3298,Primary Tumor,5.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-XF-A9SJ-01A,TCGA-XF-A9SJ,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A4A4,13419.0,male,1975,asian,291,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,85.0,TCGA-LN-A4A4-01A,TCGA-LN-A4A4,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7367,19116.0,male,1956,white,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-CR-7367-01A,TCGA-CR-7367,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9K4,19986.0,male,1954,white,2111,Primary Tumor,0.0,7.0,0.0,75.0,1.0,0.0,100.0,TCGA-5P-A9K4-01A,TCGA-5P-A9K4,
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A3QL,19755.0,male,1957,white,262,Primary Tumor,0.0,1.0,0.0,100.0,1.0,18.0,80.0,TCGA-IG-A3QL-01A,TCGA-IG-A3QL,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6X,23208.0,male,1950,white,60,Primary Tumor,0.0,0.0,0.0,60.0,4.0,0.0,100.0,TCGA-DK-AA6X-01A,TCGA-DK-AA6X,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A4PL,30069.0,female,1929,white,672,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,93.0,TCGA-N8-A4PL-01A,TCGA-N8-A4PL,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5979,9567.0,male,1981,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CV-5979-01A,TCGA-CV-5979,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA56,28937.0,female,1931,white,1344,Primary Tumor,0.0,0.0,0.0,65.0,7.0,0.0,97.0,TCGA-ZF-AA56-01A,TCGA-ZF-AA56,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7R,26781.0,male,1937,black or african american,1189,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-4Z-AA7R-01A,TCGA-4Z-AA7R,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6021,23212.0,female,1947,white,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-CN-6021-01A,TCGA-CN-6021,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A62O,27310.0,male,1938,white,141,Primary Tumor,3.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-FD-A62O-01A,TCGA-FD-A62O,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5355,23670.0,male,1946,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-CN-5355-01A,TCGA-CN-5355,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-5N-A9KM,26906.0,female,1939,white,524,Primary Tumor,0.0,0.0,0.0,60.0,0.0,40.0,60.0,TCGA-5N-A9KM-01A,TCGA-5N-A9KM,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A6B5,16453.0,male,1965,white,984,Primary Tumor,0.0,0.0,0.0,80.0,3.0,20.0,80.0,TCGA-DK-A6B5-01A,TCGA-DK-A6B5,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A8O8,21629.0,male,1954,asian,105,Primary Tumor,1.0,1.0,0.0,95.0,3.0,8.0,90.0,TCGA-E7-A8O8-01A,TCGA-E7-A8O8,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-T2-A6WZ,19397.0,male,1959,white,406,Primary Tumor,2.0,0.0,0.0,65.0,10.0,0.0,100.0,TCGA-T2-A6WZ-01A,TCGA-T2-A6WZ,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-XP-A8T6,19886.0,male,1955,black or african american,1546,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-XP-A8T6-01A,TCGA-XP-A8T6,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3X1,28757.0,female,1931,white,1157,Primary Tumor,1.0,1.0,0.0,70.0,6.0,47.0,50.0,TCGA-DK-A3X1-01A,TCGA-DK-A3X1,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-WN-A9G9,None,male,1957,white,591,Primary Tumor,0.0,2.0,0.0,75.0,4.0,0.0,100.0,TCGA-WN-A9G9-01A,TCGA-WN-A9G9,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6998,19447.0,male,1958,white,None,Primary Tumor,None,None,0.0,70.0,None,60.0,None,TCGA-CN-6998-01A,TCGA-CN-6998,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A6EK,24558.0,male,1945,white,211,Primary Tumor,0.0,0.0,0.0,75.0,10.0,0.0,100.0,TCGA-D6-A6EK-01A,TCGA-D6-A6EK,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA4W,20611.0,male,1953,white,1742,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-ZF-AA4W-01A,TCGA-ZF-AA4W,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3B4,20379.0,female,1956,black or african american,141,Primary Tumor,0.0,0.0,0.0,80.0,2.0,35.0,55.0,TCGA-FD-A3B4-01A,TCGA-FD-A3B4,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3YS,22515.0,male,1951,white,90,Primary Tumor,2.0,2.0,0.0,80.0,4.0,20.0,80.0,TCGA-GC-A3YS-01A,TCGA-GC-A3YS,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JE,28658.0,male,1933,white,844,Primary Tumor,3.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-CV-A6JE-01A,TCGA-CV-A6JE,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-7065,14676.0,male,1969,asian,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,100.0,TCGA-CQ-7065-01A,TCGA-CQ-7065,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A63W,17693.0,female,1964,white,279,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-CN-A63W-01A,TCGA-CN-A63W,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7287,27621.0,female,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,85.0,TCGA-A4-7287-01A,TCGA-A4-7287,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6018,31242.0,female,1926,white,None,Primary Tumor,None,None,0.0,65.0,None,30.0,68.0,TCGA-CN-6018-01A,TCGA-CN-6018,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A56S,27519.0,female,1937,white,93,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-N8-A56S-01A,TCGA-N8-A56S,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-7632,24986.0,female,1943,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-IQ-7632-01A,TCGA-IQ-7632,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7062,23559.0,male,1947,black or african american,None,Primary Tumor,0.0,20.0,0.0,65.0,0.0,0.0,100.0,TCGA-BQ-7062-01A,TCGA-BQ-7062,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A43S,25993.0,female,1941,white,127,Primary Tumor,0.0,0.0,60.0,60.0,3.0,0.0,40.0,TCGA-FD-A43S-01A,TCGA-FD-A43S,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A5U7,16928.0,male,1966,asian,141,Primary Tumor,0.0,1.0,0.0,100.0,2.0,8.0,90.0,TCGA-LN-A5U7-01A,TCGA-LN-A5U7,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PL,21550.0,male,None,white,None,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-UZ-A9PL-01A,TCGA-UZ-A9PL,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PZ,23741.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-UZ-A9PZ-01A,TCGA-UZ-A9PZ,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A43J,32872,male,1921,white,391,Primary Tumor,0.0,0.0,30.0,65.0,2.0,0.0,70.0,TCGA-L5-A43J-01A,TCGA-L5-A43J,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-PJ-A5Z8,21968.0,female,1953,white,21,Primary Tumor,0.0,5.0,0.0,80.0,5.0,20.0,78.0,TCGA-PJ-A5Z8-01A,TCGA-PJ-A5Z8,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-AATQ,25185.0,male,1945,white,95,Primary Tumor,5.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-GU-AATQ-01A,TCGA-GU-AATQ,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6DJ,22967.0,male,1950,asian,388,Primary Tumor,1.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-BA-A6DJ-01A,TCGA-BA-A6DJ,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-S8-A6BV,28111.0,male,1936,white,261,Primary Tumor,2.0,2.0,0.0,75.0,8.0,60.0,35.0,TCGA-S8-A6BV-01A,TCGA-S8-A6BV,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-6792,14664.0,male,1967,black or african american,None,Primary Tumor,None,None,0.0,90.0,None,0.0,100.0,TCGA-G7-6792-01A,TCGA-G7-6792,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A71U,21079.0,male,1954,white,776,Primary Tumor,0.0,10.0,0.0,75.0,0.0,25.0,75.0,TCGA-SX-A71U-01A,TCGA-SX-A71U,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OJ,25657.0,female,1942,white,266,Primary Tumor,0.0,0.0,0.0,70.0,0.0,5.0,95.0,TCGA-L5-A4OJ-01A,TCGA-L5-A4OJ,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EP,18942.0,male,1962,white,248,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-VR-A8EP-01A,TCGA-VR-A8EP,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7W,20424.0,male,1957,white,518,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-4Z-AA7W-01A,TCGA-4Z-AA7W,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A59E,22650.0,female,1949,white,567,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-N5-A59E-01A,TCGA-N5-A59E,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T5,28977.0,female,1930,white,1364,Primary Tumor,0.0,0.0,0.0,65.0,10.0,0.0,100.0,TCGA-P3-A6T5-01A,TCGA-P3-A6T5,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-A5Y0,22341.0,female,1951,white,198,Primary Tumor,0.0,3.0,0.0,80.0,1.0,0.0,90.0,TCGA-A4-A5Y0-01A,TCGA-A4-A5Y0,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L7-A56G,24106.0,male,1947,black or african american,149,Primary Tumor,0.0,2.0,0.0,100.0,1.0,45.0,50.0,TCGA-L7-A56G-01A,TCGA-L7-A56G,
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6DD,16401.0,male,1969,black or african american,113,Primary Tumor,4.0,2.0,5.0,65.0,5.0,30.0,65.0,TCGA-BA-A6DD-01A,TCGA-BA-A6DD,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B1-5398,26820.0,male,1937,white,None,Primary Tumor,None,None,0.0,60.0,None,5.0,95.0,TCGA-B1-5398-01A,TCGA-B1-5398,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3QF,28890.0,male,1932,white,149,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,100.0,TCGA-GV-A3QF-01A,TCGA-GV-A3QF,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-5557,15247.0,female,1969,not reported,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-BA-5557-01A,TCGA-BA-5557,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A71V,29332.0,male,1931,white,630,Primary Tumor,0.0,10.0,0.0,75.0,0.0,25.0,75.0,TCGA-SX-A71V-01A,TCGA-SX-A71V,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A0YO,30817.0,male,1925,white,482,Primary Tumor,1.0,1.0,0.0,55.0,3.0,45.0,55.0,TCGA-CU-A0YO-01A,TCGA-CU-A0YO,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A7HY,18296.0,male,1963,asian,162,Primary Tumor,0.0,0.0,4.0,84.0,15.0,21.0,72.0,TCGA-LN-A7HY-01A,TCGA-LN-A7HY,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A8OB,23360.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-UY-A8OB-01A,TCGA-UY-A8OB,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6IG,25334.0,male,1944,white,45,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,100.0,TCGA-QK-A6IG-01A,TCGA-QK-A6IG,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JK,21696.0,male,1951,not reported,1302,Primary Tumor,0.0,4.0,10.0,80.0,4.0,20.0,70.0,TCGA-UF-A7JK-01A,TCGA-UF-A7JK,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-WA-A7GZ,21207.0,male,1954,white,258,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-WA-A7GZ-01A,TCGA-WA-A7GZ,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6VB,24144.0,male,1947,white,25,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,70.0,TCGA-QK-A6VB-01A,TCGA-QK-A6VB,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN5,22411.0,female,1947,white,2172,Primary Tumor,2.0,2.0,0.0,80.0,10.0,18.0,67.0,TCGA-XF-AAN5-01A,TCGA-XF-AAN5,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7397,16351.0,male,1967,white,None,Primary Tumor,0.0,0.0,0.0,90.0,5.0,0.0,100.0,TCGA-CR-7397-01A,TCGA-CR-7397,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-A6HZ,29045.0,female,1933,white,167,Primary Tumor,0.0,0.0,5.0,70.0,30.0,24.0,70.0,TCGA-HD-A6HZ-01A,TCGA-HD-A6HZ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-LT-A5Z6,20746.0,male,1957,white,14,Primary Tumor,5.0,2.0,0.0,65.0,9.0,33.0,65.0,TCGA-LT-A5Z6-01A,TCGA-LT-A5Z6,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A4PQ,27772.0,female,1936,white,173,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-N8-A4PQ-01A,TCGA-N8-A4PQ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9T2,19945.0,male,1953,white,2288,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-XF-A9T2-01A,TCGA-XF-A9T2,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A93F,21257.0,female,1954,white,394,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-JY-A93F-01A,TCGA-JY-A93F,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5332,32032.0,male,1921,white,None,Primary Tumor,5.0,1.0,0.0,70.0,20.0,0.0,90.0,TCGA-CQ-5332-01A,TCGA-CQ-5332,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6940,29382.0,female,1922,white,None,Primary Tumor,5.0,0.0,0.0,80.0,10.0,0.0,95.0,TCGA-CV-6940-01A,TCGA-CV-6940,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A8I1,24551.0,female,1946,asian,145,Primary Tumor,2.0,2.0,0.0,88.0,8.0,15.0,81.0,TCGA-LN-A8I1-01A,TCGA-LN-A8I1,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A43C,29753.0,male,1928,white,1091,Primary Tumor,0.0,0.0,0.0,85.0,2.0,18.0,80.0,TCGA-L5-A43C-01A,TCGA-L5-A43C,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5329,17028.0,female,1962,white,None,Primary Tumor,1.0,None,0.0,80.0,10.0,0.0,99.0,TCGA-CQ-5329-01A,TCGA-CQ-5329,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6516,25242.0,male,1941,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-D6-6516-01A,TCGA-D6-6516,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-5N-A9KI,27777.0,female,1935,white,903,Primary Tumor,5.0,1.0,0.0,80.0,2.0,19.0,80.0,TCGA-5N-A9KI-01A,TCGA-5N-A9KI,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-MV-A51V,27430.0,male,1937,white,171,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-MV-A51V-01A,TCGA-MV-A51V,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A4A9,21217.0,male,1954,asian,136,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,97.0,TCGA-LN-A4A9-01A,TCGA-LN-A4A9,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RM,22886.0,female,1948,white,830,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,85.0,TCGA-N5-A4RM-01A,TCGA-N5-A4RM,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A939,28181.0,male,1935,white,366,Primary Tumor,20.0,20.0,20.0,60.0,40.0,20.0,60.0,TCGA-JY-A939-01A,TCGA-JY-A939,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-KQ-A41O,30774.0,male,1927,not reported,475,Primary Tumor,0.0,0.0,0.0,80.0,3.0,20.0,80.0,TCGA-KQ-A41O-01A,TCGA-KQ-A41O,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-A5HY,23640.0,male,1948,white,141,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,80.0,TCGA-BB-A5HY-01A,TCGA-BB-A5HY,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A4PA,22614.0,male,1951,white,190,Primary Tumor,0.0,0.0,30.0,75.0,2.0,0.0,70.0,TCGA-85-A4PA-01A,TCGA-85-A4PA,1.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F4,15332.0,male,1972,white,316,Primary Tumor,0.0,0.0,0.0,88.0,10.0,0.0,98.0,TCGA-V4-A9F4-01A,TCGA-V4-A9F4,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8136,27193.0,female,1928,not reported,None,Primary Tumor,None,None,None,60.0,None,None,None,TCGA-77-8136-01A,TCGA-77-8136,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-90-A4EE,19676.0,male,1959,white,136,Primary Tumor,0.0,3.0,10.0,70.0,12.0,30.0,40.0,TCGA-90-A4EE-01A,TCGA-90-A4EE,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2737,26390.0,male,1933,not reported,None,Primary Tumor,None,None,25.0,60.0,25.0,30.0,40.0,TCGA-66-2737-01A,TCGA-66-2737,2.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A885,21978.0,male,1953,white,196,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-WC-A885-01A,TCGA-WC-A885,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P6,23485.0,female,1946,white,249,Primary Tumor,1.0,1.0,0.0,85.0,2.0,14.0,85.0,TCGA-EW-A1P6-01A,TCGA-EW-A1P6,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8668,22383.0,female,1951,white,None,Primary Tumor,5.0,0.0,0.0,65.0,20.0,0.0,100.0,TCGA-86-8668-01A,TCGA-86-8668,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6980,None,male,1950,white,None,Primary Tumor,None,None,0.0,60.0,None,40.0,60.0,TCGA-55-6980-01A,TCGA-55-6980,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09G,29006.0,female,1929,not reported,759,Primary Tumor,0.0,0.0,0.0,85.0,5.0,9.0,90.0,TCGA-A8-A09G-01A,TCGA-A8-A09G,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66J,29345.0,female,1928,white,1645,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-OL-A66J-01A,TCGA-OL-A66J,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JH,20497.0,female,1954,white,263,Primary Tumor,1.0,1.0,2.0,60.0,5.0,38.0,60.0,TCGA-D8-A1JH-01A,TCGA-D8-A1JH,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A3XG,16948.0,female,1963,white,899,Primary Tumor,0.0,0.0,20.0,60.0,1.0,30.0,50.0,TCGA-GM-A3XG-01A,TCGA-GM-A3XG,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1J5,21559.0,female,1951,white,123,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-EW-A1J5-01A,TCGA-EW-A1J5,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7552,25578.0,male,1937,white,None,Primary Tumor,None,5.0,35.0,50.0,20.0,None,65.0,TCGA-97-7552-01A,TCGA-97-7552,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-UU-A93S,23278.0,female,1950,black or african american,22,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-UU-A93S-01A,TCGA-UU-A93S,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N5,16736.0,female,1965,white,63,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E9-A1N5-01A,TCGA-E9-A1N5,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8513,28284.0,female,1935,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-55-8513-01A,TCGA-55-8513,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24S,22587.0,female,1945,white,1812,Primary Tumor,0.0,0.0,0.0,85.0,4.0,40.0,60.0,TCGA-AR-A24S-01A,TCGA-AR-A24S,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A3XN,16109.0,female,1963,white,1627,Primary Tumor,0.0,0.0,0.0,82.0,0.0,0.0,100.0,TCGA-GM-A3XN-01A,TCGA-GM-A3XN,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-PE-A5DE,15216.0,female,1966,white,2066,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-PE-A5DE-01A,TCGA-PE-A5DE,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27H,26588.0,female,1939,white,84,Primary Tumor,0.0,0.0,1.0,94.0,0.0,0.0,99.0,TCGA-D8-A27H-01A,TCGA-D8-A27H,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-YY-A8LH,22376.0,female,1948,white,1717,Primary Tumor,20.0,20.0,0.0,40.0,40.0,50.0,40.0,TCGA-YY-A8LH-01A,TCGA-YY-A8LH,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-8648,21443.0,female,1944,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-78-8648-01A,TCGA-78-8648,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CQ,22810.0,female,1941,black or african american,2310,Primary Tumor,0.0,1.0,0.0,65.0,15.0,32.0,65.0,TCGA-A2-A0CQ-01A,TCGA-A2-A0CQ,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-XD-AAUG,24291.0,female,1947,white,67,Primary Tumor,10.0,10.0,20.0,50.0,70.0,30.0,50.0,TCGA-XD-AAUG-01A,TCGA-XD-AAUG,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A26G,18362.0,female,1960,black or african american,161,Primary Tumor,0.0,0.0,0.0,60.0,100.0,60.0,40.0,TCGA-A7-A26G-01A,TCGA-A7-A26G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N3,25714.0,female,1940,white,65,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-E9-A1N3-01A,TCGA-E9-A1N3,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FV,21479.0,female,1952,white,42,Primary Tumor,0.0,0.0,0.0,70.0,0.0,50.0,50.0,TCGA-AN-A0FV-01A,TCGA-AN-A0FV,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-A4JF,20491.0,male,1956,white,140,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,95.0,TCGA-86-A4JF-01A,TCGA-86-A4JF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0E7,29115.0,female,1927,white,1259,Primary Tumor,0.0,0.0,0.0,90.0,0.0,19.0,80.0,TCGA-BH-A0E7-01A,TCGA-BH-A0E7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0A2,24380.0,female,1943,not reported,394,Primary Tumor,0.0,0.0,0.0,80.0,2.0,19.0,80.0,TCGA-A8-A0A2-01A,TCGA-A8-A0A2,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1FV,27287.0,female,1936,white,372,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-A2-A1FV-01A,TCGA-A2-A1FV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09N,21002.0,female,1949,not reported,1276,Primary Tumor,0.0,0.0,22.0,85.0,10.0,2.0,75.0,TCGA-A8-A09N-01A,TCGA-A8-A09N,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A4RW,18060.0,female,1962,white,567,Primary Tumor,10.0,10.0,0.0,60.0,40.0,30.0,60.0,TCGA-A2-A4RW-01A,TCGA-A2-A4RW,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RE,22449.0,female,1928,black or african american,7492,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-B6-A0RE-01A,TCGA-B6-A0RE,
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9J0,27453.0,male,1937,white,408,Primary Tumor,5.0,3.0,0.0,60.0,3.0,35.0,60.0,TCGA-3A-A9J0-01A,TCGA-3A-A9J0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5RX,18942.0,female,1960,black or african american,561,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-OL-A5RX-01A,TCGA-OL-A5RX,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1L7,14854.0,female,1969,white,548,Primary Tumor,0.0,0.0,0.0,60.0,0.0,25.0,75.0,TCGA-E2-A1L7-01A,TCGA-E2-A1L7,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-5T-A9QA,19031.0,female,1961,black or african american,31,Primary Tumor,0.0,0.0,20.0,75.0,5.0,5.0,75.0,TCGA-5T-A9QA-01A,TCGA-5T-A9QA,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27L,18025.0,female,1962,white,84,Primary Tumor,0.0,0.0,0.0,60.0,0.0,15.0,85.0,TCGA-D8-A27L-01A,TCGA-D8-A27L,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A3J1,23209.0,female,1948,white,49,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-A7-A3J1-01A,TCGA-A7-A3J1,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TP,15812.0,female,1960,white,2512,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,80.0,TCGA-AR-A0TP-01A,TCGA-AR-A0TP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N6,19327.0,female,1958,white,63,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E9-A1N6-01A,TCGA-E9-A1N6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CV,15289.0,female,1964,asian,1574,Primary Tumor,30.0,25.0,0.0,70.0,20.0,20.0,70.0,TCGA-A2-A0CV-01A,TCGA-A2-A0CV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-5L-AAT1,23225.0,female,1947,white,1259,Primary Tumor,20.0,20.0,0.0,60.0,40.0,35.0,60.0,TCGA-5L-AAT1-01A,TCGA-5L-AAT1,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A26V,17468.0,female,1963,asian,143,Primary Tumor,0.0,0.0,0.0,95.0,1.0,10.0,88.0,TCGA-C8-A26V-01A,TCGA-C8-A26V,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IU,22279.0,female,1950,white,136,Primary Tumor,30.0,20.0,0.0,60.0,30.0,30.0,60.0,TCGA-E2-A1IU-01A,TCGA-E2-A1IU,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7923,23760.0,male,1946,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HZ-7923-01A,TCGA-HZ-7923,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3W5,24029.0,female,1946,black or african american,120,Primary Tumor,0.0,0.0,10.0,75.0,0.0,0.0,90.0,TCGA-AC-A3W5-01A,TCGA-AC-A3W5,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4486,26415.0,male,1920,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,94.0,TCGA-49-4486-01A,TCGA-49-4486,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7166,30869.0,male,1918,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,65.0,TCGA-78-7166-01A,TCGA-78-7166,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CO,31404.0,female,1917,white,2709,Primary Tumor,0.0,0.0,0.0,50.0,0.0,60.0,40.0,TCGA-A2-A0CO-01A,TCGA-A2-A0CO,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7535,16571.0,male,1955,white,None,Primary Tumor,0.0,5.0,0.0,80.0,5.0,0.0,100.0,TCGA-78-7535-01A,TCGA-78-7535,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABO,15869.0,male,1970,white,314,Primary Tumor,10.0,2.0,5.0,35.0,12.0,60.0,35.0,TCGA-2J-AABO-01A,TCGA-2J-AABO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CX,19152.0,female,1954,white,1316,Primary Tumor,0.0,0.0,0.0,60.0,0.0,10.0,90.0,TCGA-A2-A0CX-01A,TCGA-A2-A0CX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FE,22746.0,female,1943,white,2228,Primary Tumor,0.0,0.0,40.0,75.0,0.0,25.0,35.0,TCGA-AC-A2FE-01A,TCGA-AC-A2FE,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A440,22497.0,female,1951,white,32,Primary Tumor,0.0,0.0,10.0,65.0,5.0,0.0,90.0,TCGA-LL-A440-01A,TCGA-LL-A440,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A3M8,24877.0,female,1943,asian,264,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-C8-A3M8-01A,TCGA-C8-A3M8,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IE,22510.0,female,1947,white,938,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-E2-A1IE-01A,TCGA-E2-A1IE,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8638,30821.0,female,1928,white,None,Primary Tumor,0.0,0.0,0.0,80.0,19.0,0.0,100.0,TCGA-HZ-8638-01A,TCGA-HZ-8638,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AARN,20605.0,female,1944,black or african american,4882,Primary Tumor,0.0,2.0,10.0,60.0,2.0,25.0,60.0,TCGA-49-AARN-01A,TCGA-49-AARN,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5051,15585.0,female,1965,white,None,Primary Tumor,None,None,10.0,80.0,None,10.0,80.0,TCGA-50-5051-01A,TCGA-50-5051,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RL,22238.0,female,1933,black or african american,6336,Primary Tumor,0.0,0.0,0.0,75.0,2.0,24.0,75.0,TCGA-B6-A0RL-01A,TCGA-B6-A0RL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-HN-A2OB,16672.0,female,None,not reported,None,Primary Tumor,0.0,0.0,20.0,65.0,0.0,20.0,60.0,TCGA-HN-A2OB-01A,TCGA-HN-A2OB,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0GZ,22714.0,female,1947,white,206,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-BH-A0GZ-01A,TCGA-BH-A0GZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FF,11929.0,female,1978,white,75,Primary Tumor,0.0,0.0,0.0,90.0,1.0,15.0,85.0,TCGA-AN-A0FF-01A,TCGA-AN-A0FF,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1OZ,20664.0,female,1952,black or african american,928,Primary Tumor,0.0,0.0,10.0,75.0,10.0,26.0,64.0,TCGA-EW-A1OZ-01A,TCGA-EW-A1OZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2BM,15212.0,female,1964,black or african american,2164,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,80.0,TCGA-AC-A2BM-01A,TCGA-AC-A2BM,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4M5,30665.0,male,1929,white,104,Primary Tumor,1.0,3.0,18.0,75.0,3.0,27.0,35.0,TCGA-97-A4M5-01A,TCGA-97-A4M5,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1FZ,23055.0,female,1947,white,335,Primary Tumor,0.0,0.0,0.0,75.0,0.0,45.0,55.0,TCGA-A2-A1FZ-01A,TCGA-A2-A1FZ,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7897,19718.0,female,1955,white,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-IB-7897-01A,TCGA-IB-7897,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A26X,21463.0,female,1952,asian,136,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-C8-A26X-01A,TCGA-C8-A26X,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EU,30339.0,female,1916,white,4106,Primary Tumor,0.0,0.0,5.0,65.0,0.0,10.0,85.0,TCGA-BH-A1EU-01A,TCGA-BH-A1EU,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1FX,22344.0,female,1947,white,937,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-A2-A1FX-01A,TCGA-A2-A1FX,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1FW,22779.0,female,1948,white,198,Primary Tumor,0.0,0.0,10.0,75.0,0.0,30.0,60.0,TCGA-A2-A1FW-01A,TCGA-A2-A1FW,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-UL-AAZ6,26999.0,female,1940,black or african american,187,Primary Tumor,0.0,0.0,5.0,70.0,5.0,25.0,70.0,TCGA-UL-AAZ6-01A,TCGA-UL-AAZ6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A093,22373.0,female,1948,not reported,422,Primary Tumor,0.0,0.0,59.0,60.0,10.0,0.0,40.0,TCGA-A8-A093-01A,TCGA-A8-A093,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A10F,17257.0,female,1961,white,801,Primary Tumor,0.0,0.0,0.0,60.0,0.0,60.0,40.0,TCGA-E2-A10F-01A,TCGA-E2-A10F,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-A6ZG,26141.0,female,1942,black or african american,102,Primary Tumor,2.0,3.0,20.0,60.0,10.0,20.0,60.0,TCGA-S3-A6ZG-01A,TCGA-S3-A6ZG,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUS,30684.0,female,1929,white,70,Primary Tumor,0.0,1.0,0.0,60.0,8.0,0.0,100.0,TCGA-IB-AAUS-01A,TCGA-IB-AAUS,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A1KF,24891.0,female,1930,white,4536,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-B6-A1KF-01A,TCGA-B6-A1KF,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4659,24253.0,male,1940,white,None,Primary Tumor,None,None,30.0,80.0,None,10.0,60.0,TCGA-73-4659-01A,TCGA-73-4659,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JI,20072.0,female,1956,white,226,Primary Tumor,0.0,1.0,0.0,95.0,1.0,5.0,95.0,TCGA-D8-A1JI-01A,TCGA-D8-A1JI,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-7109,21979.0,male,1951,white,None,Primary Tumor,0.0,5.0,3.0,60.0,1.0,10.0,80.0,TCGA-50-7109-01A,TCGA-50-7109,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YF,24660.0,female,1942,black or african american,343,Primary Tumor,0.0,0.0,0.0,92.0,0.0,15.0,80.0,TCGA-A2-A0YF-01A,TCGA-A2-A0YF,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUQ,18315.0,male,1963,white,79,Primary Tumor,20.0,20.0,0.0,40.0,40.0,40.0,40.0,TCGA-IB-AAUQ-01A,TCGA-IB-AAUQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A25A,16084.0,female,1959,white,2927,Primary Tumor,0.0,0.0,2.0,80.0,1.0,28.0,70.0,TCGA-A2-A25A-01A,TCGA-A2-A25A,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-1677,28482.0,female,1928,white,None,Primary Tumor,None,None,5.0,90.0,None,13.0,80.0,TCGA-64-1677-01A,TCGA-64-1677,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TU,13039.0,female,1971,not reported,1633,Primary Tumor,0.0,0.0,0.0,96.0,3.0,2.0,75.0,TCGA-AR-A0TU-01A,TCGA-AR-A0TU,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4397,23833.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,75.0,None,5.0,None,TCGA-05-4397-01A,TCGA-05-4397,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-Z7-A8R6,16955.0,female,1959,white,3020,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-Z7-A8R6-01A,TCGA-Z7-A8R6,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8359,19088.0,male,1960,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-86-8359-01A,TCGA-86-8359,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HF,None,female,1962,asian,109,Primary Tumor,0.0,0.0,0.0,95.0,1.0,0.0,99.0,TCGA-C8-A1HF-01A,TCGA-C8-A1HF,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7289,28174.0,male,1933,white,None,Primary Tumor,None,None,0.0,65.0,None,60.0,40.0,TCGA-HZ-7289-01A,TCGA-HZ-7289,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A128,22340.0,female,1941,white,2960,Primary Tumor,0.0,0.0,0.0,93.0,5.0,6.0,93.0,TCGA-AO-A128-01A,TCGA-AO-A128,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-F2-A44G,29150.0,female,1933,white,105,Primary Tumor,1.0,5.0,60.0,30.0,10.0,0.0,40.0,TCGA-F2-A44G-01A,TCGA-F2-A44G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YG,23058.0,female,1946,white,329,Primary Tumor,1.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-A2-A0YG-01A,TCGA-A2-A0YG,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08L,32842.0,female,1919,not reported,698,Primary Tumor,0.0,0.0,0.0,75.0,13.0,40.0,60.0,TCGA-A8-A08L-01A,TCGA-A8-A08L,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A076,24230.0,female,1940,not reported,1518,Primary Tumor,0.0,0.0,0.0,85.0,10.0,15.0,85.0,TCGA-A8-A076-01A,TCGA-A8-A076,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7941,26298.0,female,1939,white,None,Primary Tumor,0.0,5.0,5.0,80.0,5.0,0.0,95.0,TCGA-97-7941-01A,TCGA-97-7941,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-XD-AAUH,20858.0,female,1956,white,43,Primary Tumor,10.0,10.0,10.0,60.0,70.0,30.0,60.0,TCGA-XD-AAUH-01A,TCGA-XD-AAUH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12M,25811.0,female,1940,asian,57,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-C8-A12M-01A,TCGA-C8-A12M,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FJ,21910.0,female,1951,white,70,Primary Tumor,0.0,0.0,0.0,85.0,1.0,18.0,80.0,TCGA-AN-A0FJ-01A,TCGA-AN-A0FJ,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66I,13458.0,female,1972,black or african american,1715,Primary Tumor,0.0,0.0,5.0,75.0,3.0,0.0,95.0,TCGA-OL-A66I-01A,TCGA-OL-A66I,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0WW,21479.0,female,1939,black or african american,4664,Primary Tumor,2.0,1.0,2.0,80.0,3.0,18.0,80.0,TCGA-B6-A0WW-01A,TCGA-B6-A0WW,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18H,23065.0,female,1947,white,16,Primary Tumor,0.0,0.0,5.0,60.0,10.0,35.0,50.0,TCGA-BH-A18H-01A,TCGA-BH-A18H,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A145,29280.0,female,1930,white,191,Primary Tumor,0.0,0.0,10.0,75.0,0.0,30.0,60.0,TCGA-D8-A145-01A,TCGA-D8-A145,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27K,17426.0,female,1964,white,77,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-D8-A27K-01A,TCGA-D8-A27K,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8001,25227.0,male,1942,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HZ-8001-01A,TCGA-HZ-8001,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAPS,22981.0,female,1946,white,2035,Primary Tumor,10.0,10.0,0.0,70.0,70.0,30.0,70.0,TCGA-FB-AAPS-01A,TCGA-FB-AAPS,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2B8,31003.0,female,1927,white,101,Primary Tumor,0.0,0.0,1.0,75.0,1.0,43.0,55.0,TCGA-AC-A2B8-01A,TCGA-AC-A2B8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15F,23660.0,female,1945,white,360,Primary Tumor,1.0,1.0,2.0,70.0,2.0,27.0,70.0,TCGA-E2-A15F-01A,TCGA-E2-A15F,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YH,19596.0,female,1956,white,321,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-A2-A0YH-01A,TCGA-A2-A0YH,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A62Y,28876.0,female,1933,white,112,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-AC-A62Y-01A,TCGA-AC-A62Y,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AAR3,25469.0,male,1939,black or african american,1927,Primary Tumor,5.0,3.0,0.0,75.0,3.0,23.0,75.0,TCGA-49-AAR3-01A,TCGA-49-AAR3,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XN,25029.0,female,1942,white,163,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-AN-A0XN-01A,TCGA-AN-A0XN,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1F6,18691.0,female,1945,white,5230,Primary Tumor,0.0,0.0,10.0,80.0,2.0,35.0,55.0,TCGA-BH-A1F6-01A,TCGA-BH-A1F6,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FF,None,female,1966,asian,1904,Primary Tumor,0.0,0.0,3.0,80.0,2.0,37.0,60.0,TCGA-AC-A2FF-01A,TCGA-AC-A2FF,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-6216,20967.0,female,1953,white,None,Primary Tumor,None,None,0.0,40.0,None,30.0,70.0,TCGA-67-6216-01A,TCGA-67-6216,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-A5VM,27362.0,male,1938,white,91,Primary Tumor,0.0,0.0,5.0,65.0,5.0,0.0,95.0,TCGA-FB-A5VM-01A,TCGA-FB-A5VM,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7764,27693.0,male,1935,white,None,Primary Tumor,0.0,0.0,10.0,80.0,10.0,0.0,90.0,TCGA-69-7764-01A,TCGA-69-7764,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15D,17224.0,female,1962,white,393,Primary Tumor,0.0,0.0,5.0,70.0,2.0,60.0,35.0,TCGA-E2-A15D-01A,TCGA-E2-A15D,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A25E,12601.0,female,1970,black or african american,2441,Primary Tumor,0.0,0.0,0.0,85.0,5.0,26.0,72.0,TCGA-A2-A25E-01A,TCGA-A2-A25E,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A249,16689.0,female,1966,white,59,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-E9-A249-01A,TCGA-E9-A249,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IV,21732.0,female,1952,white,787,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-3A-A9IV-01A,TCGA-3A-A9IV,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4390,21430.0,female,1947,not reported,None,Primary Tumor,None,None,0.0,73.0,10.0,20.0,70.0,TCGA-05-4390-01A,TCGA-05-4390,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DO,19842.0,female,1952,black or african american,1932,Primary Tumor,0.0,0.0,0.0,90.0,2.0,20.0,77.0,TCGA-GM-A2DO-01A,TCGA-GM-A2DO,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A131,29966.0,female,1928,asian,163,Primary Tumor,20.0,20.0,0.0,60.0,40.0,20.0,60.0,TCGA-C8-A131-01A,TCGA-C8-A131,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0E2,18152.0,female,1960,black or african american,210,Primary Tumor,0.0,2.0,0.0,85.0,2.0,8.0,90.0,TCGA-BH-A0E2-01A,TCGA-BH-A0E2,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4M6,16764.0,female,1967,white,115,Primary Tumor,1.0,4.0,33.0,75.0,6.0,22.0,41.0,TCGA-97-A4M6-01A,TCGA-97-A4M6,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5RV,15820.0,female,1968,black or african american,755,Primary Tumor,0.0,0.0,4.0,70.0,5.0,71.0,25.0,TCGA-OL-A5RV-01A,TCGA-OL-A5RV,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4TF,21387.0,female,1952,white,784,Primary Tumor,0.0,0.0,0.0,88.0,0.0,0.0,85.0,TCGA-MP-A4TF-01A,TCGA-MP-A4TF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08R,19298.0,female,1956,not reported,728,Primary Tumor,0.0,0.0,0.0,70.0,10.0,12.0,85.0,TCGA-A8-A08R-01A,TCGA-A8-A08R,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LH,20288.0,female,1952,white,1661,Primary Tumor,0.0,1.0,3.0,80.0,1.0,47.0,50.0,TCGA-AR-A2LH-01A,TCGA-AR-A2LH,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-MS-A51U,16213.0,female,1968,white,129,Primary Tumor,0.0,0.0,20.0,65.0,1.0,50.0,30.0,TCGA-MS-A51U-01A,TCGA-MS-A51U,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TX,23653.0,female,1941,not reported,1976,Primary Tumor,0.0,0.0,0.0,80.0,3.0,19.0,80.0,TCGA-AR-A0TX-01A,TCGA-AR-A0TX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LD-A74U,28981.0,female,1934,white,59,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-LD-A74U-01A,TCGA-LD-A74U,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-PL-A8LX,12840.0,female,1978,black or african american,74,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-PL-A8LX-01A,TCGA-PL-A8LX,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TY,19836.0,female,1950,white,2141,Primary Tumor,0.0,0.0,10.0,0.0,3.0,90.0,0.0,TCGA-AR-A0TY-01A,TCGA-AR-A0TY,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7220,19480.0,female,1947,white,None,Primary Tumor,None,None,8.0,80.0,None,5.0,79.0,TCGA-78-7220-01A,TCGA-78-7220,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAPP,26239.0,male,1938,white,1790,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-FB-AAPP-01A,TCGA-FB-AAPP,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A494,22540.0,female,1951,white,28,Primary Tumor,0.0,0.0,0.0,90.0,1.0,19.0,80.0,TCGA-55-A494-01A,TCGA-55-A494,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L9-A8F4,23617.0,female,1949,black or african american,93,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-L9-A8F4-01A,TCGA-L9-A8F4,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-7910,18289.0,female,1961,black or african american,None,Primary Tumor,None,None,5.0,75.0,None,10.0,75.0,TCGA-55-7910-01A,TCGA-55-7910,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A13Z,18942.0,female,1959,white,214,Primary Tumor,0.0,0.0,2.0,70.0,3.0,43.0,35.0,TCGA-D8-A13Z-01A,TCGA-D8-A13Z,
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUN,27128.0,female,1939,white,97,Primary Tumor,6.0,1.0,40.0,10.0,3.0,50.0,10.0,TCGA-IB-AAUN-01A,TCGA-IB-AAUN,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IE,13982.0,female,1957,black or african american,5557,Primary Tumor,0.0,0.0,0.0,70.0,2.0,28.0,70.0,TCGA-B6-A0IE-01A,TCGA-B6-A0IE,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUU,13127.0,male,1978,white,16,Primary Tumor,0.0,0.0,0.0,25.0,10.0,0.0,100.0,TCGA-IB-AAUU-01A,TCGA-IB-AAUU,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-71-6725,17793.0,female,1963,asian,None,Primary Tumor,None,None,5.0,80.0,None,10.0,85.0,TCGA-71-6725-01A,TCGA-71-6725,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08C,24017.0,female,1943,not reported,484,Primary Tumor,0.0,0.0,0.0,90.0,3.0,20.0,78.0,TCGA-A8-A08C-01A,TCGA-A8-A08C,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A6UG,23751.0,male,1947,white,254,Primary Tumor,0.0,0.0,40.0,35.0,0.0,35.0,25.0,TCGA-IB-A6UG-01A,TCGA-IB-A6UG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A126,14264.0,female,1963,asian,3033,Primary Tumor,0.0,0.0,0.0,90.0,1.0,19.0,80.0,TCGA-AO-A126-01A,TCGA-AO-A126,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4506,25132.0,female,1929,white,None,Primary Tumor,None,None,0.0,70.0,None,5.0,95.0,TCGA-49-4506-01A,TCGA-49-4506,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18K,16824.0,female,1953,white,4011,Primary Tumor,0.0,0.0,10.0,80.0,0.0,10.0,80.0,TCGA-BH-A18K-01A,TCGA-BH-A18K,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0SX,17774.0,female,1959,white,1177,Primary Tumor,1.0,0.0,0.0,70.0,20.0,23.0,75.0,TCGA-A2-A0SX-01A,TCGA-A2-A0SX,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XT,22448.0,female,1949,white,144,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-D8-A1XT-01A,TCGA-D8-A1XT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07G,23926.0,female,1944,not reported,453,Primary Tumor,0.0,0.0,0.0,70.0,15.0,38.0,60.0,TCGA-A8-A07G-01A,TCGA-A8-A07G,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4382,24868.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,None,TCGA-05-4382-01A,TCGA-05-4382,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-A4SS,26991.0,male,1939,white,86,Primary Tumor,0.0,0.0,10.0,70.0,7.0,20.0,70.0,TCGA-44-A4SS-01A,TCGA-44-A4SS,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A8OR,27605.0,female,1938,white,98,Primary Tumor,0.0,0.0,0.0,96.0,1.0,5.0,95.0,TCGA-AC-A8OR-01A,TCGA-AC-A8OR,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XB,22976.0,female,1948,white,251,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-D8-A1XB-01A,TCGA-D8-A1XB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8056,23369.0,female,1948,white,None,Primary Tumor,None,None,2.0,90.0,3.0,4.0,92.0,TCGA-86-8056-01A,TCGA-86-8056,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0X4,22688.0,female,1934,white,5323,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-B6-A0X4-01A,TCGA-B6-A0X4,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAQ3,23953.0,female,1945,white,1275,Primary Tumor,0.0,0.0,0.0,60.0,3.0,0.0,100.0,TCGA-FB-AAQ3-01A,TCGA-FB-AAQ3,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AY,23927.0,female,1943,white,1085,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-AR-A1AY-01A,TCGA-AR-A1AY,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FB,21933.0,female,1940,white,3871,Primary Tumor,1.0,1.0,4.0,70.0,4.0,26.0,70.0,TCGA-BH-A1FB-01A,TCGA-BH-A1FB,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HN,24731.0,female,1942,white,359,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-BH-A0HN-01A,TCGA-BH-A0HN,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8175,20206.0,female,1956,white,None,Primary Tumor,5.0,None,0.0,70.0,20.0,0.0,100.0,TCGA-97-8175-01A,TCGA-97-8175,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06N,24288.0,female,1943,not reported,241,Primary Tumor,0.0,0.0,0.0,90.0,1.0,40.0,53.0,TCGA-A8-A06N-01A,TCGA-A8-A06N,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4426,26084.0,male,1937,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,88.0,TCGA-05-4426-01A,TCGA-05-4426,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XT,16649.0,female,1961,black or african american,2164,Primary Tumor,0.0,0.0,0.0,85.0,0.0,35.0,65.0,TCGA-A2-A3XT-01A,TCGA-A2-A3XT,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-93-A4JQ,17951.0,male,1963,white,57,Primary Tumor,2.0,2.0,0.0,75.0,5.0,25.0,75.0,TCGA-93-A4JQ-01A,TCGA-93-A4JQ,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MN-A4N5,23257.0,male,1948,white,408,Primary Tumor,0.0,2.0,0.0,80.0,2.0,0.0,100.0,TCGA-MN-A4N5-01A,TCGA-MN-A4N5,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RU,14920.0,female,1950,white,7290,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-B6-A0RU-01A,TCGA-B6-A0RU,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A12D,15774.0,female,1962,white,1948,Primary Tumor,0.0,0.0,0.0,90.0,3.0,14.0,85.0,TCGA-AO-A12D-01A,TCGA-AO-A12D,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6831,24436.0,male,1935,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,65.0,TCGA-91-6831-01A,TCGA-91-6831,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AP,29406.0,female,1927,white,1450,Primary Tumor,0.0,0.0,5.0,90.0,0.0,0.0,95.0,TCGA-AR-A1AP-01A,TCGA-AR-A1AP,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0ER,23021.0,female,1942,white,1862,Primary Tumor,0.0,1.0,34.0,60.0,6.0,5.0,60.0,TCGA-A2-A0ER-01A,TCGA-A2-A0ER,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0AS,25658.0,female,1940,white,33,Primary Tumor,0.0,0.0,3.0,73.0,13.0,28.0,65.0,TCGA-AN-A0AS-01A,TCGA-AN-A0AS,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-8497,27632.0,female,1937,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,80.0,TCGA-91-8497-01A,TCGA-91-8497,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0WZ,18584.0,female,1946,black or african american,5179,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-B6-A0WZ-01A,TCGA-B6-A0WZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12K,29463.0,female,1930,asian,57,Primary Tumor,0.0,0.0,0.0,70.0,0.0,5.0,65.0,TCGA-C8-A12K-01A,TCGA-C8-A12K,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7156,22720.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-78-7156-01A,TCGA-78-7156,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A099,28063.0,female,1933,not reported,180,Primary Tumor,0.0,0.0,0.0,85.0,2.0,17.0,80.0,TCGA-A8-A099-01A,TCGA-A8-A099,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24M,14119.0,female,1967,white,2245,Primary Tumor,1.0,1.0,2.0,75.0,4.0,23.0,75.0,TCGA-AR-A24M-01A,TCGA-AR-A24M,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18L,18519.0,female,1953,white,2669,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-BH-A18L-01A,TCGA-BH-A18L,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0SW,30085.0,female,1924,white,1337,Primary Tumor,0.0,0.0,0.0,88.0,1.0,20.0,80.0,TCGA-A2-A0SW-01A,TCGA-A2-A0SW,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-8662,19563.0,female,1947,not reported,None,Primary Tumor,None,None,23.0,70.0,None,10.0,67.0,TCGA-78-8662-01A,TCGA-78-8662,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0X7,22723.0,female,1932,white,6002,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-B6-A0X7-01A,TCGA-B6-A0X7,
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7926,21024.0,male,1954,black or african american,None,Primary Tumor,None,None,None,20.0,None,None,None,TCGA-HZ-7926-01A,TCGA-HZ-7926,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4433,30194.0,male,1926,not reported,None,Primary Tumor,None,None,20.0,70.0,None,10.0,70.0,TCGA-05-4433-01A,TCGA-05-4433,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUW,23306.0,female,1950,white,13,Primary Tumor,0.0,0.0,98.0,2.0,15.0,0.0,2.0,TCGA-IB-AAUW-01A,TCGA-IB-AAUW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AL,22023.0,female,1946,white,1528,Primary Tumor,0.0,0.0,5.0,80.0,0.0,10.0,85.0,TCGA-AR-A1AL-01A,TCGA-AR-A1AL,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-5L-AAT0,15393.0,female,1968,white,1320,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-5L-AAT0-01A,TCGA-5L-AAT0,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6830,23922.0,female,1937,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,65.0,TCGA-91-6830-01A,TCGA-91-6830,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-3773,30706.0,female,1925,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-67-3773-01A,TCGA-67-3773,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T6,18334.0,female,1959,white,343,Primary Tumor,10.0,10.0,0.0,80.0,40.0,15.0,80.0,TCGA-A2-A0T6-01A,TCGA-A2-A0T6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CL,13556.0,female,1969,black or african american,1552,Primary Tumor,0.0,1.0,10.0,30.0,60.0,47.0,40.0,TCGA-A2-A0CL-01A,TCGA-A2-A0CL,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A204,29529.0,female,1916,white,5538,Primary Tumor,0.0,0.0,5.0,85.0,0.0,15.0,80.0,TCGA-BH-A204-01A,TCGA-BH-A204,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8514,25608.0,female,1942,black or african american,None,Primary Tumor,None,None,0.0,65.0,None,15.0,85.0,TCGA-55-8514-01A,TCGA-55-8514,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T1,20227.0,female,1954,american indian or alaska native,233,Primary Tumor,20.0,10.0,0.0,80.0,30.0,15.0,80.0,TCGA-A2-A0T1-01A,TCGA-A2-A0T1,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-8459,24859.0,male,1944,white,None,Primary Tumor,None,None,0.0,70.0,15.0,10.0,90.0,TCGA-50-8459-01A,TCGA-50-8459,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07Z,31351.0,female,1923,not reported,698,Primary Tumor,0.0,0.0,10.0,90.0,5.0,20.0,70.0,TCGA-A8-A07Z-01A,TCGA-A8-A07Z,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3TM,18535.0,female,1961,white,136,Primary Tumor,0.0,0.0,1.0,85.0,2.0,33.0,65.0,TCGA-AC-A3TM-01A,TCGA-AC-A3TM,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AAR0,20932.0,male,1945,black or african american,4298,Primary Tumor,0.0,1.0,0.0,70.0,4.0,0.0,100.0,TCGA-49-AAR0-01A,TCGA-49-AAR0,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7150,21891.0,male,1943,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,75.0,TCGA-78-7150-01A,TCGA-78-7150,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AK,25825.0,female,1936,white,1744,Primary Tumor,0.0,0.0,5.0,80.0,0.0,30.0,65.0,TCGA-AR-A1AK-01A,TCGA-AR-A1AK,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-US-A774,27957.0,female,1935,white,670,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-US-A774-01A,TCGA-US-A774,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2L-AAQI,24381.0,male,1945,white,912,Primary Tumor,0.0,0.0,15.0,10.0,0.0,80.0,5.0,TCGA-2L-AAQI-01A,TCGA-2L-AAQI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A7T0,25867.0,female,1943,black or african american,70,Primary Tumor,0.0,0.0,25.0,60.0,0.0,10.0,65.0,TCGA-LL-A7T0-01A,TCGA-LL-A7T0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N8,17652.0,female,1962,white,66,Primary Tumor,1.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-E9-A1N8-01A,TCGA-E9-A1N8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XY,27106.0,female,1936,white,135,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,100.0,TCGA-D8-A1XY-01A,TCGA-D8-A1XY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A109,23521.0,female,1943,white,1155,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,88.0,TCGA-E2-A109-01A,TCGA-E2-A109,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABV,27082.0,male,1938,white,495,Primary Tumor,0.0,0.0,60.0,15.0,3.0,0.0,40.0,TCGA-2J-AABV-01A,TCGA-2J-AABV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BP,27917.0,female,1930,white,1217,Primary Tumor,0.0,0.0,54.0,65.0,10.0,5.0,40.0,TCGA-BH-A0BP-01A,TCGA-BH-A0BP,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09A,14883.0,female,1969,not reported,180,Primary Tumor,0.0,0.0,2.0,80.0,2.0,18.0,80.0,TCGA-A8-A09A-01A,TCGA-A8-A09A,
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4488,27332.0,female,1918,white,None,Primary Tumor,None,None,1.0,60.0,None,10.0,89.0,TCGA-49-4488-01A,TCGA-49-4488,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A5FL,24053.0,female,1947,white,73,Primary Tumor,0.0,0.0,15.0,70.0,2.0,0.0,85.0,TCGA-E9-A5FL-01A,TCGA-E9-A5FL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A046,25158.0,female,1942,white,27,Primary Tumor,0.0,2.0,0.0,80.0,6.0,10.0,89.0,TCGA-AN-A046-01A,TCGA-AN-A046,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0AB,19814.0,female,1955,not reported,394,Primary Tumor,0.0,1.0,15.0,60.0,5.0,50.0,30.0,TCGA-A8-A0AB-01A,TCGA-A8-A0AB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4677,27381.0,male,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,40.0,60.0,TCGA-73-4677-01A,TCGA-73-4677,
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-1596,20381.0,male,1949,asian,None,Primary Tumor,None,None,0.0,85.0,4.0,5.0,85.0,TCGA-55-1596-01A,TCGA-55-1596,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A54X,31173.0,female,1927,white,78,Primary Tumor,0.0,0.0,0.0,90.0,0.0,95.0,5.0,TCGA-E9-A54X-01A,TCGA-E9-A54X,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A1KS,25230.0,female,1941,white,147,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-AO-A1KS-01A,TCGA-AO-A1KS,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3YI,27143.0,female,1938,white,87,Primary Tumor,1.0,1.0,5.0,80.0,3.0,15.0,80.0,TCGA-AC-A3YI-01A,TCGA-AC-A3YI,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LL,27028.0,female,1935,black or african american,988,Primary Tumor,1.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-E2-A1LL-01A,TCGA-E2-A1LL,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-PL-A8LY,11199.0,female,1983,black or african american,129,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-PL-A8LY-01A,TCGA-PL-A8LY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3EH,29014.0,female,1932,white,67,Primary Tumor,0.0,0.0,0.0,85.0,1.0,40.0,60.0,TCGA-AC-A3EH-01A,TCGA-AC-A3EH,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A5SP,28317.0,male,1934,white,397,Primary Tumor,2.0,2.0,2.0,75.0,8.0,59.0,35.0,TCGA-IB-A5SP-01A,TCGA-IB-A5SP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LH,21628.0,female,1943,white,2998,Primary Tumor,0.0,0.0,0.0,80.0,100.0,30.0,70.0,TCGA-E2-A1LH-01A,TCGA-E2-A1LH,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JA,13307.0,female,1973,black or african american,258,Primary Tumor,0.0,0.0,5.0,80.0,1.0,15.0,80.0,TCGA-AO-A0JA-01A,TCGA-AO-A0JA,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A107,20065.0,female,1954,white,715,Primary Tumor,0.0,0.0,3.0,80.0,1.0,27.0,70.0,TCGA-E2-A107-01A,TCGA-E2-A107,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4TD,25983.0,male,1937,white,1471,Primary Tumor,0.0,2.0,0.0,90.0,15.0,65.0,35.0,TCGA-MP-A4TD-01A,TCGA-MP-A4TD,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A141,14626.0,female,1970,white,205,Primary Tumor,20.0,20.0,0.0,60.0,50.0,40.0,60.0,TCGA-D8-A141-01A,TCGA-D8-A141,
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6590,26444.0,female,1933,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-50-6590-01A,TCGA-50-6590,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-35-4123,14064.0,male,1972,white,None,Primary Tumor,None,None,2.0,75.0,None,20.0,70.0,TCGA-35-4123-01A,TCGA-35-4123,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EM,26845.0,female,1929,white,2696,Primary Tumor,0.0,2.0,5.0,75.0,5.0,64.0,30.0,TCGA-A2-A0EM-01A,TCGA-A2-A0EM,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A57B,29452.0,female,1932,black or african american,64,Primary Tumor,0.0,10.0,0.0,85.0,8.0,50.0,50.0,TCGA-55-A57B-01A,TCGA-55-A57B,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5044,26567.0,female,1930,white,None,Primary Tumor,None,None,15.0,80.0,None,5.0,80.0,TCGA-50-5044-01A,TCGA-50-5044,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5049,25577.0,male,1936,white,None,Primary Tumor,None,None,10.0,65.0,None,30.0,57.0,TCGA-50-5049-01A,TCGA-50-5049,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T2,24235.0,female,1943,white,261,Primary Tumor,30.0,10.0,0.0,80.0,40.0,15.0,80.0,TCGA-A2-A0T2-01A,TCGA-A2-A0T2,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A274,23337.0,female,1947,asian,163,Primary Tumor,0.0,0.0,0.0,85.0,1.0,34.0,65.0,TCGA-C8-A274-01A,TCGA-C8-A274,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A5PX,23753.0,female,1946,white,616,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-GM-A5PX-01A,TCGA-GM-A5PX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A62V,21389.0,male,1955,black or african american,38,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-AC-A62V-01A,TCGA-AC-A62V,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4SW,19640.0,male,1949,white,3723,Primary Tumor,0.0,0.0,10.0,60.0,0.0,30.0,60.0,TCGA-MP-A4SW-01A,TCGA-MP-A4SW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A5EH,27964.0,female,1936,black or african american,86,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,97.0,TCGA-AC-A5EH-01A,TCGA-AC-A5EH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P3,17637.0,female,1960,white,919,Primary Tumor,1.0,1.0,1.0,80.0,3.0,17.0,80.0,TCGA-EW-A1P3-01A,TCGA-EW-A1P3,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CM,14969.0,female,1963,black or african american,2546,Primary Tumor,10.0,10.0,0.0,80.0,20.0,15.0,80.0,TCGA-A2-A0CM-01A,TCGA-A2-A0CM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12W,18140.0,female,1961,asian,57,Primary Tumor,1.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-C8-A12W-01A,TCGA-C8-A12W,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3KC,20401.0,female,1956,black or african american,299,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-A2-A3KC-01A,TCGA-A2-A3KC,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15T,24054.0,female,1945,white,162,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,70.0,TCGA-E2-A15T-01A,TCGA-E2-A15T,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7973,15355.0,female,1969,white,None,Primary Tumor,0.0,5.0,0.0,80.0,5.0,0.0,98.0,TCGA-69-7973-01A,TCGA-69-7973,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0EE,24850.0,female,1939,white,946,Primary Tumor,20.0,30.0,0.0,70.0,10.0,20.0,70.0,TCGA-BH-A0EE-01A,TCGA-BH-A0EE,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XF,16787.0,female,1965,white,170,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-D8-A1XF-01A,TCGA-D8-A1XF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A259,25666.0,female,1937,black or african american,1238,Primary Tumor,0.0,0.0,1.0,85.0,1.0,34.0,65.0,TCGA-A2-A259-01A,TCGA-A2-A259,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1Y3,22317.0,female,1950,white,62,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D8-A1Y3-01A,TCGA-D8-A1Y3,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OK-A5Q2,21555.0,female,1953,not reported,149,Primary Tumor,0.0,0.0,0.0,60.0,2.0,0.0,100.0,TCGA-OK-A5Q2-01A,TCGA-OK-A5Q2,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-53-7626,28024.0,female,1932,white,None,Primary Tumor,None,None,50.0,40.0,None,10.0,40.0,TCGA-53-7626-01A,TCGA-53-7626,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-80-5607,None,female,None,not reported,None,Primary Tumor,None,None,0.0,70.0,20.0,25.0,75.0,TCGA-80-5607-01A,TCGA-80-5607,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4434,24472.0,female,1941,not reported,None,Primary Tumor,None,None,2.0,75.0,None,30.0,63.0,TCGA-05-4434-01A,TCGA-05-4434,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EP,20585.0,female,1948,white,2198,Primary Tumor,0.0,0.0,1.0,75.0,1.0,65.0,33.0,TCGA-A2-A0EP-01A,TCGA-A2-A0EP,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A256,16642.0,female,1956,white,3740,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-AR-A256-01A,TCGA-AR-A256,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A8FY,31932.0,female,1925,white,477,Primary Tumor,20.0,20.0,0.0,90.0,40.0,10.0,90.0,TCGA-BH-A8FY-01A,TCGA-BH-A8FY,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L9-A50W,27414.0,male,1937,black or african american,205,Primary Tumor,0.0,5.0,0.0,100.0,3.0,30.0,70.0,TCGA-L9-A50W-01A,TCGA-L9-A50W,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07C,20820.0,female,1951,not reported,637,Primary Tumor,0.0,0.0,0.0,80.0,15.0,10.0,85.0,TCGA-A8-A07C-01A,TCGA-A8-A07C,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-5147,None,female,None,not reported,None,Primary Tumor,None,None,0.0,65.0,None,10.0,80.0,TCGA-75-5147-01A,TCGA-75-5147,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAQ1,18172.0,male,1962,white,1091,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-FB-AAQ1-01A,TCGA-FB-AAQ1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2BK,28625.0,female,1928,black or african american,1717,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-AC-A2BK-01A,TCGA-AC-A2BK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0E6,25408.0,female,1940,white,134,Primary Tumor,0.0,2.0,0.0,80.0,4.0,4.0,95.0,TCGA-BH-A0E6-01A,TCGA-BH-A0E6,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABT,26379.0,female,1940,white,399,Primary Tumor,0.0,0.0,0.0,60.0,5.0,0.0,100.0,TCGA-2J-AABT-01A,TCGA-2J-AABT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CZ,17026.0,female,1961,white,1204,Primary Tumor,0.0,0.0,55.0,90.0,0.0,0.0,45.0,TCGA-A2-A0CZ-01A,TCGA-A2-A0CZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BF,20691.0,female,1953,white,413,Primary Tumor,0.0,0.0,5.0,60.0,35.0,5.0,89.0,TCGA-BH-A0BF-01A,TCGA-BH-A0BF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NG,22896.0,female,1949,white,30,Primary Tumor,0.0,0.0,0.0,60.0,0.0,60.0,40.0,TCGA-E9-A1NG-01A,TCGA-E9-A1NG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TT,19679.0,female,1953,black or african american,1567,Primary Tumor,1.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-AR-A0TT-01A,TCGA-AR-A0TT,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7761,31041.0,male,1927,white,None,Primary Tumor,None,None,0.0,50.0,40.0,25.0,75.0,TCGA-69-7761-01A,TCGA-69-7761,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4389,25660.0,male,1935,not reported,None,Primary Tumor,None,None,0.0,75.0,None,15.0,82.0,TCGA-05-4389-01A,TCGA-05-4389,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7161,25294.0,female,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-78-7161-01A,TCGA-78-7161,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FL,25558.0,female,1929,white,4572,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-BH-A1FL-01A,TCGA-BH-A1FL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FD,26007.0,female,1939,white,84,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-AN-A0FD-01A,TCGA-AN-A0FD,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0SY,22928.0,female,1945,white,1083,Primary Tumor,0.0,0.0,0.0,80.0,3.0,18.0,80.0,TCGA-A2-A0SY-01A,TCGA-A2-A0SY,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-6212,None,female,None,not reported,None,Primary Tumor,2.0,3.0,0.0,80.0,12.0,0.0,100.0,TCGA-75-6212-01A,TCGA-75-6212,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-QS-A5YQ,20425.0,female,1958,black or african american,43,Primary Tumor,0.0,0.0,0.0,70.0,20.0,30.0,70.0,TCGA-QS-A5YQ-01A,TCGA-QS-A5YQ,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5794,23924.0,male,1941,white,None,Primary Tumor,0.0,0.0,10.0,75.0,0.0,15.0,75.0,TCGA-CH-5794-01A,TCGA-CH-5794,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GY,23435.0,female,1943,white,2340,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-2Y-A9GY-01A,TCGA-2Y-A9GY,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-MI-A75H,28371.0,male,1935,white,287,Primary Tumor,0.0,2.0,0.0,90.0,4.0,5.0,83.0,TCGA-MI-A75H-01A,TCGA-MI-A75H,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HI-7168,22881.0,male,1943,white,None,Primary Tumor,None,None,0.0,55.0,None,60.0,40.0,TCGA-HI-7168-01A,TCGA-HI-7168,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-PG-A916,25617.0,female,1943,black or african american,224,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,60.0,TCGA-PG-A916-01A,TCGA-PG-A916,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-7525,23481.0,male,1946,not reported,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-G9-7525-01A,TCGA-G9-7525,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3EM,25557.0,female,1942,white,296,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,75.0,TCGA-AJ-A3EM-01A,TCGA-AJ-A3EM,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8I9,22295.0,male,1951,not reported,528,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-KK-A8I9-01A,TCGA-KK-A8I9,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A1N2,25612.0,female,1940,black or african american,93,Primary Tumor,3.0,5.0,0.0,70.0,30.0,30.0,70.0,TCGA-B5-A1N2-01A,TCGA-B5-A1N2,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZN,22026.0,female,1949,white,567,Primary Tumor,1.0,0.0,2.0,60.0,8.0,38.0,60.0,TCGA-D1-A0ZN-01A,TCGA-D1-A0ZN,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A876,16934.0,male,1959,not reported,3054,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-VP-A876-01A,TCGA-VP-A876,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8WL,23725.0,male,None,not reported,None,Primary Tumor,1.0,1.0,8.0,75.0,3.0,17.0,75.0,TCGA-V1-A8WL-01A,TCGA-V1-A8WL,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0V7,17810.0,female,1958,native hawaiian or other pacific islander,1455,Primary Tumor,1.0,2.0,15.0,35.0,20.0,47.0,30.0,TCGA-BS-A0V7-01A,TCGA-BS-A0V7,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CN,19860.0,female,1955,white,701,Primary Tumor,1.0,0.0,13.0,90.0,1.0,2.0,75.0,TCGA-AX-A1CN-01A,TCGA-AX-A1CN,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H9,25670.0,male,1941,white,731,Primary Tumor,0.0,0.0,0.0,96.0,3.0,3.0,95.0,TCGA-2Y-A9H9-01A,TCGA-2Y-A9H9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LI,24573.0,female,1936,black or african american,2567,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-AP-A0LI-01A,TCGA-AP-A0LI,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HI-7170,21199.0,male,1948,white,None,Primary Tumor,None,None,0.0,70.0,None,40.0,60.0,TCGA-HI-7170-01A,TCGA-HI-7170,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A87B,23271.0,male,1944,not reported,2297,Primary Tumor,0.0,0.0,10.0,95.0,0.0,0.0,90.0,TCGA-VP-A87B-01A,TCGA-VP-A87B,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-AAYF,20866.0,male,1954,not reported,897,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-2A-AAYF-01A,TCGA-2A-AAYF,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7818,24391.0,male,1945,white,None,Primary Tumor,None,None,20.0,70.0,None,10.0,70.0,TCGA-HC-7818-01A,TCGA-HC-7818,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-7522,18033.0,male,1962,not reported,None,Primary Tumor,None,None,20.0,70.0,None,10.0,70.0,TCGA-G9-7522-01A,TCGA-G9-7522,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67O,21714.0,male,1953,not reported,392,Primary Tumor,0.0,0.0,3.0,60.0,0.0,57.0,40.0,TCGA-J4-A67O-01A,TCGA-J4-A67O,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EC-A24G,20857.0,female,1954,white,78,Primary Tumor,3.0,3.0,0.0,85.0,10.0,15.0,85.0,TCGA-EC-A24G-01A,TCGA-EC-A24G,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZP-A9D4,23656.0,female,1948,white,472,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-ZP-A9D4-01A,TCGA-ZP-A9D4,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZS-A9CE,29051.0,female,1932,white,967,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-ZS-A9CE-01A,TCGA-ZS-A9CE,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17A,21560.0,female,1950,white,553,Primary Tumor,50.0,10.0,0.0,80.0,30.0,10.0,80.0,TCGA-D1-A17A-01A,TCGA-D1-A17A,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A7XO,10828.0,male,1984,asian,77,Primary Tumor,1.0,1.0,0.0,75.0,4.0,60.0,30.0,TCGA-ED-A7XO-01A,TCGA-ED-A7XO,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADY,20233.0,female,1958,asian,308,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-DD-AADY-01A,TCGA-DD-AADY,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OQ,24820.0,male,None,not reported,None,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-V1-A9OQ-01A,TCGA-V1-A9OQ,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K0,17810.0,female,1960,white,615,Primary Tumor,10.0,0.0,10.0,80.0,30.0,10.0,70.0,TCGA-B5-A0K0-01A,TCGA-B5-A0K0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-X4-A8KS,22571.0,male,1950,not reported,735,Primary Tumor,0.0,0.0,15.0,60.0,0.0,50.0,35.0,TCGA-X4-A8KS-01A,TCGA-X4-A8KS,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MC,27136.0,female,1934,white,779,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-BG-A0MC-01A,TCGA-BG-A0MC,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-M7-A720,19642.0,male,1960,not reported,190,Primary Tumor,20.0,20.0,10.0,60.0,40.0,30.0,60.0,TCGA-M7-A720-01A,TCGA-M7-A720,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1O5,22580.0,female,1949,white,174,Primary Tumor,20.0,20.0,10.0,70.0,40.0,15.0,70.0,TCGA-D1-A1O5-01A,TCGA-D1-A1O5,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3OJ,19826.0,female,1957,white,97,Primary Tumor,2.0,1.0,5.0,80.0,5.0,0.0,90.0,TCGA-AJ-A3OJ-01A,TCGA-AJ-A3OJ,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A15W,21545.0,female,1950,white,906,Primary Tumor,0.0,0.0,5.0,80.0,0.0,0.0,95.0,TCGA-D1-A15W-01A,TCGA-D1-A15W,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2KU,None,female,None,not reported,None,Primary Tumor,3.0,3.0,0.0,90.0,15.0,10.0,90.0,TCGA-DF-A2KU-01A,TCGA-DF-A2KU,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-M7-A71Z,22785.0,male,1951,not reported,136,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-M7-A71Z-01A,TCGA-M7-A71Z,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A9FS,20157.0,male,1958,asian,142,Primary Tumor,0.0,0.0,0.0,95.0,4.0,5.0,93.0,TCGA-CC-A9FS-01A,TCGA-CC-A9FS,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-AAYU,20582.0,male,1956,not reported,693,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-2A-AAYU-01A,TCGA-2A-AAYU,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAW3,25254.0,male,1940,asian,1507,Primary Tumor,2.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-DD-AAW3-01A,TCGA-DD-AAW3,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9ZR,25185.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-V1-A9ZR-01A,TCGA-V1-A9ZR,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17N,17045.0,female,1963,not reported,451,Primary Tumor,0.0,0.0,15.0,80.0,0.0,0.0,85.0,TCGA-D1-A17N-01A,TCGA-D1-A17N,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0G1,24477.0,female,1929,white,5015,Primary Tumor,0.0,0.0,10.0,60.0,90.0,25.0,60.0,TCGA-A5-A0G1-01A,TCGA-A5-A0G1,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3KW,26492.0,female,1939,not reported,205,Primary Tumor,0.0,0.0,20.0,90.0,1.0,0.0,80.0,TCGA-EO-A3KW-01A,TCGA-EO-A3KW,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A167,25575.0,female,1938,white,841,Primary Tumor,3.0,1.0,0.0,85.0,4.0,15.0,82.0,TCGA-D1-A167-01A,TCGA-D1-A167,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3GB,26724.0,female,1937,white,469,Primary Tumor,0.0,1.0,0.0,90.0,2.0,20.0,78.0,TCGA-AX-A3GB-01A,TCGA-AX-A3GB,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0R9,18982.0,female,1958,white,471,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-A5-A0R9-01A,TCGA-A5-A0R9,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A5,24288.0,female,1930,white,5538,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-A3A5-01A,TCGA-DD-A3A5,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-H9-A6BX,22039.0,male,1952,not reported,479,Primary Tumor,1.0,0.0,3.0,60.0,8.0,75.0,20.0,TCGA-H9-A6BX-01A,TCGA-H9-A6BX,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8X3,18980.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-V1-A8X3-01A,TCGA-V1-A8X3,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A83M,23624.0,male,1948,not reported,412,Primary Tumor,0.0,0.0,30.0,70.0,0.0,10.0,60.0,TCGA-J4-A83M-01A,TCGA-J4-A83M,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3AU,26406.0,female,1938,not reported,393,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-EO-A3AU-01A,TCGA-EO-A3AU,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3FX,25260.0,female,1940,white,736,Primary Tumor,0.0,1.0,5.0,96.0,1.0,1.0,92.0,TCGA-AX-A3FX-01A,TCGA-AX-A3FX,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M2,22822.0,female,1947,white,185,Primary Tumor,0.0,0.0,0.0,90.0,0.0,2.0,97.0,TCGA-BG-A0M2-01A,TCGA-BG-A0M2,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A5UD,16702.0,male,1967,asian,92,Primary Tumor,0.0,0.0,0.0,95.0,2.0,10.0,89.0,TCGA-CC-A5UD-01A,TCGA-CC-A5UD,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A06H,22270.0,female,1948,american indian or alaska native,654,Primary Tumor,0.0,0.0,5.0,20.0,70.0,35.0,55.0,TCGA-AX-A06H-01A,TCGA-AX-A06H,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GW,26979.0,female,1937,white,155,Primary Tumor,30.0,20.0,0.0,80.0,30.0,10.0,80.0,TCGA-EY-A1GW-01A,TCGA-EY-A1GW,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-H5-A2HR,25986.0,female,1935,black or african american,1627,Primary Tumor,10.0,0.0,0.0,90.0,20.0,10.0,70.0,TCGA-H5-A2HR-01A,TCGA-H5-A2HR,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A11D,21003.0,female,1949,white,1731,Primary Tumor,0.0,2.0,0.0,80.0,3.0,20.0,75.0,TCGA-DD-A11D-01A,TCGA-DD-A11D,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GU,21192.0,female,1951,white,471,Primary Tumor,20.0,20.0,0.0,70.0,25.0,30.0,60.0,TCGA-A5-A0GU-01A,TCGA-A5-A0GU,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-WQ-AB4B,22769.0,male,1951,white,107,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-WQ-AB4B-01A,TCGA-WQ-AB4B,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A65G,20821.0,male,1955,not reported,299,Primary Tumor,0.0,1.0,0.0,95.0,1.0,25.0,75.0,TCGA-EJ-A65G-01A,TCGA-EJ-A65G,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A11C,25403.0,male,1937,white,1703,Primary Tumor,0.0,2.0,0.0,80.0,2.0,20.0,80.0,TCGA-DD-A11C-01A,TCGA-DD-A11C,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE2,18695.0,male,1962,asian,337,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DD-AAE2-01A,TCGA-DD-AAE2,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A4NB,9426.0,male,1986,white,464,Primary Tumor,0.0,0.0,0.0,75.0,2.0,10.0,90.0,TCGA-DD-A4NB-01A,TCGA-DD-A4NB,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAD1,18794.0,female,1959,asian,1114,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AAD1-01A,TCGA-DD-AAD1,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1C7,28198.0,female,1932,white,423,Primary Tumor,1.0,1.0,0.0,94.0,1.0,5.0,93.0,TCGA-AX-A1C7-01A,TCGA-AX-A1C7,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-MG-AAMC,21846.0,male,1954,not reported,278,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-MG-AAMC-01A,TCGA-MG-AAMC,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0UT,22775.0,female,1943,asian,1886,Primary Tumor,20.0,0.0,0.0,70.0,80.0,25.0,70.0,TCGA-BS-A0UT-01A,TCGA-BS-A0UT,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3TW,28559.0,female,1934,white,71,Primary Tumor,0.0,1.0,0.0,90.0,3.0,0.0,95.0,TCGA-AJ-A3TW-01A,TCGA-AJ-A3TW,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IC,19902.0,male,1954,not reported,1784,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-KK-A8IC-01A,TCGA-KK-A8IC,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1E3,16544.0,female,1964,white,440,Primary Tumor,0.0,0.0,0.0,60.0,0.0,30.0,65.0,TCGA-AP-A1E3-01A,TCGA-AP-A1E3,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A3S1,26031.0,female,1940,white,127,Primary Tumor,0.0,1.0,0.0,90.0,1.0,0.0,95.0,TCGA-B5-A3S1-01A,TCGA-B5-A3S1,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0W1,32750.0,female,1918,white,1014,Primary Tumor,40.0,20.0,0.0,70.0,30.0,25.0,70.0,TCGA-BG-A0W1-01A,TCGA-BG-A0W1,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67T,23211.0,male,1949,not reported,409,Primary Tumor,0.0,0.0,30.0,75.0,0.0,0.0,70.0,TCGA-J4-A67T-01A,TCGA-J4-A67T,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CE,21969.0,female,1949,white,504,Primary Tumor,0.0,0.0,8.0,80.0,10.0,2.0,82.0,TCGA-AX-A1CE-01A,TCGA-AX-A1CE,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-KP-A3W4,23200.0,female,1947,white,688,Primary Tumor,10.0,20.0,0.0,70.0,60.0,20.0,70.0,TCGA-KP-A3W4-01A,TCGA-KP-A3W4,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HK,28316.0,female,1928,white,2045,Primary Tumor,0.0,0.0,0.0,96.0,0.0,2.0,88.0,TCGA-AX-A2HK-01A,TCGA-AX-A2HK,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZQ,32872,female,1919,white,540,Primary Tumor,20.0,0.0,20.0,70.0,20.0,10.0,50.0,TCGA-D1-A0ZQ-01A,TCGA-D1-A0ZQ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5767,24287.0,male,1941,white,None,Primary Tumor,0.0,0.0,20.0,40.0,2.0,55.0,25.0,TCGA-CH-5767-01A,TCGA-CH-5767,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GA,24659.0,female,1939,white,1312,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-A5-A0GA-01A,TCGA-A5-A0GA,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GR,25353.0,female,1939,black or african american,632,Primary Tumor,25.0,20.0,0.0,70.0,35.0,30.0,60.0,TCGA-A5-A0GR-01A,TCGA-A5-A0GR,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MA,22036.0,female,1948,white,805,Primary Tumor,20.0,0.0,20.0,80.0,20.0,0.0,60.0,TCGA-BG-A0MA-01A,TCGA-BG-A0MA,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9L6,23681.0,male,1947,not reported,733,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-ZG-A9L6-01A,TCGA-ZG-A9L6,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5754,23803.0,male,1943,white,None,Primary Tumor,0.0,2.0,2.0,75.0,3.0,38.0,58.0,TCGA-CH-5754-01A,TCGA-CH-5754,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A064,29625.0,female,1926,white,1024,Primary Tumor,4.0,0.0,2.0,90.0,0.0,3.0,80.0,TCGA-AX-A064-01A,TCGA-AX-A064,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAJR,22643.0,male,1950,not reported,776,Primary Tumor,0.0,0.0,18.0,75.0,3.0,55.0,25.0,TCGA-XK-AAJR-01A,TCGA-XK-AAJR,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HJ,13112.0,female,1974,asian,779,Primary Tumor,0.0,0.0,0.0,90.0,1.0,25.0,70.0,TCGA-AX-A2HJ-01A,TCGA-AX-A2HJ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HH,21924.0,female,1950,white,462,Primary Tumor,0.0,0.0,0.0,96.0,1.0,2.0,80.0,TCGA-AX-A2HH-01A,TCGA-AX-A2HH,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IF,20888.0,male,1950,not reported,2351,Primary Tumor,0.0,0.0,0.0,85.0,0.0,20.0,80.0,TCGA-KK-A8IF-01A,TCGA-KK-A8IF,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9Z7,20075.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,75.0,0.0,10.0,90.0,TCGA-V1-A9Z7-01A,TCGA-V1-A9Z7,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A8CY,23154.0,male,1950,not reported,153,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-HC-A8CY-01A,TCGA-HC-A8CY,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8WN,17520.0,male,None,not reported,None,Primary Tumor,1.0,1.0,5.0,75.0,3.0,20.0,75.0,TCGA-V1-A8WN-01A,TCGA-V1-A8WN,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2F4,23621.0,female,1945,black or african american,860,Primary Tumor,20.0,30.0,0.0,90.0,40.0,5.0,90.0,TCGA-FI-A2F4-01A,TCGA-FI-A2F4,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8HL,21249.0,male,1952,not reported,1387,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-YL-A8HL-01A,TCGA-YL-A8HL,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A221,30960.0,female,1926,white,99,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-BG-A221-01A,TCGA-BG-A221,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M6,26666.0,female,1935,white,618,Primary Tumor,0.0,0.0,20.0,80.0,10.0,0.0,70.0,TCGA-BG-A0M6-01A,TCGA-BG-A0M6,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16Y,20455.0,female,1953,white,610,Primary Tumor,1.0,2.0,0.0,75.0,4.0,25.0,75.0,TCGA-D1-A16Y-01A,TCGA-D1-A16Y,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1C4,19209.0,female,1957,white,575,Primary Tumor,0.0,0.0,6.0,95.0,1.0,2.0,91.0,TCGA-AX-A1C4-01A,TCGA-AX-A1C4,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A4,13739.0,male,1961,white,4776,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DD-A3A4-01A,TCGA-DD-A3A4,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GP,20011.0,female,1956,black or african american,262,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-EY-A1GP-01A,TCGA-EY-A1GP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JV,23295.0,female,1944,black or african american,1001,Primary Tumor,10.0,0.0,5.0,70.0,30.0,25.0,50.0,TCGA-B5-A0JV-01A,TCGA-B5-A0JV,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A4NF,26330.0,male,1939,white,364,Primary Tumor,0.0,1.0,0.0,100.0,1.0,10.0,90.0,TCGA-DD-A4NF-01A,TCGA-DD-A4NF,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZP-A9CY,24223.0,female,1945,white,839,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-ZP-A9CY-01A,TCGA-ZP-A9CY,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6366,22428.0,male,1948,white,None,Primary Tumor,0.0,0.0,12.0,80.0,2.0,13.0,75.0,TCGA-G9-6366-01A,TCGA-G9-6366,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H3,16443.0,male,1965,white,1309,Primary Tumor,3.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-2Y-A9H3-01A,TCGA-2Y-A9H3,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A54A,24822.0,female,1945,black or african american,105,Primary Tumor,0.0,3.0,0.0,65.0,5.0,0.0,100.0,TCGA-EY-A54A-01A,TCGA-EY-A54A,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0L8,25733.0,female,1930,black or african american,3510,Primary Tumor,10.0,0.0,30.0,70.0,10.0,0.0,60.0,TCGA-AP-A0L8-01A,TCGA-AP-A0L8,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0VP,27335.0,female,1934,white,930,Primary Tumor,20.0,0.0,0.0,100.0,20.0,0.0,80.0,TCGA-A5-A0VP-01A,TCGA-A5-A0VP,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-QU-A6IM,21792.0,male,1944,not reported,3796,Primary Tumor,0.0,0.0,1.0,90.0,2.0,28.0,70.0,TCGA-QU-A6IM-01A,TCGA-QU-A6IM,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GM,22010.0,female,1950,black or african american,323,Primary Tumor,40.0,20.0,0.0,90.0,20.0,5.0,90.0,TCGA-EY-A1GM-01A,TCGA-EY-A1GM,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6336,20851.0,male,1950,white,None,Primary Tumor,2.0,0.0,15.0,70.0,2.0,20.0,65.0,TCGA-G9-6336-01A,TCGA-G9-6336,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACT,25292.0,female,1941,asian,1317,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DD-AACT-01A,TCGA-DD-AACT,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A23O,25433.0,female,1941,white,165,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-AJ-A23O-01A,TCGA-AJ-A23O,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-EP-A2KA,19214.0,female,1959,white,106,Primary Tumor,0.0,0.0,0.0,92.0,0.0,5.0,95.0,TCGA-EP-A2KA-01A,TCGA-EP-A2KA,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A110,18951.0,female,1952,black or african american,2629,Primary Tumor,0.0,0.0,0.0,60.0,5.0,40.0,60.0,TCGA-BC-A110-01A,TCGA-BC-A110,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A46D,19466.0,male,1959,not reported,181,Primary Tumor,0.0,0.0,20.0,70.0,0.0,30.0,50.0,TCGA-EJ-A46D-01A,TCGA-EJ-A46D,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-QA-A7B7,17636.0,male,1965,black or african american,27,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,90.0,TCGA-QA-A7B7-01A,TCGA-QA-A7B7,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-PG-A6IB,24969.0,female,1944,black or african american,160,Primary Tumor,2.0,1.0,10.0,60.0,1.0,20.0,60.0,TCGA-PG-A6IB-01A,TCGA-PG-A6IB,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BW-A5NO,18510.0,male,1960,black or african american,840,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-BW-A5NO-01A,TCGA-BW-A5NO,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3FZ,12331.0,female,1977,white,658,Primary Tumor,0.0,0.0,0.0,96.0,1.0,3.0,94.0,TCGA-AX-A3FZ-01A,TCGA-AX-A3FZ,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-A7MD,24717.0,male,1946,black or african american,128,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-UB-A7MD-01A,TCGA-UB-A7MD,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MK,19034.0,female,1954,black or african american,1399,Primary Tumor,0.0,0.0,0.0,60.0,0.0,15.0,70.0,TCGA-BG-A0MK-01A,TCGA-BG-A0MK,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-A8VV,19065.0,male,1958,not reported,1155,Primary Tumor,1.0,1.0,7.0,80.0,4.0,45.0,45.0,TCGA-2A-A8VV-01A,TCGA-2A-A8VV,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3G3,21308.0,female,1951,white,713,Primary Tumor,0.0,0.0,0.0,97.0,0.0,3.0,82.0,TCGA-AX-A3G3-01A,TCGA-AX-A3G3,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7IJ,20751.0,male,1957,asian,168,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-CC-A7IJ-01A,TCGA-CC-A7IJ,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HI-7169,20133.0,male,1951,white,None,Primary Tumor,None,None,0.0,70.0,None,40.0,60.0,TCGA-HI-7169-01A,TCGA-HI-7169,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-T1-A6J8,24853.0,male,1945,white,77,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-T1-A6J8-01A,TCGA-T1-A6J8,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2726,20618.0,male,1953,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,70.0,TCGA-60-2726-01A,TCGA-60-2726,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2794,23710.0,male,1942,not reported,None,Primary Tumor,0.0,0.0,15.0,60.0,30.0,5.0,75.0,TCGA-66-2794-01A,TCGA-66-2794,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A41A,32872,male,1922,white,121,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-EB-A41A-01A,TCGA-EB-A41A,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A97M,24228.0,male,1947,white,87,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,85.0,TCGA-EB-A97M-01A,TCGA-EB-A97M,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8353,26549.0,male,1939,white,None,Primary Tumor,None,None,15.0,60.0,None,10.0,55.0,TCGA-85-8353-01A,TCGA-85-8353,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A4IS,28315.0,male,1935,white,70,Primary Tumor,0.0,0.0,20.0,80.0,3.0,0.0,80.0,TCGA-EB-A4IS-01A,TCGA-EB-A4IS,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7463,27520.0,male,1926,white,None,Primary Tumor,5.0,0.0,0.0,75.0,10.0,10.0,90.0,TCGA-77-7463-01A,TCGA-77-7463,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5029,24713.0,male,1939,white,None,Primary Tumor,None,None,10.0,70.0,None,30.0,57.0,TCGA-39-5029-01A,TCGA-39-5029,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2785,23772.0,male,1943,not reported,None,Primary Tumor,0.0,0.0,0.0,70.0,22.0,5.0,75.0,TCGA-66-2785-01A,TCGA-66-2785,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-37-3789,23782.0,male,1941,white,None,Primary Tumor,None,None,5.0,90.0,None,5.0,85.0,TCGA-37-3789-01A,TCGA-37-3789,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A553,22972.0,male,1950,white,95,Primary Tumor,0.0,0.0,20.0,85.0,0.0,0.0,80.0,TCGA-EB-A553-01A,TCGA-EB-A553,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2795,24897.0,male,1940,not reported,None,Primary Tumor,None,None,5.0,80.0,None,5.0,85.0,TCGA-66-2795-01A,TCGA-66-2795,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-AASL,20940.0,female,1943,black or african american,4936,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-33-AASL-01A,TCGA-33-AASL,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8287,26401.0,male,1939,white,None,Primary Tumor,None,None,10.0,70.0,None,10.0,75.0,TCGA-85-8287-01A,TCGA-85-8287,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8414,18502.0,female,1956,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8414-01A,TCGA-KO-8414,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-5784,29362.0,female,1928,white,None,Primary Tumor,20.0,5.0,50.0,50.0,20.0,0.0,50.0,TCGA-21-5784-01A,TCGA-21-5784,1.0
UVM,Uveal Melanoma,Eye,TCGA-YZ-A983,18769.0,female,1962,white,230,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-YZ-A983-01A,TCGA-YZ-A983,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7697,17921.0,male,1962,white,None,Primary Tumor,None,None,25.0,62.0,12.0,10.0,60.0,TCGA-85-7697-01A,TCGA-85-7697,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3416,30435.0,male,1923,not reported,None,Primary Tumor,None,None,0.0,70.0,25.0,7.0,88.0,TCGA-18-3416-01A,TCGA-18-3416,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-A46N,19050.0,male,1959,white,566,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,98.0,TCGA-58-A46N-01A,TCGA-58-A46N,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-O2-A52W,23156.0,male,1943,black or african american,2324,Primary Tumor,0.0,0.0,30.0,65.0,0.0,10.0,50.0,TCGA-O2-A52W-01A,TCGA-O2-A52W,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8334,13602.0,female,1968,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,6.0,94.0,TCGA-KL-8334-01A,TCGA-KL-8334,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A3Y7,31622.0,female,1926,white,111,Primary Tumor,0.0,0.0,30.0,65.0,0.0,5.0,65.0,TCGA-EB-A3Y7-01A,TCGA-EB-A3Y7,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-68-8250,24118.0,male,1945,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,0.0,0.0,TCGA-68-8250-01A,TCGA-68-8250,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A6QZ,28078.0,female,1937,white,172,Primary Tumor,0.0,0.0,0.0,80.0,3.0,20.0,80.0,TCGA-EB-A6QZ-01A,TCGA-EB-A6QZ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HM,27938.0,male,1934,white,841,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-NC-A5HM-01A,TCGA-NC-A5HM,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A4JC,30942.0,male,1928,white,140,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,90.0,TCGA-85-A4JC-01A,TCGA-85-A4JC,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5472,24482.0,male,1938,white,None,Primary Tumor,None,None,10.0,80.0,None,10.0,60.0,TCGA-22-5472-01A,TCGA-22-5472,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7221,28873.0,male,1932,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,82.0,TCGA-56-7221-01A,TCGA-56-7221,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8007,25102.0,male,1933,not reported,None,Primary Tumor,None,None,0.0,65.0,None,5.0,85.0,TCGA-77-8007-01A,TCGA-77-8007,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A49D,24745.0,male,1945,white,76,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,80.0,TCGA-56-A49D-01A,TCGA-56-A49D,3.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KB,24393.0,female,1945,not reported,763,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KB-01A,TCGA-VD-A8KB,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-AASB,24183.0,male,1936,black or african american,4286,Primary Tumor,5.0,2.0,0.0,75.0,2.0,20.0,75.0,TCGA-33-AASB-01A,TCGA-33-AASB,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NK-A5CT,25726.0,male,1938,white,1473,Primary Tumor,0.0,2.0,0.0,95.0,2.0,10.0,85.0,TCGA-NK-A5CT-01A,TCGA-NK-A5CT,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8305,26428.0,male,1939,white,None,Primary Tumor,None,None,0.0,70.0,None,12.0,88.0,TCGA-56-8305-01A,TCGA-56-8305,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7223,24288.0,male,1945,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,80.0,TCGA-56-7223-01A,TCGA-56-7223,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-FR-A728,19936.0,female,1959,white,136,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-FR-A728-01A,TCGA-FR-A728,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2708,23691.0,female,1940,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,70.0,TCGA-60-2708-01A,TCGA-60-2708,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4583,26799.0,male,1926,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,70.0,TCGA-33-4583-01A,TCGA-33-4583,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-4086,23731.0,male,1945,not reported,None,Primary Tumor,None,None,0.0,80.0,None,15.0,80.0,TCGA-18-4086-01A,TCGA-18-4086,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-AA8T,30475.0,female,1930,not reported,69,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-AA8T-01A,TCGA-VD-AA8T,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8150,23474.0,male,1943,not reported,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-77-8150-01A,TCGA-77-8150,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TT,25794.0,male,1941,white,902,Primary Tumor,10.0,10.0,5.0,80.0,60.0,30.0,60.0,TCGA-GS-A9TT-01A,TCGA-GS-A9TT,4.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-D9-A4Z2,18462.0,male,1962,white,66,Primary Tumor,0.0,0.0,0.0,96.0,0.0,0.0,100.0,TCGA-D9-A4Z2-01A,TCGA-D9-A4Z2,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8328,21976.0,male,1943,white,None,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,98.0,TCGA-KL-8328-01A,TCGA-KL-8328,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-46-3769,20941.0,male,1952,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,87.0,TCGA-46-3769-01A,TCGA-46-3769,
UVM,Uveal Melanoma,Eye,TCGA-WC-A884,12840.0,female,1978,white,238,Primary Tumor,0.0,0.0,0.0,96.0,0.0,0.0,100.0,TCGA-WC-A884-01A,TCGA-WC-A884,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8143,27772.0,male,1928,not reported,None,Primary Tumor,None,None,0.0,65.0,None,15.0,80.0,TCGA-77-8143-01A,TCGA-77-8143,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-RQ-A68N,23127.0,male,1949,white,461,Primary Tumor,0.0,10.0,10.0,70.0,70.0,30.0,60.0,TCGA-RQ-A68N-01A,TCGA-RQ-A68N,
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KH,25388.0,male,1943,not reported,497,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KH-01A,TCGA-VD-A8KH,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5481,26419.0,female,1930,white,None,Primary Tumor,None,None,0.0,80.0,2.0,8.0,90.0,TCGA-22-5481-01A,TCGA-22-5481,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8071,19158.0,male,1959,white,None,Primary Tumor,None,None,None,85.0,None,None,None,TCGA-85-8071-01A,TCGA-85-8071,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2722,24267.0,male,1942,white,None,Primary Tumor,None,None,15.0,85.0,None,5.0,70.0,TCGA-60-2722-01A,TCGA-60-2722,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A9VF,28312.0,male,1936,white,154,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-BF-A9VF-01A,TCGA-BF-A9VF,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2788,20637.0,male,1952,not reported,None,Primary Tumor,None,None,1.0,70.0,None,15.0,74.0,TCGA-66-2788-01A,TCGA-66-2788,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8626,21908.0,male,1953,white,None,Primary Tumor,None,None,0.0,60.0,None,20.0,80.0,TCGA-56-8626-01A,TCGA-56-8626,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5485,21488.0,female,1943,white,None,Primary Tumor,1.0,1.0,18.0,80.0,5.0,0.0,76.0,TCGA-22-5485-01A,TCGA-22-5485,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A53B,25390.0,male,1943,white,85,Primary Tumor,0.0,10.0,50.0,90.0,20.0,25.0,25.0,TCGA-98-A53B-01A,TCGA-98-A53B,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2716,14345.0,male,1968,not reported,None,Primary Tumor,None,None,3.0,85.0,None,10.0,80.0,TCGA-60-2716-01A,TCGA-60-2716,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J8,22284.0,female,1948,white,241,Primary Tumor,0.0,0.0,2.0,85.0,1.0,12.0,85.0,TCGA-AO-A0J8-01A,TCGA-AO-A0J8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XD,13510.0,female,1974,white,188,Primary Tumor,0.0,0.0,0.0,75.0,0.0,30.0,70.0,TCGA-D8-A1XD-01A,TCGA-D8-A1XD,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A4YI,31867.0,female,1922,white,1385,Primary Tumor,0.0,3.0,0.0,65.0,3.0,0.0,100.0,TCGA-NJ-A4YI-01A,TCGA-NJ-A4YI,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66L,26186.0,female,1939,black or african american,952,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-OL-A66L-01A,TCGA-OL-A66L,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1G4,25966.0,female,1939,white,310,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-A2-A1G4-01A,TCGA-A2-A1G4,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BD,17275.0,female,1962,white,364,Primary Tumor,0.0,0.0,12.0,85.0,5.0,12.0,75.0,TCGA-BH-A0BD-01A,TCGA-BH-A0BD,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A8ZA,21979.0,male,1953,black or african american,35,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-QK-A8ZA-01A,TCGA-QK-A8ZA,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6478,24244.0,female,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CR-6478-01A,TCGA-CR-6478,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-AA3C,24267.0,male,1943,white,1740,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-G2-AA3C-01A,TCGA-G2-AA3C,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A4IH,21094.0,male,1955,white,97,Primary Tumor,1.0,2.0,15.0,100.0,3.0,15.0,70.0,TCGA-BA-A4IH-01A,TCGA-BA-A4IH,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6473,24857.0,male,1940,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CR-6473-01A,TCGA-CR-6473,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A622,27456.0,male,1937,white,125,Primary Tumor,1.0,0.0,0.0,75.0,8.0,0.0,100.0,TCGA-F7-A622-01A,TCGA-F7-A622,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-R6-A8WG,22093.0,male,1953,white,287,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-R6-A8WG-01A,TCGA-R6-A8WG,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-R6-A6L4,10222.0,male,1985,white,427,Primary Tumor,0.0,0.0,30.0,60.0,0.0,20.0,50.0,TCGA-R6-A6L4-01A,TCGA-R6-A6L4,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6827,20175.0,female,1956,white,None,Primary Tumor,None,None,2.0,80.0,None,20.0,75.0,TCGA-D6-6827-01A,TCGA-D6-6827,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SR,24237.0,male,1946,white,526,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,85.0,TCGA-SX-A7SR-01A,TCGA-SX-A7SR,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A78O,27234.0,female,None,white,None,Primary Tumor,5.0,1.0,0.0,70.0,3.0,23.0,70.0,TCGA-UY-A78O-01A,TCGA-UY-A78O,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-Y8-A896,22750.0,male,1951,white,142,Primary Tumor,1.0,3.0,0.0,80.0,2.0,20.0,80.0,TCGA-Y8-A896-01A,TCGA-Y8-A896,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A541,24206.0,male,1946,white,265,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-E7-A541-01A,TCGA-E7-A541,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JT,26128.0,male,1941,white,358,Primary Tumor,0.0,3.0,0.0,80.0,1.0,0.0,100.0,TCGA-2Z-A9JT-01A,TCGA-2Z-A9JT,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3RD,30529.0,female,1928,white,77,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,100.0,TCGA-GC-A3RD-01A,TCGA-GC-A3RD,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-ND-A4WF,28398.0,female,1930,white,2022,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ND-A4WF-01A,TCGA-ND-A4WF,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NA-A4R0,29449.0,female,1930,white,929,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-NA-A4R0-01A,TCGA-NA-A4R0,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A464,17669.0,male,1960,white,1470,Primary Tumor,0.0,0.0,40.0,65.0,3.0,0.0,60.0,TCGA-CV-A464-01A,TCGA-CV-A464,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GI,25097.0,male,1931,not reported,5187,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-2H-A9GI-01A,TCGA-2H-A9GI,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6994,24778.0,male,1944,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-CN-6994-01A,TCGA-CN-6994,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49W,26910.0,male,1938,asian,500,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-LN-A49W-01A,TCGA-LN-A49W,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3WY,24536.0,female,1934,white,4107,Primary Tumor,0.0,0.0,0.0,80.0,3.0,35.0,65.0,TCGA-DK-A3WY-01A,TCGA-DK-A3WY,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NV,27546.0,male,1926,white,4408,Primary Tumor,0.0,0.0,0.0,70.0,4.0,0.0,100.0,TCGA-L5-A8NV-01A,TCGA-L5-A8NV,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7429,20188.0,male,1943,white,None,Primary Tumor,0.0,0.0,0.0,61.0,10.0,0.0,100.0,TCGA-CV-7429-01A,TCGA-CV-7429,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5373,20143.0,female,1955,white,None,Primary Tumor,None,None,10.0,75.0,None,15.0,75.0,TCGA-CN-5373-01A,TCGA-CN-5373,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45R,17125.0,male,1951,white,5577,Primary Tumor,0.0,0.0,0.0,70.0,3.0,30.0,70.0,TCGA-CV-A45R-01A,TCGA-CV-A45R,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20O,27534.0,male,1928,white,2702,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,70.0,TCGA-BT-A20O-01A,TCGA-BT-A20O,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-KV-A6GE,23979.0,male,1946,white,533,Primary Tumor,0.0,8.0,0.0,80.0,3.0,18.0,80.0,TCGA-KV-A6GE-01A,TCGA-KV-A6GE,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-WN-AB4C,None,female,1951,white,808,Primary Tumor,0.0,5.0,0.0,75.0,2.0,0.0,100.0,TCGA-WN-AB4C-01A,TCGA-WN-AB4C,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A61H,27990.0,male,1936,white,418,Primary Tumor,0.0,6.0,0.0,60.0,10.0,52.0,45.0,TCGA-IQ-A61H-01A,TCGA-IQ-A61H,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SS,24408.0,male,1946,white,55,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-FD-A3SS-01A,TCGA-FD-A3SS,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-7501,20165.0,female,1956,black or african american,None,Primary Tumor,0.0,0.0,10.0,85.0,2.0,5.0,85.0,TCGA-G7-7501-01A,TCGA-G7-7501,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5366,18904.0,male,1955,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,65.0,TCGA-CN-5366-01A,TCGA-CN-5366,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-ND-A4WA,32872,female,1914,asian,3122,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,95.0,TCGA-ND-A4WA-01A,TCGA-ND-A4WA,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A50G,24285.0,male,1946,white,198,Primary Tumor,2.0,5.0,0.0,75.0,25.0,40.0,60.0,TCGA-F7-A50G-01A,TCGA-F7-A50G,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5356,20540.0,male,1954,white,None,Primary Tumor,None,None,10.0,85.0,None,20.0,70.0,TCGA-CN-5356-01A,TCGA-CN-5356,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J9,28346.0,male,1929,black or african american,2618,Primary Tumor,0.0,2.0,0.0,95.0,2.0,7.0,91.0,TCGA-2Z-A9J9-01A,TCGA-2Z-A9J9,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BX,30276.0,male,1930,white,146,Primary Tumor,3.0,2.0,0.0,70.0,5.0,24.0,70.0,TCGA-FD-A5BX-01A,TCGA-FD-A5BX,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A678,20169.0,male,1957,asian,104,Primary Tumor,0.0,0.0,0.0,95.0,1.0,14.0,85.0,TCGA-E7-A678-01A,TCGA-E7-A678,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A5Q6,17917.0,male,1956,white,2922,Primary Tumor,3.0,3.0,0.0,65.0,10.0,48.0,45.0,TCGA-P3-A5Q6-01A,TCGA-P3-A5Q6,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6K2,29114.0,male,1932,white,547,Primary Tumor,30.0,0.0,0.0,60.0,0.0,20.0,80.0,TCGA-CV-A6K2-01A,TCGA-CV-A6K2,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-A3WS,24124.0,male,1945,white,175,Primary Tumor,0.0,0.0,0.0,70.0,1.0,54.0,45.0,TCGA-K4-A3WS-01A,TCGA-K4-A3WS,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45V,31936.0,female,1912,white,4906,Primary Tumor,0.0,0.0,15.0,75.0,0.0,5.0,75.0,TCGA-CV-A45V-01A,TCGA-CV-A45V,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-4074,25282.0,male,1934,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,89.0,TCGA-BA-4074-01A,TCGA-BA-4074,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IA-A83S,29677.0,male,1922,white,3684,Primary Tumor,0.0,5.0,0.0,70.0,2.0,0.0,100.0,TCGA-IA-A83S-01A,TCGA-IA-A83S,
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6474,18840.0,male,1958,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CR-6474-01A,TCGA-CR-6474,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-A633,27057.0,male,1938,white,105,Primary Tumor,0.0,0.0,0.0,75.0,10.0,20.0,70.0,TCGA-HD-A633-01A,TCGA-HD-A633,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-8224,23069.0,male,1948,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-HD-8224-01A,TCGA-HD-8224,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5324,21803.0,male,1948,white,None,Primary Tumor,1.0,None,0.0,82.0,10.0,5.0,90.0,TCGA-CQ-5324-01A,TCGA-CQ-5324,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RO,24823.0,female,1935,black or african american,3983,Primary Tumor,5.0,20.0,30.0,60.0,50.0,5.0,60.0,TCGA-N5-A4RO-01A,TCGA-N5-A4RO,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6948,29153.0,female,1915,white,None,Primary Tumor,0.0,0.0,0.0,85.0,2.0,0.0,95.0,TCGA-CV-6948-01A,TCGA-CV-6948,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5331,26901.0,female,1935,white,None,Primary Tumor,0.0,0.0,0.0,70.0,25.0,5.0,95.0,TCGA-CQ-5331-01A,TCGA-CQ-5331,4.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8326,25267.0,male,1932,white,None,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-KL-8326-01A,TCGA-KL-8326,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-8455,24624.0,male,1944,white,None,Primary Tumor,None,None,5.0,75.0,None,10.0,80.0,TCGA-34-8455-01A,TCGA-34-8455,4.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-8061,15358.0,male,1968,asian,None,Primary Tumor,None,None,0.0,95.0,None,10.0,90.0,TCGA-FF-8061-01A,TCGA-FF-8061,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8343,26562.0,male,1935,white,None,Primary Tumor,None,None,3.0,90.0,None,10.0,87.0,TCGA-KL-8343-01A,TCGA-KL-8343,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A53L,23065.0,male,1949,asian,72,Primary Tumor,0.0,0.0,5.0,65.0,0.0,0.0,75.0,TCGA-85-A53L-01A,TCGA-85-A53L,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-A5FZ,23436.0,male,1937,not reported,4283,Primary Tumor,3.0,5.0,0.0,60.0,7.0,38.0,60.0,TCGA-77-A5FZ-01A,TCGA-77-A5FZ,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-5128,None,male,None,not reported,None,Primary Tumor,None,None,15.0,80.0,None,5.0,65.0,TCGA-63-5128-01A,TCGA-63-5128,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAP8,21414.0,male,1955,white,181,Primary Tumor,0.0,0.0,0.0,70.0,2.0,0.0,100.0,TCGA-BF-AAP8-01A,TCGA-BF-AAP8,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A82C,25850.0,female,1943,asian,83,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-EB-A82C-01A,TCGA-EB-A82C,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MW,27892.0,male,None,not reported,None,Primary Tumor,5.0,2.0,0.0,65.0,6.0,32.0,65.0,TCGA-63-A5MW-01A,TCGA-63-A5MW,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-A5GW,24586.0,male,1945,white,301,Primary Tumor,5.0,15.0,5.0,80.0,70.0,10.0,80.0,TCGA-33-A5GW-01A,TCGA-33-A5GW,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-AA8Q,26285.0,male,1942,not reported,104,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-AA8Q-01A,TCGA-VD-AA8Q,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8431,13043.0,female,1972,not reported,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8431-01A,TCGA-KN-8431,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HN,28151.0,male,1933,white,772,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-NC-A5HN-01A,TCGA-NC-A5HN,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-A5GF,25654.0,male,1941,not reported,568,Primary Tumor,0.0,0.0,5.0,65.0,0.0,0.0,85.0,TCGA-77-A5GF-01A,TCGA-77-A5GF,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8424,15384.0,female,1963,white,None,Primary Tumor,0.0,5.0,0.0,90.0,0.0,0.0,100.0,TCGA-KN-8424-01A,TCGA-KN-8424,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5ML,24947.0,male,None,not reported,None,Primary Tumor,0.0,1.0,0.0,100.0,2.0,35.0,45.0,TCGA-63-A5ML-01A,TCGA-63-A5ML,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A62T,28522.0,male,1935,black or african american,41,Primary Tumor,1.0,1.0,0.0,75.0,5.0,0.0,98.0,TCGA-56-A62T-01A,TCGA-56-A62T,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A551,28671.0,female,1934,white,107,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-EB-A551-01A,TCGA-EB-A551,3.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A87Y,21865.0,male,1952,white,896,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-WC-A87Y-01A,TCGA-WC-A87Y,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5037,23868.0,male,1942,white,None,Primary Tumor,None,None,8.0,75.0,None,10.0,77.0,TCGA-39-5037-01A,TCGA-39-5037,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8427,19854.0,male,1952,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8427-01A,TCGA-KN-8427,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2766,19814.0,male,1953,not reported,None,Primary Tumor,None,None,0.0,90.0,None,5.0,75.0,TCGA-66-2766-01A,TCGA-66-2766,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8333,25229.0,male,1936,white,None,Primary Tumor,0.0,5.0,0.0,85.0,5.0,10.0,90.0,TCGA-KL-8333-01A,TCGA-KL-8333,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HI,24981.0,female,1941,white,1228,Primary Tumor,2.0,2.0,0.0,100.0,2.0,5.0,93.0,TCGA-NC-A5HI-01A,TCGA-NC-A5HI,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-YG-AA3N,24525.0,male,1946,not reported,61,Primary Tumor,0.0,10.0,0.0,80.0,90.0,10.0,90.0,TCGA-YG-AA3N-01A,TCGA-YG-AA3N,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-96-8169,24674.0,female,1944,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-96-8169-01A,TCGA-96-8169,1.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9ES,20054.0,female,1957,white,901,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9ES-01A,TCGA-V4-A9ES,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A4OY,23773.0,female,1947,white,186,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,99.0,TCGA-EB-A4OY-01A,TCGA-EB-A4OY,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-L3-A4E7,26232.0,male,1941,white,36,Primary Tumor,0.0,0.0,0.0,85.0,5.0,15.0,85.0,TCGA-L3-A4E7-01A,TCGA-L3-A4E7,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8417,11139.0,female,1977,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8417-01A,TCGA-KO-8417,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8304,26803.0,female,1938,white,None,Primary Tumor,None,None,0.0,65.0,None,10.0,80.0,TCGA-56-8304-01A,TCGA-56-8304,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-VB-A8QN,20270.0,male,1958,white,256,Primary Tumor,0.0,5.0,40.0,60.0,90.0,10.0,50.0,TCGA-VB-A8QN-01A,TCGA-VB-A8QN,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8580,19301.0,female,1960,white,None,Primary Tumor,None,None,5.0,60.0,None,15.0,72.0,TCGA-85-8580-01A,TCGA-85-8580,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-1005,23322.0,male,1938,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-22-1005-01A,TCGA-22-1005,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1070,22273.0,female,1940,black or african american,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-21-1070-01A,TCGA-21-1070,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-68-A59I,26839.0,female,1939,black or african american,36,Primary Tumor,0.0,0.0,0.0,85.0,0.0,2.0,98.0,TCGA-68-A59I-01A,TCGA-68-A59I,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E0,21700.0,male,1952,not reported,859,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-KK-A6E0-01A,TCGA-KK-A6E0,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A46B,24305.0,male,1946,not reported,114,Primary Tumor,0.0,0.0,0.0,100.0,1.0,40.0,60.0,TCGA-EJ-A46B-01A,TCGA-EJ-A46B,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-PG-A5BC,26436.0,female,1940,black or african american,205,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-PG-A5BC-01A,TCGA-PG-A5BC,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-SL-A6JA,28401.0,female,1936,black or african american,45,Primary Tumor,1.0,1.0,5.0,85.0,1.0,5.0,85.0,TCGA-SL-A6JA-01A,TCGA-SL-A6JA,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5494,18596.0,male,1959,white,None,Primary Tumor,0.0,0.0,2.0,85.0,0.0,18.0,80.0,TCGA-EJ-5494-01A,TCGA-EJ-5494,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAW1,20288.0,male,1954,asian,1703,Primary Tumor,3.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-DD-AAW1-01A,TCGA-DD-AAW1,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A168,24586.0,female,1941,white,821,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,90.0,TCGA-D1-A168-01A,TCGA-D1-A168,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A3CJ,19305.0,male,1959,american indian or alaska native,113,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-G3-A3CJ-01A,TCGA-G3-A3CJ,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8SB,22991.0,male,1948,not reported,1422,Primary Tumor,0.0,0.0,20.0,70.0,0.0,25.0,55.0,TCGA-YL-A8SB-01A,TCGA-YL-A8SB,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A6M4,27327.0,female,1936,white,1077,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,80.0,TCGA-RC-A6M4-01A,TCGA-RC-A6M4,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACJ,27528.0,male,1933,asian,1835,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AACJ-01A,TCGA-DD-AACJ,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E3,20547.0,male,1948,not reported,3355,Primary Tumor,0.0,0.0,7.0,60.0,0.0,13.0,80.0,TCGA-KK-A6E3-01A,TCGA-KK-A6E3,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HA,13142.0,female,1970,white,2188,Primary Tumor,0.0,0.0,10.0,85.0,6.0,7.0,80.0,TCGA-AX-A2HA-01A,TCGA-AX-A2HA,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GJ,16421.0,female,1961,white,1708,Primary Tumor,5.0,0.0,30.0,70.0,10.0,0.0,60.0,TCGA-A5-A0GJ-01A,TCGA-A5-A0GJ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0TC,25560.0,female,1935,asian,2227,Primary Tumor,5.0,0.0,0.0,90.0,20.0,10.0,90.0,TCGA-BS-A0TC-01A,TCGA-BS-A0TC,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E4,25338.0,male,1935,not reported,3094,Primary Tumor,0.0,0.0,2.0,85.0,6.0,53.0,45.0,TCGA-KK-A6E4-01A,TCGA-KK-A6E4,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7AU,23118.0,male,1947,not reported,1266,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-KK-A7AU-01A,TCGA-KK-A7AU,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAJU,23958.0,male,1945,not reported,1276,Primary Tumor,0.0,0.0,10.0,60.0,0.0,40.0,50.0,TCGA-XK-AAJU-01A,TCGA-XK-AAJU,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6AN,24697.0,male,1945,not reported,209,Primary Tumor,0.0,0.0,2.0,85.0,0.0,18.0,80.0,TCGA-HC-A6AN-01A,TCGA-HC-A6AN,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6AP,22318.0,male,1951,not reported,182,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-HC-A6AP-01A,TCGA-HC-A6AP,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7788,19623.0,male,1958,white,None,Primary Tumor,0.0,0.0,2.0,95.0,2.0,8.0,90.0,TCGA-EJ-7788-01A,TCGA-EJ-7788,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GX,27962.0,female,1934,white,172,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-EY-A1GX-01A,TCGA-EY-A1GX,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2H4,24234.0,female,1940,white,1981,Primary Tumor,2.0,1.0,0.0,80.0,10.0,35.0,60.0,TCGA-AX-A2H4-01A,TCGA-AX-A2H4,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GD,27399.0,female,1924,white,4119,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-A5-A0GD-01A,TCGA-A5-A0GD,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A65B,20204.0,male,1957,not reported,359,Primary Tumor,0.0,1.0,15.0,85.0,2.0,40.0,45.0,TCGA-EJ-A65B-01A,TCGA-EJ-A65B,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3316,20931.0,male,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-A3-3316-01A,TCGA-A3-3316,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4961,17284.0,male,1958,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-BP-4961-01A,TCGA-BP-4961,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5711,18444.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,18.0,82.0,TCGA-B0-5711-01A,TCGA-B0-5711,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A032,24865.0,male,1939,not reported,1069,Primary Tumor,2.0,4.0,0.0,75.0,14.0,35.0,63.0,TCGA-AG-A032-01A,TCGA-AG-A032,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-02-2483,15964.0,male,1965,asian,None,Primary Tumor,None,None,0.0,80.0,None,0.0,90.0,TCGA-02-2483-01A,TCGA-02-2483,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4866,28878.0,female,1927,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CZ-4866-01A,TCGA-CZ-4866,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4158,25210.0,male,1932,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-4158-01A,TCGA-BP-4158,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6571,22666.0,female,1949,white,None,Primary Tumor,None,None,5.0,80.0,None,20.0,65.0,TCGA-F5-6571-01A,TCGA-F5-6571,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5088,19677.0,male,1953,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-B0-5088-01A,TCGA-B0-5088,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4706,22331.0,male,1946,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4706-01A,TCGA-B0-4706,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3594,28277.0,male,1930,not reported,None,Primary Tumor,None,None,0.0,80.0,10.0,15.0,85.0,TCGA-AG-3594-01A,TCGA-AG-3594,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-4005,23407.0,male,1943,not reported,None,Primary Tumor,None,None,0.0,80.0,None,15.0,80.0,TCGA-AG-4005-01A,TCGA-AG-4005,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4693,26659.0,female,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-4693-01A,TCGA-B0-4693,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4338,15891.0,male,1960,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BP-4338-01A,TCGA-BP-4338,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9ND,20428.0,male,1958,not reported,283,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-ZG-A9ND-01A,TCGA-ZG-A9ND,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RG-A7D4,25302.0,male,1943,black or african american,530,Primary Tumor,2.0,2.0,0.0,70.0,20.0,30.0,65.0,TCGA-RG-A7D4-01A,TCGA-RG-A7D4,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A8FO,18875.0,male,1962,not reported,177,Primary Tumor,0.0,0.0,5.0,70.0,0.0,35.0,60.0,TCGA-EJ-A8FO-01A,TCGA-EJ-A8FO,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-EP-A3JL,27886.0,male,1935,white,22,Primary Tumor,0.0,0.0,0.0,90.0,2.0,15.0,85.0,TCGA-EP-A3JL-01A,TCGA-EP-A3JL,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A9WJ,17322.0,male,1961,not reported,2017,Primary Tumor,0.0,0.0,30.0,60.0,0.0,20.0,50.0,TCGA-YL-A9WJ-01A,TCGA-YL-A9WJ,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HF,24689.0,female,1943,white,440,Primary Tumor,0.0,0.0,0.0,98.0,0.0,2.0,96.0,TCGA-AX-A2HF-01A,TCGA-AX-A2HF,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A212,30680.0,female,1927,white,112,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-EY-A212-01A,TCGA-EY-A212,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H5,21818.0,female,1951,white,1101,Primary Tumor,2.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-2Y-A9H5-01A,TCGA-2Y-A9H5,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV4,30466.0,female,1929,white,423,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-G3-AAV4-01A,TCGA-G3-AAV4,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6354,20403.0,male,1954,not reported,None,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-G9-6354-01A,TCGA-G9-6354,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A7M9,25588.0,male,1943,white,86,Primary Tumor,1.0,1.0,0.0,60.0,2.0,20.0,60.0,TCGA-G3-A7M9-01A,TCGA-G3-A7M9,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1C5,17383.0,female,1962,white,517,Primary Tumor,1.0,1.0,5.0,70.0,5.0,34.0,60.0,TCGA-AX-A1C5-01A,TCGA-AX-A1C5,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A7WK,26044.0,female,1942,black or african american,253,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-A5-A7WK-01A,TCGA-A5-A7WK,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7AP,20403.0,male,1955,not reported,1130,Primary Tumor,0.0,0.0,10.0,65.0,3.0,25.0,65.0,TCGA-KK-A7AP-01A,TCGA-KK-A7AP,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A46E,21054.0,male,1954,not reported,489,Primary Tumor,0.0,0.0,0.0,100.0,1.0,50.0,50.0,TCGA-EJ-A46E-01A,TCGA-EJ-A46E,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A1NN,23026.0,female,1945,white,813,Primary Tumor,30.0,10.0,0.0,80.0,40.0,10.0,80.0,TCGA-DI-A1NN-01A,TCGA-DI-A1NN,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A8CV,21336.0,female,1953,black or african american,966,Primary Tumor,0.0,5.0,10.0,60.0,5.0,30.0,60.0,TCGA-AJ-A8CV-01A,TCGA-AJ-A8CV,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A4ZQ,19090.0,male,1960,white,224,Primary Tumor,1.0,1.0,0.0,75.0,2.0,21.0,75.0,TCGA-FV-A4ZQ-01A,TCGA-FV-A4ZQ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A053,32872,female,1914,white,2163,Primary Tumor,0.0,0.0,30.0,70.0,0.0,2.0,60.0,TCGA-AP-A053-01A,TCGA-AP-A053,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CF,25300.0,female,1935,white,2284,Primary Tumor,0.0,0.0,20.0,75.0,1.0,5.0,73.0,TCGA-AX-A1CF-01A,TCGA-AX-A1CF,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A2OQ,22309.0,female,1950,white,217,Primary Tumor,0.0,0.0,0.0,60.0,0.0,10.0,90.0,TCGA-EY-A2OQ-01A,TCGA-EY-A2OQ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A3F9,20523.0,female,1947,black or african american,3159,Primary Tumor,0.0,2.0,0.0,95.0,1.0,0.0,97.0,TCGA-B5-A3F9-01A,TCGA-B5-A3F9,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5771,23101.0,male,1945,white,None,Primary Tumor,0.0,0.0,5.0,80.0,2.0,15.0,85.0,TCGA-CH-5771-01A,TCGA-CH-5771,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11X,24217.0,female,1944,black or african american,246,Primary Tumor,10.0,0.0,20.0,80.0,20.0,0.0,70.0,TCGA-B5-A11X-01A,TCGA-B5-A11X,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10W,18562.0,male,1952,asian,3100,Primary Tumor,0.0,0.0,0.0,90.0,2.0,10.0,90.0,TCGA-BC-A10W-01A,TCGA-BC-A10W,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-MR-A8JO,12669.0,male,1979,white,184,Primary Tumor,1.0,1.0,0.0,65.0,3.0,35.0,65.0,TCGA-MR-A8JO-01A,TCGA-MR-A8JO,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A8HU,14367.0,female,1974,asian,141,Primary Tumor,0.0,0.0,0.0,94.0,0.0,10.0,90.0,TCGA-CC-A8HU-01A,TCGA-CC-A8HU,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADG,25887.0,male,1941,asian,862,Primary Tumor,3.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AADG-01A,TCGA-DD-AADG,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV7,14229.0,male,1975,asian,52,Primary Tumor,0.0,0.0,0.0,95.0,0.0,2.0,88.0,TCGA-G3-AAV7-01A,TCGA-G3-AAV7,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DR,21904.0,female,1949,black or african american,1095,Primary Tumor,2.0,6.0,0.0,90.0,4.0,10.0,88.0,TCGA-AP-A1DR-01A,TCGA-AP-A1DR,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8WV,19345.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-V1-A8WV-01A,TCGA-V1-A8WV,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-LG-A9QD,24969.0,male,1945,white,28,Primary Tumor,0.0,0.0,0.0,97.0,2.0,3.0,96.0,TCGA-LG-A9QD-01A,TCGA-LG-A9QD,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A7XP,19504.0,female,1960,asian,62,Primary Tumor,1.0,1.0,0.0,94.0,3.0,8.0,88.0,TCGA-ED-A7XP-01A,TCGA-ED-A7XP,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GX,24963.0,male,1939,white,2365,Primary Tumor,0.0,0.0,0.0,65.0,0.0,10.0,90.0,TCGA-2Y-A9GX-01A,TCGA-2Y-A9GX,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-WW-A8ZI,25593.0,male,1943,not reported,135,Primary Tumor,0.0,0.0,5.0,95.0,0.0,10.0,85.0,TCGA-WW-A8ZI-01A,TCGA-WW-A8ZI,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16Q,19873.0,female,1956,white,136,Primary Tumor,10.0,0.0,0.0,90.0,30.0,10.0,70.0,TCGA-D1-A16Q-01A,TCGA-D1-A16Q,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE3,18271.0,male,1963,asian,342,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DD-AAE3-01A,TCGA-DD-AAE3,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4170,26596.0,female,1931,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-BP-4170-01A,TCGA-BP-4170,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-2693,27443.0,male,1934,white,None,Primary Tumor,None,None,5.0,65.0,None,10.0,83.0,TCGA-AF-2693-01A,TCGA-AF-2693,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4351,18662.0,female,1955,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-4351-01A,TCGA-BP-4351,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DT-5265,18669.0,male,1959,asian,None,Primary Tumor,None,None,0.0,80.0,None,30.0,65.0,TCGA-DT-5265-01A,TCGA-DT-5265,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4341,24727.0,male,1936,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-4341-01A,TCGA-BP-4341,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3909,25537.0,female,1939,not reported,None,Primary Tumor,None,None,5.0,75.0,None,20.0,72.0,TCGA-AG-3909-01A,TCGA-AG-3909,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5986,22456.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CZ-5986-01A,TCGA-CZ-5986,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA38,20285.0,female,1956,white,875,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-W5-AA38-01A,TCGA-W5-AA38,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4838,25268.0,female,1934,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4838-01A,TCGA-B0-4838,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6917,12113.0,male,1977,white,None,Primary Tumor,None,None,0.0,50.0,10.0,52.0,30.0,TCGA-EI-6917-01A,TCGA-EI-6917,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5081,29219.0,female,1926,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-B0-5081-01A,TCGA-B0-5081,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4784,24603.0,female,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-BP-4784-01A,TCGA-BP-4784,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZD-A8I3,26754.0,female,1940,asian,173,Primary Tumor,2.0,2.0,0.0,75.0,15.0,72.0,23.0,TCGA-ZD-A8I3-01A,TCGA-ZD-A8I3,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4843,21088.0,male,1947,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-B0-4843-01A,TCGA-B0-4843,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5680,23778.0,female,1938,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CJ-5680-01A,TCGA-CJ-5680,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3434,26490.0,male,1932,white,None,Primary Tumor,None,None,0.0,75.0,None,35.0,65.0,TCGA-AK-3434-01A,TCGA-AK-3434,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5701,23915.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5701-01A,TCGA-B0-5701,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5459,23318.0,male,1943,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CZ-5459-01A,TCGA-CZ-5459,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4904,22036.0,female,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4904-01A,TCGA-CJ-4904,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-5337,25202.0,male,1941,white,None,Primary Tumor,5.0,0.0,0.0,80.0,10.0,9.0,90.0,TCGA-DC-5337-01A,TCGA-DC-5337,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5838,19242.0,male,1958,white,None,Primary Tumor,0.0,0.0,0.0,85.0,1.0,10.0,90.0,TCGA-B4-5838-01A,TCGA-B4-5838,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4821,25013.0,female,1934,asian,None,Primary Tumor,None,None,0.0,85.0,None,10.0,87.0,TCGA-B0-4821-01A,TCGA-B0-4821,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5412,28762.0,female,1932,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-06-5412-01A,TCGA-06-5412,
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5204,26490.0,male,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,95.0,TCGA-28-5204-01A,TCGA-28-5204,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-2E-A9G8,None,female,1952,black or african american,957,Primary Tumor,0.0,0.0,0.0,80.0,10.0,15.0,80.0,TCGA-2E-A9G8-01A,TCGA-2E-A9G8,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3G8,27899.0,female,1934,white,350,Primary Tumor,0.0,0.0,0.0,97.0,1.0,2.0,96.0,TCGA-AX-A3G8-01A,TCGA-AX-A3G8,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0VV,19581.0,female,1957,white,217,Primary Tumor,30.0,5.0,0.0,70.0,60.0,20.0,70.0,TCGA-BG-A0VV-01A,TCGA-BG-A0VV,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2CY,22098.0,female,1948,black or african american,1067,Primary Tumor,2.0,8.0,0.0,98.0,5.0,2.0,96.0,TCGA-FI-A2CY-01A,TCGA-FI-A2CY,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ES-A2HT,20023.0,male,1953,black or african american,1392,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-ES-A2HT-01A,TCGA-ES-A2HT,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A6RC,23598.0,male,1947,not reported,631,Primary Tumor,0.0,0.0,40.0,60.0,0.0,10.0,50.0,TCGA-EJ-A6RC-01A,TCGA-EJ-A6RC,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A83L,22338.0,male,1952,not reported,218,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-J4-A83L-01A,TCGA-J4-A83L,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A8FS,24380.0,male,1947,not reported,126,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-EJ-A8FS-01A,TCGA-EJ-A8FS,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A4BN,20392.0,male,1954,not reported,1246,Primary Tumor,0.0,0.0,25.0,70.0,2.0,0.0,75.0,TCGA-KC-A4BN-01A,TCGA-KC-A4BN,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A56F,27523.0,female,1937,black or african american,93,Primary Tumor,0.0,0.0,0.0,60.0,3.0,0.0,90.0,TCGA-BK-A56F-01A,TCGA-BK-A56F,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVX,14016.0,male,1970,asian,2039,Primary Tumor,4.0,1.0,0.0,75.0,5.0,25.0,75.0,TCGA-DD-AAVX-01A,TCGA-DD-AAVX,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A65E,24558.0,male,1945,not reported,289,Primary Tumor,0.0,1.0,25.0,80.0,1.0,15.0,60.0,TCGA-EJ-A65E-01A,TCGA-EJ-A65E,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A214,24136.0,female,1944,white,160,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-EY-A214-01A,TCGA-EY-A214,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7AY,22220.0,male,1950,not reported,1246,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-KK-A7AY-01A,TCGA-KK-A7AY,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GF,27450.0,female,1934,black or african american,504,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-EY-A1GF-01A,TCGA-EY-A1GF,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-A7MB,8951.0,male,1989,white,176,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-UB-A7MB-01A,TCGA-UB-A7MB,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3NF,22210.0,female,1951,white,85,Primary Tumor,0.0,0.0,0.0,60.0,0.0,20.0,80.0,TCGA-AJ-A3NF-01A,TCGA-AJ-A3NF,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A2OP,23090.0,female,1947,white,521,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,92.0,TCGA-EY-A2OP-01A,TCGA-EY-A2OP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LP,27898.0,female,1929,white,1884,Primary Tumor,0.0,0.0,5.0,85.0,0.0,0.0,95.0,TCGA-AP-A0LP-01A,TCGA-AP-A0LP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0LW,17369.0,female,1963,white,107,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BG-A0LW-01A,TCGA-BG-A0LW,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-WJ-A86L,25018.0,female,1945,white,95,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-WJ-A86L-01A,TCGA-WJ-A86L,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DQ,27815.0,female,1932,white,1074,Primary Tumor,3.0,4.0,0.0,70.0,3.0,30.0,70.0,TCGA-AP-A1DQ-01A,TCGA-AP-A1DQ,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LO,16493.0,female,1960,white,1894,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-AP-A0LO-01A,TCGA-AP-A0LO,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7078,25402.0,male,1938,white,None,Primary Tumor,None,None,10.0,85.0,None,5.0,85.0,TCGA-HC-7078-01A,TCGA-HC-7078,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A1MV,30926.0,female,1926,white,226,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-B5-A1MV-01A,TCGA-B5-A1MV,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A5OE,24905.0,female,1943,black or african american,609,Primary Tumor,2.0,2.0,0.0,80.0,2.0,10.0,80.0,TCGA-B5-A5OE-01A,TCGA-B5-A5OE,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A18B,19550.0,female,1957,white,56,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-BG-A18B-01A,TCGA-BG-A18B,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7B0,24756.0,male,1944,not reported,783,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-KK-A7B0-01A,TCGA-KK-A7B0,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A872,22098.0,male,1945,not reported,3164,Primary Tumor,0.0,0.0,30.0,70.0,0.0,10.0,60.0,TCGA-VP-A872-01A,TCGA-VP-A872,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5746,20941.0,male,1950,white,None,Primary Tumor,0.0,0.0,15.0,70.0,0.0,25.0,60.0,TCGA-CH-5746-01A,TCGA-CH-5746,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-7523,16269.0,male,1967,not reported,None,Primary Tumor,None,None,15.0,65.0,None,20.0,65.0,TCGA-G9-7523-01A,TCGA-G9-7523,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A5W4,25503.0,male,1943,white,224,Primary Tumor,0.0,0.0,3.0,80.0,3.0,7.0,90.0,TCGA-BC-A5W4-01A,TCGA-BC-A5W4,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAC8,26322.0,male,1936,asian,2080,Primary Tumor,3.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AAC8-01A,TCGA-DD-AAC8,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5737,26753.0,male,1934,white,None,Primary Tumor,0.0,0.0,1.0,95.0,0.0,7.0,92.0,TCGA-CH-5737-01A,TCGA-CH-5737,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IJ,21793.0,male,1950,not reported,1749,Primary Tumor,1.0,1.0,2.0,90.0,3.0,48.0,50.0,TCGA-KK-A8IJ-01A,TCGA-KK-A8IJ,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A9FW,24891.0,male,1945,asian,125,Primary Tumor,1.0,1.0,0.0,95.0,6.0,8.0,89.0,TCGA-CC-A9FW-01A,TCGA-CC-A9FW,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2L0,22200.0,female,None,not reported,None,Primary Tumor,10.0,5.0,0.0,80.0,5.0,20.0,75.0,TCGA-DF-A2L0-01A,TCGA-DF-A2L0,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A87H,28060.0,male,1933,not reported,1714,Primary Tumor,0.0,0.0,40.0,70.0,0.0,0.0,60.0,TCGA-VP-A87H-01A,TCGA-VP-A87H,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAD2,24221.0,male,1944,asian,1105,Primary Tumor,2.0,1.0,0.0,80.0,12.0,55.0,42.0,TCGA-DD-AAD2-01A,TCGA-DD-AAD2,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4688,16804.0,male,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,65.0,TCGA-B0-4688-01A,TCGA-B0-4688,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4173,17449.0,male,1957,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-BP-4173-01A,TCGA-BP-4173,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3574,32781.0,female,1916,not reported,None,Primary Tumor,None,None,5.0,75.0,None,10.0,67.0,TCGA-AG-3574-01A,TCGA-AG-3574,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-19-1390,23063.0,female,1944,white,None,Primary Tumor,None,None,0.0,100.0,None,10.0,70.0,TCGA-19-1390-01A,TCGA-19-1390,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5467,31473.0,female,1921,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CZ-5467-01A,TCGA-CZ-5467,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6506,28587.0,female,1932,white,None,Primary Tumor,None,None,10.0,70.0,None,20.0,62.0,TCGA-EI-6506-01A,TCGA-EI-6506,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4965,16992.0,male,1959,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BP-4965-01A,TCGA-BP-4965,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3578,27851.0,female,1931,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,89.0,TCGA-AG-3578-01A,TCGA-AG-3578,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0747,19657.0,male,1954,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,95.0,TCGA-06-0747-01A,TCGA-06-0747,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5832,23806.0,male,1945,white,None,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-B4-5832-01A,TCGA-B4-5832,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5584,27352.0,male,1929,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CW-5584-01A,TCGA-CW-5584,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4959,17968.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4959-01A,TCGA-BP-4959,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5183,20881.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-5183-01A,TCGA-BP-5183,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6513,21776.0,male,1951,white,None,Primary Tumor,None,None,0.0,75.0,None,25.0,60.0,TCGA-EI-6513-01A,TCGA-EI-6513,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-1834,20568.0,male,1950,white,None,Primary Tumor,None,None,10.0,85.0,None,10.0,65.0,TCGA-27-1834-01A,TCGA-27-1834,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5084,12219.0,male,1973,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5084-01A,TCGA-B0-5084,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4790,28076.0,male,1931,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,95.0,TCGA-BP-4790-01A,TCGA-BP-4790,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3370,17621.0,female,1958,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-A3-3370-01A,TCGA-A3-3370,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2563,26643.0,female,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,95.0,TCGA-06-2563-01A,TCGA-06-2563,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5000,14868.0,male,1967,white,None,Primary Tumor,None,None,None,85.0,None,None,None,TCGA-BP-5000-01A,TCGA-BP-5000,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5454,23083.0,male,1943,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,10.0,90.0,TCGA-CZ-5454-01A,TCGA-CZ-5454,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5693,17177.0,female,1956,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5693-01A,TCGA-B0-5693,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-G6-A8L6,20306.0,male,1958,black or african american,240,Primary Tumor,0.0,0.0,0.0,90.0,4.0,35.0,63.0,TCGA-G6-A8L6-01A,TCGA-G6-A8L6,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4874,26761.0,female,1931,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CJ-4874-01A,TCGA-CJ-4874,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4713,27899.0,female,1934,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-B0-4713-01A,TCGA-B0-4713,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5168,27692.0,male,1927,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-5168-01A,TCGA-BP-5168,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6864,27058.0,female,1937,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,65.0,TCGA-F5-6864-01A,TCGA-F5-6864,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3428,22653.0,male,1942,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,95.0,TCGA-AK-3428-01A,TCGA-AK-3428,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4177,23955.0,male,1940,white,None,Primary Tumor,None,None,25.0,70.0,None,20.0,65.0,TCGA-BP-4177-01A,TCGA-BP-4177,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4329,27699.0,male,1927,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-4329-01A,TCGA-BP-4329,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5187,19999.0,male,1953,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-BP-5187-01A,TCGA-BP-5187,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5186,18348.0,female,1957,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5186-01A,TCGA-BP-5186,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0878,27319.0,male,1934,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,60.0,TCGA-06-0878-01A,TCGA-06-0878,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4962,21255.0,male,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-BP-4962-01A,TCGA-BP-4962,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A02N,24687.0,male,1938,not reported,1827,Primary Tumor,2.0,1.0,0.0,85.0,8.0,8.0,90.0,TCGA-AG-A02N-01A,TCGA-AG-A02N,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3600,22767.0,male,1945,not reported,None,Primary Tumor,None,None,10.0,85.0,None,5.0,85.0,TCGA-AG-3600-01A,TCGA-AG-3600,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6881,22057.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,87.0,TCGA-EI-6881-01A,TCGA-EI-6881,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3601,24837.0,male,1939,not reported,None,Primary Tumor,None,None,10.0,85.0,None,5.0,80.0,TCGA-AG-3601-01A,TCGA-AG-3601,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-02-2486,23394.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-02-2486-01A,TCGA-02-2486,
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2H,25775.0,female,1942,white,474,Primary Tumor,3.0,1.0,0.0,70.0,5.0,30.0,70.0,TCGA-W5-AA2H-01A,TCGA-W5-AA2H,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2564,18435.0,male,1959,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,98.0,TCGA-06-2564-01A,TCGA-06-2564,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4912,22623.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4912-01A,TCGA-CJ-4912,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4970,16228.0,male,1962,asian,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-BP-4970-01A,TCGA-BP-4970,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5453,24640.0,male,1939,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,5.0,95.0,TCGA-CZ-5453-01A,TCGA-CZ-5453,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-14-1823,21384.0,female,1949,white,None,Primary Tumor,None,None,0.0,95.0,None,2.0,90.0,TCGA-14-1823-01A,TCGA-14-1823,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5173,27436.0,male,1929,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-5173-01A,TCGA-BP-5173,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3587,24075.0,male,1942,not reported,None,Primary Tumor,None,None,0.0,80.0,None,12.0,78.0,TCGA-AG-3587-01A,TCGA-AG-3587,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4854,24876.0,male,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CZ-4854-01A,TCGA-CZ-4854,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-G5-6233,27190.0,male,1935,white,None,Primary Tumor,3.0,1.0,0.0,85.0,5.0,0.0,99.0,TCGA-G5-6233-01A,TCGA-G5-6233,
GBM,Glioblastoma Multiforme,Brain,TCGA-27-1832,21678.0,female,1948,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,95.0,TCGA-27-1832-01A,TCGA-27-1832,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6702,26123.0,male,1939,white,None,Primary Tumor,None,None,5.0,80.0,None,15.0,78.0,TCGA-F5-6702-01A,TCGA-F5-6702,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5220,24622.0,male,1943,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,98.0,TCGA-28-5220-01A,TCGA-28-5220,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3584,22189.0,male,1948,not reported,None,Primary Tumor,None,None,15.0,75.0,None,5.0,75.0,TCGA-AG-3584-01A,TCGA-AG-3584,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3326,17285.0,male,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-A3-3326-01A,TCGA-A3-3326,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-A56K,20527.0,male,1950,black or african american,2388,Primary Tumor,2.0,1.0,0.0,60.0,10.0,0.0,97.0,TCGA-AF-A56K-01A,TCGA-AF-A56K,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5115,15935.0,male,1966,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5115-01A,TCGA-B0-5115,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0158,26856.0,male,1925,white,None,Primary Tumor,None,None,0.0,95.0,None,20.0,80.0,TCGA-06-0158-01A,TCGA-06-0158,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-4745,17958.0,female,1961,white,None,Primary Tumor,None,None,3.0,75.0,None,20.0,74.0,TCGA-DC-4745-01A,TCGA-DC-4745,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5859,23211.0,male,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-06-5859-01A,TCGA-06-5859,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4886,15698.0,female,1963,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CJ-4886-01A,TCGA-CJ-4886,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AH-6643,18273.0,male,1960,white,None,Primary Tumor,None,None,0.0,85.0,None,30.0,52.0,TCGA-AH-6643-01A,TCGA-AH-6643,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0744,24471.0,male,1941,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,95.0,TCGA-06-0744-01A,TCGA-06-0744,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-6031,19905.0,male,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CJ-6031-01A,TCGA-CJ-6031,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5463,27911.0,male,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CZ-5463-01A,TCGA-CZ-5463,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2562,29753.0,male,1928,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,99.0,TCGA-06-2562-01A,TCGA-06-2562,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4824,18132.0,female,1953,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-4824-01A,TCGA-B0-4824,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3999,22311.0,female,1947,not reported,None,Primary Tumor,None,None,0.0,85.0,None,20.0,75.0,TCGA-AG-3999-01A,TCGA-AG-3999,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4837,23129.0,male,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-B0-4837-01A,TCGA-B0-4837,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5200,16197.0,male,1964,white,None,Primary Tumor,None,None,0.0,80.0,None,35.0,65.0,TCGA-BP-5200-01A,TCGA-BP-5200,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3458,17557.0,male,1959,white,None,Primary Tumor,None,None,40.0,49.0,None,0.0,60.0,TCGA-AK-3458-01A,TCGA-AK-3458,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5164,23863.0,male,1945,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-B8-5164-01A,TCGA-B8-5164,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5678,22944.0,male,1941,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CJ-5678-01A,TCGA-CJ-5678,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4804,21727.0,male,1949,white,None,Primary Tumor,None,None,0.0,90.0,None,0.0,80.0,TCGA-BP-4804-01A,TCGA-BP-4804,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4345,22879.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-BP-4345-01A,TCGA-BP-4345,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3387,17920.0,male,1957,white,None,Primary Tumor,None,None,40.0,60.0,None,5.0,55.0,TCGA-A3-3387-01A,TCGA-A3-3387,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4890,26604.0,male,1933,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-CJ-4890-01A,TCGA-CJ-4890,4.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-3X-AAV9,26349.0,male,1938,asian,1113,Primary Tumor,5.0,2.0,0.0,60.0,9.0,40.0,60.0,TCGA-3X-AAV9-01A,TCGA-3X-AAV9,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3580,24775.0,male,1940,not reported,None,Primary Tumor,None,None,0.0,80.0,None,2.0,88.0,TCGA-AG-3580-01A,TCGA-AG-3580,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4878,26224.0,female,1933,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CJ-4878-01A,TCGA-CJ-4878,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5100,26478.0,male,1926,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-B0-5100-01A,TCGA-B0-5100,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4972,16038.0,female,1963,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-BP-4972-01A,TCGA-BP-4972,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-EU-5905,24475.0,female,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,12.0,88.0,TCGA-EU-5905-01A,TCGA-EU-5905,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3427,24067.0,male,1939,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-AK-3427-01A,TCGA-AK-3427,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5580,26696.0,female,1930,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CW-5580-01A,TCGA-CW-5580,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5455,23150.0,male,1943,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,5.0,95.0,TCGA-CZ-5455-01A,TCGA-CZ-5455,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3455,26221.0,female,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-AK-3455-01A,TCGA-AK-3455,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-A8OX,23998.0,female,1947,black or african american,556,Primary Tumor,0.0,4.0,0.0,80.0,2.0,0.0,95.0,TCGA-A3-A8OX-01A,TCGA-A3-A8OX,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4768,26474.0,female,1933,white,None,Primary Tumor,None,None,None,95.0,1.0,None,100.0,TCGA-BP-4768-01A,TCGA-BP-4768,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5176,28727.0,female,1926,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-5176-01A,TCGA-BP-5176,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5080,23052.0,male,1942,white,None,Primary Tumor,None,None,0.0,70.0,None,50.0,50.0,TCGA-B0-5080-01A,TCGA-B0-5080,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3349,12431.0,female,1972,white,None,Primary Tumor,None,None,0.0,70.0,None,5.0,95.0,TCGA-A3-3349-01A,TCGA-A3-3349,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4960,17099.0,male,1958,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BP-4960-01A,TCGA-BP-4960,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5169,25615.0,male,1934,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BP-5169-01A,TCGA-BP-5169,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2567,23759.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,70.0,TCGA-06-2567-01A,TCGA-06-2567,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3358,21087.0,female,1948,white,None,Primary Tumor,None,None,0.0,60.0,None,5.0,95.0,TCGA-A3-3358-01A,TCGA-A3-3358,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5180,19413.0,male,1951,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5180-01A,TCGA-BP-5180,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3731,23923.0,male,1939,not reported,None,Primary Tumor,None,None,75.0,10.0,None,3.0,20.0,TCGA-AG-3731-01A,TCGA-AG-3731,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7J1,15926.0,male,1970,white,184,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-S9-A7J1-01A,TCGA-S9-A7J1,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FK-A3SD,22560.0,female,1948,white,1072,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-FK-A3SD-01A,TCGA-FK-A3SD,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QO,25232.0,male,1941,white,146,Primary Tumor,0.0,1.0,0.0,85.0,1.0,15.0,85.0,TCGA-DJ-A1QO-01A,TCGA-DJ-A1QO,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4G1,9844.0,female,1986,not reported,30,Primary Tumor,0.0,1.0,0.0,80.0,2.0,5.0,95.0,TCGA-EM-A4G1-01A,TCGA-EM-A4G1,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FK-A3S3,15853.0,female,1965,black or african american,1282,Primary Tumor,0.0,0.0,0.0,100.0,0.0,30.0,70.0,TCGA-FK-A3S3-01A,TCGA-FK-A3S3,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A4B4,22830.0,female,1950,white,104,Primary Tumor,0.0,0.0,0.0,82.0,0.0,5.0,95.0,TCGA-FY-A4B4-01A,TCGA-FY-A4B4,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-WY-A85B,8817.0,male,1986,white,1073,Primary Tumor,0.0,0.0,10.0,85.0,0.0,50.0,40.0,TCGA-WY-A85B-01A,TCGA-WY-A85B,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8158,21129.0,female,1944,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-8158-01A,TCGA-DU-8158,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5270,13904.0,female,1964,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-DB-5270-01A,TCGA-DB-5270,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A28Z,16912.0,female,1965,white,50,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-BJ-A28Z-01A,TCGA-BJ-A28Z,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-MK-A84Z,27185.0,male,1939,black or african american,178,Primary Tumor,0.0,2.0,0.0,80.0,2.0,0.0,100.0,TCGA-MK-A84Z-01A,TCGA-MK-A84Z,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7616,27685.0,male,1932,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HT-7616-01A,TCGA-HT-7616,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3D6,18640.0,female,1948,white,4447,Primary Tumor,0.0,1.0,0.0,90.0,1.0,40.0,60.0,TCGA-EL-A3D6-01A,TCGA-EL-A3D6,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4I9,16961.0,female,1961,black or african american,2064,Primary Tumor,0.0,0.0,0.0,80.0,2.0,15.0,85.0,TCGA-KS-A4I9-01A,TCGA-KS-A4I9,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5311,11332.0,male,1963,white,None,Primary Tumor,None,None,0.0,70.0,None,5.0,95.0,TCGA-E1-5311-01A,TCGA-E1-5311,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YQ,21341.0,female,1942,black or african american,4796,Primary Tumor,0.0,0.0,10.0,90.0,5.0,40.0,50.0,TCGA-E1-A7YQ-01A,TCGA-E1-A7YQ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A70Y,7421.0,female,1991,white,804,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-FG-A70Y-01A,TCGA-FG-A70Y,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A617,17331.0,male,1963,american indian or alaska native,961,Primary Tumor,0.0,0.0,10.0,75.0,5.0,40.0,50.0,TCGA-HT-A617-01A,TCGA-HT-A617,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8107,22880.0,male,1949,white,None,Primary Tumor,None,None,0.0,50.0,None,0.0,100.0,TCGA-HT-8107-01A,TCGA-HT-8107,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-8322,14548.0,male,1973,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HW-8322-01A,TCGA-HW-8322,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8164,18735.0,male,1960,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-8164-01A,TCGA-DU-8164,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5F6,9575.0,male,1986,white,35,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-P5-A5F6-01A,TCGA-P5-A5F6,
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A3U2,32682.0,female,1923,white,35,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-IM-A3U2-01A,TCGA-IM-A3U2,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BV,17441.0,female,1961,white,1028,Primary Tumor,0.0,2.0,0.0,70.0,3.0,30.0,70.0,TCGA-ET-A3BV-01A,TCGA-ET-A3BV,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8163,10824.0,male,1982,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-8163-01A,TCGA-DU-8163,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64R,8947.0,female,1988,not reported,436,Primary Tumor,0.0,0.0,10.0,85.0,0.0,10.0,80.0,TCGA-DB-A64R-01A,TCGA-DB-A64R,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7474,19149.0,male,1959,white,None,Primary Tumor,None,None,85.0,10.0,None,0.0,15.0,TCGA-HT-7474-01A,TCGA-HT-7474,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZB,24415.0,male,1944,white,162,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-BJ-A0ZB-01A,TCGA-BJ-A0ZB,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6408,8752.0,female,1975,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-6408-01A,TCGA-DU-6408,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AJ,14399.0,male,1972,not reported,209,Primary Tumor,0.0,2.0,0.0,85.0,10.0,10.0,90.0,TCGA-EM-A3AJ-01A,TCGA-EM-A3AJ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-7495,16460.0,female,1966,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HW-7495-01A,TCGA-HW-7495,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BU,10510.0,male,1980,white,1102,Primary Tumor,1.0,2.0,0.0,70.0,4.0,30.0,70.0,TCGA-ET-A3BU-01A,TCGA-ET-A3BU,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7691,11465.0,female,1977,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7691-01A,TCGA-HT-7691,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6U1,8271.0,female,1990,white,260,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-S9-A6U1-01A,TCGA-S9-A6U1,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13X,18689.0,female,1959,not reported,126,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DJ-A13X-01A,TCGA-DJ-A13X,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6U6,10253.0,male,1984,white,382,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-S9-A6U6-01A,TCGA-S9-A6U6,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5855,18234.0,female,1961,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-5855-01A,TCGA-DU-5855,
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A3NZ,19058.0,female,1959,white,96,Primary Tumor,0.0,1.0,0.0,100.0,2.0,15.0,85.0,TCGA-J8-A3NZ-01A,TCGA-J8-A3NZ,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6UA,24242.0,male,1942,white,1989,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-S9-A6UA-01A,TCGA-S9-A6UA,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BW,11032.0,female,1981,white,155,Primary Tumor,0.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-ET-A3BW-01A,TCGA-ET-A3BW,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7QX,13332.0,female,1977,white,81,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-S9-A7QX-01A,TCGA-S9-A7QX,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4JV,15065.0,female,1968,asian,1304,Primary Tumor,0.0,1.0,0.0,80.0,2.0,0.0,100.0,TCGA-EL-A4JV-01A,TCGA-EL-A4JV,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-A5KM,12845.0,male,1977,white,139,Primary Tumor,0.0,0.0,10.0,90.0,0.0,15.0,75.0,TCGA-HW-A5KM-01A,TCGA-HW-A5KM,
LGG,Brain Lower Grade Glioma,Brain,TCGA-RY-A845,14617.0,female,1973,white,193,Primary Tumor,0.0,0.0,10.0,85.0,0.0,40.0,50.0,TCGA-RY-A845-01A,TCGA-RY-A845,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84L,11498.0,male,1979,white,1271,Primary Tumor,0.0,0.0,10.0,70.0,0.0,45.0,45.0,TCGA-TM-A84L-01A,TCGA-TM-A84L,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6400,24122.0,female,1932,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-DU-6400-01A,TCGA-DU-6400,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V8,10398.0,female,1983,white,248,Primary Tumor,0.0,1.0,0.0,100.0,1.0,50.0,50.0,TCGA-DJ-A3V8-01A,TCGA-DJ-A3V8,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-A5KL,15513.0,female,1970,white,219,Primary Tumor,0.0,0.0,5.0,85.0,0.0,25.0,70.0,TCGA-HW-A5KL-01A,TCGA-HW-A5KL,
LGG,Brain Lower Grade Glioma,Brain,TCGA-VW-A8FI,24411.0,male,1947,white,154,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-VW-A8FI-01A,TCGA-VW-A8FI,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7690,10673.0,male,1980,white,None,Primary Tumor,None,None,15.0,85.0,None,0.0,85.0,TCGA-HT-7690-01A,TCGA-HT-7690,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QL,25713.0,male,1940,not reported,153,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DJ-A1QL-01A,TCGA-DJ-A1QL,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25N,10229.0,female,1981,white,521,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-ET-A25N-01A,TCGA-ET-A25N,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6TS,17857.0,female,1958,white,2402,Primary Tumor,0.0,0.0,10.0,75.0,0.0,50.0,40.0,TCGA-S9-A6TS-01A,TCGA-S9-A6TS,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4KH,13275.0,female,1976,white,238,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-EL-A4KH-01A,TCGA-EL-A4KH,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-5143,11291.0,male,1979,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DH-5143-01A,TCGA-DH-5143,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A239,30259.0,male,1923,white,2039,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-FE-A239-01A,TCGA-FE-A239,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FR,10316.0,male,1984,not reported,52,Primary Tumor,0.0,1.0,0.0,80.0,2.0,7.0,93.0,TCGA-EM-A4FR-01A,TCGA-EM-A4FR,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6CU,19149.0,female,1961,white,59,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-QH-A6CU-01A,TCGA-QH-A6CU,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V7,16257.0,female,1967,white,321,Primary Tumor,0.0,2.0,0.0,100.0,0.0,10.0,90.0,TCGA-DJ-A3V7-01A,TCGA-DJ-A3V7,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A4DS,20296.0,female,1957,white,137,Primary Tumor,0.0,0.0,40.0,90.0,0.0,0.0,60.0,TCGA-HT-A4DS-01A,TCGA-HT-A4DS,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZL,12649.0,female,1974,white,1595,Primary Tumor,0.0,0.0,0.0,60.0,2.0,40.0,50.0,TCGA-EL-A3ZL-01A,TCGA-EL-A3ZL,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DR,15404.0,female,1966,white,1218,Primary Tumor,0.0,0.0,0.0,90.0,0.0,2.0,98.0,TCGA-ET-A3DR-01A,TCGA-ET-A3DR,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7880,11043.0,male,1981,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7880-01A,TCGA-HT-7880,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A77X,20128.0,female,1958,white,111,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-P5-A77X-01A,TCGA-P5-A77X,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2P2,16895.0,male,1965,not reported,78,Primary Tumor,0.0,0.0,10.0,75.0,1.0,15.0,75.0,TCGA-EM-A2P2-01A,TCGA-EM-A2P2,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DV,24905.0,female,1933,white,3815,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-ET-A3DV-01A,TCGA-ET-A3DV,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YM,23263.0,male,1947,white,1280,Primary Tumor,0.0,0.0,5.0,80.0,2.0,70.0,25.0,TCGA-E1-A7YM-01A,TCGA-E1-A7YM,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5F1,11070.0,male,1982,white,55,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-P5-A5F1-01A,TCGA-P5-A5F1,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6405,18686.0,female,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-6405-01A,TCGA-DU-6405,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A4KN,18889.0,female,1961,white,108,Primary Tumor,1.0,2.0,0.0,75.0,3.0,25.0,75.0,TCGA-ET-A4KN-01A,TCGA-ET-A4KN,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7476,9614.0,male,1985,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-7476-01A,TCGA-HT-7476,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UN,18871.0,female,1960,white,282,Primary Tumor,0.0,0.0,5.0,90.0,0.0,0.0,95.0,TCGA-DJ-A3UN-01A,TCGA-DJ-A3UN,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8165,21964.0,female,1951,white,None,Primary Tumor,None,None,8.0,85.0,None,0.0,92.0,TCGA-DU-8165-01A,TCGA-DU-8165,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6CW,15847.0,male,1970,white,24,Primary Tumor,0.0,0.0,10.0,85.0,0.0,30.0,60.0,TCGA-QH-A6CW-01A,TCGA-QH-A6CW,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FQ,15534.0,female,1970,not reported,178,Primary Tumor,0.0,1.0,0.0,75.0,4.0,10.0,90.0,TCGA-EM-A4FQ-01A,TCGA-EM-A4FQ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84J,23091.0,male,1949,white,415,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-TM-A84J-01A,TCGA-TM-A84J,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FK-A3SE,11472.0,female,1977,asian,1197,Primary Tumor,0.0,0.0,18.0,85.0,2.0,0.0,80.0,TCGA-FK-A3SE-01A,TCGA-FK-A3SE,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZQ,28783.0,female,1930,white,1360,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-EL-A3ZQ-01A,TCGA-EL-A3ZQ,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8113,18173.0,female,1957,black or african american,None,Primary Tumor,None,None,0.0,60.0,None,10.0,90.0,TCGA-HT-8113-01A,TCGA-HT-8113,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3D4,22923.0,male,1946,black or african american,1080,Primary Tumor,0.0,1.0,50.0,70.0,1.0,10.0,40.0,TCGA-EL-A3D4-01A,TCGA-EL-A3D4,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25L,19159.0,female,1958,white,399,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,90.0,TCGA-ET-A25L-01A,TCGA-ET-A25L,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-6669,9809.0,female,1985,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-CS-6669-01A,TCGA-CS-6669,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QI,23072.0,female,1947,white,115,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-DJ-A1QI-01A,TCGA-DJ-A1QI,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A3PD,6386.0,female,1989,white,2094,Primary Tumor,0.0,1.0,0.0,100.0,0.0,15.0,85.0,TCGA-FE-A3PD-01A,TCGA-FE-A3PD,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UK,13145.0,female,1976,white,139,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-DJ-A3UK-01A,TCGA-DJ-A3UK,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A7CA,16415.0,male,1967,white,830,Primary Tumor,0.0,0.0,5.0,70.0,0.0,60.0,35.0,TCGA-TM-A7CA-01A,TCGA-TM-A7CA,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7693,18956.0,female,1957,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-HT-7693-01A,TCGA-HT-7693,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T0,16798.0,female,1956,white,3923,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-EL-A3T0-01A,TCGA-EL-A3T0,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZH,15685.0,female,1964,white,2228,Primary Tumor,0.0,3.0,0.0,100.0,1.0,10.0,90.0,TCGA-EL-A3ZH-01A,TCGA-EL-A3ZH,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A75O,10812.0,male,1981,white,981,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-DB-A75O-01A,TCGA-DB-A75O,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84G,20014.0,female,1956,white,1243,Primary Tumor,0.0,0.0,5.0,95.0,0.0,20.0,75.0,TCGA-TM-A84G-01A,TCGA-TM-A84G,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WE,12488.0,male,1970,white,3434,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-S9-A6WE-01A,TCGA-S9-A6WE,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XA,11195.0,male,1982,white,224,Primary Tumor,0.0,0.0,15.0,80.0,0.0,5.0,80.0,TCGA-DB-A4XA-01A,TCGA-DB-A4XA,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GY,14814.0,female,1964,white,2698,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EL-A3GY-01A,TCGA-EL-A3GY,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2P0,12127.0,male,1978,not reported,108,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-EM-A2P0-01A,TCGA-EM-A2P0,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A416,18932.0,female,1961,asian,66,Primary Tumor,2.0,1.0,2.0,65.0,10.0,33.0,65.0,TCGA-E8-A416-01A,TCGA-E8-A416,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13O,20779.0,male,1954,white,135,Primary Tumor,0.0,0.0,10.0,70.0,0.0,5.0,85.0,TCGA-DJ-A13O-01A,TCGA-DJ-A13O,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2OY,17075.0,female,1965,not reported,150,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-EM-A2OY-01A,TCGA-EM-A2OY,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25O,12924.0,female,1974,black or african american,560,Primary Tumor,0.0,0.0,0.0,94.0,0.0,0.0,100.0,TCGA-ET-A25O-01A,TCGA-ET-A25O,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4ID,20413.0,female,1955,white,702,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-KS-A4ID-01A,TCGA-KS-A4ID,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7012,27039.0,female,1927,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7012-01A,TCGA-DU-7012,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V0,20496.0,male,1954,not reported,664,Primary Tumor,0.0,0.0,0.0,80.0,0.0,35.0,65.0,TCGA-DJ-A3V0-01A,TCGA-DJ-A3V0,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39S,10000.0,female,1980,white,1507,Primary Tumor,0.0,1.0,20.0,80.0,0.0,30.0,50.0,TCGA-ET-A39S-01A,TCGA-ET-A39S,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7J3,19056.0,female,1961,white,182,Primary Tumor,0.0,0.0,10.0,70.0,0.0,50.0,40.0,TCGA-S9-A7J3-01A,TCGA-S9-A7J3,
LGG,Brain Lower Grade Glioma,Brain,TCGA-WY-A85A,7380.0,male,1990,white,1203,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-WY-A85A-01A,TCGA-WY-A85A,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4UP,5655.0,female,1997,white,231,Primary Tumor,0.0,1.0,5.0,95.0,1.0,15.0,80.0,TCGA-DJ-A4UP-01A,TCGA-DJ-A4UP,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H5,20926.0,female,1950,white,1508,Primary Tumor,0.0,0.0,0.0,85.0,3.0,15.0,85.0,TCGA-EL-A3H5-01A,TCGA-EL-A3H5,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5847,12606.0,female,1975,white,None,Primary Tumor,None,None,50.0,70.0,None,0.0,50.0,TCGA-DU-5847-01A,TCGA-DU-5847,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7TB,20704.0,male,1954,asian,1168,Primary Tumor,0.0,0.0,20.0,80.0,0.0,30.0,50.0,TCGA-DU-A7TB-01A,TCGA-DU-A7TB,
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4I5,17963.0,female,1962,white,315,Primary Tumor,0.0,0.0,0.0,85.0,2.0,10.0,90.0,TCGA-KS-A4I5-01A,TCGA-KS-A4I5,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DW,23603.0,male,1939,asian,3138,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-ET-A3DW-01A,TCGA-ET-A3DW,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RI,13799.0,female,1975,white,573,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-TQ-A7RI-01A,TCGA-TQ-A7RI,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-7643,18206.0,female,1962,white,None,Primary Tumor,None,None,None,60.0,None,None,None,TCGA-FG-7643-01A,TCGA-FG-7643,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3N2,8989.0,female,1987,white,92,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-EL-A3N2-01A,TCGA-EL-A3N2,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2QA,20784.0,female,1954,asian,273,Primary Tumor,0.0,0.0,15.0,85.0,2.0,25.0,60.0,TCGA-DJ-A2QA-01A,TCGA-DJ-A2QA,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6392,12836.0,female,1958,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-6392-01A,TCGA-DU-6392,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-5142,10678.0,male,1979,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-DH-5142-01A,TCGA-DH-5142,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A237,7207.0,female,1986,white,2173,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-FE-A237-01A,TCGA-FE-A237,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7684,21352.0,male,1950,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7684-01A,TCGA-HT-7684,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7608,22302.0,male,1946,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-7608-01A,TCGA-HT-7608,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7QZ,15300.0,male,1971,white,368,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-S9-A7QZ-01A,TCGA-S9-A7QZ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6U2,17800.0,female,1964,white,430,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-S9-A6U2-01A,TCGA-S9-A6U2,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q0,20973.0,female,1954,white,114,Primary Tumor,0.0,0.0,0.0,90.0,2.0,10.0,90.0,TCGA-DJ-A2Q0-01A,TCGA-DJ-A2Q0,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7019,14279.0,male,1970,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7019-01A,TCGA-DU-7019,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CJ,18168.0,female,1961,not reported,231,Primary Tumor,0.0,1.0,0.0,100.0,0.0,30.0,70.0,TCGA-EM-A2CJ-01A,TCGA-EM-A2CJ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RR,14022.0,male,1974,white,454,Primary Tumor,0.0,0.0,10.0,90.0,0.0,55.0,35.0,TCGA-TQ-A7RR-01A,TCGA-TQ-A7RR,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A0XZ,24020.0,female,1944,white,377,Primary Tumor,0.0,0.0,0.0,95.0,2.0,10.0,90.0,TCGA-DE-A0XZ-01A,TCGA-DE-A0XZ,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-WY-A85D,21979.0,male,1950,white,1035,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-WY-A85D-01A,TCGA-WY-A85D,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PQ,9664.0,male,1984,white,223,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-DJ-A2PQ-01A,TCGA-DJ-A2PQ,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22L,12092.0,female,1978,not reported,72,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EM-A22L-01A,TCGA-EM-A22L,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39N,12904.0,female,1969,white,2478,Primary Tumor,0.0,0.0,45.0,75.0,0.0,0.0,55.0,TCGA-ET-A39N-01A,TCGA-ET-A39N,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7854,22738.0,male,1948,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,95.0,TCGA-HT-7854-01A,TCGA-HT-7854,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BT,22108.0,female,1947,white,1396,Primary Tumor,0.0,1.0,0.0,80.0,5.0,20.0,80.0,TCGA-ET-A3BT-01A,TCGA-ET-A3BT,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A417,14019.0,female,1974,asian,52,Primary Tumor,2.0,1.0,0.0,80.0,4.0,20.0,80.0,TCGA-E8-A417-01A,TCGA-E8-A417,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A41J,10411.0,female,1972,white,4417,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KS-A41J-01A,TCGA-KS-A41J,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E3-A3E5,20993.0,male,1953,white,352,Primary Tumor,0.0,0.0,0.0,85.0,0.0,2.0,98.0,TCGA-E3-A3E5-01A,TCGA-E3-A3E5,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-6188,17729.0,male,1961,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-CS-6188-01A,TCGA-CS-6188,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A60K,12445.0,female,1978,white,85,Primary Tumor,0.0,0.0,0.0,85.0,0.0,35.0,65.0,TCGA-FG-A60K-01A,TCGA-FG-A60K,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-7487,14535.0,male,1971,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HW-7487-01A,TCGA-HW-7487,
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A41Z,13704.0,female,1975,white,106,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-IM-A41Z-01A,TCGA-IM-A41Z,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3O3,30500.0,female,1928,not reported,127,Primary Tumor,0.0,2.0,0.0,100.0,2.0,50.0,50.0,TCGA-EM-A3O3-01A,TCGA-EM-A3O3,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84M,14660.0,male,1972,white,455,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-TM-A84M-01A,TCGA-TM-A84M,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BP,12594.0,female,1974,white,1149,Primary Tumor,0.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-ET-A3BP-01A,TCGA-ET-A3BP,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2OX,16911.0,male,1965,not reported,140,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-EM-A2OX-01A,TCGA-EM-A2OX,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XF,15066.0,female,1970,white,456,Primary Tumor,0.0,0.0,20.0,80.0,0.0,5.0,75.0,TCGA-DB-A4XF-01A,TCGA-DB-A4XF,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PX,20088.0,female,1956,white,117,Primary Tumor,0.0,0.0,15.0,85.0,0.0,0.0,85.0,TCGA-DJ-A2PX-01A,TCGA-DJ-A2PX,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YV,9546.0,female,1984,white,1314,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-E1-A7YV-01A,TCGA-E1-A7YV,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XB,13990.0,male,1973,white,372,Primary Tumor,0.0,0.0,10.0,90.0,0.0,0.0,90.0,TCGA-DB-A4XB-01A,TCGA-DB-A4XB,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A6S3,22038.0,male,1953,white,55,Primary Tumor,0.0,0.0,10.0,85.0,0.0,30.0,60.0,TCGA-DU-A6S3-01A,TCGA-DU-A6S3,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-7490,15092.0,male,1970,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HW-7490-01A,TCGA-HW-7490,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-7634,10476.0,male,1980,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-FG-7634-01A,TCGA-FG-7634,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q5,18727.0,male,1960,white,139,Primary Tumor,0.0,1.0,0.0,90.0,1.0,30.0,70.0,TCGA-DJ-A2Q5-01A,TCGA-DJ-A2Q5,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A6S6,12809.0,female,1972,white,2297,Primary Tumor,0.0,0.0,20.0,70.0,0.0,40.0,40.0,TCGA-DU-A6S6-01A,TCGA-DU-A6S6,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A7UU,16037.0,male,1970,white,118,Primary Tumor,0.0,0.0,10.0,85.0,0.0,45.0,45.0,TCGA-DH-A7UU-01A,TCGA-DH-A7UU,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A3KN,18098.0,female,1962,white,183,Primary Tumor,0.0,0.0,0.0,100.0,0.0,10.0,90.0,TCGA-DE-A3KN-01A,TCGA-DE-A3KN,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A735,14152.0,female,1975,white,134,Primary Tumor,0.0,0.0,5.0,80.0,0.0,35.0,60.0,TCGA-P5-A735-01A,TCGA-P5-A735,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7Z2,21341.0,female,1954,white,614,Primary Tumor,0.0,0.0,10.0,75.0,0.0,50.0,30.0,TCGA-E1-A7Z2-01A,TCGA-E1-A7Z2,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7478,13216.0,male,1975,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-7478-01A,TCGA-HT-7478,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5F2,13396.0,female,1976,white,48,Primary Tumor,0.0,0.0,10.0,75.0,0.0,55.0,35.0,TCGA-P5-A5F2-01A,TCGA-P5-A5F2,
LGG,Brain Lower Grade Glioma,Brain,TCGA-WY-A85E,17878.0,female,1963,white,794,Primary Tumor,0.0,0.0,10.0,85.0,0.0,40.0,50.0,TCGA-WY-A85E-01A,TCGA-WY-A85E,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8110,21183.0,male,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-8110-01A,TCGA-HT-8110,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YL,16982.0,male,1963,white,1372,Primary Tumor,0.0,0.0,5.0,90.0,0.0,35.0,60.0,TCGA-E1-A7YL-01A,TCGA-E1-A7YL,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A7C5,11286.0,male,1980,white,1194,Primary Tumor,0.0,0.0,5.0,90.0,0.0,25.0,70.0,TCGA-TM-A7C5-01A,TCGA-TM-A7C5,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QN,15343.0,female,1968,not reported,204,Primary Tumor,0.0,1.0,0.0,90.0,1.0,10.0,90.0,TCGA-DJ-A1QN-01A,TCGA-DJ-A1QN,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A87N,13606.0,female,1976,asian,113,Primary Tumor,0.0,0.0,10.0,90.0,0.0,30.0,60.0,TCGA-FG-A87N-01A,TCGA-FG-A87N,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6X8,20771.0,female,1957,white,54,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-QH-A6X8-01A,TCGA-QH-A6X8,
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A13K,11122.0,female,1980,asian,75,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-CE-A13K-01A,TCGA-CE-A13K,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3SY,13461.0,male,1975,not reported,148,Primary Tumor,0.0,3.0,0.0,100.0,1.0,5.0,95.0,TCGA-EM-A3SY-01A,TCGA-EM-A3SY,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A75L,13338.0,female,1977,white,75,Primary Tumor,0.0,0.0,10.0,75.0,0.0,50.0,40.0,TCGA-DB-A75L-01A,TCGA-DB-A75L,
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A42S,16609.0,male,1967,white,98,Primary Tumor,0.0,1.0,0.0,100.0,2.0,60.0,40.0,TCGA-J8-A42S-01A,TCGA-J8-A42S,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4K7,27306.0,male,1935,white,1121,Primary Tumor,0.0,0.0,0.0,80.0,2.0,15.0,85.0,TCGA-EL-A4K7-01A,TCGA-EL-A4K7,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3MW,20186.0,female,1948,white,3067,Primary Tumor,0.0,1.0,0.0,100.0,0.0,15.0,85.0,TCGA-EL-A3MW-01A,TCGA-EL-A3MW,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UT,15767.0,female,1967,white,464,Primary Tumor,0.0,0.0,10.0,90.0,0.0,0.0,90.0,TCGA-DJ-A3UT-01A,TCGA-DJ-A3UT,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3R8,22824.0,female,1950,white,51,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-FY-A3R8-01A,TCGA-FY-A3R8,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WG,11509.0,male,1976,white,2098,Primary Tumor,0.0,0.0,10.0,70.0,0.0,50.0,40.0,TCGA-S9-A6WG-01A,TCGA-S9-A6WG,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1YC,26143.0,female,1936,not reported,1326,Primary Tumor,0.0,0.0,5.0,96.0,1.0,5.0,90.0,TCGA-EM-A1YC-01A,TCGA-EM-A1YC,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6TX,17025.0,male,1965,white,776,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6TX-01A,TCGA-S9-A6TX,
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A484,13815.0,female,1975,asian,135,Primary Tumor,0.0,2.0,0.0,100.0,0.0,15.0,85.0,TCGA-CE-A484-01A,TCGA-CE-A484,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-5395,15848.0,male,1964,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-CS-5395-01A,TCGA-CS-5395,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3R6,21009.0,female,1954,white,101,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-FY-A3R6-01A,TCGA-FY-A3R6,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6X4,17258.0,male,1966,white,129,Primary Tumor,0.0,0.0,5.0,70.0,0.0,40.0,55.0,TCGA-QH-A6X4-01A,TCGA-QH-A6X4,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A66G,18199.0,female,1964,white,77,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-DH-A66G-01A,TCGA-DH-A66G,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25M,12085.0,male,1977,white,424,Primary Tumor,0.0,0.0,15.0,70.0,0.0,5.0,80.0,TCGA-ET-A25M-01A,TCGA-ET-A25M,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39R,8828.0,female,1983,white,1583,Primary Tumor,0.0,2.0,0.0,80.0,4.0,30.0,70.0,TCGA-ET-A39R-01A,TCGA-ET-A39R,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6UB,19223.0,male,1953,white,3073,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6UB-01A,TCGA-S9-A6UB,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A436,19640.0,female,1959,asian,114,Primary Tumor,0.0,0.0,5.0,90.0,0.0,5.0,90.0,TCGA-E8-A436-01A,TCGA-E8-A436,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3D5,16217.0,female,1966,white,626,Primary Tumor,0.0,1.0,10.0,80.0,1.0,10.0,80.0,TCGA-EL-A3D5-01A,TCGA-EL-A3D5,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A40P,11843.0,female,1979,white,371,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-ET-A40P-01A,TCGA-ET-A40P,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84H,16277.0,female,1968,white,627,Primary Tumor,0.0,0.0,10.0,85.0,0.0,40.0,50.0,TCGA-TM-A84H-01A,TCGA-TM-A84H,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A780,16161.0,female,1969,white,92,Primary Tumor,0.0,0.0,10.0,75.0,0.0,45.0,45.0,TCGA-P5-A780-01A,TCGA-P5-A780,
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A3MD,11399.0,male,1980,asian,235,Primary Tumor,0.0,0.0,0.0,100.0,0.0,10.0,90.0,TCGA-CE-A3MD-01A,TCGA-CE-A3MD,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1435,21107.0,female,1942,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-24-1435-01A,TCGA-24-1435,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1122,19537.0,female,1945,white,None,Primary Tumor,None,None,0.0,80.0,None,None,None,TCGA-23-1122-01A,TCGA-23-1122,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6586,27020.0,female,1935,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-G4-6586-01A,TCGA-G4-6586,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-10-0927,23982.0,female,1935,not reported,None,Primary Tumor,None,None,10.0,75.0,None,30.0,60.0,TCGA-10-0927-01A,TCGA-10-0927,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6137,20095.0,male,1955,white,None,Primary Tumor,10.0,0.0,0.0,70.0,10.0,0.0,90.0,TCGA-A6-6137-01A,TCGA-A6-6137,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5719,19966.0,female,1956,not reported,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-CG-5719-01A,TCGA-CG-5719,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3496,30438.0,female,1919,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,85.0,TCGA-AA-3496-01A,TCGA-AA-3496,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3818,28763.0,female,1929,not reported,None,Primary Tumor,None,None,0.0,75.0,None,30.0,65.0,TCGA-AA-3818-01A,TCGA-AA-3818,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8683,27549.0,male,1937,asian,None,Primary Tumor,5.0,10.0,14.0,65.0,10.0,11.0,71.0,TCGA-BR-8683-01A,TCGA-BR-8683,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-QG-A5YV,23499.0,female,1947,black or african american,714,Primary Tumor,0.0,1.0,0.0,75.0,5.0,18.0,80.0,TCGA-QG-A5YV-01A,TCGA-QG-A5YV,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-4747,17198.0,male,1963,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,77.0,TCGA-CM-4747-01A,TCGA-CM-4747,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1403,17697.0,female,1960,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-13-1403-01A,TCGA-13-1403,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5734,25079.0,male,1937,not reported,None,Primary Tumor,None,None,30.0,60.0,None,15.0,55.0,TCGA-CG-5734-01A,TCGA-CG-5734,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1499,20668.0,female,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,75.0,TCGA-13-1499-01A,TCGA-13-1499,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4436,20941.0,male,1948,not reported,None,Primary Tumor,None,None,10.0,80.0,None,20.0,65.0,TCGA-CG-4436-01A,TCGA-CG-4436,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8MV,20771.0,male,1945,white,4350,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-RD-A8MV-01A,TCGA-RD-A8MV,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1626,23932.0,female,1941,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,65.0,TCGA-25-1626-01A,TCGA-25-1626,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3844,28521.0,female,1931,not reported,None,Primary Tumor,None,None,0.0,85.0,None,10.0,80.0,TCGA-AA-3844-01A,TCGA-AA-3844,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8526,26840.0,female,1937,asian,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-CD-8526-01A,TCGA-CD-8526,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-5X-AA5U,22438.0,female,1952,black or african american,11,Primary Tumor,0.0,0.0,5.0,75.0,2.0,20.0,75.0,TCGA-5X-AA5U-01A,TCGA-5X-AA5U,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5721,21244.0,male,1947,not reported,None,Primary Tumor,None,None,10.0,80.0,None,10.0,77.0,TCGA-CG-5721-01A,TCGA-CG-5721,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91Z,24652.0,female,1943,white,1259,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,100.0,TCGA-VQ-A91Z-01A,TCGA-VQ-A91Z,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1551,19661.0,female,1944,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,80.0,TCGA-24-1551-01A,TCGA-24-1551,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3877,30377.0,female,1924,not reported,None,Primary Tumor,None,None,8.0,85.0,None,10.0,77.0,TCGA-AA-3877-01A,TCGA-AA-3877,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4256,29441.0,male,1928,white,None,Primary Tumor,None,None,10.0,80.0,None,20.0,67.0,TCGA-BR-4256-01A,TCGA-BR-4256,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-2425,22089.0,female,1944,white,None,Primary Tumor,None,None,0.0,97.0,None,15.0,80.0,TCGA-29-2425-01A,TCGA-29-2425,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A7NT,26727.0,female,1940,white,86,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-IN-A7NT-01A,TCGA-IN-A7NT,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-20-0987,22287.0,female,1943,white,None,Primary Tumor,None,None,15.0,90.0,None,0.0,65.0,TCGA-20-0987-01A,TCGA-20-0987,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0768,26999.0,female,1935,white,None,Primary Tumor,None,None,5.0,94.0,None,1.0,85.0,TCGA-13-0768-01A,TCGA-13-0768,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6539,16703.0,female,1965,white,None,Primary Tumor,2.0,1.0,30.0,71.0,20.0,0.0,70.0,TCGA-D5-6539-01A,TCGA-D5-6539,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-5796,19353.0,female,1958,asian,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CA-5796-01A,TCGA-CA-5796,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3867,27028.0,male,1933,not reported,None,Primary Tumor,None,None,0.0,85.0,None,10.0,85.0,TCGA-AA-3867-01A,TCGA-AA-3867,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-MX-A663,24421.0,male,1946,white,147,Primary Tumor,0.0,0.0,20.0,60.0,5.0,0.0,80.0,TCGA-MX-A663-01A,TCGA-MX-A663,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5718,28763.0,female,1930,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,80.0,TCGA-CG-5718-01A,TCGA-CG-5718,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A6GC,24355.0,female,1947,black or african american,14,Primary Tumor,2.0,3.0,0.0,65.0,2.0,33.0,65.0,TCGA-NH-A6GC-01A,TCGA-NH-A6GC,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4G2,16791.0,male,1966,asian,407,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-HU-A4G2-01A,TCGA-HU-A4G2,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-5913,21399.0,female,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,78.0,TCGA-CK-5913-01A,TCGA-CK-5913,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6605,28485.0,male,1931,white,None,Primary Tumor,None,None,20.0,60.0,None,15.0,60.0,TCGA-AZ-6605-01A,TCGA-AZ-6605,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GT,26231.0,female,1940,asian,421,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,70.0,TCGA-HU-A4GT-01A,TCGA-HU-A4GT,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8530,18992.0,male,1960,asian,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CD-8530-01A,TCGA-CD-8530,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GF,25223.0,male,1942,asian,378,Primary Tumor,1.0,1.0,0.0,75.0,3.0,0.0,100.0,TCGA-HU-A4GF-01A,TCGA-HU-A4GF,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6653,29996.0,male,1929,white,None,Primary Tumor,2.0,1.0,0.0,71.0,15.0,0.0,100.0,TCGA-A6-6653-01A,TCGA-A6-6653,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3872,16651.0,male,1964,not reported,None,Primary Tumor,None,None,0.0,85.0,None,10.0,85.0,TCGA-AA-3872-01A,TCGA-AA-3872,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5860,16344.0,male,1966,white,None,Primary Tumor,2.0,1.0,1.0,75.0,5.0,0.0,99.0,TCGA-CM-5860-01A,TCGA-CM-5860,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A6GB,26100.0,female,1942,black or african american,78,Primary Tumor,5.0,2.0,0.0,70.0,2.0,25.0,70.0,TCGA-NH-A6GB-01A,TCGA-NH-A6GB,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1632,24993.0,female,1934,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-25-1632-01A,TCGA-25-1632,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-R5-A805,26122.0,male,1934,white,3046,Primary Tumor,5.0,1.0,8.0,70.0,2.0,21.0,70.0,TCGA-R5-A805-01A,TCGA-R5-A805,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0885,25763.0,female,1930,white,None,Primary Tumor,None,None,19.0,80.0,90.0,1.0,78.0,TCGA-13-0885-01A,TCGA-13-0885,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2020,24682.0,female,1927,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,90.0,TCGA-24-2020-01A,TCGA-24-2020,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8485,24845.0,female,1944,white,None,Primary Tumor,None,None,12.0,75.0,15.0,15.0,70.0,TCGA-BR-8485-01A,TCGA-BR-8485,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A7BT,24107.0,male,1936,native hawaiian or other pacific islander,4123,Primary Tumor,0.0,0.0,7.0,80.0,3.0,0.0,93.0,TCGA-RD-A7BT-01A,TCGA-RD-A7BT,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8P8,26443.0,female,1940,black or african american,544,Primary Tumor,0.0,0.0,30.0,60.0,0.0,20.0,50.0,TCGA-VQ-A8P8-01A,TCGA-VQ-A8P8,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6315,24174.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,12.0,83.0,TCGA-G4-6315-01A,TCGA-G4-6315,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-ZA-A8F6,26122.0,male,1942,white,35,Primary Tumor,2.0,2.0,0.0,80.0,14.0,50.0,47.0,TCGA-ZA-A8F6-01A,TCGA-ZA-A8F6,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A6GA,21313.0,male,1955,black or african american,78,Primary Tumor,4.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-NH-A6GA-01A,TCGA-NH-A6GA,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6607,25448.0,male,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-AZ-6607-01A,TCGA-AZ-6607,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1762,21879.0,female,1939,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,85.0,TCGA-29-1762-01A,TCGA-29-1762,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8366,29394.0,female,1931,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-BR-8366-01A,TCGA-BR-8366,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-2354,None,female,1942,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-59-2354-01A,TCGA-59-2354,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6569,22203.0,male,1951,white,None,Primary Tumor,None,None,8.0,65.0,None,30.0,47.0,TCGA-F4-6569-01A,TCGA-F4-6569,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA6K,21901.0,male,1953,white,584,Primary Tumor,0.0,0.0,25.0,60.0,5.0,0.0,75.0,TCGA-VQ-AA6K-01A,TCGA-VQ-AA6K,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4257,29014.0,female,1929,white,None,Primary Tumor,None,None,5.0,85.0,None,10.0,82.0,TCGA-BR-4257-01A,TCGA-BR-4257,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1HB,27708.0,male,1925,white,3795,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-DM-A1HB-01A,TCGA-DM-A1HB,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AM-5820,21902.0,female,1951,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-AM-5820-01A,TCGA-AM-5820,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HJ-7597,26264.0,female,1934,white,None,Primary Tumor,None,None,30.0,62.0,20.0,8.0,60.0,TCGA-HJ-7597-01A,TCGA-HJ-7597,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91V,21505.0,male,1953,not reported,756,Primary Tumor,0.0,0.0,0.0,60.0,5.0,0.0,100.0,TCGA-VQ-A91V-01A,TCGA-VQ-A91V,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8486,32872,female,1922,white,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-BR-8486-01A,TCGA-BR-8486,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3495,28886.0,male,1923,not reported,None,Primary Tumor,None,None,5.0,65.0,None,10.0,85.0,TCGA-AA-3495-01A,TCGA-AA-3495,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-AB1V,23030.0,male,1950,white,152,Primary Tumor,0.0,0.0,5.0,65.0,7.0,0.0,95.0,TCGA-IN-AB1V-01A,TCGA-IN-AB1V,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6606,29704.0,male,1928,white,None,Primary Tumor,None,None,18.0,80.0,None,10.0,62.0,TCGA-AZ-6606-01A,TCGA-AZ-6606,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1519,17671.0,female,1959,not reported,None,Primary Tumor,None,None,0.0,95.0,None,10.0,90.0,TCGA-04-1519-01A,TCGA-04-1519,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8529,23979.0,male,1946,asian,None,Primary Tumor,None,None,15.0,60.0,None,15.0,70.0,TCGA-CD-8529-01A,TCGA-CD-8529,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3858,24806.0,male,1942,not reported,None,Primary Tumor,None,None,8.0,85.0,None,10.0,74.0,TCGA-AA-3858-01A,TCGA-AA-3858,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1843,24469.0,female,1943,white,None,Primary Tumor,0.0,0.0,0.0,75.0,0.0,25.0,75.0,TCGA-24-1843-01A,TCGA-24-1843,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1924,23801.0,female,1936,white,None,Primary Tumor,10.0,0.0,0.0,70.0,0.0,10.0,70.0,TCGA-24-1924-01A,TCGA-24-1924,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2024,26476.0,female,1922,black or african american,None,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-24-2024-01A,TCGA-24-2024,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8572,20870.0,male,1955,white,None,Primary Tumor,0.0,0.0,0.0,75.0,20.0,5.0,90.0,TCGA-D7-8572-01A,TCGA-D7-8572,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3712,23831.0,male,1939,not reported,None,Primary Tumor,None,None,None,85.0,1.0,None,99.0,TCGA-AA-3712-01A,TCGA-AA-3712,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1860,21406.0,female,1944,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,90.0,TCGA-30-1860-01A,TCGA-30-1860,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6932,25466.0,male,1942,white,None,Primary Tumor,1.0,0.0,0.0,75.0,1.0,35.0,60.0,TCGA-D5-6932-01A,TCGA-D5-6932,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HF-7131,None,female,None,not reported,None,Primary Tumor,None,None,5.0,70.0,None,20.0,70.0,TCGA-HF-7131-01A,TCGA-HF-7131,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2262,20861.0,female,1935,white,None,Primary Tumor,None,None,1.0,90.0,None,9.0,75.0,TCGA-24-2262-01A,TCGA-24-2262,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1116,30464.0,female,1925,white,None,Primary Tumor,None,None,0.0,80.0,None,None,None,TCGA-23-1116-01A,TCGA-23-1116,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1511,19258.0,female,1956,asian,None,Primary Tumor,None,None,0.0,95.0,None,5.0,90.0,TCGA-13-1511-01A,TCGA-13-1511,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28A,28833.0,male,1923,white,3549,Primary Tumor,2.0,1.0,5.0,80.0,2.0,13.0,80.0,TCGA-DM-A28A-01A,TCGA-DM-A28A,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A927,29676.0,male,1932,white,159,Primary Tumor,0.0,20.0,25.0,60.0,80.0,25.0,50.0,TCGA-VQ-A927-01A,TCGA-VQ-A927,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1861,27103.0,female,1928,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-30-1861-01A,TCGA-30-1861,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3548,26175.0,female,1937,not reported,None,Primary Tumor,None,None,3.0,85.0,None,20.0,77.0,TCGA-AA-3548-01A,TCGA-AA-3548,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2033,31977.0,female,1908,white,None,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-24-2033-01A,TCGA-24-2033,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6599,26438.0,male,1929,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-AZ-6599-01A,TCGA-AZ-6599,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3971,21518.0,male,1949,not reported,None,Primary Tumor,None,None,0.0,90.0,None,15.0,80.0,TCGA-AA-3971-01A,TCGA-AA-3971,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4J5,20714.0,male,1956,asian,83,Primary Tumor,1.0,0.0,0.0,70.0,2.0,50.0,40.0,TCGA-BR-A4J5-01A,TCGA-BR-A4J5,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6600,23581.0,male,1937,black or african american,None,Primary Tumor,None,None,20.0,75.0,None,20.0,55.0,TCGA-AZ-6600-01A,TCGA-AZ-6600,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1030,23416.0,female,1942,white,None,Primary Tumor,None,None,5.0,95.0,None,5.0,85.0,TCGA-23-1030-01A,TCGA-23-1030,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-A5PD,20263.0,female,1956,black or african american,730,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-59-A5PD-01A,TCGA-59-A5PD,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2290,20530.0,female,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,70.0,TCGA-24-2290-01A,TCGA-24-2290,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1467,18652.0,female,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,19.0,80.0,TCGA-24-1467-01A,TCGA-24-1467,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2000,24723.0,female,1941,white,None,Primary Tumor,None,None,8.0,90.0,None,5.0,79.0,TCGA-61-2000-01A,TCGA-61-2000,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6854,28272.0,female,1934,white,None,Primary Tumor,None,None,5.0,80.0,None,35.0,55.0,TCGA-F4-6854-01A,TCGA-F4-6854,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1485,17642.0,female,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-13-1485-01A,TCGA-13-1485,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6628,28772.0,male,1928,white,None,Primary Tumor,None,None,10.0,75.0,None,15.0,75.0,TCGA-G4-6628-01A,TCGA-G4-6628,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6309,14729.0,female,1967,black or african american,None,Primary Tumor,None,None,3.0,80.0,None,10.0,77.0,TCGA-G4-6309-01A,TCGA-G4-6309,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3488,21519.0,male,1944,not reported,None,Primary Tumor,None,None,3.0,65.0,None,5.0,84.0,TCGA-AA-3488-01A,TCGA-AA-3488,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-57-1994,23062.0,female,1941,white,None,Primary Tumor,None,None,0.0,95.0,1.0,5.0,90.0,TCGA-57-1994-01A,TCGA-57-1994,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1616,20785.0,female,1945,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-24-1616-01A,TCGA-24-1616,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6931,28292.0,male,1934,white,None,Primary Tumor,2.0,0.0,14.0,70.0,5.0,16.0,67.0,TCGA-D5-6931-01A,TCGA-D5-6931,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3850,27090.0,male,1935,not reported,None,Primary Tumor,None,None,5.0,85.0,None,8.0,75.0,TCGA-AA-3850-01A,TCGA-AA-3850,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4477,21427.0,female,1950,not reported,None,Primary Tumor,None,None,5.0,75.0,None,15.0,77.0,TCGA-CG-4477-01A,TCGA-CG-4477,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3815,23922.0,female,1942,not reported,None,Primary Tumor,None,None,10.0,75.0,None,10.0,72.0,TCGA-AA-3815-01A,TCGA-AA-3815,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6461,15151.0,female,1970,white,None,Primary Tumor,0.0,2.0,0.0,85.0,2.0,0.0,98.0,TCGA-F4-6461-01A,TCGA-F4-6461,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-2350,None,female,1951,not reported,None,Primary Tumor,None,None,1.0,80.0,None,19.0,75.0,TCGA-59-2350-01A,TCGA-59-2350,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8P3,26582.0,male,1939,white,734,Primary Tumor,0.0,0.0,20.0,70.0,0.0,20.0,60.0,TCGA-VQ-A8P3-01A,TCGA-VQ-A8P3,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-6386,24453.0,female,1944,black or african american,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-AY-6386-01A,TCGA-AY-6386,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PQ,18318.0,female,1958,white,1786,Primary Tumor,4.0,2.0,0.0,70.0,4.0,30.0,70.0,TCGA-VQ-A8PQ-01A,TCGA-VQ-A8PQ,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8N2,21749.0,female,1943,white,4087,Primary Tumor,0.0,0.0,0.0,10.0,6.0,0.0,100.0,TCGA-RD-A8N2-01A,TCGA-RD-A8N2,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8380,20157.0,male,1957,white,None,Primary Tumor,10.0,0.0,0.0,65.0,10.0,0.0,100.0,TCGA-BR-8380-01A,TCGA-BR-8380,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8365,25725.0,female,1941,white,None,Primary Tumor,None,None,15.0,60.0,None,40.0,45.0,TCGA-BR-8365-01A,TCGA-BR-8365,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6601,25082.0,male,1933,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,75.0,TCGA-AZ-6601-01A,TCGA-AZ-6601,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-KB-A93H,28966.0,female,1932,asian,738,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-KB-A93H-01A,TCGA-KB-A93H,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PJ,19390.0,male,1958,not reported,705,Primary Tumor,3.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-VQ-A8PJ-01A,TCGA-VQ-A8PJ,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2281,25019.0,female,1938,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,70.0,TCGA-24-2281-01A,TCGA-24-2281,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-A4MG,28019.0,male,1935,asian,515,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-CD-A4MG-01A,TCGA-CD-A4MG,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8570,16150.0,male,1967,white,None,Primary Tumor,0.0,0.0,0.0,78.0,15.0,0.0,100.0,TCGA-D7-8570-01A,TCGA-D7-8570,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3688,29220.0,male,1927,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,80.0,TCGA-AA-3688-01A,TCGA-AA-3688,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3494,20089.0,male,1947,not reported,None,Primary Tumor,0.0,0.0,0.0,70.0,25.0,5.0,90.0,TCGA-AA-3494-01A,TCGA-AA-3494,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2398,26267.0,female,1933,white,None,Primary Tumor,None,None,0.0,65.0,None,35.0,60.0,TCGA-25-2398-01A,TCGA-25-2398,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-5912,29938.0,male,1925,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CK-5912-01A,TCGA-CK-5912,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6142,20485.0,female,1955,white,None,Primary Tumor,2.0,0.0,0.0,75.0,5.0,50.0,50.0,TCGA-A6-6142-01A,TCGA-A6-6142,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4H5,26232.0,male,1940,asian,287,Primary Tumor,1.0,3.0,0.0,70.0,8.0,55.0,30.0,TCGA-HU-A4H5-01A,TCGA-HU-A4H5,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6535,29278.0,female,1930,white,None,Primary Tumor,2.0,1.0,0.0,80.0,10.0,0.0,98.0,TCGA-D5-6535-01A,TCGA-D5-6535,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1496,23993.0,female,1939,white,None,Primary Tumor,None,None,0.0,99.0,None,1.0,94.0,TCGA-13-1496-01A,TCGA-13-1496,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A6RN,26409.0,female,1940,white,280,Primary Tumor,0.0,0.0,5.0,75.0,5.0,0.0,95.0,TCGA-IN-A6RN-01A,TCGA-IN-A6RN,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA69,13087.0,male,1976,white,882,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-VQ-AA69-01A,TCGA-VQ-AA69,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6927,12737.0,male,1977,white,None,Primary Tumor,3.0,2.0,0.0,75.0,10.0,21.0,67.0,TCGA-D5-6927-01A,TCGA-D5-6927,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-5577,19668.0,female,1957,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-D7-5577-01A,TCGA-D7-5577,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-31-1950,28100.0,female,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,85.0,13.0,TCGA-31-1950-01A,TCGA-31-1950,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4PF,26412.0,male,1940,white,176,Primary Tumor,100.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-BR-A4PF-01A,TCGA-BR-A4PF,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8081,26095.0,female,1940,white,None,Primary Tumor,3.0,0.0,0.0,85.0,10.0,25.0,75.0,TCGA-BR-8081-01A,TCGA-BR-8081,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1785,20417.0,female,1951,white,None,Primary Tumor,None,None,0.0,70.0,15.0,10.0,88.0,TCGA-29-1785-01A,TCGA-29-1785,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-0966,28529.0,female,1930,black or african american,None,Primary Tumor,None,None,0.0,98.0,None,5.0,95.0,TCGA-24-0966-01A,TCGA-24-0966,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6310,25243.0,male,1939,white,None,Primary Tumor,None,None,12.0,75.0,None,10.0,80.0,TCGA-G4-6310-01A,TCGA-G4-6310,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1110,15383.0,female,1961,white,None,Primary Tumor,None,None,0.0,95.0,None,None,None,TCGA-23-1110-01A,TCGA-23-1110,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-5M-AAT6,14852.0,female,1969,black or african american,1589,Primary Tumor,0.0,0.0,5.0,80.0,5.0,15.0,80.0,TCGA-5M-AAT6-01A,TCGA-5M-AAT6,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8573,20963.0,male,1955,white,None,Primary Tumor,9.0,0.0,0.0,80.0,9.0,5.0,86.0,TCGA-D7-8573-01A,TCGA-D7-8573,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8080,26546.0,female,1939,white,None,Primary Tumor,15.0,0.0,0.0,61.0,15.0,0.0,100.0,TCGA-BR-8080-01A,TCGA-BR-8080,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1361,20860.0,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,69.0,TCGA-04-1361-01A,TCGA-04-1361,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6303,19800.0,female,1952,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,67.0,TCGA-G4-6303-01A,TCGA-G4-6303,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-F1-6177,32872,male,1919,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,12.0,88.0,TCGA-F1-6177-01A,TCGA-F1-6177,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6808,19803.0,female,1957,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,90.0,TCGA-F4-6808-01A,TCGA-F4-6808,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8059,26474.0,male,1939,white,None,Primary Tumor,None,2.0,20.0,65.0,5.0,19.0,60.0,TCGA-BR-8059-01A,TCGA-BR-8059,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A94T,26702.0,male,1938,not reported,888,Primary Tumor,1.0,1.0,10.0,90.0,8.0,10.0,75.0,TCGA-VQ-A94T-01A,TCGA-VQ-A94T,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4J8,26048.0,female,1941,white,79,Primary Tumor,0.0,0.0,0.0,70.0,4.0,70.0,26.0,TCGA-BR-A4J8-01A,TCGA-BR-A4J8,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3713,24927.0,male,1937,not reported,None,Primary Tumor,None,None,44.0,73.0,1.0,None,55.0,TCGA-AA-3713-01A,TCGA-AA-3713,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1027,17588.0,female,1957,white,None,Primary Tumor,None,None,5.0,95.0,None,5.0,90.0,TCGA-23-1027-01A,TCGA-23-1027,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4476,25506.0,male,1941,not reported,None,Primary Tumor,None,None,5.0,75.0,None,20.0,70.0,TCGA-CG-4476-01A,TCGA-CG-4476,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-10-0933,28433.0,female,1926,white,None,Primary Tumor,0.0,None,5.0,90.0,0.0,5.0,90.0,TCGA-10-0933-01A,TCGA-10-0933,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1845,15599.0,female,1967,white,None,Primary Tumor,10.0,0.0,0.0,90.0,0.0,0.0,90.0,TCGA-24-1845-01A,TCGA-24-1845,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4441,30528.0,male,1923,not reported,None,Primary Tumor,2.0,None,0.0,75.0,8.0,22.0,70.0,TCGA-CG-4441-01A,TCGA-CG-4441,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2280,27356.0,female,1930,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,88.0,TCGA-24-2280-01A,TCGA-24-2280,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-8249,28012.0,male,1935,asian,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-HU-8249-01A,TCGA-HU-8249,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-2352,None,female,1924,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-59-2352-01A,TCGA-59-2352,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1024,19052.0,female,1955,white,None,Primary Tumor,None,None,10.0,80.0,None,5.0,85.0,TCGA-23-1024-01A,TCGA-23-1024,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6164,16802.0,female,1963,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,83.0,TCGA-CM-6164-01A,TCGA-CM-6164,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1733,26180.0,female,1935,white,None,Primary Tumor,None,None,0.0,85.0,5.0,0.0,98.0,TCGA-61-1733-01A,TCGA-61-1733,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01Z,24990.0,male,1936,not reported,1877,Primary Tumor,0.0,1.0,0.0,95.0,2.0,4.0,95.0,TCGA-AA-A01Z-01A,TCGA-AA-A01Z,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2298,20453.0,female,1938,white,None,Primary Tumor,None,None,25.0,89.0,None,0.0,74.0,TCGA-24-2298-01A,TCGA-24-2298,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1703,20622.0,female,1949,black or african american,None,Primary Tumor,None,None,0.0,95.0,None,0.0,90.0,TCGA-29-1703-01A,TCGA-29-1703,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6520,19467.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-D7-6520-01A,TCGA-D7-6520,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A6RL,30783.0,male,1928,white,307,Primary Tumor,0.0,0.0,30.0,65.0,5.0,0.0,70.0,TCGA-IN-A6RL-01A,TCGA-IN-A6RL,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-4070,18621.0,female,1957,black or african american,None,Primary Tumor,None,None,5.0,80.0,None,5.0,88.0,TCGA-AY-4070-01A,TCGA-AY-4070,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4H3,20790.0,female,1955,asian,467,Primary Tumor,0.0,0.0,25.0,75.0,15.0,22.0,38.0,TCGA-HU-A4H3-01A,TCGA-HU-A4H3,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3666,25020.0,male,1937,not reported,None,Primary Tumor,None,None,0.0,80.0,None,0.0,95.0,TCGA-AA-3666-01A,TCGA-AA-3666,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-57-1993,20498.0,female,1951,white,None,Primary Tumor,None,None,0.0,95.0,None,30.0,70.0,TCGA-57-1993-01A,TCGA-57-1993,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1900,18963.0,female,1957,black or african american,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-61-1900-01A,TCGA-61-1900,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8528,15986.0,female,1967,asian,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CD-8528-01A,TCGA-CD-8528,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6565,24495.0,male,1944,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,70.0,TCGA-BR-6565-01A,TCGA-BR-6565,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-4752,21519.0,male,1952,black or african american,None,Primary Tumor,None,None,15.0,75.0,None,10.0,63.0,TCGA-CM-4752-01A,TCGA-CM-4752,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5726,26998.0,male,1931,not reported,None,Primary Tumor,None,None,10.0,75.0,None,50.0,32.0,TCGA-CG-5726-01A,TCGA-CG-5726,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0714,20109.0,female,1945,white,None,Primary Tumor,None,None,19.0,81.0,None,None,80.0,TCGA-13-0714-01A,TCGA-13-0714,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6531,27633.0,male,1935,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,80.0,TCGA-D5-6531-01A,TCGA-D5-6531,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8368,30874.0,female,1927,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,85.0,TCGA-BR-8368-01A,TCGA-BR-8368,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A7NR,23415.0,female,1949,white,233,Primary Tumor,0.0,0.0,25.0,60.0,7.0,0.0,75.0,TCGA-IN-A7NR-01A,TCGA-IN-A7NR,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A7NU,25515.0,male,1944,white,100,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-IN-A7NU-01A,TCGA-IN-A7NU,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4363,22196.0,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,70.0,TCGA-BR-4363-01A,TCGA-BR-4363,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6928,29411.0,male,1931,white,None,Primary Tumor,5.0,0.0,22.0,40.0,40.0,40.0,35.0,TCGA-D5-6928-01A,TCGA-D5-6928,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2271,20399.0,female,1944,asian,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-24-2271-01A,TCGA-24-2271,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4CS,28211.0,male,1935,white,131,Primary Tumor,1.0,0.0,0.0,90.0,2.0,18.0,78.0,TCGA-BR-A4CS-01A,TCGA-BR-A4CS,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0725,16086.0,female,1958,white,None,Primary Tumor,None,None,0.0,95.0,50.0,10.0,90.0,TCGA-13-0725-01A,TCGA-13-0725,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8N6,28834.0,female,1928,white,2705,Primary Tumor,0.0,0.0,0.0,60.0,3.0,0.0,100.0,TCGA-RD-A8N6-01A,TCGA-RD-A8N6,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1425,16764.0,female,1963,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,69.0,TCGA-24-1425-01A,TCGA-24-1425,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-8631,24898.0,male,1944,white,None,Primary Tumor,5.0,0.0,0.0,70.0,15.0,0.0,100.0,TCGA-FP-8631-01A,TCGA-FP-8631,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4HD,26699.0,male,1937,asian,719,Primary Tumor,1.0,1.0,20.0,70.0,3.0,0.0,80.0,TCGA-HU-A4HD-01A,TCGA-HU-A4HD,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6926,23768.0,male,1946,white,None,Primary Tumor,1.0,0.0,15.0,10.0,15.0,76.0,10.0,TCGA-D5-6926-01A,TCGA-D5-6926,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8592,23133.0,female,1949,white,None,Primary Tumor,None,None,5.0,60.0,None,40.0,55.0,TCGA-BR-8592-01A,TCGA-BR-8592,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1319,26786.0,female,1927,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,90.0,TCGA-25-1319-01A,TCGA-25-1319,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1506,16734.0,female,1963,white,None,Primary Tumor,None,None,0.0,99.0,None,1.0,98.0,TCGA-13-1506-01A,TCGA-13-1506,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3715,28428.0,male,1929,not reported,None,Primary Tumor,None,None,19.0,75.0,5.0,None,80.0,TCGA-AA-3715-01A,TCGA-AA-3715,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1850,26369.0,female,1937,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,85.0,TCGA-24-1850-01A,TCGA-24-1850,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A02R,30834.0,female,1922,not reported,1220,Primary Tumor,5.0,0.0,0.0,80.0,5.0,30.0,60.0,TCGA-AA-A02R-01A,TCGA-AA-A02R,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6703,23644.0,male,1947,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,65.0,TCGA-F4-6703-01A,TCGA-F4-6703,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1565,27048.0,female,1923,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-24-1565-01A,TCGA-24-1565,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-20-1686,27588.0,female,1933,white,None,Primary Tumor,None,None,0.0,80.0,None,35.0,65.0,TCGA-20-1686-01A,TCGA-20-1686,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5460,20392.0,male,1951,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CZ-5460-01A,TCGA-CZ-5460,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5083,23034.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,82.0,TCGA-B0-5083-01A,TCGA-B0-5083,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3727,28641.0,female,1928,not reported,None,Primary Tumor,None,None,2.0,65.0,None,20.0,73.0,TCGA-AG-3727-01A,TCGA-AG-3727,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5565,21642.0,male,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-DV-5565-01A,TCGA-DV-5565,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4963,23373.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4963-01A,TCGA-BP-4963,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4974,21310.0,male,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-BP-4974-01A,TCGA-BP-4974,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5165,15898.0,male,1967,white,None,Primary Tumor,None,None,15.0,80.0,None,10.0,75.0,TCGA-B8-5165-01A,TCGA-B8-5165,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4907,21208.0,male,1948,white,None,Primary Tumor,None,None,5.0,80.0,None,35.0,60.0,TCGA-CJ-4907-01A,TCGA-CJ-4907,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5190,22285.0,male,1946,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,85.0,TCGA-BP-5190-01A,TCGA-BP-5190,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4822,28774.0,male,1924,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-B0-4822-01A,TCGA-B0-4822,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3357,22825.0,male,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-A3-3357-01A,TCGA-A3-3357,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-5869,22676.0,female,1948,black or african american,None,Primary Tumor,2.0,1.0,10.0,75.0,10.0,0.0,85.0,TCGA-DC-5869-01A,TCGA-DC-5869,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5573,15264.0,male,1967,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,80.0,TCGA-DV-5573-01A,TCGA-DV-5573,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5008,17008.0,male,1961,white,None,Primary Tumor,None,None,10.0,75.0,None,10.0,80.0,TCGA-BP-5008-01A,TCGA-BP-5008,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5094,22965.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,82.0,TCGA-B0-5094-01A,TCGA-B0-5094,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-2690,28119.0,female,1933,white,None,Primary Tumor,None,None,15.0,70.0,None,15.0,70.0,TCGA-AF-2690-01A,TCGA-AF-2690,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5707,14598.0,female,1965,white,None,Primary Tumor,0.0,20.0,0.0,75.0,5.0,12.0,88.0,TCGA-B0-5707-01A,TCGA-B0-5707,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3365,16915.0,male,1960,white,None,Primary Tumor,None,None,10.0,85.0,None,5.0,85.0,TCGA-A3-3365-01A,TCGA-A3-3365,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0750,16018.0,male,1965,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,80.0,TCGA-06-0750-01A,TCGA-06-0750,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5470,26494.0,female,1936,not reported,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CZ-5470-01A,TCGA-CZ-5470,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-19-2619,20159.0,female,1954,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,0.0,85.0,TCGA-19-2619-01A,TCGA-19-2619,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5192,21891.0,male,1948,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5192-01A,TCGA-BP-5192,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5159,22462.0,female,1949,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-B8-5159-01A,TCGA-B8-5159,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-26-5134,27111.0,male,1935,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,95.0,TCGA-26-5134-01A,TCGA-26-5134,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5451,27312.0,male,1932,white,None,Primary Tumor,0.0,0.0,0.0,85.0,2.0,10.0,90.0,TCGA-CZ-5451-01A,TCGA-CZ-5451,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4712,28095.0,male,1930,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,65.0,TCGA-B0-4712-01A,TCGA-B0-4712,4.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-4G-AAZO,25989.0,female,1941,white,630,Primary Tumor,0.0,0.0,0.0,90.0,4.0,40.0,45.0,TCGA-4G-AAZO-01A,TCGA-4G-AAZO,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4698,27417.0,male,1928,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4698-01A,TCGA-B0-4698,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5004,19383.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-5004-01A,TCGA-BP-5004,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5466,24669.0,male,1940,not reported,None,Primary Tumor,None,None,15.0,75.0,None,10.0,75.0,TCGA-CZ-5466-01A,TCGA-CZ-5466,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AS-3777,23039.0,male,1946,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-AS-3777-01A,TCGA-AS-3777,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-6032,23310.0,female,1941,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CJ-6032-01A,TCGA-CJ-6032,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6156,22706.0,male,1948,white,None,Primary Tumor,None,None,0.0,60.0,None,35.0,62.0,TCGA-DC-6156-01A,TCGA-DC-6156,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0882,11112.0,male,1978,white,None,Primary Tumor,None,None,10.0,90.0,None,0.0,80.0,TCGA-06-0882-01A,TCGA-06-0882,
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-8693,27468.0,male,1937,white,None,Primary Tumor,5.0,0.0,10.0,80.0,90.0,0.0,90.0,TCGA-FA-8693-01A,TCGA-FA-8693,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1081,25440.0,male,1927,white,None,Primary Tumor,None,None,None,85.0,None,None,None,TCGA-21-1081-01A,TCGA-21-1081,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EE,31421.0,male,1926,white,537,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-V4-A9EE-01A,TCGA-V4-A9EE,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2719,30379.0,female,1924,white,None,Primary Tumor,None,None,7.0,85.0,None,5.0,83.0,TCGA-60-2719-01A,TCGA-60-2719,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-A4BB,24590.0,male,1945,white,97,Primary Tumor,0.0,2.0,3.0,95.0,3.0,2.0,95.0,TCGA-FA-A4BB-01A,TCGA-FA-A4BB,4.0
UVM,Uveal Melanoma,Eye,TCGA-VD-AA8O,28250.0,male,1936,not reported,72,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-AA8O-01A,TCGA-VD-AA8O,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-8042,21005.0,female,1953,asian,None,Primary Tumor,None,None,0.0,90.0,9.0,0.0,100.0,TCGA-FF-8042-01A,TCGA-FF-8042,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-G8-6907,21021.0,female,1943,white,None,Primary Tumor,None,None,0.0,90.0,90.0,0.0,100.0,TCGA-G8-6907-01A,TCGA-G8-6907,4.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F8,25168.0,male,1944,white,402,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-V4-A9F8-01A,TCGA-V4-A9F8,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-70-6722,17328.0,male,1963,asian,None,Primary Tumor,None,None,15.0,70.0,None,10.0,67.0,TCGA-70-6722-01A,TCGA-70-6722,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8144,25796.0,male,1934,not reported,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-77-8144-01A,TCGA-77-8144,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A53I,23502.0,male,1948,white,70,Primary Tumor,2.0,1.0,0.0,80.0,4.0,19.0,80.0,TCGA-98-A53I-01A,TCGA-98-A53I,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A4XL,20486.0,female,1956,white,218,Primary Tumor,0.0,0.0,40.0,89.0,0.0,0.0,60.0,TCGA-EB-A4XL-01A,TCGA-EB-A4XL,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-J1-A4AH,25893.0,male,1942,white,104,Primary Tumor,4.0,2.0,0.0,65.0,6.0,20.0,65.0,TCGA-J1-A4AH-01A,TCGA-J1-A4AH,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-96-7544,30548.0,male,1925,white,None,Primary Tumor,1.0,1.0,5.0,40.0,20.0,50.0,45.0,TCGA-96-7544-01A,TCGA-96-7544,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-O2-A52V,27449.0,female,1931,black or african american,2303,Primary Tumor,2.0,1.0,0.0,75.0,4.0,20.0,75.0,TCGA-O2-A52V-01A,TCGA-O2-A52V,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-A4VJ,25991.0,female,1941,white,107,Primary Tumor,0.0,1.0,0.0,80.0,3.0,0.0,100.0,TCGA-94-A4VJ-01A,TCGA-94-A4VJ,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A82B,21239.0,female,1955,asian,92,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-EB-A82B-01A,TCGA-EB-A82B,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8329,20972.0,female,1946,asian,None,Primary Tumor,0.0,0.0,0.0,85.0,5.0,7.0,93.0,TCGA-KL-8329-01A,TCGA-KL-8329,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20T,23220.0,male,1944,white,1464,Primary Tumor,0.0,0.0,0.0,75.0,3.0,25.0,75.0,TCGA-BT-A20T-01A,TCGA-BT-A20T,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-AA3D,22205.0,male,1949,white,1726,Primary Tumor,0.0,0.0,40.0,65.0,3.0,0.0,60.0,TCGA-G2-AA3D-01A,TCGA-G2-AA3D,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7253,21473.0,male,1935,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,60.0,40.0,TCGA-CV-7253-01A,TCGA-CV-7253,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A50L,21214.0,male,1954,asian,81,Primary Tumor,4.0,2.0,0.0,60.0,3.0,25.0,60.0,TCGA-IG-A50L-01A,TCGA-IG-A50L,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-AA3K,22093.0,male,1953,black or african american,13,Primary Tumor,0.0,0.0,0.0,75.0,10.0,25.0,75.0,TCGA-QK-AA3K-01A,TCGA-QK-AA3K,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6950,23549.0,male,1930,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,99.0,TCGA-CV-6950-01A,TCGA-CV-6950,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-YC-A89H,28741.0,female,1935,white,205,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-YC-A89H-01A,TCGA-YC-A89H,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A8Z7,21711.0,male,1954,black or african american,93,Primary Tumor,0.0,0.0,0.0,70.0,10.0,30.0,70.0,TCGA-QK-A8Z7-01A,TCGA-QK-A8Z7,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A1A3,22235.0,male,1950,white,240,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-DK-A1A3-01A,TCGA-DK-A1A3,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RT,25386.0,female,1938,white,1977,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-N5-A4RT-01A,TCGA-N5-A4RT,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7392,24650.0,female,1942,white,None,Primary Tumor,0.0,0.0,0.0,60.0,30.0,0.0,100.0,TCGA-CR-7392-01A,TCGA-CR-7392,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NF-A4WX,22407.0,female,1950,not reported,471,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-NF-A4WX-01A,TCGA-NF-A4WX,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8148,24918.0,male,1938,not reported,None,Primary Tumor,None,None,0.0,65.0,None,15.0,80.0,TCGA-77-8148-01A,TCGA-77-8148,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5478,28978.0,male,1925,not reported,None,Primary Tumor,0.0,0.0,5.0,60.0,15.0,20.0,55.0,TCGA-22-5478-01A,TCGA-22-5478,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-AA8M,23507.0,male,1949,not reported,132,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-AA8M-01A,TCGA-VD-AA8M,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R5,21811.0,male,1952,white,743,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ZF-A9R5-01A,TCGA-ZF-A9R5,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EU,18711.0,male,1960,white,704,Primary Tumor,2.0,2.0,0.0,60.0,40.0,40.0,45.0,TCGA-VR-A8EU-01A,TCGA-VR-A8EU,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7370,26468.0,female,1937,white,None,Primary Tumor,None,None,0.0,90.0,5.0,10.0,90.0,TCGA-CR-7370-01A,TCGA-CR-7370,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-Q9-A6FW,22586.0,male,1952,white,62,Primary Tumor,2.0,1.0,3.0,60.0,10.0,0.0,97.0,TCGA-Q9-A6FW-01A,TCGA-Q9-A6FW,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A43X,30764.0,male,1928,white,26,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-FD-A43X-01A,TCGA-FD-A43X,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A8YP,18355.0,male,1963,black or african american,65,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-BA-A8YP-01A,TCGA-BA-A8YP,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A4PO,24124.0,female,1945,black or african american,362,Primary Tumor,20.0,10.0,0.0,90.0,60.0,10.0,90.0,TCGA-N8-A4PO-01A,TCGA-N8-A4PO,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMG,18021.0,male,1955,white,3366,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,65.0,TCGA-XF-AAMG-01A,TCGA-XF-AAMG,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45Z,27397.0,male,1925,white,4438,Primary Tumor,0.0,0.0,0.0,70.0,100.0,20.0,80.0,TCGA-CV-A45Z-01A,TCGA-CV-A45Z,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A8OD,24588.0,female,None,black or african american,None,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-UY-A8OD-01A,TCGA-UY-A8OD,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5977,24115.0,male,1941,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CV-5977-01A,TCGA-CV-5977,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-2F-A9KP,24428.0,male,1945,white,916,Primary Tumor,0.0,0.0,10.0,75.0,3.0,0.0,90.0,TCGA-2F-A9KP-01A,TCGA-2F-A9KP,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A4Z9,21659.0,male,1953,white,24,Primary Tumor,6.0,1.0,0.0,95.0,2.0,5.0,95.0,TCGA-D6-A4Z9-01A,TCGA-D6-A4Z9,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-68-A59J,27031.0,female,1938,white,20,Primary Tumor,0.0,0.0,0.0,77.0,0.0,0.0,80.0,TCGA-68-A59J-01A,TCGA-68-A59J,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A1PU,17025.0,female,1964,white,338,Primary Tumor,0.0,0.0,35.0,95.0,0.0,0.0,65.0,TCGA-BF-A1PU-01A,TCGA-BF-A1PU,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8344,18742.0,male,1956,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,85.0,TCGA-KL-8344-01A,TCGA-KL-8344,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-37-3783,18728.0,male,1955,white,None,Primary Tumor,5.0,None,None,60.0,30.0,None,90.0,TCGA-37-3783-01A,TCGA-37-3783,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-92-8063,19193.0,male,1959,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-92-8063-01A,TCGA-92-8063,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NK-A5CX,26879.0,male,1938,white,589,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,75.0,TCGA-NK-A5CX-01A,TCGA-NK-A5CX,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-46-3765,21762.0,female,1950,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,85.0,TCGA-46-3765-01A,TCGA-46-3765,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-5595,18611.0,male,1958,not reported,None,Primary Tumor,None,None,12.0,80.0,None,10.0,60.0,TCGA-18-5595-01A,TCGA-18-5595,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4589,22754.0,female,1930,white,None,Primary Tumor,None,None,0.0,60.0,None,10.0,85.0,TCGA-33-4589-01A,TCGA-33-4589,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-8491,26698.0,male,1939,white,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-94-8491-01A,TCGA-94-8491,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A42Y,26712.0,female,1939,asian,99,Primary Tumor,0.0,0.0,0.0,85.0,3.0,0.0,95.0,TCGA-EB-A42Y-01A,TCGA-EB-A42Y,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8410,27084.0,female,1930,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8410-01A,TCGA-KO-8410,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9RF,27281.0,male,1935,white,1536,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ZF-A9RF-01A,TCGA-ZF-A9RF,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5880,29053.0,male,1927,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,82.0,TCGA-BQ-5880-01A,TCGA-BQ-5880,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HL-7533,23950.0,male,1943,white,None,Primary Tumor,2.0,2.0,0.0,72.0,15.0,0.0,100.0,TCGA-HL-7533-01A,TCGA-HL-7533,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-Z6-A8JD,19523.0,male,1960,white,148,Primary Tumor,4.0,2.0,0.0,75.0,2.0,17.0,75.0,TCGA-Z6-A8JD-01A,TCGA-Z6-A8JD,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-6796,21252.0,male,1950,white,None,Primary Tumor,None,None,0.0,75.0,None,25.0,75.0,TCGA-G7-6796-01A,TCGA-G7-6796,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R0,30222.0,male,1931,white,309,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-ZF-A9R0-01A,TCGA-ZF-A9R0,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6941,18812.0,male,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,90.0,TCGA-CV-6941-01A,TCGA-CV-6941,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-AL-A5DJ,20079.0,female,1955,white,1345,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-AL-A5DJ-01A,TCGA-AL-A5DJ,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MT-A67F,22057.0,female,1952,white,173,Primary Tumor,0.0,0.0,0.0,75.0,20.0,25.0,75.0,TCGA-MT-A67F-01A,TCGA-MT-A67F,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4730,22828.0,male,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CN-4730-01A,TCGA-CN-4730,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A59F,23826.0,female,1947,black or african american,238,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-N5-A59F-01A,TCGA-N5-A59F,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A3PH,28030.0,male,1934,white,427,Primary Tumor,1.0,1.0,0.0,90.0,1.0,9.0,90.0,TCGA-BT-A3PH-01A,TCGA-BT-A3PH,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-4225,26687.0,male,1930,white,None,Primary Tumor,None,None,0.0,95.0,1.0,0.0,81.0,TCGA-BB-4225-01A,TCGA-BB-4225,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A47W,15497.0,male,1970,asian,192,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-CF-A47W-01A,TCGA-CF-A47W,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A64Z,29037.0,female,1932,white,555,Primary Tumor,0.0,0.0,0.0,75.0,10.0,30.0,70.0,TCGA-QK-A64Z-01A,TCGA-QK-A64Z,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9JZ,18885.0,female,1955,white,2579,Primary Tumor,0.0,10.0,0.0,70.0,1.0,0.0,100.0,TCGA-5P-A9JZ-01A,TCGA-5P-A9JZ,
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MZ-A5BI,19500.0,male,1955,white,1723,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-MZ-A5BI-01A,TCGA-MZ-A5BI,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SR,24979.0,male,1942,white,569,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-FD-A3SR-01A,TCGA-FD-A3SR,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA76,23542.0,female,1949,white,216,Primary Tumor,0.0,0.0,0.0,60.0,2.0,0.0,100.0,TCGA-DK-AA76-01A,TCGA-DK-AA76,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-5249,13047.0,female,1972,white,None,Primary Tumor,None,None,None,80.0,15.0,None,100.0,TCGA-CR-5249-01A,TCGA-CR-5249,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-A5NK,30088.0,male,None,not reported,None,Primary Tumor,0.0,3.0,0.0,80.0,2.0,0.0,98.0,TCGA-HE-A5NK-01A,TCGA-HE-A5NK,
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4725,22171.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CN-4725-01A,TCGA-CN-4725,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A7DU,27000.0,male,1940,white,149,Primary Tumor,0.0,0.0,0.0,95.0,3.0,20.0,68.0,TCGA-E7-A7DU-01A,TCGA-E7-A7DU,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-HQ-A2OE,None,male,1938,not reported,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-HQ-A2OE-01A,TCGA-HQ-A2OE,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-A764,24343.0,male,1946,white,232,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-GU-A764-01A,TCGA-GU-A764,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-QN-A5NN,20318.0,female,1957,asian,253,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-QN-A5NN-01A,TCGA-QN-A5NN,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A8HY,21636.0,male,1954,asian,119,Primary Tumor,1.0,0.0,0.0,94.0,2.0,30.0,69.0,TCGA-CF-A8HY-01A,TCGA-CF-A8HY,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OM,19845.0,female,1956,white,936,Primary Tumor,1.0,0.0,0.0,70.0,5.0,0.0,100.0,TCGA-L5-A4OM-01A,TCGA-L5-A4OM,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7834,19660.0,male,1948,white,None,Primary Tumor,0.0,15.0,0.0,80.0,0.0,20.0,80.0,TCGA-DW-7834-01A,TCGA-DW-7834,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A3Y1,20917.0,male,1955,white,101,Primary Tumor,0.0,0.0,0.0,95.0,2.0,13.0,85.0,TCGA-E7-A3Y1-01A,TCGA-E7-A3Y1,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN3,27909.0,male,1931,white,2445,Primary Tumor,4.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-XF-AAN3-01A,TCGA-XF-AAN3,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A88V,22066.0,male,1947,white,2137,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-L5-A88V-01A,TCGA-L5-A88V,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN0,24877.0,male,1939,white,2551,Primary Tumor,4.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-XF-AAN0-01A,TCGA-XF-AAN0,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6012,24286.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,77.0,TCGA-CN-6012-01A,TCGA-CN-6012,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-H7-8501,19808.0,male,1958,white,None,Primary Tumor,None,None,0.0,65.0,None,10.0,90.0,TCGA-H7-8501-01A,TCGA-H7-8501,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMZ,29667.0,female,1926,white,2557,Primary Tumor,4.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-XF-AAMZ-01A,TCGA-XF-AAMZ,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-C4-A0F1,26178.0,male,1935,not reported,1541,Primary Tumor,0.0,0.0,0.0,85.0,10.0,20.0,78.0,TCGA-C4-A0F1-01A,TCGA-C4-A0F1,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PN,19724.0,male,None,white,None,Primary Tumor,0.0,2.0,0.0,60.0,2.0,0.0,100.0,TCGA-UZ-A9PN-01A,TCGA-UZ-A9PN,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN1,27687.0,female,1931,not reported,2644,Primary Tumor,0.0,0.0,0.0,90.0,7.0,18.0,78.0,TCGA-XF-AAN1-01A,TCGA-XF-AAN1,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A4A1,21954.0,male,1951,asian,464,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,85.0,TCGA-LN-A4A1-01A,TCGA-LN-A4A1,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NR,29730.0,female,1920,not reported,4536,Primary Tumor,1.0,0.0,0.0,65.0,5.0,0.0,97.0,TCGA-L5-A8NR-01A,TCGA-L5-A8NR,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T8,19754.0,male,1956,white,1060,Primary Tumor,1.0,2.0,15.0,65.0,8.0,35.0,50.0,TCGA-P3-A6T8-01A,TCGA-P3-A6T8,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3N6,15758.0,female,1968,black or african american,181,Primary Tumor,1.0,1.0,0.0,75.0,2.0,20.0,75.0,TCGA-FD-A3N6-01A,TCGA-FD-A3N6,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NN,29891.0,male,1923,white,3400,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,90.0,TCGA-L5-A8NN-01A,TCGA-L5-A8NN,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-A5W8,18440.0,male,1962,black or african american,131,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-B9-A5W8-01A,TCGA-B9-A5W8,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9T3,25532.0,female,1939,white,2140,Primary Tumor,0.0,0.0,35.0,65.0,4.0,0.0,65.0,TCGA-XF-A9T3-01A,TCGA-XF-A9T3,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN2,26720.0,male,1934,white,2505,Primary Tumor,4.0,1.0,0.0,65.0,2.0,15.0,65.0,TCGA-XF-AAN2-01A,TCGA-XF-AAN2,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3B3,27068.0,female,1937,white,182,Primary Tumor,0.0,0.0,0.0,75.0,15.0,15.0,85.0,TCGA-FD-A3B3-01A,TCGA-FD-A3B3,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-6790,21169.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,1.0,81.0,TCGA-G7-6790-01A,TCGA-G7-6790,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JM,31147.0,male,1926,white,710,Primary Tumor,4.0,1.0,0.0,65.0,2.0,33.0,65.0,TCGA-CV-A6JM-01A,TCGA-CV-A6JM,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A4II,17011.0,male,1965,white,498,Primary Tumor,0.0,2.0,0.0,80.0,25.0,60.0,40.0,TCGA-BA-A4II-01A,TCGA-BA-A4II,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OG,29105.0,female,1933,white,184,Primary Tumor,0.0,0.0,0.0,60.0,25.0,40.0,60.0,TCGA-L5-A4OG-01A,TCGA-L5-A4OG,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-7754,25365.0,male,1942,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,88.0,TCGA-HD-7754-01A,TCGA-HD-7754,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49Y,28125.0,male,1934,asian,471,Primary Tumor,1.0,1.0,0.0,85.0,2.0,14.0,85.0,TCGA-LN-A49Y-01A,TCGA-LN-A49Y,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A3QU,21233.0,male,1953,white,182,Primary Tumor,0.0,0.0,0.0,99.0,0.0,1.0,96.0,TCGA-CU-A3QU-01A,TCGA-CU-A3QU,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A61J,19913.0,male,1958,white,344,Primary Tumor,0.0,0.0,10.0,70.0,10.0,30.0,60.0,TCGA-IQ-A61J-01A,TCGA-IQ-A61J,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NJ,28200.0,male,1923,white,4723,Primary Tumor,0.0,0.0,15.0,60.0,0.0,0.0,85.0,TCGA-L5-A8NJ-01A,TCGA-L5-A8NJ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A2I2,23116.0,female,1947,white,217,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-DK-A2I2-01A,TCGA-DK-A2I2,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A3YB,22316.0,male,1951,white,100,Primary Tumor,0.0,1.0,10.0,100.0,1.0,25.0,65.0,TCGA-IG-A3YB-01A,TCGA-IG-A3YB,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-4228,18536.0,male,1960,white,None,Primary Tumor,None,None,0.0,90.0,2.0,1.0,77.0,TCGA-BB-4228-01A,TCGA-BB-4228,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NA-A4QY,22756.0,female,1947,white,1101,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,90.0,TCGA-NA-A4QY-01A,TCGA-NA-A4QY,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A51D,23259.0,male,1949,white,135,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-IG-A51D-01A,TCGA-IG-A51D,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3RB,20021.0,male,1957,white,174,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-GC-A3RB-01A,TCGA-GC-A3RB,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-6869,22765.0,male,1948,white,None,Primary Tumor,None,None,0.0,95.0,1.0,7.0,92.0,TCGA-BA-6869-01A,TCGA-BA-6869,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A938,27633.0,male,1937,white,618,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-JY-A938-01A,TCGA-JY-A938,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A8HB,18544.0,female,1956,not reported,2731,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-XF-A8HB-01A,TCGA-XF-A8HB,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-2F-A9KR,21848.0,female,1941,not reported,4919,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-2F-A9KR-01A,TCGA-2F-A9KR,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T0,17259.0,female,1960,white,2368,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,60.0,TCGA-P3-A6T0-01A,TCGA-P3-A6T0,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-RE-A7BO,26348.0,female,1934,white,2614,Primary Tumor,0.0,20.0,0.0,70.0,80.0,30.0,70.0,TCGA-RE-A7BO-01A,TCGA-RE-A7BO,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9T4,17728.0,male,1960,white,2146,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-XF-A9T4-01A,TCGA-XF-A9T4,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6482,22741.0,male,1948,black or african american,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CR-6482-01A,TCGA-CR-6482,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-6870,22222.0,female,1950,black or african american,None,Primary Tumor,1.0,None,0.0,98.0,None,2.0,97.0,TCGA-BA-6870-01A,TCGA-BA-6870,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A72E,27963.0,male,1937,white,197,Primary Tumor,1.0,1.0,0.0,85.0,5.0,54.0,45.0,TCGA-CU-A72E-01A,TCGA-CU-A72E,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A47S,15225.0,male,1970,asian,283,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-CF-A47S-01A,TCGA-CF-A47S,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-5555,19956.0,male,1956,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,15.0,80.0,TCGA-BA-5555-01A,TCGA-BA-5555,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA4X,20579.0,male,1953,white,1603,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,70.0,TCGA-ZF-AA4X-01A,TCGA-ZF-AA4X,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A63T,22201.0,male,1951,white,519,Primary Tumor,30.0,20.0,0.0,60.0,30.0,40.0,60.0,TCGA-CN-A63T-01A,TCGA-CN-A63T,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TD,28328.0,male,1935,white,224,Primary Tumor,0.0,0.0,5.0,75.0,4.0,0.0,95.0,TCGA-FD-A6TD-01A,TCGA-FD-A6TD,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7391,13508.0,female,1973,white,None,Primary Tumor,0.0,0.0,0.0,80.0,16.0,15.0,85.0,TCGA-CR-7391-01A,TCGA-CR-7391,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-5629,23550.0,male,1945,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,75.0,TCGA-DQ-5629-01A,TCGA-DQ-5629,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-Y8-A894,20964.0,female,1956,white,260,Primary Tumor,1.0,5.0,0.0,75.0,2.0,18.0,75.0,TCGA-Y8-A894-01A,TCGA-Y8-A894,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OP,24829.0,female,1943,white,940,Primary Tumor,2.0,1.0,0.0,65.0,6.0,0.0,100.0,TCGA-L5-A4OP-01A,TCGA-L5-A4OP,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A49C,24495.0,male,1945,white,85,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-CN-A49C-01A,TCGA-CN-A49C,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-4223,17608.0,male,1955,white,None,Primary Tumor,None,None,None,72.0,10.0,10.0,80.0,TCGA-BB-4223-01A,TCGA-BB-4223,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-V9-A7HT,24610.0,male,1942,black or african american,1359,Primary Tumor,0.0,0.0,0.0,60.0,0.0,60.0,40.0,TCGA-V9-A7HT-01A,TCGA-V9-A7HT,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9JV,17973.0,male,1956,white,2950,Primary Tumor,0.0,0.0,60.0,60.0,1.0,0.0,40.0,TCGA-5P-A9JV-01A,TCGA-5P-A9JV,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A0S7,27533.0,male,1932,white,1210,Primary Tumor,0.0,0.0,0.0,70.0,3.0,30.0,70.0,TCGA-BT-A0S7-01A,TCGA-BT-A0S7,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-19-2624,18891.0,male,1958,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,98.0,TCGA-19-2624-01A,TCGA-19-2624,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-7002,21192.0,male,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,12.0,80.0,TCGA-EI-7002-01A,TCGA-EI-7002,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5703,26897.0,male,1936,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5703-01A,TCGA-B0-5703,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AH-6897,17536.0,male,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,80.0,TCGA-AH-6897-01A,TCGA-AH-6897,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3325,19126.0,male,1954,white,None,Primary Tumor,None,None,7.0,80.0,None,5.0,88.0,TCGA-A3-3325-01A,TCGA-A3-3325,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5077,28405.0,male,1928,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-B0-5077-01A,TCGA-B0-5077,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-2615,22916.0,male,1947,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,85.0,TCGA-32-2615-01A,TCGA-32-2615,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5588,28714.0,female,1926,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CW-5588-01A,TCGA-CW-5588,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4983,24558.0,female,1939,asian,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4983-01A,TCGA-BP-4983,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5812,19600.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5812-01A,TCGA-B0-5812,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4762,15358.0,male,1962,white,None,Primary Tumor,None,None,0.0,90.0,1.0,29.0,71.0,TCGA-BP-4762-01A,TCGA-BP-4762,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6465,23432.0,female,1946,white,None,Primary Tumor,2.0,0.0,0.0,80.0,7.0,0.0,97.0,TCGA-F5-6465-01A,TCGA-F5-6465,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6097,11701.0,male,1972,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CW-6097-01A,TCGA-CW-6097,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5591,20712.0,male,1948,white,None,Primary Tumor,None,None,0.0,90.0,None,8.0,92.0,TCGA-CW-5591-01A,TCGA-CW-5591,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3612,20242.0,female,1954,not reported,None,Primary Tumor,None,None,0.0,88.0,None,15.0,85.0,TCGA-AG-3612-01A,TCGA-AG-3612,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6087,22438.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,82.0,TCGA-CW-6087-01A,TCGA-CW-6087,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4853,30191.0,male,1923,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CZ-4853-01A,TCGA-CZ-4853,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-12-3653,12529.0,female,1974,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,99.0,TCGA-12-3653-01A,TCGA-12-3653,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-CL-5918,32872,female,1918,white,None,Primary Tumor,None,None,5.0,80.0,None,5.0,83.0,TCGA-CL-5918-01A,TCGA-CL-5918,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5676,17170.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,18.0,82.0,TCGA-CJ-5676-01A,TCGA-CJ-5676,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-4008,23192.0,male,1945,not reported,None,Primary Tumor,None,None,30.0,65.0,None,10.0,57.0,TCGA-AG-4008-01A,TCGA-AG-4008,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4834,18224.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,80.0,TCGA-B0-4834-01A,TCGA-B0-4834,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4174,18054.0,male,1955,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-4174-01A,TCGA-BP-4174,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-2524,20555.0,male,1952,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,95.0,TCGA-27-2524-01A,TCGA-27-2524,
GBM,Glioblastoma Multiforme,Brain,TCGA-14-0789,20050.0,male,1951,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,70.0,TCGA-14-0789-01A,TCGA-14-0789,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-G5-6641,24486.0,male,1942,white,None,Primary Tumor,5.0,1.0,0.0,80.0,5.0,0.0,100.0,TCGA-G5-6641-01A,TCGA-G5-6641,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5178,26070.0,male,1933,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,65.0,TCGA-BP-5178-01A,TCGA-BP-5178,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5162,23008.0,male,1948,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-B8-5162-01A,TCGA-B8-5162,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5378,22980.0,male,1948,white,None,Primary Tumor,1.0,0.0,0.0,90.0,2.0,5.0,95.0,TCGA-B4-5378-01A,TCGA-B4-5378,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5399,17145.0,male,1964,white,None,Primary Tumor,None,None,0.0,85.0,None,3.0,97.0,TCGA-B0-5399-01A,TCGA-B0-5399,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5209,24362.0,female,1944,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,98.0,TCGA-28-5209-01A,TCGA-28-5209,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4707,23322.0,male,1945,white,None,Primary Tumor,None,None,5.0,80.0,None,15.0,80.0,TCGA-B0-4707-01A,TCGA-B0-4707,3.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZH-A8Y5,25268.0,male,1943,white,622,Primary Tumor,0.0,0.0,0.0,60.0,2.0,0.0,100.0,TCGA-ZH-A8Y5-01A,TCGA-ZH-A8Y5,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5196,19719.0,male,1955,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,75.0,TCGA-BP-5196-01A,TCGA-BP-5196,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3602,24350.0,female,1941,not reported,None,Primary Tumor,None,None,15.0,80.0,None,5.0,80.0,TCGA-AG-3602-01A,TCGA-AG-3602,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4989,21382.0,male,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-BP-4989-01A,TCGA-BP-4989,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6511,19237.0,male,1958,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,77.0,TCGA-EI-6511-01A,TCGA-EI-6511,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4848,19892.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-4848-01A,TCGA-B0-4848,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5457,22763.0,male,1944,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CZ-5457-01A,TCGA-CZ-5457,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4701,24232.0,female,1939,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,87.0,TCGA-B0-4701-01A,TCGA-B0-4701,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3363,18596.0,male,1956,asian,None,Primary Tumor,None,None,5.0,85.0,None,5.0,90.0,TCGA-A3-3363-01A,TCGA-A3-3363,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-14-1829,20929.0,male,1952,black or african american,None,Primary Tumor,None,None,15.0,80.0,None,5.0,80.0,TCGA-14-1829-01A,TCGA-14-1829,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4795,27162.0,female,1933,white,None,Primary Tumor,None,None,10.0,75.0,None,5.0,85.0,TCGA-BP-4795-01A,TCGA-BP-4795,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5191,29207.0,male,1928,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5191-01A,TCGA-BP-5191,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-6028,21380.0,male,1945,white,None,Primary Tumor,1.0,3.0,0.0,70.0,20.0,15.0,85.0,TCGA-CJ-6028-01A,TCGA-CJ-6028,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AS-3778,12937.0,male,1975,white,None,Primary Tumor,None,None,0.0,80.0,None,8.0,92.0,TCGA-AS-3778-01A,TCGA-AS-3778,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4995,24850.0,male,1939,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-BP-4995-01A,TCGA-BP-4995,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5108,19932.0,male,1955,white,None,Primary Tumor,None,None,0.0,70.0,None,50.0,50.0,TCGA-B0-5108-01A,TCGA-B0-5108,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4710,27396.0,female,1935,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-4710-01A,TCGA-B0-4710,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0743,25434.0,male,1937,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,90.0,TCGA-06-0743-01A,TCGA-06-0743,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3385,17114.0,female,1961,white,None,Primary Tumor,None,None,0.0,85.0,None,7.0,93.0,TCGA-A3-3385-01A,TCGA-A3-3385,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4844,22220.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-B0-4844-01A,TCGA-B0-4844,4.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZH-A8Y2,21743.0,female,1952,black or african american,897,Primary Tumor,0.0,0.0,0.0,70.0,2.0,0.0,100.0,TCGA-ZH-A8Y2-01A,TCGA-ZH-A8Y2,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-08-0386,27053.0,male,1931,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,90.0,TCGA-08-0386-01A,TCGA-08-0386,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3878,23527.0,male,1943,not reported,None,Primary Tumor,None,None,15.0,75.0,None,10.0,72.0,TCGA-AG-3878-01A,TCGA-AG-3878,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3592,25141.0,male,1939,not reported,None,Primary Tumor,None,None,0.0,80.0,None,8.0,82.0,TCGA-AG-3592-01A,TCGA-AG-3592,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3611,26420.0,male,1937,not reported,None,Primary Tumor,None,None,8.0,76.0,None,32.0,60.0,TCGA-AG-3611-01A,TCGA-AG-3611,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-41-3915,17880.0,male,1962,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,60.0,TCGA-41-3915-01A,TCGA-41-3915,
GBM,Glioblastoma Multiforme,Brain,TCGA-26-5139,23782.0,female,1945,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-26-5139-01A,TCGA-26-5139,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5568,9714.0,male,1983,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-DV-5568-01A,TCGA-DV-5568,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5843,16779.0,male,1965,white,None,Primary Tumor,0.0,0.0,20.0,80.0,0.0,0.0,80.0,TCGA-B4-5843-01A,TCGA-B4-5843,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4166,25300.0,male,1934,white,None,Primary Tumor,None,None,20.0,80.0,None,10.0,70.0,TCGA-BP-4166-01A,TCGA-BP-4166,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4159,25677.0,male,1932,white,None,Primary Tumor,None,None,0.0,80.0,None,45.0,55.0,TCGA-BP-4159-01A,TCGA-BP-4159,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-19-2625,27930.0,female,1933,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,90.0,TCGA-19-2625-01A,TCGA-19-2625,
GBM,Glioblastoma Multiforme,Brain,TCGA-32-2616,17781.0,female,1960,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,90.0,TCGA-32-2616-01A,TCGA-32-2616,
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0187,25318.0,male,1937,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,90.0,TCGA-06-0187-01A,TCGA-06-0187,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4337,27906.0,female,1927,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,75.0,TCGA-BP-4337-01A,TCGA-BP-4337,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-7004,13566.0,female,1974,white,None,Primary Tumor,None,None,5.0,75.0,None,10.0,85.0,TCGA-EI-7004-01A,TCGA-EI-7004,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4691,20176.0,male,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-B0-4691-01A,TCGA-B0-4691,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-G5-6235,26348.0,male,1935,white,None,Primary Tumor,5.0,2.0,24.0,80.0,10.0,0.0,75.0,TCGA-G5-6235-01A,TCGA-G5-6235,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A01W,24745.0,female,1937,not reported,2030,Primary Tumor,12.0,0.0,12.0,75.0,1.0,10.0,75.0,TCGA-AG-A01W-01A,TCGA-AG-A01W,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3582,27636.0,male,1932,not reported,None,Primary Tumor,None,None,1.0,75.0,None,10.0,81.0,TCGA-AG-3582-01A,TCGA-AG-3582,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0749,18571.0,male,1958,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,25.0,75.0,TCGA-06-0749-01A,TCGA-06-0749,
GBM,Glioblastoma Multiforme,Brain,TCGA-76-4925,28011.0,male,1929,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,95.0,TCGA-76-4925-01A,TCGA-76-4925,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3726,23345.0,female,1943,not reported,None,Primary Tumor,None,None,0.0,75.0,None,12.0,83.0,TCGA-AG-3726-01A,TCGA-AG-3726,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-4021,31015.0,female,1921,not reported,None,Primary Tumor,None,None,0.0,80.0,None,15.0,75.0,TCGA-AG-4021-01A,TCGA-AG-4021,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4327,27556.0,female,1927,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-4327-01A,TCGA-BP-4327,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5085,27793.0,female,1929,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5085-01A,TCGA-B0-5085,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-12-0616,13451.0,female,1970,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,30.0,TCGA-12-0616-01A,TCGA-12-0616,
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5207,25975.0,male,1939,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-28-5207-01A,TCGA-28-5207,
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0219,24488.0,male,1933,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,80.0,TCGA-06-0219-01A,TCGA-06-0219,
GBM,Glioblastoma Multiforme,Brain,TCGA-19-2620,25665.0,male,1939,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-19-2620-01A,TCGA-19-2620,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5163,23293.0,female,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-B8-5163-01A,TCGA-B8-5163,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-4151,18760.0,female,1958,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,60.0,TCGA-B8-4151-01A,TCGA-B8-4151,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-2523,23034.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,95.0,TCGA-27-2523-01A,TCGA-27-2523,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4349,24853.0,female,1938,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-BP-4349-01A,TCGA-BP-4349,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-4143,24132.0,female,1936,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B8-4143-01A,TCGA-B8-4143,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-4001,27302.0,female,1935,not reported,None,Primary Tumor,None,None,0.0,75.0,None,30.0,65.0,TCGA-AG-4001-01A,TCGA-AG-4001,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4799,25842.0,male,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,0.0,85.0,TCGA-BP-4799-01A,TCGA-BP-4799,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4777,17133.0,male,1959,white,None,Primary Tumor,None,None,None,90.0,5.0,None,100.0,TCGA-BP-4777-01A,TCGA-BP-4777,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-76-4931,25812.0,female,1935,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,95.0,TCGA-76-4931-01A,TCGA-76-4931,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6155,11381.0,female,1979,white,None,Primary Tumor,0.0,0.0,2.0,75.0,20.0,10.0,83.0,TCGA-DC-6155-01A,TCGA-DC-6155,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-A4VZ,19560.0,male,1954,black or african american,1816,Primary Tumor,0.0,0.0,0.0,80.0,0.0,35.0,65.0,TCGA-DV-A4VZ-01A,TCGA-DV-A4VZ,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5712,24988.0,female,1936,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,18.0,82.0,TCGA-B0-5712-01A,TCGA-B0-5712,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3445,25494.0,male,1937,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-AK-3445-01A,TCGA-AK-3445,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0157,23128.0,female,1935,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,95.0,TCGA-06-0157-01A,TCGA-06-0157,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5697,18486.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-5697-01A,TCGA-B0-5697,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5096,26574.0,female,1926,white,None,Primary Tumor,None,None,0.0,70.0,None,70.0,22.0,TCGA-B0-5096-01A,TCGA-B0-5096,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AH-6549,24337.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,77.0,TCGA-AH-6549-01A,TCGA-AH-6549,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54K,22627.0,male,1951,black or african american,76,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-B8-A54K-01A,TCGA-B8-A54K,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4992,24438.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4992-01A,TCGA-BP-4992,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6154,21093.0,female,1953,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,70.0,TCGA-DC-6154-01A,TCGA-DC-6154,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5158,20764.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,75.0,TCGA-B8-5158-01A,TCGA-B8-5158,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DY-A1DD,28159.0,female,1922,white,4107,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-DY-A1DD-01A,TCGA-DY-A1DD,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4839,29380.0,female,1923,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4839-01A,TCGA-B0-4839,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6681,25659.0,female,1941,white,None,Primary Tumor,None,None,5.0,80.0,None,30.0,65.0,TCGA-DC-6681-01A,TCGA-DC-6681,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5182,20597.0,male,1951,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-BP-5182-01A,TCGA-BP-5182,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4895,22892.0,male,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4895-01A,TCGA-CJ-4895,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4346,21057.0,male,1949,white,None,Primary Tumor,None,None,3.0,85.0,None,20.0,77.0,TCGA-BP-4346-01A,TCGA-BP-4346,3.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA36,18882.0,female,1957,white,2007,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-W5-AA36-01A,TCGA-W5-AA36,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5120,26559.0,female,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-B0-5120-01A,TCGA-B0-5120,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5836,22341.0,female,1949,white,None,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-B4-5836-01A,TCGA-B4-5836,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4819,22220.0,female,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-4819-01A,TCGA-B0-4819,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5569,10698.0,female,1980,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-DV-5569-01A,TCGA-DV-5569,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3881,30467.0,female,1925,not reported,None,Primary Tumor,None,None,20.0,75.0,None,5.0,79.0,TCGA-AG-3881-01A,TCGA-AG-3881,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6884,25995.0,male,1940,white,None,Primary Tumor,None,None,12.0,73.0,None,12.0,76.0,TCGA-EI-6884-01A,TCGA-EI-6884,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5695,22320.0,female,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-5695-01A,TCGA-B0-5695,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4858,14343.0,male,1966,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,80.0,TCGA-CZ-4858-01A,TCGA-CZ-4858,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6158,25842.0,male,1940,white,None,Primary Tumor,None,None,10.0,70.0,None,20.0,65.0,TCGA-DC-6158-01A,TCGA-DC-6158,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4975,14710.0,male,1966,white,None,Primary Tumor,None,None,10.0,80.0,None,10.0,80.0,TCGA-BP-4975-01A,TCGA-BP-4975,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-4022,21823.0,female,1947,not reported,None,Primary Tumor,None,None,20.0,75.0,None,10.0,67.0,TCGA-AG-4022-01A,TCGA-AG-4022,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4827,28467.0,female,1925,white,None,Primary Tumor,None,None,0.0,85.0,None,30.0,70.0,TCGA-B0-4827-01A,TCGA-B0-4827,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4969,23216.0,female,1943,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,85.0,TCGA-BP-4969-01A,TCGA-BP-4969,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-A8OV,27526.0,male,1936,black or african american,909,Primary Tumor,0.0,3.0,0.0,75.0,2.0,0.0,100.0,TCGA-A3-A8OV-01A,TCGA-A3-A8OV,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-15-1444,7827.0,male,1983,white,None,Primary Tumor,None,None,0.0,40.0,None,80.0,20.0,TCGA-15-1444-01A,TCGA-15-1444,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54J,22071.0,male,1952,black or african american,82,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-B8-A54J-01A,TCGA-B8-A54J,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4332,13404.0,male,1966,white,None,Primary Tumor,None,None,5.0,75.0,None,25.0,70.0,TCGA-BP-4332-01A,TCGA-BP-4332,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6090,24909.0,male,1935,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CW-6090-01A,TCGA-CW-6090,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4908,14226.0,male,1968,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-CJ-4908-01A,TCGA-CJ-4908,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZH-A8Y8,26744.0,male,1940,white,69,Primary Tumor,0.0,0.0,15.0,75.0,0.0,0.0,85.0,TCGA-ZH-A8Y8-01A,TCGA-ZH-A8Y8,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DY-A0XA,21115.0,female,1944,white,3475,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,85.0,TCGA-DY-A0XA-01A,TCGA-DY-A0XA,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4776,19143.0,male,1953,white,None,Primary Tumor,None,None,None,90.0,3.0,5.0,95.0,TCGA-BP-4776-01A,TCGA-BP-4776,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5710,21168.0,male,1951,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5710-01A,TCGA-B0-5710,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3898,22492.0,male,1945,not reported,None,Primary Tumor,None,None,0.0,75.0,None,30.0,60.0,TCGA-AG-3898-01A,TCGA-AG-3898,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4875,24510.0,male,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,85.0,TCGA-CJ-4875-01A,TCGA-CJ-4875,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4871,23195.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CJ-4871-01A,TCGA-CJ-4871,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5683,28745.0,male,1926,white,None,Primary Tumor,None,None,0.0,85.0,None,8.0,92.0,TCGA-CJ-5683-01A,TCGA-CJ-5683,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4761,21019.0,male,1947,white,None,Primary Tumor,None,None,None,80.0,None,3.0,97.0,TCGA-BP-4761-01A,TCGA-BP-4761,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4714,29873.0,male,1929,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-4714-01A,TCGA-B0-4714,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5010,23130.0,male,1944,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,80.0,TCGA-BP-5010-01A,TCGA-BP-5010,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4803,28934.0,male,1929,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,85.0,TCGA-BP-4803-01A,TCGA-BP-4803,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5461,19030.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CZ-5461-01A,TCGA-CZ-5461,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88K,21524.0,male,1953,not reported,870,Primary Tumor,20.0,10.0,0.0,70.0,60.0,30.0,70.0,TCGA-VN-A88K-01A,TCGA-VN-A88K,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADN,21632.0,male,1953,asian,602,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADN-01A,TCGA-DD-AADN,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3L0,28003.0,female,1934,white,422,Primary Tumor,0.0,0.0,0.0,95.0,1.0,0.0,100.0,TCGA-EO-A3L0-01A,TCGA-EO-A3L0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5531,22760.0,male,1947,white,None,Primary Tumor,0.0,2.0,15.0,70.0,4.0,30.0,65.0,TCGA-EJ-5531-01A,TCGA-EJ-5531,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A103,31841.0,female,1922,white,376,Primary Tumor,20.0,30.0,0.0,80.0,40.0,15.0,80.0,TCGA-D1-A103-01A,TCGA-D1-A103,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5750,26389.0,male,1936,white,None,Primary Tumor,0.0,0.0,15.0,80.0,0.0,10.0,75.0,TCGA-CH-5750-01A,TCGA-CH-5750,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3FV,22752.0,female,1947,white,799,Primary Tumor,0.0,0.0,0.0,97.0,0.0,5.0,90.0,TCGA-AX-A3FV-01A,TCGA-AX-A3FV,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-KP-A3W3,26310.0,female,1938,white,739,Primary Tumor,10.0,20.0,0.0,90.0,60.0,5.0,90.0,TCGA-KP-A3W3-01A,TCGA-KP-A3W3,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A7NG,23458.0,male,1949,not reported,209,Primary Tumor,0.0,0.0,15.0,65.0,0.0,35.0,50.0,TCGA-EJ-A7NG-01A,TCGA-EJ-A7NG,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9HA,25892.0,male,1942,white,713,Primary Tumor,1.0,0.0,0.0,95.0,4.0,8.0,89.0,TCGA-2Y-A9HA-01A,TCGA-2Y-A9HA,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5772,23194.0,male,1945,white,None,Primary Tumor,0.0,0.0,25.0,70.0,0.0,15.0,60.0,TCGA-CH-5772-01A,TCGA-CH-5772,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A06L,23294.0,female,1943,white,1499,Primary Tumor,1.0,0.0,25.0,60.0,12.0,2.0,65.0,TCGA-AX-A06L-01A,TCGA-AX-A06L,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE0,16732.0,female,1968,asian,314,Primary Tumor,1.0,1.0,0.0,80.0,15.0,62.0,37.0,TCGA-DD-AAE0-01A,TCGA-DD-AAE0,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10T,27944.0,male,1924,white,3660,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-BC-A10T-01A,TCGA-BC-A10T,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A215,22076.0,female,1950,white,293,Primary Tumor,10.0,40.0,0.0,80.0,40.0,10.0,80.0,TCGA-EY-A215-01A,TCGA-EY-A215,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9HB,24359.0,male,1946,not reported,497,Primary Tumor,1.0,0.0,0.0,90.0,8.0,8.0,90.0,TCGA-2Y-A9HB-01A,TCGA-2Y-A9HB,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADD,18752.0,male,1960,asian,931,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADD-01A,TCGA-DD-AADD,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-WX-AA44,23654.0,female,1947,white,924,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-WX-AA44-01A,TCGA-WX-AA44,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-Y6-A8TL,23776.0,male,1947,not reported,677,Primary Tumor,0.0,0.0,15.0,70.0,0.0,30.0,55.0,TCGA-Y6-A8TL-01A,TCGA-Y6-A8TL,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7211,22768.0,male,1948,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-HC-7211-01A,TCGA-HC-7211,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A165,23526.0,female,1944,white,848,Primary Tumor,0.0,1.0,0.0,60.0,4.0,40.0,60.0,TCGA-D1-A165-01A,TCGA-D1-A165,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A05A,29914.0,female,1925,white,1479,Primary Tumor,0.0,0.0,0.0,96.0,0.0,5.0,93.0,TCGA-AP-A05A-01A,TCGA-AP-A05A,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A25Z,21509.0,male,1952,asian,233,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-G3-A25Z-01A,TCGA-G3-A25Z,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A9FV,21044.0,male,1956,asian,184,Primary Tumor,0.0,1.0,0.0,95.0,4.0,4.0,94.0,TCGA-CC-A9FV-01A,TCGA-CC-A9FV,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A160,25673.0,female,1938,white,895,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-D1-A160-01A,TCGA-D1-A160,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6338,22360.0,male,1946,white,None,Primary Tumor,0.0,0.0,10.0,75.0,2.0,15.0,75.0,TCGA-G9-6338-01A,TCGA-G9-6338,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7821,19894.0,male,1957,white,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-HC-7821-01A,TCGA-HC-7821,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2KR,31007.0,female,None,not reported,None,Primary Tumor,5.0,15.0,0.0,95.0,25.0,5.0,93.0,TCGA-DF-A2KR-01A,TCGA-DF-A2KR,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-8470,21209.0,male,1952,not reported,None,Primary Tumor,None,None,15.0,75.0,None,10.0,75.0,TCGA-EJ-8470-01A,TCGA-EJ-8470,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A3M9,16460.0,male,1966,asian,226,Primary Tumor,2.0,1.0,0.0,70.0,7.0,30.0,70.0,TCGA-CC-A3M9-01A,TCGA-CC-A3M9,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1E1,27072.0,female,1935,white,470,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-AP-A1E1-01A,TCGA-AP-A1E1,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-XR-A8TF,27145.0,male,1938,white,481,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-XR-A8TF-01A,TCGA-XR-A8TF,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17M,20685.0,female,1953,white,454,Primary Tumor,3.0,2.0,0.0,65.0,10.0,35.0,65.0,TCGA-D1-A17M-01A,TCGA-D1-A17M,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A3JP,22538.0,female,1950,white,101,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,100.0,TCGA-D1-A3JP-01A,TCGA-D1-A3JP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A1OJ,11635.0,female,1979,asian,161,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-A5-A1OJ-01A,TCGA-A5-A1OJ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3FS,30102.0,female,1928,white,609,Primary Tumor,0.0,0.0,10.0,95.0,1.0,5.0,75.0,TCGA-AX-A3FS-01A,TCGA-AX-A3FS,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-5R-AA1D,6545.0,female,1996,white,58,Primary Tumor,0.0,0.0,0.0,92.0,3.0,19.0,80.0,TCGA-5R-AA1D-01A,TCGA-5R-AA1D,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11Q,23538.0,female,1944,white,702,Primary Tumor,0.0,1.0,0.0,70.0,1.0,30.0,68.0,TCGA-B5-A11Q-01A,TCGA-B5-A11Q,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3G1,31037.0,female,1925,white,765,Primary Tumor,0.0,1.0,0.0,92.0,3.0,5.0,93.0,TCGA-AX-A3G1-01A,TCGA-AX-A3G1,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-KJ-A3U4,20392.0,female,1957,white,56,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-KJ-A3U4-01A,TCGA-KJ-A3U4,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XA-A8JR,25090.0,male,1945,not reported,223,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-XA-A8JR-01A,TCGA-XA-A8JR,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16B,23450.0,female,1944,white,793,Primary Tumor,6.0,2.0,0.0,70.0,2.0,30.0,65.0,TCGA-D1-A16B-01A,TCGA-D1-A16B,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3G4,22099.0,female,1950,native hawaiian or other pacific islander,463,Primary Tumor,1.0,0.0,3.0,94.0,1.0,3.0,90.0,TCGA-AX-A3G4-01A,TCGA-AX-A3G4,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0U8,20402.0,female,1949,white,2432,Primary Tumor,40.0,20.0,0.0,80.0,30.0,15.0,80.0,TCGA-BS-A0U8-01A,TCGA-BS-A0U8,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11M,16063.0,female,1964,white,1085,Primary Tumor,0.0,2.0,0.0,50.0,30.0,50.0,50.0,TCGA-B5-A11M-01A,TCGA-B5-A11M,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OX,20805.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-V1-A9OX-01A,TCGA-V1-A9OX,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10R,24274.0,female,1933,white,4316,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-BC-A10R-01A,TCGA-BC-A10R,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A5W2,26498.0,female,1940,black or african american,105,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-EY-A5W2-01A,TCGA-EY-A5W2,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A2K2,28456.0,female,1926,white,2812,Primary Tumor,3.0,1.0,0.0,80.0,1.0,15.0,80.0,TCGA-A5-A2K2-01A,TCGA-A5-A2K2,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADV,18300.0,male,1963,asian,286,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-DD-AADV-01A,TCGA-DD-AADV,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAW2,25420.0,male,1940,asian,1575,Primary Tumor,3.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-DD-AAW2-01A,TCGA-DD-AAW2,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7231,24278.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-HC-7231-01A,TCGA-HC-7231,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A0C9,20876.0,female,1952,white,192,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-BK-A0C9-01A,TCGA-BK-A0C9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0TG,22043.0,female,1945,white,1996,Primary Tumor,0.0,0.0,0.0,70.0,0.0,20.0,80.0,TCGA-BS-A0TG-01A,TCGA-BS-A0TG,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LL,20700.0,female,1948,white,2066,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-AP-A0LL-01A,TCGA-AP-A0LL,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M8,18308.0,female,1958,white,734,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BG-A0M8-01A,TCGA-BG-A0M8,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A18C,26602.0,female,1938,white,52,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-BG-A18C-01A,TCGA-BG-A18C,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAEG,21853.0,female,1953,asian,529,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DD-AAEG-01A,TCGA-DD-AAEG,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MG,26957.0,female,1934,white,980,Primary Tumor,7.0,1.0,0.0,85.0,2.0,5.0,85.0,TCGA-BG-A0MG-01A,TCGA-BG-A0MG,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10U,25305.0,male,1931,white,3645,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,96.0,TCGA-BC-A10U-01A,TCGA-BC-A10U,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-5C-A9VH,25608.0,male,1943,white,127,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-5C-A9VH-01A,TCGA-5C-A9VH,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1NX,24441.0,female,1944,white,204,Primary Tumor,4.0,0.0,20.0,65.0,2.0,5.0,70.0,TCGA-D1-A1NX-01A,TCGA-D1-A1NX,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A5UC,23156.0,male,1949,asian,99,Primary Tumor,2.0,2.0,0.0,80.0,10.0,23.0,75.0,TCGA-CC-A5UC-01A,TCGA-CC-A5UC,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5509,23368.0,male,1946,white,None,Primary Tumor,2.0,1.0,10.0,75.0,2.0,19.0,70.0,TCGA-EJ-5509-01A,TCGA-EJ-5509,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZS-A9CD,26915.0,male,1937,white,1268,Primary Tumor,3.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-ZS-A9CD-01A,TCGA-ZS-A9CD,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1NU,27272.0,female,1936,white,87,Primary Tumor,20.0,20.0,0.0,65.0,40.0,25.0,65.0,TCGA-D1-A1NU-01A,TCGA-D1-A1NU,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GV,20011.0,female,1953,white,2431,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-2Y-A9GV-01A,TCGA-2Y-A9GV,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A1Y5,23251.0,female,1947,not reported,223,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-EO-A1Y5-01A,TCGA-EO-A1Y5,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HI-7171,20776.0,male,1952,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-HI-7171-01A,TCGA-HI-7171,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-QF-A5YT,20981.0,female,1953,black or african american,804,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-QF-A5YT-01A,TCGA-QF-A5YT,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0UA,24872.0,female,1936,white,2361,Primary Tumor,0.0,0.0,10.0,50.0,0.0,40.0,50.0,TCGA-BS-A0UA-01A,TCGA-BS-A0UA,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A2CH,26966.0,female,1936,not reported,802,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EO-A2CH-01A,TCGA-EO-A2CH,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A0J1,29501.0,female,1925,white,1721,Primary Tumor,1.0,0.0,13.0,80.0,0.0,2.0,75.0,TCGA-AX-A0J1-01A,TCGA-AX-A0J1,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACN,12007.0,male,1977,asian,1644,Primary Tumor,1.0,1.0,15.0,70.0,4.0,15.0,70.0,TCGA-DD-AACN-01A,TCGA-DD-AACN,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A05H,27744.0,female,1933,white,706,Primary Tumor,0.0,0.0,10.0,90.0,1.0,5.0,80.0,TCGA-AP-A05H-01A,TCGA-AP-A05H,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XW,15670.0,female,1967,black or african american,1148,Primary Tumor,0.0,0.0,30.0,75.0,0.0,0.0,70.0,TCGA-A2-A3XW-01A,TCGA-A2-A3XW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0C3,17221.0,female,1959,white,1335,Primary Tumor,0.0,1.0,50.0,30.0,20.0,33.0,15.0,TCGA-BH-A0C3-01A,TCGA-BH-A0C3,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6642,23107.0,male,1943,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-55-6642-01A,TCGA-55-6642,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-3774,26704.0,female,1936,white,None,Primary Tumor,None,None,3.0,75.0,None,5.0,92.0,TCGA-67-3774-01A,TCGA-67-3774,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A12G,27705.0,female,1931,white,1415,Primary Tumor,0.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-AO-A12G-01A,TCGA-AO-A12G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04V,14250.0,female,1966,white,1812,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-A2-A04V-01A,TCGA-A2-A04V,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-99-8025,26634.0,female,1938,black or african american,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-99-8025-01A,TCGA-99-8025,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4T4,25052.0,female,1936,white,2982,Primary Tumor,0.0,0.0,0.0,65.0,0.0,15.0,85.0,TCGA-MP-A4T4-01A,TCGA-MP-A4T4,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XA,23387.0,female,1946,white,218,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-D8-A1XA-01A,TCGA-D8-A1XA,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4T7,27603.0,female,1930,not reported,2710,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-MP-A4T7-01A,TCGA-MP-A4T7,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LA,21773.0,female,1950,not reported,581,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-E2-A1LA-01A,TCGA-E2-A1LA,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A472,25893.0,male,1941,white,498,Primary Tumor,0.0,3.0,10.0,70.0,3.0,0.0,90.0,TCGA-62-A472-01A,TCGA-62-A472,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RI,15942.0,female,1968,white,64,Primary Tumor,0.0,0.0,0.0,90.0,1.0,18.0,80.0,TCGA-E9-A1RI-01A,TCGA-E9-A1RI,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XU,20052.0,female,1956,white,106,Primary Tumor,1.0,1.0,0.0,80.0,3.0,16.0,80.0,TCGA-AN-A0XU-01A,TCGA-AN-A0XU,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-93-8067,28453.0,male,1934,asian,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-93-8067-01A,TCGA-93-8067,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09E,26724.0,female,1935,not reported,819,Primary Tumor,0.0,0.0,7.0,90.0,4.0,16.0,75.0,TCGA-A8-A09E-01A,TCGA-A8-A09E,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09M,27455.0,female,1934,not reported,333,Primary Tumor,0.0,0.0,2.0,70.0,20.0,17.0,80.0,TCGA-A8-A09M-01A,TCGA-A8-A09M,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8075,24402.0,female,1945,white,None,Primary Tumor,0.0,0.0,0.0,70.0,15.0,25.0,75.0,TCGA-86-8075-01A,TCGA-86-8075,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1B0,18346.0,female,1957,white,1315,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,70.0,TCGA-E2-A1B0-01A,TCGA-E2-A1B0,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A129,10898.0,female,1973,white,2915,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,85.0,TCGA-AO-A129-01A,TCGA-AO-A129,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A8HR,17921.0,female,1964,asian,162,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-C8-A8HR-01A,TCGA-C8-A8HR,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6848,21829.0,male,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,85.0,TCGA-91-6848-01A,TCGA-91-6848,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3Y0,21024.0,female,1953,black or african american,845,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,90.0,TCGA-A2-A3Y0-01A,TCGA-A2-A3Y0,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-LB-A8F3,23624.0,female,1949,black or african american,16,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-LB-A8F3-01A,TCGA-LB-A8F3,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAQ2,29585.0,female,1930,white,879,Primary Tumor,1.0,1.0,10.0,70.0,25.0,58.0,27.0,TCGA-FB-AAQ2-01A,TCGA-FB-AAQ2,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04U,17474.0,female,1957,white,1924,Primary Tumor,0.0,0.0,0.0,65.0,1.0,32.0,65.0,TCGA-A2-A04U-01A,TCGA-A2-A04U,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2L-AAQL,30092.0,male,1929,white,1066,Primary Tumor,10.0,10.0,0.0,60.0,70.0,40.0,60.0,TCGA-2L-AAQL-01A,TCGA-2L-AAQL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27V,22958.0,female,1949,white,51,Primary Tumor,0.0,0.0,5.0,70.0,0.0,25.0,70.0,TCGA-D8-A27V-01A,TCGA-D8-A27V,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HE,None,female,1951,asian,109,Primary Tumor,0.0,0.0,4.0,95.0,2.0,10.0,85.0,TCGA-C8-A1HE-01A,TCGA-C8-A1HE,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-8255,26289.0,male,1940,white,None,Primary Tumor,None,None,0.0,60.0,None,10.0,90.0,TCGA-69-8255-01A,TCGA-69-8255,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DK,21198.0,female,1947,white,2109,Primary Tumor,0.0,0.0,0.0,70.0,1.0,56.0,40.0,TCGA-GM-A2DK-01A,TCGA-GM-A2DK,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-5815,27280.0,male,1935,white,None,Primary Tumor,None,None,5.0,75.0,None,10.0,75.0,TCGA-64-5815-01A,TCGA-64-5815,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JC,21898.0,female,1951,white,201,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-D8-A1JC-01A,TCGA-D8-A1JC,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A130,19117.0,female,1958,asian,89,Primary Tumor,None,None,None,None,None,None,None,TCGA-C8-A130-01A,TCGA-C8-A130,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IL,28495.0,female,1931,white,417,Primary Tumor,0.0,0.0,0.0,65.0,1.0,4.0,95.0,TCGA-E2-A1IL-01A,TCGA-E2-A1IL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A6FP,32872,female,1922,white,259,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-LL-A6FP-01A,TCGA-LL-A6FP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1J8,28444.0,female,1933,white,272,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D8-A1J8-01A,TCGA-D8-A1J8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-AA17,23642.0,female,1949,black or african american,92,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-S3-AA17-01A,TCGA-S3-AA17,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FB,23851.0,female,1944,white,576,Primary Tumor,0.0,0.0,0.0,70.0,0.0,15.0,85.0,TCGA-AC-A2FB-01A,TCGA-AC-A2FB,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0ES,19160.0,female,1956,white,756,Primary Tumor,0.0,0.0,15.0,10.0,2.0,75.0,10.0,TCGA-A2-A0ES-01A,TCGA-A2-A0ES,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A576,25350.0,female,1942,black or african american,343,Primary Tumor,0.0,0.0,0.0,70.0,1.0,0.0,100.0,TCGA-E2-A576-01A,TCGA-E2-A576,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J6,22462.0,female,1947,white,748,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-AO-A0J6-01A,TCGA-AO-A0J6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2D9,25490.0,female,1937,white,1910,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-GM-A2D9-01A,TCGA-GM-A2D9,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-53-7624,14794.0,female,1968,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,82.0,TCGA-53-7624-01A,TCGA-53-7624,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0H0,25223.0,female,1940,white,344,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-BH-A0H0-01A,TCGA-BH-A0H0,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0D4,13805.0,female,1972,black or african american,384,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-A2-A0D4-01A,TCGA-A2-A0D4,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-8254,31134.0,male,1927,white,None,Primary Tumor,None,None,0.0,65.0,None,25.0,75.0,TCGA-69-8254-01A,TCGA-69-8254,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A6VW,17539.0,female,1965,black or african american,71,Primary Tumor,2.0,2.0,0.0,85.0,5.0,22.0,60.0,TCGA-A7-A6VW-01A,TCGA-A7-A6VW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15H,13985.0,female,1971,white,357,Primary Tumor,1.0,1.0,1.0,75.0,2.0,22.0,75.0,TCGA-E2-A15H-01A,TCGA-E2-A15H,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IS,24621.0,male,1943,white,1141,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-3A-A9IS-01A,TCGA-3A-A9IS,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JN,29331.0,female,1930,white,273,Primary Tumor,0.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-D8-A1JN-01A,TCGA-D8-A1JN,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-1679,21310.0,female,1949,white,None,Primary Tumor,None,None,0.0,70.0,None,45.0,25.0,TCGA-64-1679-01A,TCGA-64-1679,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B4,23980.0,male,1942,white,995,Primary Tumor,0.0,0.0,20.0,90.0,2.0,5.0,74.0,TCGA-BH-A0B4-01A,TCGA-BH-A0B4,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J9,22642.0,female,1946,white,1207,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-AO-A0J9-01A,TCGA-AO-A0J9,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7891,18202.0,female,1962,white,None,Primary Tumor,None,None,25.0,60.0,None,15.0,55.0,TCGA-IB-7891-01A,TCGA-IB-7891,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07J,12965.0,female,1974,not reported,241,Primary Tumor,0.0,0.0,5.0,70.0,2.0,25.0,70.0,TCGA-A8-A07J-01A,TCGA-A8-A07J,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8002,22433.0,male,1950,white,None,Primary Tumor,None,None,90.0,10.0,None,0.0,10.0,TCGA-HZ-8002-01A,TCGA-HZ-8002,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07E,29800.0,female,1927,not reported,545,Primary Tumor,0.0,0.0,15.0,75.0,10.0,13.0,70.0,TCGA-A8-A07E-01A,TCGA-A8-A07E,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1II,18788.0,female,1957,white,854,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-E2-A1II-01A,TCGA-E2-A1II,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A079,25294.0,female,1938,not reported,1033,Primary Tumor,0.0,0.0,2.0,65.0,1.0,26.0,64.0,TCGA-A8-A079-01A,TCGA-A8-A079,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-7043,23165.0,female,1948,white,None,Primary Tumor,None,None,0.0,70.0,None,5.0,93.0,TCGA-95-7043-01A,TCGA-95-7043,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XJ,27967.0,female,1934,white,295,Primary Tumor,0.0,0.0,0.0,90.0,2.0,18.0,74.0,TCGA-D8-A1XJ-01A,TCGA-D8-A1XJ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A097,23741.0,female,1944,not reported,241,Primary Tumor,0.0,0.0,4.0,80.0,2.0,21.0,75.0,TCGA-A8-A097-01A,TCGA-A8-A097,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-8253,21771.0,female,1953,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-69-8253-01A,TCGA-69-8253,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1IX,17597.0,female,1960,asian,1030,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EW-A1IX-01A,TCGA-EW-A1IX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0A1,30742.0,female,1925,not reported,241,Primary Tumor,0.0,5.0,10.0,65.0,10.0,55.0,30.0,TCGA-A8-A0A1-01A,TCGA-A8-A0A1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0AW,20468.0,female,1952,white,545,Primary Tumor,0.0,0.0,9.0,80.0,10.0,5.0,85.0,TCGA-BH-A0AW-01A,TCGA-BH-A0AW,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IZ,17294.0,male,1965,white,574,Primary Tumor,0.0,0.0,25.0,40.0,0.0,0.0,65.0,TCGA-3A-A9IZ-01A,TCGA-3A-A9IZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YI,22961.0,female,1947,white,303,Primary Tumor,0.0,0.0,20.0,70.0,15.0,10.0,69.0,TCGA-A2-A0YI-01A,TCGA-A2-A0YI,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A245,17363.0,female,1964,white,62,Primary Tumor,0.0,0.0,10.0,75.0,0.0,55.0,35.0,TCGA-E9-A245-01A,TCGA-E9-A245,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A203,28609.0,female,1918,white,5418,Primary Tumor,0.0,0.0,0.0,75.0,0.0,20.0,80.0,TCGA-BH-A203-01A,TCGA-BH-A203,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A5YP,18041.0,female,1964,black or african american,29,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,95.0,TCGA-LL-A5YP-01A,TCGA-LL-A5YP,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AARQ,15065.0,female,1955,black or african american,6271,Primary Tumor,5.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-49-AARQ-01A,TCGA-49-AARQ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A1KR,18900.0,female,1954,white,1932,Primary Tumor,0.0,0.0,5.0,90.0,0.0,20.0,75.0,TCGA-AO-A1KR-01A,TCGA-AO-A1KR,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A7M4,29792.0,male,1932,white,97,Primary Tumor,2.0,2.0,0.0,75.0,15.0,65.0,30.0,TCGA-IB-A7M4-01A,TCGA-IB-A7M4,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-F2-7276,23713.0,male,1947,white,None,Primary Tumor,None,None,85.0,15.0,None,0.0,15.0,TCGA-F2-7276-01A,TCGA-F2-7276,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08S,25994.0,female,1937,not reported,637,Primary Tumor,0.0,1.0,0.0,80.0,3.0,39.0,60.0,TCGA-A8-A08S-01A,TCGA-A8-A08S,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AAR9,22510.0,male,1938,black or african american,5308,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-49-AAR9-01A,TCGA-49-AAR9,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-8127,21676.0,male,1952,white,None,Primary Tumor,0.0,0.0,30.0,60.0,30.0,15.0,55.0,TCGA-IB-8127-01A,TCGA-IB-8127,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-A4VP,24130.0,female,1946,white,68,Primary Tumor,2.0,4.0,0.0,70.0,5.0,0.0,100.0,TCGA-95-A4VP-01A,TCGA-95-A4VP,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A147,16736.0,female,1965,white,163,Primary Tumor,0.0,0.0,0.0,70.0,0.0,10.0,90.0,TCGA-D8-A147-01A,TCGA-D8-A147,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0WT,22362.0,female,1934,white,5606,Primary Tumor,1.0,1.0,0.0,60.0,3.0,40.0,60.0,TCGA-B6-A0WT-01A,TCGA-B6-A0WT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A4S0,28416.0,female,1935,white,159,Primary Tumor,10.0,25.0,0.0,80.0,40.0,20.0,80.0,TCGA-A2-A4S0-01A,TCGA-A2-A4S0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NE,10564.0,female,1983,white,31,Primary Tumor,0.0,0.0,8.0,85.0,4.0,19.0,70.0,TCGA-E9-A1NE-01A,TCGA-E9-A1NE,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1J9,17879.0,female,1962,white,211,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-D8-A1J9-01A,TCGA-D8-A1J9,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SN,18401.0,female,1957,white,1091,Primary Tumor,0.0,0.0,2.0,80.0,3.0,17.0,80.0,TCGA-A1-A0SN-01A,TCGA-A1-A0SN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AU,14564.0,female,1968,white,1317,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-AR-A1AU-01A,TCGA-AR-A1AU,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A105,28855.0,female,1928,white,1171,Primary Tumor,0.0,0.0,5.0,88.0,1.0,30.0,61.0,TCGA-E2-A105-01A,TCGA-E2-A105,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7889,31393.0,female,1926,white,None,Primary Tumor,None,None,0.0,60.0,None,40.0,60.0,TCGA-IB-7889-01A,TCGA-IB-7889,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-3771,28406.0,female,1932,black or african american,None,Primary Tumor,None,None,2.0,75.0,None,20.0,None,TCGA-67-3771-01A,TCGA-67-3771,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DA,16854.0,female,1947,white,6583,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-GM-A2DA-01A,TCGA-GM-A2DA,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-99-7458,27359.0,female,1936,white,None,Primary Tumor,None,None,10.0,60.0,None,20.0,70.0,TCGA-99-7458-01A,TCGA-99-7458,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6979,21780.0,female,1947,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,80.0,TCGA-55-6979-01A,TCGA-55-6979,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A143,18984.0,female,1959,white,211,Primary Tumor,10.0,10.0,0.0,80.0,70.0,25.0,70.0,TCGA-D8-A143-01A,TCGA-D8-A143,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-6217,26920.0,female,1937,white,None,Primary Tumor,None,None,5.0,60.0,None,30.0,65.0,TCGA-67-6217-01A,TCGA-67-6217,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6761,24849.0,female,1941,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,65.0,TCGA-49-6761-01A,TCGA-49-6761,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-3772,29989.0,female,1927,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,80.0,TCGA-67-3772-01A,TCGA-67-3772,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0CJ,21014.0,female,1953,white,36,Primary Tumor,0.0,0.0,0.0,75.0,11.0,17.0,78.0,TCGA-A7-A0CJ-01A,TCGA-A7-A0CJ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8673,22571.0,male,1950,white,None,Primary Tumor,0.0,0.0,None,65.0,20.0,30.0,60.0,TCGA-86-8673-01A,TCGA-86-8673,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7153,23922.0,female,1938,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-78-7153-01A,TCGA-78-7153,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18T,25674.0,female,1933,white,2737,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,85.0,TCGA-BH-A18T-01A,TCGA-BH-A18T,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FX,19309.0,female,1958,white,34,Primary Tumor,0.0,0.0,15.0,70.0,0.0,5.0,75.0,TCGA-AN-A0FX-01A,TCGA-AN-A0FX,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4514,28908.0,female,1928,white,None,Primary Tumor,None,None,10.0,60.0,None,5.0,85.0,TCGA-49-4514-01A,TCGA-49-4514,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06T,27393.0,female,1932,not reported,941,Primary Tumor,0.0,0.0,0.0,85.0,7.0,15.0,83.0,TCGA-A8-A06T-01A,TCGA-A8-A06T,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1Y1,29474.0,female,1930,white,93,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D8-A1Y1-01A,TCGA-D8-A1Y1,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1J6,25830.0,female,1939,white,528,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-EW-A1J6-01A,TCGA-EW-A1J6,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AQ,18109.0,female,1958,white,1424,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-AR-A1AQ-01A,TCGA-AR-A1AQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0AR,20152.0,female,1955,white,34,Primary Tumor,0.0,0.0,7.0,90.0,4.0,10.0,80.0,TCGA-AN-A0AR-01A,TCGA-AN-A0AR,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BG,26988.0,female,1935,white,798,Primary Tumor,0.0,0.0,20.0,60.0,35.0,10.0,70.0,TCGA-BH-A0BG-01A,TCGA-BH-A0BG,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15O,32583.0,female,1921,black or african american,273,Primary Tumor,0.0,0.0,5.0,95.0,0.0,5.0,90.0,TCGA-E2-A15O-01A,TCGA-E2-A15O,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0D1,28084.0,female,1932,white,637,Primary Tumor,0.0,0.0,0.0,75.0,2.0,24.0,75.0,TCGA-A2-A0D1-01A,TCGA-A2-A0D1,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8177,21648.0,female,1953,white,None,Primary Tumor,None,2.0,0.0,80.0,10.0,0.0,100.0,TCGA-97-8177-01A,TCGA-97-8177,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TR,25190.0,female,1938,white,1535,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,90.0,TCGA-AR-A0TR-01A,TCGA-AR-A0TR,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A4RX,24779.0,female,1945,black or african american,210,Primary Tumor,0.0,0.0,40.0,65.0,5.0,0.0,60.0,TCGA-A2-A4RX-01A,TCGA-A2-A4RX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1OX,15837.0,female,1966,white,550,Primary Tumor,0.0,0.0,0.0,85.0,2.0,80.0,20.0,TCGA-EW-A1OX-01A,TCGA-EW-A1OX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0AU,16688.0,female,1963,white,583,Primary Tumor,0.0,0.0,25.0,80.0,15.0,5.0,69.0,TCGA-BH-A0AU-01A,TCGA-BH-A0AU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SG,22380.0,female,1945,white,1581,Primary Tumor,0.0,0.0,1.0,80.0,1.0,19.0,80.0,TCGA-A1-A0SG-01A,TCGA-A1-A0SG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A23C,22751.0,female,1948,white,198,Primary Tumor,0.0,0.0,0.0,85.0,1.0,30.0,65.0,TCGA-AC-A23C-01A,TCGA-AC-A23C,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7765,20625.0,male,1955,black or african american,None,Primary Tumor,None,None,0.0,55.0,15.0,50.0,50.0,TCGA-69-7765-01A,TCGA-69-7765,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1QZ,22397.0,female,1950,white,58,Primary Tumor,0.0,0.0,0.0,80.0,0.0,80.0,20.0,TCGA-E9-A1QZ-01A,TCGA-E9-A1QZ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8358,16409.0,male,1968,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,75.0,TCGA-86-8358-01A,TCGA-86-8358,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4430,21884.0,female,1949,not reported,None,Primary Tumor,None,None,10.0,75.0,None,20.0,70.0,TCGA-05-4430-01A,TCGA-05-4430,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUT,23801.0,male,1948,white,58,Primary Tumor,0.0,3.0,0.0,20.0,10.0,0.0,100.0,TCGA-IB-AAUT-01A,TCGA-IB-AAUT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1Y2,26021.0,female,1940,white,65,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-D8-A1Y2-01A,TCGA-D8-A1Y2,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LQ,21865.0,female,1951,white,449,Primary Tumor,0.0,0.0,10.0,60.0,2.0,50.0,40.0,TCGA-AR-A2LQ-01A,TCGA-AR-A2LQ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6743,29807.0,female,1929,white,None,Primary Tumor,None,None,15.0,70.0,None,10.0,67.0,TCGA-49-6743-01A,TCGA-49-6743,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SO,24826.0,female,1940,white,1057,Primary Tumor,0.0,0.0,0.0,90.0,1.0,8.0,90.0,TCGA-A1-A0SO-01A,TCGA-A1-A0SO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CK,22094.0,female,1941,white,3080,Primary Tumor,0.0,0.0,3.0,80.0,0.0,57.0,40.0,TCGA-A2-A0CK-01A,TCGA-A2-A0CK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3QP,29113.0,female,1932,white,184,Primary Tumor,0.0,0.0,50.0,60.0,10.0,0.0,50.0,TCGA-AC-A3QP-01A,TCGA-AC-A3QP,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5072,27036.0,male,1935,white,None,Primary Tumor,None,None,15.0,80.0,None,10.0,70.0,TCGA-50-5072-01A,TCGA-50-5072,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24Q,18084.0,female,1957,white,1932,Primary Tumor,1.0,1.0,2.0,75.0,8.0,23.0,75.0,TCGA-AR-A24Q-01A,TCGA-AR-A24Q,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R7,23397.0,female,1947,white,51,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E9-A1R7-01A,TCGA-E9-A1R7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09X,22858.0,female,1947,not reported,302,Primary Tumor,0.0,0.0,0.0,85.0,1.0,13.0,85.0,TCGA-A8-A09X-01A,TCGA-A8-A09X,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-7271,26440.0,female,1934,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,60.0,TCGA-38-7271-01A,TCGA-38-7271,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-3C-AAAU,20211.0,female,1949,white,3599,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-3C-AAAU-01A,TCGA-3C-AAAU,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A3HO,18046.0,female,1962,white,245,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-E9-A3HO-01A,TCGA-E9-A3HO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TS,17141.0,female,1960,white,1549,Primary Tumor,0.0,0.0,0.0,60.0,100.0,30.0,70.0,TCGA-AR-A0TS-01A,TCGA-AR-A0TS,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-A5A6,24025.0,female,1936,asian,4142,Primary Tumor,0.0,0.0,0.0,30.0,0.0,10.0,90.0,TCGA-HV-A5A6-01A,TCGA-HV-A5A6,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AAQV,23370.0,female,1949,black or african american,717,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,80.0,TCGA-49-AAQV-01A,TCGA-49-AAQV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A572,26399.0,female,1939,black or african american,560,Primary Tumor,0.0,0.0,0.0,80.0,3.0,78.0,20.0,TCGA-E2-A572-01A,TCGA-E2-A572,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AN,16974.0,female,1960,white,1463,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-AR-A1AN-01A,TCGA-AR-A1AN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0WX,14784.0,female,1958,black or african american,4476,Primary Tumor,1.0,1.0,0.0,75.0,5.0,25.0,75.0,TCGA-B6-A0WX-01A,TCGA-B6-A0WX,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FS,20352.0,female,1955,white,44,Primary Tumor,0.0,0.0,5.0,85.0,0.0,10.0,85.0,TCGA-AN-A0FS-01A,TCGA-AN-A0FS,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4675,21614.0,male,1951,white,None,Primary Tumor,None,None,0.0,80.0,None,50.0,50.0,TCGA-73-4675-01A,TCGA-73-4675,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-AA8V,18357.0,male,1962,asian,435,Primary Tumor,2.0,5.0,15.0,55.0,12.0,58.0,25.0,TCGA-HV-AA8V-01A,TCGA-HV-AA8V,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A13D,17070.0,female,1964,black or african american,240,Primary Tumor,0.0,0.0,10.0,50.0,0.0,40.0,30.0,TCGA-A7-A13D-01A,TCGA-A7-A13D,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7553,21518.0,female,1949,white,None,Primary Tumor,None,10.0,10.0,65.0,10.0,None,90.0,TCGA-97-7553-01A,TCGA-97-7553,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-7944,26003.0,male,1940,white,None,Primary Tumor,None,None,0.0,61.0,25.0,0.0,100.0,TCGA-95-7944-01A,TCGA-95-7944,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GI-A2C9,21534.0,female,1945,black or african american,2979,Primary Tumor,0.0,0.0,0.0,80.0,1.0,42.0,55.0,TCGA-GI-A2C9-01A,TCGA-GI-A2C9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15R,23570.0,female,1946,white,247,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-E2-A15R-01A,TCGA-E2-A15R,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HA,11379.0,female,1977,white,675,Primary Tumor,0.0,0.0,5.0,75.0,12.0,48.0,45.0,TCGA-BH-A0HA-01A,TCGA-BH-A0HA,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A4DF,32432.0,male,1924,white,113,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-55-A4DF-01A,TCGA-55-A4DF,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RS,14134.0,female,1950,white,7858,Primary Tumor,0.0,0.0,0.0,92.0,0.0,10.0,90.0,TCGA-B6-A0RS-01A,TCGA-B6-A0RS,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JK,32872,female,1920,white,261,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-D8-A1JK-01A,TCGA-D8-A1JK,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-F2-A8YN,28047.0,male,1937,white,112,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-F2-A8YN-01A,TCGA-F2-A8YN,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-8397,25728.0,female,1938,white,None,Primary Tumor,None,5.0,10.0,65.0,20.0,0.0,90.0,TCGA-62-8397-01A,TCGA-62-8397,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8585,20918.0,male,1955,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,80.0,TCGA-86-8585-01A,TCGA-86-8585,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A62X,26627.0,female,1941,black or african american,70,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-AC-A62X-01A,TCGA-AC-A62X,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7163,22002.0,male,1932,white,None,Primary Tumor,None,None,0.0,80.0,None,35.0,65.0,TCGA-78-7163-01A,TCGA-78-7163,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-35-4122,25491.0,male,1941,white,None,Primary Tumor,None,None,3.0,75.0,None,10.0,84.0,TCGA-35-4122-01A,TCGA-35-4122,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A409,16178.0,female,1964,black or african american,1480,Primary Tumor,1.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-B6-A409-01A,TCGA-B6-A409,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1PE,20694.0,female,1955,white,44,Primary Tumor,1.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-EW-A1PE-01A,TCGA-EW-A1PE,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-7701,24209.0,male,1945,white,None,Primary Tumor,None,None,15.0,65.0,10.0,15.0,60.0,TCGA-86-7701-01A,TCGA-86-7701,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A140,22900.0,female,1948,white,204,Primary Tumor,1.0,0.0,0.0,70.0,3.0,54.0,45.0,TCGA-D8-A140-01A,TCGA-D8-A140,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A5YO,18354.0,female,1963,black or african american,47,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-LL-A5YO-01A,TCGA-LL-A5YO,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A10A,15085.0,female,1966,white,1096,Primary Tumor,10.0,10.0,0.0,85.0,60.0,15.0,85.0,TCGA-E2-A10A-01A,TCGA-E2-A10A,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7763,25316.0,male,1941,white,None,Primary Tumor,None,10.0,25.0,60.0,10.0,0.0,75.0,TCGA-69-7763-01A,TCGA-69-7763,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7540,24440.0,female,1933,white,None,Primary Tumor,0.0,2.0,0.0,85.0,2.0,0.0,100.0,TCGA-78-7540-01A,TCGA-78-7540,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-53-7813,18875.0,female,1957,white,None,Primary Tumor,0.0,0.0,5.0,62.0,20.0,0.0,95.0,TCGA-53-7813-01A,TCGA-53-7813,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A8HQ,19432.0,female,1960,asian,185,Primary Tumor,20.0,20.0,0.0,60.0,40.0,20.0,60.0,TCGA-C8-A8HQ-01A,TCGA-C8-A8HQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A4SB,20539.0,female,1956,white,75,Primary Tumor,0.0,0.0,0.0,80.0,1.0,57.0,40.0,TCGA-A7-A4SB-01A,TCGA-A7-A4SB,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RP,26941.0,female,1921,white,5890,Primary Tumor,0.0,0.0,0.0,85.0,3.0,30.0,70.0,TCGA-B6-A0RP-01A,TCGA-B6-A0RP,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0W3,21369.0,female,1952,white,85,Primary Tumor,0.0,0.0,0.0,85.0,0.0,30.0,70.0,TCGA-BH-A0W3-01A,TCGA-BH-A0W3,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A470,30689.0,male,1925,white,1310,Primary Tumor,0.0,4.0,0.0,80.0,2.0,0.0,95.0,TCGA-62-A470-01A,TCGA-62-A470,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FL,22805.0,female,1948,white,69,Primary Tumor,0.0,0.0,3.0,75.0,1.0,23.0,70.0,TCGA-AN-A0FL-01A,TCGA-AN-A0FL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12T,None,female,1967,asian,51,Primary Tumor,1.0,1.0,0.0,85.0,1.0,13.0,85.0,TCGA-C8-A12T-01A,TCGA-C8-A12T,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-7031,None,female,None,not reported,None,Primary Tumor,0.0,8.0,8.0,62.0,25.0,15.0,75.0,TCGA-75-7031-01A,TCGA-75-7031,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A6FQ,28375.0,female,1936,black or african american,128,Primary Tumor,3.0,1.0,1.0,75.0,2.0,24.0,75.0,TCGA-LL-A6FQ-01A,TCGA-LL-A6FQ,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IX,14729.0,male,1972,white,715,Primary Tumor,0.0,0.0,35.0,25.0,0.0,0.0,65.0,TCGA-3A-A9IX-01A,TCGA-3A-A9IX,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-A4SU,24820.0,female,1945,white,55,Primary Tumor,0.0,0.0,0.0,70.0,10.0,30.0,70.0,TCGA-44-A4SU-01A,TCGA-44-A4SU,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JA,21918.0,female,1950,white,194,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,90.0,TCGA-D8-A1JA-01A,TCGA-D8-A1JA,
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6972,26625.0,male,1933,white,None,Primary Tumor,None,None,0.0,85.0,5.0,10.0,85.0,TCGA-55-6972-01A,TCGA-55-6972,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EV,16504.0,female,1954,white,4103,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,90.0,TCGA-BH-A1EV-01A,TCGA-BH-A1EV,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABP,21484.0,female,1955,white,237,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-2J-AABP-01A,TCGA-2J-AABP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J5,17815.0,female,1960,white,554,Primary Tumor,0.0,0.0,0.0,80.0,2.0,18.0,80.0,TCGA-AO-A0J5-01A,TCGA-AO-A0J5,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A3X8,17588.0,female,1963,white,233,Primary Tumor,0.0,0.0,2.0,80.0,0.0,38.0,60.0,TCGA-E9-A3X8-01A,TCGA-E9-A3X8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5S0,24139.0,female,1946,black or african american,279,Primary Tumor,0.0,0.0,20.0,60.0,7.0,28.0,50.0,TCGA-OL-A5S0-01A,TCGA-OL-A5S0,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4420,15159.0,male,1967,not reported,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-05-4420-01A,TCGA-05-4420,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A04D,21426.0,female,1950,white,676,Primary Tumor,0.0,0.0,0.0,95.0,1.0,7.0,63.0,TCGA-AN-A04D-01A,TCGA-AN-A04D,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A9Q3,25477.0,female,1944,white,80,Primary Tumor,10.0,10.0,0.0,80.0,70.0,20.0,80.0,TCGA-LL-A9Q3-01A,TCGA-LL-A9Q3,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7546,27913.0,female,1932,white,None,Primary Tumor,None,5.0,4.0,65.0,10.0,None,95.0,TCGA-97-7546-01A,TCGA-97-7546,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A46V,28495.0,female,1929,white,1751,Primary Tumor,0.0,3.0,0.0,75.0,3.0,0.0,100.0,TCGA-62-A46V-01A,TCGA-62-A46V,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7147,24809.0,female,1934,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,83.0,TCGA-78-7147-01A,TCGA-78-7147,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HI,28644.0,female,1930,white,554,Primary Tumor,0.0,0.0,0.0,80.0,0.0,15.0,85.0,TCGA-BH-A0HI-01A,TCGA-BH-A0HI,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66O,14272.0,female,1973,black or african american,170,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-OL-A66O-01A,TCGA-OL-A66O,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-8660,25422.0,male,1936,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-78-8660-01A,TCGA-78-8660,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7937,23919.0,male,1946,white,None,Primary Tumor,0.0,0.0,0.0,71.0,5.0,0.0,100.0,TCGA-97-7937-01A,TCGA-97-7937,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-3C-AALK,19074.0,female,1959,black or african american,1022,Primary Tumor,0.0,0.0,5.0,60.0,2.0,30.0,60.0,TCGA-3C-AALK-01A,TCGA-3C-AALK,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AAB9,25920.0,female,1942,white,560,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-2J-AAB9-01A,TCGA-2J-AAB9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04R,13483.0,female,1968,black or african american,2233,Primary Tumor,0.0,0.0,0.0,90.0,0.0,19.0,80.0,TCGA-A2-A04R-01A,TCGA-A2-A04R,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A22B,26278.0,female,1940,white,59,Primary Tumor,0.0,0.0,0.0,75.0,0.0,5.0,95.0,TCGA-E9-A22B-01A,TCGA-E9-A22B,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7162,27593.0,male,1916,white,None,Primary Tumor,None,None,30.0,60.0,None,5.0,65.0,TCGA-78-7162-01A,TCGA-78-7162,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0X0,19802.0,female,1942,white,5243,Primary Tumor,0.0,30.0,0.0,60.0,60.0,40.0,60.0,TCGA-B6-A0X0-01A,TCGA-B6-A0X0,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LB,15283.0,female,1967,black or african american,909,Primary Tumor,0.0,0.0,10.0,90.0,0.0,0.0,90.0,TCGA-E2-A1LB-01A,TCGA-E2-A1LB,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14W,28664.0,male,1930,white,716,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-E2-A14W-01A,TCGA-E2-A14W,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07P,24929.0,female,1941,not reported,210,Primary Tumor,0.0,0.0,0.0,70.0,2.0,28.0,70.0,TCGA-A8-A07P-01A,TCGA-A8-A07P,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6597,29195.0,female,1928,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-50-6597-01A,TCGA-50-6597,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A5XU,27191.0,female,1939,black or african american,44,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,80.0,TCGA-AC-A5XU-01A,TCGA-AC-A5XU,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-7030,None,male,None,not reported,None,Primary Tumor,None,None,10.0,60.0,None,15.0,70.0,TCGA-75-7030-01A,TCGA-75-7030,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HI,None,female,1970,asian,120,Primary Tumor,0.0,0.0,0.0,80.0,1.0,9.0,90.0,TCGA-C8-A1HI-01A,TCGA-C8-A1HI,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09W,25659.0,female,1937,not reported,1033,Primary Tumor,0.0,0.0,0.0,70.0,1.0,28.0,70.0,TCGA-A8-A09W-01A,TCGA-A8-A09W,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LK,22800.0,female,1945,white,1340,Primary Tumor,0.0,0.0,0.0,75.0,1.0,55.0,45.0,TCGA-AR-A2LK-01A,TCGA-AR-A2LK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HU,19216.0,female,1957,white,394,Primary Tumor,0.0,0.0,0.0,80.0,1.0,18.0,80.0,TCGA-BH-A0HU-01A,TCGA-BH-A0HU,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-6215,19310.0,female,1958,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-67-6215-01A,TCGA-67-6215,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-PL-A8LZ,10869.0,female,1984,black or african american,157,Primary Tumor,2.0,2.0,2.0,80.0,14.0,30.0,63.0,TCGA-PL-A8LZ-01A,TCGA-PL-A8LZ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1X9,24417.0,female,1944,white,399,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,95.0,TCGA-D8-A1X9-01A,TCGA-D8-A1X9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06X,28338.0,female,1929,not reported,1276,Primary Tumor,0.0,0.0,75.0,75.0,16.0,5.0,20.0,TCGA-A8-A06X-01A,TCGA-A8-A06X,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27G,27521.0,female,1935,white,156,Primary Tumor,0.0,0.0,0.0,85.0,0.0,50.0,50.0,TCGA-D8-A27G-01A,TCGA-D8-A27G,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4670,25526.0,female,1941,white,None,Primary Tumor,None,None,0.0,90.0,None,0.0,95.0,TCGA-73-4670-01A,TCGA-73-4670,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A493,20027.0,female,1958,white,77,Primary Tumor,2.0,1.0,0.0,90.0,10.0,15.0,82.0,TCGA-55-A493-01A,TCGA-55-A493,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DS,25944.0,female,1939,white,79,Primary Tumor,0.0,0.0,0.0,75.0,3.0,75.0,25.0,TCGA-BH-A0DS-01A,TCGA-BH-A0DS,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-US-A776,22283.0,male,1950,white,693,Primary Tumor,0.0,0.0,0.0,90.0,0.0,40.0,60.0,TCGA-US-A776-01A,TCGA-US-A776,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A137,12729.0,female,1976,asian,102,Primary Tumor,0.0,1.0,0.0,75.0,1.0,25.0,75.0,TCGA-C8-A137-01A,TCGA-C8-A137,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0I1,26902.0,female,1925,black or african american,4248,Primary Tumor,0.0,0.0,0.0,65.0,1.0,25.0,60.0,TCGA-B6-A0I1-01A,TCGA-B6-A0I1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A12H,25515.0,female,1939,black or african american,1017,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-AO-A12H-01A,TCGA-AO-A12H,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XL,22341.0,female,1949,white,169,Primary Tumor,0.0,0.0,10.0,70.0,0.0,15.0,75.0,TCGA-AN-A0XL-01A,TCGA-AN-A0XL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CP,22133.0,female,1943,white,2445,Primary Tumor,0.0,0.0,5.0,60.0,2.0,40.0,55.0,TCGA-A2-A0CP-01A,TCGA-A2-A0CP,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A56Z,25282.0,female,1943,black or african american,254,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-E2-A56Z-01A,TCGA-E2-A56Z,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0U0,26993.0,female,1931,white,2289,Primary Tumor,0.0,0.0,0.0,70.0,0.0,10.0,85.0,TCGA-AR-A0U0-01A,TCGA-AR-A0U0,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7920,26167.0,male,1940,white,None,Primary Tumor,None,None,0.0,50.0,None,70.0,30.0,TCGA-HZ-7920-01A,TCGA-HZ-7920,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NC,22355.0,female,1950,white,38,Primary Tumor,1.0,1.0,0.0,70.0,10.0,30.0,70.0,TCGA-E9-A1NC-01A,TCGA-E9-A1NC,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7654,29292.0,male,1928,white,None,Primary Tumor,0.0,0.0,15.0,61.0,5.0,11.0,74.0,TCGA-IB-7654-01A,TCGA-IB-7654,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7887,22990.0,female,1947,white,None,Primary Tumor,None,None,0.0,65.0,None,25.0,50.0,TCGA-IB-7887-01A,TCGA-IB-7887,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAPY,26085.0,male,1936,white,2248,Primary Tumor,7.0,3.0,30.0,20.0,4.0,50.0,20.0,TCGA-FB-AAPY-01A,TCGA-FB-AAPY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A8OS,26248.0,female,1942,white,106,Primary Tumor,0.0,0.0,1.0,85.0,8.0,85.0,14.0,TCGA-AC-A8OS-01A,TCGA-AC-A8OS,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7646,22148.0,male,1947,white,None,Primary Tumor,0.0,0.0,0.0,70.0,5.0,10.0,90.0,TCGA-IB-7646-01A,TCGA-IB-7646,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-YH-A8SY,26859.0,female,1938,white,936,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-YH-A8SY-01A,TCGA-YH-A8SY,
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A55A,28022.0,female,1933,white,1199,Primary Tumor,0.0,3.0,40.0,65.0,5.0,0.0,60.0,TCGA-NJ-A55A-01A,TCGA-NJ-A55A,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4415,20880.0,male,1951,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,90.0,TCGA-05-4415-01A,TCGA-05-4415,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8508,22159.0,female,1952,black or african american,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-55-8508-01A,TCGA-55-8508,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A092,17807.0,female,1960,not reported,575,Primary Tumor,0.0,0.0,0.0,75.0,4.0,4.0,95.0,TCGA-A8-A092-01A,TCGA-A8-A092,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-7025,None,male,None,not reported,None,Primary Tumor,None,None,5.0,80.0,None,15.0,78.0,TCGA-75-7025-01A,TCGA-75-7025,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0AK,27977.0,female,1934,white,58,Primary Tumor,5.0,25.0,0.0,70.0,10.0,20.0,70.0,TCGA-AN-A0AK-01A,TCGA-AN-A0AK,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8172,27416.0,female,1936,white,None,Primary Tumor,0.0,0.0,0.0,70.0,20.0,0.0,100.0,TCGA-97-8172-01A,TCGA-97-8172,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-F2-A7TX,28239.0,male,1936,white,142,Primary Tumor,20.0,20.0,0.0,50.0,40.0,40.0,50.0,TCGA-F2-A7TX-01A,TCGA-F2-A7TX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XU,20715.0,female,1954,white,102,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-D8-A1XU-01A,TCGA-D8-A1XU,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-LB-A7SX,27295.0,female,1939,black or african american,35,Primary Tumor,20.0,20.0,10.0,65.0,40.0,25.0,65.0,TCGA-LB-A7SX-01A,TCGA-LB-A7SX,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HL,26977.0,male,1937,white,996,Primary Tumor,1.0,4.0,70.0,95.0,6.0,15.0,15.0,TCGA-NC-A5HL-01A,TCGA-NC-A5HL,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F2,28832.0,female,1934,white,385,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9F2-01A,TCGA-V4-A9F2,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TQ,25292.0,female,1943,white,549,Primary Tumor,10.0,20.0,5.0,90.0,60.0,5.0,90.0,TCGA-GS-A9TQ-01A,TCGA-GS-A9TQ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A4CN,20490.0,female,1956,white,168,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,95.0,TCGA-85-A4CN-01A,TCGA-85-A4CN,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4593,28385.0,male,1925,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,70.0,TCGA-22-4593-01A,TCGA-22-4593,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EZ,28619.0,female,1934,white,442,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9EZ-01A,TCGA-V4-A9EZ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MR,25879.0,female,None,not reported,None,Primary Tumor,0.0,1.0,0.0,100.0,2.0,40.0,50.0,TCGA-63-A5MR-01A,TCGA-63-A5MR,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2755,23348.0,male,1944,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,83.0,TCGA-66-2755-01A,TCGA-66-2755,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-A7CQ,27255.0,male,1936,asian,1062,Primary Tumor,2.0,5.0,10.0,80.0,10.0,5.0,80.0,TCGA-FF-A7CQ-01A,TCGA-FF-A7CQ,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5036,26963.0,male,1934,white,None,Primary Tumor,None,None,10.0,70.0,None,20.0,65.0,TCGA-39-5036-01A,TCGA-39-5036,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-ER-A194,28175.0,male,1928,white,1940,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-ER-A194-01A,TCGA-ER-A194,
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A44P,21519.0,female,1954,white,94,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-EB-A44P-01A,TCGA-EB-A44P,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8404,28705.0,male,1927,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-KO-8404-01A,TCGA-KO-8404,4.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-GN-A8LN,24872.0,male,1945,white,247,Primary Tumor,0.0,0.0,5.0,95.0,0.0,5.0,90.0,TCGA-GN-A8LN-01A,TCGA-GN-A8LN,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5477,24055.0,male,1939,white,None,Primary Tumor,None,None,12.0,90.0,None,5.0,70.0,TCGA-22-5477-01A,TCGA-22-5477,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A57M,20698.0,male,1956,asian,93,Primary Tumor,0.0,0.0,0.0,90.0,5.0,10.0,80.0,TCGA-EB-A57M-01A,TCGA-EB-A57M,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-37-A5EN,21600.0,male,1952,white,376,Primary Tumor,0.0,30.0,0.0,70.0,70.0,60.0,35.0,TCGA-37-A5EN-01A,TCGA-37-A5EN,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2770,28945.0,male,1928,not reported,None,Primary Tumor,None,None,0.0,80.0,None,7.0,85.0,TCGA-66-2770-01A,TCGA-66-2770,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8335,24832.0,male,1938,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,2.0,98.0,TCGA-KL-8335-01A,TCGA-KL-8335,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-A7CX,16924.0,male,1965,asian,747,Primary Tumor,5.0,5.0,5.0,90.0,85.0,5.0,85.0,TCGA-FF-A7CX-01A,TCGA-FF-A7CX,4.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8340,12696.0,male,1972,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-KL-8340-01A,TCGA-KL-8340,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8430,27467.0,male,1932,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8430-01A,TCGA-KN-8430,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7844,26141.0,male,1940,white,None,Primary Tumor,0.0,0.0,0.0,70.0,20.0,0.0,100.0,TCGA-85-7844-01A,TCGA-85-7844,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-HR-A5NC,32871.0,female,None,not reported,None,Primary Tumor,0.0,0.0,5.0,80.0,2.0,0.0,95.0,TCGA-HR-A5NC-01A,TCGA-HR-A5NC,
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8426,18345.0,male,1956,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8426-01A,TCGA-KN-8426,4.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KM,24047.0,male,1948,not reported,200,Primary Tumor,0.0,0.0,50.0,60.0,1.0,0.0,50.0,TCGA-VD-A8KM-01A,TCGA-VD-A8KM,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8639,24640.0,male,1938,white,None,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-KM-8639-01A,TCGA-KM-8639,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A5ER,23199.0,male,1949,white,91,Primary Tumor,0.0,0.0,0.0,96.0,0.0,0.0,100.0,TCGA-BF-A5ER-01A,TCGA-BF-A5ER,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8406,6556.0,female,1988,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8406-01A,TCGA-KO-8406,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A42Z,18157.0,male,1963,asian,100,Primary Tumor,0.0,0.0,29.0,80.0,2.0,0.0,70.0,TCGA-EB-A42Z-01A,TCGA-EB-A42Z,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2771,22219.0,male,1947,not reported,None,Primary Tumor,0.0,0.0,0.0,70.0,20.0,5.0,90.0,TCGA-66-2771-01A,TCGA-66-2771,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F7,28822.0,female,1933,white,747,Primary Tumor,0.0,0.0,0.0,93.0,6.0,1.0,98.0,TCGA-V4-A9F7-01A,TCGA-V4-A9F7,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2778,25080.0,female,1939,not reported,None,Primary Tumor,None,None,20.0,80.0,None,5.0,70.0,TCGA-66-2778-01A,TCGA-66-2778,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MH,25159.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,14.0,85.0,TCGA-63-A5MH-01A,TCGA-63-A5MH,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2706,21477.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,85.0,TCGA-60-2706-01A,TCGA-60-2706,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-ER-A2NB,20938.0,male,1953,white,230,Primary Tumor,0.0,3.0,0.0,85.0,2.0,15.0,85.0,TCGA-ER-A2NB-01A,TCGA-ER-A2NB,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-46-3767,27912.0,male,1933,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,70.0,TCGA-46-3767-01A,TCGA-46-3767,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8409,25419.0,male,1935,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8409-01A,TCGA-KO-8409,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8153,28253.0,female,1931,not reported,None,Primary Tumor,None,None,0.0,75.0,None,15.0,65.0,TCGA-77-8153-01A,TCGA-77-8153,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3419,26813.0,male,1934,not reported,None,Primary Tumor,2.0,2.0,None,75.0,27.0,None,None,TCGA-18-3419-01A,TCGA-18-3419,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A5DR,29828.0,male,1931,white,66,Primary Tumor,0.0,0.0,0.0,70.0,0.0,45.0,50.0,TCGA-56-A5DR-01A,TCGA-56-A5DR,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5929,28844.0,female,1932,white,None,Primary Tumor,2.0,0.0,0.0,80.0,10.0,0.0,80.0,TCGA-34-5929-01A,TCGA-34-5929,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-8454,22913.0,female,1949,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,85.0,TCGA-34-8454-01A,TCGA-34-8454,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-G8-6325,25256.0,male,1939,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-G8-6325-01A,TCGA-G8-6325,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2777,26085.0,male,1936,not reported,None,Primary Tumor,0.0,0.0,10.0,75.0,20.0,10.0,75.0,TCGA-66-2777-01A,TCGA-66-2777,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2763,23315.0,female,1944,not reported,None,Primary Tumor,None,None,3.0,85.0,None,10.0,83.0,TCGA-66-2763-01A,TCGA-66-2763,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-A5DI,28374.0,male,1929,white,2379,Primary Tumor,5.0,10.0,30.0,60.0,70.0,20.0,40.0,TCGA-21-A5DI-01A,TCGA-21-A5DI,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A3XD,19431.0,female,1958,white,170,Primary Tumor,1.0,2.0,8.0,60.0,12.0,32.0,60.0,TCGA-EB-A3XD-01A,TCGA-EB-A3XD,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5028,27707.0,male,1931,white,None,Primary Tumor,None,None,3.0,70.0,None,30.0,62.0,TCGA-39-5028-01A,TCGA-39-5028,3.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EA,24234.0,male,1946,white,666,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9EA-01A,TCGA-V4-A9EA,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5031,28106.0,female,1931,not reported,None,Primary Tumor,None,None,10.0,65.0,None,20.0,60.0,TCGA-39-5031-01A,TCGA-39-5031,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8443,21183.0,male,1952,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KM-8443-01A,TCGA-KM-8443,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-AA8R,28841.0,female,1935,not reported,90,Primary Tumor,3.0,1.0,5.0,75.0,4.0,20.0,75.0,TCGA-VD-AA8R-01A,TCGA-VD-AA8R,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A3XF,20910.0,male,1955,white,112,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-EB-A3XF-01A,TCGA-EB-A3XF,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8403,18171.0,male,1956,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-KO-8403-01A,TCGA-KO-8403,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3415,28430.0,male,1929,not reported,None,Primary Tumor,None,None,0.0,80.0,5.0,15.0,80.0,TCGA-18-3415-01A,TCGA-18-3415,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A44N,21623.0,male,1953,white,150,Primary Tumor,1.0,0.0,10.0,65.0,2.0,0.0,75.0,TCGA-EB-A44N-01A,TCGA-EB-A44N,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EV,21855.0,female,1953,white,679,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9EV-01A,TCGA-V4-A9EV,3.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EY,24187.0,female,1946,white,463,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-V4-A9EY-01A,TCGA-V4-A9EY,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A3XB,23091.0,male,1948,white,225,Primary Tumor,0.0,1.0,0.0,90.0,2.0,9.0,90.0,TCGA-EB-A3XB-01A,TCGA-EB-A3XB,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-96-A4JL,28686.0,female,1934,asian,86,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-96-A4JL-01A,TCGA-96-A4JL,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-2576,22805.0,female,1947,white,None,Primary Tumor,None,None,0.0,45.0,35.0,25.0,70.0,TCGA-43-2576-01A,TCGA-43-2576,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-52-7622,22807.0,female,1948,white,None,Primary Tumor,None,None,10.0,60.0,None,15.0,75.0,TCGA-52-7622-01A,TCGA-52-7622,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A5EP,27622.0,female,1937,white,131,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,95.0,TCGA-BF-A5EP-01A,TCGA-BF-A5EP,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAOU,26750.0,female,1940,white,199,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-BF-AAOU-01A,TCGA-BF-AAOU,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8048,22907.0,male,1949,white,None,Primary Tumor,2.0,5.0,15.0,65.0,18.0,22.0,60.0,TCGA-85-8048-01A,TCGA-85-8048,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A1Q0,29380.0,male,1930,white,75,Primary Tumor,0.0,0.0,0.0,70.0,0.0,55.0,45.0,TCGA-BF-A1Q0-01A,TCGA-BF-A1Q0,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8416,15261.0,male,1966,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8416-01A,TCGA-KO-8416,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HO,25694.0,female,1941,white,679,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-NC-A5HO-01A,TCGA-NC-A5HO,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GR-A4D5,17023.0,female,1964,white,852,Primary Tumor,0.0,5.0,15.0,80.0,20.0,5.0,80.0,TCGA-GR-A4D5-01A,TCGA-GR-A4D5,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A53H,27928.0,female,1936,white,98,Primary Tumor,0.0,6.0,20.0,80.0,8.0,50.0,30.0,TCGA-98-A53H-01A,TCGA-98-A53H,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-5898,25441.0,male,1941,white,None,Primary Tumor,0.0,0.0,0.0,85.0,5.0,10.0,87.0,TCGA-56-5898-01A,TCGA-56-5898,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A5EO,23940.0,male,1947,white,134,Primary Tumor,0.0,0.0,15.0,70.0,0.0,5.0,80.0,TCGA-BF-A5EO-01A,TCGA-BF-A5EO,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MS,28827.0,male,None,not reported,None,Primary Tumor,4.0,2.0,0.0,70.0,7.0,29.0,70.0,TCGA-63-A5MS-01A,TCGA-63-A5MS,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-FW-A5DX,26056.0,male,1941,white,96,Primary Tumor,1.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-FW-A5DX-01A,TCGA-FW-A5DX,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8070,26183.0,male,1940,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,82.0,TCGA-85-8070-01A,TCGA-85-8070,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GR-7351,20812.0,female,1945,white,None,Primary Tumor,10.0,None,0.0,95.0,90.0,10.0,90.0,TCGA-GR-7351-01A,TCGA-GR-7351,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-7943,29282.0,male,1931,white,None,Primary Tumor,None,None,0.0,85.0,10.0,0.0,90.0,TCGA-94-7943-01A,TCGA-94-7943,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5030,29893.0,female,1925,asian,None,Primary Tumor,None,None,5.0,75.0,None,25.0,65.0,TCGA-39-5030-01A,TCGA-39-5030,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-O2-A5IB,26211.0,female,1934,white,2666,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,85.0,TCGA-O2-A5IB-01A,TCGA-O2-A5IB,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-D9-A3Z4,19749.0,male,1958,white,112,Primary Tumor,0.0,0.0,0.0,90.0,3.0,0.0,100.0,TCGA-D9-A3Z4-01A,TCGA-D9-A3Z4,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-A5IX,29391.0,male,1932,white,288,Primary Tumor,0.0,0.0,50.0,65.0,0.0,0.0,50.0,TCGA-34-A5IX-01A,TCGA-34-A5IX,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EC,27655.0,female,1937,white,615,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-V4-A9EC-01A,TCGA-V4-A9EC,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4595,21146.0,male,1945,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,60.0,TCGA-22-4595-01A,TCGA-22-4595,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8440,13860.0,male,1972,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-KM-8440-01A,TCGA-KM-8440,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-8035,23399.0,male,1947,white,None,Primary Tumor,5.0,0.0,0.0,80.0,5.0,10.0,70.0,TCGA-94-8035-01A,TCGA-94-8035,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EL,22150.0,male,1952,white,376,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9EL-01A,TCGA-V4-A9EL,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8338,18667.0,male,1955,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-KL-8338-01A,TCGA-KL-8338,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A5U8,21734.0,male,1953,asian,120,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-CF-A5U8-01A,TCGA-CF-A5U8,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-8298,21445.0,male,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-F7-8298-01A,TCGA-F7-8298,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-LC-A66R,28793.0,male,1934,white,136,Primary Tumor,1.0,0.0,0.0,70.0,13.0,0.0,97.0,TCGA-LC-A66R-01A,TCGA-LC-A66R,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FT-A3EE,29293.0,female,1931,white,251,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-FT-A3EE-01A,TCGA-FT-A3EE,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-KU-A6H8,15066.0,male,1972,white,47,Primary Tumor,2.0,4.0,58.0,60.0,8.0,15.0,22.0,TCGA-KU-A6H8-01A,TCGA-KU-A6H8,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JE,21557.0,male,1951,white,1373,Primary Tumor,0.0,5.0,0.0,80.0,0.0,20.0,80.0,TCGA-2Z-A9JE-01A,TCGA-2Z-A9JE,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-PQ-A6FI,25672.0,male,1941,white,721,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,90.0,TCGA-PQ-A6FI-01A,TCGA-PQ-A6FI,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SQ,22687.0,male,1946,white,1375,Primary Tumor,0.0,0.0,0.0,80.0,3.0,20.0,75.0,TCGA-FD-A3SQ-01A,TCGA-FD-A3SQ,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NG,28219.0,male,1924,white,4602,Primary Tumor,0.0,0.0,0.0,60.0,10.0,0.0,100.0,TCGA-L5-A8NG-01A,TCGA-L5-A8NG,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6220,25366.0,male,1938,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,75.0,TCGA-CQ-6220-01A,TCGA-CQ-6220,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A5B8,26574.0,male,1940,white,86,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,90.0,TCGA-IG-A5B8-01A,TCGA-IG-A5B8,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A61V,19857.0,male,1958,white,219,Primary Tumor,0.0,1.0,10.0,90.0,8.0,25.0,65.0,TCGA-F7-A61V-01A,TCGA-F7-A61V,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GQ,29497.0,male,1921,not reported,4670,Primary Tumor,0.0,0.0,15.0,70.0,5.0,0.0,85.0,TCGA-2H-A9GQ-01A,TCGA-2H-A9GQ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A85H,23497.0,male,1949,asian,106,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-E7-A85H-01A,TCGA-E7-A85H,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JV,22985.0,female,1949,white,835,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-UF-A7JV-01A,TCGA-UF-A7JV,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-7831,27334.0,male,1937,white,None,Primary Tumor,None,None,60.0,60.0,None,25.0,75.0,TCGA-HD-7831-01A,TCGA-HD-7831,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JK,18540.0,male,1961,white,829,Primary Tumor,0.0,5.0,0.0,70.0,0.0,30.0,70.0,TCGA-2Z-A9JK-01A,TCGA-2Z-A9JK,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6IJ,25966.0,male,1942,white,17,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,100.0,TCGA-QK-A6IJ-01A,TCGA-QK-A6IJ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A1A5,29111.0,male,1931,white,120,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-DK-A1A5-01A,TCGA-DK-A1A5,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-4075,17951.0,male,1955,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,15.0,70.0,TCGA-BA-4075-01A,TCGA-BA-4075,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7401,23420.0,male,1944,white,None,Primary Tumor,None,None,12.0,75.0,10.0,10.0,78.0,TCGA-CR-7401-01A,TCGA-CR-7401,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JN,19635.0,male,1958,white,721,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-CV-A6JN-01A,TCGA-CV-A6JN,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A78L,22717.0,male,None,white,None,Primary Tumor,5.0,1.0,0.0,70.0,4.0,30.0,70.0,TCGA-UY-A78L-01A,TCGA-UY-A78L,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7734,19612.0,female,1958,white,None,Primary Tumor,None,None,None,80.0,None,None,None,TCGA-A4-7734-01A,TCGA-A4-7734,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A3MF,12557.0,male,1977,asian,165,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-CF-A3MF-01A,TCGA-CF-A3MF,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-7630,18131.0,male,1962,white,None,Primary Tumor,None,None,0.0,60.0,None,30.0,70.0,TCGA-IQ-7630-01A,TCGA-IQ-7630,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-PJ-A5Z9,29365.0,female,1932,white,91,Primary Tumor,0.0,10.0,0.0,80.0,3.0,25.0,74.0,TCGA-PJ-A5Z9-01A,TCGA-PJ-A5Z9,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7Y,22056.0,male,1950,white,1172,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-4Z-AA7Y-01A,TCGA-4Z-AA7Y,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A6B6,21007.0,male,1954,white,549,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-DK-A6B6-01A,TCGA-DK-A6B6,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9JW,23570.0,male,1942,white,2897,Primary Tumor,0.0,8.0,0.0,70.0,1.0,0.0,81.0,TCGA-5P-A9JW-01A,TCGA-5P-A9JW,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6S,22027.0,male,1940,white,4782,Primary Tumor,0.0,0.0,0.0,65.0,2.0,0.0,100.0,TCGA-DK-AA6S-01A,TCGA-DK-AA6S,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A719,19797.0,male,1955,not reported,1481,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-UF-A719-01A,TCGA-UF-A719,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAML,27422.0,male,1932,white,2288,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-XF-AAML-01A,TCGA-XF-AAML,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5877,22095.0,male,1944,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,10.0,80.0,TCGA-BQ-5877-01A,TCGA-BQ-5877,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A5Q5,19728.0,male,1950,white,3207,Primary Tumor,0.0,0.0,0.0,60.0,30.0,30.0,70.0,TCGA-P3-A5Q5-01A,TCGA-P3-A5Q5,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5327,22307.0,female,1947,asian,None,Primary Tumor,None,None,0.0,80.0,10.0,8.0,90.0,TCGA-CQ-5327-01A,TCGA-CQ-5327,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PM,22646.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,75.0,1.0,0.0,85.0,TCGA-UZ-A9PM-01A,TCGA-UZ-A9PM,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-7753,22774.0,male,1949,black or african american,None,Primary Tumor,None,None,0.0,68.0,None,10.0,90.0,TCGA-HD-7753-01A,TCGA-HD-7753,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5889,23267.0,male,1946,white,None,Primary Tumor,None,None,18.0,75.0,None,15.0,66.0,TCGA-BQ-5889-01A,TCGA-BQ-5889,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BL-A3JM,23000.0,male,1948,white,513,Primary Tumor,0.0,0.0,0.0,80.0,0.0,35.0,65.0,TCGA-BL-A3JM-01A,TCGA-BL-A3JM,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-2F-A9KQ,25259.0,male,1938,white,2470,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-2F-A9KQ-01A,TCGA-2F-A9KQ,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NA-A4QV,26379.0,female,1930,black or african american,3861,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-NA-A4QV-01A,TCGA-NA-A4QV,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-V5-AASV,24559.0,male,None,black or african american,None,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-V5-AASV-01A,TCGA-V5-AASV,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7372,16610.0,male,1964,white,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-CR-7372-01A,TCGA-CR-7372,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T2,16588.0,male,1963,white,1912,Primary Tumor,0.0,0.0,0.0,60.0,0.0,55.0,40.0,TCGA-P3-A6T2-01A,TCGA-P3-A6T2,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T3,18143.0,male,1959,white,1698,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,55.0,TCGA-P3-A6T3-01A,TCGA-P3-A6T3,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6995,28850.0,male,1933,white,None,Primary Tumor,None,None,0.0,50.0,None,15.0,85.0,TCGA-CN-6995-01A,TCGA-CN-6995,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A71R,18742.0,male,1959,white,1088,Primary Tumor,0.0,5.0,0.0,80.0,0.0,20.0,80.0,TCGA-SX-A71R-01A,TCGA-SX-A71R,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A4P3,17860.0,male,1964,white,198,Primary Tumor,1.0,0.0,5.0,75.0,4.0,0.0,95.0,TCGA-IG-A4P3-01A,TCGA-IG-A4P3,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A9PH,26654.0,male,None,white,None,Primary Tumor,5.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-UY-A9PH-01A,TCGA-UY-A9PH,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-6873,10512.0,male,1983,white,None,Primary Tumor,None,None,18.0,80.0,7.0,10.0,70.0,TCGA-BA-6873-01A,TCGA-BA-6873,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-AAVO,25354.0,male,1939,white,2029,Primary Tumor,1.0,4.0,0.0,75.0,3.0,25.0,75.0,TCGA-P4-AAVO-01A,TCGA-P4-AAVO,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6433,20855.0,male,1953,white,None,Primary Tumor,0.0,0.0,0.0,70.0,25.0,20.0,80.0,TCGA-CV-6433-01A,TCGA-CV-6433,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A623,25592.0,male,1942,white,101,Primary Tumor,1.0,0.0,0.0,75.0,7.0,0.0,100.0,TCGA-F7-A623-01A,TCGA-F7-A623,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7407,24475.0,female,1925,white,None,Primary Tumor,2.0,2.0,0.0,65.0,2.0,29.0,71.0,TCGA-CV-7407-01A,TCGA-CV-7407,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5365,14190.0,male,1968,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CN-5365-01A,TCGA-CN-5365,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-8601,30721.0,male,1926,black or african american,None,Primary Tumor,0.0,0.0,0.0,80.0,10.0,15.0,85.0,TCGA-BB-8601-01A,TCGA-BB-8601,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7383,29122.0,female,1929,white,None,Primary Tumor,None,None,2.0,65.0,20.0,35.0,63.0,TCGA-CR-7383-01A,TCGA-CR-7383,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A8HZ,20510.0,male,1957,asian,200,Primary Tumor,3.0,0.0,0.0,70.0,22.0,35.0,58.0,TCGA-LN-A8HZ-01A,TCGA-LN-A8HZ,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20Q,26778.0,male,1933,white,1898,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-BT-A20Q-01A,TCGA-BT-A20Q,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6471,21315.0,male,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,80.0,TCGA-CR-6471-01A,TCGA-CR-6471,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J2,26134.0,female,1937,white,2047,Primary Tumor,0.0,4.0,1.0,92.0,3.0,7.0,90.0,TCGA-2Z-A9J2-01A,TCGA-2Z-A9J2,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6227,28466.0,male,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,25.0,75.0,TCGA-CQ-6227-01A,TCGA-CQ-6227,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6Q,22314.0,female,1951,white,516,Primary Tumor,0.0,0.0,15.0,70.0,3.0,0.0,85.0,TCGA-DK-AA6Q-01A,TCGA-DK-AA6Q,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A2I4,29037.0,male,1922,white,3656,Primary Tumor,2.0,1.0,0.0,80.0,4.0,19.0,80.0,TCGA-DK-A2I4-01A,TCGA-DK-A2I4,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SM,22044.0,male,1952,black or african american,380,Primary Tumor,0.0,1.0,0.0,75.0,1.0,0.0,100.0,TCGA-SX-A7SM-01A,TCGA-SX-A7SM,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A3IE,18983.0,male,1956,white,1539,Primary Tumor,1.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-G2-A3IE-01A,TCGA-G2-A3IE,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7411,23696.0,female,1930,white,None,Primary Tumor,2.0,0.0,5.0,75.0,15.0,8.0,87.0,TCGA-CV-7411-01A,TCGA-CV-7411,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49X,16154.0,male,1967,asian,480,Primary Tumor,0.0,0.0,0.0,70.0,2.0,30.0,70.0,TCGA-LN-A49X-01A,TCGA-LN-A49X,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A625,22070.0,male,1952,asian,102,Primary Tumor,2.0,1.0,6.0,75.0,3.0,19.0,75.0,TCGA-IG-A625-01A,TCGA-IG-A625,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7049,16717.0,female,1960,white,None,Primary Tumor,30.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-BQ-7049-01A,TCGA-BQ-7049,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7841,22403.0,male,1949,black or african american,None,Primary Tumor,5.0,5.0,0.0,80.0,5.0,0.0,100.0,TCGA-DW-7841-01A,TCGA-DW-7841,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4739,26081.0,male,1938,white,None,Primary Tumor,2.0,None,0.0,59.0,36.0,13.0,85.0,TCGA-CN-4739-01A,TCGA-CN-4739,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6470,14133.0,male,1969,white,None,Primary Tumor,None,None,0.0,85.0,None,35.0,65.0,TCGA-CR-6470-01A,TCGA-CR-6470,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A8HH,22393.0,female,1943,white,3312,Primary Tumor,0.0,0.0,20.0,80.0,0.0,10.0,70.0,TCGA-XF-A8HH-01A,TCGA-XF-A8HH,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MT-A67D,20386.0,male,1957,white,313,Primary Tumor,0.0,0.0,40.0,65.0,2.0,0.0,60.0,TCGA-MT-A67D-01A,TCGA-MT-A67D,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8327,17121.0,female,1955,white,None,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-KL-8327-01A,TCGA-KL-8327,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A3DJ,13332.0,female,1975,white,183,Primary Tumor,0.0,0.0,5.0,70.0,0.0,20.0,75.0,TCGA-BF-A3DJ-01A,TCGA-BF-A3DJ,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-GF-A769,14304.0,male,1971,white,1120,Primary Tumor,0.0,3.0,0.0,80.0,2.0,20.0,65.0,TCGA-GF-A769-01A,TCGA-GF-A769,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5927,25857.0,female,1939,white,None,Primary Tumor,0.0,10.0,32.0,70.0,2.0,0.0,54.0,TCGA-34-5927-01A,TCGA-34-5927,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8154,24640.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-77-8154-01A,TCGA-77-8154,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-4721,27076.0,male,1928,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,75.0,TCGA-18-4721-01A,TCGA-18-4721,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8325,20768.0,female,1944,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,100.0,TCGA-KL-8325-01A,TCGA-KL-8325,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2780,23955.0,male,1942,not reported,None,Primary Tumor,None,None,0.0,70.0,None,30.0,60.0,TCGA-66-2780-01A,TCGA-66-2780,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8072,22069.0,male,1951,white,None,Primary Tumor,None,None,0.0,65.0,None,15.0,85.0,TCGA-85-8072-01A,TCGA-85-8072,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SL,22020.0,male,1951,white,322,Primary Tumor,0.0,0.0,0.0,75.0,3.0,25.0,75.0,TCGA-FD-A3SL-01A,TCGA-FD-A3SL,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A4A3,22313.0,male,1950,asian,403,Primary Tumor,4.0,3.0,0.0,70.0,6.0,29.0,70.0,TCGA-LN-A4A3-01A,TCGA-LN-A4A3,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7O,23645.0,male,1949,black or african american,189,Primary Tumor,4.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-4Z-AA7O-01A,TCGA-4Z-AA7O,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7056,27467.0,female,1933,white,None,Primary Tumor,0.0,2.0,0.0,75.0,3.0,30.0,70.0,TCGA-BQ-7056-01A,TCGA-BQ-7056,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7044,26831.0,male,1927,white,None,Primary Tumor,1.0,1.0,0.0,90.0,3.0,0.0,100.0,TCGA-BQ-7044-01A,TCGA-BQ-7044,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6484,24569.0,female,1943,asian,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-CR-6484-01A,TCGA-CR-6484,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-KH-A6WC,30167.0,male,1931,white,78,Primary Tumor,0.0,0.0,30.0,60.0,0.0,0.0,70.0,TCGA-KH-A6WC-01A,TCGA-KH-A6WC,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4CI,26664.0,male,1938,white,524,Primary Tumor,1.0,1.0,0.0,75.0,4.0,50.0,40.0,TCGA-CQ-A4CI-01A,TCGA-CQ-A4CI,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-A7UZ,26264.0,male,1942,white,90,Primary Tumor,3.0,8.0,0.0,65.0,20.0,28.0,70.0,TCGA-A4-A7UZ-01A,TCGA-A4-A7UZ,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9K8,18880.0,female,1959,white,1186,Primary Tumor,0.0,5.0,0.0,75.0,1.0,0.0,100.0,TCGA-5P-A9K8-01A,TCGA-5P-A9K8,
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A88Y,28061.0,male,1930,white,2738,Primary Tumor,0.0,0.0,7.0,75.0,5.0,0.0,93.0,TCGA-L5-A88Y-01A,TCGA-L5-A88Y,
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RU,20025.0,female,1953,white,1988,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-N5-A4RU-01A,TCGA-N5-A4RU,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A88T,31480.0,male,1926,white,299,Primary Tumor,1.0,0.0,40.0,60.0,10.0,0.0,60.0,TCGA-L5-A88T-01A,TCGA-L5-A88T,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45P,30297.0,female,1916,white,5313,Primary Tumor,0.0,0.0,15.0,80.0,5.0,5.0,80.0,TCGA-CV-A45P-01A,TCGA-CV-A45P,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6989,23515.0,male,1947,white,None,Primary Tumor,None,None,0.0,65.0,None,40.0,60.0,TCGA-CN-6989-01A,TCGA-CN-6989,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GJ,21180.0,male,1943,not reported,5062,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-2H-A9GJ-01A,TCGA-2H-A9GJ,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A6QS,19900.0,male,1959,white,173,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-IG-A6QS-01A,TCGA-IG-A6QS,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A6V7,14895.0,male,1973,white,118,Primary Tumor,5.0,2.0,0.0,75.0,3.0,24.0,75.0,TCGA-CN-A6V7-01A,TCGA-CN-A6V7,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-KU-A66T,19405.0,female,1959,white,197,Primary Tumor,0.0,0.0,0.0,90.0,10.0,10.0,90.0,TCGA-KU-A66T-01A,TCGA-KU-A66T,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-5248,19441.0,male,1953,white,None,Primary Tumor,5.0,2.0,None,60.0,20.0,None,100.0,TCGA-CR-5248-01A,TCGA-CR-5248,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4727,20748.0,male,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,70.0,TCGA-CN-4727-01A,TCGA-CN-4727,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-AA7I,25855.0,male,1940,white,1141,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,95.0,TCGA-VR-AA7I-01A,TCGA-VR-AA7I,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-S5-AA26,16972.0,male,1967,black or african american,31,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-S5-AA26-01A,TCGA-S5-AA26,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5973,22771.0,female,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CV-5973-01A,TCGA-CV-5973,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SW,31049.0,male,1921,white,2721,Primary Tumor,5.0,2.0,0.0,70.0,3.0,30.0,70.0,TCGA-XF-A9SW-01A,TCGA-XF-A9SW,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5482,29657.0,male,1924,white,None,Primary Tumor,2.0,1.0,0.0,80.0,4.0,6.0,88.0,TCGA-22-5482-01A,TCGA-22-5482,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-1002,25359.0,male,1932,white,None,Primary Tumor,None,None,None,60.0,None,None,None,TCGA-22-1002-01A,TCGA-22-1002,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-A7DS,20087.0,female,1959,asian,138,Primary Tumor,5.0,5.0,0.0,80.0,80.0,15.0,80.0,TCGA-FA-A7DS-01A,TCGA-FA-A7DS,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-XV-A9W5,18739.0,male,1962,white,49,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-XV-A9W5-01A,TCGA-XV-A9W5,
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A5VU,20610.0,male,1956,asian,97,Primary Tumor,0.0,1.0,20.0,75.0,3.0,0.0,80.0,TCGA-EB-A5VU-01A,TCGA-EB-A5VU,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2715,18990.0,male,1957,white,None,Primary Tumor,None,None,20.0,75.0,None,10.0,67.0,TCGA-60-2715-01A,TCGA-60-2715,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAP4,22303.0,male,1952,white,58,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-BF-AAP4-01A,TCGA-BF-AAP4,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3409,27154.0,male,1930,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,60.0,TCGA-18-3409-01A,TCGA-18-3409,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-A5GH,29843.0,male,1930,not reported,559,Primary Tumor,1.0,1.0,0.0,65.0,5.0,0.0,97.0,TCGA-77-A5GH-01A,TCGA-77-A5GH,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5024,23975.0,female,1940,white,None,Primary Tumor,2.0,2.0,5.0,70.0,15.0,20.0,70.0,TCGA-39-5024-01A,TCGA-39-5024,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-FS-A1ZN,15890.0,male,1959,white,3050,Primary Tumor,0.0,0.0,8.0,92.0,0.0,0.0,92.0,TCGA-FS-A1ZN-01A,TCGA-FS-A1ZN,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-1016,24078.0,male,1936,white,None,Primary Tumor,None,None,None,60.0,None,None,None,TCGA-22-1016-01A,TCGA-22-1016,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7950,16975.0,male,1965,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,72.0,TCGA-85-7950-01A,TCGA-85-7950,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A461,23955.0,male,1939,white,2875,Primary Tumor,0.0,0.0,0.0,80.0,4.0,0.0,90.0,TCGA-CV-A461-01A,TCGA-CV-A461,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-AA4D,19714.0,male,1957,white,1322,Primary Tumor,0.0,1.0,0.0,70.0,1.0,35.0,55.0,TCGA-VR-AA4D-01A,TCGA-VR-AA4D,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5330,25255.0,female,1939,white,None,Primary Tumor,1.0,None,9.0,85.0,5.0,3.0,88.0,TCGA-CQ-5330-01A,TCGA-CQ-5330,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-LT-A8JT,25498.0,female,1944,white,303,Primary Tumor,0.0,0.0,20.0,90.0,0.0,0.0,80.0,TCGA-LT-A8JT-01A,TCGA-LT-A8JT,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IA-A83V,23238.0,male,1939,white,4013,Primary Tumor,3.0,10.0,0.0,80.0,4.0,50.0,40.0,TCGA-IA-A83V-01A,TCGA-IA-A83V,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-WA-A7H4,25363.0,male,1944,white,76,Primary Tumor,20.0,10.0,0.0,60.0,60.0,40.0,60.0,TCGA-WA-A7H4-01A,TCGA-WA-A7H4,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CX-7086,19434.0,male,1958,black or african american,None,Primary Tumor,10.0,0.0,0.0,80.0,7.0,0.0,99.0,TCGA-CX-7086-01A,TCGA-CX-7086,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NF-A4X2,21908.0,female,1953,white,341,Primary Tumor,20.0,20.0,0.0,90.0,40.0,10.0,90.0,TCGA-NF-A4X2-01A,TCGA-NF-A4X2,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A61I,23035.0,male,1949,black or african american,352,Primary Tumor,1.0,2.0,0.0,90.0,6.0,18.0,80.0,TCGA-IQ-A61I-01A,TCGA-IQ-A61I,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6517,21791.0,male,1951,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-D6-6517-01A,TCGA-D6-6517,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6024,24259.0,male,1944,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,75.0,TCGA-CN-6024-01A,TCGA-CN-6024,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IV,22237.0,male,1951,white,226,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-DK-A3IV-01A,TCGA-DK-A3IV,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JT,23806.0,male,1946,white,631,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,70.0,TCGA-CV-A6JT-01A,TCGA-CV-A6JT,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7368,19876.0,male,1954,white,None,Primary Tumor,None,None,10.0,75.0,None,15.0,75.0,TCGA-CR-7368-01A,TCGA-CR-7368,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45W,27743.0,male,1924,white,4786,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,65.0,TCGA-CV-A45W-01A,TCGA-CV-A45W,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9T6,32207.0,female,1920,white,2044,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-XF-A9T6-01A,TCGA-XF-A9T6,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-SY-A9G5,24260.0,male,1945,white,805,Primary Tumor,0.0,0.0,2.0,70.0,0.0,38.0,60.0,TCGA-SY-A9G5-01A,TCGA-SY-A9G5,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7059,26136.0,male,1939,white,None,Primary Tumor,0.0,20.0,0.0,70.0,2.0,0.0,100.0,TCGA-BQ-7059-01A,TCGA-BQ-7059,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A5W6,25706.0,male,1942,white,133,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,80.0,TCGA-CU-A5W6-01A,TCGA-CU-A5W6,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6W,28853.0,male,1935,white,68,Primary Tumor,0.0,0.0,0.0,65.0,2.0,0.0,100.0,TCGA-DK-AA6W-01A,TCGA-DK-AA6W,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-8568,22796.0,male,1950,white,None,Primary Tumor,10.0,0.0,0.0,60.0,25.0,60.0,40.0,TCGA-D6-8568-01A,TCGA-D6-8568,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NF,21134.0,male,1944,white,4682,Primary Tumor,0.0,6.0,0.0,96.0,2.0,40.0,60.0,TCGA-L5-A8NF-01A,TCGA-L5-A8NF,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A1AC,26307.0,male,1928,white,3689,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-DK-A1AC-01A,TCGA-DK-A1AC,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN8,27309.0,female,1933,white,2275,Primary Tumor,3.0,0.0,0.0,85.0,10.0,75.0,15.0,TCGA-XF-AAN8-01A,TCGA-XF-AAN8,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4CE,27793.0,female,1935,not reported,307,Primary Tumor,2.0,2.0,0.0,65.0,15.0,60.0,35.0,TCGA-CQ-A4CE-01A,TCGA-CQ-A4CE,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA89,22271.0,male,1951,white,763,Primary Tumor,0.0,0.0,0.0,87.0,10.0,10.0,73.0,TCGA-4Z-AA89-01A,TCGA-4Z-AA89,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J3,24626.0,male,1941,white,1996,Primary Tumor,0.0,2.0,0.0,94.0,3.0,4.0,89.0,TCGA-2Z-A9J3-01A,TCGA-2Z-A9J3,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PV,23741.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-UZ-A9PV-01A,TCGA-UZ-A9PV,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IZ-A6M9,23149.0,male,1950,white,35,Primary Tumor,0.0,90.0,0.0,85.0,10.0,10.0,90.0,TCGA-IZ-A6M9-01A,TCGA-IZ-A6M9,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4599,26925.0,female,1929,white,None,Primary Tumor,None,None,0.0,60.0,None,20.0,70.0,TCGA-22-4599-01A,TCGA-22-4599,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A4A8,19046.0,male,1960,asian,143,Primary Tumor,2.0,2.0,0.0,75.0,5.0,25.0,75.0,TCGA-LN-A4A8-01A,TCGA-LN-A4A8,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5333,27110.0,male,1934,white,None,Primary Tumor,5.0,None,None,70.0,20.0,None,100.0,TCGA-CQ-5333-01A,TCGA-CQ-5333,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A74Q,24702.0,male,1946,white,108,Primary Tumor,0.0,0.0,0.0,75.0,20.0,25.0,75.0,TCGA-D6-A74Q-01A,TCGA-D6-A74Q,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NG-A4VU,23323.0,female,1948,white,500,Primary Tumor,20.0,20.0,0.0,90.0,40.0,0.0,90.0,TCGA-NG-A4VU-01A,TCGA-NG-A4VU,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-A634,20810.0,male,1957,white,41,Primary Tumor,0.0,0.0,0.0,95.0,0.0,1.0,79.0,TCGA-HD-A634-01A,TCGA-HD-A634,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SN,19116.0,male,1960,white,574,Primary Tumor,0.0,1.0,0.0,80.0,1.0,0.0,100.0,TCGA-SX-A7SN-01A,TCGA-SX-A7SN,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMQ,21660.0,female,1947,white,2785,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-XF-AAMQ-01A,TCGA-XF-AAMQ,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NL,20542.0,male,1948,white,3519,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-L5-A8NL-01A,TCGA-L5-A8NL,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JD,29988.0,female,1930,white,430,Primary Tumor,3.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-CV-A6JD-01A,TCGA-CV-A6JD,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A2EO,25440.0,male,1940,white,597,Primary Tumor,0.0,0.0,0.0,85.0,2.0,35.0,60.0,TCGA-G2-A2EO-01A,TCGA-G2-A2EO,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A5U6,19840.0,male,1958,asian,127,Primary Tumor,0.0,2.0,0.0,80.0,4.0,55.0,40.0,TCGA-LN-A5U6-01A,TCGA-LN-A5U6,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A5QA,15125.0,male,1967,not reported,1596,Primary Tumor,0.0,0.0,0.0,60.0,10.0,50.0,50.0,TCGA-P3-A5QA-01A,TCGA-P3-A5QA,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6377,22419.0,male,1948,white,None,Primary Tumor,0.0,0.0,3.0,90.0,2.0,12.0,85.0,TCGA-G9-6377-01A,TCGA-G9-6377,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAK1,22965.0,male,1950,not reported,575,Primary Tumor,0.0,0.0,2.0,90.0,3.0,40.0,57.0,TCGA-XK-AAK1-01A,TCGA-XK-AAK1,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A1OF,17308.0,female,1963,not reported,128,Primary Tumor,10.0,0.0,0.0,90.0,30.0,10.0,70.0,TCGA-A5-A1OF-01A,TCGA-A5-A1OF,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GQ,27905.0,female,1934,white,274,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-EY-A1GQ-01A,TCGA-EY-A1GQ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A59V,23483.0,male,1941,not reported,2742,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-KK-A59V-01A,TCGA-KK-A59V,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LD,23216.0,female,1939,white,2993,Primary Tumor,10.0,0.0,10.0,90.0,10.0,0.0,80.0,TCGA-AP-A0LD-01A,TCGA-AP-A0LD,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A4ZV,20634.0,male,1956,not reported,79,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-HC-A4ZV-01A,TCGA-HC-A4ZV,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K6,21515.0,female,1951,white,206,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-B5-A0K6-01A,TCGA-B5-A0K6,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M4,22090.0,female,1948,white,643,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-BG-A0M4-01A,TCGA-BG-A0M4,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-FC-A8O0,25115.0,male,1945,not reported,168,Primary Tumor,0.0,0.0,0.0,90.0,0.0,30.0,70.0,TCGA-FC-A8O0-01A,TCGA-FC-A8O0,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A2QY,23398.0,female,1939,white,2957,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-DI-A2QY-01A,TCGA-DI-A2QY,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5507,19759.0,male,1956,white,None,Primary Tumor,2.0,2.0,25.0,60.0,2.0,20.0,55.0,TCGA-EJ-5507-01A,TCGA-EJ-5507,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GP,21365.0,female,1949,asian,1030,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-A5-A0GP-01A,TCGA-A5-A0GP,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVY,20709.0,male,1953,asian,1826,Primary Tumor,3.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-DD-AAVY-01A,TCGA-DD-AAVY,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A73F,28234.0,female,1933,white,975,Primary Tumor,1.0,1.0,0.0,80.0,12.0,20.0,73.0,TCGA-DD-A73F-01A,TCGA-DD-A73F,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9Z8,21900.0,male,None,not reported,None,Primary Tumor,0.0,0.0,15.0,80.0,0.0,0.0,85.0,TCGA-V1-A9Z8-01A,TCGA-V1-A9Z8,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7B3,22830.0,male,1950,not reported,486,Primary Tumor,0.0,0.0,0.0,85.0,7.0,35.0,60.0,TCGA-KK-A7B3-01A,TCGA-KK-A7B3,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A83N,20841.0,male,1955,not reported,519,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-J4-A83N-01A,TCGA-J4-A83N,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11V,23630.0,female,1946,black or african american,294,Primary Tumor,0.0,0.0,10.0,80.0,10.0,10.0,70.0,TCGA-B5-A11V-01A,TCGA-B5-A11V,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8HK,21850.0,male,1950,not reported,1477,Primary Tumor,1.0,2.0,2.0,70.0,3.0,28.0,70.0,TCGA-YL-A8HK-01A,TCGA-YL-A8HK,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5766,20392.0,male,1952,white,None,Primary Tumor,0.0,0.0,15.0,80.0,0.0,10.0,75.0,TCGA-CH-5766-01A,TCGA-CH-5766,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A1Y8,31971.0,female,1923,not reported,204,Primary Tumor,0.0,0.0,0.0,90.0,0.0,8.0,90.0,TCGA-EO-A1Y8-01A,TCGA-EO-A1Y8,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5498,20472.0,male,1954,white,None,Primary Tumor,0.0,0.0,35.0,20.0,1.0,50.0,15.0,TCGA-EJ-5498-01A,TCGA-EJ-5498,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-E6-A2P8,19448.0,female,1957,black or african american,254,Primary Tumor,0.0,0.0,0.0,85.0,1.0,10.0,90.0,TCGA-E6-A2P8-01A,TCGA-E6-A2P8,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7B4,23644.0,male,1948,not reported,434,Primary Tumor,0.0,0.0,0.0,90.0,5.0,25.0,73.0,TCGA-KK-A7B4-01A,TCGA-KK-A7B4,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9ZI,25185.0,male,None,not reported,None,Primary Tumor,0.0,0.0,3.0,90.0,3.0,33.0,62.0,TCGA-V1-A9ZI-01A,TCGA-V1-A9ZI,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LN,20704.0,female,1949,black or african american,1907,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-AP-A0LN-01A,TCGA-AP-A0LN,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6AQ,22208.0,male,1952,not reported,204,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-HC-A6AQ-01A,TCGA-HC-A6AQ,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-5C-A9VG,21273.0,male,1955,white,133,Primary Tumor,0.0,0.0,50.0,65.0,5.0,0.0,50.0,TCGA-5C-A9VG-01A,TCGA-5C-A9VG,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A52C,20966.0,male,1955,not reported,156,Primary Tumor,0.0,0.0,20.0,75.0,0.0,0.0,80.0,TCGA-J9-A52C-01A,TCGA-J9-A52C,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAEA,24027.0,male,1947,asian,461,Primary Tumor,0.0,0.0,0.0,96.0,3.0,4.0,95.0,TCGA-DD-AAEA-01A,TCGA-DD-AAEA,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39Y,24769.0,male,1935,asian,3530,Primary Tumor,0.0,1.0,0.0,90.0,1.0,10.0,90.0,TCGA-DD-A39Y-01A,TCGA-DD-A39Y,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GN,24020.0,female,1941,white,1354,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-A5-A0GN-01A,TCGA-A5-A0GN,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADI,15928.0,female,1968,asian,819,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADI-01A,TCGA-DD-AADI,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A1MW,20183.0,female,1955,white,148,Primary Tumor,5.0,0.0,0.0,90.0,10.0,10.0,87.0,TCGA-B5-A1MW-01A,TCGA-B5-A1MW,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16I,22836.0,female,1946,white,763,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,80.0,TCGA-D1-A16I-01A,TCGA-D1-A16I,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XJ-A83H,None,male,1950,not reported,2241,Primary Tumor,0.0,0.0,10.0,75.0,0.0,20.0,70.0,TCGA-XJ-A83H-01A,TCGA-XJ-A83H,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10Y,28049.0,male,1926,white,2961,Primary Tumor,0.0,0.0,0.0,85.0,5.0,15.0,85.0,TCGA-BC-A10Y-01A,TCGA-BC-A10Y,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DP,25601.0,female,1938,white,1105,Primary Tumor,2.0,0.0,0.0,90.0,5.0,10.0,90.0,TCGA-AP-A1DP-01A,TCGA-AP-A1DP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M7,22096.0,female,1948,white,659,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-BG-A0M7-01A,TCGA-BG-A0M7,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5788,25233.0,male,1938,white,None,Primary Tumor,0.0,3.0,0.0,80.0,3.0,20.0,75.0,TCGA-CH-5788-01A,TCGA-CH-5788,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A9TE,23543.0,male,1949,not reported,159,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-HC-A9TE-01A,TCGA-HC-A9TE,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5752,24290.0,male,1940,white,None,Primary Tumor,0.0,0.0,0.0,65.0,2.0,45.0,50.0,TCGA-CH-5752-01A,TCGA-CH-5752,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LV,14556.0,female,1970,white,341,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-AP-A0LV-01A,TCGA-AP-A0LV,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AA3A,29712.0,female,1928,white,1559,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-DD-AA3A-01A,TCGA-DD-AA3A,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A8FP,21769.0,male,1954,not reported,145,Primary Tumor,0.0,0.0,30.0,70.0,0.0,30.0,40.0,TCGA-EJ-A8FP-01A,TCGA-EJ-A8FP,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE9,25451.0,male,1943,asian,419,Primary Tumor,0.0,0.0,0.0,98.0,1.0,2.0,97.0,TCGA-DD-AAE9-01A,TCGA-DD-AAE9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3EJ,27317.0,female,1936,white,332,Primary Tumor,0.0,0.0,0.0,70.0,0.0,15.0,75.0,TCGA-AJ-A3EJ-01A,TCGA-AJ-A3EJ,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A0WH,23692.0,female,1946,white,244,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-DI-A0WH-01A,TCGA-DI-A0WH,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-5261,16373.0,male,1966,asian,110,Primary Tumor,None,None,0.0,85.0,None,20.0,77.0,TCGA-CC-5261-01A,TCGA-CC-5261,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3FT,23543.0,female,1946,white,524,Primary Tumor,0.0,0.0,8.0,80.0,10.0,20.0,70.0,TCGA-AX-A3FT-01A,TCGA-AX-A3FT,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8MU,20805.0,male,None,not reported,None,Primary Tumor,0.0,0.0,30.0,70.0,0.0,10.0,60.0,TCGA-V1-A8MU-01A,TCGA-V1-A8MU,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5516,17980.0,male,1960,white,None,Primary Tumor,0.0,0.0,10.0,75.0,3.0,20.0,70.0,TCGA-EJ-5516-01A,TCGA-EJ-5516,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7AV,21192.0,male,1954,not reported,587,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-KK-A7AV-01A,TCGA-KK-A7AV,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CK,21200.0,female,1947,white,2115,Primary Tumor,1.0,1.0,1.0,85.0,8.0,8.0,89.0,TCGA-AX-A1CK-01A,TCGA-AX-A1CK,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LT,21107.0,female,1949,white,1404,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,85.0,TCGA-AP-A0LT-01A,TCGA-AP-A0LT,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17L,29899.0,female,1928,white,493,Primary Tumor,2.0,0.0,2.0,85.0,12.0,15.0,83.0,TCGA-D1-A17L-01A,TCGA-D1-A17L,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3EL,17442.0,female,1963,native hawaiian or other pacific islander,317,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-AJ-A3EL-01A,TCGA-AJ-A3EL,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9L5,21293.0,male,1953,not reported,953,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-ZG-A9L5-01A,TCGA-ZG-A9L5,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A1BU,20114.0,female,1953,white,903,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-DI-A1BU-01A,TCGA-DI-A1BU,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GQ,28078.0,female,1931,white,1022,Primary Tumor,30.0,5.0,0.0,2.0,20.0,92.0,5.0,TCGA-A5-A0GQ-01A,TCGA-A5-A0GQ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-7521,19216.0,male,1958,not reported,None,Primary Tumor,None,None,5.0,80.0,None,15.0,80.0,TCGA-G9-7521-01A,TCGA-G9-7521,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6HX,20263.0,male,1958,not reported,112,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-HC-A6HX-01A,TCGA-HC-A6HX,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV6,19556.0,female,1960,white,24,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-G3-AAV6-01A,TCGA-G3-AAV6,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7II,20079.0,male,1959,asian,169,Primary Tumor,0.0,0.0,0.0,60.0,1.0,0.0,100.0,TCGA-CC-A7II-01A,TCGA-CC-A7II,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A66Y,18797.0,female,1962,asian,75,Primary Tumor,0.0,2.0,0.0,95.0,1.0,9.0,90.0,TCGA-ED-A66Y-01A,TCGA-ED-A66Y,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A8QY,24731.0,male,1946,not reported,250,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-ZG-A8QY-01A,TCGA-ZG-A8QY,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EK,23437.0,female,1944,white,819,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,75.0,TCGA-DD-A1EK-01A,TCGA-DD-A1EK,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A73D,24941.0,female,1944,white,313,Primary Tumor,0.0,0.0,0.0,97.0,1.0,2.0,98.0,TCGA-DD-A73D-01A,TCGA-DD-A73D,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DK,19509.0,female,1953,white,1541,Primary Tumor,20.0,0.0,0.0,80.0,20.0,20.0,60.0,TCGA-AP-A1DK-01A,TCGA-AP-A1DK,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9LN,21050.0,male,1956,not reported,76,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-ZG-A9LN-01A,TCGA-ZG-A9LN,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1NZ,22027.0,female,1950,white,191,Primary Tumor,20.0,20.0,10.0,70.0,50.0,15.0,70.0,TCGA-D1-A1NZ-01A,TCGA-D1-A1NZ,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A69H,23380.0,male,1949,white,94,Primary Tumor,1.0,1.0,0.0,85.0,2.0,14.0,85.0,TCGA-BC-A69H-01A,TCGA-BC-A69H,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7736,21703.0,male,1951,white,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-HC-7736-01A,TCGA-HC-7736,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A7M5,27963.0,male,1937,asian,217,Primary Tumor,1.0,1.0,0.0,85.0,1.0,13.0,85.0,TCGA-G3-A7M5-01A,TCGA-G3-A7M5,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A7NK,21530.0,male,1954,not reported,254,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-EJ-A7NK-01A,TCGA-EJ-A7NK,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACE,22727.0,male,1946,asian,1973,Primary Tumor,0.0,2.0,0.0,93.0,4.0,5.0,93.0,TCGA-DD-AACE-01A,TCGA-DD-AACE,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-TP-A8TV,22872.0,male,1951,not reported,194,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-TP-A8TV-01A,TCGA-TP-A8TV,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A9,23526.0,female,1937,white,3584,Primary Tumor,0.0,0.0,0.0,70.0,2.0,30.0,70.0,TCGA-DD-A3A9-01A,TCGA-DD-A3A9,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A65F,21681.0,male,1953,not reported,293,Primary Tumor,20.0,20.0,20.0,60.0,40.0,20.0,60.0,TCGA-EJ-A65F-01A,TCGA-EJ-A65F,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7791,24621.0,male,1944,white,None,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-EJ-7791-01A,TCGA-EJ-7791,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MQ,26284.0,female,1937,white,692,Primary Tumor,3.0,1.0,0.0,88.0,5.0,5.0,77.0,TCGA-BG-A0MQ-01A,TCGA-BG-A0MQ,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A8HT,27334.0,male,1939,asian,197,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-CC-A8HT-01A,TCGA-CC-A8HT,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3KX,29260.0,female,1931,white,184,Primary Tumor,0.0,1.0,0.0,95.0,1.0,0.0,85.0,TCGA-EO-A3KX-01A,TCGA-EO-A3KX,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-AA0V,25340.0,female,1944,white,7,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-UB-AA0V-01A,TCGA-UB-AA0V,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A8QZ,23980.0,male,1948,not reported,322,Primary Tumor,0.0,0.0,20.0,80.0,0.0,20.0,60.0,TCGA-ZG-A8QZ-01A,TCGA-ZG-A8QZ,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7IL,22319.0,male,1952,asian,161,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-CC-A7IL-01A,TCGA-CC-A7IL,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3EK,19609.0,female,1958,white,127,Primary Tumor,0.0,0.0,5.0,85.0,4.0,0.0,90.0,TCGA-AJ-A3EK-01A,TCGA-AJ-A3EK,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-4E-A92E,19818.0,female,1959,black or african american,90,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-4E-A92E-01A,TCGA-4E-A92E,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GV,27581.0,female,1935,white,156,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-EY-A1GV-01A,TCGA-EY-A1GV,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11Z,22505.0,female,1949,white,213,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-B5-A11Z-01A,TCGA-B5-A11Z,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3B1,23162.0,female,1948,not reported,163,Primary Tumor,20.0,20.0,0.0,90.0,60.0,10.0,90.0,TCGA-EO-A3B1-01A,TCGA-EO-A3B1,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A943,26162.0,male,1942,not reported,139,Primary Tumor,0.0,0.0,5.0,77.0,0.0,0.0,95.0,TCGA-VN-A943-01A,TCGA-VN-A943,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16O,16114.0,female,1964,white,756,Primary Tumor,0.0,0.0,10.0,80.0,10.0,10.0,60.0,TCGA-D1-A16O-01A,TCGA-D1-A16O,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0RA,25060.0,female,1941,white,492,Primary Tumor,40.0,20.0,0.0,80.0,20.0,5.0,85.0,TCGA-A5-A0RA-01A,TCGA-A5-A0RA,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A52B,22849.0,male,1950,not reported,301,Primary Tumor,0.0,0.0,5.0,92.0,0.0,0.0,95.0,TCGA-J9-A52B-01A,TCGA-J9-A52B,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5768,26480.0,male,1935,white,None,Primary Tumor,0.0,0.0,45.0,35.0,0.0,20.0,35.0,TCGA-CH-5768-01A,TCGA-CH-5768,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A2G7,23913.0,female,1942,white,1339,Primary Tumor,10.0,0.0,20.0,80.0,10.0,0.0,60.0,TCGA-D1-A2G7-01A,TCGA-D1-A2G7,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GS,26012.0,female,1939,black or african american,211,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-EY-A1GS-01A,TCGA-EY-A1GS,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OY,21170.0,male,None,not reported,None,Primary Tumor,0.0,0.0,10.0,70.0,0.0,30.0,60.0,TCGA-V1-A9OY-01A,TCGA-V1-A9OY,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0R6,23449.0,female,1945,white,259,Primary Tumor,25.0,15.0,10.0,75.0,30.0,5.0,75.0,TCGA-A5-A0R6-01A,TCGA-A5-A0R6,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A6RA,25679.0,male,1942,not reported,213,Primary Tumor,0.0,0.0,30.0,80.0,0.0,10.0,60.0,TCGA-EJ-A6RA-01A,TCGA-EJ-A6RA,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9N3,26902.0,male,1940,not reported,69,Primary Tumor,1.0,1.0,0.0,80.0,3.0,19.0,80.0,TCGA-ZG-A9N3-01A,TCGA-ZG-A9N3,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BD-A3ER,22657.0,male,1949,white,23,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BD-A3ER-01A,TCGA-BD-A3ER,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A8O5,21648.0,female,1954,asian,100,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ED-A8O5-01A,TCGA-ED-A8O5,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1NW,26556.0,female,1938,white,199,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-D1-A1NW-01A,TCGA-D1-A1NW,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZV,21374.0,female,1951,white,324,Primary Tumor,20.0,0.0,0.0,80.0,20.0,20.0,70.0,TCGA-D1-A0ZV-01A,TCGA-D1-A0ZV,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A210,30095.0,female,1929,black or african american,70,Primary Tumor,15.0,5.0,0.0,95.0,35.0,5.0,95.0,TCGA-EY-A210-01A,TCGA-EY-A210,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IM,20425.0,male,1954,not reported,1466,Primary Tumor,2.0,2.0,8.0,75.0,12.0,50.0,42.0,TCGA-KK-A8IM-01A,TCGA-KK-A8IM,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A7F5,20015.0,male,1959,not reported,138,Primary Tumor,0.0,0.0,0.0,75.0,2.0,25.0,75.0,TCGA-KC-A7F5-01A,TCGA-KC-A7F5,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0VQ,22995.0,female,1948,not reported,133,Primary Tumor,10.0,0.0,0.0,90.0,10.0,10.0,80.0,TCGA-A5-A0VQ-01A,TCGA-A5-A0VQ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A87J,20792.0,male,1954,not reported,1379,Primary Tumor,0.0,0.0,30.0,60.0,0.0,20.0,50.0,TCGA-VP-A87J-01A,TCGA-VP-A87J,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-A9S0,19530.0,male,1958,not reported,840,Primary Tumor,2.0,1.0,5.0,75.0,3.0,20.0,75.0,TCGA-G9-A9S0-01A,TCGA-G9-A9S0,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A06D,30024.0,female,1925,white,1066,Primary Tumor,0.0,0.0,15.0,60.0,3.0,5.0,55.0,TCGA-AX-A06D-01A,TCGA-AX-A06D,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE1,19073.0,male,1961,asian,321,Primary Tumor,0.0,0.0,0.0,96.0,3.0,2.0,97.0,TCGA-DD-AAE1-01A,TCGA-DD-AAE1,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-M7-A722,23880.0,male,1946,not reported,577,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-M7-A722-01A,TCGA-M7-A722,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IA,25284.0,male,1940,not reported,1665,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-KK-A8IA-01A,TCGA-KK-A8IA,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GV,24540.0,female,1942,white,454,Primary Tumor,0.0,1.0,0.0,95.0,1.0,3.0,92.0,TCGA-A5-A0GV-01A,TCGA-A5-A0GV,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7080,24243.0,male,1944,white,None,Primary Tumor,None,None,10.0,70.0,None,20.0,70.0,TCGA-HC-7080-01A,TCGA-HC-7080,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A25T,16461.0,female,1962,white,1224,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-G3-A25T-01A,TCGA-G3-A25T,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GO,23853.0,female,1945,white,259,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-EY-A1GO-01A,TCGA-EY-A1GO,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EC-A1NJ,27002.0,female,1937,white,60,Primary Tumor,10.0,0.0,20.0,60.0,20.0,20.0,50.0,TCGA-EC-A1NJ-01A,TCGA-EC-A1NJ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1NS,19638.0,female,1957,white,92,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-D1-A1NS-01A,TCGA-D1-A1NS,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A632,24916.0,male,1945,not reported,85,Primary Tumor,0.0,0.0,0.0,80.0,100.0,30.0,70.0,TCGA-HC-A632-01A,TCGA-HC-A632,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GH,25802.0,female,1939,white,452,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-EY-A1GH-01A,TCGA-EY-A1GH,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GK,27127.0,female,1935,white,409,Primary Tumor,30.0,30.0,0.0,80.0,30.0,15.0,80.0,TCGA-EY-A1GK-01A,TCGA-EY-A1GK,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A3MC,20067.0,male,1957,asian,268,Primary Tumor,1.0,1.0,0.0,75.0,4.0,25.0,75.0,TCGA-CC-A3MC-01A,TCGA-CC-A3MC,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A7NF,20587.0,male,1957,not reported,195,Primary Tumor,0.0,0.0,15.0,60.0,0.0,40.0,45.0,TCGA-EJ-A7NF-01A,TCGA-EJ-A7NF,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-M7-A71Y,20357.0,male,1958,not reported,183,Primary Tumor,20.0,20.0,20.0,60.0,40.0,20.0,60.0,TCGA-M7-A71Y-01A,TCGA-M7-A71Y,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2CX,30224.0,female,1926,white,1067,Primary Tumor,2.0,35.0,0.0,98.0,40.0,2.0,88.0,TCGA-FI-A2CX-01A,TCGA-FI-A2CX,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A9TH,21460.0,male,1955,not reported,320,Primary Tumor,0.0,0.0,0.0,80.0,0.0,35.0,60.0,TCGA-HC-A9TH-01A,TCGA-HC-A9TH,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A7SB,19698.0,male,1959,asian,343,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-RC-A7SB-01A,TCGA-RC-A7SB,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A7SH,15560.0,male,1970,asian,271,Primary Tumor,0.0,0.0,0.0,60.0,1.0,35.0,65.0,TCGA-RC-A7SH-01A,TCGA-RC-A7SH,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GD,18638.0,female,1958,black or african american,511,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-EY-A1GD-01A,TCGA-EY-A1GD,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A65D,24297.0,male,1946,not reported,240,Primary Tumor,0.0,3.0,0.0,95.0,2.0,15.0,85.0,TCGA-EJ-A65D-01A,TCGA-EJ-A65D,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E8,25026.0,male,1939,not reported,2128,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-KK-A6E8-01A,TCGA-KK-A6E8,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GB,23883.0,female,1943,white,583,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-A5-A0GB-01A,TCGA-A5-A0GB,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A9WY,21164.0,male,1954,not reported,785,Primary Tumor,0.0,0.0,10.0,60.0,0.0,0.0,90.0,TCGA-YL-A9WY-01A,TCGA-YL-A9WY,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0G9,29122.0,female,1925,white,2095,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-A5-A0G9-01A,TCGA-A5-A0G9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A2QK,23945.0,female,1946,white,146,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-AJ-A2QK-01A,TCGA-AJ-A2QK,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-8469,17014.0,male,1961,not reported,None,Primary Tumor,None,None,10.0,75.0,None,15.0,75.0,TCGA-EJ-8469-01A,TCGA-EJ-8469,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAEK,18757.0,male,1959,asian,1162,Primary Tumor,0.0,0.0,0.0,75.0,7.0,0.0,100.0,TCGA-DD-AAEK-01A,TCGA-DD-AAEK,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6347,21721.0,male,1949,not reported,None,Primary Tumor,0.0,0.0,30.0,60.0,0.0,0.0,70.0,TCGA-G9-6347-01A,TCGA-G9-6347,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A459,17402.0,male,1965,asian,87,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ED-A459-01A,TCGA-ED-A459,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A059,25311.0,female,1937,white,1476,Primary Tumor,2.0,0.0,0.0,60.0,25.0,1.0,98.0,TCGA-AP-A059-01A,TCGA-AP-A059,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A15V,24886.0,female,1940,white,895,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-D1-A15V-01A,TCGA-D1-A15V,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A5DW,20711.0,female,1956,black or african american,133,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-AJ-A5DW-01A,TCGA-AJ-A5DW,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0TD,23950.0,female,1940,asian,2004,Primary Tumor,20.0,10.0,0.0,80.0,40.0,20.0,80.0,TCGA-BS-A0TD-01A,TCGA-BS-A0TD,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A7F3,24676.0,male,1946,not reported,195,Primary Tumor,0.0,0.0,20.0,60.0,2.0,20.0,60.0,TCGA-KC-A7F3-01A,TCGA-KC-A7F3,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-MI-A75E,22457.0,male,1952,white,157,Primary Tumor,1.0,2.0,0.0,88.0,7.0,20.0,73.0,TCGA-MI-A75E-01A,TCGA-MI-A75E,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACD,17828.0,male,1960,asian,2015,Primary Tumor,0.0,1.0,0.0,90.0,6.0,15.0,83.0,TCGA-DD-AACD-01A,TCGA-DD-AACD,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17S,21794.0,female,1950,white,419,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D1-A17S-01A,TCGA-D1-A17S,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-E6-A1LZ,28054.0,female,1931,black or african american,1233,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,80.0,TCGA-E6-A1LZ-01A,TCGA-E6-A1LZ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A3K1,20594.0,female,1954,white,450,Primary Tumor,0.0,0.0,0.0,95.0,1.0,0.0,100.0,TCGA-AP-A3K1-01A,TCGA-AP-A3K1,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACO,14796.0,male,1969,asian,1637,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AACO-01A,TCGA-DD-AACO,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2IO,30539.0,female,1925,white,1262,Primary Tumor,0.0,0.0,38.0,60.0,10.0,10.0,50.0,TCGA-AX-A2IO-01A,TCGA-AX-A2IO,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZP-A9D1,20584.0,female,1956,white,699,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-ZP-A9D1-01A,TCGA-ZP-A9D1,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-A7ME,18846.0,male,1962,asian,154,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-UB-A7ME-01A,TCGA-UB-A7ME,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A1HT,18553.0,male,1960,asian,86,Primary Tumor,0.0,0.0,0.0,60.0,15.0,40.0,60.0,TCGA-CC-A1HT-01A,TCGA-CC-A1HT,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0U5,27945.0,female,1927,white,2525,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,90.0,TCGA-BS-A0U5-01A,TCGA-BS-A0U5,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A7NM,23603.0,male,1949,not reported,115,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-EJ-A7NM-01A,TCGA-EJ-A7NM,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H0,18109.0,male,1955,white,3538,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-2Y-A9H0-01A,TCGA-2Y-A9H0,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K3,22664.0,female,1947,black or african american,523,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,95.0,TCGA-B5-A0K3-01A,TCGA-B5-A0K3,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3G9,23361.0,female,1947,white,560,Primary Tumor,0.0,0.0,10.0,90.0,1.0,5.0,83.0,TCGA-AX-A3G9-01A,TCGA-AX-A3G9,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88P,21916.0,male,1951,not reported,911,Primary Tumor,0.0,0.0,0.0,85.0,0.0,30.0,70.0,TCGA-VN-A88P-01A,TCGA-VN-A88P,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6X3,10184.0,male,1986,white,76,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-QH-A6X3-01A,TCGA-QH-A6X3,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5302,15230.0,male,1957,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-E1-5302-01A,TCGA-E1-5302,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7471,13564.0,female,1973,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7471-01A,TCGA-HT-7471,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DO,12158.0,female,1972,white,2339,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-ET-A3DO-01A,TCGA-ET-A3DO,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A23A,10177.0,female,1979,white,1838,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-FE-A23A-01A,TCGA-FE-A23A,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BO,16110.0,female,1966,white,283,Primary Tumor,0.0,1.0,0.0,90.0,1.0,10.0,90.0,TCGA-ET-A3BO-01A,TCGA-ET-A3BO,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7TA,11764.0,male,1975,white,2287,Primary Tumor,0.0,0.0,5.0,95.0,0.0,15.0,80.0,TCGA-DU-A7TA-01A,TCGA-DU-A7TA,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84R,16843.0,male,1966,white,346,Primary Tumor,0.0,0.0,10.0,70.0,0.0,45.0,45.0,TCGA-TM-A84R-01A,TCGA-TM-A84R,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6CS,15092.0,male,1972,white,53,Primary Tumor,0.0,0.0,10.0,80.0,0.0,55.0,35.0,TCGA-QH-A6CS-01A,TCGA-QH-A6CS,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7882,24450.0,male,1944,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-HT-7882-01A,TCGA-HT-7882,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7603,10883.0,male,1979,white,None,Primary Tumor,None,None,20.0,60.0,None,0.0,80.0,TCGA-HT-7603-01A,TCGA-HT-7603,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64S,7389.0,male,1992,white,352,Primary Tumor,0.0,0.0,10.0,75.0,0.0,20.0,70.0,TCGA-DB-A64S-01A,TCGA-DB-A64S,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A415,14288.0,female,1973,asian,58,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-E8-A415-01A,TCGA-E8-A415,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8166,10641.0,female,1983,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-DU-8166-01A,TCGA-DU-8166,
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-1680,23267.0,male,1944,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,77.0,TCGA-64-1680-01A,TCGA-64-1680,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-8496,23358.0,female,1948,white,None,Primary Tumor,None,None,15.0,75.0,None,10.0,75.0,TCGA-91-8496-01A,TCGA-91-8496,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-RB-A7B8,29585.0,female,1932,white,84,Primary Tumor,0.0,2.0,50.0,25.0,10.0,30.0,20.0,TCGA-RB-A7B8-01A,TCGA-RB-A7B8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HY,22179.0,female,1949,white,470,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-BH-A0HY-01A,TCGA-BH-A0HY,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SM,28198.0,male,1930,white,1115,Primary Tumor,0.0,0.0,0.0,90.0,2.0,9.0,90.0,TCGA-A1-A0SM-01A,TCGA-A1-A0SM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DX,22833.0,female,1945,white,997,Primary Tumor,0.0,0.0,70.0,35.0,40.0,20.0,10.0,TCGA-BH-A0DX-01A,TCGA-BH-A0DX,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-5715,25383.0,female,1941,not reported,None,Primary Tumor,1.0,10.0,10.0,75.0,5.0,0.0,90.0,TCGA-05-5715-01A,TCGA-05-5715,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A124,14174.0,female,1964,white,3213,Primary Tumor,1.0,1.0,0.0,75.0,2.0,22.0,75.0,TCGA-AO-A124-01A,TCGA-AO-A124,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8302,20011.0,male,1958,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,4.0,94.0,TCGA-55-8302-01A,TCGA-55-8302,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-H8-A6C1,19677.0,male,1959,white,198,Primary Tumor,2.0,2.0,3.0,65.0,10.0,74.0,20.0,TCGA-H8-A6C1-01A,TCGA-H8-A6C1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A255,22809.0,female,1945,white,1225,Primary Tumor,0.0,0.0,5.0,85.0,0.0,0.0,95.0,TCGA-AR-A255-01A,TCGA-AR-A255,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A73Y,24647.0,female,1946,black or african american,55,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-LL-A73Y-01A,TCGA-LL-A73Y,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L9-A5IP,14681.0,female,1972,black or african american,94,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,80.0,TCGA-L9-A5IP-01A,TCGA-L9-A5IP,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A4YP,19106.0,male,1959,white,615,Primary Tumor,3.0,3.0,0.0,65.0,5.0,0.0,82.0,TCGA-NJ-A4YP-01A,TCGA-NJ-A4YP,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P5,28177.0,female,1933,white,325,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-EW-A1P5-01A,TCGA-EW-A1P5,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6847,22862.0,female,1940,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,70.0,TCGA-91-6847-01A,TCGA-91-6847,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-4H-AAAK,18371.0,female,1963,white,35,Primary Tumor,0.0,0.0,10.0,70.0,5.0,20.0,70.0,TCGA-4H-AAAK-01A,TCGA-4H-AAAK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-A6ZH,10832.0,female,1984,black or african american,158,Primary Tumor,1.0,1.0,7.0,85.0,4.0,8.0,85.0,TCGA-S3-A6ZH-01A,TCGA-S3-A6ZH,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-HN-A2NL,20483.0,female,None,not reported,None,Primary Tumor,1.0,1.0,0.0,80.0,3.0,19.0,80.0,TCGA-HN-A2NL-01A,TCGA-HN-A2NL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HO,12715.0,female,1976,asian,52,Primary Tumor,0.0,0.0,0.0,70.0,0.0,25.0,75.0,TCGA-C8-A1HO-01A,TCGA-C8-A1HO,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DB,22883.0,female,1944,white,1644,Primary Tumor,0.0,0.0,0.0,75.0,0.0,5.0,80.0,TCGA-GM-A2DB-01A,TCGA-GM-A2DB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4384,24411.0,male,1943,not reported,None,Primary Tumor,None,None,20.0,70.0,5.0,10.0,70.0,TCGA-05-4384-01A,TCGA-05-4384,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IG,16757.0,female,1964,white,679,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-E2-A1IG-01A,TCGA-E2-A1IG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AV,24875.0,male,1939,white,1233,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-AR-A1AV-01A,TCGA-AR-A1AV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A22A,27288.0,female,1937,white,59,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,100.0,TCGA-E9-A22A-01A,TCGA-E9-A22A,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-WT-AB41,None,female,1955,black or african american,1415,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-WT-AB41-01A,TCGA-WT-AB41,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A3J0,22672.0,female,1949,white,78,Primary Tumor,0.0,0.0,0.0,92.0,0.0,5.0,95.0,TCGA-A7-A3J0-01A,TCGA-A7-A3J0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LI,21064.0,female,1946,white,2815,Primary Tumor,0.0,0.0,0.0,85.0,0.0,30.0,70.0,TCGA-E2-A1LI-01A,TCGA-E2-A1LI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JC,23404.0,female,1942,white,1522,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-AO-A0JC-01A,TCGA-AO-A0JC,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-XD-AAUI,18607.0,female,1963,white,63,Primary Tumor,10.0,10.0,10.0,60.0,70.0,30.0,60.0,TCGA-XD-AAUI-01A,TCGA-XD-AAUI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08A,32750.0,female,1918,not reported,1033,Primary Tumor,0.0,1.0,0.0,85.0,2.0,15.0,82.0,TCGA-A8-A08A-01A,TCGA-A8-A08A,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7974,20021.0,female,1957,white,None,Primary Tumor,0.0,2.0,0.0,80.0,9.0,10.0,90.0,TCGA-69-7974-01A,TCGA-69-7974,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B5,14920.0,female,1967,white,1008,Primary Tumor,0.0,0.0,29.0,45.0,1.0,40.0,30.0,TCGA-BH-A0B5-01A,TCGA-BH-A0B5,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09D,17440.0,female,1960,not reported,1033,Primary Tumor,0.0,0.0,0.0,80.0,10.0,50.0,50.0,TCGA-A8-A09D-01A,TCGA-A8-A09D,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-35-3615,21076.0,male,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,35.0,65.0,TCGA-35-3615-01A,TCGA-35-3615,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4425,25902.0,female,1938,not reported,None,Primary Tumor,None,None,0.0,80.0,10.0,25.0,75.0,TCGA-05-4425-01A,TCGA-05-4425,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8547,28801.0,female,1934,not reported,None,Primary Tumor,0.0,0.0,0.0,65.0,10.0,10.0,90.0,TCGA-97-8547-01A,TCGA-97-8547,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HO,17710.0,female,1961,white,224,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-BH-A0HO-01A,TCGA-BH-A0HO,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8505,22676.0,male,1950,white,None,Primary Tumor,10.0,10.0,18.0,65.0,10.0,0.0,80.0,TCGA-55-8505-01A,TCGA-55-8505,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R2,18936.0,female,1960,white,64,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E9-A1R2-01A,TCGA-E9-A1R2,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6829,28841.0,male,1923,white,None,Primary Tumor,None,None,0.0,75.0,None,50.0,45.0,TCGA-91-6829-01A,TCGA-91-6829,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-6207,None,male,None,not reported,None,Primary Tumor,0.0,0.0,5.0,85.0,10.0,0.0,85.0,TCGA-75-6207-01A,TCGA-75-6207,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XT,19794.0,female,1956,white,114,Primary Tumor,0.0,0.0,0.0,85.0,2.0,14.0,85.0,TCGA-AN-A0XT-01A,TCGA-AN-A0XT,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HL,None,female,1972,asian,94,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-C8-A1HL-01A,TCGA-C8-A1HL,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14Q,18507.0,female,1958,white,960,Primary Tumor,0.0,0.0,10.0,85.0,0.0,20.0,70.0,TCGA-E2-A14Q-01A,TCGA-E2-A14Q,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6975,None,male,1943,white,None,Primary Tumor,None,None,0.0,65.0,None,15.0,85.0,TCGA-55-6975-01A,TCGA-55-6975,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-6562,19301.0,male,1959,white,None,Primary Tumor,None,None,15.0,75.0,None,15.0,65.0,TCGA-86-6562-01A,TCGA-86-6562,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A4SF,19985.0,female,1958,black or african american,245,Primary Tumor,0.0,0.0,0.0,68.0,0.0,10.0,90.0,TCGA-A7-A4SF-01A,TCGA-A7-A4SF,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-1592,None,male,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,75.0,TCGA-55-1592-01A,TCGA-55-1592,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5854,21106.0,female,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-5854-01A,TCGA-DU-5854,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A731,21715.0,female,1954,white,143,Primary Tumor,0.0,0.0,10.0,70.0,0.0,70.0,20.0,TCGA-P5-A731-01A,TCGA-P5-A731,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CS,22993.0,female,1942,white,2746,Primary Tumor,0.0,0.0,0.0,92.0,0.0,10.0,90.0,TCGA-EL-A3CS-01A,TCGA-EL-A3CS,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8558,10950.0,female,1982,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-8558-01A,TCGA-HT-8558,
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A3O0,14214.0,male,1971,white,874,Primary Tumor,0.0,6.0,0.0,100.0,1.0,50.0,50.0,TCGA-J8-A3O0-01A,TCGA-J8-A3O0,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6CZ,14007.0,male,1975,white,16,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-QH-A6CZ-01A,TCGA-QH-A6CZ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7R2,25419.0,male,1939,white,2027,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-S9-A7R2-01A,TCGA-S9-A7R2,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3O6,19856.0,female,1957,not reported,123,Primary Tumor,0.0,1.0,0.0,100.0,0.0,10.0,90.0,TCGA-EM-A3O6-01A,TCGA-EM-A3O6,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8012,11295.0,female,1980,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-8012-01A,TCGA-HT-8012,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZS,8076.0,female,1986,white,1315,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-EL-A3ZS-01A,TCGA-EL-A3ZS,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-6290,11666.0,male,1978,not reported,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-CS-6290-01A,TCGA-CS-6290,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FK,12383.0,female,1978,not reported,281,Primary Tumor,0.0,1.0,0.0,80.0,2.0,0.0,100.0,TCGA-EM-A4FK-01A,TCGA-EM-A4FK,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7309,15197.0,female,1970,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-DU-7309-01A,TCGA-DU-7309,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64X,20625.0,female,1956,white,247,Primary Tumor,0.0,0.0,5.0,90.0,0.0,20.0,75.0,TCGA-DB-A64X-01A,TCGA-DB-A64X,
LGG,Brain Lower Grade Glioma,Brain,TCGA-VM-A8CE,9363.0,male,1986,white,780,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-VM-A8CE-01A,TCGA-VM-A8CE,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3OB,12282.0,female,1978,not reported,79,Primary Tumor,0.0,0.0,0.0,100.0,0.0,5.0,95.0,TCGA-EM-A3OB-01A,TCGA-EM-A3OB,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A66F,18193.0,male,1963,white,166,Primary Tumor,0.0,0.0,10.0,90.0,0.0,30.0,60.0,TCGA-DH-A66F-01A,TCGA-DH-A66F,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22K,16890.0,female,1965,not reported,66,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EM-A22K-01A,TCGA-EM-A22K,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CW,31934.0,female,1913,white,4171,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-EL-A3CW-01A,TCGA-EL-A3CW,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A4MX,17381.0,male,1965,white,115,Primary Tumor,0.0,0.0,20.0,80.0,0.0,0.0,80.0,TCGA-FG-A4MX-01A,TCGA-FG-A4MX,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7Z4,12849.0,male,1964,white,5125,Primary Tumor,0.0,0.0,10.0,85.0,0.0,45.0,45.0,TCGA-E1-A7Z4-01A,TCGA-E1-A7Z4,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A5TU,22811.0,female,1951,white,21,Primary Tumor,0.0,0.0,10.0,70.0,0.0,15.0,75.0,TCGA-DU-A5TU-01A,TCGA-DU-A5TU,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A70Z,19717.0,female,1958,black or african american,720,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-FG-A70Z-01A,TCGA-FG-A70Z,
LGG,Brain Lower Grade Glioma,Brain,TCGA-VM-A8CH,9005.0,female,1989,white,300,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-VM-A8CH-01A,TCGA-VM-A8CH,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GQ,26478.0,female,1938,white,596,Primary Tumor,0.0,0.0,0.0,100.0,0.0,20.0,80.0,TCGA-EL-A3GQ-01A,TCGA-EL-A3GQ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6XA,8508.0,female,1990,white,19,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-QH-A6XA-01A,TCGA-QH-A6XA,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84T,6994.0,male,1993,white,522,Primary Tumor,0.0,0.0,10.0,90.0,0.0,45.0,45.0,TCGA-TM-A84T-01A,TCGA-TM-A84T,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A89V,25570.0,male,1942,white,472,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-S9-A89V-01A,TCGA-S9-A89V,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3US,13634.0,female,1973,white,524,Primary Tumor,0.0,0.0,10.0,75.0,0.0,5.0,85.0,TCGA-DJ-A3US-01A,TCGA-DJ-A3US,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3O8,12405.0,female,1978,not reported,100,Primary Tumor,0.0,0.0,0.0,100.0,0.0,10.0,90.0,TCGA-EM-A3O8-01A,TCGA-EM-A3O8,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7902,11118.0,female,1979,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7902-01A,TCGA-HT-7902,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2P3,17495.0,female,1964,not reported,69,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-EM-A2P3-01A,TCGA-EM-A2P3,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A87Q,22565.0,female,1952,white,90,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-FG-A87Q-01A,TCGA-FG-A87Q,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WP,15658.0,male,1971,white,111,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6WP-01A,TCGA-S9-A6WP,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A234,9724.0,female,1981,white,1340,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-FE-A234-01A,TCGA-FE-A234,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-H2-A421,12657.0,female,1978,white,14,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-H2-A421-01A,TCGA-H2-A421,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25P,8787.0,female,1985,asian,523,Primary Tumor,0.0,0.0,0.0,92.0,0.0,20.0,80.0,TCGA-ET-A25P-01A,TCGA-ET-A25P,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-4943,13565.0,male,1972,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-CS-4943-01A,TCGA-CS-4943,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DP,15876.0,female,1964,black or african american,1632,Primary Tumor,0.0,0.0,0.0,80.0,0.0,90.0,10.0,TCGA-ET-A3DP-01A,TCGA-ET-A3DP,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A7UR,21803.0,female,1949,white,1820,Primary Tumor,0.0,0.0,20.0,80.0,0.0,40.0,40.0,TCGA-DH-A7UR-01A,TCGA-DH-A7UR,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39O,14295.0,male,1967,white,1778,Primary Tumor,0.0,0.0,0.0,82.0,0.0,10.0,90.0,TCGA-ET-A39O-01A,TCGA-ET-A39O,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13T,13668.0,female,1972,white,641,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DJ-A13T-01A,TCGA-DJ-A13T,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A7UT,11014.0,male,1983,white,118,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-DH-A7UT-01A,TCGA-DH-A7UT,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7483,5267.0,male,1984,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7483-01A,TCGA-HT-7483,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7IZ,17874.0,female,1965,white,140,Primary Tumor,0.0,0.0,5.0,90.0,0.0,25.0,70.0,TCGA-S9-A7IZ-01A,TCGA-S9-A7IZ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7605,13892.0,male,1970,white,None,Primary Tumor,None,None,0.0,55.0,None,0.0,100.0,TCGA-HT-7605-01A,TCGA-HT-7605,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VD,12019.0,female,1979,white,275,Primary Tumor,0.0,0.0,0.0,75.0,7.0,25.0,75.0,TCGA-DJ-A3VD-01A,TCGA-DJ-A3VD,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PT,25837.0,female,1941,white,182,Primary Tumor,0.0,1.0,0.0,100.0,0.0,70.0,30.0,TCGA-DJ-A2PT-01A,TCGA-DJ-A2PT,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7875,20613.0,male,1952,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-7875-01A,TCGA-HT-7875,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q4,19689.0,male,1958,white,121,Primary Tumor,0.0,0.0,0.0,65.0,1.0,15.0,85.0,TCGA-DJ-A2Q4-01A,TCGA-DJ-A2Q4,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A870,14082.0,female,1975,white,1,Primary Tumor,0.0,0.0,10.0,85.0,0.0,40.0,50.0,TCGA-QH-A870-01A,TCGA-QH-A870,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E3-A3E0,12645.0,female,1972,white,1802,Primary Tumor,0.0,0.0,0.0,95.0,1.0,0.0,100.0,TCGA-E3-A3E0-01A,TCGA-E3-A3E0,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A5RA,23769.0,female,1947,white,385,Primary Tumor,0.0,0.0,5.0,90.0,0.0,5.0,90.0,TCGA-HT-A5RA-01A,TCGA-HT-A5RA,
THCA,Thyroid Carcinoma,Thyroid,TCGA-MK-A4N6,12904.0,male,1976,white,589,Primary Tumor,0.0,1.0,0.0,80.0,2.0,0.0,100.0,TCGA-MK-A4N6-01A,TCGA-MK-A4N6,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6TW,14679.0,male,1971,white,795,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-S9-A6TW-01A,TCGA-S9-A6TW,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E3-A3DZ,20251.0,female,1955,white,303,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-E3-A3DZ-01A,TCGA-E3-A3DZ,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A74H,22850.0,male,1951,white,121,Primary Tumor,0.0,0.0,10.0,70.0,0.0,70.0,20.0,TCGA-HT-A74H-01A,TCGA-HT-A74H,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7294,19616.0,female,1950,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-DU-7294-01A,TCGA-DU-7294,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RJ,9209.0,female,1986,white,924,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-TQ-A7RJ-01A,TCGA-TQ-A7RJ,
THCA,Thyroid Carcinoma,Thyroid,TCGA-L6-A4EU,21192.0,female,1954,black or african american,88,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-L6-A4EU-01A,TCGA-L6-A4EU,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8564,17499.0,male,1965,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-8564-01A,TCGA-HT-8564,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A3PC,13817.0,female,1969,white,2198,Primary Tumor,0.0,1.0,0.0,100.0,1.0,10.0,90.0,TCGA-FE-A3PC-01A,TCGA-FE-A3PC,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-RY-A83X,16911.0,female,1966,white,486,Primary Tumor,0.0,0.0,10.0,85.0,0.0,50.0,40.0,TCGA-RY-A83X-01A,TCGA-RY-A83X,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E3-A3DY,13860.0,male,1970,white,1682,Primary Tumor,0.0,0.0,0.0,95.0,1.0,10.0,90.0,TCGA-E3-A3DY-01A,TCGA-E3-A3DY,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3SZ,15659.0,female,1969,not reported,129,Primary Tumor,0.0,20.0,0.0,80.0,15.0,15.0,85.0,TCGA-EM-A3SZ-01A,TCGA-EM-A3SZ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5273,12152.0,male,1973,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-DB-5273-01A,TCGA-DB-5273,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A5TW,12107.0,female,1979,black or african american,42,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-DU-A5TW-01A,TCGA-DU-A5TW,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V6,19870.0,male,1957,white,378,Primary Tumor,0.0,0.0,0.0,100.0,0.0,20.0,80.0,TCGA-DJ-A3V6-01A,TCGA-DJ-A3V6,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YW,10571.0,male,1974,white,4072,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-E1-A7YW-01A,TCGA-E1-A7YW,
LGG,Brain Lower Grade Glioma,Brain,TCGA-VM-A8CD,21200.0,male,1954,white,517,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-VM-A8CD-01A,TCGA-VM-A8CD,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22P,23723.0,male,1947,not reported,31,Primary Tumor,0.0,0.0,0.0,65.0,0.0,30.0,70.0,TCGA-EM-A22P-01A,TCGA-EM-A22P,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RH,14524.0,male,1974,black or african american,167,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-TQ-A7RH-01A,TCGA-TQ-A7RH,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A5R7,12092.0,female,1979,white,147,Primary Tumor,0.0,0.0,30.0,70.0,0.0,40.0,30.0,TCGA-HT-A5R7-01A,TCGA-HT-A5R7,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4KI,23182.0,male,1949,white,254,Primary Tumor,0.0,0.0,0.0,94.0,0.0,5.0,95.0,TCGA-EL-A4KI-01A,TCGA-EL-A4KI,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3O7,16842.0,female,1965,not reported,112,Primary Tumor,0.0,1.0,0.0,100.0,0.0,5.0,95.0,TCGA-EM-A3O7-01A,TCGA-EM-A3O7,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DO-A1K0,11216.0,female,1980,white,282,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-DO-A1K0-01A,TCGA-DO-A1K0,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6399,19906.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-6399-01A,TCGA-DU-6399,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A18Z,21519.0,male,1952,white,87,Primary Tumor,1.0,0.0,0.0,70.0,2.0,30.0,70.0,TCGA-BJ-A18Z-01A,TCGA-BJ-A18Z,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RO,10890.0,male,1982,black or african american,665,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-TQ-A7RO-01A,TCGA-TQ-A7RO,
THCA,Thyroid Carcinoma,Thyroid,TCGA-L6-A4ET,17978.0,female,1962,white,282,Primary Tumor,0.0,0.0,0.0,99.0,0.0,5.0,95.0,TCGA-L6-A4ET-01A,TCGA-L6-A4ET,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4K6,27416.0,male,1935,white,750,Primary Tumor,0.0,2.0,0.0,80.0,3.0,10.0,90.0,TCGA-EL-A4K6-01A,TCGA-EL-A4K6,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-VW-A7QS,12820.0,female,1976,asian,805,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-VW-A7QS-01A,TCGA-VW-A7QS,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YK,19236.0,male,1957,white,1658,Primary Tumor,0.0,0.0,5.0,90.0,0.0,45.0,50.0,TCGA-E1-A7YK-01A,TCGA-E1-A7YK,
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-5397,19866.0,female,1956,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-CS-5397-01A,TCGA-CS-5397,
LGG,Brain Lower Grade Glioma,Brain,TCGA-WY-A858,11855.0,female,1978,white,1233,Primary Tumor,0.0,0.0,10.0,70.0,0.0,65.0,25.0,TCGA-WY-A858-01A,TCGA-WY-A858,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CM,23406.0,female,1932,white,5462,Primary Tumor,0.0,0.0,0.0,85.0,0.0,25.0,75.0,TCGA-EL-A3CM-01A,TCGA-EL-A3CM,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T2,20403.0,female,1947,white,3565,Primary Tumor,0.0,1.0,0.0,100.0,0.0,20.0,80.0,TCGA-EL-A3T2-01A,TCGA-EL-A3T2,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3ON,7403.0,male,1991,white,71,Primary Tumor,1.0,2.0,0.0,100.0,1.0,20.0,80.0,TCGA-FY-A3ON-01A,TCGA-FY-A3ON,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7QY,12853.0,female,1977,white,560,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-S9-A7QY-01A,TCGA-S9-A7QY,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VL,14219.0,male,1973,white,401,Primary Tumor,0.0,0.0,0.0,100.0,0.0,5.0,95.0,TCGA-DJ-A3VL-01A,TCGA-DJ-A3VL,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A413,13909.0,female,1974,asian,54,Primary Tumor,2.0,2.0,5.0,65.0,5.0,30.0,65.0,TCGA-E8-A413-01A,TCGA-E8-A413,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UZ,25846.0,female,1941,white,289,Primary Tumor,0.0,0.0,30.0,75.0,0.0,0.0,70.0,TCGA-DJ-A3UZ-01A,TCGA-DJ-A3UZ,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A72W,12848.0,male,1978,white,185,Primary Tumor,0.0,0.0,5.0,85.0,0.0,35.0,60.0,TCGA-P5-A72W-01A,TCGA-P5-A72W,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QD,7460.0,female,1990,white,205,Primary Tumor,0.0,0.0,0.0,60.0,0.0,10.0,90.0,TCGA-DJ-A1QD-01A,TCGA-DJ-A1QD,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A40S,22733.0,male,1949,white,240,Primary Tumor,0.0,0.0,0.0,90.0,5.0,20.0,80.0,TCGA-ET-A40S-01A,TCGA-ET-A40S,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A2MY,26406.0,female,1938,black or african american,469,Primary Tumor,0.0,0.0,10.0,90.0,1.0,20.0,70.0,TCGA-ET-A2MY-01A,TCGA-ET-A2MY,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UW,18487.0,female,1957,white,1665,Primary Tumor,1.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-DJ-A3UW-01A,TCGA-DJ-A3UW,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XD,11741.0,male,1978,white,719,Primary Tumor,0.0,0.0,35.0,85.0,0.0,5.0,60.0,TCGA-DB-A4XD-01A,TCGA-DB-A4XD,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CT,28597.0,female,1926,white,2639,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-EL-A3CT-01A,TCGA-EL-A3CT,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VF,22234.0,female,1951,white,134,Primary Tumor,0.0,0.0,0.0,100.0,10.0,40.0,60.0,TCGA-DJ-A3VF-01A,TCGA-DJ-A3VF,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3TB,17195.0,female,1958,white,2443,Primary Tumor,0.0,0.0,0.0,90.0,1.0,40.0,60.0,TCGA-EL-A3TB-01A,TCGA-EL-A3TB,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A7US,18429.0,male,1963,white,208,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-DH-A7US-01A,TCGA-DH-A7US,
LGG,Brain Lower Grade Glioma,Brain,TCGA-F6-A8O3,12578.0,male,1979,asian,105,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-F6-A8O3-01A,TCGA-F6-A8O3,
THCA,Thyroid Carcinoma,Thyroid,TCGA-H2-A422,14721.0,female,1972,white,14,Primary Tumor,0.0,0.0,0.0,85.0,2.0,0.0,100.0,TCGA-H2-A422-01A,TCGA-H2-A422,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-8191,11252.0,male,1981,white,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-FG-8191-01A,TCGA-FG-8191,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A40T,9531.0,female,1986,white,156,Primary Tumor,0.0,0.0,0.0,95.0,1.0,10.0,90.0,TCGA-ET-A40T-01A,TCGA-ET-A40T,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FL,23183.0,female,1948,not reported,280,Primary Tumor,0.0,0.0,0.0,95.0,10.0,30.0,70.0,TCGA-EM-A3FL-01A,TCGA-EM-A3FL,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PO,20058.0,male,1956,white,238,Primary Tumor,0.0,0.0,0.0,90.0,0.0,25.0,75.0,TCGA-DJ-A2PO-01A,TCGA-DJ-A2PO,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4KG,12978.0,female,1977,white,260,Primary Tumor,0.0,2.0,0.0,100.0,0.0,60.0,40.0,TCGA-EL-A4KG-01A,TCGA-EL-A4KG,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A3ED,21278.0,female,1950,white,1106,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-IM-A3ED-01A,TCGA-IM-A3ED,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A0Y2,11227.0,female,1980,white,188,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-DE-A0Y2-01A,TCGA-DE-A0Y2,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8011,20175.0,male,1954,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-8011-01A,TCGA-HT-8011,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-8321,11474.0,male,1980,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HW-8321-01A,TCGA-HW-8321,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13S,7099.0,female,1991,white,161,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-DJ-A13S-01A,TCGA-DJ-A13S,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A27D,10536.0,female,1982,asian,135,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-CE-A27D-01A,TCGA-CE-A27D,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RM,15154.0,female,1970,white,860,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-TQ-A7RM-01A,TCGA-TQ-A7RM,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PV,19547.0,female,1958,white,202,Primary Tumor,0.0,1.0,0.0,100.0,0.0,40.0,60.0,TCGA-DJ-A2PV-01A,TCGA-DJ-A2PV,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A4EB,13635.0,male,1975,white,121,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-IM-A4EB-01A,TCGA-IM-A4EB,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7290,16667.0,female,1950,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DU-7290-01A,TCGA-DU-7290,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7485,15589.0,male,1964,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7485-01A,TCGA-HT-7485,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V9,18399.0,female,1961,white,171,Primary Tumor,0.0,1.0,25.0,75.0,10.0,25.0,50.0,TCGA-DJ-A3V9-01A,TCGA-DJ-A3V9,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T7,17302.0,female,1957,white,2718,Primary Tumor,0.0,0.0,0.0,88.0,0.0,0.0,100.0,TCGA-EL-A3T7-01A,TCGA-EL-A3T7,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7013,21824.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-7013-01A,TCGA-DU-7013,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZN,10266.0,female,1980,white,1515,Primary Tumor,0.0,1.0,0.0,85.0,2.0,10.0,90.0,TCGA-EL-A3ZN-01A,TCGA-EL-A3ZN,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8010,23680.0,female,1947,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-8010-01A,TCGA-HT-8010,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FK-A3SB,10293.0,female,1980,asian,1344,Primary Tumor,0.0,1.0,0.0,90.0,1.0,25.0,70.0,TCGA-FK-A3SB-01A,TCGA-FK-A3SB,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-5393,14418.0,male,1969,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-CS-5393-01A,TCGA-CS-5393,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GR,11598.0,female,1973,white,2746,Primary Tumor,0.0,2.0,30.0,60.0,1.0,20.0,50.0,TCGA-EL-A3GR-01A,TCGA-EL-A3GR,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7010,21199.0,female,1943,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DU-7010-01A,TCGA-DU-7010,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4K4,12368.0,female,1977,white,899,Primary Tumor,0.0,0.0,0.0,80.0,2.0,30.0,70.0,TCGA-EL-A4K4-01A,TCGA-EL-A4K4,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PR,9914.0,male,1984,asian,155,Primary Tumor,0.0,1.0,0.0,100.0,0.0,50.0,50.0,TCGA-DJ-A2PR-01A,TCGA-DJ-A2PR,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6X5,21239.0,female,1955,white,65,Primary Tumor,0.0,2.0,10.0,80.0,2.0,50.0,40.0,TCGA-QH-A6X5-01A,TCGA-QH-A6X5,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q6,14193.0,female,1973,white,138,Primary Tumor,0.0,1.0,5.0,95.0,0.0,10.0,85.0,TCGA-DJ-A2Q6-01A,TCGA-DJ-A2Q6,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84O,22327.0,female,1950,white,920,Primary Tumor,0.0,0.0,10.0,80.0,0.0,45.0,45.0,TCGA-TM-A84O-01A,TCGA-TM-A84O,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A65S,11861.0,female,1981,white,56,Primary Tumor,0.0,0.0,20.0,75.0,0.0,40.0,40.0,TCGA-QH-A65S-01A,TCGA-QH-A65S,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-8319,12557.0,female,1977,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HW-8319-01A,TCGA-HW-8319,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A74L,8240.0,female,1991,white,103,Primary Tumor,0.0,0.0,10.0,80.0,0.0,45.0,45.0,TCGA-HT-A74L-01A,TCGA-HT-A74L,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4UL,24939.0,female,1944,white,244,Primary Tumor,0.0,0.0,0.0,100.0,1.0,15.0,85.0,TCGA-DJ-A4UL-01A,TCGA-DJ-A4UL,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7292,25266.0,male,1928,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-DU-7292-01A,TCGA-DU-7292,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZO,28924.0,female,1929,white,1492,Primary Tumor,2.0,2.0,0.0,80.0,3.0,20.0,80.0,TCGA-EL-A3ZO-01A,TCGA-EL-A3ZO,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7R4,17134.0,male,1966,white,565,Primary Tumor,0.0,0.0,5.0,90.0,0.0,50.0,45.0,TCGA-S9-A7R4-01A,TCGA-S9-A7R4,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5278,6480.0,male,1990,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-DB-5278-01A,TCGA-DB-5278,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39M,12441.0,male,1970,white,2520,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-ET-A39M-01A,TCGA-ET-A39M,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39L,7636.0,female,1986,not reported,2018,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-ET-A39L-01A,TCGA-ET-A39L,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4K1,24846.0,female,1942,white,753,Primary Tumor,0.0,2.0,10.0,75.0,2.0,40.0,50.0,TCGA-EL-A4K1-01A,TCGA-EL-A4K1,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BX,8791.0,male,1986,white,328,Primary Tumor,0.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-ET-A3BX-01A,TCGA-ET-A3BX,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7IX,21095.0,male,1955,white,540,Primary Tumor,0.0,0.0,5.0,90.0,0.0,25.0,70.0,TCGA-S9-A7IX-01A,TCGA-S9-A7IX,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7602,7946.0,male,1987,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7602-01A,TCGA-HT-7602,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25R,18863.0,female,1958,white,509,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-ET-A25R-01A,TCGA-ET-A25R,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2009,23772.0,female,1941,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-61-2009-01A,TCGA-61-2009,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2404,14184.0,female,1967,american indian or alaska native,None,Primary Tumor,None,None,1.0,70.0,None,28.0,70.0,TCGA-25-2404-01A,TCGA-25-2404,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-7916,28475.0,male,1934,asian,None,Primary Tumor,None,None,0.0,45.0,None,30.0,70.0,TCGA-FP-7916-01A,TCGA-FP-7916,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1627,26784.0,female,1930,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,90.0,TCGA-25-1627-01A,TCGA-25-1627,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1422,30234.0,female,1926,black or african american,None,Primary Tumor,None,None,10.0,75.0,None,0.0,82.0,TCGA-24-1422-01A,TCGA-24-1422,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A280,25649.0,female,1928,white,4563,Primary Tumor,0.0,1.0,0.0,75.0,1.0,30.0,70.0,TCGA-DM-A280-01A,TCGA-DM-A280,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A03F,32872,female,1914,not reported,2164,Primary Tumor,1.0,0.0,0.0,75.0,3.0,25.0,75.0,TCGA-AA-A03F-01A,TCGA-AA-A03F,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5725,26329.0,male,1933,not reported,None,Primary Tumor,None,None,35.0,75.0,None,25.0,37.0,TCGA-CG-5725-01A,TCGA-CG-5725,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A74A,22435.0,female,1952,white,29,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-D7-A74A-01A,TCGA-D7-A74A,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1552,28129.0,female,1920,white,None,Primary Tumor,None,None,0.0,99.0,None,3.0,95.0,TCGA-24-1552-01A,TCGA-24-1552,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1407,18896.0,female,1957,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-13-1407-01A,TCGA-13-1407,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6529,25394.0,male,1941,white,None,Primary Tumor,12.0,0.0,0.0,71.0,13.0,0.0,95.0,TCGA-D5-6529-01A,TCGA-D5-6529,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1530,25013.0,female,1927,white,None,Primary Tumor,None,None,45.0,70.0,None,0.0,40.0,TCGA-04-1530-01A,TCGA-04-1530,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8487,23400.0,female,1948,white,None,Primary Tumor,0.0,2.0,0.0,90.0,2.0,0.0,99.0,TCGA-BR-8487-01A,TCGA-BR-8487,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3855,26541.0,male,1937,not reported,None,Primary Tumor,None,None,8.0,80.0,None,10.0,80.0,TCGA-AA-3855-01A,TCGA-AA-3855,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-A486,24879.0,male,1943,asian,521,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-CD-A486-01A,TCGA-CD-A486,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8361,25999.0,female,1941,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,85.0,TCGA-BR-8361-01A,TCGA-BR-8361,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1542,19263.0,female,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,79.0,TCGA-04-1542-01A,TCGA-04-1542,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8575,27712.0,male,1937,white,None,Primary Tumor,5.0,0.0,0.0,85.0,10.0,0.0,99.0,TCGA-D7-8575-01A,TCGA-D7-8575,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1313,22982.0,female,1938,white,None,Primary Tumor,None,None,0.0,90.0,None,30.0,70.0,TCGA-25-1313-01A,TCGA-25-1313,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A44U,25577.0,male,1942,white,161,Primary Tumor,1.0,2.0,0.0,70.0,5.0,30.0,70.0,TCGA-BR-A44U-01A,TCGA-BR-A44U,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1724,17168.0,female,1960,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,85.0,TCGA-61-1724-01A,TCGA-61-1724,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5716,31411.0,male,1924,not reported,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-CG-5716-01A,TCGA-CG-5716,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8295,22256.0,female,1951,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-BR-8295-01A,TCGA-BR-8295,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-4746,22403.0,male,1948,black or african american,None,Primary Tumor,None,None,10.0,80.0,None,15.0,75.0,TCGA-CM-4746-01A,TCGA-CM-4746,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A7C1,30171.0,male,1923,white,2771,Primary Tumor,3.0,3.0,0.0,75.0,18.0,15.0,65.0,TCGA-RD-A7C1-01A,TCGA-RD-A7C1,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6890,23769.0,male,1945,white,None,Primary Tumor,None,None,0.0,80.0,10.0,10.0,82.0,TCGA-AD-6890-01A,TCGA-AD-6890,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1477,18111.0,female,1951,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,80.0,TCGA-13-1477-01A,TCGA-13-1477,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3544,24959.0,male,1940,not reported,None,Primary Tumor,None,None,0.0,85.0,None,35.0,65.0,TCGA-AA-3544-01A,TCGA-AA-3544,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8373,23744.0,female,1946,white,None,Primary Tumor,None,None,None,80.0,None,None,None,TCGA-BR-8373-01A,TCGA-BR-8373,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3854,26022.0,female,1938,not reported,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-AA-3854-01A,TCGA-AA-3854,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1338,28789.0,female,1927,white,None,Primary Tumor,None,None,None,85.0,None,40.0,45.0,TCGA-04-1338-01A,TCGA-04-1338,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1768,18396.0,female,1956,white,None,Primary Tumor,None,None,0.0,90.0,None,50.0,50.0,TCGA-29-1768-01A,TCGA-29-1768,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6678,23070.0,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,12.0,80.0,TCGA-CM-6678-01A,TCGA-CM-6678,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1842,18227.0,female,1960,white,None,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-24-1842-01A,TCGA-24-1842,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6675,12935.0,male,1976,black or african american,None,Primary Tumor,None,None,8.0,80.0,None,12.0,75.0,TCGA-CM-6675-01A,TCGA-CM-6675,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1408,21635.0,female,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,79.0,TCGA-13-1408-01A,TCGA-13-1408,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0906,18383.0,female,1955,white,None,Primary Tumor,None,None,30.0,70.0,None,0.0,50.0,TCGA-13-0906-01A,TCGA-13-0906,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2409,26267.0,female,1934,white,None,Primary Tumor,None,None,1.0,95.0,None,4.0,94.0,TCGA-25-2409-01A,TCGA-25-2409,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6140,22835.0,male,1949,white,None,Primary Tumor,7.0,0.0,0.0,80.0,8.0,0.0,95.0,TCGA-A6-6140-01A,TCGA-A6-6140,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6522,21465.0,male,1952,white,None,Primary Tumor,None,None,0.0,65.0,None,50.0,50.0,TCGA-D7-6522-01A,TCGA-D7-6522,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A50U,15450.0,male,1970,black or african american,22,Primary Tumor,0.0,0.0,0.0,60.0,0.0,5.0,95.0,TCGA-NH-A50U-01A,TCGA-NH-A50U,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1714,25032.0,female,1933,white,None,Primary Tumor,None,None,0.0,85.0,None,23.0,75.0,TCGA-30-1714-01A,TCGA-30-1714,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-4105,29097.0,male,1931,white,None,Primary Tumor,None,None,20.0,70.0,None,10.0,60.0,TCGA-A6-4105-01A,TCGA-A6-4105,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4H2,21496.0,female,1953,asian,489,Primary Tumor,0.0,0.0,15.0,60.0,15.0,30.0,43.0,TCGA-HU-A4H2-01A,TCGA-HU-A4H2,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6920,28124.0,female,1934,white,None,Primary Tumor,0.0,0.0,32.0,60.0,3.0,10.0,58.0,TCGA-D5-6920-01A,TCGA-D5-6920,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-2363,None,female,1967,asian,None,Primary Tumor,None,None,1.0,90.0,None,10.0,84.0,TCGA-59-2363-01A,TCGA-59-2363,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6563,21936.0,male,1951,white,None,Primary Tumor,None,None,5.0,70.0,None,30.0,65.0,TCGA-BR-6563-01A,TCGA-BR-6563,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1781,25404.0,female,1940,white,None,Primary Tumor,None,None,0.0,85.0,10.0,5.0,85.0,TCGA-29-1781-01A,TCGA-29-1781,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3966,32537.0,female,1920,not reported,None,Primary Tumor,None,None,0.0,90.0,None,0.0,95.0,TCGA-AA-3966-01A,TCGA-AA-3966,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6168,30834.0,female,1926,black or african american,None,Primary Tumor,None,None,8.0,70.0,None,30.0,57.0,TCGA-CM-6168-01A,TCGA-CM-6168,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3930,24321.0,male,1942,not reported,None,Primary Tumor,None,None,5.0,85.0,None,5.0,85.0,TCGA-AA-3930-01A,TCGA-AA-3930,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6651,20110.0,female,1955,white,None,Primary Tumor,0.0,2.0,40.0,60.0,20.0,0.0,50.0,TCGA-A6-6651-01A,TCGA-A6-6651,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-5540,26972.0,male,1937,white,None,Primary Tumor,2.0,1.0,0.0,80.0,10.0,0.0,95.0,TCGA-D5-5540-01A,TCGA-D5-5540,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8677,27223.0,female,1938,white,None,Primary Tumor,0.0,0.0,22.0,61.0,25.0,10.0,68.0,TCGA-BR-8677-01A,TCGA-BR-8677,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3875,28640.0,female,1929,not reported,None,Primary Tumor,None,None,20.0,70.0,None,15.0,60.0,TCGA-AA-3875-01A,TCGA-AA-3875,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1312,25537.0,female,1932,white,None,Primary Tumor,None,None,0.0,95.0,None,15.0,85.0,TCGA-25-1312-01A,TCGA-25-1312,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-6751,32354.0,female,1914,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,70.0,TCGA-CK-6751-01A,TCGA-CK-6751,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1331,28848.0,female,1926,white,None,Primary Tumor,None,None,0.0,88.0,None,65.0,30.0,TCGA-04-1331-01A,TCGA-04-1331,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-QG-A5YW,20391.0,female,1956,black or african american,568,Primary Tumor,4.0,2.0,10.0,65.0,7.0,25.0,65.0,TCGA-QG-A5YW-01A,TCGA-QG-A5YW,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-57-1583,21167.0,female,1949,black or african american,None,Primary Tumor,None,None,0.0,95.0,None,10.0,94.0,TCGA-57-1583-01A,TCGA-57-1583,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3976,25599.0,male,1939,not reported,None,Primary Tumor,None,None,20.0,80.0,None,10.0,70.0,TCGA-AA-3976-01A,TCGA-AA-3976,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A8F8,29185.0,male,1934,black or african american,14,Primary Tumor,2.0,1.0,0.0,85.0,8.0,48.0,40.0,TCGA-NH-A8F8-01A,TCGA-NH-A8F8,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3952,24868.0,male,1940,not reported,None,Primary Tumor,None,None,1.0,90.0,None,16.0,80.0,TCGA-AA-3952-01A,TCGA-AA-3952,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1428,18306.0,female,1958,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-24-1428-01A,TCGA-24-1428,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1321,23987.0,female,1936,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-25-1321-01A,TCGA-25-1321,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2097,25961.0,female,1932,white,None,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-61-2097-01A,TCGA-61-2097,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8589,20727.0,male,1955,white,None,Primary Tumor,None,None,10.0,75.0,None,20.0,70.0,TCGA-BR-8589-01A,TCGA-BR-8589,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8296,21527.0,female,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,80.0,TCGA-BR-8296-01A,TCGA-BR-8296,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-RU-A8FL,18975.0,male,1960,black or african american,861,Primary Tumor,0.0,1.0,7.0,80.0,3.0,10.0,80.0,TCGA-RU-A8FL-01A,TCGA-RU-A8FL,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A94U,25925.0,male,1942,white,458,Primary Tumor,0.0,0.0,0.0,96.0,2.0,20.0,79.0,TCGA-VQ-A94U-01A,TCGA-VQ-A94U,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6521,23776.0,male,1945,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-D7-6521-01A,TCGA-D7-6521,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3968,20089.0,female,1953,not reported,None,Primary Tumor,None,None,0.0,80.0,None,0.0,95.0,TCGA-AA-3968-01A,TCGA-AA-3968,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-6747,32052.0,female,1921,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-CK-6747-01A,TCGA-CK-6747,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8382,24737.0,female,1944,white,None,Primary Tumor,25.0,2.0,14.0,65.0,5.0,0.0,86.0,TCGA-BR-8382-01A,TCGA-BR-8382,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6818,19391.0,male,1958,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,90.0,TCGA-D7-6818-01A,TCGA-D7-6818,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-5916,26024.0,female,1932,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CK-5916-01A,TCGA-CK-5916,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A5IV,32872,female,1922,black or african american,77,Primary Tumor,6.0,3.0,0.0,70.0,5.0,26.0,70.0,TCGA-NH-A5IV-01A,TCGA-NH-A5IV,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6603,28424.0,female,1925,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,80.0,TCGA-AZ-6603-01A,TCGA-AZ-6603,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3866,28672.0,female,1928,not reported,None,Primary Tumor,None,None,0.0,85.0,None,15.0,77.0,TCGA-AA-3866-01A,TCGA-AA-3866,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1914,23850.0,female,1938,not reported,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-61-1914-01A,TCGA-61-1914,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1D4,29403.0,male,1919,white,4128,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-DM-A1D4-01A,TCGA-DM-A1D4,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3811,30893.0,female,1923,not reported,None,Primary Tumor,None,None,5.0,85.0,None,5.0,None,TCGA-AA-3811-01A,TCGA-AA-3811,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6299,25318.0,male,1936,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,60.0,TCGA-G4-6299-01A,TCGA-G4-6299,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0883,22395.0,female,1941,white,None,Primary Tumor,None,None,20.0,80.0,None,0.0,78.0,TCGA-13-0883-01A,TCGA-13-0883,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6626,32871.0,male,1916,white,None,Primary Tumor,None,None,18.0,80.0,None,15.0,67.0,TCGA-G4-6626-01A,TCGA-G4-6626,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1357,18999.0,female,1953,not reported,None,Primary Tumor,None,None,0.0,90.0,50.0,20.0,79.0,TCGA-04-1357-01A,TCGA-04-1357,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-A5ZU,21554.0,male,1954,black or african american,50,Primary Tumor,5.0,2.0,0.0,70.0,2.0,27.0,70.0,TCGA-A6-A5ZU-01A,TCGA-A6-A5ZU,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1329,28093.0,female,1926,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,75.0,TCGA-25-1329-01A,TCGA-25-1329,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3869,28062.0,male,1933,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,70.0,TCGA-AA-3869-01A,TCGA-AA-3869,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3492,32871.0,female,1912,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,82.0,TCGA-AA-3492-01A,TCGA-AA-3492,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01R,17289.0,male,1957,not reported,2181,Primary Tumor,5.0,0.0,0.0,80.0,3.0,17.0,80.0,TCGA-AA-A01R-01A,TCGA-AA-A01R,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6307,13648.0,female,1970,white,None,Primary Tumor,None,None,5.0,80.0,None,12.0,78.0,TCGA-G4-6307-01A,TCGA-G4-6307,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1D8,18311.0,female,1950,white,3937,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,90.0,TCGA-DM-A1D8-01A,TCGA-DM-A1D8,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-10-0931,16262.0,female,1958,white,None,Primary Tumor,None,None,5.0,85.0,None,10.0,85.0,TCGA-10-0931-01A,TCGA-10-0931,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1776,23016.0,female,1945,black or african american,None,Primary Tumor,None,None,0.0,90.0,5.0,25.0,75.0,TCGA-29-1776-01A,TCGA-29-1776,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4J4,14459.0,male,1973,asian,86,Primary Tumor,0.0,0.0,0.0,80.0,6.0,35.0,53.0,TCGA-BR-A4J4-01A,TCGA-BR-A4J4,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6165,27302.0,male,1936,white,None,Primary Tumor,None,None,2.0,80.0,None,20.0,58.0,TCGA-CM-6165-01A,TCGA-CM-6165,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2396,26145.0,female,1933,white,None,Primary Tumor,None,None,1.0,90.0,None,10.0,88.0,TCGA-25-2396-01A,TCGA-25-2396,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4462,26511.0,female,1936,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,85.0,TCGA-CG-4462-01A,TCGA-CG-4462,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PF,28116.0,male,1936,not reported,568,Primary Tumor,4.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-VQ-A8PF-01A,TCGA-VQ-A8PF,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2288,25831.0,female,1929,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-24-2288-01A,TCGA-24-2288,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1111,23171.0,female,1945,white,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-23-1111-01A,TCGA-23-1111,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-57-1582,None,female,1956,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-57-1582-01A,TCGA-57-1582,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A50T,25089.0,female,1944,black or african american,27,Primary Tumor,0.0,0.0,15.0,90.0,0.0,10.0,70.0,TCGA-NH-A50T-01A,TCGA-NH-A50T,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3660,18932.0,female,1954,not reported,None,Primary Tumor,None,None,0.0,80.0,None,40.0,60.0,TCGA-AA-3660-01A,TCGA-AA-3660,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1891,22344.0,female,1943,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,70.0,TCGA-30-1891-01A,TCGA-30-1891,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PO,27250.0,male,1934,white,1821,Primary Tumor,2.0,2.0,0.0,75.0,3.0,25.0,75.0,TCGA-VQ-A8PO-01A,TCGA-VQ-A8PO,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-R5-A7ZI,16396.0,female,1965,white,1679,Primary Tumor,8.0,3.0,0.0,80.0,6.0,20.0,65.0,TCGA-R5-A7ZI-01A,TCGA-R5-A7ZI,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-1666,21066.0,female,1946,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,93.0,TCGA-09-1666-01A,TCGA-09-1666,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1416,12772.0,female,1974,white,None,Primary Tumor,None,None,40.0,80.0,None,0.0,55.0,TCGA-24-1416-01A,TCGA-24-1416,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28F,26856.0,male,1929,white,3347,Primary Tumor,1.0,1.0,0.0,80.0,2.0,17.0,80.0,TCGA-DM-A28F-01A,TCGA-DM-A28F,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-A4BF,25030.0,male,1943,white,425,Primary Tumor,0.0,0.0,0.0,70.0,5.0,0.0,100.0,TCGA-FP-A4BF-01A,TCGA-FP-A4BF,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4466,29739.0,female,1928,not reported,None,Primary Tumor,None,None,3.0,75.0,None,10.0,82.0,TCGA-CG-4466-01A,TCGA-CG-4466,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6822,28214.0,male,1934,white,None,Primary Tumor,None,None,22.0,60.0,None,15.0,63.0,TCGA-D7-6822-01A,TCGA-D7-6822,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1558,27004.0,female,1927,white,None,Primary Tumor,None,None,0.0,95.0,None,2.0,98.0,TCGA-24-1558-01A,TCGA-24-1558,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1691,18664.0,female,1944,white,None,Primary Tumor,None,1.0,0.0,90.0,None,0.0,98.0,TCGA-29-1691-01A,TCGA-29-1691,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8590,22937.0,male,1949,white,None,Primary Tumor,None,None,8.0,65.0,None,30.0,62.0,TCGA-BR-8590-01A,TCGA-BR-8590,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2038,24957.0,female,1932,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-24-2038-01A,TCGA-24-2038,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8483,21731.0,male,1953,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-BR-8483-01A,TCGA-BR-8483,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6809,19039.0,female,1959,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,70.0,TCGA-F4-6809-01A,TCGA-F4-6809,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8588,20177.0,female,1957,white,None,Primary Tumor,None,None,8.0,70.0,None,30.0,62.0,TCGA-BR-8588-01A,TCGA-BR-8588,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1434,21810.0,female,1940,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-24-1434-01A,TCGA-24-1434,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PK,21419.0,male,1953,white,964,Primary Tumor,3.0,1.0,15.0,70.0,3.0,15.0,70.0,TCGA-VQ-A8PK-01A,TCGA-VQ-A8PK,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01T,23192.0,female,1941,not reported,2152,Primary Tumor,9.0,1.0,5.0,80.0,2.0,9.0,80.0,TCGA-AA-A01T-01A,TCGA-AA-A01T,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0887,15669.0,female,1960,white,None,Primary Tumor,None,None,10.0,90.0,None,0.0,89.0,TCGA-13-0887-01A,TCGA-13-0887,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GJ,22079.0,female,1951,asian,522,Primary Tumor,0.0,0.0,0.0,35.0,1.0,0.0,100.0,TCGA-HU-A4GJ-01A,TCGA-HU-A4GJ,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1474,20902.0,female,1943,black or african american,None,Primary Tumor,None,None,0.0,99.0,None,1.0,98.0,TCGA-24-1474-01A,TCGA-24-1474,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-4313,18765.0,female,1956,white,None,Primary Tumor,None,None,0.0,94.0,1.0,0.0,100.0,TCGA-AZ-4313-01A,TCGA-AZ-4313,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PB,23927.0,female,1946,white,963,Primary Tumor,0.0,0.0,10.0,60.0,0.0,40.0,50.0,TCGA-VQ-A8PB-01A,TCGA-VQ-A8PB,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3947,22035.0,female,1949,not reported,None,Primary Tumor,None,None,5.0,75.0,None,15.0,77.0,TCGA-AA-3947-01A,TCGA-AA-3947,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5724,21762.0,male,1944,not reported,None,Primary Tumor,None,None,0.0,75.0,None,30.0,55.0,TCGA-CG-5724-01A,TCGA-CG-5724,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1923,18628.0,female,1950,white,None,Primary Tumor,10.0,0.0,0.0,70.0,0.0,15.0,70.0,TCGA-24-1923-01A,TCGA-24-1923,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1725,14782.0,female,1967,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,90.0,TCGA-61-1725-01A,TCGA-61-1725,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8289,20849.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-BR-8289-01A,TCGA-BR-8289,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6705,25073.0,female,1943,white,None,Primary Tumor,None,None,0.0,75.0,None,25.0,75.0,TCGA-BR-6705-01A,TCGA-BR-6705,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3842,18842.0,male,1958,not reported,None,Primary Tumor,None,None,20.0,75.0,None,10.0,67.0,TCGA-AA-3842-01A,TCGA-AA-3842,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-A566,20181.0,female,1952,black or african american,1827,Primary Tumor,2.0,3.0,0.0,80.0,10.0,35.0,45.0,TCGA-A6-A566-01A,TCGA-A6-A566,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4H4,19665.0,female,1958,asian,460,Primary Tumor,0.0,0.0,40.0,75.0,3.0,0.0,60.0,TCGA-HU-A4H4-01A,TCGA-HU-A4H4,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-5M-AAT4,27095.0,male,1935,black or african american,1778,Primary Tumor,0.0,0.0,5.0,70.0,5.0,20.0,70.0,TCGA-5M-AAT4-01A,TCGA-5M-AAT4,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1426,15949.0,female,1965,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-24-1426-01A,TCGA-24-1426,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8676,21619.0,male,1953,white,None,Primary Tumor,5.0,0.0,9.0,75.0,10.0,11.0,73.0,TCGA-BR-8676-01A,TCGA-BR-8676,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-R5-A7ZR,25795.0,female,1938,black or african american,2074,Primary Tumor,10.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-R5-A7ZR-01A,TCGA-R5-A7ZR,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8534,15227.0,male,1970,asian,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CD-8534-01A,TCGA-CD-8534,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6963,21294.0,male,1953,white,None,Primary Tumor,None,None,0.0,70.0,20.0,25.0,65.0,TCGA-AD-6963-01A,TCGA-AD-6963,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1892,19256.0,female,1952,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,80.0,TCGA-30-1892-01A,TCGA-30-1892,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8N4,21324.0,female,1948,white,2830,Primary Tumor,0.0,0.0,95.0,5.0,4.0,0.0,5.0,TCGA-RD-A8N4-01A,TCGA-RD-A8N4,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A928,18058.0,male,1961,white,1351,Primary Tumor,3.0,2.0,0.0,60.0,5.0,40.0,60.0,TCGA-VQ-A928-01A,TCGA-VQ-A928,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-4323,13755.0,male,1965,white,None,Primary Tumor,None,None,20.0,70.0,None,10.0,65.0,TCGA-AZ-4323-01A,TCGA-AZ-4323,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8591,29054.0,male,1933,white,None,Primary Tumor,None,None,5.0,75.0,None,20.0,75.0,TCGA-BR-8591-01A,TCGA-BR-8591,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3950,29130.0,female,1931,not reported,None,Primary Tumor,None,None,0.0,70.0,None,20.0,70.0,TCGA-AA-3950-01A,TCGA-AA-3950,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8371,22883.0,male,1949,white,None,Primary Tumor,None,None,10.0,50.0,None,25.0,65.0,TCGA-BR-8371-01A,TCGA-BR-8371,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-10-0938,29558.0,female,1922,white,None,Primary Tumor,None,None,10.0,85.0,None,20.0,70.0,TCGA-10-0938-01A,TCGA-10-0938,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3941,31015.0,female,1926,not reported,None,Primary Tumor,None,None,10.0,80.0,None,15.0,70.0,TCGA-AA-3941-01A,TCGA-AA-3941,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1635,26200.0,female,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,80.0,TCGA-25-1635-01A,TCGA-25-1635,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1107,21561.0,female,1940,white,None,Primary Tumor,None,None,0.0,90.0,None,0.0,0.0,TCGA-23-1107-01A,TCGA-23-1107,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6648,20641.0,male,1954,white,None,Primary Tumor,10.0,2.0,30.0,65.0,10.0,0.0,65.0,TCGA-A6-6648-01A,TCGA-A6-6648,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1492,24332.0,female,1936,white,None,Primary Tumor,None,None,0.0,99.0,None,1.0,94.0,TCGA-13-1492-01A,TCGA-13-1492,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6532,22344.0,male,1949,white,None,Primary Tumor,15.0,0.0,0.0,60.0,15.0,20.0,75.0,TCGA-D5-6532-01A,TCGA-D5-6532,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1930,19387.0,female,1945,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-24-1930-01A,TCGA-24-1930,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-A5EJ,27180.0,female,1938,black or african american,188,Primary Tumor,0.0,1.0,5.0,65.0,5.0,0.0,90.0,TCGA-AD-A5EJ-01A,TCGA-AD-A5EJ,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4J9,20093.0,male,1957,white,73,Primary Tumor,0.0,0.0,0.0,75.0,3.0,60.0,25.0,TCGA-BR-A4J9-01A,TCGA-BR-A4J9,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-7000,28913.0,female,1932,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,75.0,TCGA-D5-7000-01A,TCGA-D5-7000,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1DA,26169.0,female,1928,white,4012,Primary Tumor,0.0,0.0,10.0,75.0,0.0,40.0,50.0,TCGA-DM-A1DA-01A,TCGA-DM-A1DA,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3821,29706.0,female,1927,not reported,None,Primary Tumor,None,None,0.0,85.0,None,5.0,90.0,TCGA-AA-3821-01A,TCGA-AA-3821,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-1669,20052.0,female,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,65.0,TCGA-09-1669-01A,TCGA-09-1669,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GU,27024.0,male,1938,asian,417,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-HU-A4GU-01A,TCGA-HU-A4GU,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-4T-AA8H,15494.0,female,1971,black or african american,107,Primary Tumor,2.0,2.0,25.0,60.0,5.0,15.0,60.0,TCGA-4T-AA8H-01A,TCGA-4T-AA8H,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-2051,15650.0,female,1962,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,95.0,TCGA-09-2051-01A,TCGA-09-2051,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2036,18582.0,female,1946,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,100.0,TCGA-24-2036-01A,TCGA-24-2036,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-57-1585,20862.0,female,1950,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-57-1585-01A,TCGA-57-1585,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2391,20939.0,female,1946,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-25-2391-01A,TCGA-25-2391,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0795,24403.0,female,1941,white,None,Primary Tumor,None,None,0.0,95.0,75.0,15.0,85.0,TCGA-13-0795-01A,TCGA-13-0795,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-5537,30505.0,male,1927,white,None,Primary Tumor,None,None,0.0,65.0,None,15.0,None,TCGA-D5-5537-01A,TCGA-D5-5537,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2393,29585.0,female,1922,white,None,Primary Tumor,None,None,1.0,85.0,None,14.0,80.0,TCGA-25-2393-01A,TCGA-25-2393,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91A,24670.0,male,1944,white,759,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-VQ-A91A-01A,TCGA-VQ-A91A,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3955,14186.0,male,1972,not reported,None,Primary Tumor,None,None,5.0,80.0,None,14.0,80.0,TCGA-AA-3955-01A,TCGA-AA-3955,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5863,22127.0,female,1950,white,None,Primary Tumor,20.0,5.0,25.0,50.0,10.0,0.0,70.0,TCGA-CM-5863-01A,TCGA-CM-5863,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-6197,21957.0,male,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-AY-6197-01A,TCGA-AY-6197,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4368,28770.0,female,1930,white,None,Primary Tumor,None,None,5.0,70.0,None,15.0,75.0,TCGA-BR-4368-01A,TCGA-BR-4368,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1560,18671.0,female,1948,white,None,Primary Tumor,None,None,0.0,95.0,None,2.0,98.0,TCGA-24-1560-01A,TCGA-24-1560,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6807,18690.0,female,1960,white,None,Primary Tumor,None,None,5.0,80.0,None,30.0,60.0,TCGA-F4-6807-01A,TCGA-F4-6807,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1487,27176.0,female,1928,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-13-1487-01A,TCGA-13-1487,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A024,29708.0,male,1924,not reported,1554,Primary Tumor,1.0,3.0,0.0,70.0,15.0,10.0,88.0,TCGA-AA-A024-01A,TCGA-AA-A024,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B1-A655,28433.0,female,1935,white,420,Primary Tumor,0.0,5.0,0.0,80.0,5.0,20.0,60.0,TCGA-B1-A655-01A,TCGA-B1-A655,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8Q7,22149.0,male,1950,white,1205,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-VR-A8Q7-01A,TCGA-VR-A8Q7,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6219,18578.0,female,1957,white,None,Primary Tumor,None,None,0.0,60.0,None,15.0,82.0,TCGA-CQ-6219-01A,TCGA-CQ-6219,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A7DV,16145.0,male,1969,white,164,Primary Tumor,0.0,0.0,0.0,92.0,5.0,20.0,60.0,TCGA-E7-A7DV-01A,TCGA-E7-A7DV,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A61G,21066.0,male,1955,white,405,Primary Tumor,0.0,1.0,0.0,95.0,3.0,20.0,80.0,TCGA-IQ-A61G-01A,TCGA-IQ-A61G,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SL,27063.0,male,1938,not reported,591,Primary Tumor,0.0,1.0,0.0,80.0,1.0,0.0,100.0,TCGA-SX-A7SL-01A,TCGA-SX-A7SL,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-KQ-A41R,29351.0,female,1931,white,294,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,75.0,TCGA-KQ-A41R-01A,TCGA-KQ-A41R,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-5152,20783.0,male,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-BA-5152-01A,TCGA-BA-5152,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3WX,24553.0,female,1944,white,223,Primary Tumor,8.0,2.0,0.0,60.0,5.0,60.0,20.0,TCGA-DK-A3WX-01A,TCGA-DK-A3WX,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5891,20945.0,female,1952,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-BQ-5891-01A,TCGA-BQ-5891,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JA,24121.0,female,1942,white,1837,Primary Tumor,0.0,0.0,0.0,60.0,5.0,40.0,60.0,TCGA-UF-A7JA-01A,TCGA-UF-A7JA,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-H7-A76A,20946.0,male,1956,white,58,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-H7-A76A-01A,TCGA-H7-A76A,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7377,21371.0,male,1950,white,None,Primary Tumor,None,None,7.0,70.0,None,25.0,68.0,TCGA-CR-7377-01A,TCGA-CR-7377,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7N,24090.0,male,1945,white,1347,Primary Tumor,5.0,1.0,0.0,60.0,12.0,39.0,60.0,TCGA-4Z-AA7N-01A,TCGA-4Z-AA7N,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A78N,29132.0,male,None,white,None,Primary Tumor,5.0,2.0,0.0,70.0,3.0,27.0,70.0,TCGA-UY-A78N-01A,TCGA-UY-A78N,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-5156,18841.0,male,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B9-5156-01A,TCGA-B9-5156,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TA,21196.0,male,1951,white,1620,Primary Tumor,2.0,2.0,0.0,82.0,8.0,35.0,60.0,TCGA-FD-A6TA-01A,TCGA-FD-A6TA,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A3PJ,27821.0,male,1935,white,98,Primary Tumor,0.0,0.0,5.0,90.0,0.0,8.0,85.0,TCGA-BT-A3PJ-01A,TCGA-BT-A3PJ,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6996,21447.0,female,1953,white,None,Primary Tumor,None,None,0.0,65.0,None,10.0,90.0,TCGA-CN-6996-01A,TCGA-CN-6996,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5326,24473.0,male,1940,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,65.0,TCGA-CQ-5326-01A,TCGA-CQ-5326,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5441,21305.0,male,1945,white,None,Primary Tumor,None,None,0.0,50.0,None,60.0,40.0,TCGA-CV-5441-01A,TCGA-CV-5441,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-A5Y1,27541.0,male,1937,white,142,Primary Tumor,0.0,2.0,0.0,80.0,3.0,0.0,100.0,TCGA-A4-A5Y1-01A,TCGA-A4-A5Y1,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BS,24963.0,male,1941,white,1107,Primary Tumor,5.0,3.0,0.0,70.0,6.0,26.0,70.0,TCGA-FD-A5BS-01A,TCGA-FD-A5BS,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-Y8-A898,25344.0,male,1944,white,128,Primary Tumor,1.0,7.0,0.0,70.0,2.0,30.0,70.0,TCGA-Y8-A898-01A,TCGA-Y8-A898,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7427,26975.0,female,1924,white,None,Primary Tumor,0.0,0.0,0.0,80.0,15.0,5.0,95.0,TCGA-CV-7427-01A,TCGA-CV-7427,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NS,27800.0,male,1925,white,4480,Primary Tumor,0.0,0.0,0.0,60.0,4.0,0.0,100.0,TCGA-L5-A8NS-01A,TCGA-L5-A8NS,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6467,21689.0,male,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,75.0,TCGA-CR-6467-01A,TCGA-CR-6467,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-TN-A7HL,21731.0,male,1954,white,45,Primary Tumor,0.0,0.0,30.0,70.0,5.0,0.0,70.0,TCGA-TN-A7HL-01A,TCGA-TN-A7HL,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-8516,22879.0,male,1950,white,None,Primary Tumor,None,None,None,90.0,None,None,None,TCGA-A4-8516-01A,TCGA-A4-8516,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A61E,20417.0,female,1956,white,490,Primary Tumor,0.0,2.0,0.0,70.0,6.0,40.0,60.0,TCGA-IQ-A61E-01A,TCGA-IQ-A61E,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N9-A4Q4,22575.0,female,1949,black or african american,1050,Primary Tumor,5.0,15.0,10.0,60.0,70.0,15.0,60.0,TCGA-N9-A4Q4-01A,TCGA-N9-A4Q4,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8438,16683.0,female,1955,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-KM-8438-01A,TCGA-KM-8438,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4591,29250.0,male,1921,white,None,Primary Tumor,None,None,20.0,80.0,None,5.0,75.0,TCGA-22-4591-01A,TCGA-22-4591,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TY,30256.0,female,1923,white,3053,Primary Tumor,10.0,10.0,5.0,90.0,60.0,5.0,90.0,TCGA-GS-A9TY-01A,TCGA-GS-A9TY,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-A5I4,22299.0,male,1951,white,50,Primary Tumor,3.0,2.0,0.0,70.0,4.0,19.0,70.0,TCGA-94-A5I4-01A,TCGA-94-A5I4,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-G8-6326,19238.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-G8-6326-01A,TCGA-G8-6326,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MI,24040.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-63-A5MI-01A,TCGA-63-A5MI,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-ER-A42H,28110.0,male,1934,white,736,Primary Tumor,1.0,2.0,0.0,80.0,3.0,20.0,80.0,TCGA-ER-A42H-01A,TCGA-ER-A42H,
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A5SF,28772.0,female,1934,white,155,Primary Tumor,0.0,0.0,10.0,88.0,0.0,0.0,90.0,TCGA-EB-A5SF-01A,TCGA-EB-A5SF,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-LA-A7SW,26116.0,male,1942,black or african american,42,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-LA-A7SW-01A,TCGA-LA-A7SW,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-37-4133,23083.0,male,1947,white,None,Primary Tumor,None,None,20.0,75.0,None,15.0,55.0,TCGA-37-4133-01A,TCGA-37-4133,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67S,23332.0,male,1949,not reported,427,Primary Tumor,0.0,0.0,30.0,70.0,0.0,0.0,70.0,TCGA-J4-A67S-01A,TCGA-J4-A67S,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A3DG,29771.0,female,1930,white,49,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-D1-A3DG-01A,TCGA-D1-A3DG,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17K,27283.0,female,1935,white,513,Primary Tumor,2.0,10.0,0.0,95.0,3.0,5.0,90.0,TCGA-D1-A17K-01A,TCGA-D1-A17K,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JY,18475.0,female,1958,white,632,Primary Tumor,10.0,0.0,30.0,70.0,20.0,0.0,40.0,TCGA-B5-A0JY-01A,TCGA-B5-A0JY,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A875,24742.0,male,1938,not reported,3124,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-VP-A875-01A,TCGA-VP-A875,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0V4,20777.0,female,1950,white,1576,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-BS-A0V4-01A,TCGA-BS-A0V4,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A59Z,24306.0,male,1941,not reported,1985,Primary Tumor,0.0,0.0,3.0,80.0,0.0,22.0,75.0,TCGA-KK-A59Z-01A,TCGA-KK-A59Z,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A0IS,19173.0,female,1956,white,805,Primary Tumor,1.0,0.0,10.0,80.0,8.0,10.0,77.0,TCGA-AX-A0IS-01A,TCGA-AX-A0IS,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A7SK,21814.0,male,1954,asian,232,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-RC-A7SK-01A,TCGA-RC-A7SK,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A4NA,24603.0,female,1942,white,1198,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-DD-A4NA-01A,TCGA-DD-A4NA,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5505,21164.0,male,1953,white,None,Primary Tumor,0.0,0.0,15.0,85.0,0.0,15.0,70.0,TCGA-EJ-5505-01A,TCGA-EJ-5505,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GM,19452.0,female,1953,white,1518,Primary Tumor,0.0,0.0,10.0,85.0,1.0,0.0,90.0,TCGA-A5-A0GM-01A,TCGA-A5-A0GM,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACZ,23230.0,female,1947,asian,1147,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-DD-AACZ-01A,TCGA-DD-AACZ,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A73E,24377.0,male,1946,white,336,Primary Tumor,1.0,1.0,0.0,92.0,2.0,6.0,88.0,TCGA-DD-A73E-01A,TCGA-DD-A73E,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YJ-A8SW,None,male,1941,not reported,2051,Primary Tumor,0.0,0.0,5.0,70.0,5.0,25.0,65.0,TCGA-YJ-A8SW-01A,TCGA-YJ-A8SW,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0V6,20369.0,female,1951,asian,1462,Primary Tumor,20.0,0.0,0.0,90.0,30.0,10.0,70.0,TCGA-BS-A0V6-01A,TCGA-BS-A0V6,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9ZG,23725.0,male,None,not reported,None,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-V1-A9ZG-01A,TCGA-V1-A9ZG,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-KP-A3VZ,25366.0,female,1941,white,633,Primary Tumor,10.0,20.0,0.0,90.0,60.0,5.0,90.0,TCGA-KP-A3VZ-01A,TCGA-KP-A3VZ,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4699,27225.0,male,1930,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4699-01A,TCGA-B0-4699,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-19-5960,20641.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,98.0,TCGA-19-5960-01A,TCGA-19-5960,
GBM,Glioblastoma Multiforme,Brain,TCGA-27-2528,22867.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,3.0,82.0,TCGA-27-2528-01A,TCGA-27-2528,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5184,19746.0,male,1953,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5184-01A,TCGA-BP-5184,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6508,17827.0,female,1962,white,None,Primary Tumor,None,None,5.0,75.0,None,18.0,74.0,TCGA-EI-6508-01A,TCGA-EI-6508,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3346,25118.0,male,1937,white,None,Primary Tumor,0.0,1.0,0.0,80.0,15.0,5.0,77.0,TCGA-A3-3346-01A,TCGA-A3-3346,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5682,22244.0,male,1944,white,None,Primary Tumor,None,None,0.0,85.0,None,12.0,88.0,TCGA-CJ-5682-01A,TCGA-CJ-5682,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3425,24912.0,male,1932,white,None,Primary Tumor,0.0,5.0,0.0,70.0,18.0,30.0,65.0,TCGA-AK-3425-01A,TCGA-AK-3425,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4902,22424.0,male,1945,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-CJ-4902-01A,TCGA-CJ-4902,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5684,22561.0,male,1944,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,80.0,TCGA-CJ-5684-01A,TCGA-CJ-5684,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4818,24853.0,female,1934,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-B0-4818-01A,TCGA-B0-4818,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4814,21374.0,male,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-4814-01A,TCGA-B0-4814,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6863,25936.0,female,1940,white,None,Primary Tumor,None,None,2.0,80.0,None,15.0,81.0,TCGA-F5-6863-01A,TCGA-F5-6863,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4694,26582.0,male,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,85.0,TCGA-B0-4694-01A,TCGA-B0-4694,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4759,18569.0,male,1954,white,None,Primary Tumor,None,None,None,90.0,2.0,None,100.0,TCGA-BP-4759-01A,TCGA-BP-4759,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6861,21936.0,female,1951,white,None,Primary Tumor,None,None,3.0,80.0,None,10.0,87.0,TCGA-F5-6861-01A,TCGA-F5-6861,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3454,30862.0,male,1922,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-AK-3454-01A,TCGA-AK-3454,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-3X-AAVE,21943.0,male,1953,asian,28,Primary Tumor,4.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-3X-AAVE-01A,TCGA-3X-AAVE,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5213,26491.0,male,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,99.0,TCGA-28-5213-01A,TCGA-28-5213,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5679,26858.0,male,1930,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,87.0,TCGA-CJ-5679-01A,TCGA-CJ-5679,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5121,20635.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5121-01A,TCGA-B0-5121,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2558,27511.0,female,1933,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-06-2558-01A,TCGA-06-2558,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4325,23588.0,female,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-4325-01A,TCGA-BP-4325,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA39,29594.0,male,1929,white,1286,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-W5-AA39-01A,TCGA-W5-AA39,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-12-0821,22949.0,male,1936,white,None,Primary Tumor,None,None,0.0,95.0,0.0,10.0,75.0,TCGA-12-0821-01A,TCGA-12-0821,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5713,27644.0,female,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5713-01A,TCGA-B0-5713,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5581,16195.0,male,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CW-5581-01A,TCGA-CW-5581,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4326,19376.0,female,1949,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-BP-4326-01A,TCGA-BP-4326,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-4621,23176.0,male,1947,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-B8-4621-01A,TCGA-B8-4621,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5119,22607.0,female,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-5119-01A,TCGA-B0-5119,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-3X-AAVA,18303.0,female,1962,white,510,Primary Tumor,0.0,0.0,10.0,60.0,0.0,40.0,50.0,TCGA-3X-AAVA-01A,TCGA-3X-AAVA,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6512,23537.0,female,1946,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,75.0,TCGA-EI-6512-01A,TCGA-EI-6512,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5418,27584.0,female,1935,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-06-5418-01A,TCGA-06-5418,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3433,17853.0,female,1956,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-AK-3433-01A,TCGA-AK-3433,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-6655,24417.0,male,1944,white,None,Primary Tumor,15.0,5.0,20.0,55.0,15.0,10.0,69.0,TCGA-AF-6655-01A,TCGA-AF-6655,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0132,18125.0,male,1958,white,None,Primary Tumor,None,None,10.0,100.0,None,0.0,90.0,TCGA-06-0132-01A,TCGA-06-0132,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5553,24729.0,female,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B8-5553-01A,TCGA-B8-5553,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5987,21928.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CZ-5987-01A,TCGA-CZ-5987,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A7U6,19803.0,female,1959,black or african american,57,Primary Tumor,0.0,2.0,0.0,90.0,3.0,25.0,60.0,TCGA-B8-A7U6-01A,TCGA-B8-A7U6,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6514,21618.0,female,1951,white,None,Primary Tumor,None,None,0.0,80.0,None,40.0,52.0,TCGA-EI-6514-01A,TCGA-EI-6514,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5194,14551.0,male,1969,white,None,Primary Tumor,None,None,0.0,85.0,None,25.0,75.0,TCGA-BP-5194-01A,TCGA-BP-5194,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5589,19312.0,male,1952,white,None,Primary Tumor,0.0,3.0,12.0,85.0,3.0,8.0,80.0,TCGA-CW-5589-01A,TCGA-CW-5589,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-MW-A4EC,26649.0,female,1940,black or african american,190,Primary Tumor,0.0,1.0,0.0,80.0,1.0,0.0,100.0,TCGA-MW-A4EC-01A,TCGA-MW-A4EC,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3583,24107.0,male,1942,not reported,None,Primary Tumor,None,None,5.0,75.0,None,7.0,80.0,TCGA-AG-3583-01A,TCGA-AG-3583,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0686,19503.0,male,1955,white,None,Primary Tumor,None,None,30.0,90.0,None,0.0,65.0,TCGA-06-0686-01A,TCGA-06-0686,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4849,18843.0,male,1953,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,85.0,TCGA-B0-4849-01A,TCGA-B0-4849,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4331,19022.0,male,1950,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-4331-01A,TCGA-BP-4331,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3605,31078.0,female,1923,not reported,None,Primary Tumor,None,None,10.0,93.0,None,3.0,82.0,TCGA-AG-3605-01A,TCGA-AG-3605,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-02-0055,22798.0,female,1943,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,80.0,TCGA-02-0055-01A,TCGA-02-0055,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-4110,28289.0,male,1933,white,None,Primary Tumor,None,None,40.0,60.0,None,5.0,50.0,TCGA-AF-4110-01A,TCGA-AF-4110,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4881,15197.0,male,1963,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4881-01A,TCGA-CJ-4881,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4889,23051.0,female,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,50.0,50.0,TCGA-CJ-4889-01A,TCGA-CJ-4889,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4343,23498.0,male,1939,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BP-4343-01A,TCGA-BP-4343,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-CI-6622,27336.0,male,1936,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,75.0,TCGA-CI-6622-01A,TCGA-CI-6622,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5575,19022.0,female,1955,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-DV-5575-01A,TCGA-DV-5575,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5984,18775.0,male,1954,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CZ-5984-01A,TCGA-CZ-5984,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4797,12508.0,male,1973,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,100.0,TCGA-BP-4797-01A,TCGA-BP-4797,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4807,15360.0,male,1966,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,85.0,TCGA-BP-4807-01A,TCGA-BP-4807,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4964,20084.0,female,1951,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4964-01A,TCGA-BP-4964,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5686,21836.0,female,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,70.0,TCGA-CJ-5686-01A,TCGA-CJ-5686,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3725,32872,female,1915,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,88.0,TCGA-AG-3725-01A,TCGA-AG-3725,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4771,22771.0,male,1943,white,None,Primary Tumor,None,None,None,90.0,5.0,None,95.0,TCGA-BP-4771-01A,TCGA-BP-4771,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4833,30190.0,female,1921,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-B0-4833-01A,TCGA-B0-4833,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-A6NI,17190.0,male,1964,black or african american,659,Primary Tumor,0.0,0.0,1.0,90.0,2.0,40.0,59.0,TCGA-A3-A6NI-01A,TCGA-A3-A6NI,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5452,25486.0,male,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,80.0,TCGA-CZ-5452-01A,TCGA-CZ-5452,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-2632,29281.0,male,1928,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-32-2632-01A,TCGA-32-2632,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5170,20229.0,male,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-BP-5170-01A,TCGA-BP-5170,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5468,30729.0,male,1923,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,5.0,95.0,TCGA-CZ-5468-01A,TCGA-CZ-5468,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5413,24477.0,male,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,85.0,TCGA-06-5413-01A,TCGA-06-5413,
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2570,7936.0,female,1988,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-06-2570-01A,TCGA-06-2570,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4696,21317.0,male,1943,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4696-01A,TCGA-B0-4696,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-A8CQ,21572.0,female,1952,black or african american,730,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-A3-A8CQ-01A,TCGA-A3-A8CQ,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4810,17402.0,male,1954,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-B0-4810-01A,TCGA-B0-4810,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-14-0787,25326.0,male,1930,asian,None,Primary Tumor,None,None,0.0,95.0,None,0.0,70.0,TCGA-14-0787-01A,TCGA-14-0787,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4760,25268.0,male,1935,black or african american,None,Primary Tumor,None,None,None,85.0,1.0,5.0,95.0,TCGA-BP-4760-01A,TCGA-BP-4760,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5692,24140.0,female,1938,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5692-01A,TCGA-B0-5692,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5698,28438.0,male,1928,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5698-01A,TCGA-B0-5698,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-12-3650,17138.0,male,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,85.0,TCGA-12-3650-01A,TCGA-12-3650,
GBM,Glioblastoma Multiforme,Brain,TCGA-32-2638,24658.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,60.0,TCGA-32-2638-01A,TCGA-32-2638,
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2569,8922.0,female,1985,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-06-2569-01A,TCGA-06-2569,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5095,29921.0,male,1927,white,None,Primary Tumor,None,None,0.0,85.0,None,20.0,80.0,TCGA-B0-5095-01A,TCGA-B0-5095,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A01Y,18112.0,female,1955,not reported,1877,Primary Tumor,0.0,0.0,8.0,75.0,5.0,17.0,75.0,TCGA-AG-A01Y-01A,TCGA-AG-A01Y,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5856,21232.0,male,1952,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,82.0,TCGA-06-5856-01A,TCGA-06-5856,
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZH-A8Y6,14976.0,female,1972,black or african american,148,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-ZH-A8Y6-01A,TCGA-ZH-A8Y6,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3598,25324.0,male,1938,not reported,None,Primary Tumor,40.0,None,20.0,75.0,50.0,5.0,75.0,TCGA-AG-3598-01A,TCGA-AG-3598,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5107,23929.0,female,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5107-01A,TCGA-B0-5107,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-41-2571,32612.0,male,1920,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-41-2571-01A,TCGA-41-2571,
GBM,Glioblastoma Multiforme,Brain,TCGA-26-1442,15950.0,male,1965,white,None,Primary Tumor,None,None,10.0,65.0,None,20.0,70.0,TCGA-26-1442-01A,TCGA-26-1442,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4758,14824.0,male,1964,white,None,Primary Tumor,None,None,None,95.0,1.0,5.0,95.0,TCGA-BP-4758-01A,TCGA-BP-4758,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4982,15451.0,male,1964,white,None,Primary Tumor,None,None,15.0,80.0,None,15.0,70.0,TCGA-BP-4982-01A,TCGA-BP-4982,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3586,26542.0,female,1934,not reported,None,Primary Tumor,None,None,10.0,70.0,None,5.0,75.0,TCGA-AG-3586-01A,TCGA-AG-3586,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-4749,21092.0,male,1953,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,80.0,TCGA-DC-4749-01A,TCGA-DC-4749,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4703,18921.0,male,1954,white,None,Primary Tumor,None,None,10.0,80.0,None,10.0,70.0,TCGA-B0-4703-01A,TCGA-B0-4703,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4998,17997.0,male,1958,asian,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-BP-4998-01A,TCGA-BP-4998,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3882,24198.0,female,1942,not reported,None,Primary Tumor,None,None,None,65.0,20.0,10.0,80.0,TCGA-AG-3882-01A,TCGA-AG-3882,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EF-5830,19802.0,male,1956,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,73.0,TCGA-EF-5830-01A,TCGA-EF-5830,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5116,19352.0,male,1958,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5116-01A,TCGA-B0-5116,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-26-5133,21560.0,male,1950,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-26-5133-01A,TCGA-26-5133,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5705,23746.0,female,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5705-01A,TCGA-B0-5705,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-6027,28359.0,male,1926,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CJ-6027-01A,TCGA-CJ-6027,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5189,22156.0,male,1947,white,None,Primary Tumor,None,None,0.0,85.0,None,30.0,70.0,TCGA-BP-5189-01A,TCGA-BP-5189,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3575,18932.0,male,1955,not reported,None,Primary Tumor,None,None,0.0,80.0,None,25.0,74.0,TCGA-AG-3575-01A,TCGA-AG-3575,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5465,27838.0,female,1931,not reported,None,Primary Tumor,None,None,0.0,85.0,None,25.0,75.0,TCGA-CZ-5465-01A,TCGA-CZ-5465,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-14-0817,25425.0,female,1933,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,90.0,TCGA-14-0817-01A,TCGA-14-0817,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4891,21059.0,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,75.0,TCGA-CJ-4891-01A,TCGA-CJ-4891,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5681,16121.0,female,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-5681-01A,TCGA-CJ-5681,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-3911,17609.0,male,1961,white,None,Primary Tumor,None,None,70.0,50.0,None,5.0,20.0,TCGA-AF-3911-01A,TCGA-AF-3911,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3742,31078.0,female,1919,not reported,None,Primary Tumor,None,None,0.0,70.0,None,15.0,75.0,TCGA-AG-3742-01A,TCGA-AG-3742,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5099,32364.0,female,1914,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-5099-01A,TCGA-B0-5099,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4903,18510.0,male,1956,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-CJ-4903-01A,TCGA-CJ-4903,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5414,22527.0,male,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-06-5414-01A,TCGA-06-5414,
GBM,Glioblastoma Multiforme,Brain,TCGA-27-1835,19444.0,female,1954,white,None,Primary Tumor,None,None,10.0,85.0,None,10.0,80.0,TCGA-27-1835-01A,TCGA-27-1835,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4967,27857.0,male,1929,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4967-01A,TCGA-BP-4967,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4335,23860.0,female,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BP-4335-01A,TCGA-BP-4335,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4885,23437.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CJ-4885-01A,TCGA-CJ-4885,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-12-5295,22161.0,female,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-12-5295-01A,TCGA-12-5295,
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5858,16662.0,female,1965,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,82.0,TCGA-06-5858-01A,TCGA-06-5858,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AH-6544,21977.0,male,1950,white,None,Primary Tumor,None,None,8.0,60.0,10.0,22.0,60.0,TCGA-AH-6544-01A,TCGA-AH-6544,
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5218,23096.0,male,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,90.0,TCGA-28-5218-01A,TCGA-28-5218,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4697,16844.0,female,1957,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-B0-4697-01A,TCGA-B0-4697,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6509,19666.0,male,1957,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,67.0,TCGA-EI-6509-01A,TCGA-EI-6509,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-CI-6620,15322.0,female,1969,white,None,Primary Tumor,None,None,15.0,65.0,None,15.0,70.0,TCGA-CI-6620-01A,TCGA-CI-6620,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4354,14973.0,male,1966,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,75.0,TCGA-BP-4354-01A,TCGA-BP-4354,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0644,26247.0,male,1936,black or african american,None,Primary Tumor,None,None,0.0,95.0,None,10.0,70.0,TCGA-06-0644-01A,TCGA-06-0644,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4846,19139.0,male,1952,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4846-01A,TCGA-B0-4846,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5174,16693.0,female,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-5174-01A,TCGA-BP-5174,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5709,22843.0,female,1941,white,None,Primary Tumor,None,None,0.0,72.0,None,20.0,80.0,TCGA-B0-5709-01A,TCGA-B0-5709,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0184,23317.0,male,1942,white,None,Primary Tumor,None,None,0.0,95.0,None,20.0,75.0,TCGA-06-0184-01A,TCGA-06-0184,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3581,23345.0,male,1944,not reported,None,Primary Tumor,None,None,10.0,75.0,None,10.0,75.0,TCGA-AG-3581-01A,TCGA-AG-3581,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A4BR,27741.0,male,1934,not reported,1161,Primary Tumor,0.0,0.0,10.0,60.0,0.0,50.0,40.0,TCGA-KC-A4BR-01A,TCGA-KC-A4BR,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A3KF,24328.0,female,1945,white,91,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-BC-A3KF-01A,TCGA-BC-A3KF,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-H9-A6BY,23297.0,male,1949,not reported,303,Primary Tumor,0.0,0.0,0.0,75.0,4.0,45.0,55.0,TCGA-H9-A6BY-01A,TCGA-H9-A6BY,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K8,25992.0,female,1938,white,191,Primary Tumor,0.0,0.0,0.0,90.0,10.0,10.0,80.0,TCGA-B5-A0K8-01A,TCGA-B5-A0K8,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LF,30027.0,female,1920,white,2891,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,100.0,TCGA-AP-A0LF-01A,TCGA-AP-A0LF,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7AQ,22731.0,male,1948,not reported,1066,Primary Tumor,0.0,0.0,0.0,75.0,3.0,25.0,75.0,TCGA-KK-A7AQ-01A,TCGA-KK-A7AQ,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XJ-A9DQ,None,male,1959,not reported,2265,Primary Tumor,0.0,0.0,18.0,75.0,4.0,52.0,30.0,TCGA-XJ-A9DQ-01A,TCGA-XJ-A9DQ,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3OK,26851.0,female,1938,white,162,Primary Tumor,1.0,0.0,5.0,85.0,3.0,0.0,92.0,TCGA-AJ-A3OK-01A,TCGA-AJ-A3OK,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67N,22420.0,male,1950,not reported,504,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-J4-A67N-01A,TCGA-J4-A67N,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1G7,31603.0,female,1922,white,1002,Primary Tumor,20.0,0.0,20.0,70.0,20.0,10.0,50.0,TCGA-EY-A1G7-01A,TCGA-EY-A1G7,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0R7,20250.0,female,1955,white,173,Primary Tumor,30.0,30.0,0.0,70.0,40.0,25.0,70.0,TCGA-A5-A0R7-01A,TCGA-A5-A0R7,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-A7MC,21733.0,male,1954,white,88,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-UB-A7MC-01A,TCGA-UB-A7MC,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M0,24427.0,female,1944,white,147,Primary Tumor,2.0,2.0,0.0,95.0,0.0,0.0,100.0,TCGA-BG-A0M0-01A,TCGA-BG-A0M0,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3GI,24388.0,female,1945,black or african american,300,Primary Tumor,0.0,0.0,0.0,98.0,0.0,2.0,94.0,TCGA-AX-A3GI-01A,TCGA-AX-A3GI,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-MR-A520,21398.0,male,1954,white,106,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,70.0,TCGA-MR-A520-01A,TCGA-MR-A520,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3G6,24681.0,female,1943,white,456,Primary Tumor,1.0,0.0,0.0,94.0,1.0,2.0,90.0,TCGA-AX-A3G6-01A,TCGA-AX-A3G6,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OH,23360.0,male,None,not reported,None,Primary Tumor,0.0,0.0,10.0,70.0,2.0,20.0,70.0,TCGA-V1-A9OH-01A,TCGA-V1-A9OH,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-A8VT,17365.0,male,1964,not reported,923,Primary Tumor,0.0,0.0,3.0,80.0,0.0,3.0,94.0,TCGA-2A-A8VT-01A,TCGA-2A-A8VT,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0VI,21198.0,female,1948,white,1514,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-BS-A0VI-01A,TCGA-BS-A0VI,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A186,22370.0,female,1949,black or african american,104,Primary Tumor,0.0,0.0,20.0,70.0,0.0,0.0,80.0,TCGA-BG-A186-01A,TCGA-BG-A186,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A6W4,22766.0,female,1951,black or african american,118,Primary Tumor,2.0,2.0,15.0,75.0,5.0,10.0,75.0,TCGA-BK-A6W4-01A,TCGA-BK-A6W4,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3BG,23861.0,female,1946,white,137,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,95.0,TCGA-AJ-A3BG-01A,TCGA-AJ-A3BG,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV2,18363.0,male,1963,white,136,Primary Tumor,2.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-G3-AAV2-01A,TCGA-G3-AAV2,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6370,19149.0,male,1957,white,None,Primary Tumor,0.0,3.0,25.0,3.0,3.0,72.0,3.0,TCGA-G9-6370-01A,TCGA-G9-6370,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A3DA,28142.0,female,1934,white,128,Primary Tumor,0.0,0.0,0.0,85.0,2.0,5.0,90.0,TCGA-D1-A3DA-01A,TCGA-D1-A3DA,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-HP-A5MZ,22702.0,male,None,not reported,None,Primary Tumor,1.0,1.0,0.0,85.0,8.0,25.0,73.0,TCGA-HP-A5MZ-01A,TCGA-HP-A5MZ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JS,19995.0,female,1953,white,1183,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-B5-A0JS-01A,TCGA-B5-A0JS,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3AV,18713.0,female,1959,not reported,407,Primary Tumor,10.0,10.0,0.0,90.0,70.0,5.0,90.0,TCGA-EO-A3AV-01A,TCGA-EO-A3AV,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5510,17895.0,male,1961,white,None,Primary Tumor,0.0,0.0,15.0,75.0,0.0,10.0,75.0,TCGA-EJ-5510-01A,TCGA-EJ-5510,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A6M6,27649.0,male,1936,white,748,Primary Tumor,0.0,0.0,0.0,85.0,10.0,35.0,62.0,TCGA-RC-A6M6-01A,TCGA-RC-A6M6,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A69I,25370.0,male,1944,white,80,Primary Tumor,1.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-BC-A69I-01A,TCGA-BC-A69I,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAUZ,17760.0,male,1965,not reported,168,Primary Tumor,2.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-G3-AAUZ-01A,TCGA-G3-AAUZ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3AY,21291.0,female,1953,not reported,227,Primary Tumor,0.0,0.0,0.0,90.0,0.0,8.0,90.0,TCGA-EO-A3AY-01A,TCGA-EO-A3AY,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BD-A2L6,25489.0,male,1942,white,148,Primary Tumor,0.0,0.0,0.0,95.0,1.0,10.0,90.0,TCGA-BD-A2L6-01A,TCGA-BD-A2L6,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8I4,23706.0,male,1944,not reported,1798,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-KK-A8I4-01A,TCGA-KK-A8I4,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BW-A5NQ,23353.0,male,1947,white,1022,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-BW-A5NQ-01A,TCGA-BW-A5NQ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A1MX,17320.0,female,1963,white,103,Primary Tumor,2.0,2.0,0.0,97.0,5.0,3.0,95.0,TCGA-B5-A1MX-01A,TCGA-B5-A1MX,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A46G,26219.0,male,1941,not reported,219,Primary Tumor,0.0,0.0,0.0,100.0,1.0,35.0,65.0,TCGA-EJ-A46G-01A,TCGA-EJ-A46G,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A631,24749.0,male,1945,not reported,101,Primary Tumor,0.0,0.0,0.0,80.0,0.0,35.0,65.0,TCGA-HC-A631-01A,TCGA-HC-A631,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GS,21318.0,male,1948,white,2558,Primary Tumor,3.0,2.0,0.0,65.0,4.0,35.0,65.0,TCGA-2Y-A9GS-01A,TCGA-2Y-A9GS,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A121,21018.0,female,1953,white,188,Primary Tumor,None,None,None,None,None,None,None,TCGA-B5-A121-01A,TCGA-B5-A121,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6379,25126.0,male,1941,not reported,None,Primary Tumor,0.0,1.0,30.0,70.0,1.0,20.0,50.0,TCGA-G9-6379-01A,TCGA-G9-6379,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A2QN,21915.0,female,1950,white,289,Primary Tumor,0.0,0.0,0.0,75.0,0.0,15.0,75.0,TCGA-AJ-A2QN-01A,TCGA-AJ-A2QN,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2F9,28886.0,female,1930,white,709,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-FI-A2F9-01A,TCGA-FI-A2F9,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-XR-A8TG,21544.0,male,1954,white,439,Primary Tumor,1.0,1.0,0.0,70.0,3.0,30.0,70.0,TCGA-XR-A8TG-01A,TCGA-XR-A8TG,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2IN,23275.0,female,1944,white,1321,Primary Tumor,0.0,0.0,20.0,80.0,6.0,20.0,60.0,TCGA-AX-A2IN-01A,TCGA-AX-A2IN,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A2G5,18322.0,female,1957,white,1354,Primary Tumor,10.0,0.0,10.0,90.0,10.0,0.0,80.0,TCGA-D1-A2G5-01A,TCGA-D1-A2G5,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-QU-A6IL,23710.0,male,1938,not reported,4048,Primary Tumor,0.0,0.0,14.0,70.0,4.0,40.0,45.0,TCGA-QU-A6IL-01A,TCGA-QU-A6IL,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-AAYO,21183.0,male,1954,not reported,854,Primary Tumor,0.0,0.0,2.0,90.0,7.0,42.0,55.0,TCGA-2A-AAYO-01A,TCGA-2A-AAYO,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A8D0,22465.0,male,1951,not reported,517,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-HC-A8D0-01A,TCGA-HC-A8D0,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-XR-A8TE,5862.0,male,1996,white,487,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-XR-A8TE-01A,TCGA-XR-A8TE,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9LU,24742.0,male,1945,not reported,617,Primary Tumor,0.0,0.0,0.0,70.0,1.0,0.0,100.0,TCGA-ZG-A9LU-01A,TCGA-ZG-A9LU,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0VX,21425.0,female,1950,white,729,Primary Tumor,20.0,15.0,10.0,50.0,60.0,35.0,50.0,TCGA-BG-A0VX-01A,TCGA-BG-A0VX,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0TI,23705.0,female,1942,white,1507,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-BS-A0TI-01A,TCGA-BS-A0TI,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MS,19547.0,female,1956,white,420,Primary Tumor,0.0,0.0,0.0,85.0,7.0,10.0,89.0,TCGA-BG-A0MS-01A,TCGA-BG-A0MS,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0L9,26185.0,female,1930,white,3402,Primary Tumor,20.0,0.0,0.0,100.0,20.0,0.0,80.0,TCGA-AP-A0L9-01A,TCGA-AP-A0L9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A05D,24597.0,female,1940,white,1063,Primary Tumor,0.0,0.0,0.0,80.0,8.0,15.0,84.0,TCGA-AP-A05D-01A,TCGA-AP-A05D,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5501,20409.0,male,1955,white,None,Primary Tumor,0.0,0.0,15.0,75.0,1.0,25.0,60.0,TCGA-EJ-5501-01A,TCGA-EJ-5501,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XJ-A83G,None,male,1959,not reported,1114,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-XJ-A83G-01A,TCGA-XJ-A83G,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88R,19513.0,male,1959,not reported,402,Primary Tumor,0.0,0.0,5.0,85.0,0.0,25.0,70.0,TCGA-VN-A88R-01A,TCGA-VN-A88R,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LE,20967.0,female,1945,white,2988,Primary Tumor,0.0,1.0,0.0,85.0,5.0,20.0,79.0,TCGA-AP-A0LE-01A,TCGA-AP-A0LE,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADO,20139.0,male,1958,asian,155,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,85.0,TCGA-DD-AADO-01A,TCGA-DD-AADO,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A13B,21493.0,female,1952,black or african american,140,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,97.0,TCGA-BK-A13B-01A,TCGA-BK-A13B,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1E4,19814.0,female,1956,white,154,Primary Tumor,0.0,0.0,0.0,75.0,0.0,20.0,80.0,TCGA-AP-A1E4-01A,TCGA-AP-A1E4,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EA,24925.0,male,1934,asian,3298,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-DD-A1EA-01A,TCGA-DD-A1EA,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-A9S7,20213.0,male,1957,not reported,452,Primary Tumor,0.0,2.0,1.0,85.0,10.0,35.0,62.0,TCGA-G9-A9S7-01A,TCGA-G9-A9S7,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A161,28695.0,female,1930,white,864,Primary Tumor,0.0,0.0,25.0,60.0,0.0,0.0,75.0,TCGA-D1-A161-01A,TCGA-D1-A161,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A59Y,20768.0,male,1953,not reported,1158,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-KK-A59Y-01A,TCGA-KK-A59Y,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GE,24667.0,female,1942,white,506,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-EY-A1GE-01A,TCGA-EY-A1GE,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A25X,26988.0,male,1934,asian,1346,Primary Tumor,0.0,0.0,0.0,70.0,0.0,35.0,65.0,TCGA-G3-A25X-01A,TCGA-G3-A25X,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-7510,24187.0,male,1944,not reported,None,Primary Tumor,None,None,25.0,55.0,None,20.0,55.0,TCGA-G9-7510-01A,TCGA-G9-7510,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K9,32289.0,female,1921,white,182,Primary Tumor,20.0,0.0,20.0,80.0,20.0,0.0,70.0,TCGA-B5-A0K9-01A,TCGA-B5-A0K9,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8S8,25119.0,male,1940,not reported,2146,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-YL-A8S8-01A,TCGA-YL-A8S8,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A5SL,25671.0,male,1942,white,236,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-G3-A5SL-01A,TCGA-G3-A5SL,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A9WI,23184.0,male,1947,not reported,1325,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-YL-A9WI-01A,TCGA-YL-A9WI,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACQ,18429.0,male,1959,asian,1665,Primary Tumor,0.0,0.0,0.0,94.0,0.0,0.0,100.0,TCGA-DD-AACQ-01A,TCGA-DD-AACQ,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6SW,18536.0,male,1955,white,3039,Primary Tumor,20.0,20.0,0.0,85.0,40.0,10.0,85.0,TCGA-P3-A6SW-01A,TCGA-P3-A6SW,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IK,32076.0,male,1924,white,124,Primary Tumor,0.0,0.0,10.0,75.0,2.0,10.0,80.0,TCGA-DK-A3IK-01A,TCGA-DK-A3IK,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NE,28243.0,male,1923,white,4726,Primary Tumor,1.0,3.0,0.0,98.0,2.0,5.0,94.0,TCGA-L5-A8NE-01A,TCGA-L5-A8NE,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7048,23460.0,male,1939,white,None,Primary Tumor,0.0,5.0,0.0,85.0,2.0,0.0,100.0,TCGA-BQ-7048-01A,TCGA-BQ-7048,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-A44B,25763.0,male,1942,black or african american,45,Primary Tumor,0.0,2.0,0.0,100.0,0.0,10.0,90.0,TCGA-B9-A44B-01A,TCGA-B9-A44B,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7394,25581.0,male,1939,white,None,Primary Tumor,0.0,0.0,0.0,75.0,25.0,0.0,100.0,TCGA-CR-7394-01A,TCGA-CR-7394,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A97I,21271.0,male,1955,white,90,Primary Tumor,1.0,1.0,0.0,65.0,4.0,65.0,25.0,TCGA-IG-A97I-01A,TCGA-IG-A97I,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R7,28063.0,female,1935,white,910,Primary Tumor,0.0,0.0,20.0,75.0,3.0,0.0,80.0,TCGA-ZF-A9R7-01A,TCGA-ZF-A9R7,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A652,22023.0,male,1953,white,35,Primary Tumor,0.0,0.0,10.0,70.0,10.0,30.0,60.0,TCGA-QK-A652-01A,TCGA-QK-A652,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A2EC,21215.0,female,1952,black or african american,481,Primary Tumor,0.0,0.0,0.0,70.0,3.0,30.0,70.0,TCGA-G2-A2EC-01A,TCGA-G2-A2EC,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GR,29451.0,male,1919,not reported,5258,Primary Tumor,0.0,0.0,0.0,60.0,8.0,0.0,100.0,TCGA-2H-A9GR-01A,TCGA-2H-A9GR,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A6EM,23865.0,female,1947,white,155,Primary Tumor,0.0,0.0,30.0,75.0,8.0,0.0,70.0,TCGA-D6-A6EM-01A,TCGA-D6-A6EM,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5359,21858.0,male,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CN-5359-01A,TCGA-CN-5359,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-4227,24322.0,male,1944,white,None,Primary Tumor,10.0,None,5.0,75.0,1.0,5.0,90.0,TCGA-BB-4227-01A,TCGA-BB-4227,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A40E,27569.0,male,1937,white,135,Primary Tumor,0.0,1.0,0.0,85.0,2.0,0.0,95.0,TCGA-GV-A40E-01A,TCGA-GV-A40E,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-AAQO,20683.0,male,1957,white,332,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-K4-AAQO-01A,TCGA-K4-AAQO,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-PQ-A6FN,28546.0,female,1933,white,562,Primary Tumor,0.0,0.0,10.0,70.0,5.0,0.0,90.0,TCGA-PQ-A6FN-01A,TCGA-PQ-A6FN,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-A8YI,28917.0,male,1934,black or african american,54,Primary Tumor,1.0,5.0,0.0,75.0,2.0,20.0,75.0,TCGA-B9-A8YI-01A,TCGA-B9-A8YI,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45Q,25379.0,female,1926,white,6297,Primary Tumor,0.0,0.0,5.0,90.0,5.0,5.0,90.0,TCGA-CV-A45Q-01A,TCGA-CV-A45Q,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-8517,26090.0,male,1941,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-A4-8517-01A,TCGA-A4-8517,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-AL-3473,20104.0,male,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,90.0,TCGA-AL-3473-01A,TCGA-AL-3473,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAN7,21951.0,male,1948,white,2087,Primary Tumor,0.0,0.0,0.0,96.0,2.0,7.0,90.0,TCGA-XF-AAN7-01A,TCGA-XF-AAN7,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SK,24019.0,male,1939,white,3598,Primary Tumor,5.0,1.0,0.0,70.0,4.0,30.0,70.0,TCGA-XF-A9SK-01A,TCGA-XF-A9SK,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9K3,21829.0,male,1948,white,2201,Primary Tumor,0.0,9.0,0.0,75.0,1.0,0.0,100.0,TCGA-5P-A9K3-01A,TCGA-5P-A9K3,
ESCA,Esophageal Carcinoma,Esophagus,TCGA-V5-A7RB,21654.0,male,None,not reported,None,Primary Tumor,1.0,2.0,50.0,60.0,3.0,10.0,40.0,TCGA-V5-A7RB-01A,TCGA-V5-A7RB,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA80,26873.0,male,1939,white,612,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-4Z-AA80-01A,TCGA-4Z-AA80,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9RL,22480.0,male,1946,white,2221,Primary Tumor,1.0,0.0,0.0,95.0,3.0,15.0,70.0,TCGA-ZF-A9RL-01A,TCGA-ZF-A9RL,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A47V,19265.0,male,1960,asian,206,Primary Tumor,0.0,0.0,0.0,99.0,0.0,5.0,95.0,TCGA-CF-A47V-01A,TCGA-CF-A47V,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-5561,18744.0,male,1957,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-DW-5561-01A,TCGA-DW-5561,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-5625,19211.0,female,1956,white,None,Primary Tumor,None,None,40.0,80.0,None,5.0,55.0,TCGA-DQ-5625-01A,TCGA-DQ-5625,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-A5W9,14668.0,male,1972,white,112,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-B9-A5W9-01A,TCGA-B9-A5W9,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BL-A13I,20885.0,female,1953,white,127,Primary Tumor,0.0,0.0,0.0,96.0,2.0,5.0,90.0,TCGA-BL-A13I-01A,TCGA-BL-A13I,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OX,22015.0,male,1946,white,2226,Primary Tumor,0.0,0.0,28.0,65.0,0.0,0.0,70.0,TCGA-L5-A4OX-01A,TCGA-L5-A4OX,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A624,26667.0,male,1939,white,154,Primary Tumor,1.0,0.0,0.0,75.0,9.0,0.0,100.0,TCGA-F7-A624-01A,TCGA-F7-A624,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6V9,20461.0,male,1956,white,478,Primary Tumor,0.0,0.0,20.0,75.0,20.0,5.0,75.0,TCGA-QK-A6V9-01A,TCGA-QK-A6V9,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-7229,22076.0,male,1951,white,None,Primary Tumor,None,None,0.0,60.0,None,5.0,87.0,TCGA-HD-7229-01A,TCGA-HD-7229,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A3YL,24524.0,male,1944,white,191,Primary Tumor,0.0,0.0,0.0,95.0,2.0,18.0,80.0,TCGA-CU-A3YL-01A,TCGA-CU-A3YL,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6225,23988.0,male,1943,white,None,Primary Tumor,None,None,5.0,85.0,None,35.0,58.0,TCGA-CQ-6225-01A,TCGA-CQ-6225,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-5247,17810.0,male,1958,black or african american,None,Primary Tumor,None,None,None,75.0,5.0,15.0,80.0,TCGA-CR-5247-01A,TCGA-CR-5247,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5443,23287.0,male,1941,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,20.0,70.0,TCGA-CV-5443-01A,TCGA-CV-5443,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6937,26156.0,male,1932,white,None,Primary Tumor,0.0,0.0,0.0,60.0,2.0,0.0,90.0,TCGA-CV-6937-01A,TCGA-CV-6937,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MZ-A6I9,24939.0,male,1944,white,156,Primary Tumor,1.0,1.0,20.0,70.0,8.0,30.0,46.0,TCGA-MZ-A6I9-01A,TCGA-MZ-A6I9,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5439,22686.0,male,1940,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CV-5439-01A,TCGA-CV-5439,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A0YX,25570.0,female,1939,white,296,Primary Tumor,5.0,0.0,0.0,70.0,10.0,30.0,60.0,TCGA-BT-A0YX-01A,TCGA-BT-A0YX,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A9FQ,22717.0,male,1951,asian,115,Primary Tumor,0.0,0.0,0.0,65.0,5.0,35.0,65.0,TCGA-LN-A9FQ-01A,TCGA-LN-A9FQ,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A8HC,28996.0,male,1926,asian,3146,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-XF-A8HC-01A,TCGA-XF-A8HC,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5369,32871.0,female,1916,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CN-5369-01A,TCGA-CN-5369,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-A5RJ,27518.0,male,1937,white,101,Primary Tumor,0.0,0.0,0.0,90.0,2.0,10.0,85.0,TCGA-K4-A5RJ-01A,TCGA-K4-A5RJ,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-2F-A9KW,24703.0,female,1946,white,56,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-2F-A9KW-01A,TCGA-2F-A9KW,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMY,28509.0,male,1928,white,2758,Primary Tumor,3.0,1.0,0.0,75.0,4.0,25.0,75.0,TCGA-XF-AAMY-01A,TCGA-XF-AAMY,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAME,23448.0,female,1942,white,2877,Primary Tumor,0.0,0.0,0.0,65.0,10.0,35.0,65.0,TCGA-XF-AAME-01A,TCGA-XF-AAME,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-7268,21705.0,male,1952,white,None,Primary Tumor,0.0,1.0,0.0,90.0,0.0,0.0,100.0,TCGA-B9-7268-01A,TCGA-B9-7268,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JN,18264.0,female,1962,black or african american,623,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-2Z-A9JN-01A,TCGA-2Z-A9JN,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7090,14515.0,male,1962,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-CV-7090-01A,TCGA-CV-7090,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A49A,21995.0,male,1951,white,309,Primary Tumor,0.0,0.0,0.0,95.0,2.0,1.0,80.0,TCGA-CN-A49A-01A,TCGA-CN-A49A,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-AA3F,28457.0,male,1935,white,459,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-G2-AA3F-01A,TCGA-G2-AA3F,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A857,23114.0,male,1949,black or african american,365,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-MH-A857-01A,TCGA-MH-A857,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3WW,20909.0,male,1954,white,210,Primary Tumor,8.0,2.0,0.0,60.0,15.0,15.0,80.0,TCGA-DK-A3WW-01A,TCGA-DK-A3WW,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-A6UM,19194.0,male,1958,white,1149,Primary Tumor,0.0,0.0,13.0,80.0,3.0,0.0,85.0,TCGA-BB-A6UM-01A,TCGA-BB-A6UM,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45T,23452.0,female,1934,white,5215,Primary Tumor,0.0,0.0,0.0,100.0,0.0,0.0,100.0,TCGA-CV-A45T-01A,TCGA-CV-A45T,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-TN-A7HJ,18809.0,male,1962,white,45,Primary Tumor,0.0,0.0,35.0,65.0,3.0,0.0,65.0,TCGA-TN-A7HJ-01A,TCGA-TN-A7HJ,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OS,31601.0,female,1924,white,996,Primary Tumor,0.0,0.0,0.0,92.0,0.0,15.0,85.0,TCGA-L5-A4OS-01A,TCGA-L5-A4OS,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7839,21347.0,female,1952,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-DW-7839-01A,TCGA-DW-7839,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SQ,17696.0,male,1962,white,1071,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-SX-A7SQ-01A,TCGA-SX-A7SQ,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5361,29383.0,male,1927,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-CN-5361-01A,TCGA-CN-5361,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SM,25852.0,male,1941,white,195,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-FD-A3SM-01A,TCGA-FD-A3SM,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A4PM,26971.0,female,1938,white,435,Primary Tumor,0.0,0.0,0.0,85.0,2.0,0.0,100.0,TCGA-N8-A4PM-01A,TCGA-N8-A4PM,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3OO,29065.0,male,1932,white,111,Primary Tumor,0.0,0.0,0.0,60.0,0.0,20.0,80.0,TCGA-GC-A3OO-01A,TCGA-GC-A3OO,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3JX,21888.0,male,1952,white,161,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,95.0,TCGA-GV-A3JX-01A,TCGA-GV-A3JX,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A5U5,20993.0,male,1955,asian,126,Primary Tumor,1.0,2.0,10.0,90.0,6.0,20.0,70.0,TCGA-LN-A5U5-01A,TCGA-LN-A5U5,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5E8,21132.0,male,1947,white,3086,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-P4-A5E8-01A,TCGA-P4-A5E8,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A62S,22000.0,female,1953,black or african american,49,Primary Tumor,4.0,2.0,0.0,75.0,4.0,25.0,75.0,TCGA-FD-A62S-01A,TCGA-FD-A62S,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NA-A4QW,22588.0,female,1946,white,2143,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-NA-A4QW-01A,TCGA-NA-A4QW,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA54,26128.0,male,1938,white,1472,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-ZF-AA54-01A,TCGA-ZF-AA54,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6492,28600.0,male,1932,white,None,Primary Tumor,None,None,15.0,75.0,None,20.0,65.0,TCGA-CR-6492-01A,TCGA-CR-6492,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4R8,24102.0,female,1938,white,3487,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-N5-A4R8-01A,TCGA-N5-A4R8,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7046,22337.0,male,1941,white,None,Primary Tumor,0.0,12.0,0.0,75.0,10.0,0.0,100.0,TCGA-BQ-7046-01A,TCGA-BQ-7046,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TH,23236.0,male,1950,white,80,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-FD-A6TH-01A,TCGA-FD-A6TH,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-2F-A9KO,23323.0,male,1945,white,2168,Primary Tumor,0.0,0.0,0.0,65.0,4.0,0.0,100.0,TCGA-2F-A9KO-01A,TCGA-2F-A9KO,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5C0,22500.0,male,1951,white,70,Primary Tumor,3.0,2.0,0.0,80.0,5.0,20.0,80.0,TCGA-FD-A5C0-01A,TCGA-FD-A5C0,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RJ,22341.0,female,1948,white,1198,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,60.0,TCGA-N5-A4RJ-01A,TCGA-N5-A4RJ,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA82,21893.0,male,1951,black or african american,1384,Primary Tumor,0.0,0.0,0.0,65.0,2.0,0.0,100.0,TCGA-4Z-AA82-01A,TCGA-4Z-AA82,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-5559,26286.0,male,1935,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-BA-5559-01A,TCGA-BA-5559,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3B8,20555.0,male,1955,white,232,Primary Tumor,0.0,0.0,30.0,85.0,0.0,0.0,70.0,TCGA-FD-A3B8-01A,TCGA-FD-A3B8,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6R,25196.0,male,1933,white,4591,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DK-AA6R-01A,TCGA-DK-AA6R,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PS,22646.0,female,None,black or african american,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-UZ-A9PS-01A,TCGA-UZ-A9PS,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A6FD,18808.0,female,1957,asian,1805,Primary Tumor,0.0,2.0,0.0,85.0,6.0,10.0,90.0,TCGA-JY-A6FD-01A,TCGA-JY-A6FD,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9RC,28275.0,male,1930,white,2386,Primary Tumor,0.0,0.0,0.0,60.0,2.0,0.0,100.0,TCGA-ZF-A9RC-01A,TCGA-ZF-A9RC,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A9PF,28470.0,male,None,white,None,Primary Tumor,4.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-UY-A9PF-01A,TCGA-UY-A9PF,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A6ZA,19871.0,male,1958,white,322,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,85.0,TCGA-GV-A6ZA-01A,TCGA-GV-A6ZA,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7386,25238.0,male,1939,white,None,Primary Tumor,None,None,0.0,65.0,None,40.0,60.0,TCGA-CR-7386-01A,TCGA-CR-7386,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A6UY,20967.0,male,1955,white,229,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,100.0,TCGA-CN-A6UY-01A,TCGA-CN-A6UY,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EX,23226.0,male,1946,not reported,1480,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,100.0,TCGA-VR-A8EX-01A,TCGA-VR-A8EX,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7399,22182.0,female,1948,white,None,Primary Tumor,0.0,0.0,0.0,65.0,25.0,0.0,98.0,TCGA-CR-7399-01A,TCGA-CR-7399,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BR,20964.0,male,1955,white,307,Primary Tumor,3.0,2.0,0.0,65.0,5.0,35.0,65.0,TCGA-FD-A5BR-01A,TCGA-FD-A5BR,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6515,30099.0,female,1928,white,None,Primary Tumor,None,None,0.0,65.0,None,10.0,90.0,TCGA-D6-6515-01A,TCGA-D6-6515,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A9PD,29565.0,male,None,white,None,Primary Tumor,5.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-UY-A9PD-01A,TCGA-UY-A9PD,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IA-A40Y,21996.0,female,1951,white,418,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-IA-A40Y-01A,TCGA-IA-A40Y,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-H7-8502,18286.0,male,1962,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-H7-8502-01A,TCGA-H7-8502,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-4617,15053.0,male,1969,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-B9-4617-01A,TCGA-B9-4617,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A43Y,23889.0,male,1947,white,201,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-FD-A43Y-01A,TCGA-FD-A43Y,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A4IJ,20723.0,male,1956,asian,114,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-E7-A4IJ-01A,TCGA-E7-A4IJ,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-AA4G,18909.0,female,1962,white,190,Primary Tumor,1.0,8.0,10.0,80.0,4.0,40.0,50.0,TCGA-VR-AA4G-01A,TCGA-VR-AA4G,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6823,18611.0,male,1960,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-D6-6823-01A,TCGA-D6-6823,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4737,7301.0,male,1991,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CN-4737-01A,TCGA-CN-4737,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7997,24486.0,male,1944,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-A4-7997-01A,TCGA-A4-7997,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA4V,24448.0,male,1942,white,1850,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-ZF-AA4V-01A,TCGA-ZF-AA4V,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6011,21016.0,male,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CN-6011-01A,TCGA-CN-6011,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J5,29275.0,male,1926,white,2716,Primary Tumor,0.0,35.0,0.0,60.0,2.0,55.0,27.0,TCGA-2Z-A9J5-01A,TCGA-2Z-A9J5,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A6V6,21811.0,male,1954,white,89,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-CN-A6V6-01A,TCGA-CN-A6V6,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A3MH,27458.0,male,1936,asian,64,Primary Tumor,1.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-CF-A3MH-01A,TCGA-CF-A3MH,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3B6,27541.0,male,1936,white,133,Primary Tumor,0.0,0.0,0.0,75.0,8.0,25.0,70.0,TCGA-FD-A3B6-01A,TCGA-FD-A3B6,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A3YA,19567.0,male,1959,white,115,Primary Tumor,1.0,1.0,30.0,90.0,10.0,44.0,25.0,TCGA-IG-A3YA-01A,TCGA-IG-A3YA,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A97Q,22249.0,female,1953,white,171,Primary Tumor,0.0,0.0,0.0,85.0,0.0,40.0,60.0,TCGA-E7-A97Q-01A,TCGA-E7-A97Q,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-GL-A4EM,22635.0,male,1950,white,458,Primary Tumor,0.0,2.0,0.0,75.0,3.0,0.0,100.0,TCGA-GL-A4EM-01A,TCGA-GL-A4EM,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6992,22598.0,male,1950,white,None,Primary Tumor,None,None,0.0,70.0,None,18.0,82.0,TCGA-CN-6992-01A,TCGA-CN-6992,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A1HR,22777.0,male,1948,asian,64,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-CF-A1HR-01A,TCGA-CF-A1HR,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A7PW,23057.0,male,1950,asian,117,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-E7-A7PW-01A,TCGA-E7-A7PW,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JG,23458.0,male,1946,white,1295,Primary Tumor,0.0,10.0,0.0,70.0,0.0,30.0,65.0,TCGA-2Z-A9JG-01A,TCGA-2Z-A9JG,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-5155,26149.0,male,1939,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B9-5155-01A,TCGA-B9-5155,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NG-A4VW,27326.0,female,1932,white,2264,Primary Tumor,20.0,20.0,0.0,95.0,40.0,0.0,95.0,TCGA-NG-A4VW-01A,TCGA-NG-A4VW,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A63U,18272.0,male,1961,white,504,Primary Tumor,20.0,20.0,5.0,80.0,40.0,10.0,80.0,TCGA-CN-A63U-01A,TCGA-CN-A63U,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GM,19484.0,male,1947,not reported,4788,Primary Tumor,2.0,2.0,6.0,75.0,12.0,43.0,48.0,TCGA-2H-A9GM-01A,TCGA-2H-A9GM,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3QG,23847.0,male,1946,white,64,Primary Tumor,1.0,1.0,40.0,65.0,10.0,0.0,55.0,TCGA-GV-A3QG-01A,TCGA-GV-A3QG,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7842,19166.0,male,1959,white,None,Primary Tumor,None,None,0.0,95.0,None,2.0,98.0,TCGA-DW-7842-01A,TCGA-DW-7842,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EQ,26912.0,male,1936,white,1704,Primary Tumor,15.0,3.0,0.0,65.0,15.0,40.0,57.0,TCGA-VR-A8EQ-01A,TCGA-VR-A8EQ,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9KE,25805.0,male,1941,white,753,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-5P-A9KE-01A,TCGA-5P-A9KE,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA86,24465.0,male,1943,black or african american,1466,Primary Tumor,0.0,0.0,0.0,90.0,5.0,50.0,30.0,TCGA-4Z-AA86-01A,TCGA-4Z-AA86,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A78K,22020.0,male,None,white,None,Primary Tumor,4.0,1.0,0.0,70.0,5.0,29.0,70.0,TCGA-UY-A78K-01A,TCGA-UY-A78K,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A6AV,30089.0,female,1926,asian,1836,Primary Tumor,1.0,0.0,0.0,85.0,10.0,30.0,66.0,TCGA-DK-A6AV-01A,TCGA-DK-A6AV,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A2I1,26726.0,female,1937,white,245,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-DK-A2I1-01A,TCGA-DK-A2I1,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5325,23833.0,male,1942,white,None,Primary Tumor,2.0,None,14.0,71.0,25.0,None,80.0,TCGA-CQ-5325-01A,TCGA-CQ-5325,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IN,26562.0,male,1939,white,209,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DK-A3IN-01A,TCGA-DK-A3IN,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TF,29317.0,female,1933,white,80,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-FD-A6TF-01A,TCGA-FD-A6TF,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EZ,17449.0,male,1966,white,293,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-VR-A8EZ-01A,TCGA-VR-A8EZ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BV,17501.0,female,1965,white,156,Primary Tumor,3.0,2.0,0.0,70.0,4.0,30.0,70.0,TCGA-FD-A5BV-01A,TCGA-FD-A5BV,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-YC-A9TC,26283.0,male,1942,white,39,Primary Tumor,5.0,2.0,0.0,75.0,3.0,20.0,75.0,TCGA-YC-A9TC-01A,TCGA-YC-A9TC,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9RM,25642.0,male,1940,white,1133,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-ZF-A9RM-01A,TCGA-ZF-A9RM,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7389,20169.0,male,1952,black or african american,None,Primary Tumor,0.0,0.0,10.0,75.0,15.0,15.0,75.0,TCGA-CR-7389-01A,TCGA-CR-7389,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SP,21776.0,male,1945,white,3382,Primary Tumor,6.0,1.0,0.0,70.0,2.0,30.0,70.0,TCGA-XF-A9SP-01A,TCGA-XF-A9SP,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7058,29856.0,male,1929,white,None,Primary Tumor,0.0,0.0,0.0,90.0,5.0,0.0,100.0,TCGA-BQ-7058-01A,TCGA-BQ-7058,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JY,25321.0,male,1942,white,567,Primary Tumor,1.0,0.0,0.0,92.0,4.0,10.0,80.0,TCGA-CV-A6JY-01A,TCGA-CV-A6JY,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-A42Q,24534.0,male,1945,white,191,Primary Tumor,3.0,1.0,0.0,70.0,7.0,27.0,70.0,TCGA-GU-A42Q-01A,TCGA-GU-A42Q,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A4PI,26270.0,female,1938,white,1094,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,98.0,TCGA-N8-A4PI-01A,TCGA-N8-A4PI,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-R3-A69X,25576.0,male,1942,white,448,Primary Tumor,1.0,1.0,4.0,75.0,4.0,56.0,38.0,TCGA-R3-A69X-01A,TCGA-R3-A69X,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6016,23664.0,male,1946,white,None,Primary Tumor,None,None,0.0,65.0,None,25.0,75.0,TCGA-CN-6016-01A,TCGA-CN-6016,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IQ,27194.0,male,1937,white,230,Primary Tumor,0.0,0.0,20.0,75.0,2.0,5.0,75.0,TCGA-DK-A3IQ-01A,TCGA-DK-A3IQ,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A71S,24211.0,female,1944,white,1058,Primary Tumor,2.0,6.0,0.0,75.0,2.0,25.0,75.0,TCGA-SX-A71S-01A,TCGA-SX-A71S,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-AAVL,31082.0,male,1925,white,1364,Primary Tumor,2.0,4.0,0.0,75.0,2.0,21.0,75.0,TCGA-P4-AAVL-01A,TCGA-P4-AAVL,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6U,23611.0,male,1949,white,172,Primary Tumor,5.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-DK-AA6U-01A,TCGA-DK-AA6U,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-6797,17004.0,male,1964,white,None,Primary Tumor,None,None,0.0,90.0,None,0.0,100.0,TCGA-G7-6797-01A,TCGA-G7-6797,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A62P,27843.0,male,1936,white,120,Primary Tumor,1.0,1.0,0.0,70.0,5.0,30.0,70.0,TCGA-FD-A62P-01A,TCGA-FD-A62P,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SP,24382.0,female,1946,white,539,Primary Tumor,0.0,10.0,0.0,65.0,1.0,0.0,100.0,TCGA-SX-A7SP-01A,TCGA-SX-A7SP,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6945,15158.0,male,1952,white,None,Primary Tumor,1.0,0.0,0.0,90.0,5.0,0.0,99.0,TCGA-CV-6945-01A,TCGA-CV-6945,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4734,25753.0,male,1940,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CN-4734-01A,TCGA-CN-4734,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B1-A654,15721.0,female,1969,black or african american,163,Primary Tumor,0.0,0.0,0.0,95.0,0.0,20.0,80.0,TCGA-B1-A654-01A,TCGA-B1-A654,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-5624,15867.0,female,1964,white,None,Primary Tumor,0.0,0.0,5.0,75.0,10.0,1.0,83.0,TCGA-DQ-5624-01A,TCGA-DQ-5624,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6826,23722.0,female,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,82.0,TCGA-D6-6826-01A,TCGA-D6-6826,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IZ-A6M8,25545.0,male,1944,black or african american,141,Primary Tumor,0.0,90.0,0.0,85.0,10.0,10.0,90.0,TCGA-IZ-A6M8-01A,TCGA-IZ-A6M8,1.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A4PP,32415.0,female,1924,white,189,Primary Tumor,20.0,20.0,0.0,70.0,40.0,10.0,70.0,TCGA-N8-A4PP-01A,TCGA-N8-A4PP,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6013,20703.0,male,1954,white,None,Primary Tumor,None,None,0.0,60.0,None,15.0,85.0,TCGA-CN-6013-01A,TCGA-CN-6013,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A9FO,15551.0,male,1971,asian,233,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-LN-A9FO-01A,TCGA-LN-A9FO,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-7068,29530.0,female,1930,white,None,Primary Tumor,2.0,0.0,0.0,75.0,15.0,0.0,100.0,TCGA-CQ-7068-01A,TCGA-CQ-7068,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMW,28903.0,female,1927,white,2682,Primary Tumor,0.0,70.0,10.0,70.0,30.0,30.0,60.0,TCGA-XF-AAMW-01A,TCGA-XF-AAMW,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A8HI,21059.0,female,1948,white,3153,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-XF-A8HI-01A,TCGA-XF-A8HI,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9Q1,32142.0,female,None,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-UZ-A9Q1-01A,TCGA-UZ-A9Q1,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A498,22330.0,female,1950,white,339,Primary Tumor,0.0,0.0,0.0,90.0,5.0,10.0,90.0,TCGA-CN-A498-01A,TCGA-CN-A498,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A8O2,22869.0,male,1951,asian,91,Primary Tumor,0.0,12.0,0.0,80.0,8.0,70.0,30.0,TCGA-IG-A8O2-01A,TCGA-IG-A8O2,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-A5HU,17502.0,male,1965,white,246,Primary Tumor,0.0,0.0,0.0,70.0,10.0,30.0,60.0,TCGA-BB-A5HU-01A,TCGA-BB-A5HU,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N7-A4Y0,23983.0,female,1938,white,3605,Primary Tumor,40.0,20.0,0.0,70.0,20.0,20.0,70.0,TCGA-N7-A4Y0-01A,TCGA-N7-A4Y0,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JD,24370.0,male,1943,white,1563,Primary Tumor,0.0,5.0,0.0,75.0,0.0,25.0,75.0,TCGA-2Z-A9JD-01A,TCGA-2Z-A9JD,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-A5NJ,21485.0,male,None,not reported,None,Primary Tumor,0.0,3.0,0.0,80.0,2.0,0.0,100.0,TCGA-HE-A5NJ-01A,TCGA-HE-A5NJ,
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7583,21962.0,male,1951,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-A4-7583-01A,TCGA-A4-7583,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMH,29547.0,male,1925,white,3271,Primary Tumor,0.0,0.0,0.0,75.0,0.0,25.0,65.0,TCGA-XF-AAMH-01A,TCGA-XF-AAMH,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-HQ-A5ND,28555.0,male,None,not reported,None,Primary Tumor,2.0,2.0,0.0,80.0,7.0,45.0,51.0,TCGA-HQ-A5ND-01A,TCGA-HQ-A5ND,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-6795,20478.0,male,1952,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,99.0,TCGA-G7-6795-01A,TCGA-G7-6795,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A7HV,21462.0,male,1954,asian,246,Primary Tumor,3.0,5.0,0.0,70.0,10.0,75.0,20.0,TCGA-LN-A7HV-01A,TCGA-LN-A7HV,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-A4C1,15096.0,female,1971,black or african american,67,Primary Tumor,1.0,1.0,0.0,75.0,4.0,60.0,30.0,TCGA-HD-A4C1-01A,TCGA-HD-A4C1,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-8596,25408.0,female,1936,white,None,Primary Tumor,0.0,0.0,0.0,65.0,20.0,10.0,90.0,TCGA-BB-8596-01A,TCGA-BB-8596,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A6FA,18978.0,male,1955,asian,2444,Primary Tumor,0.0,2.0,0.0,100.0,2.0,30.0,70.0,TCGA-JY-A6FA-01A,TCGA-JY-A6FA,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A3LO,23401.0,female,1947,white,182,Primary Tumor,0.0,0.0,0.0,75.0,0.0,15.0,85.0,TCGA-A5-A3LO-01A,TCGA-A5-A3LO,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-PG-A914,26992.0,female,1940,black or african american,263,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-PG-A914-01A,TCGA-PG-A914,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5512,17127.0,male,1963,white,None,Primary Tumor,0.0,0.0,20.0,65.0,1.0,30.0,50.0,TCGA-EJ-5512-01A,TCGA-EJ-5512,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EC,7363.0,female,1984,white,2254,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DD-A1EC-01A,TCGA-DD-A1EC,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACL,24355.0,female,1942,asian,1826,Primary Tumor,1.0,2.0,0.0,65.0,3.0,15.0,65.0,TCGA-DD-AACL-01A,TCGA-DD-AACL,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5526,20558.0,male,1953,white,None,Primary Tumor,0.0,0.0,5.0,80.0,2.0,15.0,80.0,TCGA-EJ-5526-01A,TCGA-EJ-5526,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5748,23649.0,male,1945,white,None,Primary Tumor,0.0,0.0,30.0,60.0,0.0,15.0,55.0,TCGA-CH-5748-01A,TCGA-CH-5748,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17B,25504.0,female,1940,white,685,Primary Tumor,50.0,10.0,0.0,70.0,30.0,20.0,70.0,TCGA-D1-A17B-01A,TCGA-D1-A17B,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-7519,21276.0,male,1952,not reported,None,Primary Tumor,None,None,3.0,80.0,None,17.0,80.0,TCGA-G9-7519-01A,TCGA-G9-7519,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A3MA,22375.0,male,1950,asian,177,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-CC-A3MA-01A,TCGA-CC-A3MA,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A1OG,23956.0,female,1945,asian,223,Primary Tumor,10.0,0.0,0.0,70.0,10.0,30.0,50.0,TCGA-A5-A1OG-01A,TCGA-A5-A1OG,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-5S-A9Q8,18785.0,female,1962,black or african american,103,Primary Tumor,0.0,0.0,2.0,90.0,2.0,5.0,90.0,TCGA-5S-A9Q8-01A,TCGA-5S-A9Q8,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-AA1N,25781.0,male,1938,not reported,2112,Primary Tumor,0.0,0.0,10.0,75.0,0.0,30.0,60.0,TCGA-VP-AA1N-01A,TCGA-VP-AA1N,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6AL,23618.0,male,1948,not reported,224,Primary Tumor,0.0,0.0,5.0,85.0,0.0,15.0,80.0,TCGA-HC-A6AL-01A,TCGA-HC-A6AL,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-QF-A5YS,20841.0,female,1955,black or african american,158,Primary Tumor,1.0,1.0,0.0,90.0,1.0,10.0,90.0,TCGA-QF-A5YS-01A,TCGA-QF-A5YS,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88I,21576.0,male,1952,not reported,730,Primary Tumor,20.0,5.0,0.0,70.0,60.0,30.0,70.0,TCGA-VN-A88I-01A,TCGA-VN-A88I,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7230,18577.0,male,1961,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-HC-7230-01A,TCGA-HC-7230,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3I9,19139.0,female,1959,white,84,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-AJ-A3I9-01A,TCGA-AJ-A3I9,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11O,22720.0,female,1946,white,993,Primary Tumor,8.0,8.0,0.0,95.0,20.0,5.0,85.0,TCGA-B5-A11O-01A,TCGA-B5-A11O,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A7FD,22745.0,male,1951,not reported,157,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-KC-A7FD-01A,TCGA-KC-A7FD,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A176,24521.0,female,1942,white,555,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-D1-A176-01A,TCGA-D1-A176,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-4R-AA8I,24279.0,male,1947,white,43,Primary Tumor,0.0,0.0,10.0,80.0,1.0,0.0,90.0,TCGA-4R-AA8I-01A,TCGA-4R-AA8I,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A7PX,17638.0,female,1965,asian,86,Primary Tumor,0.0,0.0,0.0,60.0,4.0,0.0,100.0,TCGA-ED-A7PX-01A,TCGA-ED-A7PX,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2D4,16163.0,female,1965,white,853,Primary Tumor,8.0,10.0,0.0,85.0,5.0,15.0,80.0,TCGA-FI-A2D4-01A,TCGA-FI-A2D4,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZP-A9D2,18717.0,male,1961,white,654,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-ZP-A9D2-01A,TCGA-ZP-A9D2,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A3KG,25061.0,female,1943,white,140,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-BC-A3KG-01A,TCGA-BC-A3KG,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A878,21402.0,male,1948,not reported,2725,Primary Tumor,0.0,0.0,10.0,85.0,0.0,35.0,55.0,TCGA-VP-A878-01A,TCGA-VP-A878,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAD0,26781.0,female,1937,asian,1134,Primary Tumor,0.0,1.0,0.0,95.0,3.0,5.0,75.0,TCGA-DD-AAD0-01A,TCGA-DD-AAD0,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GT,18768.0,male,1955,white,2603,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-2Y-A9GT-01A,TCGA-2Y-A9GT,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A051,25269.0,female,1934,white,2475,Primary Tumor,0.0,0.0,0.0,98.0,0.0,6.0,90.0,TCGA-AP-A051-01A,TCGA-AP-A051,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A3CI,26224.0,male,1940,white,258,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-G3-A3CI-01A,TCGA-G3-A3CI,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16X,19799.0,female,1955,white,618,Primary Tumor,15.0,10.0,0.0,95.0,3.0,5.0,94.0,TCGA-D1-A16X-01A,TCGA-D1-A16X,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-AB20,22626.0,male,1952,not reported,136,Primary Tumor,2.0,1.0,5.0,70.0,3.0,25.0,70.0,TCGA-EJ-AB20-01A,TCGA-EJ-AB20,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GU,24304.0,female,1944,black or african american,189,Primary Tumor,40.0,10.0,0.0,80.0,40.0,15.0,80.0,TCGA-EY-A1GU-01A,TCGA-EY-A1GU,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ES-A2HS,29268.0,male,1928,white,1113,Primary Tumor,0.0,0.0,0.0,90.0,2.0,10.0,90.0,TCGA-ES-A2HS-01A,TCGA-ES-A2HS,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9MC,25477.0,male,1943,not reported,434,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-ZG-A9MC-01A,TCGA-ZG-A9MC,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A3MB,13255.0,male,1975,asian,205,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-CC-A3MB-01A,TCGA-CC-A3MB,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10X,19140.0,female,1950,white,3080,Primary Tumor,0.0,0.0,45.0,45.0,0.0,5.0,50.0,TCGA-BC-A10X-01A,TCGA-BC-A10X,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11U,27160.0,female,1935,black or african american,371,Primary Tumor,10.0,0.0,0.0,70.0,10.0,30.0,50.0,TCGA-B5-A11U-01A,TCGA-B5-A11U,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K2,20080.0,female,1954,white,534,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-B5-A0K2-01A,TCGA-B5-A0K2,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16V,28635.0,female,1931,white,609,Primary Tumor,3.0,2.0,2.0,90.0,15.0,10.0,82.0,TCGA-D1-A16V-01A,TCGA-D1-A16V,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8ID,25851.0,male,1939,not reported,1717,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-KK-A8ID-01A,TCGA-KK-A8ID,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XQ-A8TA,21889.0,male,1953,not reported,601,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-XQ-A8TA-01A,TCGA-XQ-A8TA,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A76W,26755.0,male,1939,not reported,260,Primary Tumor,0.0,0.0,40.0,70.0,0.0,10.0,50.0,TCGA-HC-A76W-01A,TCGA-HC-A76W,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8MK,15330.0,male,None,not reported,None,Primary Tumor,0.0,0.0,20.0,60.0,0.0,30.0,50.0,TCGA-V1-A8MK-01A,TCGA-V1-A8MK,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DM,22239.0,female,1947,white,1309,Primary Tumor,20.0,20.0,20.0,60.0,20.0,20.0,40.0,TCGA-AP-A1DM-01A,TCGA-AP-A1DM,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A7M8,11527.0,male,1982,asian,97,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-G3-A7M8-01A,TCGA-G3-A7M8,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8I7,20256.0,male,1954,not reported,1634,Primary Tumor,20.0,20.0,10.0,70.0,40.0,20.0,70.0,TCGA-KK-A8I7-01A,TCGA-KK-A8I7,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A3I0,28101.0,female,1935,white,70,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-FV-A3I0-01A,TCGA-FV-A3I0,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A8CW,23554.0,female,1947,black or african american,840,Primary Tumor,0.0,0.0,5.0,85.0,3.0,8.0,85.0,TCGA-AJ-A8CW-01A,TCGA-AJ-A8CW,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A4BV,24138.0,male,1944,not reported,943,Primary Tumor,0.0,0.0,5.0,80.0,0.0,35.0,60.0,TCGA-KC-A4BV-01A,TCGA-KC-A4BV,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-X4-A8KQ,23999.0,male,1945,not reported,1078,Primary Tumor,0.0,0.0,10.0,60.0,0.0,50.0,40.0,TCGA-X4-A8KQ-01A,TCGA-X4-A8KQ,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EJ,26009.0,female,1937,white,909,Primary Tumor,0.0,0.0,0.0,85.0,5.0,15.0,85.0,TCGA-DD-A1EJ-01A,TCGA-DD-A1EJ,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8SA,25340.0,male,1940,not reported,1465,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-YL-A8SA-01A,TCGA-YL-A8SA,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVZ,14005.0,male,1971,asian,1777,Primary Tumor,4.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-DD-AAVZ-01A,TCGA-DD-AAVZ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6371,21365.0,male,1951,white,None,Primary Tumor,0.0,0.0,30.0,35.0,2.0,35.0,35.0,TCGA-G9-6371-01A,TCGA-G9-6371,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2KZ,31973.0,female,None,not reported,None,Primary Tumor,0.0,0.0,0.0,75.0,0.0,25.0,75.0,TCGA-DF-A2KZ-01A,TCGA-DF-A2KZ,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A1,24046.0,male,1936,not reported,3753,Primary Tumor,1.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-DD-A3A1-01A,TCGA-DD-A3A1,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E2,19974.0,male,1946,not reported,4724,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-KK-A6E2-01A,TCGA-KK-A6E2,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-FC-A5OB,19413.0,male,1959,not reported,162,Primary Tumor,0.0,0.0,2.0,90.0,0.0,13.0,85.0,TCGA-FC-A5OB-01A,TCGA-FC-A5OB,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DV,21901.0,female,1949,white,876,Primary Tumor,2.0,4.0,0.0,90.0,2.0,10.0,85.0,TCGA-AP-A1DV-01A,TCGA-AP-A1DV,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17H,22389.0,female,1948,white,531,Primary Tumor,0.0,0.0,0.0,60.0,5.0,40.0,60.0,TCGA-D1-A17H-01A,TCGA-D1-A17H,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17R,21382.0,female,1951,white,443,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-D1-A17R-01A,TCGA-D1-A17R,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A8CK,24285.0,male,1946,not reported,365,Primary Tumor,0.0,0.0,10.0,70.0,0.0,20.0,70.0,TCGA-J9-A8CK-01A,TCGA-J9-A8CK,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACS,14473.0,male,1970,asian,1532,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AACS-01A,TCGA-DD-AACS,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-WQ-A9G7,None,female,1942,white,165,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-WQ-A9G7-01A,TCGA-WQ-A9G7,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A162,25543.0,female,1939,white,874,Primary Tumor,0.0,0.0,25.0,70.0,0.0,0.0,75.0,TCGA-D1-A162-01A,TCGA-D1-A162,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A5DV,23892.0,female,1947,black or african american,220,Primary Tumor,0.0,0.0,0.0,75.0,5.0,0.0,90.0,TCGA-AJ-A5DV-01A,TCGA-AJ-A5DV,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8SC,24206.0,male,1944,not reported,1387,Primary Tumor,0.0,0.0,0.0,85.0,0.0,35.0,65.0,TCGA-YL-A8SC-01A,TCGA-YL-A8SC,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A3R3,14231.0,female,1974,white,28,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-FV-A3R3-01A,TCGA-FV-A3R3,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-QS-A8F1,31386.0,female,1928,black or african american,29,Primary Tumor,0.0,1.0,5.0,70.0,1.0,20.0,70.0,TCGA-QS-A8F1-01A,TCGA-QS-A8F1,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H1,21222.0,male,1952,white,1445,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-2Y-A9H1-01A,TCGA-2Y-A9H1,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-K7-AAU7,22476.0,male,1952,white,9,Primary Tumor,0.0,0.0,0.0,65.0,2.0,0.0,100.0,TCGA-K7-AAU7-01A,TCGA-K7-AAU7,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9L0,26055.0,male,1942,not reported,152,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-ZG-A9L0-01A,TCGA-ZG-A9L0,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-EP-A2KB,16835.0,female,1965,white,50,Primary Tumor,0.0,0.0,0.0,98.0,0.0,3.0,97.0,TCGA-EP-A2KB-01A,TCGA-EP-A2KB,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-3K-AAZ8,24046.0,male,1948,black or african american,65,Primary Tumor,0.0,0.0,0.0,95.0,4.0,3.0,96.0,TCGA-3K-AAZ8-01A,TCGA-3K-AAZ8,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A123,9107.0,female,1986,asian,49,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-CC-A123-01A,TCGA-CC-A123,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A52E,23741.0,male,1947,not reported,299,Primary Tumor,0.0,0.0,30.0,70.0,0.0,0.0,70.0,TCGA-J9-A52E-01A,TCGA-J9-A52E,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-FC-A6HD,28197.0,male,1936,not reported,140,Primary Tumor,0.0,0.0,30.0,85.0,0.0,0.0,70.0,TCGA-FC-A6HD-01A,TCGA-FC-A6HD,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-E6-A8L9,22333.0,female,1951,black or african american,657,Primary Tumor,1.0,1.0,10.0,70.0,5.0,20.0,70.0,TCGA-E6-A8L9-01A,TCGA-E6-A8L9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A2K7,14980.0,female,1970,not reported,195,Primary Tumor,0.0,0.0,0.0,85.0,1.0,25.0,75.0,TCGA-A5-A2K7-01A,TCGA-A5-A2K7,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAEI,26465.0,male,1938,asian,1238,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-DD-AAEI-01A,TCGA-DD-AAEI,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5739,23953.0,male,1941,white,None,Primary Tumor,0.0,0.0,2.0,85.0,0.0,8.0,90.0,TCGA-CH-5739-01A,TCGA-CH-5739,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-Y6-A9XI,26471.0,male,1940,not reported,413,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-Y6-A9XI-01A,TCGA-Y6-A9XI,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-SJ-A6ZJ,22597.0,female,1951,black or african american,216,Primary Tumor,1.0,1.0,20.0,70.0,1.0,10.0,70.0,TCGA-SJ-A6ZJ-01A,TCGA-SJ-A6ZJ,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZS-A9CG,20100.0,male,1958,white,201,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-ZS-A9CG-01A,TCGA-ZS-A9CG,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OF,18250.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-V1-A9OF-01A,TCGA-V1-A9OF,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16G,27065.0,female,1934,white,769,Primary Tumor,30.0,0.0,0.0,60.0,10.0,40.0,60.0,TCGA-D1-A16G-01A,TCGA-D1-A16G,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0VW,28383.0,female,1933,white,246,Primary Tumor,30.0,30.0,10.0,60.0,40.0,25.0,60.0,TCGA-BG-A0VW-01A,TCGA-BG-A0VW,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZP-A9CV,21633.0,male,1952,white,955,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-ZP-A9CV-01A,TCGA-ZP-A9CV,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7233,None,male,1937,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HC-7233-01A,TCGA-HC-7233,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADW,17781.0,male,1965,asian,287,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-DD-AADW-01A,TCGA-DD-AADW,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17U,19544.0,female,1957,white,314,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-D1-A17U-01A,TCGA-D1-A17U,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-MI-A75C,23441.0,male,1948,white,573,Primary Tumor,0.0,0.0,0.0,95.0,3.0,5.0,93.0,TCGA-MI-A75C-01A,TCGA-MI-A75C,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-EP-A2KC,22677.0,male,1949,black or african american,30,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-EP-A2KC-01A,TCGA-EP-A2KC,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAD3,15706.0,male,1968,asian,1072,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AAD3-01A,TCGA-DD-AAD3,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5499,22286.0,male,1949,asian,None,Primary Tumor,0.0,0.0,40.0,2.0,1.0,49.0,1.0,TCGA-EJ-5499-01A,TCGA-EJ-5499,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HG,20771.0,female,1953,white,582,Primary Tumor,0.0,0.0,20.0,70.0,20.0,9.0,70.0,TCGA-AX-A2HG-01A,TCGA-AX-A2HG,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JZ,22106.0,female,1948,white,642,Primary Tumor,10.0,0.0,0.0,70.0,20.0,30.0,60.0,TCGA-B5-A0JZ-01A,TCGA-B5-A0JZ,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A118,28406.0,female,1926,white,2854,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-DD-A118-01A,TCGA-DD-A118,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17T,24652.0,female,1943,white,318,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-D1-A17T-01A,TCGA-D1-A17T,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A46I,21046.0,male,1954,not reported,520,Primary Tumor,0.0,0.0,20.0,60.0,0.0,30.0,50.0,TCGA-EJ-A46I-01A,TCGA-EJ-A46I,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A23B,25788.0,female,1935,white,2030,Primary Tumor,0.0,0.0,0.0,95.0,1.0,8.0,90.0,TCGA-FV-A23B-01A,TCGA-FV-A23B,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A2CG,25279.0,female,1940,asian,643,Primary Tumor,0.0,0.0,20.0,75.0,0.0,0.0,80.0,TCGA-EO-A2CG-01A,TCGA-EO-A2CG,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A1NO,24996.0,female,1941,black or african american,688,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-DI-A1NO-01A,TCGA-DI-A1NO,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8266,20280.0,male,1957,not reported,None,Primary Tumor,None,None,0.0,70.0,None,0.0,0.0,TCGA-HC-8266-01A,TCGA-HC-8266,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3FW,24419.0,female,1943,white,723,Primary Tumor,0.0,1.0,0.0,95.0,2.0,2.0,96.0,TCGA-AX-A3FW-01A,TCGA-AX-A3FW,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A7PZ,22601.0,male,1952,asian,78,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ED-A7PZ-01A,TCGA-ED-A7PZ,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A2QQ,29354.0,male,1931,white,71,Primary Tumor,0.0,0.0,0.0,97.0,1.0,5.0,95.0,TCGA-FV-A2QQ-01A,TCGA-FV-A2QQ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-KP-A3W0,26378.0,female,1939,not reported,351,Primary Tumor,10.0,20.0,0.0,60.0,60.0,30.0,60.0,TCGA-KP-A3W0-01A,TCGA-KP-A3W0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5525,24535.0,male,1942,white,None,Primary Tumor,0.0,5.0,10.0,60.0,5.0,30.0,55.0,TCGA-EJ-5525-01A,TCGA-EJ-5525,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZS,19821.0,female,1955,white,308,Primary Tumor,30.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-D1-A0ZS-01A,TCGA-D1-A0ZS,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11H,24556.0,female,1937,white,2324,Primary Tumor,5.0,10.0,0.0,85.0,5.0,5.0,85.0,TCGA-B5-A11H-01A,TCGA-B5-A11H,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A3FD,25813.0,female,1939,black or african american,679,Primary Tumor,1.0,2.0,0.0,90.0,2.0,5.0,90.0,TCGA-B5-A3FD-01A,TCGA-B5-A3FD,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8S9,23204.0,male,1945,not reported,1891,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-YL-A8S9-01A,TCGA-YL-A8S9,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A2G0,25573.0,female,1937,white,1416,Primary Tumor,10.0,0.0,10.0,90.0,20.0,0.0,70.0,TCGA-D1-A2G0-01A,TCGA-D1-A2G0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A48F,17434.0,male,1965,not reported,115,Primary Tumor,0.0,1.0,0.0,100.0,2.0,30.0,69.0,TCGA-HC-A48F-01A,TCGA-HC-A48F,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A3FB,26779.0,female,1933,black or african american,2066,Primary Tumor,5.0,5.0,0.0,80.0,1.0,0.0,85.0,TCGA-B5-A3FB-01A,TCGA-B5-A3FB,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GW,17092.0,female,1963,asian,302,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-A5-A0GW-01A,TCGA-A5-A0GW,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A2K5,28057.0,female,1935,white,171,Primary Tumor,0.0,3.0,0.0,90.0,5.0,20.0,75.0,TCGA-A5-A2K5-01A,TCGA-A5-A2K5,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88Q,22087.0,male,1950,not reported,1029,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-VN-A88Q-01A,TCGA-VN-A88Q,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A216,22968.0,female,1946,white,1052,Primary Tumor,0.0,1.0,0.0,95.0,1.0,4.0,94.0,TCGA-BC-A216-01A,TCGA-BC-A216,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A9FU,19326.0,female,1961,asian,205,Primary Tumor,1.0,1.0,0.0,90.0,5.0,6.0,84.0,TCGA-CC-A9FU-01A,TCGA-CC-A9FU,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A2K3,24907.0,female,1939,white,1431,Primary Tumor,0.0,1.0,0.0,85.0,3.0,5.0,90.0,TCGA-A5-A2K3-01A,TCGA-A5-A2K3,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MI,30334.0,female,1924,white,1014,Primary Tumor,1.0,2.0,0.0,85.0,5.0,15.0,75.0,TCGA-BG-A0MI-01A,TCGA-BG-A0MI,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1C8,28452.0,female,1932,white,475,Primary Tumor,0.0,1.0,0.0,80.0,1.0,20.0,75.0,TCGA-AX-A1C8-01A,TCGA-AX-A1C8,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-K7-A6G5,24233.0,male,1947,white,31,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-K7-A6G5-01A,TCGA-K7-A6G5,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MO,23287.0,female,1945,white,854,Primary Tumor,0.0,0.0,0.0,97.0,1.0,3.0,96.0,TCGA-BG-A0MO-01A,TCGA-BG-A0MO,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3OL,20115.0,female,1956,white,81,Primary Tumor,0.0,0.0,0.0,90.0,3.0,0.0,97.0,TCGA-AJ-A3OL-01A,TCGA-AJ-A3OL,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GW,23587.0,male,1943,white,2375,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-2Y-A9GW-01A,TCGA-2Y-A9GW,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A177,25602.0,female,1940,white,227,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-D1-A177-01A,TCGA-D1-A177,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A101,22078.0,female,1949,white,349,Primary Tumor,0.0,0.0,35.0,60.0,0.0,0.0,65.0,TCGA-D1-A101-01A,TCGA-D1-A101,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-5264,25979.0,male,1939,asian,84,Primary Tumor,None,None,0.0,85.0,None,5.0,90.0,TCGA-CC-5264-01A,TCGA-CC-5264,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A9WH,24755.0,male,1944,not reported,853,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-YL-A9WH-01A,TCGA-YL-A9WH,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5738,26329.0,male,1934,white,None,Primary Tumor,0.0,0.0,15.0,70.0,2.0,15.0,70.0,TCGA-CH-5738-01A,TCGA-CH-5738,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6369,20238.0,male,1954,white,None,Primary Tumor,0.0,0.0,10.0,80.0,0.0,10.0,80.0,TCGA-G9-6369-01A,TCGA-G9-6369,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11N,25442.0,female,1938,white,1140,Primary Tumor,0.0,2.0,0.0,75.0,30.0,25.0,70.0,TCGA-B5-A11N-01A,TCGA-B5-A11N,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-QS-A5YR,22372.0,female,1951,black or african american,118,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-QS-A5YR-01A,TCGA-QS-A5YR,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-5B-A90C,25518.0,female,1942,black or african american,811,Primary Tumor,20.0,20.0,0.0,80.0,60.0,10.0,80.0,TCGA-5B-A90C-01A,TCGA-5B-A90C,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-4L-AA1F,23665.0,male,1949,not reported,64,Primary Tumor,20.0,20.0,10.0,60.0,40.0,30.0,60.0,TCGA-4L-AA1F-01A,TCGA-4L-AA1F,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A7FE,22718.0,male,1951,not reported,212,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-KC-A7FE-01A,TCGA-KC-A7FE,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A22Y,25127.0,female,1941,white,692,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-EO-A22Y-01A,TCGA-EO-A22Y,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-PD-A5DF,21414.0,female,1949,white,1906,Primary Tumor,0.0,0.0,0.0,60.0,13.0,0.0,100.0,TCGA-PD-A5DF-01A,TCGA-PD-A5DF,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1E0,14653.0,female,1969,white,582,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-AP-A1E0-01A,TCGA-AP-A1E0,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-AA0U,21985.0,male,1953,white,18,Primary Tumor,0.0,0.0,0.0,70.0,2.0,0.0,100.0,TCGA-UB-AA0U-01A,TCGA-UB-AA0U,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2KS,25313.0,female,None,not reported,None,Primary Tumor,8.0,3.0,0.0,95.0,5.0,5.0,75.0,TCGA-DF-A2KS-01A,TCGA-DF-A2KS,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-QU-A6IO,19564.0,male,1950,not reported,3614,Primary Tumor,0.0,0.0,0.0,80.0,2.0,53.0,40.0,TCGA-QU-A6IO-01A,TCGA-QU-A6IO,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4604,26952.0,male,1930,white,None,Primary Tumor,None,None,0.0,60.0,None,40.0,45.0,TCGA-22-4604-01A,TCGA-22-4604,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KF,25066.0,male,1945,not reported,309,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KF-01A,TCGA-VD-A8KF,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5039,27781.0,male,1932,white,None,Primary Tumor,None,None,0.0,70.0,None,40.0,55.0,TCGA-39-5039-01A,TCGA-39-5039,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EX,20447.0,female,1957,white,606,Primary Tumor,0.0,0.0,10.0,90.0,0.0,0.0,90.0,TCGA-V4-A9EX-01A,TCGA-V4-A9EX,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8277,25793.0,male,1941,white,None,Primary Tumor,0.0,0.0,0.0,70.0,20.0,0.0,95.0,TCGA-85-8277-01A,TCGA-85-8277,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-G8-6909,24661.0,male,1935,white,None,Primary Tumor,0.0,0.0,0.0,95.0,95.0,0.0,100.0,TCGA-G8-6909-01A,TCGA-G8-6909,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8441,22303.0,female,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-KM-8441-01A,TCGA-KM-8441,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2742,25688.0,male,1936,not reported,None,Primary Tumor,None,None,0.0,80.0,5.0,35.0,60.0,TCGA-66-2742-01A,TCGA-66-2742,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8503,28095.0,female,1936,white,None,Primary Tumor,None,None,0.0,60.0,None,15.0,85.0,TCGA-56-8503-01A,TCGA-56-8503,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8405,10671.0,male,1976,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-KO-8405-01A,TCGA-KO-8405,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1079,26176.0,male,1924,white,None,Primary Tumor,None,None,None,90.0,None,None,None,TCGA-21-1079-01A,TCGA-21-1079,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HJ,21730.0,male,1950,white,1213,Primary Tumor,0.0,4.0,0.0,95.0,2.0,10.0,80.0,TCGA-NC-A5HJ-01A,TCGA-NC-A5HJ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8350,22526.0,male,1950,white,None,Primary Tumor,None,None,15.0,70.0,None,15.0,70.0,TCGA-85-8350-01A,TCGA-85-8350,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5034,26682.0,female,1934,white,None,Primary Tumor,None,None,0.0,65.0,None,30.0,60.0,TCGA-39-5034-01A,TCGA-39-5034,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4594,22115.0,female,1942,not reported,None,Primary Tumor,None,None,0.0,70.0,None,20.0,65.0,TCGA-22-4594-01A,TCGA-22-4594,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2790,26420.0,male,1936,not reported,None,Primary Tumor,None,None,15.0,70.0,None,10.0,70.0,TCGA-66-2790-01A,TCGA-66-2790,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8009,25037.0,male,1939,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-77-8009-01A,TCGA-77-8009,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-GN-A26C,28336.0,male,1929,white,1609,Primary Tumor,1.0,1.0,0.0,70.0,6.0,30.0,70.0,TCGA-GN-A26C-01A,TCGA-GN-A26C,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-6202,None,male,None,not reported,None,Primary Tumor,2.0,2.0,15.0,80.0,10.0,0.0,85.0,TCGA-63-6202-01A,TCGA-63-6202,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8341,15045.0,male,1965,asian,None,Primary Tumor,None,None,0.0,95.0,None,5.0,85.0,TCGA-KL-8341-01A,TCGA-KL-8341,4.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A3DN,29801.0,female,1930,white,177,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-BF-A3DN-01A,TCGA-BF-A3DN,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8156,22198.0,male,1950,not reported,None,Primary Tumor,None,None,0.0,60.0,None,15.0,77.0,TCGA-77-8156-01A,TCGA-77-8156,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-90-A59Q,22420.0,female,1951,white,52,Primary Tumor,3.0,5.0,0.0,65.0,15.0,30.0,60.0,TCGA-90-A59Q-01A,TCGA-90-A59Q,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9ED,16528.0,male,1967,white,566,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9ED-01A,TCGA-V4-A9ED,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-A46L,26685.0,male,1935,white,1426,Primary Tumor,2.0,3.0,0.0,75.0,5.0,45.0,50.0,TCGA-58-A46L-01A,TCGA-58-A46L,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A2EJ,20649.0,female,1953,white,741,Primary Tumor,0.0,3.0,0.0,80.0,2.0,20.0,70.0,TCGA-G2-A2EJ-01A,TCGA-G2-A2EJ,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-EV-5902,21344.0,male,1952,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-EV-5902-01A,TCGA-EV-5902,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9T0,25190.0,male,1939,white,2323,Primary Tumor,0.0,0.0,15.0,80.0,0.0,15.0,70.0,TCGA-XF-A9T0-01A,TCGA-XF-A9T0,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N9-A4Q3,24031.0,female,1944,white,1347,Primary Tumor,5.0,10.0,10.0,80.0,70.0,5.0,80.0,TCGA-N9-A4Q3-01A,TCGA-N9-A4Q3,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49U,22969.0,male,1949,asian,513,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,95.0,TCGA-LN-A49U-01A,TCGA-LN-A49U,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20J,27646.0,male,1924,white,4466,Primary Tumor,0.0,0.0,0.0,75.0,0.0,20.0,80.0,TCGA-BT-A20J-01A,TCGA-BT-A20J,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4741,27506.0,male,1933,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,75.0,TCGA-CN-4741-01A,TCGA-CN-4741,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5875,24153.0,female,1938,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,92.0,TCGA-BQ-5875-01A,TCGA-BQ-5875,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EW,20902.0,male,1955,asian,584,Primary Tumor,1.0,1.0,0.0,60.0,40.0,60.0,25.0,TCGA-VR-A8EW-01A,TCGA-VR-A8EW,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-5630,26855.0,male,1936,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,80.0,TCGA-DQ-5630-01A,TCGA-DQ-5630,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A891,18925.0,male,1954,white,2983,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-L5-A891-01A,TCGA-L5-A891,
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5888,27346.0,female,1935,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,92.0,TCGA-BQ-5888-01A,TCGA-BQ-5888,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6221,29026.0,male,1929,white,None,Primary Tumor,None,None,0.0,85.0,3.0,5.0,94.0,TCGA-CQ-6221-01A,TCGA-CQ-6221,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7390,24575.0,male,1942,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,12.0,88.0,TCGA-CR-7390-01A,TCGA-CR-7390,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A854,22804.0,female,1951,black or african american,248,Primary Tumor,0.0,3.0,0.0,75.0,3.0,0.0,100.0,TCGA-MH-A854-01A,TCGA-MH-A854,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A7HW,21840.0,male,1954,asian,232,Primary Tumor,2.0,3.0,0.0,75.0,12.0,45.0,45.0,TCGA-LN-A7HW-01A,TCGA-LN-A7HW,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-YF-AA3L,17268.0,female,1966,not reported,88,Primary Tumor,3.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-YF-AA3L-01A,TCGA-YF-AA3L,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9K0,27434.0,male,1932,white,2441,Primary Tumor,0.0,3.0,0.0,70.0,1.0,0.0,100.0,TCGA-5P-A9K0-01A,TCGA-5P-A9K0,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GD-A3OS,19776.0,female,1957,white,205,Primary Tumor,0.0,0.0,0.0,85.0,0.0,17.0,80.0,TCGA-GD-A3OS-01A,TCGA-GD-A3OS,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-7832,19192.0,male,1959,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,70.0,TCGA-HD-7832-01A,TCGA-HD-7832,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A538,24698.0,male,1945,white,266,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,98.0,TCGA-98-A538-01A,TCGA-98-A538,2.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A88A,27722.0,male,1938,white,57,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-WC-A88A-01A,TCGA-WC-A88A,4.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAP6,20384.0,male,1958,white,48,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-BF-AAP6-01A,TCGA-BF-AAP6,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8ET,23517.0,male,1946,white,1369,Primary Tumor,1.0,0.0,0.0,60.0,40.0,40.0,50.0,TCGA-VR-A8ET-01A,TCGA-VR-A8ET,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-R6-A6KZ,15512.0,male,1968,white,1049,Primary Tumor,2.0,2.0,25.0,75.0,2.0,10.0,60.0,TCGA-R6-A6KZ-01A,TCGA-R6-A6KZ,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MM,25348.0,female,None,not reported,None,Primary Tumor,3.0,3.0,0.0,75.0,10.0,42.0,50.0,TCGA-63-A5MM-01A,TCGA-63-A5MM,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2769,27515.0,male,1932,not reported,None,Primary Tumor,None,None,0.0,70.0,None,20.0,72.0,TCGA-66-2769-01A,TCGA-66-2769,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-6737,26033.0,male,1937,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,70.0,TCGA-33-6737-01A,TCGA-33-6737,3.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EK,13731.0,female,1975,white,377,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9EK-01A,TCGA-V4-A9EK,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A4CL,24005.0,male,1947,white,172,Primary Tumor,3.0,3.0,0.0,65.0,15.0,30.0,50.0,TCGA-85-A4CL-01A,TCGA-85-A4CL,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-L3-A524,16765.0,female,1966,white,393,Primary Tumor,0.0,0.0,0.0,70.0,5.0,55.0,25.0,TCGA-L3-A524-01A,TCGA-L3-A524,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7699,26965.0,male,1938,white,None,Primary Tumor,None,None,2.0,75.0,10.0,11.0,80.0,TCGA-85-7699-01A,TCGA-85-7699,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8428,26252.0,male,1935,white,None,Primary Tumor,0.0,0.0,0.0,85.0,6.0,10.0,85.0,TCGA-KN-8428-01A,TCGA-KN-8428,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-52-7809,27233.0,male,1935,white,None,Primary Tumor,2.0,2.0,0.0,85.0,2.0,0.0,95.0,TCGA-52-7809-01A,TCGA-52-7809,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4596,25448.0,female,1933,white,None,Primary Tumor,None,None,5.0,70.0,None,15.0,65.0,TCGA-22-4596-01A,TCGA-22-4596,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2781,24471.0,male,1940,not reported,None,Primary Tumor,None,None,2.0,70.0,None,15.0,68.0,TCGA-66-2781-01A,TCGA-66-2781,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-92-8065,27049.0,female,1938,white,None,Primary Tumor,None,None,None,80.0,None,None,None,TCGA-92-8065-01A,TCGA-92-8065,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-XV-A9VZ,32872,female,1923,white,99,Primary Tumor,0.0,0.0,50.0,75.0,0.0,0.0,50.0,TCGA-XV-A9VZ-01A,TCGA-XV-A9VZ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A4ZJ,27516.0,female,1937,white,108,Primary Tumor,5.0,0.0,0.0,61.0,10.0,0.0,100.0,TCGA-56-A4ZJ-01A,TCGA-56-A4ZJ,1.0
UVM,Uveal Melanoma,Eye,TCGA-YZ-A984,18342.0,female,1961,white,971,Primary Tumor,0.0,0.0,20.0,75.0,3.0,0.0,80.0,TCGA-YZ-A984-01A,TCGA-YZ-A984,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MG,24957.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,60.0,TCGA-63-A5MG-01A,TCGA-63-A5MG,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3417,24019.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,70.0,2.0,40.0,50.0,TCGA-18-3417-01A,TCGA-18-3417,4.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9E9,18387.0,male,1962,white,675,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9E9-01A,TCGA-V4-A9E9,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-GN-A4U5,22499.0,female,1950,white,519,Primary Tumor,0.0,0.0,10.0,90.0,8.0,5.0,85.0,TCGA-GN-A4U5-01A,TCGA-GN-A4U5,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAP2,22734.0,male,1951,white,128,Primary Tumor,0.0,0.0,15.0,75.0,2.0,0.0,85.0,TCGA-BF-AAP2-01A,TCGA-BF-AAP2,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2707,25758.0,male,1933,not reported,None,Primary Tumor,None,None,0.0,70.0,None,15.0,75.0,TCGA-60-2707-01A,TCGA-60-2707,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8418,15086.0,female,1961,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8418-01A,TCGA-KN-8418,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-0940,26272.0,male,1929,white,None,Primary Tumor,None,None,None,90.0,None,None,None,TCGA-22-0940-01A,TCGA-22-0940,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5492,26838.0,female,1930,not reported,None,Primary Tumor,2.0,1.0,0.0,80.0,10.0,0.0,95.0,TCGA-22-5492-01A,TCGA-22-5492,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA83,19280.0,male,1957,white,1701,Primary Tumor,0.0,0.0,0.0,95.0,2.0,24.0,74.0,TCGA-4Z-AA83-01A,TCGA-4Z-AA83,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMT,27397.0,female,1931,white,2680,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-XF-AAMT-01A,TCGA-XF-AAMT,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5885,23173.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BQ-5885-01A,TCGA-BQ-5885,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A53C,28146.0,female,1935,white,289,Primary Tumor,0.0,6.0,20.0,80.0,10.0,30.0,50.0,TCGA-98-A53C-01A,TCGA-98-A53C,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-G8-6914,24569.0,male,1929,white,None,Primary Tumor,0.0,0.0,0.0,90.0,90.0,0.0,100.0,TCGA-G8-6914-01A,TCGA-G8-6914,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A44O,25537.0,male,1943,white,126,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-EB-A44O-01A,TCGA-EB-A44O,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-1622,21371.0,male,1949,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-56-1622-01A,TCGA-56-1622,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8342,16550.0,female,1961,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-KL-8342-01A,TCGA-KL-8342,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAOX,30318.0,male,1930,white,167,Primary Tumor,0.0,0.0,30.0,65.0,2.0,0.0,70.0,TCGA-BF-AAOX-01A,TCGA-BF-AAOX,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2792,21428.0,male,1950,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,70.0,TCGA-66-2792-01A,TCGA-66-2792,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-5782,24969.0,female,1936,white,None,Primary Tumor,0.0,5.0,0.0,80.0,5.0,0.0,77.0,TCGA-21-5782-01A,TCGA-21-5782,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-XV-AAZY,27938.0,female,1937,white,112,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-XV-AAZY-01A,TCGA-XV-AAZY,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A1PV,27124.0,female,1936,white,106,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-BF-A1PV-01A,TCGA-BF-A1PV,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2753,25506.0,male,1938,not reported,None,Primary Tumor,None,None,0.0,60.0,None,10.0,82.0,TCGA-66-2753-01A,TCGA-66-2753,1.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A87U,26933.0,male,1934,white,2199,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-WC-A87U-01A,TCGA-WC-A87U,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TW,8493.0,female,1987,white,1255,Primary Tumor,5.0,5.0,0.0,90.0,85.0,15.0,85.0,TCGA-GS-A9TW-01A,TCGA-GS-A9TW,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2754,24471.0,male,1940,not reported,None,Primary Tumor,None,None,0.0,90.0,None,5.0,80.0,TCGA-66-2754-01A,TCGA-66-2754,3.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F0,21675.0,male,1953,white,428,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-V4-A9F0-01A,TCGA-V4-A9F0,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5040,21790.0,male,1949,white,None,Primary Tumor,None,None,5.0,70.0,None,15.0,40.0,TCGA-39-5040-01A,TCGA-39-5040,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FM-8000,25724.0,female,1941,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-FM-8000-01A,TCGA-FM-8000,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-ER-A19K,28916.0,female,1927,white,1689,Primary Tumor,0.0,0.0,20.0,88.0,0.0,5.0,75.0,TCGA-ER-A19K-01A,TCGA-ER-A19K,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GR-A4D6,19838.0,female,1956,asian,880,Primary Tumor,0.0,2.0,13.0,85.0,13.0,5.0,80.0,TCGA-GR-A4D6-01A,TCGA-GR-A4D6,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-92-8064,21417.0,male,1953,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-92-8064-01A,TCGA-92-8064,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HE,22179.0,male,1948,white,1598,Primary Tumor,4.0,5.0,0.0,85.0,20.0,35.0,60.0,TCGA-NC-A5HE-01A,TCGA-NC-A5HE,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1072,27397.0,male,1926,white,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-21-1072-01A,TCGA-21-1072,1.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EQ,23408.0,male,1946,white,1262,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9EQ-01A,TCGA-V4-A9EQ,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MB,22930.0,male,None,not reported,None,Primary Tumor,0.0,0.0,5.0,90.0,0.0,0.0,85.0,TCGA-63-A5MB-01A,TCGA-63-A5MB,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5011,25788.0,female,1932,white,None,Primary Tumor,None,2.0,2.0,80.0,10.0,6.0,88.0,TCGA-39-5011-01A,TCGA-39-5011,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-6A-AB49,None,female,1936,black or african american,1691,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-6A-AB49-01A,TCGA-6A-AB49,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-7557,26802.0,male,1938,black or african american,None,Primary Tumor,None,None,8.0,65.0,None,15.0,77.0,TCGA-94-7557-01A,TCGA-94-7557,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HP,25286.0,male,1942,white,654,Primary Tumor,0.0,0.0,5.0,75.0,0.0,0.0,95.0,TCGA-NC-A5HP-01A,TCGA-NC-A5HP,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-1012,29273.0,female,1921,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-22-1012-01A,TCGA-22-1012,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-5783,27904.0,male,1928,white,None,Primary Tumor,None,None,0.0,60.0,2.0,15.0,65.0,TCGA-21-5783-01A,TCGA-21-5783,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A431,12484.0,male,1978,white,135,Primary Tumor,0.0,0.0,10.0,90.0,1.0,0.0,90.0,TCGA-EB-A431-01A,TCGA-EB-A431,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-46-3768,21307.0,male,1952,white,None,Primary Tumor,None,None,8.0,75.0,None,10.0,74.0,TCGA-46-3768-01A,TCGA-46-3768,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-6546,24594.0,male,1944,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-56-6546-01A,TCGA-56-6546,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-AASI,23965.0,female,1943,black or african american,2032,Primary Tumor,3.0,6.0,10.0,65.0,25.0,30.0,40.0,TCGA-33-AASI-01A,TCGA-33-AASI,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7335,22863.0,female,1934,white,None,Primary Tumor,2.0,10.0,24.0,40.0,20.0,21.0,50.0,TCGA-77-7335-01A,TCGA-77-7335,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5471,27749.0,male,1930,white,None,Primary Tumor,5.0,1.0,0.0,65.0,20.0,20.0,75.0,TCGA-22-5471-01A,TCGA-22-5471,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-51-6867,26523.0,female,1931,white,None,Primary Tumor,None,None,0.0,95.0,1.0,14.0,85.0,TCGA-51-6867-01A,TCGA-51-6867,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8415,16395.0,female,1963,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8415-01A,TCGA-KO-8415,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-A7CW,26520.0,male,1940,asian,544,Primary Tumor,5.0,10.0,5.0,90.0,80.0,5.0,90.0,TCGA-FF-A7CW-01A,TCGA-FF-A7CW,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-8393,25132.0,female,1942,white,None,Primary Tumor,None,2.0,1.0,75.0,18.0,7.0,90.0,TCGA-58-8393-01A,TCGA-58-8393,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-0944,22329.0,male,1939,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-22-0944-01A,TCGA-22-0944,1.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9E7,28025.0,male,1935,white,711,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9E7-01A,TCGA-V4-A9E7,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8352,24788.0,male,1944,white,None,Primary Tumor,0.0,7.0,0.0,80.0,10.0,0.0,95.0,TCGA-85-8352-01A,TCGA-85-8352,3.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EU,30409.0,female,1928,white,736,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,90.0,TCGA-V4-A9EU-01A,TCGA-V4-A9EU,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2724,17462.0,male,1961,white,None,Primary Tumor,None,None,2.0,85.0,None,10.0,83.0,TCGA-60-2724-01A,TCGA-60-2724,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5035,26383.0,female,1935,white,None,Primary Tumor,None,None,10.0,75.0,None,20.0,65.0,TCGA-39-5035-01A,TCGA-39-5035,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8049,20995.0,male,1954,white,None,Primary Tumor,None,1.0,20.0,60.0,25.0,13.0,65.0,TCGA-85-8049-01A,TCGA-85-8049,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5489,23618.0,male,1939,white,None,Primary Tumor,0.0,0.0,11.0,65.0,15.0,17.0,66.0,TCGA-22-5489-01A,TCGA-22-5489,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A4BX,25745.0,male,1942,white,89,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,98.0,TCGA-56-A4BX-01A,TCGA-56-A4BX,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8411,21371.0,male,1946,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8411-01A,TCGA-KO-8411,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-D3-A5GT,15935.0,male,1969,white,84,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-D3-A5GT-01A,TCGA-D3-A5GT,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8432,31591.0,female,1924,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8432-01A,TCGA-KN-8432,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A4JB,27315.0,male,1938,white,140,Primary Tumor,3.0,3.0,30.0,60.0,15.0,20.0,30.0,TCGA-85-A4JB-01A,TCGA-85-A4JB,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-O2-A52N,28520.0,male,1927,white,2730,Primary Tumor,0.0,2.0,0.0,75.0,4.0,36.0,52.0,TCGA-O2-A52N-01A,TCGA-O2-A52N,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2782,26237.0,male,1933,not reported,None,Primary Tumor,None,None,2.0,75.0,None,15.0,80.0,TCGA-66-2782-01A,TCGA-66-2782,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F3,17997.0,female,1963,white,366,Primary Tumor,0.0,2.0,0.0,65.0,30.0,0.0,97.0,TCGA-V4-A9F3-01A,TCGA-V4-A9F3,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-2581,17447.0,female,1962,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-43-2581-01A,TCGA-43-2581,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A5EQ,23353.0,male,1949,white,119,Primary Tumor,0.0,0.0,50.0,75.0,0.0,0.0,50.0,TCGA-BF-A5EQ-01A,TCGA-BF-A5EQ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-1000,27901.0,male,1924,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-22-1000-01A,TCGA-22-1000,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MP,20818.0,male,None,not reported,None,Primary Tumor,2.0,3.0,0.0,70.0,15.0,50.0,42.0,TCGA-63-A5MP-01A,TCGA-63-A5MP,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-5897,27118.0,male,1936,white,None,Primary Tumor,0.0,0.0,0.0,65.0,25.0,25.0,65.0,TCGA-56-5897-01A,TCGA-56-5897,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-37-A5EL,19371.0,male,1958,white,524,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,95.0,TCGA-37-A5EL-01A,TCGA-37-A5EL,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EF,20763.0,male,1956,white,535,Primary Tumor,None,None,None,None,None,None,None,TCGA-V4-A9EF-01A,TCGA-V4-A9EF,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2723,27225.0,female,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,75.0,TCGA-60-2723-01A,TCGA-60-2723,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BN,12122.0,female,1976,asian,918,Primary Tumor,0.0,1.0,6.0,80.0,2.0,14.0,80.0,TCGA-ET-A3BN-01A,TCGA-ET-A3BN,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2OW,13761.0,female,1974,not reported,142,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-EM-A2OW-01A,TCGA-EM-A2OW,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A3YF,30661.0,male,1926,white,1038,Primary Tumor,0.0,1.0,0.0,100.0,6.0,60.0,40.0,TCGA-J8-A3YF-01A,TCGA-J8-A3YF,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7IS,12402.0,female,1971,white,3506,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-S9-A7IS-01A,TCGA-S9-A7IS,
THCA,Thyroid Carcinoma,Thyroid,TCGA-H2-A26U,19927.0,female,1957,white,27,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-H2-A26U-01A,TCGA-H2-A26U,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-R8-A6MO,19432.0,female,1956,asian,1519,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-R8-A6MO-01A,TCGA-R8-A6MO,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A4B3,18969.0,male,1961,white,62,Primary Tumor,0.0,0.0,0.0,65.0,0.0,35.0,65.0,TCGA-FY-A4B3-01A,TCGA-FY-A4B3,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VI,19053.0,female,1959,white,342,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-DJ-A3VI-01A,TCGA-DJ-A3VI,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A2MZ,14408.0,male,1971,white,280,Primary Tumor,0.0,0.0,6.0,90.0,0.0,6.0,88.0,TCGA-ET-A2MZ-01A,TCGA-ET-A2MZ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A5TT,25726.0,male,1943,white,24,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-DU-A5TT-01A,TCGA-DU-A5TT,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8018,14910.0,female,1970,white,None,Primary Tumor,None,None,0.0,50.0,None,0.0,100.0,TCGA-HT-8018-01A,TCGA-HT-8018,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A76O,10960.0,male,1983,white,138,Primary Tumor,0.0,0.0,0.0,85.0,0.0,40.0,60.0,TCGA-DU-A76O-01A,TCGA-DU-A76O,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5EZ,14375.0,male,1973,white,65,Primary Tumor,0.0,0.0,10.0,85.0,0.0,40.0,50.0,TCGA-P5-A5EZ-01A,TCGA-P5-A5EZ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A5TR,18791.0,male,1961,white,259,Primary Tumor,0.0,0.0,10.0,90.0,5.0,5.0,85.0,TCGA-DU-A5TR-01A,TCGA-DU-A5TR,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5EW,7612.0,female,1992,white,77,Primary Tumor,0.0,0.0,10.0,75.0,0.0,45.0,45.0,TCGA-P5-A5EW-01A,TCGA-P5-A5EW,
LGG,Brain Lower Grade Glioma,Brain,TCGA-IK-8125,22745.0,male,1947,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-IK-8125-01A,TCGA-IK-8125,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H4,16944.0,female,1963,black or african american,849,Primary Tumor,0.0,0.0,0.0,85.0,3.0,15.0,85.0,TCGA-EL-A3H4-01A,TCGA-EL-A3H4,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A618,13595.0,female,1976,white,71,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-HT-A618-01A,TCGA-HT-A618,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A419,11306.0,female,1982,white,125,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-E8-A419-01A,TCGA-E8-A419,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7860,22034.0,female,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7860-01A,TCGA-HT-7860,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5849,17663.0,male,1962,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-5849-01A,TCGA-DU-5849,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0Z0,20361.0,male,1955,not reported,183,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-BJ-A0Z0-01A,TCGA-BJ-A0Z0,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E3-A3E3,18140.0,female,1961,white,643,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-E3-A3E3-01A,TCGA-E3-A3E3,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A6S8,27084.0,female,1939,white,76,Primary Tumor,0.0,0.0,10.0,90.0,0.0,30.0,60.0,TCGA-DU-A6S8-01A,TCGA-DU-A6S8,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3D0,22622.0,male,1940,white,3829,Primary Tumor,0.0,1.0,10.0,65.0,1.0,50.0,40.0,TCGA-EL-A3D0-01A,TCGA-EL-A3D0,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-A5KJ,24966.0,male,1944,white,286,Primary Tumor,0.0,0.0,5.0,90.0,0.0,10.0,85.0,TCGA-HW-A5KJ-01A,TCGA-HW-A5KJ,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A2N5,17137.0,female,1962,black or african american,1190,Primary Tumor,0.0,3.0,0.0,95.0,1.0,0.0,100.0,TCGA-ET-A2N5-01A,TCGA-ET-A2N5,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-4C-A93U,27348.0,female,1939,black or african american,75,Primary Tumor,0.0,0.0,0.0,65.0,5.0,20.0,80.0,TCGA-4C-A93U-01A,TCGA-4C-A93U,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5853,10624.0,male,1981,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DU-5853-01A,TCGA-DU-5853,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5F4,12851.0,female,1977,white,37,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-P5-A5F4-01A,TCGA-P5-A5F4,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7301,19644.0,male,1953,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7301-01A,TCGA-DU-7301,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25I,13786.0,female,1971,white,1064,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-ET-A25I-01A,TCGA-ET-A25I,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8109,23486.0,male,1947,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-8109-01A,TCGA-HT-8109,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4K0,20042.0,female,1956,white,757,Primary Tumor,0.0,1.0,0.0,65.0,2.0,40.0,60.0,TCGA-EL-A4K0-01A,TCGA-EL-A4K0,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7R8,16275.0,female,1960,white,3282,Primary Tumor,0.0,0.0,5.0,90.0,0.0,35.0,60.0,TCGA-S9-A7R8-01A,TCGA-S9-A7R8,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PW,23987.0,male,1946,white,145,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-DJ-A2PW-01A,TCGA-DJ-A2PW,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-IK-7675,15900.0,male,1966,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-IK-7675-01A,TCGA-IK-7675,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5874,22847.0,female,1948,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-5874-01A,TCGA-DU-5874,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CX,8344.0,female,1983,white,2292,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-EL-A3CX-01A,TCGA-EL-A3CX,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q9,23951.0,female,1946,white,181,Primary Tumor,0.0,1.0,10.0,70.0,4.0,30.0,60.0,TCGA-DJ-A2Q9-01A,TCGA-DJ-A2Q9,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YE,11971.0,female,1969,white,4541,Primary Tumor,0.0,0.0,5.0,85.0,0.0,55.0,40.0,TCGA-E1-A7YE-01A,TCGA-E1-A7YE,
THCA,Thyroid Carcinoma,Thyroid,TCGA-MK-A4N7,7570.0,female,1991,white,525,Primary Tumor,0.0,1.0,0.0,80.0,2.0,5.0,95.0,TCGA-MK-A4N7-01A,TCGA-MK-A4N7,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8019,12669.0,female,1975,white,None,Primary Tumor,None,None,0.0,60.0,None,15.0,85.0,TCGA-HT-8019-01A,TCGA-HT-8019,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3BL,10667.0,male,1982,white,92,Primary Tumor,0.0,0.0,0.0,96.0,0.0,8.0,92.0,TCGA-FY-A3BL-01A,TCGA-FY-A3BL,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64P,14936.0,male,1972,white,443,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-DB-A64P-01A,TCGA-DB-A64P,
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-6186,21321.0,male,1951,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-CS-6186-01A,TCGA-CS-6186,
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A3O1,12113.0,female,1977,white,575,Primary Tumor,0.0,2.0,0.0,100.0,1.0,10.0,90.0,TCGA-J8-A3O1-01A,TCGA-J8-A3O1,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7306,24800.0,male,1941,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7306-01A,TCGA-DU-7306,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YY,9867.0,female,1971,white,5621,Primary Tumor,0.0,5.0,20.0,75.0,5.0,55.0,25.0,TCGA-E1-A7YY-01A,TCGA-E1-A7YY,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7009,11854.0,female,1968,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DU-7009-01A,TCGA-DU-7009,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A65Z,19921.0,male,1959,white,19,Primary Tumor,0.0,0.0,5.0,85.0,0.0,20.0,75.0,TCGA-QH-A65Z-01A,TCGA-QH-A65Z,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7TD,19025.0,male,1960,white,616,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-DU-A7TD-01A,TCGA-DU-A7TD,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7T8,13108.0,male,1968,white,3705,Primary Tumor,0.0,0.0,10.0,60.0,0.0,40.0,50.0,TCGA-DU-A7T8-01A,TCGA-DU-A7T8,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2QC,25690.0,female,1940,not reported,237,Primary Tumor,0.0,0.0,0.0,100.0,0.0,10.0,90.0,TCGA-DJ-A2QC-01A,TCGA-DJ-A2QC,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E3-A3E2,12714.0,female,1973,white,1704,Primary Tumor,0.0,0.0,20.0,65.0,0.0,10.0,70.0,TCGA-E3-A3E2-01A,TCGA-E3-A3E2,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8168,20136.0,female,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-DU-8168-01A,TCGA-DU-8168,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-8188,15051.0,male,1971,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-FG-8188-01A,TCGA-FG-8188,
THCA,Thyroid Carcinoma,Thyroid,TCGA-L6-A4EQ,17351.0,male,1963,white,847,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-L6-A4EQ-01A,TCGA-L6-A4EQ,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PS,14916.0,female,1971,white,207,Primary Tumor,0.0,0.0,35.0,70.0,0.0,5.0,60.0,TCGA-DJ-A2PS-01A,TCGA-DJ-A2PS,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13P,19297.0,female,1947,white,4082,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-DJ-A13P-01A,TCGA-DJ-A13P,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YJ,20180.0,male,1953,white,1847,Primary Tumor,0.0,0.0,5.0,90.0,0.0,45.0,50.0,TCGA-E1-A7YJ-01A,TCGA-E1-A7YJ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7609,12607.0,male,1973,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7609-01A,TCGA-HT-7609,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A730,8043.0,male,1991,white,161,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-P5-A730-01A,TCGA-P5-A730,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A236,12348.0,male,1971,white,2465,Primary Tumor,0.0,0.0,0.0,85.0,0.0,25.0,75.0,TCGA-FE-A236-01A,TCGA-FE-A236,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZA,24528.0,female,1943,white,174,Primary Tumor,0.0,1.0,0.0,85.0,1.0,15.0,85.0,TCGA-BJ-A0ZA-01A,TCGA-BJ-A0ZA,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6TZ,14592.0,female,1972,white,571,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6TZ-01A,TCGA-S9-A6TZ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6U0,16890.0,male,1966,white,495,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-S9-A6U0-01A,TCGA-S9-A6U0,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5303,14212.0,male,1960,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-E1-5303-01A,TCGA-E1-5303,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7469,11097.0,male,1981,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7469-01A,TCGA-HT-7469,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A710,18415.0,female,1961,white,823,Primary Tumor,0.0,0.0,10.0,70.0,0.0,40.0,50.0,TCGA-FG-A710-01A,TCGA-FG-A710,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GU,26632.0,female,1930,white,3486,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-EL-A3GU-01A,TCGA-EL-A3GU,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7604,18443.0,male,1953,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-7604-01A,TCGA-HT-7604,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2800,25810.0,male,1934,not reported,None,Primary Tumor,0.0,1.0,15.0,60.0,30.0,8.0,47.0,TCGA-66-2800-01A,TCGA-66-2800,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-XV-A9W2,29836.0,male,1932,white,74,Primary Tumor,0.0,0.0,50.0,65.0,0.0,0.0,50.0,TCGA-XV-A9W2-01A,TCGA-XV-A9W2,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7696,23413.0,male,1947,white,None,Primary Tumor,None,None,10.0,70.0,5.0,22.0,60.0,TCGA-85-7696-01A,TCGA-85-7696,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2725,27073.0,male,1935,white,None,Primary Tumor,None,None,20.0,60.0,None,20.0,55.0,TCGA-60-2725-01A,TCGA-60-2725,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2756,24929.0,male,1939,not reported,None,Primary Tumor,None,None,0.0,85.0,None,15.0,77.0,TCGA-66-2756-01A,TCGA-66-2756,3.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-WD-A7RX,26006.0,female,1942,white,86,Primary Tumor,1.0,1.0,4.0,80.0,15.0,39.0,56.0,TCGA-WD-A7RX-01A,TCGA-WD-A7RX,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-CL-4957,29081.0,female,1929,not reported,None,Primary Tumor,None,None,20.0,70.0,None,15.0,63.0,TCGA-CL-4957-01A,TCGA-CL-4957,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54F,18028.0,female,1963,black or african american,321,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-B8-A54F-01A,TCGA-B8-A54F,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-1837,13368.0,male,1971,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,90.0,TCGA-27-1837-01A,TCGA-27-1837,
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-3X-AAVB,25819.0,female,1942,white,386,Primary Tumor,0.0,0.0,0.0,70.0,5.0,0.0,100.0,TCGA-3X-AAVB-01A,TCGA-3X-AAVB,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5574,13517.0,male,1971,white,None,Primary Tumor,None,None,5.0,75.0,None,30.0,65.0,TCGA-DV-5574-01A,TCGA-DV-5574,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5699,19647.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,8.0,92.0,TCGA-B0-5699-01A,TCGA-B0-5699,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5550,25937.0,male,1939,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-B8-5550-01A,TCGA-B8-5550,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A150,17580.0,female,1961,white,506,Primary Tumor,0.0,0.0,0.0,90.0,1.0,13.0,85.0,TCGA-E2-A150-01A,TCGA-E2-A150,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LE,25499.0,female,1932,white,3755,Primary Tumor,0.0,0.0,0.0,92.0,1.0,35.0,65.0,TCGA-AR-A2LE-01A,TCGA-AR-A2LE,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A490,28728.0,male,1934,white,77,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,85.0,TCGA-55-A490-01A,TCGA-55-A490,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24U,17523.0,female,1959,white,1763,Primary Tumor,0.0,0.0,0.0,85.0,3.0,75.0,25.0,TCGA-AR-A24U-01A,TCGA-AR-A24U,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A8P1,29631.0,male,1932,white,37,Primary Tumor,0.0,4.0,5.0,90.0,2.0,65.0,30.0,TCGA-HZ-A8P1-01A,TCGA-HZ-A8P1,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07O,18870.0,female,1958,not reported,180,Primary Tumor,0.0,0.0,0.0,90.0,2.0,10.0,81.0,TCGA-A8-A07O-01A,TCGA-A8-A07O,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HJ,19629.0,female,1957,asian,121,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,95.0,TCGA-C8-A1HJ-01A,TCGA-C8-A1HJ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0ST,22922.0,female,1941,white,2597,Primary Tumor,1.0,0.0,0.0,85.0,2.0,28.0,70.0,TCGA-A2-A0ST-01A,TCGA-A2-A0ST,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A2L8,16658.0,female,1966,white,86,Primary Tumor,0.0,0.0,0.0,75.0,0.0,25.0,75.0,TCGA-BH-A2L8-01A,TCGA-BH-A2L8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04W,18345.0,female,1955,white,1630,Primary Tumor,0.0,0.0,39.0,55.0,1.0,0.0,60.0,TCGA-A2-A04W-01A,TCGA-A2-A04W,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B6,17346.0,female,1959,white,1405,Primary Tumor,0.0,0.0,29.0,55.0,35.0,10.0,60.0,TCGA-BH-A0B6-01A,TCGA-BH-A0B6,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9I7,16766.0,male,1965,black or african american,1212,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-3A-A9I7-01A,TCGA-3A-A9I7,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8074,22862.0,female,1949,white,None,Primary Tumor,0.0,0.0,2.0,80.0,8.0,0.0,96.0,TCGA-86-8074-01A,TCGA-86-8074,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4M1,19272.0,female,1960,white,126,Primary Tumor,0.0,2.0,0.0,65.0,10.0,0.0,100.0,TCGA-97-A4M1-01A,TCGA-97-A4M1,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NH,26221.0,female,1940,white,30,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-E9-A1NH-01A,TCGA-E9-A1NH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14P,28923.0,female,1929,white,965,Primary Tumor,0.0,0.0,2.0,80.0,10.0,23.0,70.0,TCGA-E2-A14P-01A,TCGA-E2-A14P,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27T,19591.0,female,1958,white,68,Primary Tumor,0.0,0.0,0.0,60.0,0.0,60.0,40.0,TCGA-D8-A27T-01A,TCGA-D8-A27T,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1OW,21465.0,female,1951,black or african american,444,Primary Tumor,0.0,0.0,1.0,85.0,8.0,8.0,90.0,TCGA-EW-A1OW-01A,TCGA-EW-A1OW,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-7567,22437.0,male,1950,white,None,Primary Tumor,None,None,0.0,60.0,None,20.0,75.0,TCGA-95-7567-01A,TCGA-95-7567,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07W,27942.0,female,1933,not reported,180,Primary Tumor,0.0,1.0,2.0,80.0,5.0,35.0,58.0,TCGA-A8-A07W-01A,TCGA-A8-A07W,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6592,26191.0,female,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,30.0,TCGA-50-6592-01A,TCGA-50-6592,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A273,None,female,1981,asian,168,Primary Tumor,0.0,1.0,0.0,90.0,3.0,20.0,75.0,TCGA-C8-A273-01A,TCGA-C8-A273,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A4Z1,25097.0,female,1944,white,114,Primary Tumor,0.0,0.0,10.0,70.0,0.0,0.0,90.0,TCGA-D8-A4Z1-01A,TCGA-D8-A4Z1,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IH,29907.0,female,1914,white,5388,Primary Tumor,0.0,0.0,6.0,25.0,2.0,69.0,25.0,TCGA-B6-A0IH-01A,TCGA-B6-A0IH,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7652,18129.0,female,1962,asian,None,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,97.0,TCGA-IB-7652-01A,TCGA-IB-7652,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RC,20795.0,female,1951,white,1246,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-E9-A1RC-01A,TCGA-E9-A1RC,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T5,14503.0,female,1970,white,263,Primary Tumor,30.0,10.0,0.0,75.0,30.0,25.0,75.0,TCGA-A2-A0T5-01A,TCGA-A2-A0T5,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SP,14954.0,female,1967,not reported,958,Primary Tumor,0.0,0.0,1.0,75.0,2.0,24.0,75.0,TCGA-A1-A0SP-01A,TCGA-A1-A0SP,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-5781,20219.0,female,1952,white,None,Primary Tumor,0.0,5.0,0.0,75.0,15.0,10.0,90.0,TCGA-64-5781-01A,TCGA-64-5781,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06Z,30984.0,female,1923,not reported,1003,Primary Tumor,0.0,0.0,10.0,90.0,2.0,16.0,70.0,TCGA-A8-A06Z-01A,TCGA-A8-A06Z,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HW,22962.0,female,1944,asian,1591,Primary Tumor,0.0,0.0,0.0,90.0,1.0,7.0,90.0,TCGA-BH-A0HW-01A,TCGA-BH-A0HW,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A2FS,15302.0,female,1967,black or african american,1074,Primary Tumor,0.0,1.0,0.0,70.0,1.0,55.0,40.0,TCGA-EW-A2FS-01A,TCGA-EW-A2FS,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-A4P7,23330.0,female,1949,white,220,Primary Tumor,0.0,3.0,0.0,65.0,8.0,0.0,100.0,TCGA-86-A4P7-01A,TCGA-86-A4P7,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8637,27929.0,female,1936,white,None,Primary Tumor,0.0,0.0,20.0,55.0,27.0,8.0,70.0,TCGA-HZ-8637-01A,TCGA-HZ-8637,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IN,22199.0,female,1950,white,368,Primary Tumor,0.0,0.0,0.0,85.0,1.0,4.0,95.0,TCGA-E2-A1IN-01A,TCGA-E2-A1IN,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04X,12642.0,female,1972,white,1390,Primary Tumor,0.0,1.0,0.0,85.0,2.0,12.0,85.0,TCGA-A2-A04X-01A,TCGA-A2-A04X,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07I,25263.0,female,1940,not reported,302,Primary Tumor,0.0,0.0,5.0,80.0,11.0,18.0,75.0,TCGA-A8-A07I-01A,TCGA-A8-A07I,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A252,18611.0,female,1957,white,1405,Primary Tumor,0.0,0.0,3.0,80.0,3.0,22.0,75.0,TCGA-AR-A252-01A,TCGA-AR-A252,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A275,20774.0,female,1954,asian,169,Primary Tumor,0.0,0.0,0.0,75.0,5.0,27.0,55.0,TCGA-C8-A275-01A,TCGA-C8-A275,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AAR2,23479.0,male,1945,black or african american,1778,Primary Tumor,3.0,5.0,0.0,80.0,2.0,19.0,80.0,TCGA-49-AAR2-01A,TCGA-49-AAR2,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B1,24315.0,female,1941,white,1071,Primary Tumor,0.0,0.0,89.0,80.0,0.0,0.0,10.0,TCGA-BH-A0B1-01A,TCGA-BH-A0B1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A73Z,20118.0,female,1958,black or african american,40,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-LL-A73Z-01A,TCGA-LL-A73Z,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YM,24831.0,female,1941,white,691,Primary Tumor,0.0,0.0,0.0,85.0,0.0,70.0,30.0,TCGA-A2-A0YM-01A,TCGA-A2-A0YM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1X7,14858.0,female,1970,white,141,Primary Tumor,0.0,0.0,5.0,65.0,0.0,35.0,60.0,TCGA-D8-A1X7-01A,TCGA-D8-A1X7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A2FV,14316.0,female,1972,white,133,Primary Tumor,0.0,0.0,3.0,60.0,5.0,67.0,30.0,TCGA-EW-A2FV-01A,TCGA-EW-A2FV,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1AZ,23230.0,female,1941,white,2527,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E2-A1AZ-01A,TCGA-E2-A1AZ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4395,27971.0,male,1930,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-05-4395-01A,TCGA-05-4395,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1X8,22995.0,female,1948,white,225,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D8-A1X8-01A,TCGA-D8-A1X8,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A8F5,22544.0,female,1952,black or african american,78,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-LL-A8F5-01A,TCGA-LL-A8F5,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YC,21685.0,female,1949,white,673,Primary Tumor,0.0,0.0,0.0,75.0,0.0,10.0,90.0,TCGA-A2-A0YC-01A,TCGA-A2-A0YC,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A48X,23341.0,female,1949,white,111,Primary Tumor,0.0,0.0,0.0,70.0,0.0,20.0,80.0,TCGA-55-A48X-01A,TCGA-55-A48X,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HG,None,female,1960,asian,122,Primary Tumor,0.0,0.0,0.0,90.0,2.0,4.0,95.0,TCGA-C8-A1HG-01A,TCGA-C8-A1HG,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A46S,26825.0,male,1934,white,1936,Primary Tumor,0.0,2.0,0.0,75.0,3.0,0.0,100.0,TCGA-62-A46S-01A,TCGA-62-A46S,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A5ST,23672.0,female,1948,white,103,Primary Tumor,6.0,2.0,6.0,20.0,15.0,73.0,18.0,TCGA-IB-A5ST-01A,TCGA-IB-A5ST,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A2KD,19563.0,female,1958,black or african american,141,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-A7-A2KD-01A,TCGA-A7-A2KD,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A084,29858.0,female,1926,not reported,1033,Primary Tumor,0.0,1.0,0.0,70.0,1.0,6.0,93.0,TCGA-A8-A084-01A,TCGA-A8-A084,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A142,27313.0,female,1936,white,212,Primary Tumor,20.0,10.0,0.0,60.0,60.0,35.0,60.0,TCGA-D8-A142-01A,TCGA-D8-A142,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A2FW,19085.0,female,1959,white,99,Primary Tumor,0.0,0.0,0.0,95.0,1.0,13.0,85.0,TCGA-EW-A2FW-01A,TCGA-EW-A2FW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AQ-A04J,16615.0,female,1964,white,118,Primary Tumor,0.0,0.0,10.0,80.0,5.0,20.0,65.0,TCGA-AQ-A04J-01A,TCGA-AQ-A04J,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A26Z,None,female,1951,asian,125,Primary Tumor,0.0,0.0,0.0,80.0,1.0,54.0,45.0,TCGA-C8-A26Z-01A,TCGA-C8-A26Z,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4T8,25069.0,male,1938,not reported,2352,Primary Tumor,30.0,20.0,0.0,80.0,30.0,10.0,80.0,TCGA-MP-A4T8-01A,TCGA-MP-A4T8,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JP,26862.0,female,1937,white,292,Primary Tumor,1.0,1.0,1.0,75.0,3.0,24.0,75.0,TCGA-D8-A1JP-01A,TCGA-D8-A1JP,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8315,19839.0,female,1958,white,None,Primary Tumor,None,None,20.0,50.0,None,30.0,50.0,TCGA-HZ-8315-01A,TCGA-HZ-8315,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7888,24117.0,female,1942,black or african american,None,Primary Tumor,None,None,0.0,50.0,None,40.0,60.0,TCGA-IB-7888-01A,TCGA-IB-7888,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-8126,29213.0,female,1932,white,None,Primary Tumor,5.0,0.0,30.0,15.0,20.0,40.0,30.0,TCGA-IB-8126-01A,TCGA-IB-8126,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0GY,24493.0,female,1941,white,745,Primary Tumor,0.0,0.0,1.0,75.0,0.0,9.0,90.0,TCGA-BH-A0GY-01A,TCGA-BH-A0GY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A24A,25370.0,female,1942,white,41,Primary Tumor,0.0,0.0,0.0,88.0,0.0,20.0,80.0,TCGA-E9-A24A-01A,TCGA-E9-A24A,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TQ,9873.0,female,1979,white,1512,Primary Tumor,0.0,0.0,10.0,70.0,0.0,40.0,50.0,TCGA-AR-A0TQ-01A,TCGA-AR-A0TQ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IK,26052.0,female,1938,white,423,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-E2-A1IK-01A,TCGA-E2-A1IK,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A7XG,18127.0,male,1964,black or african american,72,Primary Tumor,1.0,1.0,0.0,90.0,6.0,25.0,73.0,TCGA-NJ-A7XG-01A,TCGA-NJ-A7XG,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JM,14653.0,female,1965,not reported,1828,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-AO-A0JM-01A,TCGA-AO-A0JM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J2,15324.0,female,1967,white,668,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-AO-A0J2-01A,TCGA-AO-A0J2,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AQ-A7U7,20239.0,female,1958,white,223,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-AQ-A7U7-01A,TCGA-AQ-A7U7,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A423,27627.0,female,1937,white,161,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-EW-A423-01A,TCGA-EW-A423,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A49G,21491.0,female,1954,white,66,Primary Tumor,0.0,0.0,25.0,65.0,2.0,0.0,75.0,TCGA-HZ-A49G-01A,TCGA-HZ-A49G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A090,27121.0,female,1934,not reported,667,Primary Tumor,0.0,0.0,3.0,70.0,1.0,27.0,70.0,TCGA-A8-A090-01A,TCGA-A8-A090,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-XN-A8T5,19707.0,female,1959,white,334,Primary Tumor,0.0,0.0,0.0,5.0,5.0,0.0,100.0,TCGA-XN-A8T5-01A,TCGA-XN-A8T5,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A26W,21391.0,female,1952,asian,142,Primary Tumor,0.0,0.0,0.0,80.0,1.0,34.0,65.0,TCGA-C8-A26W-01A,TCGA-C8-A26W,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3TN,27421.0,female,1937,white,78,Primary Tumor,0.0,1.0,8.0,70.0,2.0,61.0,30.0,TCGA-AC-A3TN-01A,TCGA-AC-A3TN,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8073,21214.0,male,1953,white,None,Primary Tumor,2.0,2.0,8.0,80.0,10.0,16.0,74.0,TCGA-86-8073-01A,TCGA-86-8073,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUP,24864.0,male,1945,white,146,Primary Tumor,8.0,2.0,5.0,15.0,10.0,80.0,15.0,TCGA-IB-AAUP-01A,TCGA-IB-AAUP,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-7039,19981.0,female,1957,white,None,Primary Tumor,None,None,10.0,75.0,None,10.0,75.0,TCGA-95-7039-01A,TCGA-95-7039,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YE,17727.0,female,1962,white,238,Primary Tumor,1.0,1.0,0.0,80.0,3.0,18.0,80.0,TCGA-A2-A0YE-01A,TCGA-A2-A0YE,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N9,21228.0,female,1953,white,44,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-E9-A1N9-01A,TCGA-E9-A1N9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TZ,15720.0,female,1961,white,2239,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-AR-A0TZ-01A,TCGA-AR-A0TZ,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A159,18621.0,female,1959,white,434,Primary Tumor,1.0,2.0,0.0,80.0,3.0,20.0,80.0,TCGA-E2-A159-01A,TCGA-E2-A159,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IN,22799.0,female,1946,white,2002,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,80.0,TCGA-3A-A9IN-01A,TCGA-3A-A9IN,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-5899,None,male,1952,white,None,Primary Tumor,0.0,0.0,0.0,80.0,10.0,20.0,70.0,TCGA-55-5899-01A,TCGA-55-5899,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A108,23530.0,female,1945,white,596,Primary Tumor,0.0,0.0,5.0,80.0,4.0,74.0,20.0,TCGA-E2-A108-01A,TCGA-E2-A108,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-53-A4EZ,23201.0,male,1949,white,163,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,65.0,TCGA-53-A4EZ-01A,TCGA-53-A4EZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A54Y,23057.0,female,1949,white,76,Primary Tumor,0.0,0.0,0.0,70.0,0.0,60.0,40.0,TCGA-E9-A54Y-01A,TCGA-E9-A54Y,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HX,19900.0,female,1954,white,672,Primary Tumor,0.0,0.0,0.0,70.0,4.0,30.0,70.0,TCGA-BH-A0HX-01A,TCGA-BH-A0HX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5DA,22411.0,female,1948,white,1407,Primary Tumor,0.0,0.0,5.0,85.0,0.0,10.0,85.0,TCGA-OL-A5DA-01A,TCGA-OL-A5DA,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IJ,15625.0,female,1953,black or african american,5350,Primary Tumor,0.0,0.0,0.0,95.0,0.0,3.0,95.0,TCGA-B6-A0IJ-01A,TCGA-B6-A0IJ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A4S1,24353.0,female,1946,white,282,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-A2-A4S1-01A,TCGA-A2-A4S1,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4402,20819.0,female,1950,not reported,None,Primary Tumor,None,None,0.0,70.0,None,15.0,None,TCGA-05-4402-01A,TCGA-05-4402,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12L,24710.0,female,1943,asian,62,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,85.0,TCGA-C8-A12L-01A,TCGA-C8-A12L,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-7573,26302.0,female,1939,white,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-55-7573-01A,TCGA-55-7573,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-A9RS,15162.0,male,1972,black or african american,162,Primary Tumor,0.0,0.0,10.0,80.0,10.0,10.0,80.0,TCGA-73-A9RS-01A,TCGA-73-A9RS,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HN,20712.0,female,1954,asian,88,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-C8-A1HN-01A,TCGA-C8-A1HN,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A4YQ,25427.0,female,1942,white,592,Primary Tumor,0.0,2.0,0.0,65.0,13.0,0.0,100.0,TCGA-NJ-A4YQ-01A,TCGA-NJ-A4YQ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JJ,19758.0,female,1952,white,1477,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,80.0,TCGA-AO-A0JJ-01A,TCGA-AO-A0JJ,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-Q3-AA2A,23685.0,female,1949,white,18,Primary Tumor,0.0,0.0,0.0,50.0,0.0,60.0,40.0,TCGA-Q3-AA2A-01A,TCGA-Q3-AA2A,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IJ,23791.0,male,1944,white,1520,Primary Tumor,20.0,20.0,0.0,90.0,40.0,10.0,90.0,TCGA-3A-A9IJ-01A,TCGA-3A-A9IJ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1ET,20425.0,female,1944,white,4137,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-BH-A1ET-01A,TCGA-BH-A1ET,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4494,28387.0,male,1918,white,None,Primary Tumor,None,None,20.0,70.0,None,5.0,70.0,TCGA-49-4494-01A,TCGA-49-4494,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A5C7,28015.0,female,1932,white,1555,Primary Tumor,5.0,15.0,5.0,80.0,60.0,5.0,80.0,TCGA-MP-A5C7-01A,TCGA-MP-A5C7,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14V,19643.0,female,1955,white,722,Primary Tumor,0.0,0.0,0.0,60.0,0.0,25.0,75.0,TCGA-E2-A14V-01A,TCGA-E2-A14V,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A4S3,21762.0,female,1953,black or african american,147,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-A2-A4S3-01A,TCGA-A2-A4S3,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JG,18021.0,female,1960,white,395,Primary Tumor,0.0,0.0,1.0,75.0,6.0,24.0,75.0,TCGA-AO-A0JG-01A,TCGA-AO-A0JG,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YK,22625.0,female,1948,white,280,Primary Tumor,0.0,0.0,15.0,75.0,0.0,10.0,75.0,TCGA-A2-A0YK-01A,TCGA-A2-A0YK,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-5775,26058.0,male,1934,white,None,Primary Tumor,None,None,10.0,80.0,None,10.0,80.0,TCGA-64-5775-01A,TCGA-64-5775,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A28O,18501.0,female,1960,white,163,Primary Tumor,0.0,0.0,15.0,70.0,0.0,45.0,40.0,TCGA-BH-A28O-01A,TCGA-BH-A28O,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0D2,16623.0,female,1963,white,614,Primary Tumor,0.0,0.0,3.0,80.0,1.0,16.0,80.0,TCGA-A2-A0D2-01A,TCGA-A2-A0D2,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A152,20705.0,female,1953,white,484,Primary Tumor,0.0,0.0,2.0,90.0,2.0,41.0,55.0,TCGA-E2-A152-01A,TCGA-E2-A152,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A03L,12443.0,female,1969,asian,2456,Primary Tumor,0.0,0.0,6.0,60.0,20.0,8.0,85.0,TCGA-AO-A03L-01A,TCGA-AO-A03L,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4M3,25384.0,female,1943,white,99,Primary Tumor,1.0,2.0,0.0,75.0,2.0,0.0,100.0,TCGA-97-A4M3-01A,TCGA-97-A4M3,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SF,19731.0,female,1952,white,1648,Primary Tumor,0.0,0.0,6.0,65.0,3.0,29.0,65.0,TCGA-A1-A0SF-01A,TCGA-A1-A0SF,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8616,21225.0,female,1954,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,100.0,TCGA-55-8616-01A,TCGA-55-8616,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A5SQ,20760.0,female,1956,white,204,Primary Tumor,0.0,1.0,10.0,70.0,3.0,53.0,35.0,TCGA-IB-A5SQ-01A,TCGA-IB-A5SQ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FH,17172.0,female,1951,white,4670,Primary Tumor,0.0,0.0,5.0,60.0,0.0,10.0,85.0,TCGA-BH-A1FH-01A,TCGA-BH-A1FH,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A6SC,21918.0,female,1952,black or african american,350,Primary Tumor,0.0,0.0,2.0,90.0,1.0,8.0,90.0,TCGA-EW-A6SC-01A,TCGA-EW-A6SC,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YJ,14448.0,female,1971,white,264,Primary Tumor,0.0,0.0,0.0,95.0,0.0,20.0,75.0,TCGA-A2-A0YJ-01A,TCGA-A2-A0YJ,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-M8-A5N4,17628.0,female,None,not reported,None,Primary Tumor,12.0,5.0,0.0,65.0,8.0,55.0,25.0,TCGA-M8-A5N4-01A,TCGA-M8-A5N4,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4405,27241.0,female,1932,not reported,None,Primary Tumor,None,None,10.0,65.0,None,20.0,70.0,TCGA-05-4405-01A,TCGA-05-4405,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6970,24773.0,female,1937,white,None,Primary Tumor,0.0,5.0,0.0,80.0,2.0,0.0,100.0,TCGA-55-6970-01A,TCGA-55-6970,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-5774,22059.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,87.0,TCGA-64-5774-01A,TCGA-64-5774,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-PE-A5DC,26514.0,female,1933,white,2858,Primary Tumor,0.0,0.0,0.0,85.0,0.0,25.0,75.0,TCGA-PE-A5DC-01A,TCGA-PE-A5DC,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-93-A4JP,23620.0,male,1948,asian,72,Primary Tumor,1.0,5.0,5.0,65.0,3.0,30.0,65.0,TCGA-93-A4JP-01A,TCGA-93-A4JP,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4630,27667.0,female,1925,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,80.0,TCGA-38-4630-01A,TCGA-38-4630,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8519,26947.0,male,1939,white,None,Primary Tumor,0.0,0.0,30.0,50.0,20.0,20.0,50.0,TCGA-HZ-8519-01A,TCGA-HZ-8519,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0H6,30125.0,female,1926,white,583,Primary Tumor,0.0,0.0,5.0,75.0,7.0,35.0,60.0,TCGA-BH-A0H6-01A,TCGA-BH-A0H6,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4SV,24516.0,male,1934,not reported,3964,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-MP-A4SV-01A,TCGA-MP-A4SV,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L4-A4E5,17680.0,female,1964,white,227,Primary Tumor,0.0,3.0,0.0,80.0,2.0,0.0,100.0,TCGA-L4-A4E5-01A,TCGA-L4-A4E5,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IL,14599.0,female,1968,white,2505,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-3A-A9IL-01A,TCGA-3A-A9IL,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-A47G,26800.0,female,1939,white,71,Primary Tumor,0.0,5.0,20.0,75.0,2.0,0.0,80.0,TCGA-44-A47G-01A,TCGA-44-A47G,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-AA14,17352.0,female,1966,black or african american,127,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-S3-AA14-01A,TCGA-S3-AA14,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1L9,14868.0,female,1969,white,465,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E2-A1L9-01A,TCGA-E2-A1L9,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-5125,None,male,None,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,90.0,TCGA-75-5125-01A,TCGA-75-5125,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A7VB,18806.0,female,1962,black or african american,131,Primary Tumor,1.0,1.0,4.0,90.0,2.0,4.0,90.0,TCGA-AC-A7VB-01A,TCGA-AC-A7VB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7167,28295.0,male,1925,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-78-7167-01A,TCGA-78-7167,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DT,15078.0,female,1966,white,1044,Primary Tumor,0.0,0.0,5.0,50.0,22.0,45.0,45.0,TCGA-BH-A0DT-01A,TCGA-BH-A0DT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FG,32295.0,female,1910,white,4460,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-BH-A1FG-01A,TCGA-BH-A1FG,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LG,18492.0,female,1960,black or african american,252,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-E2-A1LG-01A,TCGA-E2-A1LG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EQ,23543.0,female,1940,black or african american,2038,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-A2-A0EQ-01A,TCGA-A2-A0EQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A6R8,16829.0,female,1966,black or african american,260,Primary Tumor,1.0,1.0,10.0,85.0,5.0,5.0,85.0,TCGA-BH-A6R8-01A,TCGA-BH-A6R8,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A4YF,18584.0,female,1957,black or african american,1819,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-NJ-A4YF-01A,TCGA-NJ-A4YF,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A5QQ,24841.0,female,1943,white,576,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-AR-A5QQ-01A,TCGA-AR-A5QQ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A135,23667.0,female,1946,asian,162,Primary Tumor,20.0,15.0,0.0,80.0,50.0,20.0,80.0,TCGA-C8-A135-01A,TCGA-C8-A135,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9I9,24731.0,male,1944,white,1038,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-3A-A9I9-01A,TCGA-3A-A9I9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A570,17456.0,female,1964,black or african american,416,Primary Tumor,0.0,2.0,0.0,70.0,5.0,60.0,35.0,TCGA-E2-A570-01A,TCGA-E2-A570,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-J2-A4AD,22414.0,female,1951,white,178,Primary Tumor,0.0,3.0,10.0,70.0,5.0,20.0,70.0,TCGA-J2-A4AD-01A,TCGA-J2-A4AD,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EW,19413.0,female,1955,white,542,Primary Tumor,0.0,0.0,10.0,65.0,2.0,25.0,65.0,TCGA-A2-A0EW-01A,TCGA-A2-A0EW,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-3C-AALJ,22848.0,female,1949,black or african american,1026,Primary Tumor,0.0,0.0,0.0,65.0,4.0,0.0,100.0,TCGA-3C-AALJ-01A,TCGA-3C-AALJ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A25B,14454.0,female,1971,black or african american,183,Primary Tumor,0.0,0.0,0.0,80.0,2.0,25.0,75.0,TCGA-A2-A25B-01A,TCGA-A2-A25B,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R4,24181.0,female,1945,white,45,Primary Tumor,0.0,0.0,5.0,90.0,0.0,30.0,65.0,TCGA-E9-A1R4-01A,TCGA-E9-A1R4,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4666,19074.0,female,1957,white,None,Primary Tumor,None,None,5.0,90.0,None,5.0,85.0,TCGA-73-4666-01A,TCGA-73-4666,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A278,22598.0,female,1949,asian,163,Primary Tumor,30.0,10.0,0.0,60.0,40.0,35.0,60.0,TCGA-C8-A278-01A,TCGA-C8-A278,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A156,22422.0,female,1948,white,447,Primary Tumor,1.0,1.0,0.0,85.0,1.0,10.0,85.0,TCGA-E2-A156-01A,TCGA-E2-A156,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0A9,29370.0,female,1929,not reported,272,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-A8-A0A9-01A,TCGA-A8-A0A9,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6593,18152.0,female,1959,white,None,Primary Tumor,None,None,20.0,75.0,None,15.0,65.0,TCGA-50-6593-01A,TCGA-50-6593,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T4,22849.0,female,1947,white,303,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-A2-A0T4-01A,TCGA-A2-A0T4,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7143,22673.0,female,1930,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,93.0,TCGA-78-7143-01A,TCGA-78-7143,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0U2,17390.0,female,1957,white,2395,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-AR-A0U2-01A,TCGA-AR-A0U2,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A1KP,28247.0,female,1926,white,2604,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-AO-A1KP-01A,TCGA-AO-A1KP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DI,23327.0,female,1946,white,267,Primary Tumor,0.0,0.0,15.0,60.0,20.0,50.0,35.0,TCGA-BH-A0DI-01A,TCGA-BH-A0DI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3YJ,24439.0,female,1946,white,114,Primary Tumor,1.0,1.0,1.0,80.0,4.0,19.0,80.0,TCGA-AC-A3YJ-01A,TCGA-AC-A3YJ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-8453,28413.0,male,1935,white,None,Primary Tumor,0.0,20.0,2.0,70.0,10.0,9.0,89.0,TCGA-69-8453-01A,TCGA-69-8453,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5944,25440.0,female,1941,white,None,Primary Tumor,0.0,7.0,0.0,80.0,7.0,0.0,100.0,TCGA-50-5944-01A,TCGA-50-5944,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A202,22052.0,female,1951,white,62,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,50.0,TCGA-BH-A202-01A,TCGA-BH-A202,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12U,17045.0,female,1964,asian,57,Primary Tumor,1.0,1.0,0.0,85.0,1.0,15.0,85.0,TCGA-C8-A12U-01A,TCGA-C8-A12U,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A244,19778.0,female,1957,white,58,Primary Tumor,0.0,0.0,5.0,60.0,0.0,5.0,90.0,TCGA-E9-A244-01A,TCGA-E9-A244,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07R,29251.0,female,1929,not reported,149,Primary Tumor,0.0,0.0,0.0,80.0,1.0,19.0,80.0,TCGA-A8-A07R-01A,TCGA-A8-A07R,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4244,25752.0,male,1939,not reported,None,Primary Tumor,None,None,10.0,80.0,None,20.0,70.0,TCGA-05-4244-01A,TCGA-05-4244,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NF,21981.0,female,1951,white,31,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-E9-A1NF-01A,TCGA-E9-A1NF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JE,19516.0,female,1952,black or african american,1910,Primary Tumor,0.0,0.0,2.0,85.0,1.0,13.0,85.0,TCGA-AO-A0JE-01A,TCGA-AO-A0JE,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8620,22091.0,male,1952,white,None,Primary Tumor,2.0,0.0,0.0,80.0,15.0,0.0,95.0,TCGA-55-8620-01A,TCGA-55-8620,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18M,14532.0,female,1962,white,3629,Primary Tumor,0.0,0.0,5.0,85.0,1.0,29.0,65.0,TCGA-BH-A18M-01A,TCGA-BH-A18M,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-A7OP,26322.0,male,1940,asian,453,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-HV-A7OP-01A,TCGA-HV-A7OP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JJ,19966.0,female,1956,white,260,Primary Tumor,0.0,0.0,0.0,60.0,0.0,60.0,40.0,TCGA-D8-A1JJ-01A,TCGA-D8-A1JJ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A6IV,17521.0,female,1965,white,289,Primary Tumor,0.0,0.0,5.0,60.0,5.0,0.0,95.0,TCGA-AC-A6IV-01A,TCGA-AC-A6IV,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AARR,24942.0,male,1933,black or african american,4634,Primary Tumor,3.0,1.0,3.0,70.0,3.0,27.0,70.0,TCGA-49-AARR-01A,TCGA-49-AARR,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A4YG,23812.0,male,1943,white,1691,Primary Tumor,0.0,0.0,0.0,75.0,0.0,20.0,80.0,TCGA-NJ-A4YG-01A,TCGA-NJ-A4YG,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A5UO,15050.0,female,1971,white,98,Primary Tumor,20.0,20.0,0.0,95.0,40.0,5.0,95.0,TCGA-E9-A5UO-01A,TCGA-E9-A5UO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IJ,20956.0,female,1952,white,707,Primary Tumor,0.0,0.0,0.0,65.0,0.0,10.0,90.0,TCGA-E2-A1IJ-01A,TCGA-E2-A1IJ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1OY,23266.0,female,1946,white,526,Primary Tumor,0.0,0.0,0.0,80.0,9.0,36.0,64.0,TCGA-EW-A1OY-01A,TCGA-EW-A1OY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24X,19030.0,female,1954,white,1717,Primary Tumor,0.0,0.0,1.0,85.0,2.0,34.0,65.0,TCGA-AR-A24X-01A,TCGA-AR-A24X,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XZ,29916.0,female,1929,white,98,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-D8-A1XZ-01A,TCGA-D8-A1XZ,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MN-A4N1,21939.0,male,1951,black or african american,330,Primary Tumor,0.0,1.0,40.0,65.0,3.0,0.0,60.0,TCGA-MN-A4N1-01A,TCGA-MN-A4N1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09K,24960.0,female,1940,not reported,788,Primary Tumor,0.0,2.0,0.0,70.0,20.0,9.0,90.0,TCGA-A8-A09K-01A,TCGA-A8-A09K,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A1KN,21183.0,female,1941,white,4537,Primary Tumor,0.0,0.0,10.0,65.0,0.0,40.0,50.0,TCGA-B6-A1KN-01A,TCGA-B6-A1KN,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-A4VN,22927.0,female,1950,white,23,Primary Tumor,0.0,0.0,0.0,75.0,5.0,0.0,100.0,TCGA-95-A4VN-01A,TCGA-95-A4VN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XS,23358.0,female,1947,white,120,Primary Tumor,1.0,1.0,4.0,75.0,2.0,21.0,75.0,TCGA-AN-A0XS-01A,TCGA-AN-A0XS,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14U,27389.0,female,1934,white,796,Primary Tumor,0.0,0.0,20.0,60.0,0.0,40.0,40.0,TCGA-E2-A14U-01A,TCGA-E2-A14U,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0DA,22708.0,female,1947,white,177,Primary Tumor,0.0,0.0,20.0,75.0,2.0,47.0,30.0,TCGA-A7-A0DA-01A,TCGA-A7-A0DA,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-JL-A3YW,None,female,1962,asian,312,Primary Tumor,0.0,0.0,0.0,80.0,2.0,42.0,40.0,TCGA-JL-A3YW-01A,TCGA-JL-A3YW,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7633,24713.0,male,1942,white,None,Primary Tumor,None,None,3.0,80.0,None,10.0,87.0,TCGA-78-7633-01A,TCGA-78-7633,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NI,18985.0,female,1960,white,21,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-E9-A1NI-01A,TCGA-E9-A1NI,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8003,23868.0,female,1946,white,None,Primary Tumor,None,None,40.0,25.0,None,10.0,50.0,TCGA-HZ-8003-01A,TCGA-HZ-8003,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8507,19390.0,male,1959,white,None,Primary Tumor,None,None,8.0,80.0,None,10.0,82.0,TCGA-55-8507-01A,TCGA-55-8507,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6840,21854.0,female,1952,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-91-6840-01A,TCGA-91-6840,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A3Z6,20629.0,female,1955,white,160,Primary Tumor,0.0,1.0,0.0,75.0,2.0,0.0,100.0,TCGA-D8-A3Z6-01A,TCGA-D8-A3Z6,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-US-A779,20051.0,female,1957,white,937,Primary Tumor,0.0,4.0,40.0,30.0,8.0,40.0,20.0,TCGA-US-A779-01A,TCGA-US-A779,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-AA12,30101.0,female,1931,black or african american,156,Primary Tumor,0.0,0.0,5.0,80.0,5.0,10.0,80.0,TCGA-S3-AA12-01A,TCGA-S3-AA12,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-93-A4JN,26273.0,male,1941,white,209,Primary Tumor,2.0,2.0,0.0,80.0,4.0,20.0,80.0,TCGA-93-A4JN-01A,TCGA-93-A4JN,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1B4,27241.0,female,1934,white,798,Primary Tumor,0.0,0.0,0.0,65.0,0.0,5.0,95.0,TCGA-E2-A1B4-01A,TCGA-E2-A1B4,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0I6,18014.0,female,1941,black or african american,7362,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-B6-A0I6-01A,TCGA-B6-A0I6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0AZ,17465.0,female,1961,white,575,Primary Tumor,0.0,0.0,5.0,70.0,1.0,14.0,80.0,TCGA-BH-A0AZ-01A,TCGA-BH-A0AZ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0A7,20940.0,female,1952,not reported,302,Primary Tumor,0.0,0.0,0.0,85.0,2.0,13.0,85.0,TCGA-A8-A0A7-01A,TCGA-A8-A0A7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LN,23992.0,female,1945,white,513,Primary Tumor,0.0,0.0,1.0,75.0,1.0,59.0,40.0,TCGA-AR-A2LN-01A,TCGA-AR-A2LN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A22G,17300.0,female,1964,white,45,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-E9-A22G-01A,TCGA-E9-A22G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P0,20107.0,female,1953,white,1142,Primary Tumor,0.0,0.0,0.0,75.0,15.0,35.0,65.0,TCGA-EW-A1P0-01A,TCGA-EW-A1P0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1F2,19701.0,female,1946,white,4147,Primary Tumor,0.0,0.0,30.0,60.0,0.0,30.0,40.0,TCGA-BH-A1F2-01A,TCGA-BH-A1F2,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0G0,20504.0,female,1954,white,34,Primary Tumor,0.0,0.0,0.0,85.0,2.0,14.0,85.0,TCGA-AN-A0G0-01A,TCGA-AN-A0G0,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAPZ,19847.0,male,1954,white,1882,Primary Tumor,5.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-FB-AAPZ-01A,TCGA-FB-AAPZ,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AAB6,27600.0,male,1937,white,707,Primary Tumor,10.0,10.0,0.0,60.0,70.0,40.0,60.0,TCGA-2J-AAB6-01A,TCGA-2J-AAB6,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L9-A444,22202.0,female,1952,white,8,Primary Tumor,1.0,2.0,0.0,65.0,10.0,53.0,45.0,TCGA-L9-A444-01A,TCGA-L9-A444,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RG,22788.0,female,1949,white,53,Primary Tumor,0.0,0.0,0.0,85.0,2.0,31.0,65.0,TCGA-E9-A1RG-01A,TCGA-E9-A1RG,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A5UP,23371.0,female,1949,white,85,Primary Tumor,20.0,20.0,0.0,90.0,40.0,10.0,90.0,TCGA-E9-A5UP-01A,TCGA-E9-A5UP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A243,19035.0,female,1959,white,94,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E9-A243-01A,TCGA-E9-A243,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AAB4,17794.0,male,1964,white,713,Primary Tumor,20.0,20.0,30.0,40.0,40.0,30.0,40.0,TCGA-2J-AAB4-01A,TCGA-2J-AAB4,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JI,20694.0,female,1951,white,1011,Primary Tumor,0.0,0.0,0.0,85.0,0.0,70.0,30.0,TCGA-AO-A0JI-01A,TCGA-AO-A0JI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DD,21386.0,male,1948,white,1248,Primary Tumor,0.0,0.0,10.0,65.0,15.0,25.0,55.0,TCGA-BH-A0DD-01A,TCGA-BH-A0DD,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4676,16746.0,male,1965,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,50.0,TCGA-73-4676-01A,TCGA-73-4676,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-S2-AA1A,24903.0,female,1945,black or african american,95,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,100.0,TCGA-S2-AA1A-01A,TCGA-S2-AA1A,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-J2-A4AE,28163.0,female,1935,white,177,Primary Tumor,0.0,2.0,0.0,65.0,4.0,0.0,100.0,TCGA-J2-A4AE-01A,TCGA-J2-A4AE,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XX,17981.0,female,1960,black or african american,1143,Primary Tumor,0.0,0.0,50.0,88.0,0.0,0.0,50.0,TCGA-A2-A3XX-01A,TCGA-A2-A3XX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-PE-A5DD,23686.0,female,1942,asian,2411,Primary Tumor,0.0,0.0,0.0,80.0,0.0,35.0,65.0,TCGA-PE-A5DD-01A,TCGA-PE-A5DD,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAPU,15129.0,female,1967,asian,1852,Primary Tumor,20.0,20.0,0.0,60.0,40.0,35.0,60.0,TCGA-FB-AAPU-01A,TCGA-FB-AAPU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BQ,14494.0,female,1968,white,1197,Primary Tumor,0.0,0.0,31.0,40.0,30.0,35.0,30.0,TCGA-BH-A0BQ-01A,TCGA-BH-A0BQ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EN,28724.0,female,1921,white,4343,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-BH-A1EN-01A,TCGA-BH-A1EN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HP,23883.0,female,1944,white,346,Primary Tumor,0.0,0.0,3.0,75.0,4.0,21.0,75.0,TCGA-BH-A0HP-01A,TCGA-BH-A0HP,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-6178,25593.0,female,1940,white,None,Primary Tumor,None,None,0.0,65.0,None,20.0,80.0,TCGA-38-6178-01A,TCGA-38-6178,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4T6,27993.0,female,1929,white,2778,Primary Tumor,0.0,2.0,0.0,100.0,8.0,50.0,50.0,TCGA-MP-A4T6-01A,TCGA-MP-A4T6,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04Y,19533.0,female,1955,white,756,Primary Tumor,0.0,0.0,2.0,80.0,2.0,17.0,80.0,TCGA-A2-A04Y-01A,TCGA-A2-A04Y,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4631,26538.0,female,1925,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,82.0,TCGA-38-4631-01A,TCGA-38-4631,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0WY,14778.0,female,1956,white,5294,Primary Tumor,0.0,0.0,20.0,70.0,2.0,9.0,70.0,TCGA-B6-A0WY-01A,TCGA-B6-A0WY,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07F,23742.0,female,1944,not reported,453,Primary Tumor,0.0,0.0,0.0,85.0,7.0,23.0,75.0,TCGA-A8-A07F-01A,TCGA-A8-A07F,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-A456,28533.0,female,1934,asian,90,Primary Tumor,0.0,3.0,0.0,100.0,2.0,20.0,80.0,TCGA-86-A456-01A,TCGA-86-A456,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27E,24315.0,female,1944,white,204,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-D8-A27E-01A,TCGA-D8-A27E,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IR,23406.0,female,1946,white,1268,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-3A-A9IR-01A,TCGA-3A-A9IR,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12V,20346.0,female,1955,asian,57,Primary Tumor,1.0,1.0,0.0,75.0,1.0,24.0,75.0,TCGA-C8-A12V-01A,TCGA-C8-A12V,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A400,16022.0,female,1965,black or african american,1610,Primary Tumor,0.0,0.0,0.0,75.0,0.0,10.0,90.0,TCGA-B6-A400-01A,TCGA-B6-A400,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XR,20488.0,female,1954,white,162,Primary Tumor,0.0,0.0,0.0,70.0,0.0,50.0,50.0,TCGA-D8-A1XR-01A,TCGA-D8-A1XR,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24Z,20900.0,female,1949,white,1673,Primary Tumor,0.0,0.0,0.0,90.0,2.0,25.0,70.0,TCGA-AR-A24Z-01A,TCGA-AR-A24Z,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A5SS,23431.0,female,1947,white,491,Primary Tumor,3.0,1.0,0.0,60.0,12.0,55.0,30.0,TCGA-IB-A5SS-01A,TCGA-IB-A5SS,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RH,23224.0,female,1948,white,32,Primary Tumor,0.0,0.0,0.0,85.0,5.0,26.0,70.0,TCGA-E9-A1RH-01A,TCGA-E9-A1RH,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6591,23067.0,female,1944,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,75.0,TCGA-50-6591-01A,TCGA-50-6591,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4418,25417.0,male,1939,not reported,None,Primary Tumor,None,None,0.0,65.0,None,10.0,None,TCGA-05-4418-01A,TCGA-05-4418,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-V7-A7HQ,27684.0,female,1934,black or african american,1493,Primary Tumor,0.0,0.0,8.0,70.0,4.0,20.0,70.0,TCGA-V7-A7HQ-01A,TCGA-V7-A7HQ,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A492,25719.0,female,1942,white,31,Primary Tumor,0.0,5.0,0.0,70.0,5.0,30.0,70.0,TCGA-55-A492-01A,TCGA-55-A492,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RH,18759.0,female,1940,black or african american,6821,Primary Tumor,0.0,0.0,0.0,40.0,0.0,70.0,30.0,TCGA-B6-A0RH-01A,TCGA-B6-A0RH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XV,30830.0,female,1926,white,103,Primary Tumor,0.0,0.0,0.0,80.0,0.0,40.0,60.0,TCGA-D8-A1XV-01A,TCGA-D8-A1XV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LK,30757.0,female,1924,black or african american,1051,Primary Tumor,0.0,0.0,0.0,90.0,0.0,30.0,70.0,TCGA-E2-A1LK-01A,TCGA-E2-A1LK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A6SB,22844.0,female,1950,black or african american,244,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-EW-A6SB-01A,TCGA-EW-A6SB,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7645,16126.0,female,1963,not reported,None,Primary Tumor,10.0,0.0,0.0,40.0,15.0,20.0,80.0,TCGA-IB-7645-01A,TCGA-IB-7645,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0WV,24803.0,female,1928,white,5531,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-B6-A0WV-01A,TCGA-B6-A0WV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IO,13671.0,female,1972,white,416,Primary Tumor,0.0,0.0,0.0,70.0,15.0,4.0,95.0,TCGA-E2-A1IO-01A,TCGA-E2-A1IO,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAQ6,31319.0,male,1926,white,818,Primary Tumor,1.0,0.0,1.0,88.0,5.0,51.0,45.0,TCGA-FB-AAQ6-01A,TCGA-FB-AAQ6,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6982,None,female,1925,white,None,Primary Tumor,None,None,0.0,60.0,None,10.0,90.0,TCGA-55-6982-01A,TCGA-55-6982,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4SY,22448.0,male,1941,white,3620,Primary Tumor,0.0,0.0,0.0,65.0,0.0,5.0,95.0,TCGA-MP-A4SY-01A,TCGA-MP-A4SY,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6985,21381.0,female,1946,white,None,Primary Tumor,None,None,0.0,60.0,None,30.0,70.0,TCGA-55-6985-01A,TCGA-55-6985,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6767,17108.0,female,1964,white,None,Primary Tumor,0.0,0.0,0.0,80.0,15.0,0.0,100.0,TCGA-49-6767-01A,TCGA-49-6767,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A4BH,27637.0,male,1936,white,250,Primary Tumor,0.0,0.0,0.0,50.0,3.0,65.0,30.0,TCGA-HZ-A4BH-01A,TCGA-HZ-A4BH,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5055,28988.0,female,1929,white,None,Primary Tumor,None,None,40.0,35.0,None,15.0,45.0,TCGA-50-5055-01A,TCGA-50-5055,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A7SZ,18161.0,female,1964,black or african american,63,Primary Tumor,0.0,0.0,50.0,70.0,0.0,0.0,50.0,TCGA-LL-A7SZ-01A,TCGA-LL-A7SZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A3IY,26042.0,female,1940,white,143,Primary Tumor,0.0,0.0,10.0,65.0,0.0,25.0,65.0,TCGA-A7-A3IY-01A,TCGA-A7-A3IY,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A4E0,24788.0,female,1940,white,1871,Primary Tumor,0.0,0.0,0.0,80.0,0.0,40.0,60.0,TCGA-GM-A4E0-01A,TCGA-GM-A4E0,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A23G,27934.0,female,1930,white,1590,Primary Tumor,0.0,0.0,10.0,65.0,1.0,40.0,50.0,TCGA-AC-A23G-01A,TCGA-AC-A23G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XQ,25345.0,female,1941,white,158,Primary Tumor,0.0,0.0,0.0,90.0,3.0,23.0,70.0,TCGA-D8-A1XQ-01A,TCGA-D8-A1XQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RQ,25010.0,female,1926,white,5890,Primary Tumor,0.0,0.0,10.0,60.0,2.0,45.0,45.0,TCGA-B6-A0RQ-01A,TCGA-B6-A0RQ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8619,26616.0,female,1940,white,None,Primary Tumor,None,None,8.0,60.0,None,15.0,72.0,TCGA-55-8619-01A,TCGA-55-8619,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JD,21831.0,female,1946,white,1863,Primary Tumor,0.0,0.0,4.0,75.0,1.0,21.0,75.0,TCGA-AO-A0JD-01A,TCGA-AO-A0JD,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4427,23893.0,female,1943,not reported,None,Primary Tumor,None,None,2.0,70.0,None,10.0,86.0,TCGA-05-4427-01A,TCGA-05-4427,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08H,24137.0,female,1941,not reported,1184,Primary Tumor,0.0,0.0,0.0,80.0,3.0,19.0,80.0,TCGA-A8-A08H-01A,TCGA-A8-A08H,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A155,21348.0,female,1951,white,457,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-E2-A155-01A,TCGA-E2-A155,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1J3,22332.0,female,1949,white,155,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-EW-A1J3-01A,TCGA-EW-A1J3,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8171,29627.0,male,1930,asian,None,Primary Tumor,None,2.0,0.0,85.0,None,0.0,98.0,TCGA-97-8171-01A,TCGA-97-8171,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8510,20410.0,female,1957,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-55-8510-01A,TCGA-55-8510,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BZ,21856.0,female,1948,white,1084,Primary Tumor,0.0,0.0,0.0,55.0,23.0,49.0,50.0,TCGA-BH-A0BZ-01A,TCGA-BH-A0BZ,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6742,25839.0,male,1940,white,None,Primary Tumor,None,None,50.0,50.0,None,15.0,35.0,TCGA-49-6742-01A,TCGA-49-6742,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SD,21793.0,female,1946,white,1697,Primary Tumor,0.0,0.0,15.0,25.0,2.0,60.0,25.0,TCGA-A1-A0SD-01A,TCGA-A1-A0SD,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09T,25110.0,female,1941,not reported,394,Primary Tumor,0.0,0.0,1.0,90.0,0.0,9.0,89.0,TCGA-A8-A09T-01A,TCGA-A8-A09T,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AI,17229.0,female,1958,white,1939,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-AR-A1AI-01A,TCGA-AR-A1AI,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-AA8X,27662.0,female,1938,asian,57,Primary Tumor,0.0,0.0,3.0,80.0,10.0,72.0,22.0,TCGA-HV-AA8X-01A,TCGA-HV-AA8X,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A55O,20628.0,female,1955,white,428,Primary Tumor,0.0,2.0,0.0,100.0,0.0,15.0,85.0,TCGA-NJ-A55O-01A,TCGA-NJ-A55O,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1ND,27400.0,female,1936,white,37,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-E9-A1ND-01A,TCGA-E9-A1ND,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1PG,19464.0,female,1955,white,829,Primary Tumor,1.0,1.0,5.0,70.0,3.0,25.0,70.0,TCGA-EW-A1PG-01A,TCGA-EW-A1PG,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6986,None,female,1930,white,None,Primary Tumor,None,None,5.0,80.0,None,0.0,95.0,TCGA-55-6986-01A,TCGA-55-6986,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AO,17332.0,female,1959,white,1471,Primary Tumor,0.0,0.0,8.0,80.0,0.0,10.0,80.0,TCGA-AR-A1AO-01A,TCGA-AR-A1AO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FJ,24262.0,female,1932,white,4574,Primary Tumor,0.0,0.0,0.0,80.0,0.0,60.0,40.0,TCGA-BH-A1FJ-01A,TCGA-BH-A1FJ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A6VQ,18151.0,female,1963,white,278,Primary Tumor,0.0,0.0,10.0,80.0,2.0,10.0,80.0,TCGA-OL-A6VQ-01A,TCGA-OL-A6VQ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4410,22888.0,male,1945,not reported,None,Primary Tumor,None,10.0,10.0,60.0,20.0,25.0,65.0,TCGA-05-4410-01A,TCGA-05-4410,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4396,28094.0,male,1930,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,None,TCGA-05-4396-01A,TCGA-05-4396,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66N,21608.0,female,1952,white,505,Primary Tumor,0.0,0.0,0.0,70.0,0.0,60.0,40.0,TCGA-OL-A66N-01A,TCGA-OL-A66N,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7154,26481.0,male,1931,white,None,Primary Tumor,None,None,12.0,75.0,None,10.0,75.0,TCGA-78-7154-01A,TCGA-78-7154,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4M2,24313.0,male,1946,white,93,Primary Tumor,1.0,2.0,0.0,65.0,10.0,0.0,95.0,TCGA-97-A4M2-01A,TCGA-97-A4M2,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XG,31748.0,female,1924,white,169,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-D8-A1XG-01A,TCGA-D8-A1XG,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A12F,13409.0,female,1970,white,1578,Primary Tumor,0.0,1.0,0.0,85.0,2.0,13.0,85.0,TCGA-AO-A12F-01A,TCGA-AO-A12F,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A46Y,25905.0,female,1938,white,1608,Primary Tumor,0.0,4.0,0.0,75.0,2.0,0.0,100.0,TCGA-62-A46Y-01A,TCGA-62-A46Y,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8621,27485.0,female,1937,white,None,Primary Tumor,2.0,2.0,0.0,61.0,30.0,0.0,100.0,TCGA-55-8621-01A,TCGA-55-8621,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6745,30133.0,male,1929,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-49-6745-01A,TCGA-49-6745,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AQ-A0Y5,25793.0,female,1940,white,212,Primary Tumor,0.0,1.0,2.0,70.0,2.0,70.0,27.0,TCGA-AQ-A0Y5-01A,TCGA-AQ-A0Y5,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-1678,25931.0,female,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,45.0,35.0,TCGA-64-1678-01A,TCGA-64-1678,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A138,20053.0,female,1956,asian,93,Primary Tumor,1.0,4.0,0.0,70.0,2.0,30.0,70.0,TCGA-C8-A138-01A,TCGA-C8-A138,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0I2,16702.0,female,1950,white,5305,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-B6-A0I2-01A,TCGA-B6-A0I2,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A2JT,23318.0,female,1948,white,94,Primary Tumor,0.0,0.0,0.0,60.0,0.0,60.0,40.0,TCGA-E9-A2JT-01A,TCGA-E9-A2JT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A251,18771.0,female,1955,white,1611,Primary Tumor,0.0,0.0,0.0,85.0,2.0,39.0,60.0,TCGA-AR-A251-01A,TCGA-AR-A251,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-A7OL,25768.0,male,1942,asian,303,Primary Tumor,3.0,3.0,0.0,50.0,35.0,71.0,27.0,TCGA-HV-A7OL-01A,TCGA-HV-A7OL,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-7955,22772.0,male,1949,white,None,Primary Tumor,None,None,0.0,85.0,10.0,0.0,95.0,TCGA-86-7955-01A,TCGA-86-7955,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AQ-A1H2,30958.0,female,1926,white,156,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-AQ-A1H2-01A,TCGA-AQ-A1H2,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08T,23560.0,female,1938,not reported,2767,Primary Tumor,0.0,0.0,0.0,60.0,1.0,69.0,30.0,TCGA-A8-A08T-01A,TCGA-A8-A08T,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1PB,25770.0,female,1939,black or african american,569,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-EW-A1PB-01A,TCGA-EW-A1PB,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A5ZV,22966.0,female,1950,black or african american,154,Primary Tumor,40.0,20.0,0.0,70.0,20.0,10.0,70.0,TCGA-A7-A5ZV-01A,TCGA-A7-A5ZV,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-LB-A9Q5,23218.0,female,1950,white,11,Primary Tumor,10.0,10.0,0.0,70.0,70.0,30.0,70.0,TCGA-LB-A9Q5-01A,TCGA-LB-A9Q5,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A5SO,26129.0,male,1941,white,252,Primary Tumor,2.0,3.0,8.0,50.0,4.0,65.0,25.0,TCGA-IB-A5SO-01A,TCGA-IB-A5SO,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-7953,25315.0,female,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,80.0,TCGA-86-7953-01A,TCGA-86-7953,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-8499,27853.0,female,1935,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,30.0,TCGA-91-8499-01A,TCGA-91-8499,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6595,27197.0,female,1935,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-50-6595-01A,TCGA-50-6595,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A402,17314.0,female,1961,black or african american,1563,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-B6-A402-01A,TCGA-B6-A402,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0D3,15524.0,female,1966,white,545,Primary Tumor,0.0,0.0,0.0,65.0,6.0,34.0,65.0,TCGA-A2-A0D3-01A,TCGA-A2-A0D3,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HL,20804.0,female,1953,white,352,Primary Tumor,0.0,0.0,0.0,98.0,0.0,10.0,90.0,TCGA-BH-A0HL-01A,TCGA-BH-A0HL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66H,None,female,None,black or african american,441,Primary Tumor,0.0,0.0,30.0,70.0,2.0,0.0,70.0,TCGA-OL-A66H-01A,TCGA-OL-A66H,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0W4,16911.0,female,1964,white,119,Primary Tumor,1.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-BH-A0W4-01A,TCGA-BH-A0W4,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6673,30689.0,female,1920,white,None,Primary Tumor,None,None,10.0,75.0,None,20.0,65.0,TCGA-50-6673-01A,TCGA-50-6673,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2L-AAQA,28074.0,male,1934,white,1378,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-2L-AAQA-01A,TCGA-2L-AAQA,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9I5,21175.0,male,1952,white,1492,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-3A-A9I5-01A,TCGA-3A-A9I5,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LM,18053.0,female,1958,white,1339,Primary Tumor,0.0,2.0,8.0,75.0,1.0,32.0,60.0,TCGA-AR-A2LM-01A,TCGA-AR-A2LM,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4510,18762.0,female,1950,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,5.0,95.0,TCGA-49-4510-01A,TCGA-49-4510,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A4DG,26044.0,male,1941,white,229,Primary Tumor,0.0,0.0,0.0,65.0,0.0,30.0,70.0,TCGA-55-A4DG-01A,TCGA-55-A4DG,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0U4,19729.0,female,1952,white,1517,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,85.0,TCGA-AR-A0U4-01A,TCGA-AR-A0U4,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8280,19977.0,female,1957,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-86-8280-01A,TCGA-86-8280,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4512,25502.0,female,1938,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,80.0,TCGA-49-4512-01A,TCGA-49-4512,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8552,20331.0,female,1957,white,None,Primary Tumor,0.0,2.0,0.0,80.0,10.0,0.0,100.0,TCGA-97-8552-01A,TCGA-97-8552,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8076,15605.0,male,1969,white,None,Primary Tumor,None,None,0.0,60.0,None,25.0,70.0,TCGA-86-8076-01A,TCGA-86-8076,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JT,25677.0,female,1940,white,250,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,70.0,TCGA-D8-A1JT-01A,TCGA-D8-A1JT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SJ,14383.0,female,1967,black or african american,1399,Primary Tumor,0.0,0.0,5.0,50.0,2.0,45.0,50.0,TCGA-A1-A0SJ-01A,TCGA-A1-A0SJ,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3NN,17613.0,female,1963,not reported,56,Primary Tumor,0.0,0.0,10.0,80.0,0.0,10.0,80.0,TCGA-FY-A3NN-01A,TCGA-FY-A3NN,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7302,17656.0,female,1958,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-DU-7302-01A,TCGA-DU-7302,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GV,23787.0,female,1943,white,1095,Primary Tumor,0.0,2.0,0.0,100.0,0.0,10.0,90.0,TCGA-EL-A3GV-01A,TCGA-EL-A3GV,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5319,17612.0,female,1950,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,None,TCGA-E1-5319-01A,TCGA-E1-5319,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5322,13903.0,female,1961,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-E1-5322-01A,TCGA-E1-5322,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YU,15345.0,male,1954,white,6383,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-E1-A7YU-01A,TCGA-E1-A7YU,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7298,14205.0,female,1968,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DU-7298-01A,TCGA-DU-7298,
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-5394,14920.0,male,1965,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-CS-5394-01A,TCGA-CS-5394,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YN,23180.0,female,1947,white,1148,Primary Tumor,0.0,0.0,10.0,75.0,5.0,45.0,45.0,TCGA-E1-A7YN-01A,TCGA-E1-A7YN,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84C,11849.0,male,1980,white,459,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-TM-A84C-01A,TCGA-TM-A84C,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A75M,17289.0,male,1966,white,189,Primary Tumor,0.0,0.0,5.0,80.0,0.0,45.0,50.0,TCGA-DB-A75M-01A,TCGA-DB-A75M,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A2N4,19671.0,female,1955,white,1218,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-ET-A2N4-01A,TCGA-ET-A2N4,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4K2,15962.0,female,1967,white,708,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-EL-A4K2-01A,TCGA-EL-A4K2,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-8187,11684.0,male,1980,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-FG-8187-01A,TCGA-FG-8187,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WL,19234.0,male,1960,white,545,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-S9-A6WL-01A,TCGA-S9-A6WL,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A2MX,10044.0,male,1980,white,1359,Primary Tumor,0.0,1.0,0.0,90.0,0.0,20.0,80.0,TCGA-ET-A2MX-01A,TCGA-ET-A2MX,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A7U5,13411.0,female,1977,black or african american,105,Primary Tumor,0.0,3.0,0.0,95.0,3.0,70.0,30.0,TCGA-DE-A7U5-01A,TCGA-DE-A7U5,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A3ME,18714.0,female,1960,asian,158,Primary Tumor,0.0,0.0,0.0,100.0,0.0,40.0,60.0,TCGA-CE-A3ME-01A,TCGA-CE-A3ME,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YI,12229.0,female,1975,white,2022,Primary Tumor,0.0,0.0,5.0,90.0,0.0,25.0,70.0,TCGA-E1-A7YI-01A,TCGA-E1-A7YI,
THCA,Thyroid Carcinoma,Thyroid,TCGA-QD-A8IV,18288.0,female,1963,black or african american,42,Primary Tumor,0.0,1.0,0.0,100.0,0.0,5.0,95.0,TCGA-QD-A8IV-01A,TCGA-QD-A8IV,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-RY-A840,17501.0,male,1965,not reported,444,Primary Tumor,0.0,0.0,10.0,90.0,0.0,35.0,55.0,TCGA-RY-A840-01A,TCGA-RY-A840,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZK,15121.0,female,1966,white,1646,Primary Tumor,0.0,0.0,0.0,100.0,2.0,20.0,80.0,TCGA-EL-A3ZK-01A,TCGA-EL-A3ZK,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39T,20164.0,female,1951,white,1721,Primary Tumor,0.0,2.0,0.0,100.0,1.0,5.0,95.0,TCGA-ET-A39T-01A,TCGA-ET-A39T,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A619,18857.0,female,1961,asian,84,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-HT-A619-01A,TCGA-HT-A619,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QH,21184.0,female,1952,white,146,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-DJ-A1QH-01A,TCGA-DJ-A1QH,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7IY,14422.0,male,1973,white,398,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-S9-A7IY-01A,TCGA-S9-A7IY,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A76K,31776.0,male,1912,white,5192,Primary Tumor,0.0,0.0,5.0,75.0,0.0,85.0,10.0,TCGA-DU-A76K-01A,TCGA-DU-A76K,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-8320,13503.0,male,1975,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HW-8320-01A,TCGA-HW-8320,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WQ,21133.0,female,1956,white,104,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6WQ-01A,TCGA-S9-A6WQ,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A4MC,15996.0,female,1968,american indian or alaska native,444,Primary Tumor,0.0,2.0,0.0,100.0,3.0,5.0,95.0,TCGA-DE-A4MC-01A,TCGA-DE-A4MC,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RQ,14187.0,female,1974,white,504,Primary Tumor,0.0,0.0,5.0,90.0,0.0,25.0,70.0,TCGA-TQ-A7RQ-01A,TCGA-TQ-A7RQ,
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4I7,22398.0,female,1950,white,399,Primary Tumor,0.0,1.0,0.0,85.0,1.0,15.0,85.0,TCGA-KS-A4I7-01A,TCGA-KS-A4I7,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7874,15045.0,female,1967,white,None,Primary Tumor,None,None,10.0,60.0,None,0.0,90.0,TCGA-HT-7874-01A,TCGA-HT-7874,
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-4941,24578.0,male,1938,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-CS-4941-01A,TCGA-CS-4941,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6395,11584.0,male,1963,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-6395-01A,TCGA-DU-6395,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22J,20539.0,female,1955,not reported,70,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-EM-A22J-01A,TCGA-EM-A22J,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7606,11233.0,female,1978,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7606-01A,TCGA-HT-7606,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A86X,12385.0,male,1980,white,7,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-QH-A86X-01A,TCGA-QH-A86X,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UR,18808.0,female,1959,white,623,Primary Tumor,0.0,0.0,2.0,98.0,1.0,0.0,98.0,TCGA-DJ-A3UR-01A,TCGA-DJ-A3UR,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A7C4,14603.0,female,1971,white,1215,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-TM-A7C4-01A,TCGA-TM-A7C4,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7482,6857.0,female,1987,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-7482-01A,TCGA-HT-7482,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7601,10989.0,female,1978,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7601-01A,TCGA-HT-7601,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WH,26904.0,female,1938,white,697,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-S9-A6WH-01A,TCGA-S9-A6WH,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7857,8912.0,female,1982,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7857-01A,TCGA-HT-7857,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UQ,16545.0,female,1966,asian,210,Primary Tumor,0.0,1.0,2.0,85.0,2.0,13.0,85.0,TCGA-DJ-A3UQ-01A,TCGA-DJ-A3UQ,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A69J,12493.0,female,1978,black or african american,126,Primary Tumor,0.0,0.0,0.0,70.0,0.0,15.0,85.0,TCGA-DE-A69J-01A,TCGA-DE-A69J,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-6670,16066.0,male,1968,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-CS-6670-01A,TCGA-CS-6670,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A76L,19823.0,male,1946,white,4769,Primary Tumor,0.0,0.0,0.0,90.0,0.0,25.0,75.0,TCGA-DU-A76L-01A,TCGA-DU-A76L,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13U,22130.0,male,1950,white,276,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-DJ-A13U-01A,TCGA-DJ-A13U,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FK-A3SH,18609.0,female,1958,white,1338,Primary Tumor,0.0,0.0,0.0,85.0,2.0,5.0,95.0,TCGA-FK-A3SH-01A,TCGA-FK-A3SH,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A6IZ,22275.0,male,1953,white,157,Primary Tumor,0.0,0.0,5.0,90.0,0.0,10.0,85.0,TCGA-FG-A6IZ-01A,TCGA-FG-A6IZ,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A2EA,19159.0,female,1959,white,65,Primary Tumor,0.0,0.0,30.0,70.0,20.0,30.0,40.0,TCGA-E8-A2EA-01A,TCGA-E8-A2EA,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3I4,12677.0,female,1977,white,92,Primary Tumor,0.0,1.0,5.0,90.0,4.0,45.0,50.0,TCGA-FY-A3I4-01A,TCGA-FY-A3I4,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RP,24109.0,male,1946,black or african american,553,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-TQ-A7RP-01A,TCGA-TQ-A7RP,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1022,24798.0,female,1936,white,None,Primary Tumor,None,None,5.0,90.0,None,5.0,90.0,TCGA-23-1022-01A,TCGA-23-1022,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8N1,25737.0,male,1931,white,4466,Primary Tumor,0.0,0.0,60.0,60.0,8.0,0.0,40.0,TCGA-RD-A8N1-01A,TCGA-RD-A8N1,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-A48A,20839.0,male,1954,asian,419,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-CD-A48A-01A,TCGA-CD-A48A,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1571,19608.0,female,1954,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-36-1571-01A,TCGA-36-1571,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1633,23407.0,female,1938,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-25-1633-01A,TCGA-25-1633,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0891,26886.0,female,1930,white,None,Primary Tumor,None,None,5.0,95.0,None,0.0,94.0,TCGA-13-0891-01A,TCGA-13-0891,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8E3,28919.0,male,1932,white,816,Primary Tumor,0.0,0.0,0.0,80.0,4.0,0.0,100.0,TCGA-VQ-A8E3-01A,TCGA-VQ-A8E3,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-A4MH,31683.0,female,1925,asian,502,Primary Tumor,0.0,0.0,0.0,85.0,0.0,20.0,80.0,TCGA-CD-A4MH-01A,TCGA-CD-A4MH,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1696,15818.0,female,1960,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-29-1696-01A,TCGA-29-1696,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6806,21625.0,female,1952,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,77.0,TCGA-F4-6806-01A,TCGA-F4-6806,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-5797,20662.0,male,1954,asian,None,Primary Tumor,None,None,1.0,80.0,None,30.0,69.0,TCGA-CA-5797-01A,TCGA-CA-5797,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6166,17807.0,female,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,77.0,TCGA-CM-6166-01A,TCGA-CM-6166,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1853,21404.0,female,1942,white,None,Primary Tumor,None,None,0.0,99.0,None,1.0,98.0,TCGA-30-1853-01A,TCGA-30-1853,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2003,19605.0,female,1955,white,None,Primary Tumor,None,None,7.0,95.0,None,5.0,85.0,TCGA-61-2003-01A,TCGA-61-2003,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8574,26586.0,male,1940,white,None,Primary Tumor,0.0,0.0,0.0,65.0,20.0,30.0,70.0,TCGA-D7-8574-01A,TCGA-D7-8574,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3831,24411.0,male,1942,not reported,None,Primary Tumor,None,None,0.0,85.0,None,10.0,80.0,TCGA-AA-3831-01A,TCGA-AA-3831,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3864,26237.0,male,1934,not reported,None,Primary Tumor,None,None,5.0,85.0,None,10.0,80.0,TCGA-AA-3864-01A,TCGA-AA-3864,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PC,23912.0,male,1944,white,1719,Primary Tumor,0.0,0.0,5.0,90.0,0.0,10.0,85.0,TCGA-VQ-A8PC-01A,TCGA-VQ-A8PC,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2261,27897.0,female,1916,white,None,Primary Tumor,None,None,1.0,90.0,None,9.0,85.0,TCGA-24-2261-01A,TCGA-24-2261,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2012,29830.0,female,1925,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,80.0,TCGA-61-2012-01A,TCGA-61-2012,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PP,27774.0,male,1932,not reported,1846,Primary Tumor,3.0,2.0,7.0,60.0,5.0,33.0,60.0,TCGA-VQ-A8PP-01A,TCGA-VQ-A8PP,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8N0,19491.0,female,1953,white,2579,Primary Tumor,0.0,0.0,0.0,60.0,8.0,0.0,100.0,TCGA-RD-A8N0-01A,TCGA-RD-A8N0,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q7,19193.0,female,1959,asian,160,Primary Tumor,0.0,0.0,5.0,85.0,1.0,15.0,80.0,TCGA-DJ-A2Q7-01A,TCGA-DJ-A2Q7,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-R8-A6ML,19185.0,male,1953,white,2735,Primary Tumor,0.0,0.0,10.0,85.0,0.0,30.0,60.0,TCGA-R8-A6ML-01A,TCGA-R8-A6ML,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VB,19248.0,male,1959,not reported,273,Primary Tumor,0.0,0.0,0.0,100.0,1.0,35.0,65.0,TCGA-DJ-A3VB-01A,TCGA-DJ-A3VB,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7607,22585.0,female,1947,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7607-01A,TCGA-HT-7607,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5EU,12851.0,male,1977,white,86,Primary Tumor,0.0,0.0,5.0,80.0,0.0,45.0,50.0,TCGA-P5-A5EU-01A,TCGA-P5-A5EU,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5318,15372.0,female,1955,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-E1-5318-01A,TCGA-E1-5318,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7015,15041.0,female,1963,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7015-01A,TCGA-DU-7015,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZG,29375.0,male,1930,white,68,Primary Tumor,0.0,0.0,0.0,99.0,0.0,30.0,70.0,TCGA-BJ-A0ZG-01A,TCGA-BJ-A0ZG,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6TY,18564.0,male,1961,white,614,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-S9-A6TY-01A,TCGA-S9-A6TY,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5275,13371.0,male,1970,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-DB-5275-01A,TCGA-DB-5275,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13W,16558.0,female,1965,white,307,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-DJ-A13W-01A,TCGA-DJ-A13W,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1YA,27224.0,female,1936,not reported,290,Primary Tumor,0.0,2.0,10.0,90.0,0.0,10.0,80.0,TCGA-EM-A1YA-01A,TCGA-EM-A1YA,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A40K,17092.0,female,1966,white,58,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-FY-A40K-01A,TCGA-FY-A40K,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5852,22348.0,female,1949,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-5852-01A,TCGA-DU-5852,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A76R,18939.0,male,1955,white,2739,Primary Tumor,0.0,0.0,0.0,70.0,0.0,50.0,50.0,TCGA-DU-A76R-01A,TCGA-DU-A76R,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8563,11305.0,female,1981,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HT-8563-01A,TCGA-HT-8563,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A75P,9413.0,female,1988,not reported,163,Primary Tumor,0.0,5.0,10.0,80.0,5.0,45.0,45.0,TCGA-DB-A75P-01A,TCGA-DB-A75P,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A615,13892.0,female,1974,white,300,Primary Tumor,0.0,0.0,5.0,80.0,0.0,45.0,50.0,TCGA-HT-A615-01A,TCGA-HT-A615,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0Z3,12295.0,female,1977,white,162,Primary Tumor,0.0,0.0,80.0,0.0,0.0,20.0,0.0,TCGA-BJ-A0Z3-01A,TCGA-BJ-A0Z3,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7TJ,20394.0,male,1958,black or african american,29,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-DU-A7TJ-01A,TCGA-DU-A7TJ,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7J0,10989.0,female,1983,white,229,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-S9-A7J0-01A,TCGA-S9-A7J0,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A74K,21189.0,female,1954,white,293,Primary Tumor,0.0,0.0,5.0,80.0,0.0,30.0,50.0,TCGA-HT-A74K-01A,TCGA-HT-A74K,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A40L,20243.0,female,1957,white,132,Primary Tumor,0.0,1.0,5.0,95.0,3.0,35.0,60.0,TCGA-FY-A40L-01A,TCGA-FY-A40L,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FK-A4UB,18792.0,male,1954,white,2822,Primary Tumor,0.0,0.0,0.0,95.0,0.0,25.0,75.0,TCGA-FK-A4UB-01A,TCGA-FK-A4UB,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A3F0,23545.0,female,1947,white,49,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-BJ-A3F0-01A,TCGA-BJ-A3F0,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5EV,14310.0,male,1973,white,86,Primary Tumor,0.0,0.0,15.0,85.0,0.0,40.0,45.0,TCGA-P5-A5EV-01A,TCGA-P5-A5EV,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6XC,17692.0,male,1965,white,27,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-QH-A6XC-01A,TCGA-QH-A6XC,
LGG,Brain Lower Grade Glioma,Brain,TCGA-RY-A843,11083.0,male,1982,white,312,Primary Tumor,0.0,0.0,10.0,75.0,0.0,45.0,45.0,TCGA-RY-A843-01A,TCGA-RY-A843,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-7489,14201.0,male,1973,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HW-7489-01A,TCGA-HW-7489,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FN-7833,9228.0,male,1986,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-FN-7833-01A,TCGA-FN-7833,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22O,27758.0,male,1936,asian,42,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-EM-A22O-01A,TCGA-EM-A22O,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A6J3,19138.0,female,1960,white,267,Primary Tumor,0.0,0.0,15.0,80.0,0.0,45.0,40.0,TCGA-FG-A6J3-01A,TCGA-FG-A6J3,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6410,20567.0,male,1954,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-DU-6410-01A,TCGA-DU-6410,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A733,19142.0,female,1961,white,134,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-P5-A733-01A,TCGA-P5-A733,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7620,14659.0,male,1967,white,None,Primary Tumor,None,None,5.0,60.0,None,0.0,95.0,TCGA-HT-7620-01A,TCGA-HT-7620,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GP,25696.0,male,1939,black or african american,940,Primary Tumor,1.0,0.0,0.0,100.0,0.0,60.0,40.0,TCGA-EL-A3GP-01A,TCGA-EL-A3GP,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-RY-A83Z,19903.0,female,1958,white,375,Primary Tumor,0.0,0.0,10.0,90.0,0.0,35.0,55.0,TCGA-RY-A83Z-01A,TCGA-RY-A83Z,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7689,21331.0,female,1951,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-7689-01A,TCGA-HT-7689,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A418,27737.0,female,1936,white,205,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-E8-A418-01A,TCGA-E8-A418,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A45H,16541.0,male,1967,white,160,Primary Tumor,0.0,1.0,0.0,80.0,2.0,10.0,90.0,TCGA-BJ-A45H-01A,TCGA-BJ-A45H,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39K,17789.0,female,1958,white,1989,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-ET-A39K-01A,TCGA-ET-A39K,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A76V,19872.0,male,1959,black or african american,136,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-FY-A76V-01A,TCGA-FY-A76V,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PP,17410.0,male,1964,not reported,148,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-DJ-A2PP-01A,TCGA-DJ-A2PP,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VK,23255.0,male,1948,white,374,Primary Tumor,0.0,0.0,5.0,95.0,0.0,15.0,80.0,TCGA-DJ-A3VK-01A,TCGA-DJ-A3VK,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A74J,12393.0,male,1980,white,91,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-HT-A74J-01A,TCGA-HT-A74J,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8161,23064.0,female,1946,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-8161-01A,TCGA-DU-8161,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A433,9145.0,female,1987,asian,84,Primary Tumor,0.0,0.0,20.0,70.0,10.0,10.0,70.0,TCGA-E8-A433-01A,TCGA-E8-A433,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22Q,13341.0,male,1975,not reported,34,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EM-A22Q-01A,TCGA-EM-A22Q,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FP,26158.0,female,1940,not reported,137,Primary Tumor,0.0,0.0,0.0,80.0,1.0,20.0,80.0,TCGA-EM-A3FP-01A,TCGA-EM-A3FP,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6TU,14108.0,male,1969,white,2301,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6TU-01A,TCGA-S9-A6TU,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7TI,11906.0,male,1966,white,5441,Primary Tumor,0.0,0.0,20.0,80.0,0.0,40.0,40.0,TCGA-DU-A7TI-01A,TCGA-DU-A7TI,
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8P5,24571.0,male,1944,white,725,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-VQ-A8P5-01A,TCGA-VQ-A8P5,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A4YU,26781.0,male,1939,white,125,Primary Tumor,2.0,2.0,0.0,60.0,25.0,57.0,40.0,TCGA-D7-A4YU-01A,TCGA-D7-A4YU,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6170,26663.0,female,1937,white,None,Primary Tumor,None,None,25.0,65.0,None,10.0,60.0,TCGA-CM-6170-01A,TCGA-CM-6170,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4306,32871.0,male,1916,not reported,None,Primary Tumor,5.0,0.0,18.0,75.0,10.0,0.0,80.0,TCGA-CG-4306-01A,TCGA-CG-4306,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A6EZ,24425.0,male,1947,white,54,Primary Tumor,0.0,0.0,30.0,80.0,0.0,10.0,60.0,TCGA-D7-A6EZ-01A,TCGA-D7-A6EZ,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1763,16021.0,female,1961,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,0.0,95.0,TCGA-29-1763-01A,TCGA-29-1763,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PH,22940.0,male,1948,white,1406,Primary Tumor,3.0,1.0,7.0,65.0,6.0,28.0,65.0,TCGA-VQ-A8PH-01A,TCGA-VQ-A8PH,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-6716,23943.0,male,1945,asian,None,Primary Tumor,None,None,0.0,80.0,None,20.0,75.0,TCGA-CA-6716-01A,TCGA-CA-6716,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3555,29617.0,female,1927,not reported,None,Primary Tumor,None,None,0.0,60.0,None,60.0,40.0,TCGA-AA-3555-01A,TCGA-AA-3555,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A925,24230.0,male,1946,white,487,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-VQ-A925-01A,TCGA-VQ-A925,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3672,32872,female,1916,not reported,None,Primary Tumor,None,None,2.0,90.0,None,8.0,85.0,TCGA-AA-3672-01A,TCGA-AA-3672,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3861,26602.0,male,1937,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-AA-3861-01A,TCGA-AA-3861,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6524,19532.0,male,1957,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-D7-6524-01A,TCGA-D7-6524,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91N,21753.0,female,1950,not reported,1715,Primary Tumor,1.0,1.0,0.0,90.0,5.0,22.0,75.0,TCGA-VQ-A91N-01A,TCGA-VQ-A91N,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A029,24686.0,male,1939,not reported,1493,Primary Tumor,2.0,1.0,0.0,85.0,8.0,10.0,88.0,TCGA-AA-A029-01A,TCGA-AA-A029,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5861,23253.0,female,1947,white,None,Primary Tumor,1.0,1.0,0.0,80.0,5.0,0.0,100.0,TCGA-CM-5861-01A,TCGA-CM-5861,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8484,22583.0,male,1951,white,None,Primary Tumor,5.0,0.0,15.0,70.0,20.0,0.0,85.0,TCGA-BR-8484-01A,TCGA-BR-8484,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1694,16523.0,female,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-29-1694-01A,TCGA-29-1694,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5732,24379.0,male,1937,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-CG-5732-01A,TCGA-CG-5732,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3970,23741.0,male,1944,not reported,None,Primary Tumor,None,None,50.0,50.0,None,0.0,50.0,TCGA-AA-3970-01A,TCGA-AA-3970,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1109,23002.0,female,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,None,None,TCGA-23-1109-01A,TCGA-23-1109,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-3M-AB46,None,male,1939,white,1507,Primary Tumor,0.0,0.0,0.0,60.0,3.0,0.0,100.0,TCGA-3M-AB46-01A,TCGA-3M-AB46,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91K,25424.0,male,1940,white,1678,Primary Tumor,2.0,1.0,0.0,75.0,20.0,60.0,33.0,TCGA-VQ-A91K-01A,TCGA-VQ-A91K,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1318,19755.0,female,1946,white,None,Primary Tumor,None,None,None,98.0,None,15.0,80.0,TCGA-25-1318-01A,TCGA-25-1318,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1862,23895.0,female,1938,white,None,Primary Tumor,None,None,0.0,70.0,None,40.0,60.0,TCGA-30-1862-01A,TCGA-30-1862,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-5539,22097.0,male,1950,white,None,Primary Tumor,2.0,0.0,0.0,80.0,11.0,10.0,90.0,TCGA-D5-5539-01A,TCGA-D5-5539,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6899,30693.0,male,1927,white,None,Primary Tumor,None,None,0.0,65.0,20.0,25.0,70.0,TCGA-AD-6899-01A,TCGA-AD-6899,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6704,21949.0,male,1951,american indian or alaska native,None,Primary Tumor,None,None,3.0,85.0,None,15.0,82.0,TCGA-F4-6704-01A,TCGA-F4-6704,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-6715,23075.0,male,1947,asian,None,Primary Tumor,10.0,5.0,0.0,70.0,10.0,20.0,60.0,TCGA-CA-6715-01A,TCGA-CA-6715,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AU-6004,25259.0,female,1941,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-AU-6004-01A,TCGA-AU-6004,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3812,29980.0,female,1925,not reported,None,Primary Tumor,None,None,20.0,70.0,None,10.0,None,TCGA-AA-3812-01A,TCGA-AA-3812,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1409,26836.0,female,1935,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-13-1409-01A,TCGA-13-1409,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8DU,23042.0,male,1947,white,1123,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-VQ-A8DU-01A,TCGA-VQ-A8DU,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1322,22646.0,female,1939,white,None,Primary Tumor,None,None,None,95.0,None,10.0,75.0,TCGA-25-1322-01A,TCGA-25-1322,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4442,31350.0,male,1921,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,75.0,TCGA-CG-4442-01A,TCGA-CG-4442,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-6718,17109.0,male,1964,asian,None,Primary Tumor,None,None,8.0,75.0,None,25.0,67.0,TCGA-CA-6718-01A,TCGA-CA-6718,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A288,25084.0,male,1933,white,3699,Primary Tumor,0.0,0.0,0.0,80.0,1.0,20.0,70.0,TCGA-DM-A288-01A,TCGA-DM-A288,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2088,18770.0,female,1958,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-61-2088-01A,TCGA-61-2088,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-R5-A7O7,18984.0,male,1959,white,1010,Primary Tumor,2.0,2.0,2.0,77.0,15.0,35.0,63.0,TCGA-R5-A7O7-01A,TCGA-R5-A7O7,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6526,24477.0,female,1943,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,75.0,TCGA-D7-6526-01A,TCGA-D7-6526,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1648,21113.0,female,1946,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,75.0,TCGA-04-1648-01A,TCGA-04-1648,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-5798,30310.0,male,1928,asian,None,Primary Tumor,None,None,0.0,65.0,None,40.0,60.0,TCGA-CD-5798-01A,TCGA-CD-5798,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A6EX,26525.0,female,1941,white,65,Primary Tumor,0.0,0.0,10.0,60.0,0.0,40.0,50.0,TCGA-D7-A6EX-01A,TCGA-D7-A6EX,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2392,27667.0,female,1928,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-25-2392-01A,TCGA-25-2392,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4444,27912.0,male,1930,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-CG-4444-01A,TCGA-CG-4444,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1419,22659.0,female,1946,white,None,Primary Tumor,None,None,25.0,95.0,None,0.0,75.0,TCGA-24-1419-01A,TCGA-24-1419,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6801,25637.0,male,1941,white,None,Primary Tumor,None,None,0.0,75.0,None,25.0,70.0,TCGA-BR-6801-01A,TCGA-BR-6801,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6548,29758.0,female,1930,white,None,Primary Tumor,None,None,30.0,40.0,None,30.0,37.0,TCGA-AD-6548-01A,TCGA-AD-6548,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1783,21284.0,female,1951,white,None,Primary Tumor,None,None,0.0,90.0,5.0,20.0,78.0,TCGA-29-1783-01A,TCGA-29-1783,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8678,28037.0,male,1936,white,None,Primary Tumor,0.0,0.0,0.0,85.0,10.0,4.0,84.0,TCGA-BR-8678-01A,TCGA-BR-8678,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-2348,None,female,1935,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-59-2348-01A,TCGA-59-2348,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-4616,30043.0,female,1927,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,75.0,TCGA-AZ-4616-01A,TCGA-AZ-4616,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8680,16637.0,male,1967,asian,None,Primary Tumor,0.0,0.0,20.0,65.0,15.0,2.0,68.0,TCGA-BR-8680-01A,TCGA-BR-8680,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1418,24842.0,female,1940,white,None,Primary Tumor,None,None,20.0,70.0,None,0.0,75.0,TCGA-24-1418-01A,TCGA-24-1418,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-2427,21940.0,female,1944,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,80.0,TCGA-29-2427-01A,TCGA-29-2427,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8077,21413.0,female,1953,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-BR-8077-01A,TCGA-BR-8077,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2113,19722.0,female,1946,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,70.0,TCGA-61-2113-01A,TCGA-61-2113,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0726,20134.0,female,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,40.0,60.0,TCGA-13-0726-01A,TCGA-13-0726,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4367,28817.0,male,1930,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,90.0,TCGA-BR-4367-01A,TCGA-BR-4367,
STAD,Stomach Adenocarcinoma,Stomach,TCGA-F1-A72C,25104.0,male,1945,asian,115,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-F1-A72C-01A,TCGA-F1-A72C,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3664,27363.0,female,1931,not reported,None,Primary Tumor,50.0,5.0,0.0,80.0,40.0,0.0,100.0,TCGA-AA-3664-01A,TCGA-AA-3664,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1688,14574.0,female,1953,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-29-1688-01A,TCGA-29-1688,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7958,22204.0,male,1951,white,None,Primary Tumor,None,None,0.0,60.0,None,10.0,90.0,TCGA-BR-7958-01A,TCGA-BR-7958,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-F1-A448,25846.0,male,1942,white,216,Primary Tumor,0.0,5.0,0.0,70.0,2.0,0.0,100.0,TCGA-F1-A448-01A,TCGA-F1-A448,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PM,20665.0,male,1953,white,1709,Primary Tumor,4.0,2.0,4.0,70.0,3.0,16.0,70.0,TCGA-VQ-A8PM-01A,TCGA-VQ-A8PM,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3663,15675.0,male,1963,not reported,None,Primary Tumor,None,None,0.0,60.0,None,20.0,80.0,TCGA-AA-3663-01A,TCGA-AA-3663,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5723,30376.0,male,1920,not reported,None,Primary Tumor,None,None,0.0,75.0,None,50.0,50.0,TCGA-CG-5723-01A,TCGA-CG-5723,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1469,25937.0,female,1937,white,None,Primary Tumor,None,None,0.0,95.0,None,4.0,95.0,TCGA-24-1469-01A,TCGA-24-1469,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-A5FT,24743.0,female,1942,black or african american,1211,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,92.0,TCGA-13-A5FT-01A,TCGA-13-A5FT,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3489,27606.0,male,1927,not reported,None,Primary Tumor,None,None,30.0,60.0,30.0,10.0,52.0,TCGA-AA-3489-01A,TCGA-AA-3489,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-5800,None,female,1959,asian,None,Primary Tumor,None,None,0.0,80.0,None,10.0,80.0,TCGA-CD-5800-01A,TCGA-CD-5800,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1721,13894.0,female,1970,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,85.0,TCGA-61-1721-01A,TCGA-61-1721,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8E2,21112.0,male,1954,asian,855,Primary Tumor,0.0,0.0,0.0,60.0,10.0,0.0,100.0,TCGA-VQ-A8E2-01A,TCGA-VQ-A8E2,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1509,23481.0,female,1944,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-13-1509-01A,TCGA-13-1509,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6588,21532.0,female,1951,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-G4-6588-01A,TCGA-G4-6588,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3710,29465.0,female,1928,not reported,None,Primary Tumor,4.0,None,9.0,95.0,2.0,None,90.0,TCGA-AA-3710-01A,TCGA-AA-3710,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6537,23381.0,male,1946,white,None,Primary Tumor,1.0,1.0,0.0,90.0,2.0,0.0,100.0,TCGA-D5-6537-01A,TCGA-D5-6537,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1701,20737.0,female,1948,white,None,Primary Tumor,None,None,0.0,90.0,None,0.0,98.0,TCGA-29-1701-01A,TCGA-29-1701,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-MX-A666,22288.0,male,1952,white,21,Primary Tumor,1.0,1.0,20.0,65.0,8.0,0.0,80.0,TCGA-MX-A666-01A,TCGA-MX-A666,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA6A,20764.0,male,1956,white,706,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-VQ-AA6A-01A,TCGA-VQ-AA6A,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6453,20061.0,male,1957,white,None,Primary Tumor,10.0,0.0,8.0,70.0,10.0,7.0,85.0,TCGA-BR-6453-01A,TCGA-BR-6453,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5341,30163.0,female,1928,white,None,Primary Tumor,3.0,1.0,0.0,75.0,5.0,3.0,87.0,TCGA-CM-5341-01A,TCGA-CM-5341,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0916,18189.0,female,1957,white,None,Primary Tumor,None,None,0.0,98.0,None,5.0,95.0,TCGA-13-0916-01A,TCGA-13-0916,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1728,21582.0,female,1948,white,None,Primary Tumor,None,None,0.0,90.0,None,0.0,85.0,TCGA-61-1728-01A,TCGA-61-1728,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6463,18804.0,male,1960,white,None,Primary Tumor,1.0,0.0,0.0,80.0,2.0,0.0,95.0,TCGA-F4-6463-01A,TCGA-F4-6463,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA68,19304.0,female,1959,white,978,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-VQ-AA68-01A,TCGA-VQ-AA68,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-6746,30957.0,female,1925,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CK-6746-01A,TCGA-CK-6746,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-A56B,20903.0,male,1951,black or african american,1497,Primary Tumor,0.0,0.0,0.0,70.0,5.0,0.0,83.0,TCGA-A6-A56B-01A,TCGA-A6-A56B,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3556,28704.0,male,1930,not reported,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-AA-3556-01A,TCGA-AA-3556,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3851,27090.0,male,1935,not reported,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-AA-3851-01A,TCGA-AA-3851,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1557,17943.0,female,1951,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,85.0,TCGA-24-1557-01A,TCGA-24-1557,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HF-7133,None,female,None,not reported,None,Primary Tumor,15.0,0.0,1.0,60.0,20.0,0.0,99.0,TCGA-HF-7133-01A,TCGA-HF-7133,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3667,13302.0,female,1969,not reported,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-AA-3667-01A,TCGA-AA-3667,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1603,19681.0,female,1943,white,None,Primary Tumor,None,None,8.0,95.0,None,0.0,87.0,TCGA-24-1603-01A,TCGA-24-1603,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1536,21939.0,female,1941,black or african american,None,Primary Tumor,None,None,10.0,70.0,None,0.0,85.0,TCGA-04-1536-01A,TCGA-04-1536,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1470,20007.0,female,1955,white,None,Primary Tumor,None,None,0.0,70.0,None,29.0,70.0,TCGA-24-1470-01A,TCGA-24-1470,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1998,17855.0,female,1961,white,None,Primary Tumor,None,None,15.0,90.0,None,72.0,8.0,TCGA-61-1998-01A,TCGA-61-1998,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3543,30772.0,male,1924,not reported,None,Primary Tumor,None,None,0.0,70.0,None,38.0,60.0,TCGA-AA-3543-01A,TCGA-AA-3543,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1510,22708.0,female,1946,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,75.0,TCGA-13-1510-01A,TCGA-13-1510,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2027,18835.0,female,1944,white,None,Primary Tumor,0.0,0.0,0.0,85.0,0.0,7.0,90.0,TCGA-24-2027-01A,TCGA-24-2027,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6540,24282.0,male,1944,white,None,Primary Tumor,8.0,2.0,0.0,80.0,8.0,0.0,100.0,TCGA-D5-6540-01A,TCGA-D5-6540,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1113,17791.0,female,1954,white,None,Primary Tumor,None,None,0.0,95.0,None,None,None,TCGA-23-1113-01A,TCGA-23-1113,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3549,25415.0,male,1939,not reported,None,Primary Tumor,None,None,5.0,85.0,None,15.0,80.0,TCGA-AA-3549-01A,TCGA-AA-3549,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-0366,20440.0,female,1944,white,None,Primary Tumor,None,None,0.0,98.0,None,5.0,95.0,TCGA-09-0366-01A,TCGA-09-0366,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6570,28772.0,female,1933,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,70.0,TCGA-F4-6570-01A,TCGA-F4-6570,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-5M-AATE,27870.0,male,1935,black or african american,963,Primary Tumor,2.0,0.0,8.0,80.0,5.0,8.0,80.0,TCGA-5M-AATE-01A,TCGA-5M-AATE,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1483,22342.0,female,1939,white,None,Primary Tumor,50.0,10.0,0.0,75.0,40.0,45.0,50.0,TCGA-13-1483-01A,TCGA-13-1483,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8686,25372.0,male,1943,asian,None,Primary Tumor,5.0,0.0,10.0,80.0,5.0,0.0,90.0,TCGA-BR-8686-01A,TCGA-BR-8686,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A94R,23246.0,male,1947,white,1368,Primary Tumor,1.0,2.0,0.0,85.0,10.0,65.0,32.0,TCGA-VQ-A94R-01A,TCGA-VQ-A94R,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-2045,18285.0,female,1946,asian,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-09-2045-01A,TCGA-09-2045,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1569,19151.0,female,1955,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-36-1569-01A,TCGA-36-1569,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6528,25815.0,female,1940,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,55.0,TCGA-D7-6528-01A,TCGA-D7-6528,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6652,21638.0,male,1952,black or african american,None,Primary Tumor,1.0,1.0,25.0,80.0,2.0,0.0,65.0,TCGA-A6-6652-01A,TCGA-A6-6652,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PE,28755.0,male,1934,white,368,Primary Tumor,3.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-VQ-A8PE-01A,TCGA-VQ-A8PE,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2101,20287.0,female,1944,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-61-2101-01A,TCGA-61-2101,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6541,18029.0,male,1961,white,None,Primary Tumor,5.0,2.0,0.0,80.0,5.0,0.0,99.0,TCGA-D5-6541-01A,TCGA-D5-6541,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A922,25700.0,male,1940,not reported,1273,Primary Tumor,0.0,0.0,20.0,70.0,0.0,20.0,60.0,TCGA-VQ-A922-01A,TCGA-VQ-A922,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8NB,29503.0,female,1920,white,4752,Primary Tumor,0.0,0.0,40.0,60.0,0.0,10.0,50.0,TCGA-RD-A8NB-01A,TCGA-RD-A8NB,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0888,28498.0,female,1925,white,None,Primary Tumor,None,None,15.0,85.0,None,0.0,65.0,TCGA-13-0888-01A,TCGA-13-0888,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8535,21559.0,male,1952,asian,None,Primary Tumor,None,None,0.0,85.0,None,10.0,72.0,TCGA-CD-8535-01A,TCGA-CD-8535,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A00J,29371.0,male,1929,not reported,326,Primary Tumor,0.0,1.0,0.0,95.0,2.0,14.0,85.0,TCGA-AA-A00J-01A,TCGA-AA-A00J,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3833,23011.0,female,1945,not reported,None,Primary Tumor,None,None,5.0,70.0,None,15.0,80.0,TCGA-AA-3833-01A,TCGA-AA-3833,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1514,16725.0,female,1959,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,85.0,TCGA-04-1514-01A,TCGA-04-1514,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4475,28065.0,male,1934,not reported,None,Primary Tumor,None,None,0.0,70.0,None,40.0,55.0,TCGA-CG-4475-01A,TCGA-CG-4475,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-MX-A5UJ,31517.0,female,1926,white,76,Primary Tumor,0.0,0.0,60.0,80.0,0.0,0.0,20.0,TCGA-MX-A5UJ-01A,TCGA-MX-A5UJ,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A4YX,23249.0,male,1949,white,197,Primary Tumor,10.0,2.0,0.0,65.0,20.0,28.0,60.0,TCGA-D7-A4YX-01A,TCGA-D7-A4YX,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2042,22127.0,female,1946,american indian or alaska native,None,Primary Tumor,None,None,0.0,85.0,None,68.0,30.0,TCGA-25-2042-01A,TCGA-25-2042,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-5900,24776.0,male,1943,white,None,Primary Tumor,0.0,0.0,0.0,85.0,8.0,15.0,85.0,TCGA-AD-5900-01A,TCGA-AD-5900,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A748,15190.0,female,1972,white,57,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-D7-A748-01A,TCGA-D7-A748,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0886,24724.0,female,1935,white,None,Primary Tumor,None,None,30.0,70.0,None,0.0,65.0,TCGA-13-0886-01A,TCGA-13-0886,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HF-7132,None,male,None,not reported,None,Primary Tumor,5.0,2.0,13.0,70.0,10.0,0.0,87.0,TCGA-HF-7132-01A,TCGA-HF-7132,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0727,26185.0,female,1932,white,None,Primary Tumor,None,None,10.0,95.0,None,10.0,80.0,TCGA-13-0727-01A,TCGA-13-0727,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4438,20574.0,male,1950,not reported,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CG-4438-01A,TCGA-CG-4438,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A6F2,22801.0,male,1950,white,146,Primary Tumor,1.0,1.0,0.0,65.0,15.0,0.0,100.0,TCGA-D7-A6F2-01A,TCGA-D7-A6F2,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1847,16529.0,female,1964,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-24-1847-01A,TCGA-24-1847,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1343,26428.0,female,1930,white,None,Primary Tumor,None,None,0.0,93.0,None,4.0,95.0,TCGA-04-1343-01A,TCGA-04-1343,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-20-1687,16961.0,female,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,35.0,65.0,TCGA-20-1687-01A,TCGA-20-1687,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3678,22219.0,female,1946,not reported,None,Primary Tumor,None,None,1.0,85.0,None,35.0,64.0,TCGA-AA-3678-01A,TCGA-AA-3678,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4CR,25669.0,female,1942,white,154,Primary Tumor,0.0,0.0,0.0,85.0,4.0,33.0,65.0,TCGA-BR-A4CR-01A,TCGA-BR-A4CR,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4G8,26254.0,female,1940,asian,263,Primary Tumor,2.0,1.0,15.0,65.0,5.0,20.0,65.0,TCGA-HU-A4G8-01A,TCGA-HU-A4G8,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1341,31215.0,female,1921,white,None,Primary Tumor,None,None,None,80.0,None,28.0,55.0,TCGA-04-1341-01A,TCGA-04-1341,
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91D,25686.0,male,1940,white,1071,Primary Tumor,0.0,0.0,0.0,70.0,4.0,0.0,100.0,TCGA-VQ-A91D-01A,TCGA-VQ-A91D,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8527,26503.0,female,1938,asian,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CD-8527-01A,TCGA-CD-8527,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1784,20210.0,female,1954,white,None,Primary Tumor,None,None,0.0,75.0,20.0,10.0,90.0,TCGA-29-1784-01A,TCGA-29-1784,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28M,23043.0,male,1940,white,2698,Primary Tumor,0.0,5.0,0.0,60.0,10.0,35.0,60.0,TCGA-DM-A28M-01A,TCGA-DM-A28M,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3870,26086.0,female,1938,not reported,None,Primary Tumor,None,None,10.0,85.0,None,5.0,80.0,TCGA-AA-3870-01A,TCGA-AA-3870,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A02Y,26724.0,male,1934,not reported,1128,Primary Tumor,1.0,0.0,10.0,80.0,8.0,10.0,79.0,TCGA-AA-A02Y-01A,TCGA-AA-A02Y,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1857,23689.0,female,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,85.0,TCGA-30-1857-01A,TCGA-30-1857,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1413,18846.0,female,1957,white,None,Primary Tumor,None,None,40.0,85.0,None,0.0,50.0,TCGA-24-1413-01A,TCGA-24-1413,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-QL-A97D,30914.0,female,1928,black or african american,378,Primary Tumor,2.0,0.0,10.0,80.0,8.0,5.0,80.0,TCGA-QL-A97D-01A,TCGA-QL-A97D,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6534,22778.0,female,1948,white,None,Primary Tumor,2.0,1.0,20.0,80.0,5.0,0.0,80.0,TCGA-D5-6534-01A,TCGA-D5-6534,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4469,25598.0,male,1939,not reported,None,Primary Tumor,None,None,0.0,75.0,None,5.0,90.0,TCGA-CG-4469-01A,TCGA-CG-4469,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1118,16471.0,female,1956,white,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-23-1118-01A,TCGA-23-1118,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3989,30712.0,male,1925,not reported,None,Primary Tumor,None,None,0.0,96.0,None,5.0,94.0,TCGA-AA-3989-01A,TCGA-AA-3989,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-4743,25291.0,male,1941,white,None,Primary Tumor,None,None,5.0,70.0,None,5.0,90.0,TCGA-CM-4743-01A,TCGA-CM-4743,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1317,24199.0,female,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,40.0,50.0,TCGA-25-1317-01A,TCGA-25-1317,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1411,29874.0,female,1927,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-13-1411-01A,TCGA-13-1411,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3975,29310.0,male,1929,not reported,None,Primary Tumor,None,None,20.0,80.0,None,20.0,60.0,TCGA-AA-3975-01A,TCGA-AA-3975,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4QL,27668.0,female,1937,white,64,Primary Tumor,0.0,0.0,10.0,60.0,0.0,20.0,70.0,TCGA-BR-A4QL-01A,TCGA-BR-A4QL,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3655,24896.0,male,1937,not reported,None,Primary Tumor,None,None,0.0,95.0,None,10.0,90.0,TCGA-AA-3655-01A,TCGA-AA-3655,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6627,30697.0,male,1923,white,None,Primary Tumor,None,None,1.0,60.0,None,30.0,69.0,TCGA-G4-6627-01A,TCGA-G4-6627,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1347,29695.0,female,1923,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,93.0,TCGA-04-1347-01A,TCGA-04-1347,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1512,18134.0,female,1959,white,None,Primary Tumor,None,None,0.0,99.0,None,1.0,89.0,TCGA-13-1512-01A,TCGA-13-1512,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A6EV,26226.0,female,1942,white,98,Primary Tumor,10.0,20.0,5.0,80.0,60.0,10.0,80.0,TCGA-D7-A6EV-01A,TCGA-D7-A6EV,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA64,25109.0,male,1943,white,787,Primary Tumor,20.0,20.0,20.0,60.0,40.0,20.0,60.0,TCGA-VQ-AA64-01A,TCGA-VQ-AA64,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-20-1682,20583.0,female,1951,white,None,Primary Tumor,None,None,0.0,80.0,5.0,14.0,85.0,TCGA-20-1682-01A,TCGA-20-1682,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1316,20331.0,female,1945,white,None,Primary Tumor,None,None,0.0,98.0,None,5.0,95.0,TCGA-25-1316-01A,TCGA-25-1316,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A282,22265.0,female,1940,white,4047,Primary Tumor,0.0,0.0,0.0,80.0,1.0,24.0,64.0,TCGA-DM-A282-01A,TCGA-DM-A282,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-WS-AB45,None,female,1956,black or african american,1872,Primary Tumor,0.0,0.0,5.0,75.0,0.0,0.0,95.0,TCGA-WS-AB45-01A,TCGA-WS-AB45,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6530,19591.0,male,1957,white,None,Primary Tumor,5.0,0.0,0.0,80.0,10.0,0.0,99.0,TCGA-D5-6530-01A,TCGA-D5-6530,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1430,24939.0,female,1932,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-24-1430-01A,TCGA-24-1430,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-5804,32872,male,1920,asian,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-CD-5804-01A,TCGA-CD-5804,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-6719,28343.0,male,1934,asian,None,Primary Tumor,None,None,0.0,75.0,None,30.0,60.0,TCGA-CA-6719-01A,TCGA-CA-6719,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HF-A5NB,27676.0,female,None,not reported,None,Primary Tumor,20.0,20.0,0.0,90.0,20.0,10.0,90.0,TCGA-HF-A5NB-01A,TCGA-HF-A5NB,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6649,24237.0,male,1944,white,None,Primary Tumor,7.0,7.0,10.0,71.0,7.0,0.0,80.0,TCGA-A6-6649-01A,TCGA-A6-6649,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3680,24655.0,female,1939,not reported,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-AA-3680-01A,TCGA-AA-3680,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6455,21865.0,male,1952,white,None,Primary Tumor,2.0,0.0,10.0,85.0,5.0,10.0,80.0,TCGA-BR-6455-01A,TCGA-BR-6455,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4304,31017.0,male,1924,not reported,None,Primary Tumor,0.0,0.0,0.0,70.0,20.0,20.0,80.0,TCGA-CG-4304-01A,TCGA-CG-4304,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6964,21457.0,male,1953,white,None,Primary Tumor,None,None,0.0,60.0,30.0,50.0,50.0,TCGA-AD-6964-01A,TCGA-AD-6964,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-4N-A93T,24523.0,male,1946,black or african american,98,Primary Tumor,4.0,4.0,10.0,75.0,12.0,35.0,45.0,TCGA-4N-A93T-01A,TCGA-4N-A93T,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-T9-A92H,30058.0,male,1931,black or african american,91,Primary Tumor,0.0,0.0,5.0,65.0,10.0,30.0,60.0,TCGA-T9-A92H-01A,TCGA-T9-A92H,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5348,26543.0,male,1938,white,None,Primary Tumor,2.0,10.0,0.0,70.0,10.0,10.0,88.0,TCGA-CM-5348-01A,TCGA-CM-5348,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AU-3779,29460.0,female,1930,white,None,Primary Tumor,None,None,0.0,65.0,None,15.0,75.0,TCGA-AU-3779-01A,TCGA-AU-3779,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-B7-5818,22792.0,male,1948,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-B7-5818-01A,TCGA-B7-5818,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TZ,18691.0,male,1961,white,381,Primary Tumor,0.0,5.0,0.0,95.0,90.0,5.0,95.0,TCGA-GS-A9TZ-01A,TCGA-GS-A9TZ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HF,27038.0,male,1934,white,1458,Primary Tumor,0.0,1.0,0.0,100.0,3.0,15.0,80.0,TCGA-NC-A5HF-01A,TCGA-NC-A5HF,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A430,30344.0,male,1929,white,125,Primary Tumor,0.0,0.0,25.0,75.0,10.0,0.0,75.0,TCGA-EB-A430-01A,TCGA-EB-A430,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-4083,23125.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,75.0,TCGA-18-4083-01A,TCGA-18-4083,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HK,21531.0,female,1952,white,1018,Primary Tumor,0.0,1.0,0.0,100.0,2.0,20.0,75.0,TCGA-NC-A5HK-01A,TCGA-NC-A5HK,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8351,26437.0,male,1939,white,None,Primary Tumor,None,None,10.0,75.0,None,10.0,70.0,TCGA-85-8351-01A,TCGA-85-8351,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-6738,29368.0,male,1929,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,72.0,TCGA-33-6738-01A,TCGA-33-6738,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7698,17651.0,male,1963,white,None,Primary Tumor,None,None,8.0,65.0,None,15.0,67.0,TCGA-85-7698-01A,TCGA-85-7698,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8439,11266.0,male,1981,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-KM-8439-01A,TCGA-KM-8439,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-A475,24680.0,female,1945,white,148,Primary Tumor,0.0,0.0,0.0,60.0,0.0,15.0,85.0,TCGA-43-A475-01A,TCGA-43-A475,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EW,16140.0,female,1968,white,606,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9EW-01A,TCGA-V4-A9EW,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-A5G6,24215.0,male,1943,not reported,1420,Primary Tumor,0.0,0.0,5.0,60.0,0.0,35.0,50.0,TCGA-77-A5G6-01A,TCGA-77-A5G6,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-68-7756,30763.0,male,1927,white,None,Primary Tumor,None,None,15.0,45.0,15.0,20.0,50.0,TCGA-68-7756-01A,TCGA-68-7756,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-6561,24234.0,male,1945,white,None,Primary Tumor,None,None,10.0,55.0,None,10.0,65.0,TCGA-85-6561-01A,TCGA-85-6561,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5483,27109.0,male,1931,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,25.0,60.0,TCGA-22-5483-01A,TCGA-22-5483,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2696,27991.0,female,1933,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-60-2696-01A,TCGA-60-2696,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2773,25355.0,male,1938,not reported,None,Primary Tumor,2.0,3.0,1.0,60.0,30.0,5.0,89.0,TCGA-66-2773-01A,TCGA-66-2773,1.0
UVM,Uveal Melanoma,Eye,TCGA-V3-A9ZX,20539.0,male,1957,white,15,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-V3-A9ZX-01A,TCGA-V3-A9ZX,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MT,27263.0,male,None,not reported,None,Primary Tumor,5.0,2.0,0.0,65.0,5.0,33.0,65.0,TCGA-63-A5MT-01A,TCGA-63-A5MT,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-D9-A4Z5,24979.0,male,1944,white,38,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,80.0,TCGA-D9-A4Z5-01A,TCGA-D9-A4Z5,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7843,18353.0,male,1961,white,None,Primary Tumor,0.0,0.0,8.0,75.0,20.0,0.0,92.0,TCGA-85-7843-01A,TCGA-85-7843,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HH,19485.0,male,1956,white,1346,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-NC-A5HH-01A,TCGA-NC-A5HH,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A24C,20539.0,male,1955,white,51,Primary Tumor,0.0,0.0,5.0,90.0,0.0,0.0,95.0,TCGA-EB-A24C-01A,TCGA-EB-A24C,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-37-A5EM,18011.0,male,1962,white,492,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,70.0,TCGA-37-A5EM-01A,TCGA-37-A5EM,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-GN-A263,8952.0,male,1980,white,2417,Primary Tumor,0.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-GN-A263-01A,TCGA-GN-A263,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-XC-AA0X,28211.0,female,1936,black or african american,81,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,83.0,TCGA-XC-AA0X-01A,TCGA-XC-AA0X,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A512,16811.0,male,1966,white,107,Primary Tumor,1.0,2.0,0.0,95.0,3.0,30.0,60.0,TCGA-85-A512-01A,TCGA-85-A512,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-8046,18853.0,male,1960,asian,None,Primary Tumor,0.0,0.0,14.0,80.0,18.0,0.0,85.0,TCGA-FF-8046-01A,TCGA-FF-8046,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A1PZ,26240.0,female,1939,white,97,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-BF-A1PZ-01A,TCGA-BF-A1PZ,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A3XC,27124.0,male,1938,white,112,Primary Tumor,1.0,1.0,1.0,80.0,2.0,19.0,80.0,TCGA-EB-A3XC-01A,TCGA-EB-A3XC,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-A46K,21867.0,male,1949,white,1491,Primary Tumor,2.0,5.0,0.0,85.0,5.0,30.0,50.0,TCGA-58-A46K-01A,TCGA-58-A46K,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-A5C4,25629.0,male,1942,white,49,Primary Tumor,5.0,10.0,5.0,80.0,70.0,5.0,80.0,TCGA-22-A5C4-01A,TCGA-22-A5C4,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4976,28380.0,male,1929,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4976-01A,TCGA-BP-4976,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4869,17923.0,male,1955,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,88.0,TCGA-CJ-4869-01A,TCGA-CJ-4869,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A02X,28399.0,male,1930,not reported,1128,Primary Tumor,3.0,2.0,0.0,75.0,12.0,5.0,92.0,TCGA-AG-A02X-01A,TCGA-AG-A02X,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-5222,24134.0,male,1944,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-32-5222-01A,TCGA-32-5222,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54H,25243.0,female,1943,black or african american,160,Primary Tumor,0.0,0.0,0.0,95.0,0.0,20.0,80.0,TCGA-B8-A54H-01A,TCGA-B8-A54H,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-41-2572,24505.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,99.0,TCGA-41-2572-01A,TCGA-41-2572,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4842,27019.0,female,1931,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4842-01A,TCGA-B0-4842,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6088,22020.0,male,1943,white,None,Primary Tumor,None,None,18.0,80.0,None,10.0,82.0,TCGA-CW-6088-01A,TCGA-CW-6088,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3593,26480.0,female,1935,not reported,None,Primary Tumor,None,None,2.0,85.0,5.0,12.0,85.0,TCGA-AG-3593-01A,TCGA-AG-3593,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-1970,21613.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,95.0,TCGA-32-1970-01A,TCGA-32-1970,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5672,30900.0,male,1920,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-CJ-5672-01A,TCGA-CJ-5672,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5989,22170.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CZ-5989-01A,TCGA-CZ-5989,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4816,18133.0,male,1953,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-B0-4816-01A,TCGA-B0-4816,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5109,25428.0,male,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,70.0,TCGA-B0-5109-01A,TCGA-B0-5109,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4635,17620.0,male,1956,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4635-01A,TCGA-CJ-4635,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-1982,27764.0,female,1932,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,90.0,TCGA-32-1982-01A,TCGA-32-1982,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54E,22900.0,female,1949,black or african american,603,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-B8-A54E-01A,TCGA-B8-A54E,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4920,23656.0,female,1940,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4920-01A,TCGA-CJ-4920,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4811,17792.0,male,1953,white,None,Primary Tumor,None,None,20.0,75.0,None,10.0,70.0,TCGA-B0-4811-01A,TCGA-B0-4811,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5696,25552.0,male,1938,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5696-01A,TCGA-B0-5696,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5199,21256.0,male,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-5199-01A,TCGA-BP-5199,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3890,22950.0,male,1947,not reported,None,Primary Tumor,None,None,0.0,70.0,None,20.0,72.0,TCGA-AG-3890-01A,TCGA-AG-3890,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8114,13198.0,male,1975,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-8114-01A,TCGA-HT-8114,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A45C,28490.0,male,1934,black or african american,198,Primary Tumor,0.0,2.0,0.0,100.0,0.0,10.0,90.0,TCGA-BJ-A45C-01A,TCGA-BJ-A45C,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-VM-A8CA,19991.0,male,1957,not reported,798,Primary Tumor,0.0,0.0,10.0,75.0,0.0,60.0,30.0,TCGA-VM-A8CA-01A,TCGA-VM-A8CA,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64Q,11637.0,female,1981,not reported,251,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-DB-A64Q-01A,TCGA-DB-A64Q,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39P,26817.0,female,1934,black or african american,1617,Primary Tumor,0.0,1.0,0.0,100.0,1.0,5.0,95.0,TCGA-ET-A39P-01A,TCGA-ET-A39P,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7014,21865.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-7014-01A,TCGA-DU-7014,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FM,21595.0,female,1953,not reported,241,Primary Tumor,0.0,1.0,0.0,75.0,2.0,50.0,50.0,TCGA-EM-A4FM-01A,TCGA-EM-A4FM,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FO,26589.0,male,1940,not reported,234,Primary Tumor,0.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-EM-A4FO-01A,TCGA-EM-A4FO,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A72X,7913.0,male,1992,white,178,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-P5-A72X-01A,TCGA-P5-A72X,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AR,15313.0,male,1970,not reported,103,Primary Tumor,0.0,1.0,0.0,95.0,0.0,50.0,50.0,TCGA-EM-A3AR-01A,TCGA-EM-A3AR,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V2,16382.0,female,1967,white,295,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-DJ-A3V2-01A,TCGA-DJ-A3V2,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3MX,24178.0,female,1938,white,2906,Primary Tumor,0.0,2.0,0.0,100.0,0.0,10.0,90.0,TCGA-EL-A3MX-01A,TCGA-EL-A3MX,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A432,20874.0,female,1955,asian,98,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-E8-A432-01A,TCGA-E8-A432,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4IB,15157.0,female,1966,asian,2022,Primary Tumor,0.0,2.0,0.0,100.0,3.0,5.0,95.0,TCGA-KS-A4IB-01A,TCGA-KS-A4IB,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-KT-A7W1,16560.0,female,1968,white,27,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-KT-A7W1-01A,TCGA-KT-A7W1,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6542,9380.0,male,1986,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-6542-01A,TCGA-DU-6542,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7687,27186.0,male,1936,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-7687-01A,TCGA-HT-7687,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T6,12777.0,female,1969,white,3292,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-EL-A3T6-01A,TCGA-EL-A3T6,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4K9,24980.0,male,1941,white,1114,Primary Tumor,0.0,1.0,0.0,100.0,2.0,55.0,45.0,TCGA-EL-A4K9-01A,TCGA-EL-A4K9,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A4MY,16310.0,female,1968,white,212,Primary Tumor,0.0,0.0,20.0,80.0,0.0,0.0,80.0,TCGA-FG-A4MY-01A,TCGA-FG-A4MY,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZH,19114.0,female,1958,white,89,Primary Tumor,0.0,0.0,0.0,99.0,0.0,5.0,95.0,TCGA-BJ-A0ZH-01A,TCGA-BJ-A0ZH,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FK,10992.0,female,1980,not reported,436,Primary Tumor,0.0,0.0,0.0,100.0,1.0,40.0,60.0,TCGA-EM-A3FK-01A,TCGA-EM-A3FK,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XH,19710.0,female,1958,white,397,Primary Tumor,0.0,0.0,35.0,85.0,0.0,5.0,60.0,TCGA-DB-A4XH-01A,TCGA-DB-A4XH,
THCA,Thyroid Carcinoma,Thyroid,TCGA-MK-A4N9,15255.0,female,1970,white,447,Primary Tumor,0.0,1.0,0.0,80.0,2.0,10.0,90.0,TCGA-MK-A4N9-01A,TCGA-MK-A4N9,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6U8,9044.0,male,1981,white,2962,Primary Tumor,0.0,0.0,10.0,80.0,0.0,70.0,20.0,TCGA-S9-A6U8-01A,TCGA-S9-A6U8,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FK-A3SG,7710.0,female,1987,white,1444,Primary Tumor,0.0,0.0,0.0,85.0,2.0,0.0,100.0,TCGA-FK-A3SG-01A,TCGA-FK-A3SG,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A711,12248.0,female,1977,white,1265,Primary Tumor,0.0,0.0,10.0,75.0,0.0,40.0,50.0,TCGA-FG-A711-01A,TCGA-FG-A711,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7676,9667.0,male,1983,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7676-01A,TCGA-HT-7676,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DU,7869.0,female,1988,white,665,Primary Tumor,0.0,0.0,5.0,65.0,0.0,10.0,85.0,TCGA-ET-A3DU-01A,TCGA-ET-A3DU,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FU,12912.0,male,1974,not reported,1120,Primary Tumor,0.0,1.0,0.0,80.0,2.0,3.0,97.0,TCGA-EM-A4FU-01A,TCGA-EM-A4FU,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A65X,10440.0,female,1985,white,39,Primary Tumor,0.0,0.0,5.0,85.0,0.0,15.0,80.0,TCGA-QH-A65X-01A,TCGA-QH-A65X,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4UR,13463.0,female,1976,asian,216,Primary Tumor,0.0,1.0,0.0,100.0,0.0,15.0,85.0,TCGA-DJ-A4UR-01A,TCGA-DJ-A4UR,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6CX,24252.0,male,1947,white,23,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-QH-A6CX-01A,TCGA-QH-A6CX,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7695,10827.0,female,1980,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7695-01A,TCGA-HT-7695,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1YB,26852.0,female,1937,not reported,171,Primary Tumor,0.0,1.0,10.0,95.0,0.0,5.0,85.0,TCGA-EM-A1YB-01A,TCGA-EM-A1YB,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-5871,13673.0,female,1972,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-5871-01A,TCGA-DU-5871,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A5R9,17775.0,female,1964,white,79,Primary Tumor,0.0,0.0,5.0,80.0,0.0,15.0,80.0,TCGA-HT-A5R9-01A,TCGA-HT-A5R9,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DS,12252.0,female,1976,white,784,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-ET-A3DS-01A,TCGA-ET-A3DS,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8013,13753.0,female,1968,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-8013-01A,TCGA-HT-8013,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0Z2,21008.0,male,1953,black or african american,169,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-BJ-A0Z2-01A,TCGA-BJ-A0Z2,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CR,28785.0,female,1924,white,3278,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EL-A3CR-01A,TCGA-EL-A3CR,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZE,23250.0,female,1947,white,96,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-BJ-A0ZE-01A,TCGA-BJ-A0ZE,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A736,16300.0,female,1969,white,126,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-P5-A736-01A,TCGA-P5-A736,
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A485,11997.0,male,1980,asian,132,Primary Tumor,1.0,1.0,0.0,100.0,2.0,50.0,50.0,TCGA-CE-A485-01A,TCGA-CE-A485,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A22Z,22286.0,female,1946,white,1526,Primary Tumor,0.0,0.0,0.0,95.0,0.0,2.0,98.0,TCGA-FE-A22Z-01A,TCGA-FE-A22Z,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QG,22859.0,male,1948,white,115,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DJ-A1QG-01A,TCGA-DJ-A1QG,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VJ,8341.0,male,1988,white,541,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-DJ-A3VJ-01A,TCGA-DJ-A3VJ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7007,12245.0,male,1964,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7007-01A,TCGA-DU-7007,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7Z3,11330.0,female,1961,black or african american,7912,Primary Tumor,0.0,0.0,10.0,70.0,0.0,70.0,20.0,TCGA-E1-A7Z3-01A,TCGA-E1-A7Z3,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4V2,14126.0,female,1973,not reported,283,Primary Tumor,0.0,0.0,5.0,70.0,5.0,25.0,70.0,TCGA-DJ-A4V2-01A,TCGA-DJ-A4V2,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GS,13542.0,female,1970,white,1533,Primary Tumor,0.0,1.0,0.0,100.0,0.0,10.0,90.0,TCGA-EL-A3GS-01A,TCGA-EL-A3GS,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-6688,21745.0,female,1951,black or african american,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-FG-6688-01A,TCGA-FG-6688,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A4M8,22357.0,female,1951,white,104,Primary Tumor,0.0,1.0,10.0,90.0,6.0,50.0,40.0,TCGA-DE-A4M8-01A,TCGA-DE-A4M8,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7R1,12828.0,male,1964,white,5213,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A7R1-01A,TCGA-S9-A7R1,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2OZ,24195.0,male,1945,not reported,129,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-EM-A2OZ-01A,TCGA-EM-A2OZ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-7486,13546.0,male,1973,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HW-7486-01A,TCGA-HW-7486,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8111,11810.0,male,1979,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-8111-01A,TCGA-HT-8111,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A60J,17339.0,female,1965,white,240,Primary Tumor,0.0,0.0,0.0,90.0,5.0,40.0,60.0,TCGA-FG-A60J-01A,TCGA-FG-A60J,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2OV,23656.0,female,1947,asian,205,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-EM-A2OV-01A,TCGA-EM-A2OV,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-H2-A3RH,15068.0,female,1970,white,114,Primary Tumor,0.0,2.0,0.0,100.0,0.0,10.0,90.0,TCGA-H2-A3RH-01A,TCGA-H2-A3RH,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5274,13680.0,female,1969,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DB-5274-01A,TCGA-DB-5274,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3NP,25462.0,male,1942,white,58,Primary Tumor,0.0,0.0,5.0,85.0,0.0,0.0,95.0,TCGA-FY-A3NP-01A,TCGA-FY-A3NP,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AL,16439.0,female,1966,not reported,174,Primary Tumor,0.0,1.0,0.0,100.0,0.0,5.0,95.0,TCGA-EM-A3AL-01A,TCGA-EM-A3AL,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A3PT,18903.0,female,1960,white,255,Primary Tumor,0.0,1.0,10.0,90.0,1.0,60.0,30.0,TCGA-BJ-A3PT-01A,TCGA-BJ-A3PT,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4I3,14992.0,male,1970,asian,413,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-KS-A4I3-01A,TCGA-KS-A4I3,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6396,11427.0,female,1965,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-6396-01A,TCGA-DU-6396,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FV,23627.0,female,1947,not reported,337,Primary Tumor,0.0,1.0,0.0,80.0,2.0,5.0,95.0,TCGA-EM-A4FV-01A,TCGA-EM-A4FV,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A190,20407.0,male,1955,white,55,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-BJ-A190-01A,TCGA-BJ-A190,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-5144,20558.0,female,1953,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DH-5144-01A,TCGA-DH-5144,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AO,22347.0,male,1950,not reported,136,Primary Tumor,0.0,1.0,0.0,95.0,3.0,10.0,90.0,TCGA-EM-A3AO-01A,TCGA-EM-A3AO,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7475,24686.0,male,1943,white,None,Primary Tumor,None,None,25.0,60.0,None,0.0,75.0,TCGA-HT-7475-01A,TCGA-HT-7475,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UY,12004.0,female,1979,white,295,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-DJ-A3UY-01A,TCGA-DJ-A3UY,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GO,11604.0,female,1977,white,1128,Primary Tumor,0.0,1.0,0.0,100.0,0.0,5.0,95.0,TCGA-EL-A3GO-01A,TCGA-EL-A3GO,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FN,15655.0,female,1969,not reported,234,Primary Tumor,0.0,0.0,3.0,80.0,1.0,17.0,80.0,TCGA-EM-A3FN-01A,TCGA-EM-A3FN,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-4944,18494.0,male,1960,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-CS-4944-01A,TCGA-CS-4944,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7481,14306.0,male,1967,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-7481-01A,TCGA-HT-7481,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A77W,13545.0,female,1976,white,114,Primary Tumor,0.0,0.0,10.0,70.0,0.0,40.0,50.0,TCGA-P5-A77W-01A,TCGA-P5-A77W,
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A3YD,17416.0,female,1962,white,1045,Primary Tumor,0.0,1.0,10.0,90.0,0.0,40.0,50.0,TCGA-J8-A3YD-01A,TCGA-J8-A3YD,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22M,19059.0,male,1959,asian,50,Primary Tumor,0.0,0.0,0.0,78.0,0.0,0.0,100.0,TCGA-EM-A22M-01A,TCGA-EM-A22M,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7879,11622.0,male,1980,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7879-01A,TCGA-HT-7879,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A231,25703.0,male,1940,white,248,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-FE-A231-01A,TCGA-FE-A231,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CK,10485.0,male,1982,not reported,163,Primary Tumor,0.0,0.0,0.0,96.0,0.0,10.0,90.0,TCGA-EM-A2CK-01A,TCGA-EM-A2CK,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7Z6,14985.0,female,1968,white,1588,Primary Tumor,0.0,0.0,10.0,75.0,0.0,60.0,30.0,TCGA-E1-A7Z6-01A,TCGA-E1-A7Z6,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-5141,11846.0,male,1973,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DH-5141-01A,TCGA-DH-5141,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3W9,24136.0,female,1946,white,72,Primary Tumor,0.0,2.0,0.0,100.0,0.0,20.0,80.0,TCGA-FY-A3W9-01A,TCGA-FY-A3W9,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GZ,12665.0,female,1967,white,3741,Primary Tumor,0.0,2.0,0.0,100.0,1.0,10.0,90.0,TCGA-EL-A3GZ-01A,TCGA-EL-A3GZ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7467,19944.0,male,1957,white,None,Primary Tumor,None,None,50.0,15.0,None,0.0,50.0,TCGA-HT-7467-01A,TCGA-HT-7467,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6U9,13460.0,male,1970,white,2706,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-S9-A6U9-01A,TCGA-S9-A6U9,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UO,23292.0,male,1947,white,482,Primary Tumor,0.0,0.0,0.0,88.0,0.0,0.0,100.0,TCGA-DJ-A3UO-01A,TCGA-DJ-A3UO,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-R8-A73M,17610.0,female,1960,white,1758,Primary Tumor,0.0,0.0,5.0,80.0,0.0,35.0,60.0,TCGA-R8-A73M-01A,TCGA-R8-A73M,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4JW,13928.0,female,1971,white,1295,Primary Tumor,0.0,1.0,0.0,80.0,2.0,15.0,85.0,TCGA-EL-A4JW-01A,TCGA-EL-A4JW,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZF,19978.0,female,1956,white,118,Primary Tumor,0.0,0.0,0.0,75.0,2.0,10.0,90.0,TCGA-BJ-A0ZF-01A,TCGA-BJ-A0ZF,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7611,13314.0,male,1971,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7611-01A,TCGA-HT-7611,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A192,19878.0,female,1956,white,154,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BJ-A192-01A,TCGA-BJ-A192,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A232,16280.0,female,1963,white,1325,Primary Tumor,0.0,0.0,0.0,93.0,0.0,10.0,90.0,TCGA-FE-A232-01A,TCGA-FE-A232,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XE,10150.0,female,1984,white,635,Primary Tumor,0.0,0.0,35.0,80.0,0.0,5.0,60.0,TCGA-DB-A4XE-01A,TCGA-DB-A4XE,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7855,14496.0,male,1969,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HT-7855-01A,TCGA-HT-7855,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RG,13227.0,male,1976,white,287,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-TQ-A7RG-01A,TCGA-TQ-A7RG,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25G,20816.0,female,1952,white,1071,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-ET-A25G-01A,TCGA-ET-A25G,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-WY-A859,12631.0,female,1976,white,1143,Primary Tumor,0.0,0.0,10.0,70.0,0.0,70.0,20.0,TCGA-WY-A859-01A,TCGA-WY-A859,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-8182,12972.0,male,1977,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-FG-8182-01A,TCGA-FG-8182,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4JX,11465.0,female,1978,black or african american,1269,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,100.0,TCGA-EL-A4JX-01A,TCGA-EL-A4JX,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PU,18998.0,female,1959,white,202,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DJ-A2PU-01A,TCGA-DJ-A2PU,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3NM,17734.0,female,1963,white,88,Primary Tumor,0.0,1.0,0.0,100.0,1.0,20.0,80.0,TCGA-FY-A3NM-01A,TCGA-FY-A3NM,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CN,22817.0,male,1948,not reported,163,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EM-A2CN-01A,TCGA-EM-A2CN,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-8181,8642.0,male,1989,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-FG-8181-01A,TCGA-FG-8181,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6U5,12417.0,male,1978,white,636,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6U5-01A,TCGA-S9-A6U5,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A5TY,16945.0,female,1966,white,276,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-DU-A5TY-01A,TCGA-DU-A5TY,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-7491,12874.0,male,1974,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HW-7491-01A,TCGA-HW-7491,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64L,24690.0,female,1945,white,289,Primary Tumor,0.0,0.0,5.0,80.0,0.0,20.0,75.0,TCGA-DB-A64L-01A,TCGA-DB-A64L,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RN,11823.0,male,1979,white,714,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-TQ-A7RN-01A,TCGA-TQ-A7RN,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-7636,17843.0,male,1963,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-FG-7636-01A,TCGA-FG-7636,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5ET,10027.0,male,1985,white,98,Primary Tumor,0.0,5.0,20.0,80.0,0.0,50.0,30.0,TCGA-P5-A5ET-01A,TCGA-P5-A5ET,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H8,12992.0,female,1967,white,3556,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,80.0,TCGA-EL-A3H8-01A,TCGA-EL-A3H8,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RS,9172.0,female,1987,white,398,Primary Tumor,0.0,0.0,10.0,90.0,0.0,30.0,60.0,TCGA-TQ-A7RS-01A,TCGA-TQ-A7RS,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6394,19541.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-DU-6394-01A,TCGA-DU-6394,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64V,19950.0,male,1958,white,352,Primary Tumor,0.0,5.0,10.0,75.0,0.0,30.0,60.0,TCGA-DB-A64V-01A,TCGA-DB-A64V,
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6978,None,male,1929,white,None,Primary Tumor,1.0,1.0,0.0,70.0,20.0,0.0,99.0,TCGA-55-6978-01A,TCGA-55-6978,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FK,16627.0,female,1961,white,1833,Primary Tumor,0.0,0.0,7.0,70.0,1.0,68.0,25.0,TCGA-AC-A2FK-01A,TCGA-AC-A2FK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A5QP,19805.0,female,1957,white,498,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-AR-A5QP-01A,TCGA-AR-A5QP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SI,19250.0,female,1955,white,1267,Primary Tumor,0.0,0.0,2.0,70.0,3.0,27.0,70.0,TCGA-A1-A0SI-01A,TCGA-A1-A0SI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JS,28178.0,female,1933,white,212,Primary Tumor,0.0,1.0,0.0,85.0,1.0,15.0,85.0,TCGA-D8-A1JS-01A,TCGA-D8-A1JS,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A574,16195.0,female,1967,black or african american,429,Primary Tumor,0.0,0.0,0.0,70.0,1.0,0.0,100.0,TCGA-E2-A574-01A,TCGA-E2-A574,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DM,21160.0,female,1947,white,2464,Primary Tumor,0.0,0.0,0.0,90.0,1.0,32.0,65.0,TCGA-GM-A2DM-01A,TCGA-GM-A2DM,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-F2-6880,25809.0,male,1939,white,None,Primary Tumor,None,None,1.0,98.0,None,2.0,97.0,TCGA-F2-6880-01A,TCGA-F2-6880,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YT,20482.0,female,1952,white,884,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-A2-A0YT-01A,TCGA-A2-A0YT,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6835,29887.0,female,1929,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,70.0,TCGA-91-6835-01A,TCGA-91-6835,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A73X,19607.0,female,1960,white,140,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-D8-A73X-01A,TCGA-D8-A73X,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7554,30327.0,female,1927,white,None,Primary Tumor,None,2.0,None,65.0,10.0,None,100.0,TCGA-97-7554-01A,TCGA-97-7554,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-JL-A3YX,None,female,1965,asian,306,Primary Tumor,0.0,0.0,0.0,80.0,2.0,39.0,60.0,TCGA-JL-A3YX-01A,TCGA-JL-A3YX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14T,19237.0,female,1956,white,792,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-E2-A14T-01A,TCGA-E2-A14T,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1PA,21837.0,female,1951,white,220,Primary Tumor,1.0,1.0,0.0,70.0,4.0,29.0,70.0,TCGA-EW-A1PA-01A,TCGA-EW-A1PA,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5935,31610.0,female,1920,white,None,Primary Tumor,2.0,1.0,0.0,80.0,5.0,0.0,100.0,TCGA-50-5935-01A,TCGA-50-5935,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RG,9840.0,female,1965,white,6869,Primary Tumor,0.0,0.0,0.0,80.0,0.0,50.0,40.0,TCGA-B6-A0RG-01A,TCGA-B6-A0RG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AH,18991.0,female,1953,white,2368,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-AR-A1AH-01A,TCGA-AR-A1AH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FR,26684.0,female,1924,white,4876,Primary Tumor,0.0,1.0,1.0,85.0,1.0,14.0,85.0,TCGA-BH-A1FR-01A,TCGA-BH-A1FR,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-A47A,28782.0,female,1934,white,117,Primary Tumor,0.0,0.0,0.0,78.0,0.0,0.0,100.0,TCGA-44-A47A-01A,TCGA-44-A47A,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A091,22554.0,female,1947,not reported,637,Primary Tumor,0.0,0.0,36.0,80.0,1.0,8.0,55.0,TCGA-A8-A091-01A,TCGA-A8-A091,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4TE,20627.0,male,1954,white,1009,Primary Tumor,0.0,0.0,0.0,88.0,0.0,0.0,80.0,TCGA-MP-A4TE-01A,TCGA-MP-A4TE,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A12C,15469.0,female,1963,white,2086,Primary Tumor,0.0,0.0,2.0,80.0,3.0,38.0,60.0,TCGA-AO-A12C-01A,TCGA-AO-A12C,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7918,26573.0,male,1939,white,None,Primary Tumor,5.0,None,0.0,71.0,15.0,10.0,90.0,TCGA-HZ-7918-01A,TCGA-HZ-7918,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A6VY,17640.0,female,1965,black or african american,29,Primary Tumor,0.0,0.0,0.0,90.0,5.0,44.0,55.0,TCGA-A7-A6VY-01A,TCGA-A7-A6VY,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2L-AAQJ,18103.0,female,1961,white,1254,Primary Tumor,20.0,20.0,10.0,40.0,40.0,50.0,40.0,TCGA-2L-AAQJ-01A,TCGA-2L-AAQJ,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4LX,29915.0,male,1931,white,127,Primary Tumor,0.0,2.0,0.0,65.0,15.0,0.0,100.0,TCGA-97-A4LX-01A,TCGA-97-A4LX,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TV,24279.0,female,1939,not reported,1716,Primary Tumor,0.0,0.0,0.0,85.0,2.0,13.0,85.0,TCGA-AR-A0TV-01A,TCGA-AR-A0TV,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-KB-A93G,24924.0,male,1945,white,301,Primary Tumor,10.0,20.0,0.0,80.0,60.0,20.0,80.0,TCGA-KB-A93G-01A,TCGA-KB-A93G,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A6RR,30734.0,male,1929,white,126,Primary Tumor,5.0,1.0,5.0,70.0,3.0,25.0,70.0,TCGA-IN-A6RR-01A,TCGA-IN-A6RR,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-A567,20493.0,male,1951,black or african american,2056,Primary Tumor,2.0,1.0,10.0,65.0,5.0,25.0,65.0,TCGA-A6-A567-01A,TCGA-A6-A567,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A03J,23986.0,female,1939,not reported,2193,Primary Tumor,2.0,2.0,7.0,82.0,6.0,10.0,76.0,TCGA-AA-A03J-01A,TCGA-AA-A03J,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA6G,25091.0,male,1943,white,878,Primary Tumor,0.0,0.0,0.0,60.0,5.0,0.0,100.0,TCGA-VQ-AA6G-01A,TCGA-VQ-AA6G,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1488,21726.0,female,1943,white,None,Primary Tumor,5.0,None,0.0,95.0,95.0,15.0,80.0,TCGA-13-1488-01A,TCGA-13-1488,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A02H,27362.0,female,1933,not reported,855,Primary Tumor,2.0,4.0,5.0,75.0,10.0,15.0,75.0,TCGA-AA-A02H-01A,TCGA-AA-A02H,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6608,20094.0,female,1954,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,87.0,TCGA-AZ-6608-01A,TCGA-AZ-6608,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4280,28515.0,female,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,80.0,TCGA-BR-4280-01A,TCGA-BR-4280,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-31-1953,19064.0,female,1956,asian,None,Primary Tumor,None,None,0.0,95.0,3.0,10.0,90.0,TCGA-31-1953-01A,TCGA-31-1953,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4443,24990.0,male,1938,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,87.0,TCGA-CG-4443-01A,TCGA-CG-4443,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7141,23584.0,male,1939,white,None,Primary Tumor,None,None,18.0,75.0,None,10.0,62.0,TCGA-77-7141-01A,TCGA-77-7141,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TX,13708.0,male,1974,white,919,Primary Tumor,0.0,5.0,0.0,95.0,90.0,5.0,95.0,TCGA-GS-A9TX-01A,TCGA-GS-A9TX,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3406,24477.0,male,1936,white,None,Primary Tumor,None,None,5.0,60.0,20.0,34.0,60.0,TCGA-18-3406-01A,TCGA-18-3406,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-8047,13996.0,female,1973,asian,None,Primary Tumor,0.0,0.0,0.0,95.0,2.0,0.0,100.0,TCGA-FF-8047-01A,TCGA-FF-8047,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1078,28125.0,male,1929,white,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-21-1078-01A,TCGA-21-1078,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A6QY,26216.0,male,1942,white,169,Primary Tumor,0.0,0.0,7.0,80.0,3.0,13.0,75.0,TCGA-EB-A6QY-01A,TCGA-EB-A6QY,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JC,15452.0,male,1970,white,482,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-UF-A7JC-01A,TCGA-UF-A7JC,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7053,20837.0,female,1950,black or african american,None,Primary Tumor,0.0,5.0,0.0,80.0,2.0,0.0,100.0,TCGA-BQ-7053-01A,TCGA-BQ-7053,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6T,23198.0,male,1950,white,186,Primary Tumor,0.0,0.0,25.0,65.0,2.0,0.0,75.0,TCGA-DK-AA6T-01A,TCGA-DK-AA6T,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-O9-A75Z,16183.0,male,1969,white,149,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-O9-A75Z-01A,TCGA-O9-A75Z,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-7592,21041.0,male,1954,american indian or alaska native,None,Primary Tumor,None,None,0.0,75.0,15.0,15.0,85.0,TCGA-DQ-7592-01A,TCGA-DQ-7592,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A4MQ,16990.0,male,1964,asian,647,Primary Tumor,0.0,0.0,50.0,65.0,5.0,0.0,50.0,TCGA-LN-A4MQ-01A,TCGA-LN-A4MQ,3.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A880,23325.0,male,1948,white,728,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-WC-A880-01A,TCGA-WC-A880,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SM,27826.0,male,1928,white,3364,Primary Tumor,4.0,1.0,0.0,75.0,4.0,25.0,75.0,TCGA-XF-A9SM-01A,TCGA-XF-A9SM,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IA-A40X,18239.0,female,1962,black or african american,432,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-IA-A40X-01A,TCGA-IA-A40X,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA84,22397.0,male,1947,white,1880,Primary Tumor,0.0,0.0,0.0,93.0,4.0,8.0,86.0,TCGA-4Z-AA84-01A,TCGA-4Z-AA84,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A893,26143.0,female,1934,white,3030,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-L5-A893-01A,TCGA-L5-A893,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4CG,28637.0,female,1933,white,285,Primary Tumor,1.0,1.0,0.0,80.0,6.0,50.0,42.0,TCGA-CQ-A4CG-01A,TCGA-CQ-A4CG,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MZ-A7D7,18974.0,male,1962,white,99,Primary Tumor,0.0,0.0,10.0,75.0,10.0,20.0,70.0,TCGA-MZ-A7D7-01A,TCGA-MZ-A7D7,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4ON,23970.0,male,1945,white,848,Primary Tumor,1.0,0.0,5.0,80.0,4.0,0.0,95.0,TCGA-L5-A4ON-01A,TCGA-L5-A4ON,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-GL-7773,23239.0,male,1948,white,None,Primary Tumor,0.0,1.0,0.0,90.0,1.0,0.0,100.0,TCGA-GL-7773-01A,TCGA-GL-7773,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JP,23207.0,male,1948,white,762,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-2Z-A9JP-01A,TCGA-2Z-A9JP,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-H7-7774,27519.0,female,1936,white,None,Primary Tumor,1.0,0.0,0.0,65.0,25.0,10.0,90.0,TCGA-H7-7774-01A,TCGA-H7-7774,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7S,24111.0,male,1944,black or african american,1190,Primary Tumor,0.0,0.0,20.0,70.0,4.0,0.0,80.0,TCGA-4Z-AA7S-01A,TCGA-4Z-AA7S,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6224,19051.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CQ-6224-01A,TCGA-CQ-6224,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7393,9750.0,male,1983,white,None,Primary Tumor,0.0,0.0,0.0,60.0,35.0,25.0,75.0,TCGA-CR-7393-01A,TCGA-CR-7393,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6223,25266.0,male,1939,white,None,Primary Tumor,None,None,0.0,75.0,None,18.0,82.0,TCGA-CQ-6223-01A,TCGA-CQ-6223,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2K-A9WE,19603.0,male,1960,white,105,Primary Tumor,0.0,15.0,0.0,60.0,2.0,0.0,100.0,TCGA-2K-A9WE-01A,TCGA-2K-A9WE,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-AL-7173,26326.0,female,1936,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,52.0,TCGA-AL-7173-01A,TCGA-AL-7173,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7374,24558.0,female,1942,white,None,Primary Tumor,None,None,0.0,65.0,None,15.0,85.0,TCGA-CR-7374-01A,TCGA-CR-7374,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JD,26101.0,male,1941,not reported,576,Primary Tumor,0.0,0.0,0.0,90.0,0.0,40.0,60.0,TCGA-UF-A7JD-01A,TCGA-UF-A7JD,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9KC,18975.0,female,1962,white,139,Primary Tumor,0.0,8.0,0.0,65.0,2.0,0.0,100.0,TCGA-5P-A9KC-01A,TCGA-5P-A9KC,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DY-A1DC,26436.0,female,1928,white,3946,Primary Tumor,0.0,0.0,5.0,75.0,0.0,5.0,90.0,TCGA-DY-A1DC-01A,TCGA-DY-A1DC,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3894,23954.0,male,1944,not reported,None,Primary Tumor,None,None,0.0,80.0,None,12.0,83.0,TCGA-AG-3894-01A,TCGA-AG-3894,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A125,26466.0,female,1930,black or african american,3193,Primary Tumor,0.0,0.0,0.0,96.0,1.0,4.0,96.0,TCGA-AO-A125-01A,TCGA-AO-A125,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A2IU,22905.0,female,1936,white,4665,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-B6-A2IU-01A,TCGA-B6-A2IU,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5932,27454.0,male,1926,white,None,Primary Tumor,0.0,5.0,15.0,80.0,10.0,0.0,85.0,TCGA-50-5932-01A,TCGA-50-5932,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8636,21501.0,female,1954,white,None,Primary Tumor,None,None,0.0,25.0,None,70.0,30.0,TCGA-HZ-8636-01A,TCGA-HZ-8636,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XR,20381.0,female,1955,white,155,Primary Tumor,1.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-AN-A0XR-01A,TCGA-AN-A0XR,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3BB,16983.0,female,1965,black or african american,106,Primary Tumor,0.0,0.0,10.0,85.0,0.0,0.0,90.0,TCGA-AC-A3BB-01A,TCGA-AC-A3BB,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A27B,17763.0,female,1963,asian,93,Primary Tumor,50.0,10.0,0.0,90.0,30.0,5.0,90.0,TCGA-C8-A27B-01A,TCGA-C8-A27B,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7148,25990.0,male,1930,white,None,Primary Tumor,None,None,0.0,65.0,None,15.0,85.0,TCGA-78-7148-01A,TCGA-78-7148,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FG,29211.0,female,1928,white,1517,Primary Tumor,0.0,0.0,10.0,60.0,1.0,72.0,18.0,TCGA-AC-A2FG-01A,TCGA-AC-A2FG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XV,24779.0,female,1943,white,121,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-AN-A0XV-01A,TCGA-AN-A0XV,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A10B,24577.0,female,1940,white,1065,Primary Tumor,1.0,1.0,4.0,70.0,4.0,25.0,70.0,TCGA-E2-A10B-01A,TCGA-E2-A10B,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4417,18780.0,female,1957,not reported,None,Primary Tumor,None,None,15.0,70.0,None,10.0,72.0,TCGA-05-4417-01A,TCGA-05-4417,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A096,26723.0,female,1936,not reported,394,Primary Tumor,0.0,0.0,0.0,85.0,3.0,25.0,75.0,TCGA-A8-A096-01A,TCGA-A8-A096,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24V,19027.0,female,1954,white,1720,Primary Tumor,0.0,0.0,0.0,85.0,1.0,35.0,65.0,TCGA-AR-A24V-01A,TCGA-AR-A24V,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1IW,29529.0,female,1930,white,213,Primary Tumor,0.0,0.0,0.0,70.0,0.0,10.0,90.0,TCGA-EW-A1IW-01A,TCGA-EW-A1IW,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-5126,None,female,None,not reported,None,Primary Tumor,None,None,45.0,60.0,None,5.0,45.0,TCGA-75-5126-01A,TCGA-75-5126,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A1KI,23031.0,female,1940,white,2634,Primary Tumor,1.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-B6-A1KI-01A,TCGA-B6-A1KI,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0SV,23126.0,female,1943,white,1513,Primary Tumor,1.0,0.0,1.0,90.0,2.0,13.0,80.0,TCGA-A2-A0SV-01A,TCGA-A2-A0SV,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0ET,21464.0,female,1950,white,674,Primary Tumor,0.0,0.0,15.0,90.0,7.0,0.0,84.0,TCGA-A2-A0ET-01A,TCGA-A2-A0ET,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4250,29068.0,female,1928,not reported,None,Primary Tumor,None,None,5.0,85.0,None,5.0,87.0,TCGA-05-4250-01A,TCGA-05-4250,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FN,22629.0,female,1949,white,57,Primary Tumor,0.0,0.0,0.0,80.0,2.0,27.0,73.0,TCGA-AN-A0FN-01A,TCGA-AN-A0FN,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A085,16377.0,male,1964,not reported,788,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-A8-A085-01A,TCGA-A8-A085,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-6214,None,female,None,not reported,None,Primary Tumor,None,None,0.0,70.0,15.0,0.0,95.0,TCGA-75-6214-01A,TCGA-75-6214,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A97C,24735.0,female,1946,black or african american,216,Primary Tumor,0.0,0.0,5.0,65.0,4.0,25.0,65.0,TCGA-OL-A97C-01A,TCGA-OL-A97C,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09V,18628.0,female,1958,not reported,333,Primary Tumor,0.0,0.0,0.0,75.0,1.0,25.0,75.0,TCGA-A8-A09V-01A,TCGA-A8-A09V,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-80-5608,None,female,None,not reported,None,Primary Tumor,None,None,0.0,90.0,3.0,5.0,95.0,TCGA-80-5608-01A,TCGA-80-5608,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-80-5611,None,male,None,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,85.0,TCGA-80-5611-01A,TCGA-80-5611,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A049,22710.0,female,1946,white,769,Primary Tumor,0.0,0.0,0.0,90.0,1.0,38.0,60.0,TCGA-AN-A049-01A,TCGA-AN-A049,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A408,20102.0,female,1953,black or african american,1500,Primary Tumor,2.0,2.0,1.0,75.0,4.0,23.0,75.0,TCGA-B6-A408-01A,TCGA-B6-A408,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7760,26777.0,male,1938,white,None,Primary Tumor,None,None,0.0,65.0,None,25.0,70.0,TCGA-69-7760-01A,TCGA-69-7760,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A46R,20063.0,female,1952,white,2071,Primary Tumor,0.0,0.0,0.0,60.0,20.0,0.0,100.0,TCGA-62-A46R-01A,TCGA-62-A46R,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XL,12668.0,female,1976,white,282,Primary Tumor,0.0,0.0,0.0,75.0,2.0,43.0,50.0,TCGA-D8-A1XL-01A,TCGA-D8-A1XL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A26H,26423.0,female,1939,white,79,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,60.0,TCGA-A7-A26H-01A,TCGA-A7-A26H,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7537,26610.0,male,1930,not reported,None,Primary Tumor,0.0,0.0,0.0,80.0,10.0,0.0,100.0,TCGA-78-7537-01A,TCGA-78-7537,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0AD,30407.0,female,1924,not reported,1033,Primary Tumor,0.0,0.0,2.0,80.0,7.0,38.0,58.0,TCGA-A8-A0AD-01A,TCGA-A8-A0AD,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-5429,22066.0,male,1950,not reported,None,Primary Tumor,5.0,1.0,0.0,80.0,5.0,0.0,100.0,TCGA-05-5429-01A,TCGA-05-5429,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A6R9,22325.0,female,1951,white,237,Primary Tumor,2.0,2.0,10.0,80.0,5.0,5.0,80.0,TCGA-BH-A6R9-01A,TCGA-BH-A6R9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5RU,23108.0,female,1947,black or african american,826,Primary Tumor,0.0,2.0,2.0,65.0,10.0,65.0,30.0,TCGA-OL-A5RU-01A,TCGA-OL-A5RU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A1KO,16817.0,female,1962,white,832,Primary Tumor,1.0,1.0,10.0,70.0,2.0,20.0,70.0,TCGA-AO-A1KO-01A,TCGA-AO-A1KO,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A513,21967.0,female,1952,asian,97,Primary Tumor,1.0,15.0,0.0,60.0,10.0,50.0,50.0,TCGA-85-A513-01A,TCGA-85-A513,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8345,27412.0,male,1933,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,90.0,TCGA-KL-8345-01A,TCGA-KL-8345,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JU,22591.0,female,1950,white,588,Primary Tumor,50.0,0.0,0.0,70.0,50.0,30.0,60.0,TCGA-CV-A6JU-01A,TCGA-CV-A6JU,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4738,19621.0,male,1956,white,None,Primary Tumor,0.0,0.0,5.0,40.0,40.0,40.0,50.0,TCGA-CN-4738-01A,TCGA-CN-4738,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45Y,22442.0,male,1939,american indian or alaska native,4481,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,80.0,TCGA-CV-A45Y-01A,TCGA-CV-A45Y,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-7848,17251.0,male,1964,white,None,Primary Tumor,5.0,0.0,0.0,75.0,15.0,0.0,100.0,TCGA-F7-7848-01A,TCGA-F7-7848,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3JZ,20420.0,male,1956,white,132,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,100.0,TCGA-GV-A3JZ-01A,TCGA-GV-A3JZ,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMX,31884.0,female,1919,black or african american,2730,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-XF-AAMX-01A,TCGA-XF-AAMX,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MT-A51W,19098.0,female,1960,white,49,Primary Tumor,0.0,0.0,0.0,90.0,3.0,20.0,80.0,TCGA-MT-A51W-01A,TCGA-MT-A51W,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A3MI,22716.0,male,1949,asian,57,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-CF-A3MI-01A,TCGA-CF-A3MI,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-7071,27928.0,female,1934,white,None,Primary Tumor,None,None,0.0,60.0,35.0,15.0,85.0,TCGA-CQ-7071-01A,TCGA-CQ-7071,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R9,21491.0,male,1952,white,1239,Primary Tumor,0.0,0.0,0.0,60.0,2.0,0.0,100.0,TCGA-ZF-A9R9-01A,TCGA-ZF-A9R9,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A47X,22200.0,male,1952,asian,151,Primary Tumor,0.0,1.0,0.0,80.0,3.0,0.0,95.0,TCGA-CF-A47X-01A,TCGA-CF-A47X,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-A42P,26546.0,male,1940,white,176,Primary Tumor,2.0,2.0,0.0,75.0,6.0,25.0,75.0,TCGA-GU-A42P-01A,TCGA-GU-A42P,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OO,27757.0,male,1935,white,901,Primary Tumor,1.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-L5-A4OO-01A,TCGA-L5-A4OO,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SX,23349.0,female,1943,white,2702,Primary Tumor,0.0,0.0,10.0,60.0,90.0,40.0,50.0,TCGA-XF-A9SX-01A,TCGA-XF-A9SX,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A4IF,21635.0,male,1952,white,483,Primary Tumor,0.0,1.0,0.0,100.0,2.0,50.0,50.0,TCGA-BA-A4IF-01A,TCGA-BA-A4IF,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7376,30670.0,male,1926,white,None,Primary Tumor,None,None,0.0,60.0,None,5.0,95.0,TCGA-CR-7376-01A,TCGA-CR-7376,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A562,20933.0,male,1955,black or african american,160,Primary Tumor,0.0,100.0,0.0,90.0,0.0,10.0,90.0,TCGA-MH-A562-01A,TCGA-MH-A562,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA71,25950.0,male,1942,white,337,Primary Tumor,5.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-DK-AA71-01A,TCGA-DK-AA71,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-A6UO,22506.0,female,1951,white,201,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-BB-A6UO-01A,TCGA-BB-A6UO,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4742,17793.0,female,1960,white,None,Primary Tumor,None,None,0.0,65.0,None,30.0,70.0,TCGA-CN-4742-01A,TCGA-CN-4742,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3N5,25342.0,male,1942,black or african american,260,Primary Tumor,1.0,1.0,0.0,80.0,2.0,13.0,80.0,TCGA-FD-A3N5-01A,TCGA-FD-A3N5,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-5556,21444.0,female,1952,white,None,Primary Tumor,None,None,0.0,65.0,None,35.0,65.0,TCGA-BA-5556-01A,TCGA-BA-5556,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5444,23650.0,male,1940,black or african american,None,Primary Tumor,None,None,0.0,60.0,None,70.0,30.0,TCGA-CV-5444-01A,TCGA-CV-5444,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-T2-A6X0,18114.0,male,1963,white,314,Primary Tumor,1.0,0.0,0.0,75.0,8.0,0.0,100.0,TCGA-T2-A6X0-01A,TCGA-T2-A6X0,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6824,22633.0,male,1949,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-D6-6824-01A,TCGA-D6-6824,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FJ-A3Z7,28052.0,male,1934,white,539,Primary Tumor,2.0,2.0,0.0,75.0,3.0,21.0,75.0,TCGA-FJ-A3Z7-01A,TCGA-FJ-A3Z7,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A1A7,24499.0,female,1943,white,164,Primary Tumor,1.0,1.0,0.0,85.0,2.0,14.0,85.0,TCGA-DK-A1A7-01A,TCGA-DK-A1A7,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A42E,27045.0,male,1938,white,143,Primary Tumor,3.0,2.0,0.0,70.0,7.0,27.0,70.0,TCGA-BT-A42E-01A,TCGA-BT-A42E,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A8HF,29288.0,male,1924,white,3418,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-XF-A8HF-01A,TCGA-XF-A8HF,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-4A-A93X,21348.0,male,1955,white,62,Primary Tumor,1.0,1.0,0.0,95.0,2.0,20.0,60.0,TCGA-4A-A93X-01A,TCGA-4A-A93X,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R3,19384.0,female,1959,white,499,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ZF-A9R3-01A,TCGA-ZF-A9R3,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-4217,25020.0,male,1940,black or african american,None,Primary Tumor,None,None,6.0,80.0,10.0,0.0,73.0,TCGA-BB-4217-01A,TCGA-BB-4217,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6472,21654.0,male,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CR-6472-01A,TCGA-CR-6472,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6VC,22865.0,female,1951,black or african american,24,Primary Tumor,0.0,0.0,0.0,80.0,20.0,20.0,80.0,TCGA-QK-A6VC-01A,TCGA-QK-A6VC,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A43P,27201.0,male,1938,black or african american,168,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-FD-A43P-01A,TCGA-FD-A43P,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20P,29634.0,female,1924,white,2270,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BT-A20P-01A,TCGA-BT-A20P,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-FR-A726,32872,male,1923,white,140,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,80.0,TCGA-FR-A726-01A,TCGA-FR-A726,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8131,26611.0,male,1928,not reported,None,Primary Tumor,None,None,0.0,60.0,None,10.0,70.0,TCGA-77-8131-01A,TCGA-77-8131,1.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EO,27190.0,male,1939,white,272,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9EO-01A,TCGA-V4-A9EO,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TI,26874.0,male,1940,white,68,Primary Tumor,0.0,0.0,0.0,85.0,0.0,20.0,80.0,TCGA-FD-A6TI-01A,TCGA-FD-A6TI,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-7129,None,male,None,not reported,None,Primary Tumor,0.0,5.0,0.0,90.0,2.0,0.0,100.0,TCGA-HE-7129-01A,TCGA-HE-7129,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6DG,18052.0,male,1963,white,471,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-BA-A6DG-01A,TCGA-BA-A6DG,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA81,29457.0,male,1930,white,1400,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-4Z-AA81-01A,TCGA-4Z-AA81,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-XP-A8T8,18048.0,male,1962,black or african american,930,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-XP-A8T8-01A,TCGA-XP-A8T8,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RA,23359.0,female,1941,white,2958,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,90.0,TCGA-N5-A4RA-01A,TCGA-N5-A4RA,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9KA,22545.0,male,1952,white,220,Primary Tumor,0.0,5.0,0.0,70.0,2.0,0.0,100.0,TCGA-5P-A9KA-01A,TCGA-5P-A9KA,
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A6SG,22529.0,female,1952,white,26,Primary Tumor,0.0,0.0,0.0,70.0,10.0,50.0,50.0,TCGA-IQ-A6SG-01A,TCGA-IQ-A6SG,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-M9-A5M8,21433.0,male,None,not reported,None,Primary Tumor,20.0,20.0,0.0,90.0,40.0,10.0,90.0,TCGA-M9-A5M8-01A,TCGA-M9-A5M8,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A6AW,25644.0,male,1940,white,1183,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,80.0,TCGA-DK-A6AW-01A,TCGA-DK-A6AW,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-A5HZ,23906.0,male,1947,white,213,Primary Tumor,0.0,0.0,0.0,70.0,2.0,20.0,60.0,TCGA-BB-A5HZ-01A,TCGA-BB-A5HZ,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7840,22141.0,male,1951,black or african american,None,Primary Tumor,0.0,5.0,0.0,90.0,0.0,0.0,100.0,TCGA-DW-7840-01A,TCGA-DW-7840,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A1HS,27565.0,female,1935,asian,56,Primary Tumor,0.0,0.0,0.0,65.0,15.0,35.0,65.0,TCGA-CF-A1HS-01A,TCGA-CF-A1HS,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GH,16197.0,male,1954,not reported,5481,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-2H-A9GH-01A,TCGA-2H-A9GH,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-HQ-A2OF,19016.0,female,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-HQ-A2OF-01A,TCGA-HQ-A2OF,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5C1,22505.0,female,1948,white,1387,Primary Tumor,5.0,2.0,0.0,75.0,6.0,25.0,75.0,TCGA-FD-A5C1-01A,TCGA-FD-A5C1,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J1,26244.0,male,1937,white,2116,Primary Tumor,1.0,3.0,0.0,90.0,5.0,6.0,88.0,TCGA-2Z-A9J1-01A,TCGA-2Z-A9J1,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NU,30738.0,male,1917,white,4465,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-L5-A8NU-01A,TCGA-L5-A8NU,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-T2-A6WX,27005.0,female,1937,white,1017,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,97.0,TCGA-T2-A6WX-01A,TCGA-T2-A6WX,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-7588,24106.0,male,1944,white,None,Primary Tumor,None,None,0.0,85.0,10.0,15.0,85.0,TCGA-DQ-7588-01A,TCGA-DQ-7588,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6487,18331.0,male,1960,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CR-6487-01A,TCGA-CR-6487,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-C9-A480,16567.0,female,1966,asian,432,Primary Tumor,1.0,0.0,2.0,70.0,10.0,0.0,98.0,TCGA-C9-A480-01A,TCGA-C9-A480,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A4ZB,22455.0,male,1951,white,14,Primary Tumor,2.0,4.0,0.0,90.0,12.0,14.0,85.0,TCGA-D6-A4ZB-01A,TCGA-D6-A4ZB,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-8630,21884.0,female,1953,white,None,Primary Tumor,None,None,None,85.0,None,None,None,TCGA-A4-8630-01A,TCGA-A4-8630,1.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-ND-A4WC,30434.0,female,1928,asian,438,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,85.0,TCGA-ND-A4WC-01A,TCGA-ND-A4WC,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TG,26893.0,male,1940,white,69,Primary Tumor,0.0,0.0,0.0,75.0,0.0,40.0,60.0,TCGA-FD-A6TG-01A,TCGA-FD-A6TG,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FJ-A3Z9,26515.0,male,1940,white,110,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,90.0,TCGA-FJ-A3Z9-01A,TCGA-FJ-A3Z9,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A4XJ,24279.0,male,1946,asian,82,Primary Tumor,0.0,0.0,0.0,80.0,0.0,15.0,85.0,TCGA-E7-A4XJ-01A,TCGA-E7-A4XJ,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OU,29674.0,male,1928,white,1233,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-L5-A4OU-01A,TCGA-L5-A4OU,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7104,22349.0,female,1939,white,None,Primary Tumor,None,None,15.0,60.0,None,35.0,50.0,TCGA-CV-7104-01A,TCGA-CV-7104,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA52,25579.0,male,1939,white,1543,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,70.0,TCGA-ZF-AA52-01A,TCGA-ZF-AA52,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-A69E,26198.0,male,1942,white,112,Primary Tumor,1.0,3.0,0.0,80.0,2.0,20.0,80.0,TCGA-B9-A69E-01A,TCGA-B9-A69E,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A8HX,20259.0,female,1958,asian,119,Primary Tumor,1.0,0.0,0.0,92.0,3.0,23.0,75.0,TCGA-CF-A8HX-01A,TCGA-CF-A8HX,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-KQ-A41S,32041.0,female,1924,white,321,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-KQ-A41S-01A,TCGA-KQ-A41S,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-T3-A92N,28879.0,male,1934,black or african american,68,Primary Tumor,0.0,0.0,0.0,90.0,5.0,10.0,90.0,TCGA-T3-A92N-01A,TCGA-T3-A92N,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A8Z8,22107.0,female,1953,black or african american,50,Primary Tumor,0.0,0.0,5.0,90.0,0.0,5.0,90.0,TCGA-QK-A8Z8-01A,TCGA-QK-A8Z8,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMJ,25838.0,male,1936,asian,2914,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-XF-AAMJ-01A,TCGA-XF-AAMJ,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-S8-A6BW,18944.0,male,1961,white,222,Primary Tumor,1.0,1.0,0.0,75.0,4.0,54.0,40.0,TCGA-S8-A6BW-01A,TCGA-S8-A6BW,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BZ,28451.0,female,1932,white,1304,Primary Tumor,4.0,2.0,0.0,75.0,6.0,21.0,75.0,TCGA-FD-A5BZ-01A,TCGA-FD-A5BZ,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-C4-A0F6,29951.0,female,1926,not reported,568,Primary Tumor,1.0,0.0,12.0,75.0,2.0,12.0,75.0,TCGA-C4-A0F6-01A,TCGA-C4-A0F6,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3B5,31442.0,male,1925,black or african american,218,Primary Tumor,1.0,0.0,0.0,85.0,2.0,26.0,70.0,TCGA-FD-A3B5-01A,TCGA-FD-A3B5,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GD-A6C6,23631.0,male,1948,white,328,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,87.0,TCGA-GD-A6C6-01A,TCGA-GD-A6C6,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4C6,23205.0,male,1947,asian,847,Primary Tumor,0.0,0.0,0.0,99.0,0.0,5.0,85.0,TCGA-CQ-A4C6-01A,TCGA-CQ-A4C6,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A499,21971.0,female,1951,white,293,Primary Tumor,0.0,0.0,0.0,90.0,5.0,10.0,90.0,TCGA-CN-A499-01A,TCGA-CN-A499,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JF,29468.0,male,1930,white,1219,Primary Tumor,0.0,0.0,0.0,75.0,0.0,35.0,65.0,TCGA-UF-A7JF-01A,TCGA-UF-A7JF,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N6-A4VC,30643.0,female,1926,white,1268,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-N6-A4VC-01A,TCGA-N6-A4VC,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CX-A4AQ,20709.0,male,1952,white,1659,Primary Tumor,0.0,0.0,0.0,80.0,10.0,48.0,50.0,TCGA-CX-A4AQ-01A,TCGA-CX-A4AQ,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JS,27053.0,male,1938,white,412,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-2Z-A9JS-01A,TCGA-2Z-A9JS,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OW,20796.0,female,1950,not reported,2444,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,98.0,TCGA-L5-A4OW-01A,TCGA-L5-A4OW,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6491,22125.0,male,1950,black or african american,None,Primary Tumor,None,None,0.0,90.0,None,30.0,70.0,TCGA-CR-6491-01A,TCGA-CR-6491,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A2LA,20032.0,male,1956,white,257,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-BT-A2LA-01A,TCGA-BT-A2LA,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-ND-A4W6,24835.0,female,1945,black or african american,351,Primary Tumor,0.0,1.0,0.0,100.0,4.0,10.0,90.0,TCGA-ND-A4W6-01A,TCGA-ND-A4W6,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7Q,28981.0,male,1933,white,518,Primary Tumor,5.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-4Z-AA7Q-01A,TCGA-4Z-AA7Q,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7388,25728.0,female,1938,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-CR-7388-01A,TCGA-CR-7388,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20V,21551.0,female,1949,black or african american,1072,Primary Tumor,0.0,0.0,0.0,60.0,0.0,35.0,60.0,TCGA-BT-A20V-01A,TCGA-BT-A20V,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7421,27961.0,male,1921,white,None,Primary Tumor,0.0,0.0,0.0,75.0,5.0,0.0,100.0,TCGA-CV-7421-01A,TCGA-CV-7421,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N6-A4VF,18806.0,female,1958,white,1154,Primary Tumor,0.0,0.0,0.0,60.0,1.0,0.0,100.0,TCGA-N6-A4VF-01A,TCGA-N6-A4VF,1.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N6-A4VG,28428.0,female,1933,white,825,Primary Tumor,40.0,20.0,0.0,90.0,20.0,5.0,90.0,TCGA-N6-A4VG-01A,TCGA-N6-A4VG,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A71D,19747.0,female,1956,white,950,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-UF-A71D-01A,TCGA-UF-A71D,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GL,27115.0,male,1926,not reported,5051,Primary Tumor,3.0,1.0,0.0,70.0,25.0,40.0,55.0,TCGA-2H-A9GL-01A,TCGA-2H-A9GL,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9T8,23403.0,male,1944,white,1972,Primary Tumor,0.0,0.0,20.0,70.0,0.0,20.0,60.0,TCGA-XF-A9T8-01A,TCGA-XF-A9T8,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6222,23326.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CQ-6222-01A,TCGA-CQ-6222,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IU,21369.0,male,1953,white,261,Primary Tumor,0.0,0.0,25.0,90.0,5.0,0.0,75.0,TCGA-DK-A3IU-01A,TCGA-DK-A3IU,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-2F-A9KT,30520.0,male,1923,white,2898,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-2F-A9KT-01A,TCGA-2F-A9KT,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-7072,18841.0,male,1956,white,None,Primary Tumor,5.0,0.0,0.0,62.0,10.0,0.0,100.0,TCGA-CQ-7072-01A,TCGA-CQ-7072,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5ED,18698.0,male,1954,white,2879,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,80.0,TCGA-P4-A5ED-01A,TCGA-P4-A5ED,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-8098,26685.0,male,1938,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-A4-8098-01A,TCGA-A4-8098,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A71W,24110.0,male,1946,white,548,Primary Tumor,0.0,5.0,0.0,80.0,0.0,20.0,80.0,TCGA-SX-A71W-01A,TCGA-SX-A71W,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-5323,30173.0,male,1925,white,None,Primary Tumor,1.0,None,0.0,80.0,12.0,0.0,96.0,TCGA-CQ-5323-01A,TCGA-CQ-5323,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A718,22836.0,male,1947,white,1494,Primary Tumor,0.0,0.0,10.0,70.0,0.0,30.0,60.0,TCGA-UF-A718-01A,TCGA-UF-A718,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A71E,23071.0,male,1947,white,1004,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,100.0,TCGA-UF-A71E-01A,TCGA-UF-A71E,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6DL,21886.0,male,1953,white,228,Primary Tumor,1.0,0.0,10.0,65.0,10.0,0.0,90.0,TCGA-BA-A6DL-01A,TCGA-BA-A6DL,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A7DP,18364.0,female,1963,white,118,Primary Tumor,2.0,1.0,0.0,65.0,30.0,35.0,62.0,TCGA-IG-A7DP-01A,TCGA-IG-A7DP,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4729,26713.0,male,1937,white,None,Primary Tumor,None,None,15.0,75.0,None,20.0,65.0,TCGA-CN-4729-01A,TCGA-CN-4729,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9T5,28578.0,female,1930,white,2105,Primary Tumor,0.0,0.0,10.0,75.0,3.0,0.0,90.0,TCGA-XF-A9T5-01A,TCGA-XF-A9T5,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7422,22098.0,female,1937,white,None,Primary Tumor,5.0,0.0,0.0,60.0,25.0,40.0,60.0,TCGA-CV-7422-01A,TCGA-CV-7422,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9J7,23230.0,male,1944,white,2524,Primary Tumor,0.0,2.0,0.0,95.0,2.0,3.0,95.0,TCGA-2Z-A9J7-01A,TCGA-2Z-A9J7,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-S5-A6DX,30594.0,male,1930,white,113,Primary Tumor,0.0,0.0,0.0,65.0,4.0,0.0,100.0,TCGA-S5-A6DX-01A,TCGA-S5-A6DX,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A9FL,31099.0,male,1928,asian,294,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-CF-A9FL-01A,TCGA-CF-A9FL,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6488,25176.0,female,1942,white,None,Primary Tumor,None,None,5.0,85.0,None,10.0,85.0,TCGA-CR-6488-01A,TCGA-CR-6488,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3QH,24681.0,male,1944,white,162,Primary Tumor,1.0,1.0,0.0,80.0,8.0,0.0,85.0,TCGA-GV-A3QH-01A,TCGA-GV-A3QH,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA5P,23971.0,male,1948,white,85,Primary Tumor,0.0,0.0,0.0,90.0,0.0,25.0,75.0,TCGA-ZF-AA5P-01A,TCGA-ZF-AA5P,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-5631,19172.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-DQ-5631-01A,TCGA-DQ-5631,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-4113,23613.0,male,1938,black or african american,None,Primary Tumor,None,None,2.0,80.0,None,15.0,None,TCGA-B9-4113-01A,TCGA-B9-4113,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6988,17308.0,male,1964,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CN-6988-01A,TCGA-CN-6988,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JT,26375.0,female,1937,white,1631,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-UF-A7JT-01A,TCGA-UF-A7JT,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45X,17464.0,male,1953,white,4598,Primary Tumor,0.0,0.0,0.0,60.0,100.0,40.0,60.0,TCGA-CV-A45X-01A,TCGA-CV-A45X,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3NA,21936.0,male,1949,white,997,Primary Tumor,2.0,2.0,0.0,75.0,5.0,25.0,75.0,TCGA-FD-A3NA-01A,TCGA-FD-A3NA,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A497,23310.0,male,1948,not reported,450,Primary Tumor,0.0,0.0,15.0,80.0,30.0,5.0,80.0,TCGA-CN-A497-01A,TCGA-CN-A497,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7236,28250.0,female,1930,white,None,Primary Tumor,None,None,0.0,50.0,None,70.0,30.0,TCGA-CV-7236-01A,TCGA-CV-7236,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-AT-A5NU,28137.0,male,1934,white,714,Primary Tumor,0.0,0.0,0.0,65.0,2.0,0.0,100.0,TCGA-AT-A5NU-01A,TCGA-AT-A5NU,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-8200,17167.0,male,1964,not reported,None,Primary Tumor,None,None,10.0,60.0,None,30.0,60.0,TCGA-J4-8200-01A,TCGA-J4-8200,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A0IU,29063.0,female,1929,black or african american,636,Primary Tumor,1.0,0.0,0.0,85.0,7.0,15.0,55.0,TCGA-AX-A0IU-01A,TCGA-AX-A0IU,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZP-A9D0,24525.0,female,1944,black or african american,723,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-ZP-A9D0-01A,TCGA-ZP-A9D0,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-KR-A7K0,23974.0,male,1948,white,126,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-KR-A7K0-01A,TCGA-KR-A7K0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-M7-A724,23595.0,male,1948,not reported,351,Primary Tumor,20.0,20.0,0.0,90.0,40.0,8.0,90.0,TCGA-M7-A724-01A,TCGA-M7-A724,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A0IW,24488.0,female,1941,white,854,Primary Tumor,0.0,0.0,0.0,75.0,15.0,25.0,70.0,TCGA-AX-A0IW-01A,TCGA-AX-A0IW,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CC,23795.0,female,1945,white,356,Primary Tumor,1.0,1.0,10.0,65.0,20.0,20.0,68.0,TCGA-AX-A1CC-01A,TCGA-AX-A1CC,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1H0,20937.0,female,1953,black or african american,262,Primary Tumor,30.0,20.0,0.0,70.0,30.0,25.0,70.0,TCGA-EY-A1H0-01A,TCGA-EY-A1H0,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A2QO,31222.0,female,1926,white,174,Primary Tumor,0.0,0.0,0.0,65.0,0.0,30.0,55.0,TCGA-AJ-A2QO-01A,TCGA-AJ-A2QO,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A73B,26390.0,female,1940,white,345,Primary Tumor,0.0,1.0,0.0,96.0,1.0,2.0,96.0,TCGA-DD-A73B-01A,TCGA-DD-A73B,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9LY,21942.0,male,1952,not reported,404,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-ZG-A9LY-01A,TCGA-ZG-A9LY,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-FC-A4JI,25931.0,male,1942,not reported,101,Primary Tumor,0.0,0.0,0.0,90.0,0.0,7.0,90.0,TCGA-FC-A4JI-01A,TCGA-FC-A4JI,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A97K,20073.0,male,1959,asian,92,Primary Tumor,0.0,0.0,10.0,60.0,0.0,40.0,50.0,TCGA-ED-A97K-01A,TCGA-ED-A97K,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAD5,19748.0,male,1957,asian,1058,Primary Tumor,0.0,0.0,0.0,95.0,3.0,3.0,94.0,TCGA-DD-AAD5-01A,TCGA-DD-AAD5,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E1,21063.0,male,1951,not reported,1598,Primary Tumor,0.0,0.0,0.0,70.0,0.0,15.0,75.0,TCGA-KK-A6E1-01A,TCGA-KK-A6E1,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7AZ,20507.0,male,1954,not reported,1045,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-KK-A7AZ-01A,TCGA-KK-A7AZ,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0RY,24952.0,female,1942,white,49,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BG-A0RY-01A,TCGA-BG-A0RY,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A1OK,23179.0,female,1947,white,113,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-A5-A1OK-01A,TCGA-A5-A1OK,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7077,23636.0,male,1942,black or african american,None,Primary Tumor,None,None,5.0,85.0,None,10.0,85.0,TCGA-HC-7077-01A,TCGA-HC-7077,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3BF,23906.0,female,1946,white,92,Primary Tumor,0.0,1.0,5.0,90.0,2.0,3.0,90.0,TCGA-AJ-A3BF-01A,TCGA-AJ-A3BF,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E6,25320.0,male,1933,not reported,3813,Primary Tumor,0.0,0.0,2.0,80.0,2.0,57.0,40.0,TCGA-KK-A6E6-01A,TCGA-KK-A6E6,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7IF,21845.0,male,1954,asian,236,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-CC-A7IF-01A,TCGA-CC-A7IF,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A8QX,20683.0,male,1957,not reported,167,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-ZG-A8QX-01A,TCGA-ZG-A8QX,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7212,20576.0,male,1955,white,None,Primary Tumor,None,None,5.0,75.0,None,18.0,75.0,TCGA-HC-7212-01A,TCGA-HC-7212,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A8CL,24145.0,male,1947,not reported,278,Primary Tumor,0.0,0.0,0.0,85.0,0.0,25.0,75.0,TCGA-J9-A8CL-01A,TCGA-J9-A8CL,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2EX,21489.0,female,1947,white,2201,Primary Tumor,20.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-FI-A2EX-01A,TCGA-FI-A2EX,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A7PY,7556.0,female,1993,asian,83,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ED-A7PY-01A,TCGA-ED-A7PY,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39X,28528.0,female,1920,white,4705,Primary Tumor,0.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-DD-A39X-01A,TCGA-DD-A39X,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2EW,26267.0,female,1934,black or african american,2321,Primary Tumor,20.0,20.0,0.0,85.0,40.0,10.0,85.0,TCGA-FI-A2EW-01A,TCGA-FI-A2EW,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CR,25812.0,female,1940,white,274,Primary Tumor,1.0,0.0,10.0,88.0,4.0,9.0,80.0,TCGA-AX-A1CR-01A,TCGA-AX-A1CR,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1O7,22037.0,female,1950,white,154,Primary Tumor,40.0,10.0,10.0,70.0,40.0,15.0,70.0,TCGA-D1-A1O7-01A,TCGA-D1-A1O7,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A72D,31818.0,female,1926,black or african american,120,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-EY-A72D-01A,TCGA-EY-A72D,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3KU,25116.0,female,1943,not reported,93,Primary Tumor,15.0,5.0,0.0,90.0,5.0,10.0,80.0,TCGA-EO-A3KU-01A,TCGA-EO-A3KU,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2KV,20160.0,female,None,not reported,None,Primary Tumor,25.0,5.0,0.0,85.0,5.0,15.0,85.0,TCGA-DF-A2KV-01A,TCGA-DF-A2KV,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A8CM,24118.0,male,1947,not reported,238,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-J9-A8CM-01A,TCGA-J9-A8CM,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7IE,20985.0,male,1955,asian,243,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-CC-A7IE-01A,TCGA-CC-A7IE,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-O8-A75V,19850.0,male,1959,not reported,142,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-O8-A75V-01A,TCGA-O8-A75V,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-5260,22345.0,female,1949,asian,105,Primary Tumor,None,None,0.0,85.0,None,15.0,80.0,TCGA-CC-5260-01A,TCGA-CC-5260,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6AO,19298.0,male,1960,not reported,301,Primary Tumor,0.0,0.0,2.0,90.0,0.0,13.0,85.0,TCGA-HC-A6AO-01A,TCGA-HC-A6AO,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACI,25236.0,male,1939,asian,1870,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-DD-AACI-01A,TCGA-DD-AACI,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7IH,21381.0,male,1955,asian,181,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-CC-A7IH-01A,TCGA-CC-A7IH,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A3PV,24898.0,female,1935,black or african american,3199,Primary Tumor,0.0,0.0,0.0,65.0,0.0,35.0,65.0,TCGA-FI-A3PV-01A,TCGA-FI-A3PV,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GC,22656.0,female,1947,white,519,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EY-A1GC-01A,TCGA-EY-A1GC,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A23M,22430.0,female,1949,white,274,Primary Tumor,20.0,10.0,0.0,60.0,60.0,30.0,60.0,TCGA-AJ-A23M-01A,TCGA-AJ-A23M,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVW,12986.0,male,1973,asian,2156,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AAVW-01A,TCGA-DD-AAVW,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A3FC,19422.0,female,1953,black or african american,1814,Primary Tumor,0.0,2.0,0.0,95.0,1.0,0.0,95.0,TCGA-B5-A3FC-01A,TCGA-B5-A3FC,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A112,29511.0,male,1929,white,538,Primary Tumor,0.0,0.0,0.0,70.0,10.0,30.0,70.0,TCGA-BC-A112-01A,TCGA-BC-A112,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7748,22072.0,male,1951,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HC-7748-01A,TCGA-HC-7748,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACP,23728.0,male,1945,asian,1625,Primary Tumor,0.0,0.0,20.0,80.0,0.0,0.0,70.0,TCGA-DD-AACP-01A,TCGA-DD-AACP,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A627,27303.0,male,1938,white,157,Primary Tumor,0.0,0.0,20.0,65.0,8.0,0.0,80.0,TCGA-ED-A627-01A,TCGA-ED-A627,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8MM,22265.0,male,None,not reported,None,Primary Tumor,0.0,0.0,10.0,85.0,0.0,10.0,80.0,TCGA-V1-A8MM-01A,TCGA-V1-A8MM,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A7NH,20734.0,male,1957,not reported,230,Primary Tumor,0.0,0.0,20.0,75.0,6.0,45.0,35.0,TCGA-EJ-A7NH-01A,TCGA-EJ-A7NH,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-YA-A8S7,25188.0,male,1944,white,383,Primary Tumor,1.0,1.0,0.0,95.0,3.0,8.0,90.0,TCGA-YA-A8S7-01A,TCGA-YA-A8S7,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A9WX,25008.0,male,1941,not reported,1520,Primary Tumor,0.0,0.0,35.0,75.0,0.0,5.0,60.0,TCGA-YL-A9WX-01A,TCGA-YL-A9WX,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5745,24837.0,male,1940,white,None,Primary Tumor,0.0,0.0,2.0,75.0,0.0,33.0,65.0,TCGA-CH-5745-01A,TCGA-CH-5745,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-A7MA,22843.0,female,1951,white,109,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-UB-A7MA-01A,TCGA-UB-A7MA,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6339,21305.0,male,1949,not reported,None,Primary Tumor,0.0,0.0,15.0,60.0,0.0,45.0,40.0,TCGA-G9-6339-01A,TCGA-G9-6339,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5514,24165.0,male,1943,white,None,Primary Tumor,2.0,2.0,5.0,70.0,2.0,28.0,65.0,TCGA-EJ-5514-01A,TCGA-EJ-5514,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5496,21897.0,male,1950,white,None,Primary Tumor,0.0,2.0,20.0,45.0,4.0,35.0,45.0,TCGA-EJ-5496-01A,TCGA-EJ-5496,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-H9-7775,24898.0,male,1943,white,None,Primary Tumor,None,None,10.0,75.0,None,15.0,75.0,TCGA-H9-7775-01A,TCGA-H9-7775,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7213,19699.0,male,1957,white,None,Primary Tumor,None,None,0.0,90.0,None,8.0,90.0,TCGA-HC-7213-01A,TCGA-HC-7213,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAD6,24185.0,male,1945,asian,1035,Primary Tumor,0.0,1.0,0.0,96.0,2.0,3.0,92.0,TCGA-DD-AAD6-01A,TCGA-DD-AAD6,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7081,None,male,1948,white,None,Primary Tumor,None,None,10.0,70.0,None,20.0,70.0,TCGA-HC-7081-01A,TCGA-HC-7081,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACB,27103.0,female,1934,asian,2045,Primary Tumor,1.0,1.0,0.0,90.0,7.0,10.0,85.0,TCGA-DD-AACB-01A,TCGA-DD-AACB,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5792,21002.0,male,1952,white,None,Primary Tumor,0.0,2.0,20.0,60.0,3.0,25.0,55.0,TCGA-CH-5792-01A,TCGA-CH-5792,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A05J,24119.0,female,1942,white,566,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,85.0,TCGA-AP-A05J-01A,TCGA-AP-A05J,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8I6,21499.0,male,1953,not reported,808,Primary Tumor,0.0,0.0,0.0,70.0,2.0,0.0,100.0,TCGA-KK-A8I6-01A,TCGA-KK-A8I6,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JX,22834.0,female,1945,white,952,Primary Tumor,10.0,0.0,30.0,70.0,20.0,0.0,50.0,TCGA-B5-A0JX-01A,TCGA-B5-A0JX,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A76X,22756.0,male,1951,not reported,149,Primary Tumor,0.0,0.0,40.0,60.0,0.0,10.0,50.0,TCGA-HC-A76X-01A,TCGA-HC-A76X,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A22X,13245.0,female,1972,not reported,842,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-EO-A22X-01A,TCGA-EO-A22X,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88M,20157.0,male,1958,not reported,288,Primary Tumor,20.0,10.0,0.0,70.0,60.0,30.0,70.0,TCGA-VN-A88M-01A,TCGA-VN-A88M,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A547,27686.0,female,1936,black or african american,645,Primary Tumor,0.0,2.0,0.0,80.0,2.0,0.0,100.0,TCGA-EY-A547-01A,TCGA-EY-A547,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV0,21249.0,male,1955,asian,163,Primary Tumor,2.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-G3-AAV0-01A,TCGA-G3-AAV0,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-SL-A6J9,26701.0,female,1940,black or african american,86,Primary Tumor,0.0,5.0,0.0,90.0,0.0,10.0,90.0,TCGA-SL-A6J9-01A,TCGA-SL-A6J9,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8WS,20805.0,male,None,not reported,None,Primary Tumor,0.0,0.0,5.0,70.0,0.0,10.0,85.0,TCGA-V1-A8WS-01A,TCGA-V1-A8WS,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LG,20047.0,female,1948,white,2833,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,80.0,TCGA-AP-A0LG-01A,TCGA-AP-A0LG,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A175,17802.0,female,1961,white,566,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-D1-A175-01A,TCGA-D1-A175,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A2OM,20398.0,female,1956,white,176,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-EY-A2OM-01A,TCGA-EY-A2OM,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8HJ,21416.0,male,1951,not reported,1653,Primary Tumor,0.0,0.0,0.0,70.0,0.0,45.0,55.0,TCGA-YL-A8HJ-01A,TCGA-YL-A8HJ,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3335,15250.0,male,1965,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,90.0,TCGA-A3-3335-01A,TCGA-A3-3335,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4342,29032.0,male,1924,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,80.0,TCGA-BP-4342-01A,TCGA-BP-4342,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5104,32872,female,1912,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5104-01A,TCGA-B0-5104,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-4154,26882.0,female,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,15.0,85.0,TCGA-B8-4154-01A,TCGA-B8-4154,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6813,25651.0,male,1941,white,None,Primary Tumor,2.0,1.0,15.0,80.0,8.0,None,80.0,TCGA-F5-6813-01A,TCGA-F5-6813,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-4213,17237.0,female,1962,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,90.0,TCGA-32-4213-01A,TCGA-32-4213,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4986,27612.0,male,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4986-01A,TCGA-BP-4986,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0745,21884.0,male,1948,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,50.0,TCGA-06-0745-01A,TCGA-06-0745,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EF-5831,26331.0,male,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,80.0,TCGA-EF-5831-01A,TCGA-EF-5831,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4160,24720.0,male,1935,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-BP-4160-01A,TCGA-BP-4160,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4774,20827.0,female,1948,white,None,Primary Tumor,None,None,None,95.0,1.0,None,100.0,TCGA-BP-4774-01A,TCGA-BP-4774,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4756,23001.0,female,1941,asian,None,Primary Tumor,None,None,0.0,90.0,2.0,0.0,100.0,TCGA-BP-4756-01A,TCGA-BP-4756,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5988,14131.0,male,1968,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CZ-5988-01A,TCGA-CZ-5988,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-MM-A564,24916.0,male,1944,black or african american,173,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-MM-A564-01A,TCGA-MM-A564,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5215,22686.0,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-28-5215-01A,TCGA-28-5215,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-EU-5907,29863.0,male,1929,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-EU-5907-01A,TCGA-EU-5907,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AH-6903,17030.0,male,1964,white,None,Primary Tumor,None,None,3.0,75.0,None,25.0,69.0,TCGA-AH-6903-01A,TCGA-AH-6903,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5117,14612.0,male,1970,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5117-01A,TCGA-B0-5117,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4916,25470.0,female,1938,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4916-01A,TCGA-CJ-4916,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5098,19620.0,female,1945,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,10.0,75.0,TCGA-B0-5098-01A,TCGA-B0-5098,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4905,22864.0,female,1944,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4905-01A,TCGA-CJ-4905,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZH-A8Y4,21503.0,male,1952,white,1315,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-ZH-A8Y4-01A,TCGA-ZH-A8Y4,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-G6-A8L7,29883.0,female,1927,black or african american,1797,Primary Tumor,0.0,0.0,0.0,85.0,10.0,30.0,60.0,TCGA-G6-A8L7-01A,TCGA-G6-A8L7,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4999,20518.0,male,1951,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-4999-01A,TCGA-BP-4999,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5202,27556.0,male,1933,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5202-01A,TCGA-BP-5202,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-1980,26467.0,male,1936,white,None,Primary Tumor,None,None,95.0,0.0,None,5.0,0.0,TCGA-32-1980-01A,TCGA-32-1980,
GBM,Glioblastoma Multiforme,Brain,TCGA-16-0846,31111.0,male,1921,white,None,Primary Tumor,None,None,10.0,85.0,None,5.0,80.0,TCGA-16-0846-01A,TCGA-16-0846,
GBM,Glioblastoma Multiforme,Brain,TCGA-12-0619,21920.0,male,1943,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,95.0,TCGA-12-0619-01A,TCGA-12-0619,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5566,24717.0,female,1940,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-DV-5566-01A,TCGA-DV-5566,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5400,21819.0,female,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-5400-01A,TCGA-B0-5400,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-CL-5917,26084.0,female,1935,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,79.0,TCGA-CL-5917-01A,TCGA-CL-5917,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4987,15041.0,female,1965,asian,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-BP-4987-01A,TCGA-BP-4987,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5177,17147.0,female,1958,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-BP-5177-01A,TCGA-BP-5177,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3599,25749.0,male,1937,not reported,None,Primary Tumor,None,None,15.0,80.0,None,5.0,80.0,TCGA-AG-3599-01A,TCGA-AG-3599,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5675,25617.0,male,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,12.0,88.0,TCGA-CJ-5675-01A,TCGA-CJ-5675,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-A56L,17734.0,female,1960,black or african american,1685,Primary Tumor,1.0,0.0,12.0,60.0,5.0,0.0,85.0,TCGA-AF-A56L-01A,TCGA-AF-A56L,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4884,26475.0,female,1933,white,None,Primary Tumor,None,None,0.0,85.0,None,25.0,75.0,TCGA-CJ-4884-01A,TCGA-CJ-4884,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6883,23268.0,male,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,55.0,TCGA-EI-6883-01A,TCGA-EI-6883,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-2521,12685.0,male,1975,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,95.0,TCGA-27-2521-01A,TCGA-27-2521,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4763,29150.0,female,1925,white,None,Primary Tumor,None,None,24.0,75.0,1.0,None,76.0,TCGA-BP-4763-01A,TCGA-BP-4763,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4862,17077.0,male,1960,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CZ-4862-01A,TCGA-CZ-4862,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5195,27547.0,male,1933,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-5195-01A,TCGA-BP-5195,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5590,18905.0,male,1953,white,None,Primary Tumor,0.0,1.0,0.0,90.0,3.0,5.0,95.0,TCGA-CW-5590-01A,TCGA-CW-5590,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-15-0742,24050.0,male,1940,white,None,Primary Tumor,100.0,None,None,95.0,None,None,70.0,TCGA-15-0742-01A,TCGA-15-0742,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4353,22415.0,male,1946,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,73.0,TCGA-BP-4353-01A,TCGA-BP-4353,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2565,21559.0,male,1950,asian,None,Primary Tumor,None,None,0.0,85.0,None,0.0,98.0,TCGA-06-2565-01A,TCGA-06-2565,
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5208,19053.0,male,1958,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,90.0,TCGA-28-5208-01A,TCGA-28-5208,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-6136,26490.0,female,1939,white,None,Primary Tumor,5.0,0.0,16.0,75.0,15.0,0.0,83.0,TCGA-AF-6136-01A,TCGA-AF-6136,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-1753,19366.0,male,1956,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,65.0,TCGA-28-1753-01A,TCGA-28-1753,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3367,26489.0,male,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-A3-3367-01A,TCGA-A3-3367,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-EU-5906,20246.0,male,1955,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-EU-5906-01A,TCGA-EU-5906,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6811,26575.0,female,1939,white,None,Primary Tumor,2.0,None,5.0,80.0,12.0,None,93.0,TCGA-F5-6811-01A,TCGA-F5-6811,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4828,28948.0,male,1924,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4828-01A,TCGA-B0-4828,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3893,27272.0,male,1935,not reported,None,Primary Tumor,None,None,10.0,70.0,None,20.0,65.0,TCGA-AG-3893-01A,TCGA-AG-3893,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3376,18954.0,male,1955,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-A3-3376-01A,TCGA-A3-3376,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3883,25415.0,male,1939,not reported,None,Primary Tumor,None,None,0.0,70.0,None,30.0,55.0,TCGA-AG-3883-01A,TCGA-AG-3883,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6812,24490.0,male,1944,white,None,Primary Tumor,None,None,None,70.0,15.0,None,99.0,TCGA-F5-6812-01A,TCGA-F5-6812,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0238,17037.0,male,1961,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,95.0,TCGA-06-0238-01A,TCGA-06-0238,
GBM,Glioblastoma Multiforme,Brain,TCGA-28-2509,28240.0,female,1932,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,95.0,TCGA-28-2509-01A,TCGA-28-2509,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3609,23925.0,female,1943,not reported,None,Primary Tumor,None,None,0.0,91.0,None,15.0,75.0,TCGA-AG-3609-01A,TCGA-AG-3609,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4813,25018.0,male,1933,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-4813-01A,TCGA-B0-4813,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4887,17611.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CJ-4887-01A,TCGA-CJ-4887,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4865,25709.0,female,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CZ-4865-01A,TCGA-CZ-4865,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5456,21164.0,male,1949,white,None,Primary Tumor,0.0,2.0,0.0,90.0,2.0,15.0,85.0,TCGA-CZ-5456-01A,TCGA-CZ-5456,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5462,30659.0,male,1924,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CZ-5462-01A,TCGA-CZ-5462,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4330,22239.0,female,1942,black or african american,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-4330-01A,TCGA-BP-4330,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-5216,19239.0,male,1958,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,99.0,TCGA-28-5216-01A,TCGA-28-5216,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4169,27778.0,female,1927,white,None,Primary Tumor,None,None,10.0,80.0,None,5.0,85.0,TCGA-BP-4169-01A,TCGA-BP-4169,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3885,26145.0,female,1937,not reported,None,Primary Tumor,None,None,18.0,75.0,None,5.0,72.0,TCGA-AG-3885-01A,TCGA-AG-3885,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4340,25752.0,female,1933,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-4340-01A,TCGA-BP-4340,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4981,27676.0,female,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4981-01A,TCGA-BP-4981,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4894,21524.0,male,1947,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CJ-4894-01A,TCGA-CJ-4894,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DY-A1DG,27396.0,male,1925,white,3719,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DY-A1DG-01A,TCGA-DY-A1DG,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5377,25115.0,female,1942,white,None,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-B4-5377-01A,TCGA-B4-5377,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4861,23053.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,85.0,TCGA-CZ-4861-01A,TCGA-CZ-4861,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A02G,24259.0,male,1941,not reported,1097,Primary Tumor,2.0,2.0,0.0,80.0,10.0,5.0,93.0,TCGA-AG-A02G-01A,TCGA-AG-A02G,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5985,21242.0,male,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CZ-5985-01A,TCGA-CZ-5985,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5181,21514.0,female,1948,white,None,Primary Tumor,None,None,5.0,90.0,None,5.0,90.0,TCGA-BP-5181-01A,TCGA-BP-5181,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-19-2629,22257.0,male,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-19-2629-01A,TCGA-19-2629,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6682,21062.0,male,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,25.0,72.0,TCGA-DC-6682-01A,TCGA-DC-6682,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5464,25463.0,male,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,35.0,65.0,TCGA-CZ-5464-01A,TCGA-CZ-5464,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3732,28521.0,female,1927,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-AG-3732-01A,TCGA-AG-3732,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5411,18832.0,male,1959,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-06-5411-01A,TCGA-06-5411,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4841,23097.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-4841-01A,TCGA-B0-4841,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-14-2554,19090.0,female,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-14-2554-01A,TCGA-14-2554,
GBM,Glioblastoma Multiforme,Brain,TCGA-06-1804,29802.0,female,1928,white,None,Primary Tumor,None,None,30.0,60.0,None,5.0,60.0,TCGA-06-1804-01A,TCGA-06-1804,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-4007,31776.0,male,1920,not reported,None,Primary Tumor,None,None,10.0,75.0,None,5.0,80.0,TCGA-AG-4007-01A,TCGA-AG-4007,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-G6-A8L8,22649.0,female,1946,black or african american,1874,Primary Tumor,0.0,0.0,0.0,95.0,4.0,20.0,79.0,TCGA-G6-A8L8-01A,TCGA-G6-A8L8,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5706,16442.0,male,1959,white,None,Primary Tumor,0.0,0.0,0.0,75.0,15.0,10.0,90.0,TCGA-B0-5706-01A,TCGA-B0-5706,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3901,24502.0,female,1940,not reported,None,Primary Tumor,None,None,0.0,75.0,None,30.0,70.0,TCGA-AG-3901-01A,TCGA-AG-3901,3.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2W,11438.0,female,1979,white,1314,Primary Tumor,1.0,1.0,0.0,90.0,5.0,54.0,45.0,TCGA-W5-AA2W-01A,TCGA-W5-AA2W,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A020,20851.0,female,1948,not reported,1846,Primary Tumor,3.0,1.0,0.0,85.0,7.0,6.0,93.0,TCGA-AG-A020-01A,TCGA-AG-A020,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6510,28328.0,female,1933,white,None,Primary Tumor,None,None,15.0,75.0,None,10.0,60.0,TCGA-EI-6510-01A,TCGA-EI-6510,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4888,21701.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4888-01A,TCGA-CJ-4888,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4815,23873.0,male,1936,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-4815-01A,TCGA-B0-4815,3.0
GBM,Glioblastoma Multiforme,Brain,TCGA-02-0047,28759.0,male,1927,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,75.0,TCGA-02-0047-01A,TCGA-02-0047,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5402,23477.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5402-01A,TCGA-B0-5402,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0174,19824.0,male,1949,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,80.0,TCGA-06-0174-01A,TCGA-06-0174,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-A4VX,21670.0,male,1949,black or african american,1704,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-DV-A4VX-01A,TCGA-DV-A4VX,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5185,20470.0,male,1951,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5185-01A,TCGA-BP-5185,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4836,22488.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-B0-4836-01A,TCGA-B0-4836,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4176,23609.0,male,1941,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-BP-4176-01A,TCGA-BP-4176,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5102,27152.0,female,1925,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-B0-5102-01A,TCGA-B0-5102,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4918,23379.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4918-01A,TCGA-CJ-4918,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4977,20950.0,male,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4977-01A,TCGA-BP-4977,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-1831,24447.0,male,1940,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,85.0,TCGA-27-1831-01A,TCGA-27-1831,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4873,31096.0,female,1919,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CJ-4873-01A,TCGA-CJ-4873,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5110,25976.0,female,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-B0-5110-01A,TCGA-B0-5110,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5702,26186.0,male,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-B0-5702-01A,TCGA-B0-5702,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-6030,24096.0,male,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,77.0,TCGA-CJ-6030-01A,TCGA-CJ-6030,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4847,22147.0,male,1944,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4847-01A,TCGA-B0-4847,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4690,23985.0,male,1943,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,85.0,TCGA-B0-4690-01A,TCGA-B0-4690,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5092,19611.0,female,1955,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-B0-5092-01A,TCGA-B0-5092,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6160,24990.0,male,1941,white,None,Primary Tumor,None,None,20.0,75.0,None,10.0,65.0,TCGA-DC-6160-01A,TCGA-DC-6160,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4781,28701.0,male,1927,white,None,Primary Tumor,None,1.0,None,95.0,1.0,1.0,99.0,TCGA-BP-4781-01A,TCGA-BP-4781,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-6D-AA2E,25043.0,female,1945,black or african american,93,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,60.0,TCGA-6D-AA2E-01A,TCGA-6D-AA2E,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7160,22385.0,male,1947,white,None,Primary Tumor,None,None,0.0,60.0,None,15.0,85.0,TCGA-78-7160-01A,TCGA-78-7160,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-71-8520,21921.0,female,1951,asian,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-71-8520-01A,TCGA-71-8520,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24O,15977.0,female,1962,white,2213,Primary Tumor,1.0,1.0,3.0,80.0,2.0,17.0,80.0,TCGA-AR-A24O-01A,TCGA-AR-A24O,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A6IW,26896.0,female,1940,black or african american,74,Primary Tumor,0.0,0.0,0.0,60.0,15.0,0.0,100.0,TCGA-AC-A6IW-01A,TCGA-AC-A6IW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24W,20123.0,female,1951,white,1720,Primary Tumor,0.0,0.0,20.0,60.0,1.0,29.0,50.0,TCGA-AR-A24W-01A,TCGA-AR-A24W,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0D0,22115.0,female,1948,black or african american,720,Primary Tumor,0.0,0.0,0.0,90.0,2.0,8.0,90.0,TCGA-A2-A0D0-01A,TCGA-A2-A0D0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CR,20075.0,female,1950,asian,2191,Primary Tumor,0.0,0.0,3.0,80.0,100.0,57.0,40.0,TCGA-A2-A0CR-01A,TCGA-A2-A0CR,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FC,28706.0,female,1920,black or african american,4456,Primary Tumor,0.0,1.0,0.0,90.0,8.0,10.0,90.0,TCGA-BH-A1FC-01A,TCGA-BH-A1FC,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-S4-A8RM,24589.0,male,1946,white,323,Primary Tumor,0.0,0.0,30.0,40.0,0.0,40.0,30.0,TCGA-S4-A8RM-01A,TCGA-S4-A8RM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A13Y,19028.0,female,1958,white,184,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,88.0,TCGA-D8-A13Y-01A,TCGA-D8-A13Y,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7536,25558.0,male,1932,white,None,Primary Tumor,5.0,5.0,0.0,75.0,10.0,0.0,100.0,TCGA-78-7536-01A,TCGA-78-7536,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABU,20641.0,male,1956,white,495,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-2J-AABU-01A,TCGA-2J-AABU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BT,20625.0,female,1951,white,1167,Primary Tumor,0.0,0.0,0.0,70.0,2.0,20.0,79.0,TCGA-BH-A0BT-01A,TCGA-BH-A0BT,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-8398,20197.0,male,1952,white,None,Primary Tumor,None,5.0,0.0,70.0,20.0,0.0,95.0,TCGA-62-8398-01A,TCGA-62-8398,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JF,29199.0,female,1931,white,203,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-D8-A1JF-01A,TCGA-D8-A1JF,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IA,18748.0,female,1941,white,6664,Primary Tumor,0.0,0.0,0.0,85.0,1.0,14.0,85.0,TCGA-B6-A0IA-01A,TCGA-B6-A0IA,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5068,21728.0,female,1944,white,None,Primary Tumor,None,None,0.0,65.0,None,15.0,80.0,TCGA-50-5068-01A,TCGA-50-5068,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-US-A77J,29904.0,female,1929,white,1022,Primary Tumor,0.0,0.0,0.0,15.0,10.0,0.0,100.0,TCGA-US-A77J-01A,TCGA-US-A77J,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-7948,15363.0,female,1969,white,None,Primary Tumor,1.0,5.0,0.0,71.0,20.0,19.0,81.0,TCGA-95-7948-01A,TCGA-95-7948,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A106,12528.0,female,1972,asian,1495,Primary Tumor,0.0,0.0,0.0,85.0,1.0,33.0,65.0,TCGA-E2-A106-01A,TCGA-E2-A106,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-5146,None,male,None,not reported,None,Primary Tumor,None,None,0.0,60.0,None,10.0,90.0,TCGA-75-5146-01A,TCGA-75-5146,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-F2-6879,20984.0,male,1952,white,None,Primary Tumor,None,None,None,80.0,1.0,55.0,45.0,TCGA-F2-6879-01A,TCGA-F2-6879,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GI-A2C8,23103.0,female,1941,white,2429,Primary Tumor,0.0,0.0,0.0,85.0,1.0,25.0,55.0,TCGA-GI-A2C8-01A,TCGA-GI-A2C8,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-7027,None,male,None,not reported,None,Primary Tumor,None,None,0.0,70.0,None,15.0,77.0,TCGA-75-7027-01A,TCGA-75-7027,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0A6,23404.0,female,1945,not reported,394,Primary Tumor,0.0,0.0,3.0,75.0,2.0,20.0,75.0,TCGA-A8-A0A6-01A,TCGA-A8-A0A6,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-1594,25008.0,male,1937,white,None,Primary Tumor,None,None,5.0,90.0,None,5.0,80.0,TCGA-55-1594-01A,TCGA-55-1594,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8279,17032.0,male,1965,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,77.0,TCGA-86-8279-01A,TCGA-86-8279,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14N,13743.0,female,1970,white,1240,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-E2-A14N-01A,TCGA-E2-A14N,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A134,19010.0,female,1958,asian,162,Primary Tumor,0.0,5.0,20.0,0.0,1.0,80.0,0.0,TCGA-C8-A134-01A,TCGA-C8-A134,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A5YM,32478.0,female,1924,black or african american,131,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-LL-A5YM-01A,TCGA-LL-A5YM,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DC,21122.0,female,1949,white,1820,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-GM-A2DC-01A,TCGA-GM-A2DC,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7149,26285.0,male,1931,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,80.0,TCGA-78-7149-01A,TCGA-78-7149,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LD-A66U,16101.0,female,1968,white,183,Primary Tumor,0.0,0.0,5.0,80.0,0.0,5.0,90.0,TCGA-LD-A66U-01A,TCGA-LD-A66U,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A49I,28454.0,male,1935,white,17,Primary Tumor,1.0,0.0,40.0,5.0,15.0,55.0,5.0,TCGA-HZ-A49I-01A,TCGA-HZ-A49I,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L9-A443,23062.0,female,1949,white,50,Primary Tumor,0.0,0.0,0.0,65.0,2.0,52.0,45.0,TCGA-L9-A443-01A,TCGA-L9-A443,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T7,18756.0,female,1958,white,280,Primary Tumor,20.0,10.0,0.0,80.0,30.0,15.0,80.0,TCGA-A2-A0T7-01A,TCGA-A2-A0T7,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A77P,28403.0,male,1936,white,84,Primary Tumor,0.0,0.0,65.0,15.0,4.0,0.0,35.0,TCGA-HZ-A77P-01A,TCGA-HZ-A77P,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-6206,None,male,None,not reported,None,Primary Tumor,0.0,2.0,0.0,80.0,10.0,0.0,100.0,TCGA-75-6206-01A,TCGA-75-6206,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4501,24817.0,female,1929,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,70.0,TCGA-49-4501-01A,TCGA-49-4501,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1F0,29335.0,female,1920,white,3879,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,93.0,TCGA-BH-A1F0-01A,TCGA-BH-A1F0,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUR,24576.0,male,1946,white,79,Primary Tumor,9.0,1.0,20.0,10.0,7.0,70.0,10.0,TCGA-IB-AAUR-01A,TCGA-IB-AAUR,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A3NW,23041.0,female,1940,white,3110,Primary Tumor,0.0,0.0,10.0,75.0,1.0,60.0,30.0,TCGA-GM-A3NW-01A,TCGA-GM-A3NW,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-4B-A93V,19035.0,female,1961,black or african american,84,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,80.0,TCGA-4B-A93V-01A,TCGA-4B-A93V,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A73W,29125.0,female,1934,white,191,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-D8-A73W-01A,TCGA-D8-A73W,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XO,21640.0,female,1951,white,163,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-AN-A0XO-01A,TCGA-AN-A0XO,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CT,25959.0,female,1934,white,1931,Primary Tumor,0.0,0.0,10.0,88.0,4.0,10.0,79.0,TCGA-A2-A0CT-01A,TCGA-A2-A0CT,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-US-A77E,26745.0,male,1939,white,468,Primary Tumor,1.0,1.0,0.0,50.0,8.0,76.0,20.0,TCGA-US-A77E-01A,TCGA-US-A77E,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A6S9,12755.0,female,1979,black or african american,139,Primary Tumor,0.0,0.0,20.0,80.0,0.0,10.0,70.0,TCGA-EW-A6S9-01A,TCGA-EW-A6S9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0CD,24242.0,female,1943,white,157,Primary Tumor,0.0,0.0,7.0,85.0,7.0,26.0,65.0,TCGA-A7-A0CD-01A,TCGA-A7-A0CD,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A6VR,17702.0,female,1963,black or african american,869,Primary Tumor,0.0,0.0,3.0,75.0,3.0,75.0,20.0,TCGA-OL-A6VR-01A,TCGA-OL-A6VR,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A3Z5,19846.0,female,1957,white,418,Primary Tumor,0.0,0.0,10.0,75.0,0.0,50.0,40.0,TCGA-D8-A3Z5-01A,TCGA-D8-A3Z5,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12Y,None,female,1966,asian,57,Primary Tumor,1.0,1.0,0.0,80.0,1.0,20.0,80.0,TCGA-C8-A12Y-01A,TCGA-C8-A12Y,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RM,21047.0,female,1936,black or african american,6279,Primary Tumor,0.0,0.0,0.0,85.0,1.0,25.0,75.0,TCGA-B6-A0RM-01A,TCGA-B6-A0RM,
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABI,20316.0,female,1956,white,774,Primary Tumor,9.0,2.0,5.0,30.0,4.0,40.0,30.0,TCGA-2J-AABI-01A,TCGA-2J-AABI,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IB,25312.0,female,1942,white,1070,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-3A-A9IB-01A,TCGA-3A-A9IB,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LD-A9QF,26869.0,female,1940,black or african american,85,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-LD-A9QF-01A,TCGA-LD-A9QF,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-O1-A52J,27223.0,female,1933,white,2000,Primary Tumor,0.0,5.0,0.0,75.0,2.0,0.0,100.0,TCGA-O1-A52J-01A,TCGA-O1-A52J,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08X,15705.0,female,1964,not reported,941,Primary Tumor,0.0,0.0,1.0,65.0,7.0,33.0,65.0,TCGA-A8-A08X-01A,TCGA-A8-A08X,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EX,16858.0,female,1963,white,468,Primary Tumor,0.0,0.0,3.0,75.0,2.0,22.0,75.0,TCGA-A2-A0EX-01A,TCGA-A2-A0EX,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8512,15266.0,male,1971,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-55-8512-01A,TCGA-55-8512,4.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAQ0,24988.0,male,1943,white,1001,Primary Tumor,0.0,1.0,0.0,85.0,5.0,67.0,8.0,TCGA-FB-AAQ0-01A,TCGA-FB-AAQ0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0XP,25305.0,female,1941,white,162,Primary Tumor,0.0,0.0,0.0,70.0,0.0,75.0,25.0,TCGA-AN-A0XP-01A,TCGA-AN-A0XP,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P4,15989.0,female,1966,white,525,Primary Tumor,1.0,1.0,0.0,80.0,3.0,15.0,80.0,TCGA-EW-A1P4-01A,TCGA-EW-A1P4,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-1681,22525.0,female,1947,white,None,Primary Tumor,5.0,9.0,0.0,15.0,85.0,5.0,5.0,TCGA-64-1681-01A,TCGA-64-1681,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LE,26239.0,female,1937,white,986,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-E2-A1LE-01A,TCGA-E2-A1LE,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LO,17080.0,female,1964,white,486,Primary Tumor,1.0,1.0,0.0,85.0,3.0,50.0,50.0,TCGA-AR-A2LO-01A,TCGA-AR-A2LO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DG,11204.0,female,1977,black or african american,972,Primary Tumor,0.0,0.0,5.0,70.0,20.0,20.0,74.0,TCGA-BH-A0DG-01A,TCGA-BH-A0DG,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8669,23443.0,male,1948,white,None,Primary Tumor,0.0,0.0,0.0,80.0,12.0,0.0,100.0,TCGA-86-8669-01A,TCGA-86-8669,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A12B,23150.0,female,1941,white,2365,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-AO-A12B-01A,TCGA-AO-A12B,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YD,23021.0,female,1946,white,572,Primary Tumor,0.0,0.0,3.0,85.0,2.0,11.0,85.0,TCGA-A2-A0YD-01A,TCGA-A2-A0YD,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A229,13817.0,female,1974,white,56,Primary Tumor,1.0,1.0,1.0,85.0,2.0,14.0,85.0,TCGA-E9-A229-01A,TCGA-E9-A229,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A6FR,18520.0,female,1963,black or african american,30,Primary Tumor,4.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-LL-A6FR-01A,TCGA-LL-A6FR,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A10C,19849.0,female,1954,white,995,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-E2-A10C-01A,TCGA-E2-A10C,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24P,17490.0,female,1958,white,2161,Primary Tumor,1.0,1.0,2.0,80.0,2.0,18.0,80.0,TCGA-AR-A24P-01A,TCGA-AR-A24P,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-RL-AAAS,22126.0,female,1953,white,77,Primary Tumor,10.0,10.0,0.0,60.0,70.0,40.0,60.0,TCGA-RL-AAAS-01A,TCGA-RL-AAAS,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0I8,17073.0,female,1946,white,6372,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-B6-A0I8-01A,TCGA-B6-A0I8,
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-A78T,26179.0,female,1942,white,101,Primary Tumor,0.0,0.0,40.0,10.0,10.0,0.0,60.0,TCGA-FB-A78T-01A,TCGA-FB-A78T,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FY,20347.0,female,1955,white,34,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-AN-A0FY-01A,TCGA-AN-A0FY,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04N,24155.0,female,1936,white,2850,Primary Tumor,0.0,0.0,9.0,60.0,20.0,10.0,75.0,TCGA-A2-A04N-01A,TCGA-A2-A04N,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A04C,18851.0,female,1957,white,656,Primary Tumor,0.0,15.0,0.0,80.0,4.0,19.0,80.0,TCGA-AN-A04C-01A,TCGA-AN-A04C,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-83-5908,21760.0,female,1950,white,None,Primary Tumor,None,None,0.0,60.0,None,10.0,87.0,TCGA-83-5908-01A,TCGA-83-5908,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5941,20350.0,female,1955,white,None,Primary Tumor,5.0,0.0,0.0,71.0,10.0,0.0,94.0,TCGA-50-5941-01A,TCGA-50-5941,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08F,21641.0,female,1949,not reported,637,Primary Tumor,0.0,0.0,1.0,80.0,2.0,19.0,80.0,TCGA-A8-A08F-01A,TCGA-A8-A08F,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3KD,17372.0,female,1963,white,700,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-A2-A3KD-01A,TCGA-A2-A3KD,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A2P5,28621.0,female,1933,black or african american,219,Primary Tumor,0.0,0.0,0.0,85.0,2.0,40.0,60.0,TCGA-E2-A2P5-01A,TCGA-E2-A2P5,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LQ-A4E4,26883.0,female,1938,white,414,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-LQ-A4E4-01A,TCGA-LQ-A4E4,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AW,23855.0,female,1942,white,1157,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-AR-A1AW-01A,TCGA-AR-A1AW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15P,22524.0,female,1949,white,269,Primary Tumor,0.0,0.0,10.0,70.0,0.0,10.0,80.0,TCGA-E2-A15P-01A,TCGA-E2-A15P,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-W8-A86G,24125.0,female,1947,white,126,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-W8-A86G-01A,TCGA-W8-A86G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-AA11,24813.0,female,1946,black or african american,148,Primary Tumor,2.0,0.0,10.0,60.0,4.0,30.0,60.0,TCGA-S3-AA11-01A,TCGA-S3-AA11,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A6VV,18695.0,female,1962,black or african american,85,Primary Tumor,0.0,2.0,0.0,85.0,8.0,49.0,50.0,TCGA-A7-A6VV-01A,TCGA-A7-A6VV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5RW,14638.0,female,1970,black or african american,771,Primary Tumor,0.0,0.0,0.0,80.0,5.0,53.0,45.0,TCGA-OL-A5RW-01A,TCGA-OL-A5RW,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-A479,27024.0,female,1939,black or african american,193,Primary Tumor,0.0,5.0,0.0,65.0,10.0,0.0,100.0,TCGA-44-A479-01A,TCGA-44-A479,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T0,21575.0,female,1950,white,268,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,70.0,TCGA-A2-A0T0-01A,TCGA-A2-A0T0,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A77O,28434.0,female,1936,white,84,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-HZ-A77O-01A,TCGA-HZ-A77O,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A8P0,27850.0,male,1937,white,52,Primary Tumor,1.0,8.0,10.0,70.0,6.0,40.0,50.0,TCGA-HZ-A8P0-01A,TCGA-HZ-A8P0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SH,14595.0,female,1967,white,1305,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-A1-A0SH-01A,TCGA-A1-A0SH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04Q,17660.0,female,1956,white,2260,Primary Tumor,0.0,0.0,23.0,80.0,2.0,6.0,70.0,TCGA-A2-A04Q-01A,TCGA-A2-A04Q,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27M,21910.0,female,1952,white,83,Primary Tumor,0.0,0.0,0.0,70.0,0.0,5.0,95.0,TCGA-D8-A27M-01A,TCGA-D8-A27M,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FK,32462.0,female,1922,white,69,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-AN-A0FK-01A,TCGA-AN-A0FK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HM,27063.0,female,1936,asian,100,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,85.0,TCGA-C8-A1HM-01A,TCGA-C8-A1HM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RE,27392.0,female,1937,white,65,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-E9-A1RE-01A,TCGA-E9-A1RE,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1IY,14122.0,female,1971,asian,590,Primary Tumor,0.0,0.0,10.0,70.0,0.0,40.0,50.0,TCGA-EW-A1IY-01A,TCGA-EW-A1IY,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8208,26716.0,female,1939,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,0.0,TCGA-55-8208-01A,TCGA-55-8208,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RB,14755.0,female,1971,white,39,Primary Tumor,0.0,0.0,0.0,90.0,0.0,25.0,75.0,TCGA-E9-A1RB-01A,TCGA-E9-A1RB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-8655,28379.0,female,1926,not reported,None,Primary Tumor,None,None,0.0,60.0,None,20.0,80.0,TCGA-78-8655-01A,TCGA-78-8655,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RO,26269.0,female,1922,white,6035,Primary Tumor,0.0,0.0,0.0,80.0,2.0,48.0,50.0,TCGA-B6-A0RO-01A,TCGA-B6-A0RO,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-7771,22926.0,male,1949,white,None,Primary Tumor,5.0,5.0,0.0,61.0,20.0,0.0,100.0,TCGA-91-7771-01A,TCGA-91-7771,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-8039,26317.0,male,1940,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-95-8039-01A,TCGA-95-8039,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-7947,24752.0,male,1944,white,None,Primary Tumor,0.0,5.0,19.0,80.0,2.0,0.0,80.0,TCGA-95-7947-01A,TCGA-95-7947,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6744,23484.0,female,1946,white,None,Primary Tumor,None,None,15.0,75.0,None,15.0,70.0,TCGA-49-6744-01A,TCGA-49-6744,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABE,26943.0,male,1939,white,515,Primary Tumor,9.0,2.0,20.0,15.0,4.0,65.0,15.0,TCGA-2J-AABE-01A,TCGA-2J-AABE,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A401,17438.0,female,1960,black or african american,1935,Primary Tumor,0.0,0.0,8.0,85.0,0.0,2.0,90.0,TCGA-B6-A401-01A,TCGA-B6-A401,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FD,24940.0,female,1930,white,4420,Primary Tumor,1.0,1.0,0.0,85.0,2.0,13.0,85.0,TCGA-BH-A1FD-01A,TCGA-BH-A1FD,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A082,21338.0,female,1950,not reported,606,Primary Tumor,0.0,0.0,1.0,90.0,1.0,10.0,88.0,TCGA-A8-A082-01A,TCGA-A8-A082,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-S4-A8RP,28353.0,female,1933,white,1130,Primary Tumor,0.0,0.0,20.0,20.0,0.0,70.0,10.0,TCGA-S4-A8RP-01A,TCGA-S4-A8RP,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A1HK,None,female,1957,asian,116,Primary Tumor,0.0,0.0,0.0,75.0,0.0,25.0,75.0,TCGA-C8-A1HK-01A,TCGA-C8-A1HK,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4TK,20581.0,female,1946,not reported,3744,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-MP-A4TK-01A,TCGA-MP-A4TK,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A40B,27811.0,female,1929,white,2467,Primary Tumor,2.0,2.0,0.0,75.0,4.0,25.0,75.0,TCGA-B6-A40B-01A,TCGA-B6-A40B,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-93-A4JO,25898.0,male,1942,white,230,Primary Tumor,2.0,2.0,0.0,60.0,10.0,40.0,60.0,TCGA-93-A4JO-01A,TCGA-93-A4JO,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A227,15602.0,female,1969,white,66,Primary Tumor,0.0,0.0,0.0,80.0,0.0,35.0,65.0,TCGA-E9-A227-01A,TCGA-E9-A227,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A42V,15158.0,female,1971,black or african american,197,Primary Tumor,0.0,0.0,0.0,85.0,3.0,45.0,55.0,TCGA-BH-A42V-01A,TCGA-BH-A42V,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-XD-AAUL,20607.0,male,1957,white,47,Primary Tumor,7.0,2.0,15.0,60.0,4.0,25.0,60.0,TCGA-XD-AAUL-01A,TCGA-XD-AAUL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A5J0,23072.0,female,1949,black or african american,184,Primary Tumor,0.0,0.0,0.0,75.0,2.0,25.0,75.0,TCGA-BH-A5J0-01A,TCGA-BH-A5J0,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A254,18270.0,female,1957,white,1381,Primary Tumor,0.0,0.0,0.0,70.0,0.0,5.0,95.0,TCGA-AR-A254-01A,TCGA-AR-A254,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A73U,32208.0,female,1924,white,285,Primary Tumor,0.0,0.0,0.0,65.0,1.0,0.0,100.0,TCGA-D8-A73U-01A,TCGA-D8-A73U,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66P,27489.0,female,1938,black or african american,98,Primary Tumor,0.0,0.0,3.0,60.0,0.0,52.0,45.0,TCGA-OL-A66P-01A,TCGA-OL-A66P,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7925,24150.0,male,1945,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HZ-7925-01A,TCGA-HZ-7925,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AX,23507.0,female,1943,white,1140,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-AR-A1AX-01A,TCGA-AR-A1AX,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06P,23011.0,female,1946,not reported,241,Primary Tumor,0.0,0.0,0.0,90.0,2.0,20.0,78.0,TCGA-A8-A06P-01A,TCGA-A8-A06P,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUO,23622.0,female,1949,white,87,Primary Tumor,5.0,1.0,35.0,20.0,3.0,45.0,20.0,TCGA-IB-AAUO-01A,TCGA-IB-AAUO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0AJ,29131.0,female,1931,white,63,Primary Tumor,5.0,0.0,2.0,85.0,10.0,13.0,85.0,TCGA-AN-A0AJ-01A,TCGA-AN-A0AJ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0U3,21755.0,female,1945,white,2413,Primary Tumor,0.0,0.0,2.0,85.0,0.0,5.0,93.0,TCGA-AR-A0U3-01A,TCGA-AR-A0U3,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A22D,14115.0,female,1973,white,52,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-E9-A22D-01A,TCGA-E9-A22D,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LD-A7W6,20077.0,female,1959,white,91,Primary Tumor,0.0,0.0,30.0,80.0,0.0,0.0,70.0,TCGA-LD-A7W6-01A,TCGA-LD-A7W6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RF,25119.0,female,1943,white,56,Primary Tumor,1.0,2.0,0.0,75.0,3.0,24.0,75.0,TCGA-E9-A1RF-01A,TCGA-E9-A1RF,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-7724,27891.0,female,1935,white,None,Primary Tumor,None,None,None,65.0,None,None,None,TCGA-55-7724-01A,TCGA-55-7724,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0SU,24219.0,female,1940,white,1317,Primary Tumor,0.0,0.0,5.0,90.0,2.0,35.0,60.0,TCGA-A2-A0SU-01A,TCGA-A2-A0SU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A5YL,23395.0,female,1948,white,84,Primary Tumor,0.0,0.0,30.0,60.0,0.0,0.0,70.0,TCGA-LL-A5YL-01A,TCGA-LL-A5YL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HQ,20719.0,female,1951,white,962,Primary Tumor,0.0,0.0,3.0,85.0,1.0,12.0,85.0,TCGA-BH-A0HQ-01A,TCGA-BH-A0HQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0AL,15286.0,female,1969,white,49,Primary Tumor,25.0,10.0,0.0,80.0,10.0,10.0,80.0,TCGA-AN-A0AL-01A,TCGA-AN-A0AL,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1L8,19187.0,female,1956,black or african american,912,Primary Tumor,0.0,0.0,0.0,85.0,0.0,40.0,60.0,TCGA-E2-A1L8-01A,TCGA-E2-A1L8,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A7VC,20479.0,female,1957,white,63,Primary Tumor,2.0,2.0,20.0,60.0,5.0,10.0,60.0,TCGA-AC-A7VC-01A,TCGA-AC-A7VC,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A573,17689.0,female,1963,black or african american,595,Primary Tumor,2.0,2.0,0.0,70.0,22.0,30.0,58.0,TCGA-E2-A573-01A,TCGA-E2-A573,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5942,24781.0,female,1942,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,100.0,TCGA-50-5942-01A,TCGA-50-5942,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24H,24046.0,female,1936,white,3641,Primary Tumor,1.0,1.0,0.0,90.0,1.0,8.0,90.0,TCGA-AR-A24H-01A,TCGA-AR-A24H,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-XN-A8T3,24810.0,male,1945,white,628,Primary Tumor,0.0,0.0,80.0,10.0,5.0,0.0,20.0,TCGA-XN-A8T3-01A,TCGA-XN-A8T3,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XO,20606.0,female,1954,white,193,Primary Tumor,0.0,0.0,0.0,80.0,1.0,25.0,75.0,TCGA-D8-A1XO-01A,TCGA-D8-A1XO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DF,19614.0,female,1954,black or african american,1372,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-GM-A2DF-01A,TCGA-GM-A2DF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A441,22772.0,female,1950,black or african american,37,Primary Tumor,0.0,0.0,5.0,75.0,5.0,10.0,85.0,TCGA-LL-A441-01A,TCGA-LL-A441,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A6SD,12006.0,female,1980,black or african american,441,Primary Tumor,0.0,0.0,5.0,85.0,3.0,10.0,85.0,TCGA-EW-A6SD-01A,TCGA-EW-A6SD,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AQ-A54N,18741.0,female,1960,black or african american,639,Primary Tumor,0.0,0.0,0.0,95.0,0.0,1.0,98.0,TCGA-AQ-A54N-01A,TCGA-AQ-A54N,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XU,13046.0,female,1971,black or african american,2089,Primary Tumor,0.0,0.0,3.0,90.0,0.0,7.0,90.0,TCGA-A2-A3XU-01A,TCGA-A2-A3XU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A4S2,22936.0,female,1950,white,112,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-A2-A4S2-01A,TCGA-A2-A4S2,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18J,20678.0,female,1944,white,3948,Primary Tumor,0.0,0.0,0.0,70.0,0.0,60.0,40.0,TCGA-BH-A18J-01A,TCGA-BH-A18J,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IO,24322.0,female,1935,white,3278,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-B6-A0IO-01A,TCGA-B6-A0IO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27N,13243.0,female,1975,white,75,Primary Tumor,0.0,0.0,0.0,85.0,0.0,20.0,80.0,TCGA-D8-A27N-01A,TCGA-D8-A27N,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A25F,24319.0,female,1945,white,86,Primary Tumor,0.0,0.0,0.0,75.0,10.0,35.0,65.0,TCGA-A2-A25F-01A,TCGA-A2-A25F,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-A6ZF,23650.0,female,1949,black or african american,107,Primary Tumor,1.0,1.0,20.0,60.0,5.0,20.0,60.0,TCGA-S3-A6ZF-01A,TCGA-S3-A6ZF,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-F2-A44H,24007.0,male,1947,white,105,Primary Tumor,0.0,0.0,0.0,35.0,5.0,0.0,100.0,TCGA-F2-A44H-01A,TCGA-F2-A44H,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4M0,22206.0,female,1952,white,136,Primary Tumor,0.0,1.0,0.0,65.0,5.0,0.0,100.0,TCGA-97-A4M0-01A,TCGA-97-A4M0,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-A4M7,27062.0,male,1938,white,132,Primary Tumor,0.0,7.0,0.0,75.0,10.0,40.0,52.0,TCGA-97-A4M7-01A,TCGA-97-A4M7,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P8,21501.0,female,1952,white,224,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-EW-A1P8-01A,TCGA-EW-A1P8,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABH,22425.0,male,1950,white,1061,Primary Tumor,7.0,2.0,20.0,35.0,4.0,45.0,35.0,TCGA-2J-AABH-01A,TCGA-2J-AABH,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4487,26583.0,female,1920,white,None,Primary Tumor,None,None,0.0,65.0,None,5.0,92.0,TCGA-49-4487-01A,TCGA-49-4487,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1Y0,24083.0,female,1945,white,104,Primary Tumor,1.0,1.0,1.0,85.0,2.0,14.0,85.0,TCGA-D8-A1Y0-01A,TCGA-D8-A1Y0,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A426,18296.0,female,1962,white,132,Primary Tumor,0.0,0.0,0.0,80.0,0.0,70.0,30.0,TCGA-A7-A426-01A,TCGA-A7-A426,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1B1,16603.0,female,1962,white,1268,Primary Tumor,0.0,0.0,5.0,70.0,0.0,35.0,60.0,TCGA-E2-A1B1-01A,TCGA-E2-A1B1,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-A5A4,26311.0,female,1940,asian,219,Primary Tumor,0.0,4.0,0.0,80.0,4.0,75.0,25.0,TCGA-HV-A5A4-01A,TCGA-HV-A5A4,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AQ-A54O,18694.0,male,1960,black or african american,617,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-AQ-A54O-01A,TCGA-AQ-A54O,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0I9,22798.0,female,1930,white,6687,Primary Tumor,0.0,0.0,0.0,90.0,1.0,8.0,90.0,TCGA-B6-A0I9-01A,TCGA-B6-A0I9,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-7499,29683.0,female,1929,white,None,Primary Tumor,5.0,5.0,0.0,55.0,20.0,20.0,80.0,TCGA-73-7499-01A,TCGA-73-7499,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-Q3-A5QY,21277.0,male,1954,white,44,Primary Tumor,0.0,0.0,0.0,70.0,4.0,50.0,50.0,TCGA-Q3-A5QY-01A,TCGA-Q3-A5QY,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A48Z,22056.0,female,1952,white,64,Primary Tumor,0.0,0.0,0.0,60.0,0.0,10.0,85.0,TCGA-55-A48Z-01A,TCGA-55-A48Z,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A041,10812.0,female,1981,white,33,Primary Tumor,0.0,0.0,0.0,85.0,0.0,29.0,70.0,TCGA-AN-A041-01A,TCGA-AN-A041,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-8399,22952.0,male,1944,white,None,Primary Tumor,None,None,0.0,70.0,7.0,17.0,65.0,TCGA-62-8399-01A,TCGA-62-8399,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-5423,23863.0,male,1941,not reported,None,Primary Tumor,0.0,4.0,0.0,80.0,15.0,0.0,100.0,TCGA-05-5423-01A,TCGA-05-5423,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1F5,22842.0,female,1940,white,3091,Primary Tumor,0.0,0.0,0.0,85.0,0.0,50.0,50.0,TCGA-BH-A1F5-01A,TCGA-BH-A1F5,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5RY,19216.0,female,1959,black or african american,421,Primary Tumor,0.0,2.0,0.0,70.0,8.0,0.0,100.0,TCGA-OL-A5RY-01A,TCGA-OL-A5RY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14R,22686.0,female,1946,white,910,Primary Tumor,0.0,0.0,0.0,80.0,0.0,50.0,50.0,TCGA-E2-A14R-01A,TCGA-E2-A14R,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-35-5375,22628.0,male,1949,white,None,Primary Tumor,3.0,1.0,0.0,70.0,20.0,0.0,95.0,TCGA-35-5375-01A,TCGA-35-5375,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MN-A4N4,20888.0,male,1953,white,664,Primary Tumor,0.0,4.0,0.0,60.0,5.0,15.0,85.0,TCGA-MN-A4N4-01A,TCGA-MN-A4N4,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07B,25475.0,female,1938,not reported,880,Primary Tumor,0.0,1.0,0.0,75.0,2.0,55.0,40.0,TCGA-A8-A07B-01A,TCGA-A8-A07B,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IG,18433.0,female,1944,white,5836,Primary Tumor,0.0,0.0,5.0,70.0,2.0,25.0,70.0,TCGA-B6-A0IG-01A,TCGA-B6-A0IG,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABA,20133.0,male,1957,white,598,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-2J-AABA-01A,TCGA-2J-AABA,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A5QM,22780.0,female,1946,white,1541,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-AR-A5QM-01A,TCGA-AR-A5QM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A3M7,22096.0,female,1950,asian,401,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-C8-A3M7-01A,TCGA-C8-A3M7,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A095,16742.0,female,1962,not reported,1153,Primary Tumor,0.0,0.0,3.0,70.0,2.0,22.0,60.0,TCGA-A8-A095-01A,TCGA-A8-A095,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15J,18771.0,female,1958,white,344,Primary Tumor,1.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-E2-A15J-01A,TCGA-E2-A15J,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4507,26851.0,female,1924,white,None,Primary Tumor,None,None,0.0,70.0,None,5.0,95.0,TCGA-49-4507-01A,TCGA-49-4507,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A25D,32872,female,1920,white,224,Primary Tumor,0.0,0.0,0.0,80.0,1.0,41.0,55.0,TCGA-A2-A25D-01A,TCGA-A2-A25D,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A3ZX,18434.0,female,1957,black or african american,1954,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-B6-A3ZX-01A,TCGA-B6-A3ZX,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A5YN,16884.0,female,1967,black or african american,41,Primary Tumor,0.0,0.0,20.0,70.0,0.0,0.0,80.0,TCGA-LL-A5YN-01A,TCGA-LL-A5YN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FU,16174.0,female,1953,white,5041,Primary Tumor,1.0,1.0,3.0,60.0,2.0,35.0,60.0,TCGA-BH-A1FU-01A,TCGA-BH-A1FU,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4629,25104.0,male,1935,white,None,Primary Tumor,None,None,10.0,70.0,None,10.0,75.0,TCGA-38-4629-01A,TCGA-38-4629,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0T3,13680.0,female,1972,white,303,Primary Tumor,30.0,20.0,0.0,40.0,40.0,50.0,40.0,TCGA-A2-A0T3-01A,TCGA-A2-A0T3,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0JF,24923.0,female,1941,white,273,Primary Tumor,0.0,0.0,1.0,75.0,2.0,24.0,75.0,TCGA-AO-A0JF-01A,TCGA-AO-A0JF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1IZ,19706.0,female,1957,white,194,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-EW-A1IZ-01A,TCGA-EW-A1IZ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A27A,17779.0,female,1962,asian,435,Primary Tumor,30.0,10.0,0.0,70.0,40.0,20.0,70.0,TCGA-C8-A27A-01A,TCGA-C8-A27A,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R5,23116.0,female,1948,white,58,Primary Tumor,0.0,0.0,0.0,80.0,7.0,30.0,70.0,TCGA-E9-A1R5-01A,TCGA-E9-A1R5,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7978,21785.0,male,1952,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,75.0,TCGA-69-7978-01A,TCGA-69-7978,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-S4-A8RO,27645.0,female,1938,white,199,Primary Tumor,0.0,0.0,10.0,40.0,0.0,50.0,30.0,TCGA-S4-A8RO-01A,TCGA-S4-A8RO,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4TJ,22875.0,female,1944,not reported,2204,Primary Tumor,0.0,0.0,30.0,60.0,0.0,10.0,60.0,TCGA-MP-A4TJ-01A,TCGA-MP-A4TJ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XK,20092.0,female,1955,white,275,Primary Tumor,0.0,0.0,0.0,90.0,1.0,20.0,60.0,TCGA-D8-A1XK-01A,TCGA-D8-A1XK,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09B,21520.0,female,1951,not reported,210,Primary Tumor,0.0,0.0,25.0,70.0,6.0,34.0,40.0,TCGA-A8-A09B-01A,TCGA-A8-A09B,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-A4P6,19904.0,male,1958,white,76,Primary Tumor,0.0,0.0,15.0,40.0,0.0,55.0,30.0,TCGA-FB-A4P6-01A,TCGA-FB-A4P6,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-7980,25583.0,female,1941,white,None,Primary Tumor,0.0,4.0,0.0,80.0,7.0,0.0,100.0,TCGA-69-7980-01A,TCGA-69-7980,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7890,26747.0,male,1935,not reported,None,Primary Tumor,None,None,0.0,85.0,None,15.0,80.0,TCGA-IB-7890-01A,TCGA-IB-7890,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A075,15369.0,female,1967,not reported,394,Primary Tumor,5.0,0.0,0.0,80.0,10.0,15.0,80.0,TCGA-A8-A075-01A,TCGA-A8-A075,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A48Y,25384.0,male,1943,white,107,Primary Tumor,0.0,0.0,0.0,60.0,0.0,15.0,85.0,TCGA-55-A48Y-01A,TCGA-55-A48Y,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06R,25477.0,female,1938,not reported,1184,Primary Tumor,0.0,0.0,0.0,85.0,5.0,22.0,70.0,TCGA-A8-A06R-01A,TCGA-A8-A06R,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A22H,15504.0,female,1969,white,38,Primary Tumor,0.0,0.0,0.0,70.0,0.0,15.0,85.0,TCGA-E9-A22H-01A,TCGA-E9-A22H,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A49H,24891.0,female,1944,white,46,Primary Tumor,1.0,0.0,20.0,10.0,10.0,70.0,10.0,TCGA-HZ-A49H-01A,TCGA-HZ-A49H,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18F,18594.0,female,1960,white,114,Primary Tumor,0.0,0.0,3.0,70.0,3.0,41.0,55.0,TCGA-BH-A18F-01A,TCGA-BH-A18F,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15S,12671.0,female,1976,white,247,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,80.0,TCGA-E2-A15S-01A,TCGA-E2-A15S,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5D8,14853.0,female,1969,black or african american,1357,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-OL-A5D8-01A,TCGA-OL-A5D8,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-5122,None,male,None,not reported,None,Primary Tumor,None,None,0.0,65.0,None,10.0,90.0,TCGA-75-5122-01A,TCGA-75-5122,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RD,24719.0,female,1944,white,38,Primary Tumor,1.0,1.0,0.0,80.0,3.0,19.0,80.0,TCGA-E9-A1RD-01A,TCGA-E9-A1RD,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1X6,29256.0,female,1930,white,173,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-D8-A1X6-01A,TCGA-D8-A1X6,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2QI,27865.0,female,1935,white,91,Primary Tumor,0.0,0.0,10.0,60.0,0.0,60.0,30.0,TCGA-AC-A2QI-01A,TCGA-AC-A2QI,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6971,21734.0,female,1951,white,None,Primary Tumor,None,None,5.0,70.0,None,10.0,83.0,TCGA-55-6971-01A,TCGA-55-6971,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XZ,16978.0,female,1963,black or african american,909,Primary Tumor,0.0,0.0,5.0,85.0,6.0,52.0,40.0,TCGA-A2-A3XZ-01A,TCGA-A2-A3XZ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A03O,25362.0,female,1933,black or african american,2694,Primary Tumor,1.0,3.0,0.0,80.0,7.0,20.0,80.0,TCGA-AO-A03O-01A,TCGA-AO-A03O,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R6,23347.0,female,1947,white,100,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-E9-A1R6-01A,TCGA-E9-A1R6,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7885,28554.0,female,1932,white,None,Primary Tumor,None,None,0.0,50.0,None,40.0,60.0,TCGA-IB-7885-01A,TCGA-IB-7885,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08Z,28003.0,female,1928,not reported,2036,Primary Tumor,0.0,0.0,2.0,70.0,6.0,27.0,70.0,TCGA-A8-A08Z-01A,TCGA-A8-A08Z,
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-A4BC,21565.0,male,1953,white,225,Primary Tumor,3.0,3.0,0.0,70.0,5.0,30.0,70.0,TCGA-91-A4BC-01A,TCGA-91-A4BC,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A66K,26299.0,female,1938,white,981,Primary Tumor,0.0,0.0,0.0,70.0,2.0,50.0,50.0,TCGA-OL-A66K-01A,TCGA-OL-A66K,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6836,19216.0,female,1958,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,85.0,TCGA-91-6836-01A,TCGA-91-6836,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06U,29525.0,female,1928,not reported,759,Primary Tumor,0.0,0.0,25.0,80.0,5.0,10.0,65.0,TCGA-A8-A06U-01A,TCGA-A8-A06U,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-6205,None,female,None,not reported,None,Primary Tumor,0.0,2.0,0.0,71.0,20.0,30.0,70.0,TCGA-75-6205-01A,TCGA-75-6205,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8671,26448.0,female,1940,white,None,Primary Tumor,0.0,10.0,30.0,55.0,20.0,0.0,70.0,TCGA-86-8671-01A,TCGA-86-8671,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18N,32404.0,female,1913,white,3374,Primary Tumor,0.0,0.0,2.0,90.0,2.0,23.0,75.0,TCGA-BH-A18N-01A,TCGA-BH-A18N,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-NJ-A55R,24738.0,male,1944,white,499,Primary Tumor,1.0,4.0,0.0,100.0,3.0,75.0,25.0,TCGA-NJ-A55R-01A,TCGA-NJ-A55R,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P1,24923.0,female,1940,white,850,Primary Tumor,0.0,0.0,5.0,65.0,0.0,55.0,40.0,TCGA-EW-A1P1-01A,TCGA-EW-A1P1,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A6VO,15780.0,female,1969,black or african american,507,Primary Tumor,0.0,0.0,5.0,90.0,2.0,5.0,90.0,TCGA-OL-A6VO-01A,TCGA-OL-A6VO,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0AM,20713.0,female,1954,white,47,Primary Tumor,20.0,25.0,0.0,85.0,10.0,5.0,80.0,TCGA-AN-A0AM-01A,TCGA-AN-A0AM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A083,24746.0,female,1941,not reported,575,Primary Tumor,0.0,2.0,0.0,85.0,4.0,24.0,75.0,TCGA-A8-A083-01A,TCGA-A8-A083,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7644,24043.0,female,1946,white,None,Primary Tumor,10.0,0.0,0.0,50.0,10.0,9.0,90.0,TCGA-IB-7644-01A,TCGA-IB-7644,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-5420,24472.0,male,1941,not reported,None,Primary Tumor,0.0,0.0,0.0,70.0,24.0,0.0,100.0,TCGA-05-5420-01A,TCGA-05-5420,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IC,32872,female,1902,white,6475,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-B6-A0IC-01A,TCGA-B6-A0IC,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A154,24999.0,female,1941,white,461,Primary Tumor,0.0,0.0,1.0,85.0,0.0,42.0,55.0,TCGA-E2-A154-01A,TCGA-E2-A154,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12Q,28733.0,female,1932,asian,57,Primary Tumor,1.0,1.0,2.0,75.0,2.0,21.0,75.0,TCGA-C8-A12Q-01A,TCGA-C8-A12Q,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0FW,24692.0,female,1943,white,41,Primary Tumor,0.0,0.0,2.0,90.0,0.0,8.0,90.0,TCGA-AN-A0FW-01A,TCGA-AN-A0FW,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4TI,26565.0,male,1938,white,780,Primary Tumor,0.0,0.0,0.0,60.0,0.0,8.0,92.0,TCGA-MP-A4TI-01A,TCGA-MP-A4TI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-Z7-A8R5,22280.0,female,1944,white,2928,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-Z7-A8R5-01A,TCGA-Z7-A8R5,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUV,18059.0,male,1964,white,113,Primary Tumor,0.0,0.0,0.0,60.0,5.0,0.0,100.0,TCGA-IB-AAUV-01A,TCGA-IB-AAUV,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-6203,None,female,None,not reported,None,Primary Tumor,0.0,5.0,50.0,80.0,5.0,0.0,50.0,TCGA-75-6203-01A,TCGA-75-6203,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11F,20171.0,female,1940,white,5482,Primary Tumor,1.0,6.0,0.0,99.0,2.0,0.0,99.0,TCGA-B5-A11F-01A,TCGA-B5-A11F,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A6,26319.0,female,1925,white,5304,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-DD-A3A6-01A,TCGA-DD-A3A6,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-5258,17586.0,male,1962,asian,147,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CC-5258-01A,TCGA-CC-5258,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11W,22365.0,female,1949,white,258,Primary Tumor,20.0,0.0,0.0,90.0,10.0,10.0,60.0,TCGA-B5-A11W-01A,TCGA-B5-A11W,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5515,22097.0,male,1949,white,None,Primary Tumor,0.0,0.0,15.0,65.0,2.0,20.0,65.0,TCGA-EJ-5515-01A,TCGA-EJ-5515,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-5R-AAAM,24020.0,female,1948,white,35,Primary Tumor,0.0,0.0,50.0,60.0,4.0,0.0,50.0,TCGA-5R-AAAM-01A,TCGA-5R-AAAM,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IL,23849.0,male,1944,not reported,1420,Primary Tumor,1.0,1.0,4.0,85.0,4.0,50.0,46.0,TCGA-KK-A8IL-01A,TCGA-KK-A8IL,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A46F,21160.0,male,1954,not reported,286,Primary Tumor,0.0,0.0,0.0,100.0,2.0,40.0,60.0,TCGA-EJ-A46F-01A,TCGA-EJ-A46F,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-FC-A66V,27282.0,male,1938,not reported,287,Primary Tumor,0.0,0.0,30.0,70.0,1.0,0.0,70.0,TCGA-FC-A66V-01A,TCGA-FC-A66V,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11R,18878.0,female,1957,black or african american,734,Primary Tumor,0.0,3.0,0.0,70.0,8.0,30.0,66.0,TCGA-B5-A11R-01A,TCGA-B5-A11R,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11Y,21860.0,female,1951,white,244,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-B5-A11Y-01A,TCGA-B5-A11Y,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A3CG,29432.0,male,1931,white,261,Primary Tumor,0.0,0.0,0.0,95.0,0.0,2.0,98.0,TCGA-G3-A3CG-01A,TCGA-G3-A3CG,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5542,21942.0,male,1950,white,None,Primary Tumor,0.0,0.0,15.0,80.0,2.0,15.0,70.0,TCGA-EJ-5542-01A,TCGA-EJ-5542,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88N,22695.0,male,1951,not reported,156,Primary Tumor,20.0,10.0,0.0,80.0,60.0,20.0,80.0,TCGA-VN-A88N-01A,TCGA-VN-A88N,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5527,25234.0,male,1940,white,None,Primary Tumor,0.0,0.0,10.0,75.0,0.0,20.0,70.0,TCGA-EJ-5527-01A,TCGA-EJ-5527,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-GJ-A3OU,21671.0,male,1952,white,69,Primary Tumor,0.0,0.0,0.0,60.0,4.0,0.0,100.0,TCGA-GJ-A3OU-01A,TCGA-GJ-A3OU,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A6G1,24945.0,male,1944,not reported,408,Primary Tumor,20.0,20.0,5.0,80.0,40.0,15.0,80.0,TCGA-J4-A6G1-01A,TCGA-J4-A6G1,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17D,21441.0,female,1951,white,541,Primary Tumor,5.0,5.0,0.0,80.0,5.0,20.0,70.0,TCGA-D1-A17D-01A,TCGA-D1-A17D,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-FC-7961,22888.0,male,1949,white,None,Primary Tumor,None,None,3.0,85.0,None,10.0,87.0,TCGA-FC-7961-01A,TCGA-FC-7961,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADK,25046.0,female,1943,asian,763,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-DD-AADK-01A,TCGA-DD-AADK,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A59X,20416.0,male,1953,not reported,1731,Primary Tumor,0.0,0.0,2.0,85.0,0.0,18.0,80.0,TCGA-KK-A59X-01A,TCGA-KK-A59X,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A22R,20604.0,female,1952,not reported,925,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-EO-A22R-01A,TCGA-EO-A22R,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6361,22565.0,male,1948,white,None,Primary Tumor,0.0,0.0,10.0,70.0,2.0,20.0,70.0,TCGA-G9-6361-01A,TCGA-G9-6361,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7AW,20869.0,male,1953,not reported,983,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-KK-A7AW-01A,TCGA-KK-A7AW,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3NG,30351.0,female,1928,white,101,Primary Tumor,1.0,0.0,13.0,90.0,2.0,0.0,85.0,TCGA-AJ-A3NG-01A,TCGA-AJ-A3NG,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A4NL,16874.0,male,1961,white,1896,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-DD-A4NL-01A,TCGA-DD-A4NL,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACG,19174.0,male,1956,asian,1931,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-DD-AACG-01A,TCGA-DD-AACG,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A222,18220.0,female,1962,white,50,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-BG-A222-01A,TCGA-BG-A222,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-LG-A9QC,17842.0,male,1965,white,62,Primary Tumor,0.0,0.0,0.0,97.0,2.0,4.0,95.0,TCGA-LG-A9QC-01A,TCGA-LG-A9QC,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A3R2,27530.0,male,1930,white,2555,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-FV-A3R2-01A,TCGA-FV-A3R2,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5530,22316.0,male,1947,white,None,Primary Tumor,0.0,0.0,10.0,70.0,3.0,20.0,70.0,TCGA-EJ-5530-01A,TCGA-EJ-5530,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GR,24784.0,female,1943,black or african american,263,Primary Tumor,40.0,20.0,0.0,80.0,20.0,5.0,80.0,TCGA-EY-A1GR-01A,TCGA-EY-A1GR,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-MI-A75I,22341.0,male,1950,black or african american,665,Primary Tumor,0.0,2.0,0.0,90.0,3.0,5.0,89.0,TCGA-MI-A75I-01A,TCGA-MI-A75I,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A5SM,21236.0,male,1954,white,111,Primary Tumor,0.0,0.0,0.0,60.0,100.0,25.0,70.0,TCGA-G3-A5SM-01A,TCGA-G3-A5SM,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A7M7,24002.0,male,1948,white,112,Primary Tumor,2.0,1.0,0.0,70.0,3.0,25.0,70.0,TCGA-G3-A7M7-01A,TCGA-G3-A7M7,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A65M,23767.0,male,1948,not reported,69,Primary Tumor,0.0,0.0,35.0,65.0,0.0,0.0,65.0,TCGA-EJ-A65M-01A,TCGA-EJ-A65M,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADS,23227.0,male,1950,asian,230,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,85.0,TCGA-DD-AADS-01A,TCGA-DD-AADS,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A22U,30557.0,female,1926,white,758,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-EO-A22U-01A,TCGA-EO-A22U,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A7SF,24432.0,male,1946,asian,285,Primary Tumor,0.0,1.0,0.0,95.0,3.0,10.0,87.0,TCGA-RC-A7SF-01A,TCGA-RC-A7SF,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8216,21428.0,male,1953,not reported,None,Primary Tumor,None,None,5.0,85.0,None,10.0,85.0,TCGA-HC-8216-01A,TCGA-HC-8216,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LH,22169.0,female,1942,white,2772,Primary Tumor,0.0,0.0,5.0,90.0,0.0,0.0,95.0,TCGA-AP-A0LH-01A,TCGA-AP-A0LH,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CJ,21655.0,female,1947,black or african american,1758,Primary Tumor,2.0,2.0,0.0,90.0,8.0,7.0,91.0,TCGA-AX-A1CJ-01A,TCGA-AX-A1CJ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A2OO,20797.0,female,1953,white,715,Primary Tumor,0.0,0.0,0.0,75.0,0.0,10.0,90.0,TCGA-EY-A2OO-01A,TCGA-EY-A2OO,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K1,25291.0,female,1939,white,636,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-B5-A0K1-01A,TCGA-B5-A0K1,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-TP-A8TT,23476.0,male,1949,not reported,265,Primary Tumor,0.0,0.0,5.0,70.0,0.0,40.0,55.0,TCGA-TP-A8TT-01A,TCGA-TP-A8TT,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2D6,27060.0,female,1935,white,641,Primary Tumor,3.0,5.0,0.0,98.0,15.0,2.0,83.0,TCGA-FI-A2D6-01A,TCGA-FI-A2D6,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H2,23653.0,female,1946,white,1443,Primary Tumor,4.0,1.0,0.0,70.0,3.0,30.0,70.0,TCGA-2Y-A9H2-01A,TCGA-2Y-A9H2,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADC,19527.0,male,1958,asian,945,Primary Tumor,2.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-DD-AADC-01A,TCGA-DD-AADC,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GE,14170.0,female,1964,asian,2941,Primary Tumor,30.0,0.0,10.0,85.0,60.0,5.0,75.0,TCGA-A5-A0GE-01A,TCGA-A5-A0GE,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A3DH,25935.0,female,1940,white,43,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-D1-A3DH-01A,TCGA-D1-A3DH,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9L4,22388.0,male,1950,not reported,986,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-ZG-A9L4-01A,TCGA-ZG-A9L4,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A6G3,20836.0,male,1955,not reported,479,Primary Tumor,0.0,0.0,20.0,60.0,0.0,35.0,45.0,TCGA-J4-A6G3-01A,TCGA-J4-A6G3,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2EY,23042.0,female,1943,white,1866,Primary Tumor,20.0,20.0,0.0,85.0,40.0,5.0,85.0,TCGA-FI-A2EY-01A,TCGA-FI-A2EY,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0UJ,25149.0,female,1936,asian,2180,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-BS-A0UJ-01A,TCGA-BS-A0UJ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AW-A1PO,24225.0,female,1944,white,331,Primary Tumor,30.0,20.0,0.0,70.0,40.0,10.0,70.0,TCGA-AW-A1PO-01A,TCGA-AW-A1PO,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ZP-A9CZ,26403.0,male,1939,asian,797,Primary Tumor,0.0,0.0,0.0,85.0,0.0,20.0,80.0,TCGA-ZP-A9CZ-01A,TCGA-ZP-A9CZ,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H8,31322.0,female,1926,white,792,Primary Tumor,3.0,1.0,0.0,65.0,7.0,35.0,65.0,TCGA-2Y-A9H8-01A,TCGA-2Y-A9H8,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A4XI,21497.0,male,1954,asian,70,Primary Tumor,0.0,0.0,20.0,75.0,0.0,0.0,80.0,TCGA-ED-A4XI-01A,TCGA-ED-A4XI,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A2QR,None,male,1931,white,1764,Primary Tumor,0.0,0.0,0.0,80.0,3.0,30.0,70.0,TCGA-FV-A2QR-01A,TCGA-FV-A2QR,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5791,26390.0,male,1934,white,None,Primary Tumor,0.0,0.0,15.0,65.0,2.0,30.0,55.0,TCGA-CH-5791-01A,TCGA-CH-5791,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A5KG,22258.0,female,1952,asian,112,Primary Tumor,0.0,0.0,0.0,80.0,4.0,0.0,100.0,TCGA-ED-A5KG-01A,TCGA-ED-A5KG,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5744,23621.0,male,1944,white,None,Primary Tumor,0.0,0.0,20.0,65.0,0.0,20.0,60.0,TCGA-CH-5744-01A,TCGA-CH-5744,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A1BY,23113.0,female,1945,white,989,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-DI-A1BY-01A,TCGA-DI-A1BY,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0R8,29777.0,female,1929,white,155,Primary Tumor,30.0,20.0,0.0,75.0,30.0,20.0,75.0,TCGA-A5-A0R8-01A,TCGA-A5-A0R8,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A8O6,18572.0,female,1963,asian,97,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ED-A8O6-01A,TCGA-ED-A8O6,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9LZ,24132.0,male,1945,not reported,817,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-ZG-A9LZ-01A,TCGA-ZG-A9LZ,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OL,24090.0,male,None,not reported,None,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-V1-A9OL-01A,TCGA-V1-A9OL,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A7,24599.0,male,1931,not reported,4772,Primary Tumor,0.0,0.0,0.0,96.0,0.0,0.0,100.0,TCGA-DD-A3A7-01A,TCGA-DD-A3A7,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACU,21606.0,male,1951,asian,1272,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-DD-AACU-01A,TCGA-DD-AACU,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A7S9,17403.0,female,1965,asian,383,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-RC-A7S9-01A,TCGA-RC-A7S9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0U7,23166.0,female,1940,white,2466,Primary Tumor,40.0,10.0,0.0,80.0,30.0,15.0,80.0,TCGA-BS-A0U7-01A,TCGA-BS-A0U7,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADU,21940.0,male,1953,asian,280,Primary Tumor,0.0,0.0,0.0,90.0,0.0,50.0,40.0,TCGA-DD-AADU-01A,TCGA-DD-AADU,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAIV,23325.0,male,1948,not reported,898,Primary Tumor,0.0,10.0,10.0,60.0,90.0,40.0,50.0,TCGA-XK-AAIV-01A,TCGA-XK-AAIV,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9LS,23540.0,male,1949,not reported,215,Primary Tumor,0.0,0.0,0.0,65.0,1.0,0.0,100.0,TCGA-ZG-A9LS-01A,TCGA-ZG-A9LS,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADB,18728.0,male,1960,asian,946,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADB-01A,TCGA-DD-AADB,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A174,18702.0,female,1959,white,219,Primary Tumor,20.0,10.0,30.0,60.0,40.0,30.0,40.0,TCGA-D1-A174-01A,TCGA-D1-A174,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACY,22332.0,male,1949,asian,1154,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DD-AACY-01A,TCGA-DD-AACY,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3AS,31450.0,female,1923,not reported,850,Primary Tumor,0.0,0.0,0.0,80.0,0.0,18.0,80.0,TCGA-EO-A3AS-01A,TCGA-EO-A3AS,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-WX-AA46,22639.0,male,1951,white,456,Primary Tumor,4.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-WX-AA46-01A,TCGA-WX-AA46,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE7,26568.0,male,1940,asian,410,Primary Tumor,0.0,0.0,0.0,75.0,4.0,0.0,100.0,TCGA-DD-AAE7-01A,TCGA-DD-AAE7,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADA,24288.0,female,1945,asian,959,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AADA-01A,TCGA-DD-AADA,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9NI,26697.0,male,1940,not reported,139,Primary Tumor,1.0,1.0,3.0,80.0,3.0,17.0,80.0,TCGA-ZG-A9NI-01A,TCGA-ZG-A9NI,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A22S,21328.0,female,1950,not reported,919,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-EO-A22S-01A,TCGA-EO-A22S,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K7,23429.0,female,1945,white,184,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-B5-A0K7-01A,TCGA-B5-A0K7,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A5FX,25063.0,female,1942,black or african american,878,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,98.0,TCGA-AP-A5FX-01A,TCGA-AP-A5FX,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-5262,24787.0,male,1943,asian,97,Primary Tumor,None,None,0.0,85.0,None,20.0,80.0,TCGA-CC-5262-01A,TCGA-CC-5262,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A73G,26949.0,female,1932,white,3045,Primary Tumor,1.0,2.0,0.0,85.0,8.0,25.0,65.0,TCGA-DD-A73G-01A,TCGA-DD-A73G,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2D5,20666.0,female,1953,white,702,Primary Tumor,3.0,5.0,0.0,98.0,15.0,2.0,83.0,TCGA-FI-A2D5-01A,TCGA-FI-A2D5,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A5UE,17805.0,male,1964,asian,85,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,93.0,TCGA-CC-A5UE-01A,TCGA-CC-A5UE,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A8FU,23472.0,male,1949,not reported,89,Primary Tumor,1.0,0.0,3.0,60.0,6.0,77.0,19.0,TCGA-EJ-A8FU-01A,TCGA-EJ-A8FU,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17F,25116.0,female,1942,white,269,Primary Tumor,2.0,5.0,2.0,65.0,3.0,35.0,63.0,TCGA-D1-A17F-01A,TCGA-D1-A17F,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IH,18560.0,male,1959,not reported,1631,Primary Tumor,0.0,0.0,30.0,60.0,0.0,30.0,40.0,TCGA-KK-A8IH-01A,TCGA-KK-A8IH,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A217,27411.0,female,1935,white,408,Primary Tumor,1.0,1.0,0.0,94.0,5.0,3.0,96.0,TCGA-BC-A217-01A,TCGA-BC-A217,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZZ,29420.0,female,1929,white,349,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D1-A0ZZ-01A,TCGA-D1-A0ZZ,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A05P,20017.0,female,1955,asian,203,Primary Tumor,10.0,5.0,0.0,85.0,5.0,10.0,85.0,TCGA-AP-A05P-01A,TCGA-AP-A05P,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-FC-7708,19144.0,male,1959,asian,None,Primary Tumor,None,None,25.0,60.0,None,15.0,60.0,TCGA-FC-7708-01A,TCGA-FC-7708,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A879,25799.0,male,1936,not reported,2578,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-VP-A879-01A,TCGA-VP-A879,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0YV,24567.0,female,1943,white,62,Primary Tumor,20.0,10.0,0.0,80.0,10.0,20.0,60.0,TCGA-BG-A0YV-01A,TCGA-BG-A0YV,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5518,24313.0,male,1942,white,None,Primary Tumor,0.0,0.0,20.0,55.0,0.0,30.0,50.0,TCGA-EJ-5518-01A,TCGA-EJ-5518,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5765,20364.0,male,1952,white,None,Primary Tumor,0.0,2.0,18.0,75.0,2.0,20.0,60.0,TCGA-CH-5765-01A,TCGA-CH-5765,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A46H,22059.0,male,1952,not reported,188,Primary Tumor,0.0,0.0,0.0,98.0,4.0,80.0,20.0,TCGA-EJ-A46H-01A,TCGA-EJ-A46H,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A25Y,19055.0,female,1954,asian,1595,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-G3-A25Y-01A,TCGA-G3-A25Y,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACF,25172.0,male,1940,asian,1952,Primary Tumor,0.0,0.0,0.0,80.0,0.0,40.0,60.0,TCGA-DD-AACF-01A,TCGA-DD-AACF,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-QS-A744,31520.0,female,1927,black or african american,44,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-QS-A744-01A,TCGA-QS-A744,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17C,28571.0,female,1932,white,249,Primary Tumor,5.0,3.0,5.0,60.0,5.0,40.0,55.0,TCGA-D1-A17C-01A,TCGA-D1-A17C,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6DY,18420.0,male,1952,not reported,4010,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-KK-A6DY-01A,TCGA-KK-A6DY,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-PG-A917,27104.0,female,1938,black or african american,583,Primary Tumor,0.0,0.0,20.0,80.0,0.0,10.0,70.0,TCGA-PG-A917-01A,TCGA-PG-A917,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-AATV,25943.0,male,1942,not reported,151,Primary Tumor,1.0,1.0,3.0,80.0,8.0,63.0,30.0,TCGA-J4-AATV-01A,TCGA-J4-AATV,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2H2,31524.0,female,1922,black or african american,1079,Primary Tumor,0.0,0.0,0.0,96.0,1.0,1.0,97.0,TCGA-AX-A2H2-01A,TCGA-AX-A2H2,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-AATZ,24226.0,male,1947,not reported,170,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-J4-AATZ-01A,TCGA-J4-AATZ,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IG,20266.0,male,1953,not reported,2057,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-KK-A8IG-01A,TCGA-KK-A8IG,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A052,21721.0,female,1945,black or african american,2211,Primary Tumor,0.0,1.0,0.0,85.0,3.0,15.0,83.0,TCGA-AP-A052-01A,TCGA-AP-A052,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A6M5,7634.0,female,1992,white,484,Primary Tumor,0.0,0.0,0.0,90.0,4.0,30.0,69.0,TCGA-RC-A6M5-01A,TCGA-RC-A6M5,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVS,20586.0,male,1951,asian,2201,Primary Tumor,3.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-DD-AAVS-01A,TCGA-DD-AAVS,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0UF,23771.0,female,1939,asian,2285,Primary Tumor,0.0,0.0,0.0,92.0,3.0,8.0,82.0,TCGA-BS-A0UF-01A,TCGA-BS-A0UF,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A8D1,25137.0,male,1944,not reported,464,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-HC-A8D1-01A,TCGA-HC-A8D1,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HC,19485.0,female,1953,black or african american,1786,Primary Tumor,0.0,0.0,0.0,98.0,0.0,3.0,94.0,TCGA-AX-A2HC-01A,TCGA-AX-A2HC,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0UL,19982.0,female,1950,native hawaiian or other pacific islander,2155,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-BS-A0UL-01A,TCGA-BS-A0UL,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5532,21110.0,male,1952,white,None,Primary Tumor,0.0,0.0,10.0,70.0,3.0,20.0,70.0,TCGA-EJ-5532-01A,TCGA-EJ-5532,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A2QT,18835.0,female,1957,american indian or alaska native,1186,Primary Tumor,5.0,5.0,0.0,60.0,20.0,40.0,60.0,TCGA-DI-A2QT-01A,TCGA-DI-A2QT,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A17Q,20015.0,female,1955,white,434,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-D1-A17Q-01A,TCGA-D1-A17Q,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0T9,14253.0,female,1966,native hawaiian or other pacific islander,2009,Primary Tumor,20.0,5.0,0.0,70.0,40.0,15.0,70.0,TCGA-BS-A0T9-01A,TCGA-BS-A0T9,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H7,29752.0,female,1930,white,846,Primary Tumor,2.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-2Y-A9H7-01A,TCGA-2Y-A9H7,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVR,16157.0,male,1963,asian,2355,Primary Tumor,3.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AAVR-01A,TCGA-DD-AAVR,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A3CK,22462.0,male,1950,asian,132,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-G3-A3CK-01A,TCGA-G3-A3CK,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8213,17673.0,male,1963,not reported,None,Primary Tumor,None,None,10.0,65.0,None,5.0,85.0,TCGA-HC-8213-01A,TCGA-HC-8213,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XQ-A8TB,24623.0,male,1945,not reported,420,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-XQ-A8TB-01A,TCGA-XQ-A8TB,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2KY,18086.0,female,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-DF-A2KY-01A,TCGA-DF-A2KY,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1O8,25789.0,female,1940,white,147,Primary Tumor,30.0,30.0,0.0,80.0,30.0,10.0,80.0,TCGA-D1-A1O8-01A,TCGA-D1-A1O8,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3QS,21162.0,female,1954,black or african american,129,Primary Tumor,0.0,0.0,0.0,40.0,0.0,60.0,40.0,TCGA-AJ-A3QS-01A,TCGA-AJ-A3QS,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0G3,22421.0,female,1946,black or african american,987,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,80.0,TCGA-A5-A0G3-01A,TCGA-A5-A0G3,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADM,21349.0,male,1954,asian,704,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,85.0,TCGA-DD-AADM-01A,TCGA-DD-AADM,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7IG,17453.0,male,1966,asian,239,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-CC-A7IG-01A,TCGA-CC-A7IG,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5743,24321.0,male,1942,white,None,Primary Tumor,0.0,0.0,25.0,60.0,1.0,25.0,50.0,TCGA-CH-5743-01A,TCGA-CH-5743,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GT,25151.0,female,1942,white,225,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-EY-A1GT-01A,TCGA-EY-A1GT,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67Q,28447.0,male,1934,not reported,584,Primary Tumor,20.0,20.0,10.0,60.0,40.0,30.0,60.0,TCGA-J4-A67Q-01A,TCGA-J4-A67Q,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-M7-A725,20474.0,male,1956,not reported,240,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-M7-A725-01A,TCGA-M7-A725,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5503,18395.0,male,1960,white,None,Primary Tumor,0.0,0.0,5.0,85.0,0.0,10.0,80.0,TCGA-EJ-5503-01A,TCGA-EJ-5503,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5502,18447.0,male,1960,not reported,None,Primary Tumor,0.0,0.0,30.0,45.0,0.0,30.0,40.0,TCGA-EJ-5502-01A,TCGA-EJ-5502,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A05O,24978.0,female,1941,white,209,Primary Tumor,20.0,20.0,0.0,45.0,10.0,50.0,40.0,TCGA-AP-A05O-01A,TCGA-AP-A05O,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-8198,17935.0,male,1962,not reported,None,Primary Tumor,None,None,5.0,85.0,None,10.0,85.0,TCGA-J4-8198-01A,TCGA-J4-8198,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3BH,None,female,None,white,None,Primary Tumor,0.0,1.0,6.0,90.0,2.0,2.0,90.0,TCGA-AJ-A3BH-01A,TCGA-AJ-A3BH,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8MF,24090.0,male,None,not reported,None,Primary Tumor,0.0,0.0,10.0,90.0,0.0,5.0,85.0,TCGA-V1-A8MF-01A,TCGA-V1-A8MF,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A25S,23571.0,male,1945,white,707,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-G3-A25S-01A,TCGA-G3-A25S,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-JU-AAVI,22289.0,female,1952,black or african american,139,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-JU-AAVI-01A,TCGA-JU-AAVI,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-A7IK,21552.0,male,1954,asian,163,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-CC-A7IK-01A,TCGA-CC-A7IK,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5506,24617.0,male,1943,white,None,Primary Tumor,0.0,0.0,10.0,80.0,2.0,25.0,65.0,TCGA-EJ-5506-01A,TCGA-EJ-5506,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A7M6,22205.0,female,1953,white,212,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-G3-A7M6-01A,TCGA-G3-A7M6,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A87E,21811.0,male,1949,not reported,2059,Primary Tumor,0.0,0.0,25.0,60.0,0.0,30.0,45.0,TCGA-VP-A87E-01A,TCGA-VP-A87E,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JR,26814.0,female,1933,white,1407,Primary Tumor,0.0,0.0,0.0,65.0,0.0,50.0,50.0,TCGA-B5-A0JR-01A,TCGA-B5-A0JR,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A054,23404.0,female,1940,white,2086,Primary Tumor,0.0,0.0,23.0,88.0,0.0,2.0,67.0,TCGA-AP-A054-01A,TCGA-AP-A054,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3BK,24943.0,female,1942,white,547,Primary Tumor,0.0,1.0,10.0,90.0,2.0,0.0,85.0,TCGA-AJ-A3BK-01A,TCGA-AJ-A3BK,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6AS,25661.0,male,1942,not reported,127,Primary Tumor,0.0,0.0,10.0,70.0,0.0,30.0,60.0,TCGA-HC-A6AS-01A,TCGA-HC-A6AS,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A23N,25772.0,female,1941,white,84,Primary Tumor,1.0,1.0,0.0,65.0,5.0,0.0,95.0,TCGA-AJ-A23N-01A,TCGA-AJ-A23N,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A1Y7,24085.0,female,1945,not reported,196,Primary Tumor,0.0,8.0,0.0,90.0,4.0,10.0,90.0,TCGA-EO-A1Y7-01A,TCGA-EO-A1Y7,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8257,25629.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,80.0,None,0.0,0.0,TCGA-HC-8257-01A,TCGA-HC-8257,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16J,22319.0,female,1947,white,735,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,80.0,TCGA-D1-A16J-01A,TCGA-D1-A16J,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAIR,27703.0,male,1936,not reported,897,Primary Tumor,0.0,0.0,15.0,70.0,0.0,25.0,60.0,TCGA-XK-AAIR-01A,TCGA-XK-AAIR,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8I5,20337.0,male,1951,not reported,2717,Primary Tumor,0.0,0.0,15.0,60.0,2.0,0.0,85.0,TCGA-KK-A8I5-01A,TCGA-KK-A8I5,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1O0,28162.0,female,1933,white,195,Primary Tumor,1.0,8.0,0.0,95.0,5.0,5.0,90.0,TCGA-D1-A1O0-01A,TCGA-D1-A1O0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-A8W1,19964.0,male,1957,not reported,888,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-2A-A8W1-01A,TCGA-2A-A8W1,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A83K,19299.0,male,1961,not reported,254,Primary Tumor,0.0,0.0,5.0,70.0,0.0,35.0,60.0,TCGA-J4-A83K-01A,TCGA-J4-A83K,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5511,20409.0,male,1954,black or african american,None,Primary Tumor,0.0,0.0,15.0,70.0,1.0,20.0,65.0,TCGA-EJ-5511-01A,TCGA-EJ-5511,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MH,22475.0,female,1946,white,1000,Primary Tumor,8.0,3.0,0.0,80.0,2.0,20.0,78.0,TCGA-BG-A0MH-01A,TCGA-BG-A0MH,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A65J,22904.0,male,1950,not reported,218,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-EJ-A65J-01A,TCGA-EJ-A65J,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A3QX,23663.0,female,1947,white,112,Primary Tumor,0.0,1.0,0.0,75.0,5.0,0.0,90.0,TCGA-EY-A3QX-01A,TCGA-EY-A3QX,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GH,21090.0,female,1947,white,2256,Primary Tumor,10.0,0.0,5.0,95.0,20.0,0.0,75.0,TCGA-A5-A0GH-01A,TCGA-A5-A0GH,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39V,28254.0,male,1923,white,4180,Primary Tumor,1.0,1.0,0.0,80.0,2.0,17.0,80.0,TCGA-DD-A39V-01A,TCGA-DD-A39V,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-E6-A1LX,14731.0,female,1966,white,1539,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-E6-A1LX-01A,TCGA-E6-A1LX,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0W2,20998.0,female,1950,white,1073,Primary Tumor,30.0,10.0,10.0,70.0,40.0,15.0,70.0,TCGA-BG-A0W2-01A,TCGA-BG-A0W2,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-AB3J,19020.0,female,1961,black or african american,126,Primary Tumor,0.0,0.0,30.0,60.0,5.0,10.0,60.0,TCGA-A5-AB3J-01A,TCGA-A5-AB3J,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVV,20751.0,male,1951,asian,2513,Primary Tumor,4.0,1.0,2.0,75.0,3.0,22.0,75.0,TCGA-DD-AAVV-01A,TCGA-DD-AAVV,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DO,22787.0,female,1945,white,1210,Primary Tumor,2.0,1.0,0.0,98.0,2.0,2.0,78.0,TCGA-AP-A1DO-01A,TCGA-AP-A1DO,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-AB27,18648.0,male,1962,not reported,130,Primary Tumor,0.0,0.0,2.0,90.0,4.0,38.0,58.0,TCGA-EJ-AB27-01A,TCGA-EJ-AB27,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5522,18802.0,male,1957,white,None,Primary Tumor,0.0,0.0,15.0,65.0,2.0,20.0,65.0,TCGA-EJ-5522-01A,TCGA-EJ-5522,
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-XV-AAZV,20545.0,female,1957,white,88,Primary Tumor,0.0,0.0,15.0,65.0,4.0,0.0,85.0,TCGA-XV-AAZV-01A,TCGA-XV-AAZV,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-5786,23649.0,male,1945,white,None,Primary Tumor,5.0,5.0,0.0,80.0,5.0,20.0,75.0,TCGA-21-5786-01A,TCGA-21-5786,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2711,23651.0,female,1943,white,None,Primary Tumor,None,None,5.0,85.0,None,10.0,80.0,TCGA-60-2711-01A,TCGA-60-2711,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-8456,26183.0,female,1940,white,None,Primary Tumor,None,None,5.0,78.0,5.0,10.0,70.0,TCGA-34-8456-01A,TCGA-34-8456,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-A5G1,27555.0,male,1927,not reported,3821,Primary Tumor,2.0,2.0,0.0,60.0,12.0,40.0,50.0,TCGA-77-A5G1-01A,TCGA-77-A5G1,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-1017,22880.0,male,1937,white,None,Primary Tumor,None,None,None,80.0,None,None,None,TCGA-22-1017-01A,TCGA-22-1017,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KL,28450.0,female,1936,not reported,273,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KL-01A,TCGA-VD-A8KL,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-G8-6324,15750.0,female,1963,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-G8-6324-01A,TCGA-G8-6324,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-6560,21768.0,male,1952,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,70.0,TCGA-85-6560-01A,TCGA-85-6560,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9ET,21113.0,male,1954,white,746,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9ET-01A,TCGA-V4-A9ET,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-7022,None,female,None,not reported,None,Primary Tumor,5.0,0.0,17.0,50.0,30.0,0.0,53.0,TCGA-63-7022-01A,TCGA-63-7022,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4566,14643.0,male,1956,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-33-4566-01A,TCGA-33-4566,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-O2-A52Q,16429.0,female,1961,white,2558,Primary Tumor,3.0,3.0,0.0,70.0,16.0,30.0,50.0,TCGA-O2-A52Q-01A,TCGA-O2-A52Q,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-XV-AAZW,22778.0,female,1951,white,88,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-XV-AAZW-01A,TCGA-XV-AAZW,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-G8-6906,21272.0,male,1929,white,None,Primary Tumor,0.0,0.0,0.0,80.0,80.0,0.0,85.0,TCGA-G8-6906-01A,TCGA-G8-6906,
UVM,Uveal Melanoma,Eye,TCGA-V4-A9E8,18073.0,male,1962,white,699,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9E8-01A,TCGA-V4-A9E8,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2703,27003.0,male,1929,white,None,Primary Tumor,None,None,0.0,74.0,None,5.0,45.0,TCGA-60-2703-01A,TCGA-60-2703,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8407,15407.0,male,1963,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8407-01A,TCGA-KO-8407,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-2600,28072.0,female,1924,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-34-2600-01A,TCGA-34-2600,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A299,23322.0,male,1948,white,45,Primary Tumor,0.0,0.0,15.0,60.0,8.0,25.0,60.0,TCGA-EB-A299-01A,TCGA-EB-A299,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-5787,24071.0,male,1944,black or african american,None,Primary Tumor,10.0,2.0,5.0,70.0,10.0,0.0,90.0,TCGA-21-5787-01A,TCGA-21-5787,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4607,27601.0,male,1928,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,60.0,TCGA-22-4607-01A,TCGA-22-4607,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8664,26954.0,male,1938,white,None,Primary Tumor,7.0,0.0,15.0,80.0,7.0,5.0,80.0,TCGA-85-8664-01A,TCGA-85-8664,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-8043,25612.0,female,1940,asian,None,Primary Tumor,0.0,0.0,0.0,91.0,8.0,0.0,100.0,TCGA-FF-8043-01A,TCGA-FF-8043,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A4QR,24756.0,male,1945,white,103,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-85-A4QR-01A,TCGA-85-A4QR,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7465,21548.0,male,1952,white,None,Primary Tumor,2.0,0.0,0.0,70.0,15.0,0.0,100.0,TCGA-77-7465-01A,TCGA-77-7465,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-8041,10466.0,female,1982,asian,None,Primary Tumor,0.0,0.0,0.0,90.0,9.0,0.0,100.0,TCGA-FF-8041-01A,TCGA-FF-8041,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1082,22492.0,male,1936,white,None,Primary Tumor,None,None,None,90.0,None,None,None,TCGA-21-1082-01A,TCGA-21-1082,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4582,20402.0,male,1945,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,80.0,TCGA-33-4582-01A,TCGA-33-4582,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-68-7755,21936.0,female,1951,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,85.0,TCGA-68-7755-01A,TCGA-68-7755,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-ER-A196,23533.0,female,1943,white,1106,Primary Tumor,0.0,0.0,5.0,85.0,0.0,5.0,90.0,TCGA-ER-A196-01A,TCGA-ER-A196,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7338,23480.0,male,1931,white,None,Primary Tumor,2.0,0.0,0.0,70.0,15.0,0.0,98.0,TCGA-77-7338-01A,TCGA-77-7338,1.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A87T,23409.0,male,1943,white,2154,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-WC-A87T-01A,TCGA-WC-A87T,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3414,26938.0,male,1932,asian,None,Primary Tumor,None,None,0.0,90.0,3.0,8.0,90.0,TCGA-18-3414-01A,TCGA-18-3414,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2789,26753.0,male,1935,not reported,None,Primary Tumor,None,None,2.0,75.0,None,7.0,81.0,TCGA-66-2789-01A,TCGA-66-2789,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-96-7545,26729.0,male,1935,white,None,Primary Tumor,2.0,2.0,0.0,65.0,20.0,32.0,65.0,TCGA-96-7545-01A,TCGA-96-7545,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KD,26457.0,male,1940,not reported,603,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KD-01A,TCGA-VD-A8KD,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4586,21148.0,male,1950,white,None,Primary Tumor,None,None,0.0,65.0,None,20.0,65.0,TCGA-33-4586-01A,TCGA-33-4586,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4587,23062.0,female,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,60.0,TCGA-33-4587-01A,TCGA-33-4587,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-A6HO,21330.0,female,1955,asian,85,Primary Tumor,5.0,15.0,0.0,90.0,75.0,5.0,90.0,TCGA-FA-A6HO-01A,TCGA-FA-A6HO,
UVM,Uveal Melanoma,Eye,TCGA-WC-A883,27953.0,female,1936,white,300,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-WC-A883-01A,TCGA-WC-A883,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2757,24014.0,female,1942,not reported,None,Primary Tumor,None,None,0.0,80.0,None,15.0,80.0,TCGA-66-2757-01A,TCGA-66-2757,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-6871,27708.0,male,1936,white,None,Primary Tumor,None,None,0.0,95.0,None,19.0,80.0,TCGA-BA-6871-01A,TCGA-BA-6871,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-7269,22609.0,male,1949,white,None,Primary Tumor,3.0,0.0,0.0,70.0,10.0,0.0,100.0,TCGA-BA-7269-01A,TCGA-BA-7269,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A519,26427.0,male,1940,white,125,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-E7-A519-01A,TCGA-E7-A519,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5E6,24615.0,male,1937,black or african american,3115,Primary Tumor,0.0,100.0,0.0,70.0,0.0,30.0,70.0,TCGA-P4-A5E6-01A,TCGA-P4-A5E6,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B1-A47N,22800.0,male,1950,white,169,Primary Tumor,0.0,4.0,0.0,75.0,1.0,0.0,100.0,TCGA-B1-A47N-01A,TCGA-B1-A47N,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-4A-A93W,24117.0,female,1947,white,70,Primary Tumor,1.0,1.0,0.0,95.0,2.0,5.0,88.0,TCGA-4A-A93W-01A,TCGA-4A-A93W,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7J9,27459.0,male,1936,white,945,Primary Tumor,0.0,0.0,0.0,70.0,10.0,50.0,50.0,TCGA-UF-A7J9-01A,TCGA-UF-A7J9,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A2EL,28370.0,male,1932,white,698,Primary Tumor,0.0,0.0,0.0,80.0,3.0,20.0,80.0,TCGA-G2-A2EL-01A,TCGA-G2-A2EL,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A9FP,22104.0,female,1953,asian,111,Primary Tumor,0.0,0.0,0.0,65.0,10.0,35.0,65.0,TCGA-LN-A9FP-01A,TCGA-LN-A9FP,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JO,20466.0,female,1956,black or african american,623,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-2Z-A9JO-01A,TCGA-2Z-A9JO,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-A4AC,30655.0,male,1929,white,81,Primary Tumor,0.0,2.0,0.0,85.0,3.0,15.0,82.0,TCGA-K4-A4AC-01A,TCGA-K4-A4AC,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5E7,27029.0,female,1930,white,2976,Primary Tumor,0.0,0.0,0.0,80.0,4.0,0.0,100.0,TCGA-P4-A5E7-01A,TCGA-P4-A5E7,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7371,16568.0,female,1964,white,None,Primary Tumor,None,None,0.0,65.0,None,10.0,90.0,TCGA-CR-7371-01A,TCGA-CR-7371,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B1-A656,23702.0,male,1948,white,210,Primary Tumor,0.0,5.0,0.0,60.0,10.0,40.0,60.0,TCGA-B1-A656-01A,TCGA-B1-A656,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A2EK,20995.0,male,1953,white,147,Primary Tumor,0.0,0.0,0.0,70.0,2.0,30.0,70.0,TCGA-G2-A2EK-01A,TCGA-G2-A2EK,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-QM-A5NM,24781.0,female,1945,white,98,Primary Tumor,0.0,0.0,0.0,100.0,0.0,5.0,95.0,TCGA-QM-A5NM-01A,TCGA-QM-A5NM,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JL,17367.0,male,1965,black or african american,678,Primary Tumor,0.0,7.0,0.0,75.0,0.0,25.0,75.0,TCGA-2Z-A9JL-01A,TCGA-2Z-A9JL,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-A4TM,14966.0,male,1971,black or african american,306,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-G7-A4TM-01A,TCGA-G7-A4TM,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IA-A40U,20463.0,male,1955,white,201,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-IA-A40U-01A,TCGA-IA-A40U,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-8634,18718.0,female,1961,white,None,Primary Tumor,None,None,0.0,65.0,None,20.0,80.0,TCGA-HD-8634-01A,TCGA-HD-8634,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-8489,17873.0,male,1964,white,None,Primary Tumor,None,None,0.0,60.0,None,15.0,85.0,TCGA-F7-8489-01A,TCGA-F7-8489,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7915,12832.0,female,1976,black or african american,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-A4-7915-01A,TCGA-A4-7915,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-5153,18743.0,male,1954,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,82.0,TCGA-BA-5153-01A,TCGA-BA-5153,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9K6,23384.0,male,1945,white,1736,Primary Tumor,0.0,5.0,0.0,75.0,1.0,0.0,100.0,TCGA-5P-A9K6-01A,TCGA-5P-A9K6,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GD-A76B,31571.0,female,1927,white,121,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-GD-A76B-01A,TCGA-GD-A76B,2.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RV,22978.0,female,1946,white,1747,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-N5-A4RV-01A,TCGA-N5-A4RV,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JJ,25201.0,male,1945,not reported,87,Primary Tumor,0.0,5.0,0.0,80.0,15.0,30.0,70.0,TCGA-UF-A7JJ-01A,TCGA-UF-A7JJ,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-R6-A8WC,20812.0,male,1957,white,119,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-R6-A8WC-01A,TCGA-R6-A8WC,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-6793,22215.0,female,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-G7-6793-01A,TCGA-G7-6793,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PX,26663.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,94.0,0.0,0.0,100.0,TCGA-UZ-A9PX-01A,TCGA-UZ-A9PX,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7404,19532.0,male,1955,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-CR-7404-01A,TCGA-CR-7404,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6010,19475.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,85.0,TCGA-CN-6010-01A,TCGA-CN-6010,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FJ-A871,18051.0,male,1964,white,43,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,92.0,TCGA-FJ-A871-01A,TCGA-FJ-A871,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N6-A4V9,21677.0,female,1952,white,456,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-N6-A4V9-01A,TCGA-N6-A4V9,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-YF-AA3M,21097.0,male,1956,not reported,133,Primary Tumor,5.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-YF-AA3M-01A,TCGA-YF-AA3M,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IM,28106.0,male,1935,white,254,Primary Tumor,2.0,1.0,5.0,85.0,1.0,0.0,75.0,TCGA-DK-A3IM-01A,TCGA-DK-A3IM,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6L,17635.0,male,1962,white,1418,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-DK-AA6L-01A,TCGA-DK-AA6L,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A6ME,27670.0,male,1938,asian,93,Primary Tumor,2.0,2.0,20.0,60.0,6.0,20.0,60.0,TCGA-E7-A6ME-01A,TCGA-E7-A6ME,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A6B0,22439.0,male,1946,white,2115,Primary Tumor,1.0,0.0,0.0,80.0,2.0,0.0,80.0,TCGA-DK-A6B0-01A,TCGA-DK-A6B0,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A6FE,18105.0,male,1960,white,1479,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,90.0,TCGA-JY-A6FE-01A,TCGA-JY-A6FE,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SJ,21615.0,male,1951,white,785,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,70.0,TCGA-FD-A3SJ-01A,TCGA-FD-A3SJ,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JS,21676.0,male,1953,white,311,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-UF-A7JS-01A,TCGA-UF-A7JS,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RN,26054.0,female,1940,white,590,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,80.0,TCGA-N5-A4RN-01A,TCGA-N5-A4RN,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-GL-A9DC,24348.0,female,1947,white,127,Primary Tumor,0.0,3.0,0.0,85.0,0.0,15.0,85.0,TCGA-GL-A9DC-01A,TCGA-GL-A9DC,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A5KE,28714.0,female,1934,asian,119,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-E7-A5KE-01A,TCGA-E7-A5KE,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PR,30681.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-UZ-A9PR-01A,TCGA-UZ-A9PR,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-4A-A93Y,23226.0,female,1950,black or african american,41,Primary Tumor,2.0,4.0,0.0,75.0,6.0,55.0,40.0,TCGA-4A-A93Y-01A,TCGA-4A-A93Y,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B1-A47O,19823.0,female,1958,white,199,Primary Tumor,0.0,5.0,0.0,75.0,1.0,0.0,100.0,TCGA-B1-A47O-01A,TCGA-B1-A47O,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A0YN,21927.0,male,1945,white,1827,Primary Tumor,0.0,0.0,0.0,75.0,1.0,3.0,75.0,TCGA-CU-A0YN-01A,TCGA-CU-A0YN,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7385,15477.0,male,1966,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-CR-7385-01A,TCGA-CR-7385,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-Z6-A8JE,20855.0,male,1956,white,108,Primary Tumor,3.0,2.0,0.0,70.0,4.0,25.0,70.0,TCGA-Z6-A8JE-01A,TCGA-Z6-A8JE,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N9-A4Q7,25419.0,female,1942,black or african american,438,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,90.0,TCGA-N9-A4Q7-01A,TCGA-N9-A4Q7,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6480,19472.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CR-6480-01A,TCGA-CR-6480,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A6B1,24607.0,male,1940,white,2059,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-DK-A6B1-01A,TCGA-DK-A6B1,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-8635,22340.0,female,1951,white,None,Primary Tumor,5.0,0.0,0.0,65.0,25.0,0.0,100.0,TCGA-HD-8635-01A,TCGA-HD-8635,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5236,21935.0,male,1947,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,60.0,TCGA-34-5236-01A,TCGA-34-5236,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8433,17108.0,female,1962,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-KN-8433-01A,TCGA-KN-8433,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8324,24650.0,female,1933,white,None,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-KL-8324-01A,TCGA-KL-8324,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A1NK,17569.0,male,1962,white,63,Primary Tumor,0.0,1.0,8.0,75.0,3.0,17.0,75.0,TCGA-EB-A1NK-01A,TCGA-EB-A1NK,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A3PK,29314.0,male,1931,white,58,Primary Tumor,6.0,6.0,0.0,60.0,9.0,39.0,60.0,TCGA-BT-A3PK-01A,TCGA-BT-A3PK,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-AATO,27684.0,male,1938,white,193,Primary Tumor,5.0,2.0,0.0,75.0,3.0,25.0,75.0,TCGA-GU-AATO-01A,TCGA-GU-AATO,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6481,17203.0,male,1963,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CR-6481-01A,TCGA-CR-6481,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E5-A2PC,22308.0,female,1947,white,1052,Primary Tumor,0.0,0.0,0.0,90.0,1.0,23.0,75.0,TCGA-E5-A2PC-01A,TCGA-E5-A2PC,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-J7-8537,13628.0,female,1974,asian,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-J7-8537-01A,TCGA-J7-8537,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9ST,25080.0,male,1937,white,2992,Primary Tumor,4.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-XF-A9ST-01A,TCGA-XF-A9ST,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CX-7085,28221.0,female,1933,white,None,Primary Tumor,10.0,0.0,13.0,60.0,15.0,7.0,80.0,TCGA-CX-7085-01A,TCGA-CX-7085,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6493,25432.0,male,1941,black or african american,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CR-6493-01A,TCGA-CR-6493,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20X,20519.0,male,1953,white,555,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,70.0,TCGA-BT-A20X-01A,TCGA-BT-A20X,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-4076,14405.0,male,1964,white,None,Primary Tumor,None,None,0.0,90.0,None,3.0,95.0,TCGA-BA-4076-01A,TCGA-BA-4076,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-A772,14278.0,male,1974,white,76,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-A4-A772-01A,TCGA-A4-A772,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A8ZB,25192.0,male,1945,black or african american,30,Primary Tumor,0.0,0.0,0.0,70.0,20.0,50.0,50.0,TCGA-QK-A8ZB-01A,TCGA-QK-A8ZB,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20W,26078.0,male,1938,white,751,Primary Tumor,0.0,0.0,0.0,70.0,8.0,30.0,70.0,TCGA-BT-A20W-01A,TCGA-BT-A20W,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A61O,15920.0,male,1969,white,288,Primary Tumor,0.0,0.0,0.0,80.0,10.0,20.0,80.0,TCGA-IQ-A61O-01A,TCGA-IQ-A61O,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A855,19029.0,female,1961,black or african american,117,Primary Tumor,0.0,4.0,0.0,65.0,5.0,0.0,100.0,TCGA-MH-A855-01A,TCGA-MH-A855,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BT,30686.0,male,1927,white,447,Primary Tumor,4.0,2.0,0.0,70.0,5.0,30.0,70.0,TCGA-FD-A5BT-01A,TCGA-FD-A5BT,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A3IB,24149.0,male,1942,black or african american,1248,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-G2-A3IB-01A,TCGA-G2-A3IB,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A1AG,24095.0,male,1945,white,169,Primary Tumor,1.0,1.0,0.0,90.0,1.0,10.0,90.0,TCGA-DK-A1AG-01A,TCGA-DK-A1AG,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A2ES,31293.0,male,1924,white,694,Primary Tumor,0.0,0.0,0.0,75.0,2.0,25.0,55.0,TCGA-G2-A2ES-01A,TCGA-G2-A2ES,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A8HG,25421.0,male,1936,white,2900,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-XF-A8HG-01A,TCGA-XF-A8HG,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NA-A5I1,29329.0,female,1926,white,2415,Primary Tumor,40.0,20.0,0.0,70.0,20.0,10.0,70.0,TCGA-NA-A5I1-01A,TCGA-NA-A5I1,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NT,25259.0,male,1932,white,4480,Primary Tumor,0.0,0.0,0.0,60.0,5.0,0.0,100.0,TCGA-L5-A8NT-01A,TCGA-L5-A8NT,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A43U,25841.0,male,1942,white,119,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,80.0,TCGA-FD-A43U-01A,TCGA-FD-A43U,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9KH,28193.0,male,1928,white,2958,Primary Tumor,0.0,8.0,0.0,75.0,1.0,0.0,100.0,TCGA-5P-A9KH-01A,TCGA-5P-A9KH,
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A88W,24716.0,male,1940,white,2319,Primary Tumor,1.0,0.0,0.0,80.0,4.0,0.0,97.0,TCGA-L5-A88W-01A,TCGA-L5-A88W,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5978,19480.0,female,1955,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-CV-5978-01A,TCGA-CV-5978,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A40G,28204.0,male,1935,white,99,Primary Tumor,0.0,0.0,0.0,90.0,1.0,5.0,95.0,TCGA-GV-A40G-01A,TCGA-GV-A40G,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7414,28603.0,male,1917,white,None,Primary Tumor,0.0,0.0,0.0,71.0,2.0,35.0,65.0,TCGA-CV-7414-01A,TCGA-CV-7414,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A6V3,22397.0,male,1951,white,194,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-CN-A6V3-01A,TCGA-CN-A6V3,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A465,9015.0,male,1984,white,1470,Primary Tumor,0.0,0.0,20.0,75.0,4.0,0.0,80.0,TCGA-CV-A465-01A,TCGA-CV-A465,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B3-8121,17760.0,female,1963,black or african american,None,Primary Tumor,10.0,10.0,0.0,60.0,10.0,32.0,60.0,TCGA-B3-8121-01A,TCGA-B3-8121,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7180,12523.0,male,1962,white,None,Primary Tumor,0.0,1.0,0.0,85.0,8.0,10.0,90.0,TCGA-CV-7180-01A,TCGA-CV-7180,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-8314,21517.0,male,1954,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-HD-8314-01A,TCGA-HD-8314,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-F9-A4JJ,12893.0,female,1977,black or african american,175,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-F9-A4JJ-01A,TCGA-F9-A4JJ,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-6477,20815.0,female,1954,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-CR-6477-01A,TCGA-CR-6477,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-A5NL,18913.0,male,None,not reported,None,Primary Tumor,0.0,5.0,0.0,75.0,2.0,0.0,100.0,TCGA-HE-A5NL-01A,TCGA-HE-A5NL,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA5N,22741.0,female,1951,white,29,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-ZF-AA5N-01A,TCGA-ZF-AA5N,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DZ-6132,25417.0,male,1934,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,78.0,TCGA-DZ-6132-01A,TCGA-DZ-6132,1.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EH,19573.0,male,1959,white,474,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,95.0,TCGA-V4-A9EH-01A,TCGA-V4-A9EH,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-A767,29739.0,male,1931,white,365,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-GU-A767-01A,TCGA-GU-A767,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UP-A6WW,21427.0,male,1955,white,64,Primary Tumor,0.0,0.0,0.0,60.0,0.0,35.0,50.0,TCGA-UP-A6WW-01A,TCGA-UP-A6WW,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-C9-A47Z,26592.0,female,1939,asian,446,Primary Tumor,1.0,1.0,0.0,100.0,1.0,5.0,94.0,TCGA-C9-A47Z-01A,TCGA-C9-A47Z,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A6EQ,20876.0,male,1956,white,86,Primary Tumor,0.0,0.0,0.0,80.0,4.0,0.0,100.0,TCGA-D6-A6EQ-01A,TCGA-D6-A6EQ,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-90-A4ED,25453.0,male,1943,white,168,Primary Tumor,2.0,2.0,0.0,65.0,4.0,30.0,65.0,TCGA-90-A4ED-01A,TCGA-90-A4ED,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A539,23098.0,male,1948,white,327,Primary Tumor,3.0,1.0,0.0,70.0,2.0,25.0,70.0,TCGA-98-A539-01A,TCGA-98-A539,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-6545,28400.0,female,1933,white,None,Primary Tumor,None,None,15.0,70.0,None,15.0,65.0,TCGA-56-6545-01A,TCGA-56-6545,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SL,25460.0,male,1935,white,3423,Primary Tumor,5.0,2.0,0.0,60.0,10.0,40.0,60.0,TCGA-XF-A9SL-01A,TCGA-XF-A9SL,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6SX,24715.0,male,1938,white,2855,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-P3-A6SX-01A,TCGA-P3-A6SX,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A49B,26155.0,male,1940,white,394,Primary Tumor,0.0,0.0,0.0,99.0,0.0,5.0,95.0,TCGA-CN-A49B-01A,TCGA-CN-A49B,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N6-A4VD,29658.0,female,1928,white,1297,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-N6-A4VD-01A,TCGA-N6-A4VD,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A3YC,22774.0,male,1950,white,93,Primary Tumor,1.0,2.0,15.0,85.0,3.0,25.0,59.0,TCGA-IG-A3YC-01A,TCGA-IG-A3YC,3.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EI,28562.0,male,1934,white,483,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9EI-01A,TCGA-V4-A9EI,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4532,25169.0,male,1933,white,None,Primary Tumor,None,None,5.0,85.0,None,5.0,80.0,TCGA-33-4532-01A,TCGA-33-4532,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-7033,26948.0,male,1938,white,None,Primary Tumor,None,None,32.0,60.0,None,0.0,68.0,TCGA-94-7033-01A,TCGA-94-7033,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8K9,26292.0,female,1940,not reported,763,Primary Tumor,0.0,0.0,50.0,60.0,1.0,0.0,50.0,TCGA-VD-A8K9-01A,TCGA-VD-A8K9,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MN,28677.0,female,None,not reported,None,Primary Tumor,3.0,3.0,0.0,60.0,25.0,35.0,53.0,TCGA-63-A5MN-01A,TCGA-63-A5MN,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5239,27528.0,male,1935,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,55.0,TCGA-34-5239-01A,TCGA-34-5239,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8477,20491.0,male,1949,white,None,Primary Tumor,None,None,0.0,92.0,None,10.0,90.0,TCGA-KM-8477-01A,TCGA-KM-8477,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KG,17417.0,female,1965,not reported,504,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KG-01A,TCGA-VD-A8KG,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-A474,24286.0,male,1946,white,214,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,95.0,TCGA-43-A474-01A,TCGA-43-A474,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TU,16720.0,male,1959,white,3444,Primary Tumor,10.0,10.0,0.0,90.0,70.0,20.0,80.0,TCGA-GS-A9TU-01A,TCGA-GS-A9TU,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A550,27556.0,female,1937,white,125,Primary Tumor,0.0,0.0,20.0,65.0,0.0,0.0,80.0,TCGA-EB-A550-01A,TCGA-EB-A550,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8354,19692.0,male,1958,white,None,Primary Tumor,5.0,10.0,17.0,80.0,5.0,0.0,83.0,TCGA-85-8354-01A,TCGA-85-8354,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A53J,28485.0,male,1935,white,83,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-98-A53J-01A,TCGA-98-A53J,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MY,23276.0,male,None,not reported,None,Primary Tumor,4.0,2.0,0.0,70.0,5.0,28.0,70.0,TCGA-63-A5MY-01A,TCGA-63-A5MY,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5M9,None,female,None,not reported,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,1.0,95.0,TCGA-63-A5M9-01A,TCGA-63-A5M9,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8332,20128.0,male,1949,white,None,Primary Tumor,0.0,0.0,0.0,95.0,1.0,0.0,100.0,TCGA-KL-8332-01A,TCGA-KL-8332,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4609,29844.0,male,1922,white,None,Primary Tumor,None,None,20.0,70.0,None,10.0,60.0,TCGA-22-4609-01A,TCGA-22-4609,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-AASJ,22179.0,male,1939,black or african american,5439,Primary Tumor,3.0,3.0,0.0,75.0,15.0,25.0,55.0,TCGA-33-AASJ-01A,TCGA-33-AASJ,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8K8,20454.0,female,1955,not reported,763,Primary Tumor,0.0,0.0,50.0,60.0,1.0,0.0,50.0,TCGA-VD-A8K8-01A,TCGA-VD-A8K8,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5240,26735.0,female,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,75.0,TCGA-34-5240-01A,TCGA-34-5240,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4613,26722.0,female,1931,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,75.0,TCGA-22-4613-01A,TCGA-22-4613,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8429,13903.0,female,1968,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-KN-8429-01A,TCGA-KN-8429,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8323,20849.0,female,1943,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,96.0,TCGA-KL-8323-01A,TCGA-KL-8323,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8276,22707.0,male,1949,white,None,Primary Tumor,None,None,0.0,65.0,None,25.0,67.0,TCGA-85-8276-01A,TCGA-85-8276,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F1,16852.0,female,1966,white,409,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-V4-A9F1-01A,TCGA-V4-A9F1,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3412,19025.0,male,1953,white,None,Primary Tumor,None,None,0.0,88.0,2.0,12.0,80.0,TCGA-18-3412-01A,TCGA-18-3412,1.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A87W,20872.0,female,1953,white,1115,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-WC-A87W-01A,TCGA-WC-A87W,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8331,17710.0,female,1956,white,None,Primary Tumor,None,None,0.0,90.0,1.0,0.0,100.0,TCGA-KL-8331-01A,TCGA-KL-8331,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A1PX,20626.0,male,1954,white,122,Primary Tumor,0.0,0.0,10.0,85.0,0.0,10.0,70.0,TCGA-BF-A1PX-01A,TCGA-BF-A1PX,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2714,24169.0,female,1940,white,None,Primary Tumor,None,None,3.0,85.0,None,5.0,89.0,TCGA-60-2714-01A,TCGA-60-2714,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2783,24686.0,male,1941,not reported,None,Primary Tumor,0.0,0.0,3.0,65.0,25.0,10.0,77.0,TCGA-66-2783-01A,TCGA-66-2783,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-2596,25574.0,male,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,80.0,TCGA-34-2596-01A,TCGA-34-2596,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-7021,None,male,None,not reported,None,Primary Tumor,5.0,10.0,0.0,60.0,20.0,0.0,98.0,TCGA-63-7021-01A,TCGA-63-7021,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-A5GA,27762.0,male,1934,not reported,1044,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,60.0,TCGA-77-A5GA-01A,TCGA-77-A5GA,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CY,10423.0,male,1972,white,4097,Primary Tumor,0.0,0.0,0.0,70.0,10.0,30.0,70.0,TCGA-EL-A3CY-01A,TCGA-EL-A3CY,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CO,32146.0,male,1911,white,4439,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-EL-A3CO-01A,TCGA-EL-A3CO,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3R9,24215.0,female,1945,white,121,Primary Tumor,0.0,0.0,0.0,88.0,0.0,0.0,100.0,TCGA-FY-A3R9-01A,TCGA-FY-A3R9,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-7493,14767.0,female,1969,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HW-7493-01A,TCGA-HW-7493,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A40Q,14136.0,male,1973,white,428,Primary Tumor,0.0,0.0,0.0,95.0,1.0,25.0,75.0,TCGA-ET-A40Q-01A,TCGA-ET-A40Q,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A4MW,23077.0,male,1949,white,64,Primary Tumor,0.0,0.0,15.0,90.0,0.0,0.0,80.0,TCGA-FG-A4MW-01A,TCGA-FG-A4MW,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3TA,15366.0,male,1963,white,2457,Primary Tumor,1.0,1.0,0.0,80.0,5.0,0.0,95.0,TCGA-EL-A3TA-01A,TCGA-EL-A3TA,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A2P4,10602.0,female,1982,white,201,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-BJ-A2P4-01A,TCGA-BJ-A2P4,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-8185,13621.0,male,1975,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-FG-8185-01A,TCGA-FG-8185,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7610,9447.0,female,1982,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7610-01A,TCGA-HT-7610,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84S,13424.0,male,1977,white,163,Primary Tumor,0.0,0.0,10.0,90.0,0.0,35.0,55.0,TCGA-TM-A84S-01A,TCGA-TM-A84S,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RF,9919.0,female,1985,white,373,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-TQ-A7RF-01A,TCGA-TQ-A7RF,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V3,20997.0,female,1953,asian,464,Primary Tumor,1.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-DJ-A3V3-01A,TCGA-DJ-A3V3,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V5,27918.0,female,1935,white,240,Primary Tumor,1.0,1.0,3.0,75.0,3.0,22.0,75.0,TCGA-DJ-A3V5-01A,TCGA-DJ-A3V5,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CP,18298.0,female,1949,black or african american,4341,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-EL-A3CP-01A,TCGA-EL-A3CP,
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-5396,19399.0,female,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-CS-5396-01A,TCGA-CS-5396,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A6S7,10170.0,female,1986,white,114,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-DU-A6S7-01A,TCGA-DU-A6S7,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CO,28424.0,female,1934,not reported,132,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EM-A2CO-01A,TCGA-EM-A2CO,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4X9,12131.0,female,1977,white,832,Primary Tumor,0.0,0.0,20.0,80.0,0.0,0.0,80.0,TCGA-DB-A4X9-01A,TCGA-DB-A4X9,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A66B,19156.0,male,1958,white,845,Primary Tumor,0.0,0.0,5.0,90.0,0.0,10.0,85.0,TCGA-DH-A66B-01A,TCGA-DH-A66B,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UM,16573.0,female,1965,asian,517,Primary Tumor,1.0,1.0,0.0,75.0,5.0,25.0,75.0,TCGA-DJ-A3UM-01A,TCGA-DJ-A3UM,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7IQ,16512.0,female,1966,white,735,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-S9-A7IQ-01A,TCGA-S9-A7IQ,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CU,17231.0,female,1964,not reported,72,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-EM-A2CU-01A,TCGA-EM-A2CU,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7470,13611.0,male,1974,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-7470-01A,TCGA-HT-7470,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8108,9539.0,female,1985,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-8108-01A,TCGA-HT-8108,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5304,15481.0,male,1957,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-E1-5304-01A,TCGA-E1-5304,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZP,7101.0,male,1989,white,1393,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-EL-A3ZP-01A,TCGA-EL-A3ZP,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A61B,8335.0,male,1990,white,101,Primary Tumor,0.0,0.0,5.0,90.0,0.0,20.0,75.0,TCGA-HT-A61B-01A,TCGA-HT-A61B,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AN,13188.0,female,1975,not reported,162,Primary Tumor,0.0,1.0,0.0,95.0,0.0,40.0,60.0,TCGA-EM-A3AN-01A,TCGA-EM-A3AN,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7677,19610.0,male,1956,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HT-7677-01A,TCGA-HT-7677,
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A3EB,11822.0,female,1976,white,1055,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-IM-A3EB-01A,TCGA-IM-A3EB,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A482,10192.0,female,1984,asian,263,Primary Tumor,0.0,2.0,0.0,100.0,0.0,5.0,95.0,TCGA-CE-A482-01A,TCGA-CE-A482,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0Z5,21369.0,male,1952,white,168,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-BJ-A0Z5-01A,TCGA-BJ-A0Z5,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XG,12550.0,male,1972,white,2137,Primary Tumor,0.0,0.0,15.0,90.0,0.0,5.0,80.0,TCGA-DB-A4XG-01A,TCGA-DB-A4XG,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A28V,29508.0,female,1931,white,-138,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-BJ-A28V-01A,TCGA-BJ-A28V,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YO,16770.0,male,1950,white,6582,Primary Tumor,0.0,0.0,10.0,90.0,0.0,25.0,65.0,TCGA-E1-A7YO-01A,TCGA-E1-A7YO,
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A41L,14440.0,female,1965,white,2800,Primary Tumor,None,None,None,None,None,None,None,TCGA-KS-A41L-01A,TCGA-KS-A41L,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7856,13145.0,male,1973,white,None,Primary Tumor,None,None,20.0,60.0,None,0.0,80.0,TCGA-HT-7856-01A,TCGA-HT-7856,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A65V,15850.0,female,1970,white,48,Primary Tumor,0.0,0.0,15.0,80.0,0.0,25.0,60.0,TCGA-QH-A65V-01A,TCGA-QH-A65V,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A72Z,23482.0,female,1949,white,178,Primary Tumor,0.0,0.0,5.0,90.0,0.0,25.0,70.0,TCGA-P5-A72Z-01A,TCGA-P5-A72Z,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6TV,18321.0,male,1960,white,936,Primary Tumor,0.0,0.0,10.0,90.0,5.0,10.0,80.0,TCGA-S9-A6TV-01A,TCGA-S9-A6TV,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7R7,10108.0,male,1979,white,2647,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-S9-A7R7-01A,TCGA-S9-A7R7,
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A483,12768.0,female,1978,asian,143,Primary Tumor,0.0,1.0,0.0,100.0,0.0,10.0,90.0,TCGA-CE-A483-01A,TCGA-CE-A483,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A2N0,18692.0,female,1959,white,286,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-ET-A2N0-01A,TCGA-ET-A2N0,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A65R,14073.0,female,1975,white,54,Primary Tumor,0.0,0.0,10.0,75.0,0.0,15.0,65.0,TCGA-QH-A65R-01A,TCGA-QH-A65R,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6CV,18955.0,male,1962,asian,52,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-QH-A6CV-01A,TCGA-QH-A6CV,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7877,7581.0,female,1991,white,None,Primary Tumor,None,None,3.0,65.0,None,0.0,97.0,TCGA-HT-7877-01A,TCGA-HT-7877,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A18Y,10832.0,male,1981,white,163,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-BJ-A18Y-01A,TCGA-BJ-A18Y,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A7C3,16021.0,female,1966,white,1409,Primary Tumor,0.0,0.0,5.0,90.0,0.0,30.0,65.0,TCGA-TM-A7C3-01A,TCGA-TM-A7C3,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q3,22637.0,female,1950,asian,125,Primary Tumor,0.0,0.0,10.0,75.0,1.0,25.0,65.0,TCGA-DJ-A2Q3-01A,TCGA-DJ-A2Q3,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7018,21019.0,female,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-7018-01A,TCGA-DU-7018,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13R,18354.0,male,1960,white,95,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DJ-A13R-01A,TCGA-DJ-A13R,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7468,11209.0,male,1981,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7468-01A,TCGA-HT-7468,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7881,14171.0,male,1973,black or african american,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7881-01A,TCGA-HT-7881,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3OA,20284.0,female,1956,not reported,101,Primary Tumor,0.0,0.0,0.0,100.0,1.0,30.0,70.0,TCGA-EM-A3OA-01A,TCGA-EM-A3OA,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WI,20609.0,female,1950,white,2429,Primary Tumor,0.0,0.0,10.0,70.0,0.0,50.0,40.0,TCGA-S9-A6WI-01A,TCGA-S9-A6WI,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZG,5612.0,male,1991,asian,2291,Primary Tumor,0.0,1.0,0.0,100.0,1.0,10.0,90.0,TCGA-EL-A3ZG-01A,TCGA-EL-A3ZG,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TQ-A7RW,11804.0,male,1978,white,1022,Primary Tumor,0.0,0.0,5.0,90.0,0.0,50.0,45.0,TCGA-TQ-A7RW-01A,TCGA-TQ-A7RW,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A28S,29143.0,male,1931,white,150,Primary Tumor,0.0,0.0,0.0,90.0,2.0,10.0,90.0,TCGA-BJ-A28S-01A,TCGA-BJ-A28S,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HW-A5KK,23484.0,male,1948,white,171,Primary Tumor,0.0,0.0,5.0,90.0,0.0,35.0,60.0,TCGA-HW-A5KK-01A,TCGA-HW-A5KK,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A44K,18472.0,female,1962,asian,98,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-E8-A44K-01A,TCGA-E8-A44K,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A614,17392.0,male,1966,white,78,Primary Tumor,0.0,0.0,5.0,70.0,0.0,50.0,45.0,TCGA-HT-A614-01A,TCGA-HT-A614,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WM,21761.0,female,1953,white,224,Primary Tumor,0.0,0.0,10.0,90.0,0.0,20.0,70.0,TCGA-S9-A6WM-01A,TCGA-S9-A6WM,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FM,20938.0,male,1954,not reported,248,Primary Tumor,0.0,0.0,0.0,100.0,1.0,40.0,60.0,TCGA-EM-A3FM-01A,TCGA-EM-A3FM,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AP,11592.0,female,1980,not reported,142,Primary Tumor,0.0,2.0,0.0,95.0,0.0,10.0,90.0,TCGA-EM-A3AP-01A,TCGA-EM-A3AP,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A2OL,16253.0,female,1967,white,102,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-DE-A2OL-01A,TCGA-DE-A2OL,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A5RC,25772.0,female,1942,white,140,Primary Tumor,0.0,0.0,5.0,85.0,0.0,25.0,70.0,TCGA-HT-A5RC-01A,TCGA-HT-A5RC,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CU,25881.0,female,1930,white,4278,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-EL-A3CU-01A,TCGA-EL-A3CU,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZR,16852.0,female,1962,white,1332,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-EL-A3ZR-01A,TCGA-EL-A3ZR,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VA,14495.0,female,1972,not reported,295,Primary Tumor,1.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-DJ-A3VA-01A,TCGA-DJ-A3VA,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UX,17124.0,female,1964,white,568,Primary Tumor,0.0,0.0,25.0,90.0,0.0,10.0,65.0,TCGA-DJ-A3UX-01A,TCGA-DJ-A3UX,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3681,28399.0,female,1929,not reported,None,Primary Tumor,None,None,0.0,85.0,None,2.0,93.0,TCGA-AA-3681-01A,TCGA-AA-3681,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1628,24488.0,female,1935,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,85.0,TCGA-25-1628-01A,TCGA-25-1628,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3509,19786.0,female,1951,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,85.0,TCGA-AA-3509-01A,TCGA-AA-3509,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1424,24545.0,female,1941,white,None,Primary Tumor,None,None,12.0,95.0,None,0.0,85.0,TCGA-24-1424-01A,TCGA-24-1424,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1630,27006.0,female,1929,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-25-1630-01A,TCGA-25-1630,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1D0,28875.0,female,1922,white,3634,Primary Tumor,0.0,0.0,0.0,70.0,0.0,10.0,80.0,TCGA-DM-A1D0-01A,TCGA-DM-A1D0,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6538,29194.0,female,1931,white,None,Primary Tumor,2.0,1.0,0.0,85.0,5.0,0.0,100.0,TCGA-D5-6538-01A,TCGA-D5-6538,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1844,23542.0,female,1945,white,None,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-24-1844-01A,TCGA-24-1844,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-A5NZ,24161.0,female,1945,black or african american,515,Primary Tumor,5.0,0.0,0.0,80.0,0.0,10.0,80.0,TCGA-29-A5NZ-01A,TCGA-29-A5NZ,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2023,19901.0,female,1940,white,None,Primary Tumor,0.0,0.0,0.0,85.0,5.0,20.0,80.0,TCGA-24-2023-01A,TCGA-24-2023,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6161,13363.0,female,1974,white,None,Primary Tumor,None,None,3.0,80.0,None,10.0,79.0,TCGA-CM-6161-01A,TCGA-CM-6161,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-0979,19595.0,female,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,25.0,75.0,TCGA-24-0979-01A,TCGA-24-0979,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1693,26300.0,female,1929,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,98.0,TCGA-29-1693-01A,TCGA-29-1693,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-20-1683,24006.0,female,1942,white,None,Primary Tumor,None,None,0.0,95.0,2.0,30.0,65.0,TCGA-20-1683-01A,TCGA-20-1683,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-5403,15983.0,male,1957,white,None,Primary Tumor,None,None,8.0,75.0,None,35.0,57.0,TCGA-AZ-5403-01A,TCGA-AZ-5403,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-4751,22891.0,male,1947,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,70.0,TCGA-CM-4751-01A,TCGA-CM-4751,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-SS-A7HO,16416.0,female,1966,black or african american,1270,Primary Tumor,2.0,2.0,0.0,70.0,5.0,0.0,90.0,TCGA-SS-A7HO-01A,TCGA-SS-A7HO,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-A5EK,18731.0,male,1961,black or african american,177,Primary Tumor,0.0,0.0,15.0,65.0,5.0,0.0,85.0,TCGA-AD-A5EK-01A,TCGA-AD-A5EK,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8369,28051.0,female,1935,white,None,Primary Tumor,None,None,0.0,75.0,None,25.0,75.0,TCGA-BR-8369-01A,TCGA-BR-8369,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-A9TM,28376.0,male,1936,white,97,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-FP-A9TM-01A,TCGA-FP-A9TM,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0724,26342.0,female,1930,white,None,Primary Tumor,None,None,0.0,98.0,None,5.0,95.0,TCGA-13-0724-01A,TCGA-13-0724,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6323,18334.0,male,1960,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-G4-6323-01A,TCGA-G4-6323,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3553,22524.0,female,1947,not reported,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-AA-3553-01A,TCGA-AA-3553,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1870,21550.0,female,1935,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-25-1870-01A,TCGA-25-1870,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0911,20276.0,female,1950,white,None,Primary Tumor,None,None,0.0,99.0,10.0,1.0,90.0,TCGA-13-0911-01A,TCGA-13-0911,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1604,24471.0,female,1930,white,None,Primary Tumor,None,None,45.0,90.0,None,0.0,50.0,TCGA-24-1604-01A,TCGA-24-1604,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-F1-6874,29083.0,male,1932,white,None,Primary Tumor,2.0,None,0.0,80.0,3.0,15.0,80.0,TCGA-F1-6874-01A,TCGA-F1-6874,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4J6,25279.0,female,1943,white,69,Primary Tumor,0.0,0.0,0.0,75.0,4.0,50.0,45.0,TCGA-BR-A4J6-01A,TCGA-BR-A4J6,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-A8CX,22000.0,male,1953,white,56,Primary Tumor,20.0,20.0,10.0,70.0,40.0,20.0,70.0,TCGA-FP-A8CX-01A,TCGA-FP-A8CX,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8N9,23059.0,female,1946,asian,1644,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-RD-A8N9-01A,TCGA-RD-A8N9,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1404,17784.0,female,1960,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,79.0,TCGA-13-1404-01A,TCGA-13-1404,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1778,28147.0,female,1931,white,None,Primary Tumor,None,None,0.0,80.0,15.0,20.0,80.0,TCGA-29-1778-01A,TCGA-29-1778,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3502,26724.0,male,1930,not reported,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-AA-3502-01A,TCGA-AA-3502,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-57-1584,17263.0,female,1960,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-57-1584-01A,TCGA-57-1584,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91S,23187.0,male,1949,black or african american,549,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-VQ-A91S-01A,TCGA-VQ-A91S,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1365,31925.0,female,1916,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-04-1365-01A,TCGA-04-1365,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2110,20718.0,female,1942,white,None,Primary Tumor,None,None,45.0,70.0,None,3.0,45.0,TCGA-61-2110-01A,TCGA-61-2110,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4366,32024.0,male,1921,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,80.0,TCGA-BR-4366-01A,TCGA-BR-4366,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1544,26141.0,female,1929,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,20.0,75.0,TCGA-24-1544-01A,TCGA-24-1544,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A6RJ,23439.0,male,1948,white,386,Primary Tumor,1.0,1.0,0.0,70.0,5.0,0.0,100.0,TCGA-IN-A6RJ-01A,TCGA-IN-A6RJ,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1574,17847.0,female,1959,asian,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-36-1574-01A,TCGA-36-1574,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6169,24564.0,male,1943,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,20.0,68.0,TCGA-CM-6169-01A,TCGA-CM-6169,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4H8,28292.0,male,1935,asian,148,Primary Tumor,0.0,1.0,20.0,75.0,2.0,0.0,80.0,TCGA-HU-A4H8-01A,TCGA-HU-A4H8,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1423,22281.0,female,1947,white,None,Primary Tumor,None,None,30.0,95.0,None,0.0,60.0,TCGA-24-1423-01A,TCGA-24-1423,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6172,25902.0,female,1940,white,None,Primary Tumor,None,None,18.0,80.0,None,10.0,68.0,TCGA-CM-6172-01A,TCGA-CM-6172,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8381,18843.0,male,1961,white,None,Primary Tumor,5.0,2.0,0.0,75.0,10.0,0.0,100.0,TCGA-BR-8381-01A,TCGA-BR-8381,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8DZ,25863.0,male,1941,black or african american,920,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-VQ-A8DZ-01A,TCGA-VQ-A8DZ,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1777,17356.0,female,1961,white,None,Primary Tumor,None,None,0.0,80.0,5.0,25.0,75.0,TCGA-29-1777-01A,TCGA-29-1777,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-SW-A7EB,16475.0,male,1968,white,77,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-SW-A7EB-01A,TCGA-SW-A7EB,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-A565,12526.0,female,1974,black or african american,1755,Primary Tumor,2.0,1.0,10.0,65.0,7.0,25.0,65.0,TCGA-A6-A565-01A,TCGA-A6-A565,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91E,24549.0,female,1946,white,136,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-VQ-A91E-01A,TCGA-VQ-A91E,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2289,25191.0,female,1929,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-24-2289-01A,TCGA-24-2289,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7707,25325.0,female,1942,white,None,Primary Tumor,None,None,0.0,60.0,None,20.0,60.0,TCGA-BR-7707-01A,TCGA-BR-7707,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91U,28791.0,male,1933,asian,910,Primary Tumor,0.0,0.0,10.0,65.0,5.0,0.0,90.0,TCGA-VQ-A91U-01A,TCGA-VQ-A91U,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7196,23611.0,male,1947,white,None,Primary Tumor,5.0,5.0,0.0,60.0,20.0,20.0,80.0,TCGA-BR-7196-01A,TCGA-BR-7196,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2092,21072.0,female,1947,white,None,Primary Tumor,None,None,0.0,99.0,None,10.0,90.0,TCGA-61-2092-01A,TCGA-61-2092,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5862,29493.0,male,1930,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,99.0,TCGA-CM-5862-01A,TCGA-CM-5862,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8579,24120.0,female,1946,white,None,Primary Tumor,15.0,0.0,0.0,63.0,15.0,0.0,100.0,TCGA-D7-8579-01A,TCGA-D7-8579,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3506,28275.0,male,1927,not reported,None,Primary Tumor,None,None,2.0,80.0,None,20.0,70.0,TCGA-AA-3506-01A,TCGA-AA-3506,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-A71X,19904.0,female,1959,black or african american,95,Primary Tumor,0.0,0.0,0.0,90.0,5.0,29.0,70.0,TCGA-AY-A71X-01A,TCGA-AY-A71X,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-5801,None,male,1941,asian,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-CD-5801-01A,TCGA-CD-5801,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3852,32203.0,male,1921,not reported,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-AA-3852-01A,TCGA-AA-3852,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-SW-A7EA,22294.0,female,1952,white,180,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-SW-A7EA-01A,TCGA-SW-A7EA,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3697,28367.0,male,1926,not reported,None,Primary Tumor,None,None,20.0,65.0,None,10.0,50.0,TCGA-AA-3697-01A,TCGA-AA-3697,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6888,26816.0,male,1937,white,None,Primary Tumor,None,None,0.0,70.0,20.0,10.0,70.0,TCGA-AD-6888-01A,TCGA-AD-6888,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-0369,20705.0,female,1947,white,None,Primary Tumor,None,None,0.0,98.0,None,5.0,95.0,TCGA-09-0369-01A,TCGA-09-0369,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7723,21839.0,male,1952,white,None,Primary Tumor,10.0,0.0,0.0,70.0,15.0,0.0,100.0,TCGA-BR-7723-01A,TCGA-BR-7723,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1D9,24514.0,female,1933,white,3929,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-DM-A1D9-01A,TCGA-DM-A1D9,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6321,21921.0,female,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,80.0,TCGA-G4-6321-01A,TCGA-G4-6321,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3972,26360.0,male,1936,not reported,None,Primary Tumor,None,None,10.0,90.0,None,20.0,70.0,TCGA-AA-3972-01A,TCGA-AA-3972,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-WR-A838,26418.0,female,1941,black or african american,110,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,85.0,TCGA-WR-A838-01A,TCGA-WR-A838,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A924,25351.0,male,1939,not reported,1820,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-VQ-A924-01A,TCGA-VQ-A924,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1769,14754.0,female,1967,white,None,Primary Tumor,None,None,10.0,90.0,2.0,5.0,85.0,TCGA-29-1769-01A,TCGA-29-1769,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8058,19658.0,female,1958,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-BR-8058-01A,TCGA-BR-8058,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-5541,23109.0,male,1947,white,None,Primary Tumor,1.0,1.0,0.0,80.0,5.0,10.0,80.0,TCGA-D5-5541-01A,TCGA-D5-5541,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1846,16534.0,female,1964,not reported,None,Primary Tumor,15.0,0.0,0.0,80.0,0.0,5.0,80.0,TCGA-24-1846-01A,TCGA-24-1846,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4465,25233.0,female,1939,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,80.0,TCGA-CG-4465-01A,TCGA-CG-4465,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2399,29373.0,female,1924,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,90.0,TCGA-25-2399-01A,TCGA-25-2399,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28H,18325.0,male,1952,white,3363,Primary Tumor,2.0,1.0,8.0,65.0,4.0,25.0,65.0,TCGA-DM-A28H-01A,TCGA-DM-A28H,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2400,27789.0,female,1928,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-25-2400-01A,TCGA-25-2400,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-5803,28608.0,female,1932,asian,None,Primary Tumor,None,None,40.0,50.0,None,15.0,45.0,TCGA-CD-5803-01A,TCGA-CD-5803,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1497,17528.0,female,1957,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,80.0,TCGA-13-1497-01A,TCGA-13-1497,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91X,27314.0,male,1936,white,1295,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-VQ-A91X-01A,TCGA-VQ-A91X,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-10-0936,25454.0,female,1936,black or african american,None,Primary Tumor,None,None,5.0,90.0,None,5.0,90.0,TCGA-10-0936-01A,TCGA-10-0936,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PU,26625.0,female,1940,white,490,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-VQ-A8PU-01A,TCGA-VQ-A8PU,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6901,28579.0,male,1933,white,None,Primary Tumor,None,None,0.0,60.0,5.0,45.0,55.0,TCGA-AD-6901-01A,TCGA-AD-6901,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1362,21745.0,female,1943,white,None,Primary Tumor,None,None,0.0,99.0,None,10.0,89.0,TCGA-04-1362-01A,TCGA-04-1362,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-0968,21664.0,female,1946,white,None,Primary Tumor,None,None,0.0,92.0,None,10.0,90.0,TCGA-24-0968-01A,TCGA-24-0968,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4460,24229.0,female,1942,not reported,None,Primary Tumor,None,None,5.0,80.0,None,10.0,75.0,TCGA-CG-4460-01A,TCGA-CG-4460,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8687,24472.0,female,1945,white,None,Primary Tumor,5.0,5.0,0.0,80.0,5.0,0.0,100.0,TCGA-BR-8687-01A,TCGA-BR-8687,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1332,25786.0,female,1932,white,None,Primary Tumor,None,None,0.0,89.0,None,52.0,40.0,TCGA-04-1332-01A,TCGA-04-1332,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-2078,24223.0,female,1935,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,89.0,TCGA-23-2078-01A,TCGA-23-2078,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2002,17115.0,female,1962,white,None,Primary Tumor,None,None,10.0,95.0,None,5.0,80.0,TCGA-61-2002-01A,TCGA-61-2002,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A7BW,25036.0,female,1936,white,3395,Primary Tumor,2.0,2.0,0.0,65.0,20.0,78.0,22.0,TCGA-RD-A7BW-01A,TCGA-RD-A7BW,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4267,18699.0,male,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,3.0,95.0,TCGA-BR-4267-01A,TCGA-BR-4267,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6138,22523.0,male,1949,white,None,Primary Tumor,7.0,0.0,0.0,70.0,10.0,35.0,65.0,TCGA-A6-6138-01A,TCGA-A6-6138,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1809,23111.0,female,1946,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,70.0,TCGA-23-1809-01A,TCGA-23-1809,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1356,22855.0,female,1942,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,85.0,TCGA-04-1356-01A,TCGA-04-1356,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-4748,19509.0,male,1957,white,None,Primary Tumor,None,None,1.0,75.0,None,15.0,82.0,TCGA-CM-4748-01A,TCGA-CM-4748,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3696,27667.0,female,1934,not reported,None,Primary Tumor,None,None,8.0,80.0,None,15.0,72.0,TCGA-AA-3696-01A,TCGA-AA-3696,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-A489,21517.0,male,1953,asian,474,Primary Tumor,0.0,0.0,0.0,65.0,2.0,0.0,100.0,TCGA-CD-A489-01A,TCGA-CD-A489,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28G,27641.0,male,1926,white,3419,Primary Tumor,2.0,2.0,0.0,75.0,3.0,23.0,75.0,TCGA-DM-A28G-01A,TCGA-DM-A28G,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A00Z,25872.0,male,1938,not reported,630,Primary Tumor,2.0,1.0,0.0,80.0,10.0,4.0,90.0,TCGA-AA-A00Z-01A,TCGA-AA-A00Z,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A747,20923.0,male,1956,white,98,Primary Tumor,0.0,0.0,30.0,50.0,0.0,40.0,30.0,TCGA-D7-A747-01A,TCGA-D7-A747,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-8210,17562.0,male,1958,asian,None,Primary Tumor,None,None,20.0,60.0,None,30.0,49.0,TCGA-FP-8210-01A,TCGA-FP-8210,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-F1-6875,29209.0,male,1917,black or african american,None,Primary Tumor,0.0,0.0,0.0,85.0,2.0,0.0,99.0,TCGA-F1-6875-01A,TCGA-F1-6875,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3693,28459.0,female,1931,not reported,None,Primary Tumor,None,None,0.0,75.0,None,50.0,42.0,TCGA-AA-3693-01A,TCGA-AA-3693,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8531,24453.0,female,1945,asian,None,Primary Tumor,None,None,5.0,85.0,None,5.0,90.0,TCGA-CD-8531-01A,TCGA-CD-8531,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4437,30467.0,male,1923,not reported,None,Primary Tumor,None,None,20.0,60.0,None,10.0,68.0,TCGA-CG-4437-01A,TCGA-CG-4437,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HF-7134,None,male,None,not reported,None,Primary Tumor,5.0,2.0,0.0,80.0,10.0,0.0,100.0,TCGA-HF-7134-01A,TCGA-HF-7134,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6676,30223.0,male,1929,white,None,Primary Tumor,None,None,3.0,75.0,None,20.0,72.0,TCGA-CM-6676-01A,TCGA-CM-6676,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GQ,26200.0,male,1940,asian,439,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-HU-A4GQ-01A,TCGA-HU-A4GQ,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-10-0928,26066.0,female,1929,white,None,Primary Tumor,None,None,5.0,95.0,None,5.0,90.0,TCGA-10-0928-01A,TCGA-10-0928,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3560,26359.0,female,1937,not reported,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-AA-3560-01A,TCGA-AA-3560,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01S,17257.0,female,1957,not reported,2152,Primary Tumor,0.0,0.0,0.0,95.0,1.0,3.0,95.0,TCGA-AA-A01S-01A,TCGA-AA-A01S,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-4950,24944.0,female,1940,black or african american,None,Primary Tumor,None,None,0.0,65.0,None,20.0,80.0,TCGA-CK-4950-01A,TCGA-CK-4950,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5864,22219.0,male,1950,white,None,Primary Tumor,4.0,2.0,5.0,80.0,10.0,4.0,90.0,TCGA-CM-5864-01A,TCGA-CM-5864,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5349,24867.0,female,1942,white,None,Primary Tumor,2.0,1.0,25.0,60.0,10.0,8.0,66.0,TCGA-CM-5349-01A,TCGA-CM-5349,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1567,19843.0,female,1945,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-24-1567-01A,TCGA-24-1567,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5722,24472.0,female,1938,not reported,None,Primary Tumor,None,None,0.0,70.0,None,18.0,77.0,TCGA-CG-5722-01A,TCGA-CG-5722,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3662,29554.0,female,1925,not reported,None,Primary Tumor,None,None,10.0,90.0,1.0,10.0,80.0,TCGA-AA-3662-01A,TCGA-AA-3662,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3510,25902.0,male,1935,not reported,None,Primary Tumor,None,None,8.0,75.0,None,10.0,72.0,TCGA-AA-3510-01A,TCGA-AA-3510,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-4951,28982.0,female,1928,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,80.0,TCGA-CK-4951-01A,TCGA-CK-4951,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8367,20441.0,male,1956,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,75.0,TCGA-BR-8367-01A,TCGA-BR-8367,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A4Z0,22129.0,female,1952,white,38,Primary Tumor,2.0,2.0,0.0,60.0,15.0,69.0,25.0,TCGA-D7-A4Z0-01A,TCGA-D7-A4Z0,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01P,29554.0,female,1923,not reported,2243,Primary Tumor,12.0,6.0,0.0,65.0,12.0,38.0,60.0,TCGA-AA-A01P-01A,TCGA-AA-A01P,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-5543,23870.0,female,1945,black or african american,None,Primary Tumor,None,None,15.0,80.0,None,10.0,82.0,TCGA-AY-5543-01A,TCGA-AY-5543,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3860,19449.0,female,1956,not reported,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-AA-3860-01A,TCGA-AA-3860,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-4614,26267.0,female,1937,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-AZ-4614-01A,TCGA-AZ-4614,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1918,16689.0,female,1957,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,80.0,TCGA-61-1918-01A,TCGA-61-1918,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7722,22701.0,male,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BR-7722-01A,TCGA-BR-7722,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A02O,30288.0,male,1923,not reported,1827,Primary Tumor,1.0,2.0,0.0,90.0,2.0,5.0,93.0,TCGA-AA-A02O-01A,TCGA-AA-A02O,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-6717,20984.0,male,1953,asian,None,Primary Tumor,None,None,0.0,80.0,None,20.0,78.0,TCGA-CA-6717-01A,TCGA-CA-6717,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8372,23346.0,male,1949,white,None,Primary Tumor,None,None,10.0,80.0,None,10.0,80.0,TCGA-BR-8372-01A,TCGA-BR-8372,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8532,19284.0,male,1959,asian,None,Primary Tumor,None,None,0.0,60.0,None,15.0,85.0,TCGA-CD-8532-01A,TCGA-CD-8532,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1995,16016.0,female,1966,white,None,Primary Tumor,None,None,10.0,75.0,None,10.0,68.0,TCGA-61-1995-01A,TCGA-61-1995,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1HA,30272.0,male,1918,white,3902,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,95.0,TCGA-DM-A1HA-01A,TCGA-DM-A1HA,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3511,23407.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,65.0,None,10.0,75.0,TCGA-AA-3511-01A,TCGA-AA-3511,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4J7,17932.0,male,1963,asian,107,Primary Tumor,0.0,1.0,0.0,100.0,0.0,25.0,75.0,TCGA-BR-A4J7-01A,TCGA-BR-A4J7,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8533,17821.0,male,1963,asian,None,Primary Tumor,None,None,5.0,85.0,None,15.0,77.0,TCGA-CD-8533-01A,TCGA-CD-8533,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0730,26086.0,female,1932,white,None,Primary Tumor,50.0,None,0.0,95.0,50.0,5.0,90.0,TCGA-13-0730-01A,TCGA-13-0730,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1103,18583.0,female,1951,black or african american,None,Primary Tumor,None,None,0.0,90.0,None,0.0,0.0,TCGA-24-1103-01A,TCGA-24-1103,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A94P,21022.0,male,1954,white,1039,Primary Tumor,1.0,1.0,0.0,75.0,12.0,84.0,15.0,TCGA-VQ-A94P-01A,TCGA-VQ-A94P,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-1662,21246.0,female,1943,white,None,Primary Tumor,None,None,10.0,95.0,None,0.0,87.0,TCGA-09-1662-01A,TCGA-09-1662,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PD,25244.0,male,1943,white,447,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-VQ-A8PD-01A,TCGA-VQ-A8PD,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-20-0991,28694.0,female,1928,white,None,Primary Tumor,None,None,2.0,98.0,None,0.0,93.0,TCGA-20-0991-01A,TCGA-20-0991,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3538,19752.0,female,1954,not reported,None,Primary Tumor,None,None,0.0,90.0,None,29.0,70.0,TCGA-AA-3538-01A,TCGA-AA-3538,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3819,15280.0,female,1967,not reported,None,Primary Tumor,None,None,0.0,80.0,None,15.0,70.0,TCGA-AA-3819-01A,TCGA-AA-3819,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6306,26163.0,male,1936,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,67.0,TCGA-G4-6306-01A,TCGA-G4-6306,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-VG-A8LO,20274.0,female,1958,black or african american,122,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-VG-A8LO-01A,TCGA-VG-A8LO,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6654,23953.0,female,1946,white,None,Primary Tumor,10.0,2.0,15.0,70.0,10.0,0.0,70.0,TCGA-A6-6654-01A,TCGA-A6-6654,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4294,23758.0,male,1944,white,None,Primary Tumor,None,None,8.0,85.0,None,5.0,86.0,TCGA-BR-4294-01A,TCGA-BR-4294,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1634,27749.0,female,1927,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,84.0,TCGA-25-1634-01A,TCGA-25-1634,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1417,19775.0,female,1954,white,None,Primary Tumor,None,None,15.0,85.0,None,0.0,70.0,TCGA-24-1417-01A,TCGA-24-1417,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6782,30012.0,male,1929,white,None,Primary Tumor,1.0,1.0,0.0,61.0,20.0,4.0,95.0,TCGA-A6-6782-01A,TCGA-A6-6782,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1562,24747.0,female,1932,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,85.0,TCGA-24-1562-01A,TCGA-24-1562,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1737,15515.0,female,1963,white,None,Primary Tumor,None,None,0.0,85.0,5.0,0.0,95.0,TCGA-61-1737-01A,TCGA-61-1737,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-31-1951,21352.0,female,1949,white,None,Primary Tumor,None,None,0.0,95.0,None,19.0,80.0,TCGA-31-1951-01A,TCGA-31-1951,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1350,16942.0,female,1957,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,94.0,TCGA-04-1350-01A,TCGA-04-1350,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6454,21501.0,male,1953,white,None,Primary Tumor,5.0,0.0,0.0,55.0,30.0,0.0,100.0,TCGA-BR-6454-01A,TCGA-BR-6454,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3956,24045.0,male,1942,not reported,None,Primary Tumor,None,None,0.0,80.0,None,20.0,79.0,TCGA-AA-3956-01A,TCGA-AA-3956,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-QG-A5Z1,26220.0,male,1940,black or african american,516,Primary Tumor,1.0,1.0,0.0,65.0,5.0,0.0,99.0,TCGA-QG-A5Z1-01A,TCGA-QG-A5Z1,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8297,21224.0,male,1954,white,None,Primary Tumor,None,None,0.0,65.0,None,70.0,30.0,TCGA-BR-8297-01A,TCGA-BR-8297,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-5254,15415.0,female,1968,asian,None,Primary Tumor,None,None,0.0,75.0,None,15.0,65.0,TCGA-CA-5254-01A,TCGA-CA-5254,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-2355,None,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,60.0,TCGA-59-2355-01A,TCGA-59-2355,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1570,17956.0,female,1958,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-36-1570-01A,TCGA-36-1570,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3554,22799.0,female,1946,not reported,None,Primary Tumor,None,None,0.0,90.0,None,40.0,60.0,TCGA-AA-3554-01A,TCGA-AA-3554,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6536,26890.0,male,1937,white,None,Primary Tumor,7.0,2.0,0.0,80.0,7.0,0.0,95.0,TCGA-D5-6536-01A,TCGA-D5-6536,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1651,19628.0,female,1951,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,88.0,TCGA-04-1651-01A,TCGA-04-1651,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4191,26562.0,male,1936,white,None,Primary Tumor,None,None,5.0,85.0,None,5.0,88.0,TCGA-BR-4191-01A,TCGA-BR-4191,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-04-1655,17988.0,female,1950,white,None,Primary Tumor,None,None,0.0,99.0,None,2.0,95.0,TCGA-04-1655-01A,TCGA-04-1655,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1697,22933.0,female,1941,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,98.0,TCGA-29-1697-01A,TCGA-29-1697,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3692,17167.0,female,1961,not reported,None,Primary Tumor,None,None,10.0,70.0,None,15.0,70.0,TCGA-AA-3692-01A,TCGA-AA-3692,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1498,26820.0,female,1933,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,80.0,TCGA-13-1498-01A,TCGA-13-1498,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-5799,16533.0,male,1965,asian,None,Primary Tumor,None,None,0.0,80.0,None,20.0,72.0,TCGA-CD-5799-01A,TCGA-CD-5799,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2111,22517.0,female,1937,white,None,Primary Tumor,None,None,3.0,75.0,None,3.0,80.0,TCGA-61-2111-01A,TCGA-61-2111,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A6RO,25789.0,male,1942,asian,230,Primary Tumor,3.0,1.0,0.0,80.0,2.0,19.0,80.0,TCGA-IN-A6RO-01A,TCGA-IN-A6RO,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1631,26687.0,female,1929,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,80.0,TCGA-25-1631-01A,TCGA-25-1631,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6805,21241.0,female,1953,white,None,Primary Tumor,None,None,10.0,80.0,None,30.0,55.0,TCGA-F4-6805-01A,TCGA-F4-6805,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1427,21423.0,female,1950,not reported,None,Primary Tumor,None,None,0.0,80.0,None,20.0,79.0,TCGA-24-1427-01A,TCGA-24-1427,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-2428,21392.0,female,1947,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-29-2428-01A,TCGA-29-2428,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-MX-A5UG,28714.0,male,1929,asian,1982,Primary Tumor,3.0,3.0,0.0,60.0,10.0,67.0,30.0,TCGA-MX-A5UG-01A,TCGA-MX-A5UG,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6171,28307.0,female,1933,white,None,Primary Tumor,None,None,5.0,85.0,None,8.0,79.0,TCGA-CM-6171-01A,TCGA-CM-6171,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3846,27057.0,female,1935,not reported,None,Primary Tumor,None,None,3.0,80.0,None,10.0,77.0,TCGA-AA-3846-01A,TCGA-AA-3846,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4369,27509.0,male,1933,white,None,Primary Tumor,None,None,5.0,75.0,None,5.0,75.0,TCGA-BR-4369-01A,TCGA-BR-4369,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27R,15122.0,female,1970,white,50,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-D8-A27R-01A,TCGA-D8-A27R,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A5PV,23215.0,female,1948,white,499,Primary Tumor,0.0,0.0,75.0,65.0,0.0,10.0,15.0,TCGA-GM-A5PV-01A,TCGA-GM-A5PV,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-A47B,28869.0,male,1933,white,118,Primary Tumor,0.0,0.0,0.0,75.0,0.0,35.0,65.0,TCGA-44-A47B-01A,TCGA-44-A47B,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FM,31805.0,female,1917,white,2606,Primary Tumor,0.0,0.0,34.0,80.0,2.0,5.0,60.0,TCGA-AC-A2FM-01A,TCGA-AC-A2FM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A8HP,21613.0,female,1954,asian,231,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-C8-A8HP-01A,TCGA-C8-A8HP,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BR,21622.0,female,1948,white,1170,Primary Tumor,0.0,0.0,0.0,60.0,4.0,19.0,80.0,TCGA-BH-A0BR-01A,TCGA-BH-A0BR,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06Q,23164.0,female,1944,not reported,1184,Primary Tumor,0.0,0.0,0.0,85.0,10.0,7.0,93.0,TCGA-A8-A06Q-01A,TCGA-A8-A06Q,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A6NO,15996.0,female,1968,black or african american,605,Primary Tumor,1.0,1.0,12.0,70.0,5.0,16.0,70.0,TCGA-AC-A6NO-01A,TCGA-AC-A6NO,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B9,16310.0,female,1962,white,1391,Primary Tumor,1.0,0.0,5.0,85.0,11.0,5.0,85.0,TCGA-BH-A0B9-01A,TCGA-BH-A0B9,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0YL,17702.0,female,1962,white,205,Primary Tumor,0.0,0.0,15.0,60.0,0.0,35.0,50.0,TCGA-A2-A0YL-01A,TCGA-A2-A0YL,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AQ-A1H3,18177.0,female,1961,white,94,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,90.0,TCGA-AQ-A1H3-01A,TCGA-AQ-A1H3,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AAB1,23962.0,male,1947,white,683,Primary Tumor,20.0,20.0,40.0,40.0,40.0,20.0,40.0,TCGA-2J-AAB1-01A,TCGA-2J-AAB1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A42U,29330.0,female,1924,black or african american,3080,Primary Tumor,0.0,0.0,0.0,70.0,3.0,55.0,45.0,TCGA-BH-A42U-01A,TCGA-BH-A42U,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-8494,24773.0,male,1945,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-95-8494-01A,TCGA-95-8494,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27F,14731.0,female,1970,white,166,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,55.0,TCGA-D8-A27F-01A,TCGA-D8-A27F,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8174,24725.0,male,1944,white,None,Primary Tumor,0.0,10.0,0.0,85.0,5.0,0.0,100.0,TCGA-97-8174-01A,TCGA-97-8174,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A086,21731.0,female,1950,not reported,272,Primary Tumor,0.0,0.0,2.0,65.0,3.0,30.0,65.0,TCGA-A8-A086-01A,TCGA-A8-A086,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RA,17699.0,female,1963,white,45,Primary Tumor,0.0,0.0,0.0,75.0,0.0,15.0,85.0,TCGA-E9-A1RA-01A,TCGA-E9-A1RA,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A04A,13445.0,female,1972,white,743,Primary Tumor,0.0,1.0,15.0,70.0,13.0,16.0,67.0,TCGA-AN-A04A-01A,TCGA-AN-A04A,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-A5A5,22329.0,female,1951,asian,156,Primary Tumor,1.0,0.0,0.0,70.0,7.0,0.0,100.0,TCGA-HV-A5A5-01A,TCGA-HV-A5A5,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8278,23117.0,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-86-8278-01A,TCGA-86-8278,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6968,22344.0,male,1943,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,88.0,TCGA-55-6968-01A,TCGA-55-6968,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18U,26426.0,female,1931,white,2697,Primary Tumor,1.0,1.0,0.0,75.0,4.0,25.0,75.0,TCGA-BH-A18U-01A,TCGA-BH-A18U,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6712,None,male,1939,white,None,Primary Tumor,0.0,0.0,0.0,60.0,30.0,15.0,85.0,TCGA-55-6712-01A,TCGA-55-6712,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5931,27733.0,female,1926,white,None,Primary Tumor,5.0,2.0,0.0,80.0,10.0,10.0,85.0,TCGA-50-5931-01A,TCGA-50-5931,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A3NY,26642.0,female,1937,white,778,Primary Tumor,0.0,0.0,3.0,85.0,0.0,7.0,90.0,TCGA-GM-A3NY-01A,TCGA-GM-A3NY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A3RF,29184.0,female,1933,white,61,Primary Tumor,1.0,2.0,0.0,75.0,4.0,25.0,75.0,TCGA-A7-A3RF-01A,TCGA-A7-A3RF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A03T,15540.0,female,1965,white,1031,Primary Tumor,0.0,0.0,0.0,90.0,0.0,19.0,80.0,TCGA-AO-A03T-01A,TCGA-AO-A03T,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A3XL,18171.0,female,1958,black or african american,1779,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,65.0,TCGA-GM-A3XL-01A,TCGA-GM-A3XL,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-A4VK,27040.0,female,1938,white,155,Primary Tumor,1.0,1.0,0.0,75.0,5.0,0.0,90.0,TCGA-95-A4VK-01A,TCGA-95-A4VK,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7539,27445.0,female,1936,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,100.0,TCGA-78-7539-01A,TCGA-78-7539,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A4BK,26503.0,male,1940,white,81,Primary Tumor,2.0,2.0,20.0,45.0,15.0,47.0,30.0,TCGA-HZ-A4BK-01A,TCGA-HZ-A4BK,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-3C-AALI,18538.0,female,1953,black or african american,3772,Primary Tumor,0.0,0.0,5.0,60.0,2.0,35.0,60.0,TCGA-3C-AALI-01A,TCGA-3C-AALI,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4668,24255.0,female,1943,american indian or alaska native,None,Primary Tumor,None,None,0.0,80.0,None,0.0,95.0,TCGA-73-4668-01A,TCGA-73-4668,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4628,24057.0,female,1937,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,84.0,TCGA-38-4628-01A,TCGA-38-4628,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A133,23922.0,female,1945,white,119,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-C8-A133-01A,TCGA-C8-A133,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0RX,21857.0,female,1951,white,63,Primary Tumor,2.0,0.0,2.0,70.0,3.0,24.0,70.0,TCGA-BH-A0RX-01A,TCGA-BH-A0RX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A07U,24411.0,female,1943,not reported,210,Primary Tumor,0.0,2.0,0.0,80.0,10.0,10.0,75.0,TCGA-A8-A07U-01A,TCGA-A8-A07U,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8672,21682.0,male,1953,white,None,Primary Tumor,0.0,0.0,0.0,65.0,25.0,0.0,90.0,TCGA-86-8672-01A,TCGA-86-8672,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4490,16634.0,female,1948,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,80.0,TCGA-49-4490-01A,TCGA-49-4490,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8288,25629.0,male,1941,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,65.0,TCGA-85-8288-01A,TCGA-85-8288,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A4BW,20301.0,male,1957,white,128,Primary Tumor,0.0,0.0,0.0,65.0,0.0,25.0,75.0,TCGA-56-A4BW-01A,TCGA-56-A4BW,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KE,27290.0,female,1938,not reported,609,Primary Tumor,0.0,0.0,50.0,60.0,1.0,0.0,50.0,TCGA-VD-A8KE-01A,TCGA-VD-A8KE,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8140,24415.0,female,1937,not reported,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-77-8140-01A,TCGA-77-8140,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A510,27067.0,female,1938,white,142,Primary Tumor,2.0,2.0,0.0,100.0,4.0,10.0,80.0,TCGA-85-A510-01A,TCGA-85-A510,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2727,20150.0,female,1949,not reported,None,Primary Tumor,None,None,0.0,90.0,5.0,20.0,80.0,TCGA-66-2727-01A,TCGA-66-2727,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7730,26699.0,male,1938,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,90.0,TCGA-56-7730-01A,TCGA-56-7730,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2712,29131.0,female,1927,white,None,Primary Tumor,None,None,15.0,85.0,None,10.0,70.0,TCGA-60-2712-01A,TCGA-60-2712,2.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A882,18612.0,female,1962,white,610,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-WC-A882-01A,TCGA-WC-A882,2.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-A6HN,27025.0,male,1940,asian,97,Primary Tumor,5.0,10.0,0.0,80.0,80.0,10.0,90.0,TCGA-FA-A6HN-01A,TCGA-FA-A6HN,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-96-8170,27558.0,female,1936,white,None,Primary Tumor,10.0,8.0,0.0,70.0,10.0,0.0,100.0,TCGA-96-8170-01A,TCGA-96-8170,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1080,24253.0,male,1930,white,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-21-1080-01A,TCGA-21-1080,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-A56U,27847.0,female,1936,white,76,Primary Tumor,20.0,4.0,10.0,70.0,8.0,50.0,40.0,TCGA-43-A56U-01A,TCGA-43-A56U,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1083,27708.0,male,1922,white,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-21-1083-01A,TCGA-21-1083,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-70-6723,24035.0,male,1945,asian,None,Primary Tumor,None,None,0.0,85.0,None,10.0,82.0,TCGA-70-6723-01A,TCGA-70-6723,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KN,21935.0,female,1953,not reported,179,Primary Tumor,0.0,0.0,50.0,60.0,1.0,0.0,50.0,TCGA-VD-A8KN-01A,TCGA-VD-A8KN,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5231,26525.0,male,1934,white,None,Primary Tumor,None,None,15.0,75.0,None,15.0,58.0,TCGA-34-5231-01A,TCGA-34-5231,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-3421,23972.0,male,1942,white,None,Primary Tumor,None,None,40.0,80.0,None,5.0,50.0,TCGA-18-3421-01A,TCGA-18-3421,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-RQ-AAAT,23178.0,female,1950,white,186,Primary Tumor,5.0,5.0,0.0,80.0,80.0,30.0,60.0,TCGA-RQ-AAAT-01A,TCGA-RQ-AAAT,
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-A86F,23641.0,female,1949,white,86,Primary Tumor,5.0,10.0,10.0,90.0,80.0,5.0,80.0,TCGA-FA-A86F-01A,TCGA-FA-A86F,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HT,25466.0,male,1943,white,337,Primary Tumor,0.0,0.0,0.0,70.0,0.0,5.0,95.0,TCGA-NC-A5HT-01A,TCGA-NC-A5HT,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A50Z,20941.0,male,1955,white,143,Primary Tumor,10.0,3.0,0.0,95.0,6.0,10.0,90.0,TCGA-85-A50Z-01A,TCGA-85-A50Z,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-7020,None,male,None,not reported,None,Primary Tumor,2.0,1.0,0.0,80.0,5.0,6.0,80.0,TCGA-63-7020-01A,TCGA-63-7020,1.0
UVM,Uveal Melanoma,Eye,TCGA-RZ-AB0B,17514.0,female,1966,white,126,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-RZ-AB0B-01A,TCGA-RZ-AB0B,4.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A3DL,30805.0,female,1927,white,229,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,90.0,TCGA-BF-A3DL-01A,TCGA-BF-A3DL,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5480,24245.0,female,1936,white,None,Primary Tumor,2.0,1.0,0.0,80.0,10.0,0.0,95.0,TCGA-22-5480-01A,TCGA-22-5480,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6D8,21778.0,male,1953,black or african american,452,Primary Tumor,1.0,0.0,0.0,65.0,10.0,0.0,100.0,TCGA-BA-A6D8-01A,TCGA-BA-A6D8,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5894,15510.0,male,1968,not reported,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-BQ-5894-01A,TCGA-BQ-5894,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49S,21865.0,male,1952,asian,522,Primary Tumor,1.0,0.0,0.0,90.0,4.0,20.0,75.0,TCGA-LN-A49S-01A,TCGA-LN-A49S,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5886,27670.0,male,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BQ-5886-01A,TCGA-BQ-5886,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5370,28549.0,male,1928,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CN-5370-01A,TCGA-CN-5370,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-A5NI,26985.0,male,None,not reported,None,Primary Tumor,0.0,3.0,0.0,80.0,2.0,0.0,100.0,TCGA-HE-A5NI-01A,TCGA-HE-A5NI,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PK,25933.0,male,None,white,None,Primary Tumor,0.0,3.0,0.0,75.0,1.0,0.0,95.0,TCGA-UZ-A9PK-01A,TCGA-UZ-A9PK,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A61S,22655.0,male,1950,white,240,Primary Tumor,0.0,0.0,25.0,70.0,10.0,5.0,70.0,TCGA-F7-A61S-01A,TCGA-F7-A61S,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6K1,23848.0,male,1946,white,549,Primary Tumor,3.0,0.0,0.0,65.0,25.0,20.0,65.0,TCGA-CV-A6K1-01A,TCGA-CV-A6K1,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6023,26769.0,male,1937,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,93.0,TCGA-CN-6023-01A,TCGA-CN-6023,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A9FR,25657.0,male,1943,asian,97,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-LN-A9FR-01A,TCGA-LN-A9FR,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A3X6,25584.0,male,1941,white,280,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-E7-A3X6-01A,TCGA-E7-A3X6,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-A6MB,23664.0,male,1949,white,84,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-K4-A6MB-01A,TCGA-K4-A6MB,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A9FF,19195.0,male,1961,asian,106,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-CF-A9FF-01A,TCGA-CF-A9FF,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A5UA,24625.0,male,1945,asian,84,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-CF-A5UA-01A,TCGA-CF-A5UA,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CX-7082,30174.0,male,1928,white,None,Primary Tumor,5.0,0.0,1.0,70.0,5.0,25.0,72.0,TCGA-CX-7082-01A,TCGA-CX-7082,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7365,22101.0,male,1948,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-CR-7365-01A,TCGA-CR-7365,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7055,26749.0,male,1935,white,None,Primary Tumor,0.0,5.0,0.0,80.0,3.0,0.0,100.0,TCGA-BQ-7055-01A,TCGA-BQ-7055,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IL,29047.0,female,1932,white,149,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-DK-A3IL-01A,TCGA-DK-A3IL,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9K2,22964.0,male,1945,white,2272,Primary Tumor,0.0,8.0,0.0,75.0,1.0,0.0,100.0,TCGA-5P-A9K2-01A,TCGA-5P-A9K2,
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-C4-A0EZ,25202.0,female,1937,not reported,1299,Primary Tumor,0.0,0.0,5.0,97.0,0.0,1.0,89.0,TCGA-C4-A0EZ-01A,TCGA-C4-A0EZ,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-8310,21312.0,male,1954,white,None,Primary Tumor,None,None,0.0,90.0,2.0,0.0,100.0,TCGA-A4-8310-01A,TCGA-A4-8310,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N6-A4VE,30794.0,female,1922,white,2537,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-N6-A4VE-01A,TCGA-N6-A4VE,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5883,28877.0,female,1928,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BQ-5883-01A,TCGA-BQ-5883,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JQ,24244.0,male,1946,white,414,Primary Tumor,0.0,2.0,0.0,80.0,1.0,0.0,100.0,TCGA-2Z-A9JQ-01A,TCGA-2Z-A9JQ,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A4A5,18160.0,male,1962,asian,270,Primary Tumor,0.0,0.0,20.0,75.0,0.0,0.0,80.0,TCGA-LN-A4A5-01A,TCGA-LN-A4A5,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A61W,18879.0,male,1961,asian,164,Primary Tumor,0.0,2.0,0.0,100.0,6.0,10.0,90.0,TCGA-F7-A61W-01A,TCGA-F7-A61W,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A6JZ,25182.0,male,1943,white,564,Primary Tumor,0.0,0.0,0.0,85.0,10.0,10.0,78.0,TCGA-CV-A6JZ-01A,TCGA-CV-A6JZ,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-Z6-A9VB,19470.0,male,1960,white,126,Primary Tumor,0.0,0.0,10.0,70.0,0.0,30.0,60.0,TCGA-Z6-A9VB-01A,TCGA-Z6-A9VB,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6IH,23936.0,female,1948,white,38,Primary Tumor,0.0,0.0,0.0,80.0,4.0,0.0,100.0,TCGA-QK-A6IH-01A,TCGA-QK-A6IH,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7410,22302.0,male,1932,white,None,Primary Tumor,2.0,0.0,0.0,67.0,10.0,50.0,50.0,TCGA-CV-7410-01A,TCGA-CV-7410,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5367,22246.0,female,1946,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,75.0,TCGA-CN-5367-01A,TCGA-CN-5367,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4CB,21574.0,male,1952,not reported,439,Primary Tumor,0.0,0.0,10.0,80.0,0.0,10.0,70.0,TCGA-CQ-A4CB-01A,TCGA-CQ-A4CB,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45O,20868.0,male,1937,white,6651,Primary Tumor,0.0,0.0,0.0,75.0,10.0,25.0,75.0,TCGA-CV-A45O-01A,TCGA-CV-A45O,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-H7-A6C4,13137.0,female,1977,white,385,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-H7-A6C4-01A,TCGA-H7-A6C4,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6997,24298.0,male,1945,white,None,Primary Tumor,None,None,0.0,60.0,None,40.0,60.0,TCGA-CN-6997-01A,TCGA-CN-6997,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-8569,19212.0,male,1960,white,None,Primary Tumor,4.0,0.0,0.0,85.0,10.0,0.0,100.0,TCGA-D6-8569-01A,TCGA-D6-8569,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NH,19991.0,male,1947,white,4667,Primary Tumor,0.0,6.0,0.0,90.0,6.0,15.0,85.0,TCGA-L5-A8NH-01A,TCGA-L5-A8NH,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-5560,13964.0,female,1971,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-DW-5560-01A,TCGA-DW-5560,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-HQ-A5NE,20647.0,male,None,not reported,None,Primary Tumor,5.0,0.0,4.0,65.0,25.0,46.0,45.0,TCGA-HQ-A5NE-01A,TCGA-HQ-A5NE,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5890,25272.0,male,1940,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,65.0,TCGA-BQ-5890-01A,TCGA-BQ-5890,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-A8LC,22553.0,male,1952,white,184,Primary Tumor,0.0,0.0,0.0,95.0,5.0,8.0,90.0,TCGA-G7-A8LC-01A,TCGA-G7-A8LC,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SU,27068.0,female,1932,white,2887,Primary Tumor,5.0,1.0,0.0,70.0,2.0,30.0,70.0,TCGA-XF-A9SU-01A,TCGA-XF-A9SU,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4722,22299.0,female,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-CN-4722-01A,TCGA-CN-4722,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6022,17971.0,male,1961,white,None,Primary Tumor,None,None,0.0,65.0,None,20.0,80.0,TCGA-CN-6022-01A,TCGA-CN-6022,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3IT,22786.0,male,1949,white,145,Primary Tumor,0.0,0.0,40.0,70.0,2.0,0.0,60.0,TCGA-DK-A3IT-01A,TCGA-DK-A3IT,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA77,22365.0,male,1952,white,168,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-DK-AA77-01A,TCGA-DK-AA77,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-A763,26527.0,male,1940,white,447,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-GU-A763-01A,TCGA-GU-A763,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA53,22035.0,male,1950,white,1434,Primary Tumor,3.0,2.0,0.0,60.0,30.0,45.0,35.0,TCGA-ZF-AA53-01A,TCGA-ZF-AA53,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A71B,18404.0,male,1960,white,1071,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-UF-A71B-01A,TCGA-UF-A71B,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T6,19694.0,male,1956,white,1333,Primary Tumor,0.0,5.0,0.0,95.0,4.0,20.0,80.0,TCGA-P3-A6T6-01A,TCGA-P3-A6T6,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A9FH,31236.0,male,1928,asian,97,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,70.0,TCGA-CF-A9FH-01A,TCGA-CF-A9FH,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA4N,27056.0,male,1937,white,919,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-ZF-AA4N-01A,TCGA-ZF-AA4N,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-7130,None,female,None,not reported,None,Primary Tumor,0.0,0.0,0.0,85.0,10.0,0.0,100.0,TCGA-HE-7130-01A,TCGA-HE-7130,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A561,24271.0,male,1946,white,265,Primary Tumor,0.0,100.0,0.0,80.0,0.0,25.0,75.0,TCGA-MH-A561-01A,TCGA-MH-A561,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA4R,24537.0,male,1941,white,1834,Primary Tumor,3.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-ZF-AA4R-01A,TCGA-ZF-AA4R,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-A8LD,25977.0,male,1941,white,419,Primary Tumor,1.0,0.0,0.0,90.0,8.0,15.0,80.0,TCGA-G7-A8LD-01A,TCGA-G7-A8LD,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7433,18004.0,male,1950,white,None,Primary Tumor,None,None,0.0,60.0,None,20.0,72.0,TCGA-CV-7433-01A,TCGA-CV-7433,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5364,20362.0,male,1951,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,75.0,TCGA-CN-5364-01A,TCGA-CN-5364,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5876,27409.0,male,1929,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-BQ-5876-01A,TCGA-BQ-5876,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BB-4224,19119.0,male,1952,white,None,Primary Tumor,None,None,18.0,70.0,20.0,None,80.0,TCGA-BB-4224-01A,TCGA-BB-4224,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3QI,17383.0,male,1964,white,105,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,100.0,TCGA-GV-A3QI-01A,TCGA-GV-A3QI,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-SY-A9G0,30205.0,male,1929,white,752,Primary Tumor,0.0,0.0,10.0,65.0,5.0,25.0,65.0,TCGA-SY-A9G0-01A,TCGA-SY-A9G0,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20N,26456.0,male,1931,not reported,2955,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,80.0,TCGA-BT-A20N-01A,TCGA-BT-A20N,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-G7-6789,19593.0,female,1951,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-G7-6789-01A,TCGA-G7-6789,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A6ES,18408.0,male,1963,white,69,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-D6-A6ES-01A,TCGA-D6-A6ES,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3JV,24243.0,male,1945,white,281,Primary Tumor,0.0,0.0,0.0,90.0,3.0,0.0,100.0,TCGA-GV-A3JV-01A,TCGA-GV-A3JV,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-RS-A6TO,30104.0,female,1931,white,29,Primary Tumor,6.0,2.0,0.0,70.0,4.0,29.0,70.0,TCGA-RS-A6TO-01A,TCGA-RS-A6TO,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R1,29610.0,male,1932,white,317,Primary Tumor,3.0,1.0,0.0,70.0,2.0,30.0,70.0,TCGA-ZF-A9R1-01A,TCGA-ZF-A9R1,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L7-A6VZ,22730.0,male,1951,white,135,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,93.0,TCGA-L7-A6VZ-01A,TCGA-L7-A6VZ,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A5QE,18002.0,male,1960,white,1217,Primary Tumor,0.0,0.0,0.0,75.0,20.0,20.0,80.0,TCGA-P3-A5QE-01A,TCGA-P3-A5QE,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A677,29613.0,male,1931,asian,126,Primary Tumor,0.0,0.0,0.0,90.0,3.0,25.0,72.0,TCGA-E7-A677-01A,TCGA-E7-A677,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9K9,21600.0,female,1952,white,880,Primary Tumor,0.0,4.0,0.0,60.0,4.0,0.0,100.0,TCGA-5P-A9K9-01A,TCGA-5P-A9K9,
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SS,24660.0,male,1943,white,1163,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-SX-A7SS-01A,TCGA-SX-A7SS,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5884,21730.0,female,1949,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BQ-5884-01A,TCGA-BQ-5884,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7836,20269.0,male,1953,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-DW-7836-01A,TCGA-DW-7836,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9KF,19631.0,male,1958,white,761,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-5P-A9KF-01A,TCGA-5P-A9KF,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JH,21558.0,male,1953,black or african american,385,Primary Tumor,1.0,6.0,0.0,60.0,4.0,75.0,25.0,TCGA-UF-A7JH-01A,TCGA-UF-A7JH,4.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N9-A4PZ,28211.0,female,1928,white,2779,Primary Tumor,5.0,10.0,5.0,90.0,60.0,5.0,90.0,TCGA-N9-A4PZ-01A,TCGA-N9-A4PZ,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9RD,27496.0,female,1933,white,2074,Primary Tumor,0.0,0.0,40.0,60.0,5.0,0.0,60.0,TCGA-ZF-A9RD-01A,TCGA-ZF-A9RD,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A9PA,17520.0,male,None,white,None,Primary Tumor,3.0,1.0,3.0,80.0,2.0,17.0,80.0,TCGA-UY-A9PA-01A,TCGA-UY-A9PA,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A5S3,25414.0,female,1943,white,174,Primary Tumor,1.0,1.0,5.0,88.0,4.0,20.0,60.0,TCGA-IG-A5S3-01A,TCGA-IG-A5S3,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T4,20027.0,male,1954,white,1668,Primary Tumor,0.0,0.0,0.0,65.0,10.0,0.0,100.0,TCGA-P3-A6T4-01A,TCGA-P3-A6T4,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5EB,30395.0,male,1923,white,2334,Primary Tumor,0.0,2.0,0.0,75.0,2.0,0.0,100.0,TCGA-P4-A5EB-01A,TCGA-P4-A5EB,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-A766,22774.0,male,1951,white,99,Primary Tumor,0.0,0.0,0.0,65.0,0.0,50.0,50.0,TCGA-GU-A766-01A,TCGA-GU-A766,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-AAVM,25280.0,male,1941,white,1453,Primary Tumor,1.0,6.0,0.0,70.0,3.0,25.0,70.0,TCGA-P4-AAVM-01A,TCGA-P4-AAVM,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A3X2,31160.0,male,1925,white,548,Primary Tumor,0.0,1.0,0.0,90.0,2.0,17.0,78.0,TCGA-DK-A3X2-01A,TCGA-DK-A3X2,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4CA,None,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,80.0,100.0,20.0,80.0,TCGA-CQ-A4CA-01A,TCGA-CQ-A4CA,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA5H,22122.0,female,1952,white,437,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-ZF-AA5H-01A,TCGA-ZF-AA5H,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-V5-AASW,26571.0,male,None,white,None,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-V5-AASW-01A,TCGA-V5-AASW,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A7HZ,17931.0,male,1964,asian,161,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,100.0,TCGA-LN-A7HZ-01A,TCGA-LN-A7HZ,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-7631,22151.0,female,1951,white,None,Primary Tumor,None,None,0.0,60.0,None,30.0,70.0,TCGA-IQ-7631-01A,TCGA-IQ-7631,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA74,27730.0,male,1935,white,1258,Primary Tumor,7.0,2.0,0.0,70.0,3.0,30.0,70.0,TCGA-DK-AA74-01A,TCGA-DK-AA74,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-KQ-A41Q,32511.0,male,1920,white,1294,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-KQ-A41Q-01A,TCGA-KQ-A41Q,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6003,18600.0,female,1957,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CV-6003-01A,TCGA-CV-6003,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A49M,22933.0,male,1948,asian,634,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-LN-A49M-01A,TCGA-LN-A49M,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A5QF,18035.0,male,1960,white,1200,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,70.0,TCGA-P3-A5QF-01A,TCGA-P3-A5QF,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-UY-A9PB,17885.0,male,None,white,None,Primary Tumor,5.0,2.0,0.0,75.0,2.0,24.0,75.0,TCGA-UY-A9PB-01A,TCGA-UY-A9PB,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A1AB,27126.0,female,1936,white,162,Primary Tumor,1.0,1.0,0.0,75.0,2.0,22.0,75.0,TCGA-DK-A1AB-01A,TCGA-DK-A1AB,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SH,24060.0,female,1940,asian,3256,Primary Tumor,4.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-XF-A9SH-01A,TCGA-XF-A9SH,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A93D,18813.0,male,1961,white,573,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-JY-A93D-01A,TCGA-JY-A93D,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GU-A762,31812.0,male,1925,white,386,Primary Tumor,0.0,0.0,0.0,70.0,0.0,30.0,70.0,TCGA-GU-A762-01A,TCGA-GU-A762,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3I6,16504.0,male,1966,white,132,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-GC-A3I6-01A,TCGA-GC-A3I6,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-Q2-A5QZ,22531.0,female,1951,black or african american,48,Primary Tumor,2.0,4.0,0.0,85.0,4.0,30.0,65.0,TCGA-Q2-A5QZ-01A,TCGA-Q2-A5QZ,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7050,19550.0,female,1953,white,None,Primary Tumor,0.0,4.0,0.0,85.0,5.0,0.0,100.0,TCGA-BQ-7050-01A,TCGA-BQ-7050,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A97P,26956.0,male,1940,asian,90,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,70.0,TCGA-E7-A97P-01A,TCGA-E7-A97P,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-4078,30480.0,male,1920,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-BA-4078-01A,TCGA-BA-4078,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A856,20006.0,male,1958,white,394,Primary Tumor,0.0,3.0,0.0,80.0,1.0,0.0,100.0,TCGA-MH-A856-01A,TCGA-MH-A856,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JI,14196.0,male,1972,white,1227,Primary Tumor,0.0,10.0,0.0,70.0,0.0,30.0,65.0,TCGA-2Z-A9JI-01A,TCGA-2Z-A9JI,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GO,21486.0,male,1942,not reported,4785,Primary Tumor,2.0,2.0,0.0,80.0,10.0,22.0,63.0,TCGA-2H-A9GO-01A,TCGA-2H-A9GO,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-A6EN,26294.0,male,1942,white,118,Primary Tumor,0.0,0.0,0.0,70.0,15.0,0.0,100.0,TCGA-D6-A6EN-01A,TCGA-D6-A6EN,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A4IG,28402.0,male,1934,white,457,Primary Tumor,1.0,1.0,0.0,100.0,3.0,10.0,90.0,TCGA-BA-A4IG-01A,TCGA-BA-A4IG,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA58,22549.0,female,1949,white,1252,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,70.0,TCGA-ZF-AA58-01A,TCGA-ZF-AA58,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-A6DE,25874.0,female,1943,white,121,Primary Tumor,0.0,0.0,0.0,75.0,5.0,10.0,80.0,TCGA-BA-A6DE-01A,TCGA-BA-A6DE,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-DQ-7591,22798.0,male,1949,white,None,Primary Tumor,None,None,0.0,85.0,10.0,15.0,85.0,TCGA-DQ-7591-01A,TCGA-DQ-7591,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-KU-A66S,25454.0,female,1943,white,150,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-KU-A66S-01A,TCGA-KU-A66S,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7382,18078.0,male,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CR-7382-01A,TCGA-CR-7382,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TK,21942.0,male,1953,white,59,Primary Tumor,0.0,0.0,25.0,75.0,4.0,0.0,75.0,TCGA-FD-A6TK-01A,TCGA-FD-A6TK,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8EY,16255.0,female,1968,white,563,Primary Tumor,0.0,0.0,0.0,70.0,5.0,0.0,96.0,TCGA-VR-A8EY-01A,TCGA-VR-A8EY,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4731,23194.0,female,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,40.0,55.0,TCGA-CN-4731-01A,TCGA-CN-4731,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-AAVK,27073.0,male,1936,white,1210,Primary Tumor,2.0,5.0,0.0,75.0,2.0,21.0,75.0,TCGA-P4-AAVK-01A,TCGA-P4-AAVK,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-A5NH,22888.0,male,None,not reported,None,Primary Tumor,0.0,3.0,0.0,80.0,1.0,0.0,100.0,TCGA-HE-A5NH-01A,TCGA-HE-A5NH,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-2Z-A9JJ,25240.0,female,1942,white,918,Primary Tumor,0.0,10.0,0.0,75.0,0.0,25.0,70.0,TCGA-2Z-A9JJ-01A,TCGA-2Z-A9JJ,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A42F,23713.0,male,1947,white,282,Primary Tumor,3.0,2.0,0.0,70.0,6.0,25.0,70.0,TCGA-BT-A42F-01A,TCGA-BT-A42F,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A93E,22427.0,male,1951,white,472,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-JY-A93E-01A,TCGA-JY-A93E,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-NA-A4R1,27688.0,female,1937,black or african american,306,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-NA-A4R1-01A,TCGA-NA-A4R1,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-P3-A6T7,20301.0,male,1955,white,1182,Primary Tumor,1.0,3.0,5.0,80.0,6.0,30.0,65.0,TCGA-P3-A6T7-01A,TCGA-P3-A6T7,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PP,21915.0,male,None,white,None,Primary Tumor,0.0,3.0,0.0,75.0,1.0,0.0,100.0,TCGA-UZ-A9PP-01A,TCGA-UZ-A9PP,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A6FB,28269.0,male,1930,white,2200,Primary Tumor,0.0,0.0,20.0,90.0,0.0,10.0,70.0,TCGA-JY-A6FB-01A,TCGA-JY-A6FB,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7288,26268.0,female,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-A4-7288-01A,TCGA-A4-7288,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UN-AAZ9,27851.0,female,1937,black or african american,187,Primary Tumor,0.0,1.0,0.0,96.0,2.0,5.0,93.0,TCGA-UN-AAZ9-01A,TCGA-UN-AAZ9,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7060,19479.0,male,1958,american indian or alaska native,None,Primary Tumor,0.0,5.0,0.0,90.0,0.0,0.0,100.0,TCGA-BQ-7060-01A,TCGA-BQ-7060,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACK,25796.0,male,1938,asian,1828,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AACK-01A,TCGA-DD-AACK,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-NI-A8LF,27162.0,male,1938,white,422,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-NI-A8LF-01A,TCGA-NI-A8LF,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE6,21764.0,female,1953,asian,399,Primary Tumor,0.0,1.0,0.0,97.0,1.0,1.0,94.0,TCGA-DD-AAE6-01A,TCGA-DD-AAE6,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-MI-A75G,23284.0,male,1949,white,427,Primary Tumor,0.0,2.0,0.0,90.0,3.0,5.0,87.0,TCGA-MI-A75G-01A,TCGA-MI-A75G,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-5263,12863.0,male,1975,asian,91,Primary Tumor,None,None,0.0,85.0,None,5.0,80.0,TCGA-CC-5263-01A,TCGA-CC-5263,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E5,23144.0,male,1946,not reported,1456,Primary Tumor,0.0,0.0,0.0,85.0,5.0,48.0,50.0,TCGA-KK-A6E5-01A,TCGA-KK-A6E5,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A05Z,13529.0,female,1969,not reported,1416,Primary Tumor,0.0,0.0,0.0,80.0,5.0,10.0,80.0,TCGA-AX-A05Z-01A,TCGA-AX-A05Z,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MT,23574.0,female,1945,white,344,Primary Tumor,1.0,5.0,0.0,85.0,7.0,9.0,90.0,TCGA-BG-A0MT-01A,TCGA-BG-A0MT,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A8YO,24189.0,female,1947,white,141,Primary Tumor,2.0,1.0,0.0,80.0,3.0,17.0,80.0,TCGA-BC-A8YO-01A,TCGA-BC-A8YO,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H6,24982.0,female,1943,white,982,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-2Y-A9H6-01A,TCGA-2Y-A9H6,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A102,17991.0,female,1960,white,380,Primary Tumor,0.0,0.0,0.0,75.0,0.0,5.0,95.0,TCGA-D1-A102-01A,TCGA-D1-A102,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GX,19625.0,female,1952,white,1654,Primary Tumor,0.0,0.0,10.0,85.0,0.0,0.0,90.0,TCGA-A5-A0GX-01A,TCGA-A5-A0GX,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A3FA,26850.0,female,1931,white,2679,Primary Tumor,0.0,2.0,30.0,75.0,1.0,0.0,70.0,TCGA-B5-A3FA-01A,TCGA-B5-A3FA,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16S,25690.0,female,1940,white,177,Primary Tumor,1.0,4.0,0.0,60.0,3.0,40.0,57.0,TCGA-D1-A16S-01A,TCGA-D1-A16S,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0TE,12983.0,female,1970,asian,1835,Primary Tumor,30.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-BS-A0TE-01A,TCGA-BS-A0TE,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8II,22460.0,male,1943,not reported,3293,Primary Tumor,0.0,0.0,5.0,80.0,0.0,30.0,65.0,TCGA-KK-A8II-01A,TCGA-KK-A8II,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A6W3,12590.0,female,1979,black or african american,94,Primary Tumor,1.0,1.0,10.0,80.0,5.0,10.0,80.0,TCGA-BK-A6W3-01A,TCGA-BK-A6W3,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A187,24099.0,female,1945,white,97,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-BG-A187-01A,TCGA-BG-A187,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A2G6,19547.0,female,1954,white,1350,Primary Tumor,10.0,0.0,30.0,70.0,10.0,0.0,60.0,TCGA-D1-A2G6-01A,TCGA-D1-A2G6,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XJ-A9DK,None,male,1944,not reported,2327,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-XJ-A9DK-01A,TCGA-XJ-A9DK,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OT,22630.0,male,None,not reported,None,Primary Tumor,0.0,0.0,20.0,60.0,0.0,30.0,50.0,TCGA-V1-A9OT-01A,TCGA-V1-A9OT,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A82E,22234.0,female,1953,asian,78,Primary Tumor,0.0,0.0,0.0,90.0,4.0,59.0,40.0,TCGA-ED-A82E-01A,TCGA-ED-A82E,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAD8,26781.0,female,1938,asian,981,Primary Tumor,1.0,1.0,0.0,94.0,3.0,9.0,83.0,TCGA-DD-AAD8-01A,TCGA-DD-AAD8,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV1,18973.0,male,1962,asian,146,Primary Tumor,1.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-G3-AAV1-01A,TCGA-G3-AAV1,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A2ON,22624.0,female,1950,black or african american,80,Primary Tumor,30.0,10.0,0.0,80.0,40.0,5.0,80.0,TCGA-EY-A2ON-01A,TCGA-EY-A2ON,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACH,25544.0,male,1939,asian,1919,Primary Tumor,0.0,0.0,0.0,95.0,0.0,20.0,80.0,TCGA-DD-AACH-01A,TCGA-DD-AACH,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2D0,20393.0,female,1953,white,945,Primary Tumor,8.0,6.0,0.0,60.0,3.0,40.0,57.0,TCGA-FI-A2D0-01A,TCGA-FI-A2D0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A83J,24960.0,male,1945,not reported,272,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-J4-A83J-01A,TCGA-J4-A83J,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0G5,26827.0,female,1935,black or african american,856,Primary Tumor,0.0,3.0,0.0,75.0,20.0,0.0,100.0,TCGA-A5-A0G5-01A,TCGA-A5-A0G5,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-A8W3,25557.0,male,1942,not reported,882,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-2A-A8W3-01A,TCGA-2A-A8W3,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADJ,25863.0,female,1941,asian,804,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADJ-01A,TCGA-DD-AADJ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9KY,27000.0,male,1940,not reported,112,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-ZG-A9KY-01A,TCGA-ZG-A9KY,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-M7-A723,20064.0,male,1958,not reported,442,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-M7-A723-01A,TCGA-M7-A723,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A7F6,23367.0,male,1950,not reported,171,Primary Tumor,0.0,0.0,10.0,70.0,0.0,20.0,70.0,TCGA-KC-A7F6-01A,TCGA-KC-A7F6,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A163,18604.0,female,1958,white,854,Primary Tumor,0.0,0.0,10.0,60.0,0.0,0.0,90.0,TCGA-D1-A163-01A,TCGA-D1-A163,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16D,17933.0,female,1959,white,799,Primary Tumor,12.0,8.0,0.0,60.0,5.0,40.0,50.0,TCGA-D1-A16D-01A,TCGA-D1-A16D,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39Z,15930.0,female,1953,not reported,5728,Primary Tumor,0.0,0.0,0.0,90.0,1.0,0.0,100.0,TCGA-DD-A39Z-01A,TCGA-DD-A39Z,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A87D,19818.0,male,1953,not reported,2127,Primary Tumor,0.0,0.0,10.0,95.0,0.0,0.0,90.0,TCGA-VP-A87D-01A,TCGA-VP-A87D,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0TJ,21663.0,female,1947,asian,1431,Primary Tumor,0.0,0.0,0.0,96.0,1.0,2.0,96.0,TCGA-BS-A0TJ-01A,TCGA-BS-A0TJ,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GZ,30082.0,female,1925,white,2337,Primary Tumor,0.0,0.0,0.0,85.0,0.0,20.0,80.0,TCGA-2Y-A9GZ-01A,TCGA-2Y-A9GZ,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A1MR,24017.0,female,1930,white,5556,Primary Tumor,20.0,20.0,0.0,60.0,40.0,20.0,60.0,TCGA-B5-A1MR-01A,TCGA-B5-A1MR,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAW0,19981.0,male,1955,asian,1737,Primary Tumor,3.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-DD-AAW0-01A,TCGA-DD-AAW0,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ED-A66X,12947.0,male,1978,asian,89,Primary Tumor,0.0,4.0,0.0,80.0,5.0,58.0,35.0,TCGA-ED-A66X-01A,TCGA-ED-A66X,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5740,20880.0,male,1952,white,None,Primary Tumor,0.0,0.0,12.0,80.0,3.0,13.0,75.0,TCGA-CH-5740-01A,TCGA-CH-5740,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5741,20759.0,male,1952,white,None,Primary Tumor,0.0,0.0,4.0,90.0,0.0,6.0,90.0,TCGA-CH-5741-01A,TCGA-CH-5741,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3IA,28470.0,female,1934,white,66,Primary Tumor,0.0,0.0,0.0,75.0,0.0,10.0,90.0,TCGA-AJ-A3IA-01A,TCGA-AJ-A3IA,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3B0,15954.0,female,1968,asian,196,Primary Tumor,0.0,0.0,0.0,70.0,0.0,20.0,70.0,TCGA-EO-A3B0-01A,TCGA-EO-A3B0,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-SU-A7E7,22185.0,male,1953,not reported,165,Primary Tumor,0.0,0.0,30.0,60.0,0.0,20.0,50.0,TCGA-SU-A7E7-01A,TCGA-SU-A7E7,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5524,20854.0,male,1952,white,None,Primary Tumor,0.0,0.0,10.0,75.0,2.0,20.0,70.0,TCGA-EJ-5524-01A,TCGA-EJ-5524,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A8QW,26632.0,male,1941,not reported,156,Primary Tumor,0.0,0.0,0.0,90.0,0.0,18.0,80.0,TCGA-ZG-A8QW-01A,TCGA-ZG-A8QW,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9L1,24214.0,male,1944,not reported,1246,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-ZG-A9L1-01A,TCGA-ZG-A9L1,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LJ,15577.0,female,1962,white,2290,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-AP-A0LJ-01A,TCGA-AP-A0LJ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9LB,26447.0,male,1940,not reported,629,Primary Tumor,1.0,1.0,2.0,80.0,2.0,18.0,80.0,TCGA-ZG-A9LB-01A,TCGA-ZG-A9LB,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0VT,20602.0,female,1954,white,87,Primary Tumor,40.0,20.0,0.0,70.0,30.0,20.0,70.0,TCGA-BG-A0VT-01A,TCGA-BG-A0VT,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A6M7,19640.0,male,1959,not reported,309,Primary Tumor,0.0,0.0,5.0,70.0,0.0,35.0,60.0,TCGA-J4-A6M7-01A,TCGA-J4-A6M7,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GI,19117.0,female,1957,white,444,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EY-A1GI-01A,TCGA-EY-A1GI,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8WW,21900.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,85.0,TCGA-V1-A8WW-01A,TCGA-V1-A8WW,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10Q,26400.0,female,1926,white,4437,Primary Tumor,0.0,0.0,0.0,90.0,0.0,3.0,97.0,TCGA-BC-A10Q-01A,TCGA-BC-A10Q,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4857,20718.0,male,1949,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CZ-4857-01A,TCGA-CZ-4857,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4856,22684.0,female,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CZ-4856-01A,TCGA-CZ-4856,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-4015,31291.0,female,1924,not reported,None,Primary Tumor,None,None,8.0,80.0,None,15.0,75.0,TCGA-AG-4015-01A,TCGA-AG-4015,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5007,16793.0,male,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-5007-01A,TCGA-BP-5007,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4852,28552.0,female,1926,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-4852-01A,TCGA-B0-4852,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-14-1825,25684.0,male,1937,white,None,Primary Tumor,None,None,0.0,95.0,None,2.0,83.0,TCGA-14-1825-01A,TCGA-14-1825,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3608,29008.0,female,1929,not reported,None,Primary Tumor,None,None,8.0,93.0,None,8.0,84.0,TCGA-AG-3608-01A,TCGA-AG-3608,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-1830,21131.0,male,1950,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,70.0,TCGA-27-1830-01A,TCGA-27-1830,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4823,32290.0,male,1914,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-B0-4823-01A,TCGA-B0-4823,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6882,21682.0,male,1952,white,None,Primary Tumor,None,None,2.0,85.0,None,5.0,93.0,TCGA-EI-6882-01A,TCGA-EI-6882,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5982,21592.0,female,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CZ-5982-01A,TCGA-CZ-5982,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4769,23190.0,male,1942,white,None,Primary Tumor,None,None,0.0,80.0,None,40.0,60.0,TCGA-BP-4769-01A,TCGA-BP-4769,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-A8OW,13546.0,male,1974,black or african american,842,Primary Tumor,0.0,1.0,0.0,95.0,2.0,10.0,90.0,TCGA-A3-A8OW-01A,TCGA-A3-A8OW,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4775,20369.0,female,1950,white,None,Primary Tumor,None,None,None,90.0,5.0,5.0,95.0,TCGA-BP-4775-01A,TCGA-BP-4775,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-2513,25421.0,female,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,90.0,TCGA-28-2513-01A,TCGA-28-2513,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4945,27523.0,female,1928,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-B0-4945-01A,TCGA-B0-4945,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4901,17396.0,male,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CJ-4901-01A,TCGA-CJ-4901,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4765,15814.0,male,1961,white,None,Primary Tumor,None,None,None,90.0,1.0,5.0,95.0,TCGA-BP-4765-01A,TCGA-BP-4765,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-A8OU,27377.0,female,1937,black or african american,926,Primary Tumor,0.0,2.0,0.0,95.0,2.0,16.0,83.0,TCGA-A3-A8OU-01A,TCGA-A3-A8OU,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4968,14651.0,male,1966,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,80.0,TCGA-BP-4968-01A,TCGA-BP-4968,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4868,15601.0,male,1963,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-CJ-4868-01A,TCGA-CJ-4868,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4782,20102.0,female,1950,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,92.0,TCGA-BP-4782-01A,TCGA-BP-4782,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3359,30269.0,female,1923,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-A3-3359-01A,TCGA-A3-3359,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A8YJ,21994.0,female,1953,black or african american,68,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-B8-A8YJ-01A,TCGA-B8-A8YJ,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-02-2485,19494.0,male,1956,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-02-2485-01A,TCGA-02-2485,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4334,20609.0,male,1947,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-BP-4334-01A,TCGA-BP-4334,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5097,21852.0,female,1951,white,None,Primary Tumor,None,None,0.0,80.0,None,40.0,60.0,TCGA-B0-5097-01A,TCGA-B0-5097,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8317,25214.0,female,1943,white,None,Primary Tumor,1.0,0.0,26.0,10.0,2.0,42.0,32.0,TCGA-HZ-8317-01A,TCGA-HZ-8317,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-PL-A8LV,19746.0,female,1959,black or african american,240,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-PL-A8LV-01A,TCGA-PL-A8LV,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A6SA,21623.0,male,1954,black or african american,152,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-EW-A6SA-01A,TCGA-EW-A6SA,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7158,21742.0,female,1948,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-78-7158-01A,TCGA-78-7158,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EY,22872.0,female,1947,white,358,Primary Tumor,0.0,0.0,0.0,85.0,4.0,15.0,85.0,TCGA-A2-A0EY-01A,TCGA-A2-A0EY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IP,27047.0,female,1923,white,4565,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-B6-A0IP-01A,TCGA-B6-A0IP,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A46P,23993.0,male,1941,white,2254,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-62-A46P-01A,TCGA-62-A46P,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DV,19781.0,female,1953,white,975,Primary Tumor,0.0,0.0,8.0,70.0,7.0,45.0,45.0,TCGA-BH-A0DV-01A,TCGA-BH-A0DV,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GS-A9TV,14838.0,female,1973,white,339,Primary Tumor,0.0,5.0,0.0,90.0,85.0,20.0,80.0,TCGA-GS-A9TV-01A,TCGA-GS-A9TV,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-8388,21949.0,male,1950,white,None,Primary Tumor,None,None,2.0,85.0,2.0,10.0,78.0,TCGA-58-8388-01A,TCGA-58-8388,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HD,28916.0,male,1929,white,1697,Primary Tumor,0.0,4.0,0.0,90.0,4.0,20.0,70.0,TCGA-NC-A5HD-01A,TCGA-NC-A5HD,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A511,22759.0,male,1950,white,142,Primary Tumor,8.0,4.0,0.0,95.0,4.0,20.0,65.0,TCGA-85-A511-01A,TCGA-85-A511,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8138,27225.0,male,1929,not reported,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-77-8138-01A,TCGA-77-8138,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-2608,30958.0,male,1915,white,None,Primary Tumor,None,5.0,10.0,75.0,10.0,10.0,75.0,TCGA-34-2608-01A,TCGA-34-2608,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-A5G3,23171.0,male,1939,not reported,3816,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,80.0,TCGA-77-A5G3-01A,TCGA-77-A5G3,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1071,24515.0,male,1934,white,None,Primary Tumor,None,None,None,85.0,None,None,None,TCGA-21-1071-01A,TCGA-21-1071,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4605,28623.0,female,1925,not reported,None,Primary Tumor,None,None,15.0,70.0,None,20.0,45.0,TCGA-22-4605-01A,TCGA-22-4605,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FA-A82F,17819.0,female,1965,asian,97,Primary Tumor,5.0,10.0,0.0,90.0,75.0,5.0,90.0,TCGA-FA-A82F-01A,TCGA-FA-A82F,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MJ,20018.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-63-A5MJ-01A,TCGA-63-A5MJ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5016,16306.0,male,1959,white,None,Primary Tumor,2.0,2.0,0.0,70.0,15.0,15.0,80.0,TCGA-39-5016-01A,TCGA-39-5016,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4547,25056.0,male,1939,white,None,Primary Tumor,None,None,10.0,70.0,None,30.0,55.0,TCGA-33-4547-01A,TCGA-33-4547,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-RQ-A6JB,22859.0,female,1949,white,541,Primary Tumor,0.0,10.0,15.0,70.0,80.0,15.0,65.0,TCGA-RQ-A6JB-01A,TCGA-RQ-A6JB,
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8330,16250.0,female,1959,black or african american,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KL-8330-01A,TCGA-KL-8330,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8421,17524.0,female,1957,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8421-01A,TCGA-KN-8421,2.0
UVM,Uveal Melanoma,Eye,TCGA-YZ-A985,15164.0,female,1971,white,595,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-YZ-A985-01A,TCGA-YZ-A985,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MU,17801.0,male,None,not reported,None,Primary Tumor,3.0,2.0,0.0,75.0,4.0,25.0,75.0,TCGA-63-A5MU-01A,TCGA-63-A5MU,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-8390,25827.0,male,1940,white,None,Primary Tumor,None,None,0.0,80.0,15.0,5.0,88.0,TCGA-58-8390-01A,TCGA-58-8390,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4538,24174.0,male,1936,white,None,Primary Tumor,None,None,15.0,70.0,None,10.0,75.0,TCGA-33-4538-01A,TCGA-33-4538,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-46-6025,26168.0,male,1939,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,82.0,TCGA-46-6025-01A,TCGA-46-6025,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-37-5819,23726.0,male,1946,white,None,Primary Tumor,None,None,0.0,75.0,None,12.0,76.0,TCGA-37-5819-01A,TCGA-37-5819,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-8391,21102.0,female,1949,white,None,Primary Tumor,None,None,0.0,88.0,8.0,3.0,95.0,TCGA-58-8391-01A,TCGA-58-8391,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5019,25756.0,male,1934,white,None,Primary Tumor,10.0,2.0,0.0,50.0,20.0,24.0,64.0,TCGA-39-5019-01A,TCGA-39-5019,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7142,21796.0,female,1948,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,85.0,TCGA-77-7142-01A,TCGA-77-7142,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-46-6026,29890.0,male,1929,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,70.0,TCGA-46-6026-01A,TCGA-46-6026,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NK-A7XE,24319.0,male,1947,black or african american,50,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-NK-A7XE-01A,TCGA-NK-A7XE,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8145,26707.0,male,1927,not reported,None,Primary Tumor,None,None,0.0,60.0,None,40.0,52.0,TCGA-77-8145-01A,TCGA-77-8145,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-A4ZK,28039.0,female,1936,white,54,Primary Tumor,0.0,5.0,0.0,67.0,25.0,0.0,100.0,TCGA-56-A4ZK-01A,TCGA-56-A4ZK,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-GF-A2C7,17545.0,male,1963,white,9,Primary Tumor,0.0,0.0,10.0,80.0,3.0,10.0,80.0,TCGA-GF-A2C7-01A,TCGA-GF-A2C7,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2734,22919.0,female,1943,not reported,None,Primary Tumor,None,None,0.0,70.0,5.0,15.0,70.0,TCGA-66-2734-01A,TCGA-66-2734,1.0
UVM,Uveal Melanoma,Eye,TCGA-WC-AA9A,25641.0,female,1941,white,959,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-WC-AA9A-01A,TCGA-WC-AA9A,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2709,25453.0,male,1935,black or african american,None,Primary Tumor,None,None,0.0,60.0,None,20.0,70.0,TCGA-60-2709-01A,TCGA-60-2709,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8476,17240.0,male,1955,white,None,Primary Tumor,None,None,0.0,90.0,None,8.0,92.0,TCGA-KM-8476-01A,TCGA-KM-8476,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KM-8442,14212.0,male,1971,not reported,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KM-8442-01A,TCGA-KM-8442,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8337,9819.0,male,1980,black or african american,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-KL-8337-01A,TCGA-KL-8337,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2786,25051.0,female,1940,not reported,None,Primary Tumor,None,None,3.0,85.0,None,5.0,91.0,TCGA-66-2786-01A,TCGA-66-2786,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8336,18821.0,female,1955,white,None,Primary Tumor,0.0,2.0,0.0,80.0,10.0,15.0,84.0,TCGA-KL-8336-01A,TCGA-KL-8336,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-LA-A446,25199.0,male,1944,white,67,Primary Tumor,2.0,6.0,0.0,100.0,2.0,23.0,75.0,TCGA-LA-A446-01A,TCGA-LA-A446,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7337,24065.0,male,1935,white,None,Primary Tumor,5.0,0.0,0.0,65.0,15.0,0.0,100.0,TCGA-77-7337-01A,TCGA-77-7337,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2695,27211.0,female,1935,white,None,Primary Tumor,None,None,2.0,90.0,None,10.0,80.0,TCGA-60-2695-01A,TCGA-60-2695,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2765,23465.0,male,1943,not reported,None,Primary Tumor,None,None,15.0,80.0,None,5.0,75.0,TCGA-66-2765-01A,TCGA-66-2765,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-A53D,24891.0,male,1944,white,168,Primary Tumor,3.0,2.0,0.0,70.0,4.0,30.0,70.0,TCGA-98-A53D-01A,TCGA-98-A53D,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8346,22651.0,male,1946,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-KL-8346-01A,TCGA-KL-8346,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-96-A4JK,23974.0,male,1947,white,121,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-96-A4JK-01A,TCGA-96-A4JK,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8355,23227.0,male,1948,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,60.0,TCGA-85-8355-01A,TCGA-85-8355,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-GR-7353,13317.0,male,1969,white,None,Primary Tumor,None,None,0.0,95.0,100.0,0.0,100.0,TCGA-GR-7353-01A,TCGA-GR-7353,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-A4WN,22268.0,male,1951,white,327,Primary Tumor,0.0,0.0,10.0,90.0,0.0,10.0,80.0,TCGA-33-A4WN-01A,TCGA-33-A4WN,1.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-8062,21959.0,female,1951,asian,None,Primary Tumor,None,None,5.0,95.0,1.0,5.0,90.0,TCGA-FF-8062-01A,TCGA-FF-8062,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8133,27139.0,male,1927,not reported,None,Primary Tumor,None,None,None,60.0,None,None,None,TCGA-77-8133-01A,TCGA-77-8133,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5021,25895.0,male,1934,white,None,Primary Tumor,5.0,2.0,0.0,70.0,20.0,5.0,92.0,TCGA-39-5021-01A,TCGA-39-5021,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5234,26072.0,female,1936,white,None,Primary Tumor,None,None,10.0,50.0,None,20.0,70.0,TCGA-34-5234-01A,TCGA-34-5234,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2767,22888.0,male,1945,not reported,None,Primary Tumor,None,None,10.0,70.0,None,10.0,65.0,TCGA-66-2767-01A,TCGA-66-2767,3.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KO,18844.0,male,1961,not reported,373,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KO-01A,TCGA-VD-A8KO,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-AA8P,23555.0,female,1949,not reported,104,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-AA8P-01A,TCGA-VD-AA8P,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-J7-6720,15620.0,male,1968,asian,None,Primary Tumor,None,None,5.0,75.0,None,15.0,80.0,TCGA-J7-6720-01A,TCGA-J7-6720,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7102,27805.0,female,1924,white,None,Primary Tumor,None,None,5.0,70.0,None,10.0,85.0,TCGA-CV-7102-01A,TCGA-CV-7102,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-D6-6825,26976.0,male,1938,white,None,Primary Tumor,None,None,3.0,65.0,None,5.0,89.0,TCGA-D6-6825-01A,TCGA-D6-6825,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-E7-A7XN,24466.0,male,1947,asian,90,Primary Tumor,1.0,1.0,0.0,90.0,4.0,30.0,58.0,TCGA-E7-A7XN-01A,TCGA-E7-A7XN,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-AA3B,27646.0,female,1934,white,1754,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-G2-AA3B-01A,TCGA-G2-AA3B,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5EA,19748.0,female,1953,white,2159,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-P4-A5EA-01A,TCGA-P4-A5EA,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-8312,22231.0,male,1952,black or african american,None,Primary Tumor,1.0,1.0,0.0,85.0,2.0,20.0,80.0,TCGA-A4-8312-01A,TCGA-A4-8312,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A3MG,17600.0,male,1963,asian,158,Primary Tumor,1.0,1.0,0.0,90.0,2.0,9.0,90.0,TCGA-CF-A3MG-01A,TCGA-CF-A3MG,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-MT-A7BN,27162.0,male,1939,white,101,Primary Tumor,0.0,0.0,0.0,80.0,10.0,20.0,80.0,TCGA-MT-A7BN-01A,TCGA-MT-A7BN,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-AAMR,17670.0,male,1958,white,2686,Primary Tumor,0.0,0.0,0.0,95.0,3.0,70.0,28.0,TCGA-XF-AAMR-01A,TCGA-XF-AAMR,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N8-A4PN,25064.0,female,1943,white,390,Primary Tumor,20.0,20.0,0.0,85.0,40.0,5.0,85.0,TCGA-N8-A4PN-01A,TCGA-N8-A4PN,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-AA51,25484.0,female,1940,white,1479,Primary Tumor,0.0,10.0,0.0,70.0,90.0,30.0,60.0,TCGA-ZF-AA51-01A,TCGA-ZF-AA51,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A7HX,26517.0,male,1941,asian,217,Primary Tumor,1.0,0.0,0.0,80.0,14.0,45.0,46.0,TCGA-LN-A7HX-01A,TCGA-LN-A7HX,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4C9,20732.0,male,1955,not reported,551,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-CQ-A4C9-01A,TCGA-CQ-A4C9,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A88S,30954.0,male,1929,white,155,Primary Tumor,0.0,0.0,30.0,75.0,2.0,0.0,70.0,TCGA-L5-A88S-01A,TCGA-L5-A88S,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SU,17349.0,male,1963,not reported,1007,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-SX-A7SU-01A,TCGA-SX-A7SU,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A2HX,29332.0,female,1930,white,182,Primary Tumor,0.0,0.0,0.0,70.0,3.0,30.0,70.0,TCGA-DK-A2HX-01A,TCGA-DK-A2HX,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PU,28124.0,male,None,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-UZ-A9PU-01A,TCGA-UZ-A9PU,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-AA6M,23574.0,female,1946,white,1176,Primary Tumor,0.0,0.0,10.0,70.0,2.0,0.0,90.0,TCGA-DK-AA6M-01A,TCGA-DK-AA6M,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A7I0,20059.0,male,1959,asian,223,Primary Tumor,0.0,0.0,0.0,94.0,5.0,60.0,37.0,TCGA-CF-A7I0-01A,TCGA-CF-A7I0,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-KQ-A41P,27816.0,male,1935,white,554,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-KQ-A41P-01A,TCGA-KQ-A41P,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A6FG,18348.0,male,1959,white,1316,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-JY-A6FG-01A,TCGA-JY-A6FG,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-7069,28138.0,female,1933,white,None,Primary Tumor,None,None,0.0,65.0,15.0,28.0,70.0,TCGA-CQ-7069-01A,TCGA-CQ-7069,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NK,30719.0,female,1920,white,3539,Primary Tumor,0.0,0.0,5.0,60.0,0.0,0.0,90.0,TCGA-L5-A8NK-01A,TCGA-L5-A8NK,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SV,30265.0,male,1924,white,2848,Primary Tumor,5.0,1.0,0.0,70.0,3.0,28.0,70.0,TCGA-XF-A9SV-01A,TCGA-XF-A9SV,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5363,17635.0,male,1959,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-CN-5363-01A,TCGA-CN-5363,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-EV-5903,20888.0,male,1953,white,None,Primary Tumor,0.0,15.0,0.0,78.0,3.0,5.0,95.0,TCGA-EV-5903-01A,TCGA-EV-5903,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-TN-A7HI,20666.0,male,1957,white,75,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-TN-A7HI-01A,TCGA-TN-A7HI,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-5P-A9JU,29594.0,male,1931,white,711,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-5P-A9JU-01A,TCGA-5P-A9JU,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-DK-A2I6,29789.0,male,1924,white,2326,Primary Tumor,0.0,0.0,0.0,70.0,5.0,30.0,70.0,TCGA-DK-A2I6-01A,TCGA-DK-A2I6,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BU,27882.0,female,1936,black or african american,153,Primary Tumor,4.0,2.0,0.0,60.0,22.0,67.0,30.0,TCGA-FD-A5BU-01A,TCGA-FD-A5BU,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A468,15372.0,male,1959,not reported,4183,Primary Tumor,0.0,0.0,20.0,75.0,3.0,0.0,80.0,TCGA-CV-A468-01A,TCGA-CV-A468,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7584,21782.0,male,1952,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,12.0,88.0,TCGA-A4-7584-01A,TCGA-A4-7584,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-ZF-A9R4,30398.0,male,1929,white,588,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-ZF-A9R4-01A,TCGA-ZF-A9R4,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-QK-A6II,19113.0,male,1961,white,31,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-QK-A6II-01A,TCGA-QK-A6II,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TE,19874.0,male,1959,white,147,Primary Tumor,1.0,0.0,0.0,85.0,10.0,23.0,70.0,TCGA-FD-A6TE-01A,TCGA-FD-A6TE,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-IA-A83W,25678.0,male,1933,white,3607,Primary Tumor,1.0,8.0,0.0,85.0,3.0,30.0,65.0,TCGA-IA-A83W-01A,TCGA-IA-A83W,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IG-A4QS,26273.0,male,1941,white,79,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-IG-A4QS-01A,TCGA-IG-A4QS,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A6FH,19549.0,male,1957,white,951,Primary Tumor,1.0,2.0,0.0,85.0,4.0,15.0,85.0,TCGA-JY-A6FH-01A,TCGA-JY-A6FH,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A460,26539.0,male,1929,white,4002,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-CV-A460-01A,TCGA-CV-A460,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GF,24487.0,male,1934,not reported,4593,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-2H-A9GF-01A,TCGA-2H-A9GF,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A9SY,22212.0,female,1946,white,2734,Primary Tumor,4.0,1.0,0.0,70.0,2.0,15.0,70.0,TCGA-XF-A9SY-01A,TCGA-XF-A9SY,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-VR-A8ER,19951.0,male,1955,not reported,1475,Primary Tumor,3.0,0.0,0.0,60.0,30.0,52.0,40.0,TCGA-VR-A8ER-01A,TCGA-VR-A8ER,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SP,22005.0,male,1952,white,57,Primary Tumor,0.0,0.0,20.0,70.0,0.0,0.0,80.0,TCGA-FD-A3SP-01A,TCGA-FD-A3SP,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TC,28963.0,female,1934,white,139,Primary Tumor,2.0,1.0,0.0,80.0,4.0,55.0,35.0,TCGA-FD-A6TC-01A,TCGA-FD-A6TC,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3RC,21668.0,male,1952,white,80,Primary Tumor,0.0,0.0,0.0,60.0,0.0,15.0,85.0,TCGA-GC-A3RC-01A,TCGA-GC-A3RC,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7099,31134.0,female,1917,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,70.0,TCGA-CV-7099-01A,TCGA-CV-7099,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8435,21891.0,male,1945,white,None,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KN-8435-01A,TCGA-KN-8435,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-FR-A2OS,18122.0,female,1959,white,1257,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-FR-A2OS-01A,TCGA-FR-A2OS,2.0
UVM,Uveal Melanoma,Eye,TCGA-VD-A8KK,19958.0,male,1959,not reported,273,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-A8KK-01A,TCGA-VD-A8KK,3.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EJ,13958.0,male,1974,white,399,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,95.0,TCGA-V4-A9EJ-01A,TCGA-V4-A9EJ,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-52-7811,24782.0,male,1942,white,None,Primary Tumor,10.0,10.0,15.0,61.0,10.0,10.0,70.0,TCGA-52-7811-01A,TCGA-52-7811,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-98-8021,27738.0,female,1936,white,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-98-8021-01A,TCGA-98-8021,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A4QQ,25065.0,male,1944,white,55,Primary Tumor,20.0,20.0,20.0,60.0,40.0,10.0,60.0,TCGA-85-A4QQ-01A,TCGA-85-A4QQ,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A24D,26439.0,male,1939,white,73,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-EB-A24D-01A,TCGA-EB-A24D,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8139,26464.0,male,1931,not reported,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-77-8139-01A,TCGA-77-8139,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-IH-A3EA,22577.0,male,1947,white,1119,Primary Tumor,0.0,4.0,0.0,85.0,3.0,0.0,90.0,TCGA-IH-A3EA-01A,TCGA-IH-A3EA,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2698,22800.0,male,1931,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,70.0,TCGA-60-2698-01A,TCGA-60-2698,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A5FP,23833.0,female,1947,white,83,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-EB-A5FP-01A,TCGA-EB-A5FP,4.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A3HV,13712.0,male,1974,white,217,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-EB-A3HV-01A,TCGA-EB-A3HV,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A6R0,21367.0,female,1954,white,207,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,75.0,TCGA-EB-A6R0-01A,TCGA-EB-A6R0,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8423,16335.0,male,1961,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-KN-8423-01A,TCGA-KN-8423,1.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A85J,24263.0,female,1947,white,133,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-EB-A85J-01A,TCGA-EB-A85J,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8425,19692.0,male,1952,white,None,Primary Tumor,0.0,10.0,0.0,80.0,0.0,0.0,100.0,TCGA-KN-8425-01A,TCGA-KN-8425,1.0
UVM,Uveal Melanoma,Eye,TCGA-YZ-A980,27716.0,male,1935,white,1307,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-YZ-A980-01A,TCGA-YZ-A980,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NK-A5D1,20909.0,male,1954,white,356,Primary Tumor,0.0,0.0,0.0,70.0,0.0,5.0,90.0,TCGA-NK-A5D1-01A,TCGA-NK-A5D1,2.0
UVM,Uveal Melanoma,Eye,TCGA-WC-AA9E,21976.0,male,1953,white,272,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,90.0,TCGA-WC-AA9E-01A,TCGA-WC-AA9E,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9F5,31314.0,female,1928,white,289,Primary Tumor,0.0,0.0,0.0,96.0,3.0,0.0,98.0,TCGA-V4-A9F5-01A,TCGA-V4-A9F5,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-7023,None,male,None,not reported,None,Primary Tumor,5.0,5.0,33.0,58.0,20.0,0.0,62.0,TCGA-63-7023-01A,TCGA-63-7023,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-A3DM,23076.0,male,1948,white,61,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-BF-A3DM-01A,TCGA-BF-A3DM,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HQ,25781.0,male,1941,white,568,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,95.0,TCGA-NC-A5HQ-01A,TCGA-NC-A5HQ,3.0
DLBC,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Lymph Nodes,TCGA-FF-A7CR,22471.0,male,1951,asian,464,Primary Tumor,0.0,10.0,10.0,60.0,80.0,35.0,50.0,TCGA-FF-A7CR-01A,TCGA-FF-A7CR,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1077,23523.0,male,1942,white,None,Primary Tumor,None,None,None,80.0,None,None,None,TCGA-21-1077-01A,TCGA-21-1077,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2713,23630.0,male,1942,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,70.0,TCGA-60-2713-01A,TCGA-60-2713,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-66-2768,20970.0,male,1950,not reported,None,Primary Tumor,None,None,0.0,90.0,None,5.0,90.0,TCGA-66-2768-01A,TCGA-66-2768,2.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9E5,18948.0,female,1957,white,1923,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9E5-01A,TCGA-V4-A9E5,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-5928,30334.0,female,1927,white,None,Primary Tumor,2.0,0.0,0.0,80.0,2.0,0.0,95.0,TCGA-34-5928-01A,TCGA-34-5928,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A5B5,21450.0,male,1954,white,190,Primary Tumor,0.0,2.0,0.0,65.0,5.0,55.0,35.0,TCGA-85-A5B5-01A,TCGA-85-A5B5,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8413,17067.0,male,1960,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-KO-8413-01A,TCGA-KO-8413,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-O2-A52S,21182.0,female,1949,white,2429,Primary Tumor,2.0,2.0,5.0,70.0,15.0,15.0,70.0,TCGA-O2-A52S-01A,TCGA-O2-A52S,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8408,17299.0,male,1957,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-KO-8408-01A,TCGA-KO-8408,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4740,29186.0,female,1930,white,None,Primary Tumor,None,None,0.0,70.0,None,70.0,30.0,TCGA-CN-4740-01A,TCGA-CN-4740,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NQ,26250.0,male,1930,white,4627,Primary Tumor,0.0,0.0,30.0,80.0,0.0,0.0,70.0,TCGA-L5-A8NQ-01A,TCGA-L5-A8NQ,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7254,20306.0,male,1941,white,None,Primary Tumor,None,None,0.0,60.0,None,40.0,60.0,TCGA-CV-7254-01A,TCGA-CV-7254,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7061,30662.0,female,1928,white,None,Primary Tumor,0.0,20.0,0.0,65.0,0.0,0.0,100.0,TCGA-BQ-7061-01A,TCGA-BQ-7061,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SO,25147.0,male,1944,white,66,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-FD-A3SO-01A,TCGA-FD-A3SO,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-T3-A92M,19247.0,male,1961,black or african american,147,Primary Tumor,0.0,0.0,0.0,60.0,10.0,0.0,100.0,TCGA-T3-A92M-01A,TCGA-T3-A92M,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-YC-A8S6,26130.0,male,1942,white,21,Primary Tumor,4.0,2.0,3.0,65.0,4.0,32.0,65.0,TCGA-YC-A8S6-01A,TCGA-YC-A8S6,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-AL-3472,21166.0,male,1951,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-AL-3472-01A,TCGA-AL-3472,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7402,25138.0,male,1941,white,None,Primary Tumor,None,None,0.0,85.0,8.0,5.0,95.0,TCGA-CR-7402-01A,TCGA-CR-7402,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-5442,28040.0,female,1928,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-CV-5442-01A,TCGA-CV-5442,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5892,18785.0,male,1959,white,None,Primary Tumor,None,None,0.0,80.0,None,50.0,50.0,TCGA-BQ-5892-01A,TCGA-BQ-5892,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-6020,21232.0,male,1953,black or african american,None,Primary Tumor,None,None,8.0,70.0,None,20.0,67.0,TCGA-CN-6020-01A,TCGA-CN-6020,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAP7,28073.0,female,1937,white,41,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-BF-AAP7-01A,TCGA-BF-AAP7,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5027,26714.0,male,1933,white,None,Primary Tumor,None,None,40.0,55.0,None,5.0,50.0,TCGA-39-5027-01A,TCGA-39-5027,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-NC-A5HG,21608.0,male,1950,white,1424,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-NC-A5HG-01A,TCGA-NC-A5HG,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2697,14984.0,male,1951,white,None,Primary Tumor,None,None,0.0,60.0,None,10.0,20.0,TCGA-60-2697-01A,TCGA-60-2697,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-21-1075,21093.0,male,1945,white,None,Primary Tumor,None,None,None,95.0,None,None,None,TCGA-21-1075-01A,TCGA-21-1075,2.0
UVM,Uveal Melanoma,Eye,TCGA-WC-A881,27443.0,male,1936,white,680,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-WC-A881-01A,TCGA-WC-A881,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-BF-AAP1,31666.0,male,1927,white,132,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-BF-AAP1-01A,TCGA-BF-AAP1,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-94-8490,25588.0,male,1941,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-94-8490-01A,TCGA-94-8490,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-DA-A960,26708.0,male,1939,white,476,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-DA-A960-01A,TCGA-DA-A960,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-63-A5MV,25505.0,male,None,not reported,None,Primary Tumor,5.0,2.0,0.0,60.0,10.0,35.0,60.0,TCGA-63-A5MV-01A,TCGA-63-A5MV,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A4IQ,15516.0,female,1970,asian,71,Primary Tumor,0.0,0.0,40.0,75.0,2.0,0.0,60.0,TCGA-EB-A4IQ-01A,TCGA-EB-A4IQ,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-AAS8,21675.0,female,1939,black or african american,5727,Primary Tumor,0.0,2.0,5.0,75.0,2.0,10.0,75.0,TCGA-33-AAS8-01A,TCGA-33-AAS8,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-1011,26732.0,male,1928,white,None,Primary Tumor,None,None,None,60.0,None,None,None,TCGA-22-1011-01A,TCGA-22-1011,1.0
UVM,Uveal Melanoma,Eye,TCGA-V4-A9EM,19413.0,male,1959,white,367,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-V4-A9EM-01A,TCGA-V4-A9EM,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3SN,29169.0,male,1932,white,105,Primary Tumor,0.0,0.0,0.0,80.0,3.0,20.0,80.0,TCGA-FD-A3SN-01A,TCGA-FD-A3SN,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7286,15631.0,male,1969,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-A4-7286-01A,TCGA-A4-7286,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-6229,22541.0,male,1948,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CQ-6229-01A,TCGA-CQ-6229,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FT-A61P,28082.0,male,1937,white,83,Primary Tumor,3.0,2.0,3.0,75.0,5.0,75.0,19.0,TCGA-FT-A61P-01A,TCGA-FT-A61P,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-UZ-A9PO,29220.0,male,None,white,None,Primary Tumor,0.0,3.0,0.0,70.0,3.0,0.0,95.0,TCGA-UZ-A9PO-01A,TCGA-UZ-A9PO,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A5BY,23080.0,female,1949,white,90,Primary Tumor,3.0,2.0,0.0,80.0,6.0,34.0,60.0,TCGA-FD-A5BY-01A,TCGA-FD-A5BY,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A3KJ,27692.0,male,1936,white,204,Primary Tumor,0.0,0.0,0.0,95.0,2.0,0.0,95.0,TCGA-CU-A3KJ-01A,TCGA-CU-A3KJ,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A45U,21746.0,male,1940,white,4974,Primary Tumor,0.0,0.0,20.0,75.0,4.0,0.0,80.0,TCGA-CV-A45U-01A,TCGA-CV-A45U,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-G2-A3VY,24112.0,male,1946,asian,42,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-G2-A3VY-01A,TCGA-G2-A3VY,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A3B7,24245.0,male,1945,black or african american,152,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-FD-A3B7-01A,TCGA-FD-A3B7,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-5243,18812.0,male,1952,white,None,Primary Tumor,1.0,None,None,90.0,5.0,None,100.0,TCGA-CR-5243-01A,TCGA-CR-5243,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-XF-A8HD,28305.0,male,1929,white,2820,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,81.0,TCGA-XF-A8HD-01A,TCGA-XF-A8HD,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FJ-A3ZF,26825.0,male,1939,white,27,Primary Tumor,2.0,2.0,0.0,85.0,3.0,14.0,85.0,TCGA-FJ-A3ZF-01A,TCGA-FJ-A3ZF,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CQ-A4CH,21455.0,male,1954,asian,162,Primary Tumor,1.0,1.0,0.0,80.0,4.0,37.0,45.0,TCGA-CQ-A4CH-01A,TCGA-CQ-A4CH,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20R,28987.0,female,1927,white,1794,Primary Tumor,0.0,0.0,5.0,65.0,0.0,10.0,85.0,TCGA-BT-A20R-01A,TCGA-BT-A20R,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OT,28162.0,male,1929,white,2122,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-L5-A4OT-01A,TCGA-L5-A4OT,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-HE-7128,None,male,None,not reported,None,Primary Tumor,0.0,30.0,0.0,60.0,2.0,0.0,100.0,TCGA-HE-7128-01A,TCGA-HE-7128,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A88Z,25890.0,female,1935,white,2968,Primary Tumor,0.0,0.0,0.0,75.0,5.0,0.0,100.0,TCGA-L5-A88Z-01A,TCGA-L5-A88Z,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7373,24448.0,male,1943,white,None,Primary Tumor,None,None,0.0,70.0,None,5.0,95.0,TCGA-CR-7373-01A,TCGA-CR-7373,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7828,27122.0,female,1937,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,5.0,95.0,TCGA-A4-7828-01A,TCGA-A4-7828,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-FD-A6TB,30185.0,male,1930,white,273,Primary Tumor,2.0,2.0,0.0,65.0,28.0,39.0,60.0,TCGA-FD-A6TB-01A,TCGA-FD-A6TB,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A642,21011.0,male,1955,white,254,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-CN-A642-01A,TCGA-CN-A642,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-H4-A2HO,19630.0,male,1957,white,421,Primary Tumor,1.0,1.0,0.0,75.0,4.0,24.0,75.0,TCGA-H4-A2HO-01A,TCGA-H4-A2HO,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7364,24192.0,male,1942,white,None,Primary Tumor,None,None,0.0,75.0,None,12.0,88.0,TCGA-CR-7364-01A,TCGA-CR-7364,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7837,15891.0,male,1964,black or african american,None,Primary Tumor,0.0,15.0,0.0,80.0,0.0,0.0,100.0,TCGA-DW-7837-01A,TCGA-DW-7837,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-MH-A560,22866.0,male,1949,white,348,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-MH-A560-01A,TCGA-MH-A560,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A47T,21347.0,female,1953,asian,276,Primary Tumor,0.0,0.0,0.0,99.0,0.0,10.0,90.0,TCGA-CF-A47T-01A,TCGA-CF-A47T,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DW-7838,24247.0,male,1943,white,None,Primary Tumor,0.0,20.0,0.0,70.0,1.0,10.0,90.0,TCGA-DW-7838-01A,TCGA-DW-7838,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A8NI,29135.0,male,1925,white,3607,Primary Tumor,0.0,4.0,0.0,100.0,4.0,25.0,70.0,TCGA-L5-A8NI-01A,TCGA-L5-A8NI,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-4Z-AA7M,23817.0,male,1948,white,172,Primary Tumor,5.0,1.0,0.0,70.0,3.0,30.0,70.0,TCGA-4Z-AA7M-01A,TCGA-4Z-AA7M,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-A63V,21734.0,male,1952,white,470,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-CN-A63V-01A,TCGA-CN-A63V,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OI,29190.0,male,1933,white,211,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-L5-A4OI-01A,TCGA-L5-A4OI,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7045,28709.0,male,1923,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-BQ-7045-01A,TCGA-BQ-7045,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A6I1,32872,female,1922,white,168,Primary Tumor,1.0,0.0,0.0,80.0,12.0,10.0,70.0,TCGA-GC-A6I1-01A,TCGA-GC-A6I1,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-7585,24778.0,male,1940,white,None,Primary Tumor,None,None,8.0,75.0,None,42.0,50.0,TCGA-A4-7585-01A,TCGA-A4-7585,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A9FM,18445.0,male,1963,asian,122,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-CF-A9FM-01A,TCGA-CF-A9FM,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-H4-A2HQ,23538.0,female,1946,black or african american,200,Primary Tumor,1.0,1.0,0.0,75.0,3.0,18.0,75.0,TCGA-H4-A2HQ-01A,TCGA-H4-A2HQ,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4973,17461.0,male,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4973-01A,TCGA-BP-4973,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4801,20825.0,male,1950,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-BP-4801-01A,TCGA-BP-4801,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-32-2634,29964.0,male,1927,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,80.0,TCGA-32-2634-01A,TCGA-32-2634,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6507,22176.0,male,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,70.0,TCGA-EI-6507-01A,TCGA-EI-6507,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54D,25429.0,male,1942,black or african american,537,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-B8-A54D-01A,TCGA-B8-A54D,3.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-3X-AAVC,26493.0,female,1940,white,428,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-3X-AAVC-01A,TCGA-3X-AAVC,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-A56N,17480.0,female,1965,black or african american,26,Primary Tumor,0.0,0.0,20.0,60.0,0.0,5.0,70.0,TCGA-AF-A56N-01A,TCGA-AF-A56N,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-41-5651,21698.0,female,1951,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,0.0,88.0,TCGA-41-5651-01A,TCGA-41-5651,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A025,22952.0,female,1944,not reported,1462,Primary Tumor,1.0,2.0,0.0,60.0,20.0,39.0,60.0,TCGA-AG-A025-01A,TCGA-AG-A025,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54G,18612.0,male,1962,black or african american,313,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-B8-A54G-01A,TCGA-B8-A54G,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3450,31364.0,female,1921,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-AK-3450-01A,TCGA-AK-3450,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5834,21713.0,male,1951,white,None,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-B4-5834-01A,TCGA-B4-5834,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DY-A1DE,20504.0,female,1945,white,3614,Primary Tumor,0.0,0.0,0.0,60.0,0.0,20.0,75.0,TCGA-DY-A1DE-01A,TCGA-DY-A1DE,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-CI-6621,23240.0,male,1947,white,None,Primary Tumor,None,None,30.0,50.0,None,15.0,50.0,TCGA-CI-6621-01A,TCGA-CI-6621,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3892,20880.0,female,1952,not reported,None,Primary Tumor,None,None,0.0,75.0,None,12.0,85.0,TCGA-AG-3892-01A,TCGA-AG-3892,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4985,26611.0,male,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4985-01A,TCGA-BP-4985,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5671,18954.0,male,1953,white,None,Primary Tumor,None,None,0.0,75.0,None,40.0,60.0,TCGA-CJ-5671-01A,TCGA-CJ-5671,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4344,27561.0,female,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-4344-01A,TCGA-BP-4344,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5408,20063.0,female,1955,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,85.0,TCGA-06-5408-01A,TCGA-06-5408,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-6672,15965.0,male,1968,white,None,Primary Tumor,None,None,8.0,80.0,None,10.0,77.0,TCGA-AF-6672-01A,TCGA-AF-6672,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DY-A1DF,26763.0,female,1928,white,3621,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,90.0,TCGA-DY-A1DF-01A,TCGA-DY-A1DF,3.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-YR-A95A,19292.0,male,1957,white,1589,Primary Tumor,0.0,0.0,0.0,60.0,3.0,0.0,100.0,TCGA-YR-A95A-01A,TCGA-YR-A95A,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2561,19505.0,female,1956,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,98.0,TCGA-06-2561-01A,TCGA-06-2561,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4892,23764.0,female,1940,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4892-01A,TCGA-CJ-4892,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-2687,21098.0,male,1952,white,None,Primary Tumor,None,None,50.0,70.0,None,5.0,42.0,TCGA-AF-2687-01A,TCGA-AF-2687,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5545,15376.0,male,1968,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,50.0,50.0,TCGA-B8-5545-01A,TCGA-B8-5545,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5175,21949.0,male,1944,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-5175-01A,TCGA-BP-5175,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4897,29124.0,female,1926,white,None,Primary Tumor,None,None,0.0,80.0,None,40.0,60.0,TCGA-CJ-4897-01A,TCGA-CJ-4897,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A2QM,24776.0,female,1944,white,108,Primary Tumor,5.0,8.0,0.0,90.0,3.0,10.0,86.0,TCGA-AJ-A2QM-01A,TCGA-AJ-A2QM,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-AAU2,21656.0,male,1953,not reported,430,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-J4-AAU2-01A,TCGA-J4-AAU2,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A8CN,19662.0,male,1958,not reported,971,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-J9-A8CN-01A,TCGA-J9-A8CN,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A05N,21254.0,female,1951,white,232,Primary Tumor,20.0,10.0,0.0,65.0,15.0,30.0,65.0,TCGA-AP-A05N-01A,TCGA-AP-A05N,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAJ3,20604.0,male,1954,not reported,1185,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-XK-AAJ3-01A,TCGA-XK-AAJ3,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5521,23304.0,male,1945,white,None,Primary Tumor,0.0,0.0,20.0,60.0,3.0,28.0,50.0,TCGA-EJ-5521-01A,TCGA-EJ-5521,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-A8VX,25904.0,male,1941,not reported,922,Primary Tumor,1.0,1.0,0.0,92.0,4.0,40.0,57.0,TCGA-2A-A8VX-01A,TCGA-2A-A8VX,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A1GL,18761.0,female,1959,white,366,Primary Tumor,20.0,20.0,0.0,70.0,40.0,25.0,70.0,TCGA-EY-A1GL-01A,TCGA-EY-A1GL,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADR,21217.0,male,1951,asian,1754,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADR-01A,TCGA-DD-AADR,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZP,21581.0,female,1950,white,552,Primary Tumor,10.0,0.0,0.0,90.0,10.0,10.0,80.0,TCGA-D1-A0ZP-01A,TCGA-D1-A0ZP,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A4ZP,28771.0,male,1927,white,2519,Primary Tumor,1.0,1.0,0.0,80.0,2.0,15.0,80.0,TCGA-FV-A4ZP-01A,TCGA-FV-A4ZP,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9M4,24030.0,male,1947,not reported,509,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-ZG-A9M4-01A,TCGA-ZG-A9M4,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DF-A2KN,None,female,None,not reported,None,Primary Tumor,3.0,6.0,0.0,90.0,20.0,10.0,90.0,TCGA-DF-A2KN-01A,TCGA-DF-A2KN,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A8ML,23360.0,male,None,not reported,None,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-V1-A8ML-01A,TCGA-V1-A8ML,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAJT,27428.0,male,1935,not reported,1135,Primary Tumor,0.0,0.0,4.0,90.0,3.0,35.0,60.0,TCGA-XK-AAJT-01A,TCGA-XK-AAJT,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0WQ,20131.0,female,1951,asian,1696,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-BS-A0WQ-01A,TCGA-BS-A0WQ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8I8,25546.0,male,1943,not reported,535,Primary Tumor,20.0,20.0,5.0,80.0,40.0,15.0,80.0,TCGA-KK-A8I8-01A,TCGA-KK-A8I8,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A3JQ,22297.0,female,1950,white,77,Primary Tumor,5.0,8.0,0.0,75.0,15.0,25.0,70.0,TCGA-D1-A3JQ-01A,TCGA-D1-A3JQ,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CA,25817.0,female,1939,black or african american,591,Primary Tumor,0.0,0.0,30.0,60.0,1.0,10.0,59.0,TCGA-AX-A1CA-01A,TCGA-AX-A1CA,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-PG-A7D5,23006.0,female,1949,black or african american,618,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-PG-A7D5-01A,TCGA-PG-A7D5,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A548,30544.0,female,1929,black or african american,169,Primary Tumor,0.0,2.0,0.0,80.0,3.0,0.0,100.0,TCGA-EY-A548-01A,TCGA-EY-A548,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9L2,25573.0,male,1941,not reported,1056,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-ZG-A9L2-01A,TCGA-ZG-A9L2,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A73A,26136.0,male,1941,white,287,Primary Tumor,1.0,1.0,0.0,90.0,5.0,8.0,90.0,TCGA-DD-A73A-01A,TCGA-DD-A73A,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J9-A8CP,24299.0,male,1947,not reported,113,Primary Tumor,0.0,0.0,2.0,70.0,0.0,38.0,60.0,TCGA-J9-A8CP-01A,TCGA-J9-A8CP,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVU,16889.0,male,1962,asian,1938,Primary Tumor,3.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-DD-AAVU-01A,TCGA-DD-AAVU,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5519,23669.0,male,1944,white,None,Primary Tumor,0.0,1.0,15.0,65.0,3.0,25.0,60.0,TCGA-EJ-5519-01A,TCGA-EJ-5519,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2D2,24260.0,female,1942,white,975,Primary Tumor,5.0,5.0,0.0,98.0,5.0,2.0,96.0,TCGA-FI-A2D2-01A,TCGA-FI-A2D2,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A8FN,21506.0,male,1955,not reported,203,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-EJ-A8FN-01A,TCGA-EJ-A8FN,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A1MZ,19955.0,female,1956,white,114,Primary Tumor,5.0,3.0,0.0,85.0,20.0,15.0,85.0,TCGA-B5-A1MZ-01A,TCGA-B5-A1MZ,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADQ,21756.0,male,1954,asian,169,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADQ-01A,TCGA-DD-AADQ,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6329,24797.0,male,1942,white,None,Primary Tumor,0.0,0.0,10.0,78.0,1.0,15.0,75.0,TCGA-G9-6329-01A,TCGA-G9-6329,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A3AZ,29234.0,female,1931,not reported,241,Primary Tumor,10.0,10.0,0.0,80.0,70.0,15.0,80.0,TCGA-EO-A3AZ-01A,TCGA-EO-A3AZ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-QU-A6IN,22286.0,male,1942,not reported,3789,Primary Tumor,0.0,0.0,0.0,85.0,3.0,33.0,65.0,TCGA-QU-A6IN-01A,TCGA-QU-A6IN,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7075,None,male,1947,white,None,Primary Tumor,None,None,1.0,85.0,None,9.0,90.0,TCGA-HC-7075-01A,TCGA-HC-7075,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A8HM,24121.0,male,1944,not reported,1323,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-YL-A8HM-01A,TCGA-YL-A8HM,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2H8,23448.0,female,1942,white,1974,Primary Tumor,0.0,0.0,0.0,96.0,1.0,5.0,94.0,TCGA-AX-A2H8-01A,TCGA-AX-A2H8,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAE4,18009.0,female,1964,asian,343,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DD-AAE4-01A,TCGA-DD-AAE4,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9Z9,23360.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-V1-A9Z9-01A,TCGA-V1-A9Z9,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JT,23041.0,female,1944,white,1128,Primary Tumor,0.0,0.0,50.0,40.0,0.0,0.0,50.0,TCGA-B5-A0JT-01A,TCGA-B5-A0JT,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAIW,28721.0,male,1933,not reported,884,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,75.0,TCGA-XK-AAIW-01A,TCGA-XK-AAIW,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2H5,24757.0,female,1938,black or african american,2206,Primary Tumor,0.0,1.0,0.0,97.0,1.0,4.0,94.0,TCGA-AX-A2H5-01A,TCGA-AX-A2H5,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A2,27930.0,female,1922,white,4962,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-DD-A3A2-01A,TCGA-DD-A3A2,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5497,17523.0,male,1962,white,None,Primary Tumor,0.0,0.0,25.0,70.0,1.0,15.0,60.0,TCGA-EJ-5497-01A,TCGA-EJ-5497,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A169,23238.0,female,1945,white,800,Primary Tumor,2.0,6.0,0.0,70.0,4.0,30.0,50.0,TCGA-D1-A169-01A,TCGA-D1-A169,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A3CH,19473.0,male,1957,asian,296,Primary Tumor,0.0,0.0,0.0,96.0,0.0,0.0,100.0,TCGA-G3-A3CH-01A,TCGA-G3-A3CH,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-A6HY,18779.0,male,1961,not reported,179,Primary Tumor,0.0,0.0,2.0,80.0,0.0,18.0,80.0,TCGA-HC-A6HY-01A,TCGA-HC-A6HY,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9O7,22265.0,male,None,not reported,None,Primary Tumor,0.0,0.0,3.0,90.0,5.0,46.0,50.0,TCGA-V1-A9O7-01A,TCGA-V1-A9O7,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A18A,27086.0,female,1936,white,146,Primary Tumor,0.0,0.0,0.0,60.0,0.0,30.0,70.0,TCGA-BG-A18A-01A,TCGA-BG-A18A,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A4ND,20782.0,female,1951,white,2088,Primary Tumor,0.0,0.0,0.0,75.0,3.0,0.0,100.0,TCGA-DD-A4ND-01A,TCGA-DD-A4ND,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HD,25499.0,female,1939,white,1175,Primary Tumor,0.0,0.0,0.0,96.0,1.0,2.0,96.0,TCGA-AX-A2HD-01A,TCGA-AX-A2HD,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A4KR,20669.0,female,1956,black or african american,147,Primary Tumor,0.0,0.0,0.0,80.0,5.0,0.0,97.0,TCGA-EY-A4KR-01A,TCGA-EY-A4KR,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A0GG,27809.0,female,1927,black or african american,2369,Primary Tumor,0.0,0.0,30.0,50.0,0.0,10.0,60.0,TCGA-A5-A0GG-01A,TCGA-A5-A0GG,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5763,24380.0,male,1942,white,None,Primary Tumor,0.0,0.0,20.0,70.0,0.0,15.0,65.0,TCGA-CH-5763-01A,TCGA-CH-5763,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACC,22499.0,male,1947,asian,2029,Primary Tumor,2.0,1.0,0.0,78.0,22.0,20.0,78.0,TCGA-DD-AACC-01A,TCGA-DD-AACC,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0UV,20266.0,female,1950,native hawaiian or other pacific islander,1902,Primary Tumor,57.0,0.0,0.0,90.0,40.0,10.0,70.0,TCGA-BS-A0UV-01A,TCGA-BS-A0UV,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EY-A3L3,30138.0,female,1929,black or african american,198,Primary Tumor,0.0,0.0,0.0,90.0,2.0,0.0,100.0,TCGA-EY-A3L3-01A,TCGA-EY-A3L3,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0MU,28621.0,female,1932,white,121,Primary Tumor,1.0,1.0,0.0,94.0,1.0,7.0,90.0,TCGA-BG-A0MU-01A,TCGA-BG-A0MU,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-A8VL,18658.0,male,1959,not reported,1273,Primary Tumor,0.0,0.0,15.0,65.0,0.0,40.0,45.0,TCGA-2A-A8VL-01A,TCGA-2A-A8VL,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5508,23758.0,male,1943,white,None,Primary Tumor,0.0,0.0,20.0,65.0,2.0,25.0,55.0,TCGA-EJ-5508-01A,TCGA-EJ-5508,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAJA,22771.0,male,1948,not reported,1211,Primary Tumor,0.0,0.0,10.0,70.0,0.0,30.0,60.0,TCGA-XK-AAJA-01A,TCGA-XK-AAJA,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67R,23807.0,male,1947,not reported,440,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-J4-A67R-01A,TCGA-J4-A67R,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A1MY,22805.0,female,1948,black or african american,128,Primary Tumor,0.0,3.0,0.0,80.0,3.0,20.0,75.0,TCGA-B5-A1MY-01A,TCGA-B5-A1MY,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-RC-A6M3,8899.0,male,1985,american indian or alaska native,1539,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-RC-A6M3-01A,TCGA-RC-A6M3,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XJ-A83F,None,male,1944,not reported,872,Primary Tumor,0.0,0.0,0.0,60.0,3.0,0.0,100.0,TCGA-XJ-A83F-01A,TCGA-XJ-A83F,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A87C,24608.0,male,1940,not reported,2229,Primary Tumor,0.0,0.0,10.0,65.0,0.0,30.0,60.0,TCGA-VP-A87C-01A,TCGA-VP-A87C,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADL,21512.0,male,1954,asian,720,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-DD-AADL-01A,TCGA-DD-AADL,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VN-A88L,20026.0,male,1958,not reported,367,Primary Tumor,20.0,10.0,0.0,80.0,60.0,20.0,80.0,TCGA-VN-A88L-01A,TCGA-VN-A88L,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-KR-A7K7,22587.0,female,1951,white,461,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-KR-A7K7-01A,TCGA-KR-A7K7,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11S,23085.0,female,1946,white,615,Primary Tumor,10.0,6.0,10.0,60.0,30.0,40.0,50.0,TCGA-B5-A11S-01A,TCGA-B5-A11S,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7209,22129.0,male,1951,white,None,Primary Tumor,None,None,2.0,90.0,None,8.0,90.0,TCGA-HC-7209-01A,TCGA-HC-7209,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACW,15872.0,male,1967,asian,1184,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DD-AACW-01A,TCGA-DD-AACW,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-7509,17538.0,male,1961,not reported,None,Primary Tumor,0.0,0.0,15.0,60.0,0.0,35.0,50.0,TCGA-G9-7509-01A,TCGA-G9-7509,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11I,23857.0,female,1940,black or african american,1974,Primary Tumor,3.0,30.0,0.0,92.0,30.0,3.0,92.0,TCGA-B5-A11I-01A,TCGA-B5-A11I,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11E,19458.0,female,1957,white,198,Primary Tumor,1.0,0.0,0.0,95.0,4.0,3.0,95.0,TCGA-B5-A11E-01A,TCGA-B5-A11E,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5495,24904.0,male,1941,white,None,Primary Tumor,0.0,0.0,15.0,60.0,4.0,20.0,65.0,TCGA-EJ-5495-01A,TCGA-EJ-5495,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZO,27482.0,female,1934,white,586,Primary Tumor,10.0,0.0,30.0,60.0,20.0,10.0,50.0,TCGA-D1-A0ZO-01A,TCGA-D1-A0ZO,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5789,22494.0,male,1945,white,None,Primary Tumor,0.0,0.0,10.0,75.0,0.0,15.0,75.0,TCGA-CH-5789-01A,TCGA-CH-5789,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LS,23126.0,female,1943,white,1421,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,80.0,TCGA-AP-A0LS-01A,TCGA-AP-A0LS,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A25U,23207.0,female,1944,asian,1281,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-G3-A25U-01A,TCGA-G3-A25U,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3BI,24623.0,female,1944,white,137,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,80.0,TCGA-AJ-A3BI-01A,TCGA-AJ-A3BI,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0TA,21505.0,female,1947,native hawaiian or other pacific islander,1788,Primary Tumor,30.0,20.0,0.0,90.0,40.0,5.0,90.0,TCGA-BS-A0TA-01A,TCGA-BS-A0TA,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-WX-AA47,12056.0,female,1979,white,626,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-WX-AA47-01A,TCGA-WX-AA47,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A8CT,21515.0,female,1954,black or african american,587,Primary Tumor,0.0,5.0,20.0,60.0,5.0,20.0,60.0,TCGA-AJ-A8CT-01A,TCGA-AJ-A8CT,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A7WJ,23723.0,female,1948,black or african american,439,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-A5-A7WJ-01A,TCGA-A5-A7WJ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7232,24324.0,male,1945,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HC-7232-01A,TCGA-HC-7232,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-KR-A7K2,23699.0,male,1949,white,85,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-KR-A7K2-01A,TCGA-KR-A7K2,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IK,20594.0,male,1952,not reported,1759,Primary Tumor,1.0,3.0,0.0,85.0,7.0,35.0,62.0,TCGA-KK-A8IK-01A,TCGA-KK-A8IK,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BD-A3EP,27756.0,female,1935,black or african american,398,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BD-A3EP-01A,TCGA-BD-A3EP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1C9,26903.0,female,1936,white,521,Primary Tumor,6.0,0.0,0.0,80.0,8.0,10.0,89.0,TCGA-AX-A1C9-01A,TCGA-AX-A1C9,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-XR-A8TD,17908.0,female,1963,white,585,Primary Tumor,2.0,1.0,0.0,75.0,3.0,15.0,75.0,TCGA-XR-A8TD-01A,TCGA-XR-A8TD,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAEE,20396.0,male,1957,asian,509,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DD-AAEE-01A,TCGA-DD-AAEE,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-YL-A9WL,21626.0,male,1952,not reported,755,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-YL-A9WL-01A,TCGA-YL-A9WL,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0V8,24981.0,female,1938,native hawaiian or other pacific islander,1410,Primary Tumor,20.0,0.0,30.0,70.0,10.0,0.0,50.0,TCGA-BS-A0V8-01A,TCGA-BS-A0V8,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-KP-A3W1,27902.0,female,1935,not reported,198,Primary Tumor,10.0,20.0,0.0,90.0,60.0,5.0,90.0,TCGA-KP-A3W1-01A,TCGA-KP-A3W1,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A83I,23240.0,male,1950,not reported,183,Primary Tumor,0.0,0.0,5.0,70.0,0.0,30.0,65.0,TCGA-J4-A83I-01A,TCGA-J4-A83I,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0JN,30933.0,female,1920,black or african american,2164,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-B5-A0JN-01A,TCGA-B5-A0JN,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A15Z,26638.0,female,1936,white,884,Primary Tumor,0.0,0.0,5.0,85.0,0.0,0.0,95.0,TCGA-D1-A15Z-01A,TCGA-D1-A15Z,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A179,28037.0,female,1934,white,230,Primary Tumor,40.0,10.0,0.0,70.0,40.0,10.0,70.0,TCGA-D1-A179-01A,TCGA-D1-A179,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A25V,25144.0,male,1942,white,223,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-G3-A25V-01A,TCGA-G3-A25V,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6378,19879.0,male,1955,black or african american,None,Primary Tumor,0.0,0.0,13.0,75.0,2.0,12.0,75.0,TCGA-G9-6378-01A,TCGA-G9-6378,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAVP,17833.0,male,1959,asian,2467,Primary Tumor,1.0,1.0,0.0,80.0,2.0,20.0,80.0,TCGA-DD-AAVP-01A,TCGA-DD-AAVP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BS-A0UM,23400.0,female,1941,white,2072,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-BS-A0UM-01A,TCGA-BS-A0UM,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5761,22433.0,male,1946,white,None,Primary Tumor,0.0,3.0,2.0,80.0,5.0,25.0,70.0,TCGA-CH-5761-01A,TCGA-CH-5761,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39W,10699.0,female,1966,white,6014,Primary Tumor,0.0,0.0,20.0,75.0,1.0,5.0,75.0,TCGA-DD-A39W-01A,TCGA-DD-A39W,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACV,19660.0,male,1957,asian,1231,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DD-AACV-01A,TCGA-DD-AACV,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A1DH,22652.0,female,1943,white,1843,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,85.0,TCGA-AP-A1DH-01A,TCGA-AP-A1DH,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZR,21157.0,female,1952,white,537,Primary Tumor,10.0,0.0,0.0,90.0,20.0,10.0,80.0,TCGA-D1-A0ZR-01A,TCGA-D1-A0ZR,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADP,16760.0,male,1968,asian,161,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,100.0,TCGA-DD-AADP-01A,TCGA-DD-AADP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0LX,20928.0,female,1953,white,120,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,90.0,TCGA-BG-A0LX-01A,TCGA-BG-A0LX,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0YU,13644.0,female,1973,white,166,Primary Tumor,10.0,0.0,0.0,90.0,20.0,10.0,80.0,TCGA-BG-A0YU-01A,TCGA-BG-A0YU,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAEB,22121.0,male,1952,asian,468,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DD-AAEB-01A,TCGA-DD-AAEB,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16N,18787.0,female,1958,white,629,Primary Tumor,0.0,0.0,0.0,95.0,0.0,2.0,95.0,TCGA-D1-A16N-01A,TCGA-D1-A16N,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M3,27183.0,female,1934,white,597,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,95.0,TCGA-BG-A0M3-01A,TCGA-BG-A0M3,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A4NE,27549.0,female,1936,white,631,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-DD-A4NE-01A,TCGA-DD-A4NE,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5790,23529.0,male,1942,white,None,Primary Tumor,0.0,0.0,20.0,75.0,0.0,15.0,65.0,TCGA-CH-5790-01A,TCGA-CH-5790,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAED,18722.0,male,1961,asian,489,Primary Tumor,0.0,0.0,0.0,75.0,2.0,0.0,100.0,TCGA-DD-AAED-01A,TCGA-DD-AAED,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-5R-AA1C,21073.0,male,1956,white,60,Primary Tumor,0.0,0.0,0.0,96.0,2.0,4.0,94.0,TCGA-5R-AA1C-01A,TCGA-5R-AA1C,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A0ZU,12458.0,female,1975,white,508,Primary Tumor,10.0,0.0,10.0,80.0,10.0,10.0,70.0,TCGA-D1-A0ZU-01A,TCGA-D1-A0ZU,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-UB-A7MF,20815.0,male,1957,white,240,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-UB-A7MF-01A,TCGA-UB-A7MF,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AAC9,18911.0,male,1957,asian,2069,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AAC9-01A,TCGA-DD-AAC9,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67L,20034.0,male,1957,not reported,485,Primary Tumor,0.0,0.0,0.0,65.0,1.0,0.0,100.0,TCGA-J4-A67L-01A,TCGA-J4-A67L,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67M,20211.0,male,1956,not reported,482,Primary Tumor,0.0,0.0,10.0,85.0,0.0,15.0,75.0,TCGA-J4-A67M-01A,TCGA-J4-A67M,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2V-A95S,None,male,None,asian,None,Primary Tumor,0.0,10.0,0.0,70.0,90.0,30.0,50.0,TCGA-2V-A95S-01A,TCGA-2V-A95S,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A5SI,16126.0,male,1967,asian,418,Primary Tumor,0.0,0.0,0.0,94.0,3.0,10.0,85.0,TCGA-G3-A5SI-01A,TCGA-G3-A5SI,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A67K,24908.0,male,1943,not reported,580,Primary Tumor,0.0,0.0,40.0,65.0,1.0,0.0,60.0,TCGA-J4-A67K-01A,TCGA-J4-A67K,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-5C-AAPD,22552.0,male,1952,asian,55,Primary Tumor,4.0,2.0,0.0,68.0,24.0,35.0,53.0,TCGA-5C-AAPD-01A,TCGA-5C-AAPD,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16R,14465.0,female,1971,white,161,Primary Tumor,0.0,0.0,10.0,70.0,10.0,20.0,50.0,TCGA-D1-A16R-01A,TCGA-D1-A16R,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-PG-A915,22119.0,female,1953,black or african american,238,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-PG-A915-01A,TCGA-PG-A915,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A2QU,24488.0,female,1938,white,2296,Primary Tumor,3.0,15.0,0.0,90.0,8.0,10.0,87.0,TCGA-DI-A2QU-01A,TCGA-DI-A2QU,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9GU,20187.0,female,1954,white,1752,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-2Y-A9GU-01A,TCGA-2Y-A9GU,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-TK-A8OK,26976.0,male,1940,not reported,202,Primary Tumor,0.0,0.0,25.0,60.0,3.0,0.0,75.0,TCGA-TK-A8OK-01A,TCGA-TK-A8OK,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0VZ,21414.0,female,1950,white,876,Primary Tumor,30.0,20.0,10.0,70.0,40.0,20.0,70.0,TCGA-BG-A0VZ-01A,TCGA-BG-A0VZ,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV5,24655.0,male,1946,white,62,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-G3-AAV5-01A,TCGA-G3-AAV5,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CI,22582.0,female,1943,white,2222,Primary Tumor,0.0,0.0,3.0,95.0,2.0,3.0,93.0,TCGA-AX-A1CI-01A,TCGA-AX-A1CI,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A15X,16532.0,female,1963,white,897,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-D1-A15X-01A,TCGA-D1-A15X,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7737,20122.0,male,1955,black or african american,None,Primary Tumor,None,None,None,80.0,None,None,None,TCGA-HC-7737-01A,TCGA-HC-7737,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A5OD,24775.0,female,1944,black or african american,662,Primary Tumor,2.0,2.0,0.0,85.0,2.0,15.0,80.0,TCGA-B5-A5OD-01A,TCGA-B5-A5OD,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A056,23707.0,female,1940,white,2017,Primary Tumor,0.0,0.0,0.0,60.0,14.0,40.0,54.0,TCGA-AP-A056-01A,TCGA-AP-A056,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9ZK,25185.0,male,None,not reported,None,Primary Tumor,0.0,0.0,10.0,90.0,8.0,45.0,44.0,TCGA-V1-A9ZK-01A,TCGA-V1-A9ZK,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A3FH,27221.0,female,1937,black or african american,97,Primary Tumor,2.0,5.0,0.0,80.0,1.0,0.0,85.0,TCGA-B5-A3FH-01A,TCGA-B5-A3FH,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XJ-A9DI,None,male,1947,not reported,1443,Primary Tumor,2.0,2.0,15.0,60.0,15.0,40.0,44.0,TCGA-XJ-A9DI-01A,TCGA-XJ-A9DI,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AP-A0LM,12309.0,female,1971,black or african american,2019,Primary Tumor,0.0,0.0,15.0,65.0,0.0,0.0,85.0,TCGA-AP-A0LM-01A,TCGA-AP-A0LM,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EL,8573.0,male,1986,black or african american,577,Primary Tumor,0.0,0.0,0.0,90.0,3.0,10.0,90.0,TCGA-DD-A1EL-01A,TCGA-DD-A1EL,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A73C,23782.0,female,1947,white,288,Primary Tumor,0.0,0.0,0.0,96.0,1.0,1.0,97.0,TCGA-DD-A73C-01A,TCGA-DD-A73C,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5764,24257.0,male,1942,white,None,Primary Tumor,0.0,0.0,10.0,75.0,0.0,15.0,75.0,TCGA-CH-5764-01A,TCGA-CH-5764,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EO-A22T,20608.0,female,1952,asian,916,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-EO-A22T-01A,TCGA-EO-A22T,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A6UC,23793.0,male,1947,white,266,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-G3-A6UC-01A,TCGA-G3-A6UC,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7210,27343.0,male,1937,white,None,Primary Tumor,None,None,None,60.0,None,None,None,TCGA-HC-7210-01A,TCGA-HC-7210,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A2F8,23649.0,female,1945,white,679,Primary Tumor,20.0,20.0,0.0,70.0,40.0,20.0,70.0,TCGA-FI-A2F8-01A,TCGA-FI-A2F8,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-EC-A1QX,26259.0,female,1939,white,81,Primary Tumor,20.0,20.0,0.0,80.0,40.0,15.0,80.0,TCGA-EC-A1QX-01A,TCGA-EC-A1QX,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CP,30737.0,female,1924,white,1080,Primary Tumor,0.0,0.0,35.0,70.0,5.0,4.0,60.0,TCGA-AX-A1CP-01A,TCGA-AX-A1CP,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A7NJ,21748.0,male,1954,not reported,211,Primary Tumor,0.0,0.0,20.0,60.0,20.0,35.0,43.0,TCGA-EJ-A7NJ-01A,TCGA-EJ-A7NJ,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-VP-A87K,23030.0,male,1947,not reported,1112,Primary Tumor,0.0,0.0,10.0,80.0,0.0,20.0,70.0,TCGA-VP-A87K-01A,TCGA-VP-A87K,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-QU-A6IP,24212.0,male,1938,not reported,3118,Primary Tumor,0.0,0.0,5.0,80.0,3.0,47.0,45.0,TCGA-QU-A6IP-01A,TCGA-QU-A6IP,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-CC-5259,21946.0,female,1950,asian,106,Primary Tumor,0.0,0.0,0.0,75.0,0.0,5.0,95.0,TCGA-CC-5259-01A,TCGA-CC-5259,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10Z,22913.0,female,1941,white,2652,Primary Tumor,0.0,0.0,0.0,85.0,3.0,15.0,80.0,TCGA-BC-A10Z-01A,TCGA-BC-A10Z,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-KR-A7K8,20914.0,male,1955,not reported,435,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-KR-A7K8-01A,TCGA-KR-A7K8,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-2A-A8VO,20958.0,male,1953,not reported,1290,Primary Tumor,0.0,0.0,5.0,70.0,0.0,10.0,85.0,TCGA-2A-A8VO-01A,TCGA-2A-A8VO,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9OA,22630.0,male,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-V1-A9OA-01A,TCGA-V1-A9OA,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A16E,26859.0,female,1935,white,790,Primary Tumor,12.0,4.0,0.0,80.0,5.0,20.0,80.0,TCGA-D1-A16E-01A,TCGA-D1-A16E,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A3,16708.0,male,1954,asian,4397,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-DD-A3A3-01A,TCGA-DD-A3A3,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A0M9,26708.0,female,1935,white,772,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-BG-A0M9-01A,TCGA-BG-A0M9,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AADF,23614.0,female,1947,asian,865,Primary Tumor,2.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DD-AADF-01A,TCGA-DD-AADF,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-AACX,24329.0,male,1944,asian,1183,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DD-AACX-01A,TCGA-DD-AACX,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A8,27524.0,male,1926,white,3708,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-DD-A3A8-01A,TCGA-DD-A3A8,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A8IB,24041.0,male,1947,not reported,338,Primary Tumor,0.0,0.0,50.0,60.0,0.0,0.0,50.0,TCGA-KK-A8IB-01A,TCGA-KK-A8IB,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-HP-A5N0,32120.0,female,None,not reported,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-HP-A5N0-01A,TCGA-HP-A5N0,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-5517,20422.0,male,1953,white,None,Primary Tumor,0.0,0.0,10.0,80.0,5.0,15.0,75.0,TCGA-EJ-5517-01A,TCGA-EJ-5517,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-2Y-A9H4,25096.0,male,1942,black or african american,1210,Primary Tumor,2.0,1.0,0.0,85.0,3.0,15.0,85.0,TCGA-2Y-A9H4-01A,TCGA-2Y-A9H4,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A6E7,17074.0,male,1961,not reported,2151,Primary Tumor,0.0,0.0,0.0,60.0,1.0,0.0,100.0,TCGA-KK-A6E7-01A,TCGA-KK-A6E7,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-ZG-A9L9,22108.0,male,1952,not reported,665,Primary Tumor,1.0,1.0,3.0,75.0,2.0,22.0,75.0,TCGA-ZG-A9L9-01A,TCGA-ZG-A9L9,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-E6-A2P9,24088.0,female,1946,white,189,Primary Tumor,0.0,0.0,0.0,96.0,3.0,5.0,95.0,TCGA-E6-A2P9-01A,TCGA-E6-A2P9,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A3EW,22705.0,female,1949,white,24,Primary Tumor,0.0,0.0,5.0,85.0,2.0,15.0,80.0,TCGA-BG-A3EW-01A,TCGA-BG-A3EW,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-A5-A3LP,27131.0,female,1937,white,111,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-A5-A3LP-01A,TCGA-A5-A3LP,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A220,25346.0,female,1941,white,110,Primary Tumor,30.0,10.0,0.0,90.0,40.0,5.0,90.0,TCGA-BG-A220-01A,TCGA-BG-A220,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6498,19568.0,male,1955,not reported,None,Primary Tumor,0.0,0.0,5.0,90.0,0.0,20.0,75.0,TCGA-G9-6498-01A,TCGA-G9-6498,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-D1-A1NY,24683.0,female,1943,white,199,Primary Tumor,2.0,1.0,5.0,80.0,8.0,20.0,72.0,TCGA-D1-A1NY-01A,TCGA-D1-A1NY,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1ED,25039.0,male,1938,white,1525,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-DD-A1ED-01A,TCGA-DD-A1ED,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-SJ-A6ZI,23653.0,female,1949,black or african american,88,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,80.0,TCGA-SJ-A6ZI-01A,TCGA-SJ-A6ZI,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7B1,23803.0,male,1946,not reported,839,Primary Tumor,2.0,0.0,0.0,80.0,3.0,51.0,45.0,TCGA-KK-A7B1-01A,TCGA-KK-A7B1,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A4BL,24081.0,male,1941,not reported,2101,Primary Tumor,0.0,0.0,20.0,60.0,0.0,40.0,40.0,TCGA-KC-A4BL-01A,TCGA-KC-A4BL,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KC-A7FA,23208.0,male,1950,not reported,146,Primary Tumor,0.0,0.0,15.0,75.0,0.0,0.0,85.0,TCGA-KC-A7FA-01A,TCGA-KC-A7FA,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XK-AAJP,24320.0,male,1945,not reported,1008,Primary Tumor,0.0,0.0,5.0,90.0,3.0,25.0,70.0,TCGA-XK-AAJP-01A,TCGA-XK-AAJP,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-XJ-A9DX,None,male,1961,not reported,651,Primary Tumor,0.0,0.0,20.0,90.0,0.0,0.0,80.0,TCGA-XJ-A9DX-01A,TCGA-XJ-A9DX,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7079,18734.0,male,1959,white,None,Primary Tumor,None,None,5.0,50.0,None,45.0,50.0,TCGA-HC-7079-01A,TCGA-HC-7079,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A0K4,18631.0,female,1958,not reported,264,Primary Tumor,0.0,0.0,0.0,70.0,0.0,20.0,60.0,TCGA-B5-A0K4-01A,TCGA-B5-A0K4,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-FI-A3PX,21063.0,female,1951,white,1280,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,85.0,TCGA-FI-A3PX-01A,TCGA-FI-A3PX,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-B5-A11J,23485.0,female,1942,white,1536,Primary Tumor,1.0,10.0,0.0,92.0,8.0,7.0,92.0,TCGA-B5-A11J-01A,TCGA-B5-A11J,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-AAV3,21449.0,female,1955,white,98,Primary Tumor,0.0,0.0,0.0,75.0,2.0,25.0,75.0,TCGA-G3-AAV3-01A,TCGA-G3-AAV3,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-KK-A7B2,24845.0,male,1944,not reported,554,Primary Tumor,2.0,2.0,0.0,80.0,10.0,55.0,44.0,TCGA-KK-A7B2-01A,TCGA-KK-A7B2,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-V1-A9O9,20805.0,male,None,not reported,None,Primary Tumor,1.0,1.0,1.0,82.0,12.0,47.0,50.0,TCGA-V1-A9O9-01A,TCGA-V1-A9O9,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A3G7,26187.0,female,1939,white,520,Primary Tumor,0.0,0.0,0.0,90.0,6.0,6.0,89.0,TCGA-AX-A3G7-01A,TCGA-AX-A3G7,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-6851,26808.0,female,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-86-6851-01A,TCGA-86-6851,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A0TW,18263.0,female,1955,white,1888,Primary Tumor,0.0,0.0,0.0,90.0,2.0,9.0,90.0,TCGA-AR-A0TW-01A,TCGA-AR-A0TW,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A26Y,32872,female,1920,asian,134,Primary Tumor,0.0,0.0,0.0,80.0,5.0,30.0,55.0,TCGA-C8-A26Y-01A,TCGA-C8-A26Y,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A4ZE,23284.0,female,1949,white,169,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-AC-A4ZE-01A,TCGA-AC-A4ZE,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5933,26377.0,male,1929,white,None,Primary Tumor,5.0,2.0,0.0,70.0,10.0,0.0,90.0,TCGA-50-5933-01A,TCGA-50-5933,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18S,28974.0,female,1924,white,2695,Primary Tumor,0.0,1.0,0.0,85.0,1.0,15.0,85.0,TCGA-BH-A18S-01A,TCGA-BH-A18S,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A1KT,28660.0,female,1931,white,617,Primary Tumor,0.0,0.0,0.0,85.0,0.0,40.0,60.0,TCGA-AO-A1KT-01A,TCGA-AO-A1KT,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4424,25689.0,male,1938,not reported,None,Primary Tumor,None,None,5.0,80.0,None,5.0,85.0,TCGA-05-4424-01A,TCGA-05-4424,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A209,28403.0,female,1919,black or african american,5392,Primary Tumor,0.0,0.0,0.0,60.0,0.0,20.0,80.0,TCGA-BH-A209-01A,TCGA-BH-A209,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09I,30711.0,female,1924,not reported,698,Primary Tumor,0.0,0.0,5.0,75.0,5.0,14.0,80.0,TCGA-A8-A09I-01A,TCGA-A8-A09I,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7146,26272.0,female,1928,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,77.0,TCGA-78-7146-01A,TCGA-78-7146,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JM,21602.0,female,1951,white,243,Primary Tumor,0.0,0.0,0.0,92.0,1.0,4.0,92.0,TCGA-D8-A1JM-01A,TCGA-D8-A1JM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A094,27729.0,female,1934,not reported,363,Primary Tumor,0.0,0.0,0.0,85.0,1.0,16.0,80.0,TCGA-A8-A094-01A,TCGA-A8-A094,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1L6,16403.0,female,1963,white,1325,Primary Tumor,0.0,0.0,15.0,65.0,0.0,50.0,35.0,TCGA-E2-A1L6-01A,TCGA-E2-A1L6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1B6,16370.0,female,1964,white,729,Primary Tumor,20.0,20.0,10.0,60.0,40.0,30.0,60.0,TCGA-E2-A1B6-01A,TCGA-E2-A1B6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IB,23646.0,female,1928,white,6660,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-B6-A0IB-01A,TCGA-B6-A0IB,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B0,20776.0,female,1950,black or african american,1223,Primary Tumor,0.0,0.0,24.0,70.0,2.0,5.0,70.0,TCGA-BH-A0B0-01A,TCGA-BH-A0B0,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-5778,21927.0,male,1948,white,None,Primary Tumor,0.0,5.0,0.0,75.0,10.0,10.0,90.0,TCGA-64-5778-01A,TCGA-64-5778,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IH,24174.0,female,1946,white,686,Primary Tumor,20.0,20.0,10.0,50.0,40.0,40.0,50.0,TCGA-3A-A9IH-01A,TCGA-3A-A9IH,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8511,26986.0,female,1939,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-55-8511-01A,TCGA-55-8511,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J3,24519.0,female,1942,white,220,Primary Tumor,0.0,0.0,3.0,70.0,5.0,27.0,70.0,TCGA-AO-A0J3-01A,TCGA-AO-A0J3,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1G1,31223.0,female,1925,white,338,Primary Tumor,0.0,0.0,0.0,70.0,0.0,20.0,70.0,TCGA-A2-A1G1-01A,TCGA-A2-A1G1,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SB,25833.0,female,1938,white,764,Primary Tumor,0.0,0.0,1.0,85.0,1.0,14.0,85.0,TCGA-A1-A0SB-01A,TCGA-A1-A0SB,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A42T,27731.0,female,1937,black or african american,80,Primary Tumor,0.0,0.0,0.0,90.0,2.0,25.0,72.0,TCGA-BH-A42T-01A,TCGA-BH-A42T,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1J1,14122.0,female,1972,white,214,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-EW-A1J1-01A,TCGA-EW-A1J1,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AAR4,18939.0,male,1955,black or african american,2842,Primary Tumor,5.0,2.0,8.0,65.0,6.0,25.0,65.0,TCGA-49-AAR4-01A,TCGA-49-AAR4,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DH,21344.0,female,1949,white,1464,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-GM-A2DH-01A,TCGA-GM-A2DH,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7919,19064.0,female,1959,white,None,Primary Tumor,None,None,0.0,65.0,None,25.0,75.0,TCGA-HZ-7919-01A,TCGA-HZ-7919,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DI,19030.0,female,1953,white,2144,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-GM-A2DI-01A,TCGA-GM-A2DI,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1X5,29734.0,female,1929,white,197,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,100.0,TCGA-D8-A1X5-01A,TCGA-D8-A1X5,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A471,23689.0,male,1946,white,951,Primary Tumor,0.0,2.0,30.0,70.0,2.0,0.0,70.0,TCGA-62-A471-01A,TCGA-62-A471,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08B,19114.0,female,1956,not reported,759,Primary Tumor,0.0,0.0,15.0,75.0,20.0,23.0,60.0,TCGA-A8-A08B-01A,TCGA-A8-A08B,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SK,20048.0,female,1953,asian,1164,Primary Tumor,0.0,0.0,0.0,80.0,1.0,15.0,80.0,TCGA-A1-A0SK-01A,TCGA-A1-A0SK,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-8176,23170.0,male,1949,white,None,Primary Tumor,0.0,2.0,0.0,85.0,10.0,0.0,100.0,TCGA-97-8176-01A,TCGA-97-8176,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08J,19266.0,female,1953,not reported,1733,Primary Tumor,0.0,0.0,0.0,90.0,4.0,20.0,78.0,TCGA-A8-A08J-01A,TCGA-A8-A08J,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-A44F,29534.0,male,1932,white,127,Primary Tumor,2.0,8.0,5.0,80.0,2.0,35.0,60.0,TCGA-38-A44F-01A,TCGA-38-A44F,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A2JS,26407.0,female,1939,white,79,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-E9-A2JS-01A,TCGA-E9-A2JS,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABF,26936.0,male,1939,white,510,Primary Tumor,0.0,0.0,0.0,60.0,8.0,0.0,100.0,TCGA-2J-AABF-01A,TCGA-2J-AABF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0H3,17152.0,female,1962,white,773,Primary Tumor,0.0,0.0,5.0,80.0,0.0,20.0,75.0,TCGA-BH-A0H3-01A,TCGA-BH-A0H3,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A7LX,20898.0,male,1955,white,273,Primary Tumor,0.0,0.0,0.0,60.0,0.0,50.0,50.0,TCGA-IB-A7LX-01A,TCGA-IB-A7LX,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12O,18506.0,female,1960,asian,57,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-C8-A12O-01A,TCGA-C8-A12O,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JU,18733.0,female,1959,white,295,Primary Tumor,1.0,1.0,1.0,80.0,1.0,19.0,80.0,TCGA-D8-A1JU-01A,TCGA-D8-A1JU,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A2P6,28411.0,female,1934,not reported,174,Primary Tumor,0.0,0.0,0.0,88.0,2.0,34.0,65.0,TCGA-E2-A2P6-01A,TCGA-E2-A2P6,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8055,29124.0,male,1932,white,None,Primary Tumor,None,8.0,7.0,60.0,15.0,45.0,45.0,TCGA-86-8055-01A,TCGA-86-8055,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-8005,29674.0,male,1931,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HZ-8005-01A,TCGA-HZ-8005,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AARE,18893.0,female,1948,black or african american,5455,Primary Tumor,0.0,0.0,0.0,60.0,0.0,40.0,60.0,TCGA-49-AARE-01A,TCGA-49-AARE,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8674,18479.0,male,1962,white,None,Primary Tumor,15.0,0.0,5.0,70.0,10.0,10.0,85.0,TCGA-86-8674-01A,TCGA-86-8674,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0CG,28596.0,female,1932,white,93,Primary Tumor,0.0,0.0,18.0,75.0,17.0,15.0,65.0,TCGA-A7-A0CG-01A,TCGA-A7-A0CG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A4RY,17157.0,female,1966,white,149,Primary Tumor,0.0,0.0,2.0,85.0,0.0,0.0,98.0,TCGA-A2-A4RY-01A,TCGA-A2-A4RY,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J4,15052.0,female,1968,black or african american,224,Primary Tumor,0.0,0.0,0.0,80.0,2.0,19.0,80.0,TCGA-AO-A0J4-01A,TCGA-AO-A0J4,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IU,23998.0,male,1946,white,946,Primary Tumor,0.0,0.0,20.0,60.0,0.0,0.0,80.0,TCGA-3A-A9IU-01A,TCGA-3A-A9IU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3W7,24327.0,female,1946,white,65,Primary Tumor,0.0,0.0,5.0,85.0,0.0,0.0,95.0,TCGA-AC-A3W7-01A,TCGA-AC-A3W7,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7547,24737.0,female,1940,white,None,Primary Tumor,None,None,None,60.0,30.0,10.0,90.0,TCGA-97-7547-01A,TCGA-97-7547,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JB,19822.0,female,1956,white,232,Primary Tumor,0.0,0.0,10.0,60.0,0.0,5.0,85.0,TCGA-D8-A1JB-01A,TCGA-D8-A1JB,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1F8,32871.0,female,1909,white,4301,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-BH-A1F8-01A,TCGA-BH-A1F8,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A8OQ,26535.0,female,1939,black or african american,742,Primary Tumor,1.0,2.0,2.0,82.0,10.0,52.0,45.0,TCGA-AC-A8OQ-01A,TCGA-AC-A8OQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A28Q,16882.0,female,1964,white,223,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-BH-A28Q-01A,TCGA-BH-A28Q,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A081,29555.0,female,1928,not reported,637,Primary Tumor,1.0,0.0,5.0,75.0,2.0,20.0,70.0,TCGA-A8-A081-01A,TCGA-A8-A081,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18G,29820.0,female,1929,white,78,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-BH-A18G-01A,TCGA-BH-A18G,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AJ,30489.0,female,1922,white,1828,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,80.0,TCGA-AR-A1AJ-01A,TCGA-AR-A1AJ,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7893,23703.0,male,1945,white,None,Primary Tumor,None,None,0.0,50.0,None,60.0,40.0,TCGA-IB-7893-01A,TCGA-IB-7893,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1PF,18384.0,female,1960,white,84,Primary Tumor,1.0,1.0,3.0,70.0,3.0,26.0,70.0,TCGA-EW-A1PF-01A,TCGA-EW-A1PF,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A8OP,26550.0,female,1939,black or african american,921,Primary Tumor,2.0,1.0,5.0,70.0,10.0,73.0,22.0,TCGA-AC-A8OP-01A,TCGA-AC-A8OP,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A13H,22643.0,female,1949,white,62,Primary Tumor,0.0,0.0,5.0,55.0,0.0,15.0,80.0,TCGA-A7-A13H-01A,TCGA-A7-A13H,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-A491,29593.0,female,1931,white,31,Primary Tumor,0.0,0.0,0.0,65.0,0.0,10.0,73.0,TCGA-55-A491-01A,TCGA-55-A491,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A228,21294.0,female,1953,white,42,Primary Tumor,1.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-E9-A228-01A,TCGA-E9-A228,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-97-7938,27980.0,female,1935,white,None,Primary Tumor,0.0,0.0,10.0,70.0,10.0,10.0,80.0,TCGA-97-7938-01A,TCGA-97-7938,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-7924,22090.0,female,1951,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-HZ-7924-01A,TCGA-HZ-7924,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HZ-A77Q,20366.0,female,1958,white,78,Primary Tumor,0.0,0.0,97.0,3.0,8.0,0.0,3.0,TCGA-HZ-A77Q-01A,TCGA-HZ-A77Q,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4432,24350.0,male,1942,not reported,None,Primary Tumor,None,None,0.0,75.0,None,10.0,85.0,TCGA-05-4432-01A,TCGA-05-4432,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-A4P8,21738.0,female,1953,white,98,Primary Tumor,0.0,5.0,90.0,60.0,8.0,0.0,10.0,TCGA-86-A4P8-01A,TCGA-86-A4P8,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-8457,23055.0,female,1948,black or african american,None,Primary Tumor,None,None,12.0,70.0,None,15.0,73.0,TCGA-50-8457-01A,TCGA-50-8457,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A295,25957.0,female,1940,white,63,Primary Tumor,0.0,0.0,5.0,60.0,1.0,63.0,30.0,TCGA-E9-A295-01A,TCGA-E9-A295,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1P7,21750.0,female,1950,white,604,Primary Tumor,2.0,1.0,2.0,70.0,5.0,28.0,70.0,TCGA-EW-A1P7-01A,TCGA-EW-A1P7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1G6,18514.0,female,1960,white,229,Primary Tumor,0.0,0.0,0.0,75.0,0.0,10.0,90.0,TCGA-A2-A1G6-01A,TCGA-A2-A1G6,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27I,21327.0,female,1952,white,132,Primary Tumor,0.0,0.0,5.0,85.0,0.0,5.0,90.0,TCGA-D8-A27I-01A,TCGA-D8-A27I,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24R,16642.0,female,1961,white,1913,Primary Tumor,1.0,1.0,0.0,90.0,2.0,10.0,90.0,TCGA-AR-A24R-01A,TCGA-AR-A24R,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-8460,27270.0,male,1938,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-50-8460-01A,TCGA-50-8460,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A40C,18852.0,female,1954,white,2677,Primary Tumor,2.0,1.0,0.0,80.0,4.0,20.0,80.0,TCGA-B6-A40C-01A,TCGA-B6-A40C,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IH,29444.0,female,1928,white,883,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-E2-A1IH-01A,TCGA-E2-A1IH,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A208,17715.0,female,1947,white,5893,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,100.0,TCGA-BH-A208-01A,TCGA-BH-A208,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A1G0,18002.0,female,1961,white,315,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-A2-A1G0-01A,TCGA-A2-A1G0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AS,20028.0,female,1953,asian,1331,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-AR-A1AS-01A,TCGA-AR-A1AS,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-5428,21061.0,male,1953,not reported,None,Primary Tumor,7.0,0.0,0.0,85.0,7.0,20.0,80.0,TCGA-05-5428-01A,TCGA-05-5428,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A3Q9,28715.0,female,1933,white,198,Primary Tumor,0.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-E9-A3Q9-01A,TCGA-E9-A3Q9,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4632,15418.0,male,1956,black or african american,None,Primary Tumor,None,None,5.0,70.0,None,5.0,88.0,TCGA-38-4632-01A,TCGA-38-4632,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A8G0,19975.0,female,1958,white,436,Primary Tumor,20.0,20.0,10.0,60.0,40.0,30.0,60.0,TCGA-BH-A8G0-01A,TCGA-BH-A8G0,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-7498,21527.0,female,1952,white,None,Primary Tumor,0.0,15.0,0.0,75.0,8.0,5.0,95.0,TCGA-73-7498-01A,TCGA-73-7498,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JE,22683.0,female,1948,white,238,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D8-A1JE-01A,TCGA-D8-A1JE,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A25C,18508.0,female,1960,white,215,Primary Tumor,0.0,0.0,0.0,82.0,1.0,30.0,70.0,TCGA-A2-A25C-01A,TCGA-A2-A25C,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-7714,22619.0,female,1950,black or african american,None,Primary Tumor,0.0,0.0,0.0,80.0,10.0,0.0,100.0,TCGA-86-7714-01A,TCGA-86-7714,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A3HN,32061.0,female,1924,white,97,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-AC-A3HN-01A,TCGA-AC-A3HN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-XX-A89A,25000.0,female,1945,white,174,Primary Tumor,0.0,0.0,0.0,65.0,3.0,0.0,100.0,TCGA-XX-A89A-01A,TCGA-XX-A89A,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18I,19489.0,female,1957,white,80,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,90.0,TCGA-BH-A18I-01A,TCGA-BH-A18I,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HB,20448.0,female,1953,white,739,Primary Tumor,0.0,0.0,30.0,70.0,15.0,38.0,30.0,TCGA-BH-A0HB-01A,TCGA-BH-A0HB,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RV,15507.0,female,1954,white,5165,Primary Tumor,0.0,0.0,5.0,75.0,0.0,25.0,70.0,TCGA-B6-A0RV-01A,TCGA-B6-A0RV,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-8394,23758.0,female,1943,white,None,Primary Tumor,None,3.0,0.0,70.0,12.0,8.0,80.0,TCGA-62-8394-01A,TCGA-62-8394,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L9-A7SV,25298.0,male,1944,black or african american,42,Primary Tumor,20.0,20.0,0.0,80.0,40.0,10.0,80.0,TCGA-L9-A7SV-01A,TCGA-L9-A7SV,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-A4D0,17607.0,male,1964,white,133,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,90.0,TCGA-86-A4D0-01A,TCGA-86-A4D0,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6849,27676.0,female,1934,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-91-6849-01A,TCGA-91-6849,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4658,29508.0,female,1924,white,None,Primary Tumor,None,None,0.0,60.0,None,50.0,50.0,TCGA-73-4658-01A,TCGA-73-4658,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08O,16681.0,female,1963,not reported,819,Primary Tumor,0.0,0.0,15.0,80.0,8.0,20.0,63.0,TCGA-A8-A08O-01A,TCGA-A8-A08O,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5936,21238.0,male,1949,white,None,Primary Tumor,1.0,5.0,0.0,80.0,10.0,7.0,93.0,TCGA-50-5936-01A,TCGA-50-5936,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06O,22157.0,female,1949,not reported,272,Primary Tumor,0.0,0.0,15.0,75.0,18.0,43.0,40.0,TCGA-A8-A06O-01A,TCGA-A8-A06O,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6594,28924.0,female,1930,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,10.0,85.0,TCGA-50-6594-01A,TCGA-50-6594,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6981,19497.0,female,1952,white,None,Primary Tumor,0.0,0.0,0.0,72.0,16.0,0.0,100.0,TCGA-55-6981-01A,TCGA-55-6981,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XS,17708.0,male,1962,white,164,Primary Tumor,0.0,0.0,2.0,70.0,0.0,38.0,60.0,TCGA-D8-A1XS-01A,TCGA-D8-A1XS,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A1-A0SE,20717.0,female,1949,white,1672,Primary Tumor,0.0,0.0,7.0,80.0,2.0,13.0,80.0,TCGA-A1-A0SE-01A,TCGA-A1-A0SE,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FN,12525.0,female,1963,white,4838,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,95.0,TCGA-BH-A1FN-01A,TCGA-BH-A1FN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04P,13238.0,female,1967,black or african american,2623,Primary Tumor,0.0,0.0,7.0,85.0,7.0,7.0,84.0,TCGA-A2-A04P-01A,TCGA-A2-A04P,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A0J7,26281.0,female,1938,white,177,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-AO-A0J7-01A,TCGA-AO-A0J7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A5FK,22199.0,female,1952,white,77,Primary Tumor,0.0,0.0,5.0,70.0,1.0,0.0,95.0,TCGA-E9-A5FK-01A,TCGA-E9-A5FK,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FM,16289.0,female,1954,white,4753,Primary Tumor,0.0,0.0,0.0,90.0,1.0,18.0,80.0,TCGA-BH-A1FM-01A,TCGA-BH-A1FM,3.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-US-A77G,23443.0,male,1946,white,1077,Primary Tumor,1.0,1.0,45.0,12.0,8.0,45.0,8.0,TCGA-US-A77G-01A,TCGA-US-A77G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RN,22077.0,female,1933,white,6286,Primary Tumor,0.0,0.0,0.0,85.0,2.0,20.0,80.0,TCGA-B6-A0RN-01A,TCGA-B6-A0RN,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NA,21397.0,female,1953,white,42,Primary Tumor,1.0,1.0,0.0,85.0,2.0,15.0,85.0,TCGA-E9-A1NA-01A,TCGA-E9-A1NA,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0WA,30025.0,female,1926,white,724,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,75.0,TCGA-BH-A0WA-01A,TCGA-BH-A0WA,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09Q,30528.0,female,1925,not reported,637,Primary Tumor,0.0,0.0,0.0,75.0,8.0,24.0,74.0,TCGA-A8-A09Q-01A,TCGA-A8-A09Q,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1OV,20764.0,female,1953,white,469,Primary Tumor,0.0,0.0,2.0,80.0,18.0,10.0,83.0,TCGA-EW-A1OV-01A,TCGA-EW-A1OV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HF,28233.0,female,1931,white,549,Primary Tumor,0.0,0.0,0.0,75.0,5.0,55.0,43.0,TCGA-BH-A0HF-01A,TCGA-BH-A0HF,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XS,23000.0,female,1941,black or african american,3355,Primary Tumor,0.0,0.0,0.0,68.0,0.0,13.0,85.0,TCGA-A2-A3XS-01A,TCGA-A2-A3XS,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LL,25747.0,female,1937,white,1315,Primary Tumor,0.0,0.0,0.0,75.0,5.0,43.0,55.0,TCGA-AR-A2LL-01A,TCGA-AR-A2LL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A3U0,22520.0,female,1950,black or african american,182,Primary Tumor,0.0,0.0,0.0,80.0,0.0,45.0,55.0,TCGA-EW-A3U0-01A,TCGA-EW-A3U0,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EO,19880.0,female,1949,white,2331,Primary Tumor,0.0,0.0,4.0,80.0,3.0,20.0,75.0,TCGA-A2-A0EO-01A,TCGA-A2-A0EO,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RT,14374.0,female,1957,white,5047,Primary Tumor,0.0,0.0,0.0,60.0,0.0,60.0,40.0,TCGA-B6-A0RT-01A,TCGA-B6-A0RT,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-8640,21832.0,male,1935,not reported,None,Primary Tumor,None,None,None,70.0,None,None,None,TCGA-78-8640-01A,TCGA-78-8640,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EV,29285.0,female,1928,white,590,Primary Tumor,0.0,0.0,0.0,75.0,5.0,30.0,70.0,TCGA-A2-A0EV-01A,TCGA-A2-A0EV,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A03V,15284.0,female,1967,white,670,Primary Tumor,0.0,0.0,10.0,65.0,5.0,39.0,50.0,TCGA-AO-A03V-01A,TCGA-AO-A03V,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A06Y,24442.0,female,1942,not reported,667,Primary Tumor,0.0,0.0,25.0,75.0,5.0,50.0,25.0,TCGA-A8-A06Y-01A,TCGA-A8-A06Y,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A425,25678.0,female,1942,white,198,Primary Tumor,0.0,0.0,5.0,85.0,0.0,15.0,80.0,TCGA-A7-A425-01A,TCGA-A7-A425,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A6HE,16697.0,female,1967,white,203,Primary Tumor,0.0,5.0,5.0,80.0,5.0,15.0,80.0,TCGA-E9-A6HE-01A,TCGA-E9-A6HE,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0RI,16138.0,female,1948,white,6755,Primary Tumor,0.0,0.0,0.0,60.0,0.0,30.0,70.0,TCGA-B6-A0RI-01A,TCGA-B6-A0RI,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IM,27557.0,female,1922,black or african american,4754,Primary Tumor,0.0,0.0,0.0,80.0,1.0,20.0,80.0,TCGA-B6-A0IM-01A,TCGA-B6-A0IM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14X,20105.0,female,1954,black or african american,652,Primary Tumor,0.0,0.0,5.0,75.0,0.0,19.0,75.0,TCGA-E2-A14X-01A,TCGA-E2-A14X,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A03R,20930.0,female,1948,white,1608,Primary Tumor,0.0,1.0,0.0,80.0,12.0,63.0,35.0,TCGA-AO-A03R-01A,TCGA-AO-A03R,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-5779,22305.0,male,1948,white,None,Primary Tumor,0.0,0.0,0.0,75.0,12.0,15.0,80.0,TCGA-64-5779-01A,TCGA-64-5779,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8614,27924.0,male,1935,white,None,Primary Tumor,None,None,20.0,75.0,None,15.0,80.0,TCGA-55-8614-01A,TCGA-55-8614,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CS,26817.0,female,1931,white,2030,Primary Tumor,0.0,0.0,0.0,60.0,0.0,0.0,100.0,TCGA-A2-A0CS-01A,TCGA-A2-A0CS,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A5QN,25089.0,female,1944,white,328,Primary Tumor,20.0,20.0,0.0,60.0,40.0,35.0,60.0,TCGA-AR-A5QN-01A,TCGA-AR-A5QN,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0WS,21230.0,female,1938,black or african american,5113,Primary Tumor,1.0,1.0,0.0,80.0,4.0,20.0,80.0,TCGA-B6-A0WS-01A,TCGA-B6-A0WS,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LR,18214.0,female,1961,white,447,Primary Tumor,0.0,0.0,0.0,60.0,3.0,70.0,30.0,TCGA-AR-A2LR-01A,TCGA-AR-A2LR,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0W7,17996.0,female,1959,white,869,Primary Tumor,0.0,0.0,4.0,40.0,50.0,15.0,80.0,TCGA-BH-A0W7-01A,TCGA-BH-A0W7,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5RZ,21038.0,female,1955,black or african american,343,Primary Tumor,0.0,0.0,10.0,75.0,4.0,0.0,90.0,TCGA-OL-A5RZ-01A,TCGA-OL-A5RZ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08I,19389.0,female,1956,not reported,241,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-A8-A08I-01A,TCGA-A8-A08I,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-67-3770,25658.0,female,1939,white,None,Primary Tumor,None,None,5.0,80.0,None,10.0,82.0,TCGA-67-3770-01A,TCGA-67-3770,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7155,24863.0,male,1937,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,85.0,TCGA-78-7155-01A,TCGA-78-7155,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-95-7562,26000.0,male,1940,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,5.0,75.0,TCGA-95-7562-01A,TCGA-95-7562,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-75-6211,None,female,None,not reported,None,Primary Tumor,7.0,2.0,0.0,80.0,7.0,0.0,100.0,TCGA-75-6211-01A,TCGA-75-6211,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A23E,18500.0,female,1960,white,158,Primary Tumor,0.0,0.0,0.0,70.0,1.0,54.0,45.0,TCGA-AC-A23E-01A,TCGA-AC-A23E,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3E-AAAY,24760.0,male,1941,white,2017,Primary Tumor,0.0,0.0,20.0,10.0,0.0,30.0,50.0,TCGA-3E-AAAY-01A,TCGA-3E-AAAY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12X,22889.0,female,1948,asian,57,Primary Tumor,0.0,1.0,2.0,80.0,1.0,18.0,80.0,TCGA-C8-A12X-01A,TCGA-C8-A12X,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AO-A03P,19724.0,female,1949,black or african american,2414,Primary Tumor,0.0,1.0,0.0,90.0,3.0,33.0,65.0,TCGA-AO-A03P-01A,TCGA-AO-A03P,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A14O,27837.0,female,1932,white,1064,Primary Tumor,0.0,0.0,0.0,80.0,2.0,69.0,30.0,TCGA-E2-A14O-01A,TCGA-E2-A14O,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5939,31236.0,male,1923,white,None,Primary Tumor,10.0,5.0,0.0,71.0,10.0,0.0,0.0,TCGA-50-5939-01A,TCGA-50-5939,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-7227,28458.0,male,1934,white,None,Primary Tumor,None,None,0.0,60.0,None,10.0,90.0,TCGA-55-7227-01A,TCGA-55-7227,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A22E,20574.0,female,1955,white,52,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-E9-A22E-01A,TCGA-E9-A22E,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A3QA,12142.0,female,1978,white,282,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-E9-A3QA-01A,TCGA-E9-A3QA,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EO,25136.0,female,1931,white,4330,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BH-A1EO-01A,TCGA-BH-A1EO,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-8402,26934.0,female,1935,white,None,Primary Tumor,None,None,0.0,70.0,25.0,10.0,83.0,TCGA-62-8402-01A,TCGA-62-8402,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4422,24837.0,male,1940,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,89.0,TCGA-05-4422-01A,TCGA-05-4422,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XV,16971.0,female,1965,black or african american,344,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-A2-A3XV-01A,TCGA-A2-A3XV,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8090,29235.0,male,1931,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,75.0,TCGA-55-8090-01A,TCGA-55-8090,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09Z,30590.0,female,1925,not reported,728,Primary Tumor,0.0,0.0,0.0,75.0,1.0,24.0,75.0,TCGA-A8-A09Z-01A,TCGA-A8-A09Z,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-OE-A75W,27684.0,male,1938,white,49,Primary Tumor,0.0,0.0,0.0,35.0,10.0,0.0,100.0,TCGA-OE-A75W-01A,TCGA-OE-A75W,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-69-A59K,22093.0,female,1952,black or african american,130,Primary Tumor,0.0,0.0,0.0,97.0,0.0,0.0,100.0,TCGA-69-A59K-01A,TCGA-69-A59K,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A04T,22707.0,female,1942,white,1979,Primary Tumor,0.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-A2-A04T-01A,TCGA-A2-A04T,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A3XY,18059.0,female,1961,black or african american,703,Primary Tumor,0.0,0.0,0.0,70.0,0.0,35.0,60.0,TCGA-A2-A3XY-01A,TCGA-A2-A3XY,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-Z5-AAPL,27152.0,female,1939,white,220,Primary Tumor,10.0,10.0,0.0,70.0,70.0,25.0,70.0,TCGA-Z5-AAPL-01A,TCGA-Z5-AAPL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0X5,22380.0,female,1934,black or african american,5600,Primary Tumor,0.0,0.0,0.0,85.0,5.0,20.0,80.0,TCGA-B6-A0X5-01A,TCGA-B6-A0X5,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A03Y,24232.0,female,1944,white,36,Primary Tumor,0.0,1.0,0.0,90.0,1.0,30.0,68.0,TCGA-AN-A03Y-01A,TCGA-AN-A03Y,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1J2,18558.0,female,1960,black or african american,51,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-EW-A1J2-01A,TCGA-EW-A1J2,
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6987,28382.0,male,1929,white,None,Primary Tumor,None,None,0.0,65.0,None,1.0,98.0,TCGA-55-6987-01A,TCGA-55-6987,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-A46O,24050.0,female,1941,white,2349,Primary Tumor,0.0,0.0,0.0,93.0,0.0,0.0,87.0,TCGA-62-A46O-01A,TCGA-62-A46O,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-A6UF,23152.0,male,1949,white,266,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-IB-A6UF-01A,TCGA-IB-A6UF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0EA,26548.0,female,1936,white,567,Primary Tumor,0.0,2.0,40.0,8.0,5.0,43.0,15.0,TCGA-BH-A0EA-01A,TCGA-BH-A0EA,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DD,19415.0,female,1954,white,1490,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-GM-A2DD-01A,TCGA-GM-A2DD,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A740,22416.0,female,1952,black or african american,37,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-LL-A740-01A,TCGA-LL-A740,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1BD,19627.0,female,1957,white,260,Primary Tumor,0.0,0.0,0.0,90.0,0.0,15.0,85.0,TCGA-E2-A1BD-01A,TCGA-E2-A1BD,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-RB-AA9M,15807.0,male,1970,white,76,Primary Tumor,1.0,1.0,4.0,85.0,8.0,72.0,22.0,TCGA-RB-AA9M-01A,TCGA-RB-AA9M,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4398,17471.0,female,1959,not reported,None,Primary Tumor,None,None,0.0,70.0,None,10.0,None,TCGA-05-4398-01A,TCGA-05-4398,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A09R,30196.0,female,1927,not reported,149,Primary Tumor,0.0,1.0,3.0,80.0,10.0,34.0,60.0,TCGA-A8-A09R-01A,TCGA-A8-A09R,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8615,24786.0,male,1945,white,None,Primary Tumor,None,None,None,75.0,None,None,None,TCGA-55-8615-01A,TCGA-55-8615,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24K,16961.0,female,1958,white,2325,Primary Tumor,1.0,1.0,0.0,75.0,3.0,25.0,75.0,TCGA-AR-A24K-01A,TCGA-AR-A24K,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6543,None,female,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-55-6543-01A,TCGA-55-6543,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-J2-A4AG,24224.0,female,1946,white,129,Primary Tumor,5.0,3.0,0.0,65.0,3.0,0.0,100.0,TCGA-J2-A4AG-01A,TCGA-J2-A4AG,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-A7DR,17649.0,male,1964,asian,250,Primary Tumor,0.0,0.0,0.0,80.0,0.0,30.0,70.0,TCGA-FB-A7DR-01A,TCGA-FB-A7DR,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L4-A4E6,24631.0,male,1945,white,22,Primary Tumor,0.0,3.0,0.0,75.0,2.0,0.0,100.0,TCGA-L4-A4E6-01A,TCGA-L4-A4E6,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-64-1676,21428.0,male,1947,white,None,Primary Tumor,None,None,0.0,85.0,None,47.0,50.0,TCGA-64-1676-01A,TCGA-64-1676,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-AAUM,28013.0,male,1937,white,133,Primary Tumor,4.0,1.0,60.0,15.0,3.0,25.0,15.0,TCGA-IB-AAUM-01A,TCGA-IB-AAUM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0AV,19314.0,female,1956,black or african american,761,Primary Tumor,1.0,2.0,0.0,60.0,15.0,40.0,50.0,TCGA-BH-A0AV-01A,TCGA-BH-A0AV,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EX,24544.0,female,1933,white,3752,Primary Tumor,0.0,0.0,0.0,60.0,0.0,15.0,85.0,TCGA-BH-A1EX-01A,TCGA-BH-A1EX,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-86-8281,27409.0,male,1936,white,None,Primary Tumor,None,None,8.0,85.0,None,10.0,82.0,TCGA-86-8281-01A,TCGA-86-8281,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27P,23576.0,female,1947,white,37,Primary Tumor,0.0,0.0,20.0,60.0,0.0,30.0,50.0,TCGA-D8-A27P-01A,TCGA-D8-A27P,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1PD,22536.0,male,1949,white,112,Primary Tumor,1.0,1.0,5.0,70.0,3.0,25.0,70.0,TCGA-EW-A1PD-01A,TCGA-EW-A1PD,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A3IZ,22997.0,female,1949,white,86,Primary Tumor,0.0,0.0,0.0,88.0,0.0,0.0,100.0,TCGA-A7-A3IZ-01A,TCGA-A7-A3IZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A8FZ,21343.0,female,1954,white,468,Primary Tumor,20.0,20.0,5.0,70.0,40.0,25.0,70.0,TCGA-BH-A8FZ-01A,TCGA-BH-A8FZ,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-99-AA5R,25778.0,female,1943,black or african american,323,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-99-AA5R-01A,TCGA-99-AA5R,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EY,28940.0,female,1921,white,3840,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-BH-A1EY-01A,TCGA-BH-A1EY,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-A4P5,25412.0,female,1943,white,90,Primary Tumor,0.0,0.0,20.0,40.0,100.0,50.0,30.0,TCGA-FB-A4P5-01A,TCGA-FB-A4P5,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R0,21394.0,female,1953,white,44,Primary Tumor,0.0,0.0,0.0,65.0,0.0,5.0,95.0,TCGA-E9-A1R0-01A,TCGA-E9-A1R0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18R,18524.0,female,1951,white,3571,Primary Tumor,1.0,1.0,2.0,85.0,2.0,12.0,85.0,TCGA-BH-A18R-01A,TCGA-BH-A18R,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GM-A2DL,18475.0,female,1953,white,2723,Primary Tumor,0.0,0.0,0.0,80.0,1.0,35.0,62.0,TCGA-GM-A2DL-01A,TCGA-GM-A2DL,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-AARO,14527.0,female,1964,black or african american,3838,Primary Tumor,6.0,3.0,3.0,65.0,3.0,30.0,65.0,TCGA-49-AARO-01A,TCGA-49-AARO,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2L-AAQM,19315.0,male,1958,white,1091,Primary Tumor,10.0,10.0,0.0,80.0,70.0,20.0,80.0,TCGA-2L-AAQM-01A,TCGA-2L-AAQM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A03X,27163.0,female,1936,white,36,Primary Tumor,0.0,0.0,0.0,80.0,0.0,19.0,80.0,TCGA-AN-A03X-01A,TCGA-AN-A03X,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5D6,26052.0,female,1938,black or african american,1378,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-OL-A5D6-01A,TCGA-OL-A5D6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IK,23150.0,female,1931,white,5724,Primary Tumor,0.0,0.0,4.0,65.0,3.0,30.0,65.0,TCGA-B6-A0IK-01A,TCGA-B6-A0IK,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4662,23762.0,female,1942,white,None,Primary Tumor,None,None,0.0,80.0,20.0,20.0,70.0,TCGA-73-4662-01A,TCGA-73-4662,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3A-A9IO,20451.0,male,1954,white,1633,Primary Tumor,3.0,1.0,5.0,70.0,2.0,22.0,70.0,TCGA-3A-A9IO-01A,TCGA-3A-A9IO,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CW,24541.0,female,1939,white,1533,Primary Tumor,0.0,0.0,0.0,65.0,95.0,5.0,95.0,TCGA-A2-A0CW-01A,TCGA-A2-A0CW,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7649,26773.0,female,1934,not reported,None,Primary Tumor,15.0,5.0,13.0,53.0,15.0,13.0,74.0,TCGA-IB-7649-01A,TCGA-IB-7649,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0EB,25259.0,female,1939,white,552,Primary Tumor,15.0,10.0,1.0,85.0,10.0,12.0,85.0,TCGA-BH-A0EB-01A,TCGA-BH-A0EB,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IF,27341.0,female,1934,white,932,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-E2-A1IF-01A,TCGA-E2-A1IF,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12Z,16508.0,female,1965,asian,69,Primary Tumor,20.0,20.0,0.0,60.0,40.0,30.0,60.0,TCGA-C8-A12Z-01A,TCGA-C8-A12Z,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IN,16705.0,female,1951,white,5073,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-B6-A0IN-01A,TCGA-B6-A0IN,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-AA0Z,23314.0,female,1950,black or african american,204,Primary Tumor,0.0,0.0,2.0,90.0,2.0,8.0,90.0,TCGA-S3-AA0Z-01A,TCGA-S3-AA0Z,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AM,19123.0,female,1954,white,1506,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-AR-A1AM-01A,TCGA-AR-A1AM,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-L9-A743,20780.0,male,1957,black or african american,97,Primary Tumor,20.0,20.0,0.0,75.0,40.0,25.0,75.0,TCGA-L9-A743-01A,TCGA-L9-A743,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-MP-A4TH,25759.0,female,1942,white,78,Primary Tumor,0.0,4.0,0.0,70.0,40.0,30.0,70.0,TCGA-MP-A4TH-01A,TCGA-MP-A4TH,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0W5,28304.0,female,1931,white,906,Primary Tumor,0.0,0.0,15.0,80.0,100.0,25.0,60.0,TCGA-BH-A0W5-01A,TCGA-BH-A0W5,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-3E-AAAZ,26234.0,male,1937,white,2095,Primary Tumor,20.0,20.0,0.0,60.0,40.0,40.0,60.0,TCGA-3E-AAAZ-01A,TCGA-3E-AAAZ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24N,19989.0,female,1951,white,2219,Primary Tumor,1.0,1.0,0.0,85.0,2.0,14.0,85.0,TCGA-AR-A24N-01A,TCGA-AR-A24N,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A248,18684.0,female,1960,white,52,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E9-A248-01A,TCGA-E9-A248,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-AAPQ,24078.0,male,1943,white,2156,Primary Tumor,10.0,10.0,0.0,40.0,70.0,60.0,40.0,TCGA-FB-AAPQ-01A,TCGA-FB-AAPQ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7542,20763.0,male,1937,white,None,Primary Tumor,0.0,2.0,0.0,80.0,5.0,0.0,81.0,TCGA-78-7542-01A,TCGA-78-7542,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A08G,14976.0,female,1968,not reported,422,Primary Tumor,0.0,0.0,1.0,85.0,2.0,14.0,85.0,TCGA-A8-A08G-01A,TCGA-A8-A08G,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FO,23928.0,female,1940,white,2051,Primary Tumor,0.0,0.0,30.0,60.0,10.0,19.0,50.0,TCGA-AC-A2FO-01A,TCGA-AC-A2FO,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7145,19080.0,female,1948,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,75.0,TCGA-78-7145-01A,TCGA-78-7145,4.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-2J-AABR,22131.0,female,1953,white,243,Primary Tumor,0.0,0.0,65.0,20.0,8.0,0.0,35.0,TCGA-2J-AABR-01A,TCGA-2J-AABR,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AN-A0AT,22798.0,female,1948,white,28,Primary Tumor,0.0,0.0,1.0,75.0,18.0,12.0,57.0,TCGA-AN-A0AT-01A,TCGA-AN-A0AT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0CU,26823.0,female,1932,white,1911,Primary Tumor,0.0,0.0,5.0,85.0,0.0,15.0,80.0,TCGA-A2-A0CU-01A,TCGA-A2-A0CU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A1PH,19073.0,female,1958,white,77,Primary Tumor,1.0,1.0,0.0,85.0,2.0,13.0,85.0,TCGA-EW-A1PH-01A,TCGA-EW-A1PH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-S3-AA15,18659.0,female,1962,black or african american,93,Primary Tumor,20.0,20.0,5.0,60.0,40.0,35.0,60.0,TCGA-S3-AA15-01A,TCGA-S3-AA15,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R3,25693.0,female,1940,white,80,Primary Tumor,0.0,0.0,0.0,82.0,0.0,0.0,100.0,TCGA-E9-A1R3-01A,TCGA-E9-A1R3,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4505,22628.0,female,1935,white,None,Primary Tumor,None,None,0.0,75.0,None,15.0,85.0,TCGA-49-4505-01A,TCGA-49-4505,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-OL-A5D7,25643.0,female,1939,black or african american,1415,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,90.0,TCGA-OL-A5D7-01A,TCGA-OL-A5D7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18Q,20675.0,female,1945,white,3417,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-BH-A18Q-01A,TCGA-BH-A18Q,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A27W,20173.0,female,1956,white,43,Primary Tumor,0.0,0.0,0.0,70.0,0.0,60.0,40.0,TCGA-D8-A27W-01A,TCGA-D8-A27W,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12P,20332.0,female,1955,asian,57,Primary Tumor,1.0,2.0,0.0,70.0,2.0,28.0,70.0,TCGA-C8-A12P-01A,TCGA-C8-A12P,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JD,15166.0,female,1969,white,230,Primary Tumor,0.0,0.0,0.0,70.0,0.0,5.0,95.0,TCGA-D8-A1JD-01A,TCGA-D8-A1JD,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-C8-A12N,21428.0,female,1952,asian,57,Primary Tumor,0.0,0.0,0.0,80.0,0.0,10.0,90.0,TCGA-C8-A12N-01A,TCGA-C8-A12N,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0IQ,14669.0,female,1956,white,5238,Primary Tumor,0.0,0.0,0.0,85.0,1.0,15.0,85.0,TCGA-B6-A0IQ-01A,TCGA-B6-A0IQ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1JL,26484.0,female,1938,white,264,Primary Tumor,1.0,1.0,0.0,85.0,2.0,13.0,85.0,TCGA-D8-A1JL-01A,TCGA-D8-A1JL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A247,21562.0,female,1952,white,49,Primary Tumor,0.0,0.0,15.0,90.0,0.0,0.0,85.0,TCGA-E9-A247-01A,TCGA-E9-A247,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0EI,18741.0,female,1957,white,541,Primary Tumor,0.0,2.0,0.0,60.0,25.0,63.0,35.0,TCGA-BH-A0EI-01A,TCGA-BH-A0EI,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A201,23423.0,female,1947,white,86,Primary Tumor,0.0,0.0,5.0,65.0,0.0,30.0,65.0,TCGA-BH-A201-01A,TCGA-BH-A201,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A2-A0EU,29144.0,female,1929,white,644,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-A2-A0EU-01A,TCGA-A2-A0EU,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A2LJ,14723.0,female,1967,white,1382,Primary Tumor,0.0,0.0,10.0,70.0,1.0,50.0,40.0,TCGA-AR-A2LJ-01A,TCGA-AR-A2LJ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A24L,9706.0,female,1979,white,2275,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-AR-A24L-01A,TCGA-AR-A24L,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-62-8395,29311.0,female,1929,white,None,Primary Tumor,None,3.0,0.0,80.0,2.0,3.0,96.0,TCGA-62-8395-01A,TCGA-62-8395,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A3DX,15969.0,female,1968,white,142,Primary Tumor,0.0,0.0,5.0,60.0,10.0,65.0,30.0,TCGA-E2-A3DX-01A,TCGA-E2-A3DX,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-8506,22850.0,female,1950,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-55-8506-01A,TCGA-55-8506,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-EW-A2FR,21628.0,female,1949,black or african american,1015,Primary Tumor,0.0,0.0,0.0,75.0,10.0,38.0,60.0,TCGA-EW-A2FR-01A,TCGA-EW-A2FR,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N4,15055.0,female,1969,white,65,Primary Tumor,0.0,0.0,2.0,80.0,2.0,33.0,65.0,TCGA-E9-A1N4-01A,TCGA-E9-A1N4,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XW,19478.0,female,1958,white,76,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-D8-A1XW-01A,TCGA-D8-A1XW,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A8-A0A4,26693.0,female,1936,not reported,272,Primary Tumor,0.0,0.0,0.0,80.0,1.0,19.0,80.0,TCGA-A8-A0A4-01A,TCGA-A8-A0A4,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A6VX,25066.0,female,1945,black or african american,73,Primary Tumor,1.0,1.0,20.0,60.0,5.0,20.0,60.0,TCGA-A7-A6VX-01A,TCGA-A7-A6VX,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-IB-7886,29319.0,male,1930,white,None,Primary Tumor,None,None,0.0,60.0,None,30.0,68.0,TCGA-IB-7886-01A,TCGA-IB-7886,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AR-A1AR,18482.0,female,1957,white,1416,Primary Tumor,0.0,0.0,0.0,90.0,0.0,20.0,80.0,TCGA-AR-A1AR-01A,TCGA-AR-A1AR,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-D8-A1XM,21056.0,female,1953,white,189,Primary Tumor,0.0,0.0,0.0,65.0,5.0,48.0,50.0,TCGA-D8-A1XM-01A,TCGA-D8-A1XM,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-LL-A50Y,30934.0,female,1928,white,91,Primary Tumor,0.0,0.0,2.0,80.0,100.0,40.0,58.0,TCGA-LL-A50Y-01A,TCGA-LL-A50Y,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-B6-A0I5,18038.0,female,1939,white,7820,Primary Tumor,0.0,0.0,3.0,80.0,1.0,17.0,80.0,TCGA-B6-A0I5-01A,TCGA-B6-A0I5,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-FB-A545,26635.0,female,1940,white,65,Primary Tumor,0.0,10.0,0.0,100.0,6.0,65.0,35.0,TCGA-FB-A545-01A,TCGA-FB-A545,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-05-4249,24532.0,male,1940,not reported,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-05-4249-01A,TCGA-05-4249,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A23H,32872,female,1919,white,478,Primary Tumor,0.0,0.0,0.0,85.0,1.0,25.0,75.0,TCGA-AC-A23H-01A,TCGA-AC-A23H,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15C,22583.0,female,1948,white,393,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-E2-A15C-01A,TCGA-E2-A15C,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-78-7152,23782.0,male,1938,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,70.0,TCGA-78-7152-01A,TCGA-78-7152,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GV-A3JW,27091.0,male,1937,white,168,Primary Tumor,0.0,0.0,0.0,90.0,3.0,0.0,95.0,TCGA-GV-A3JW-01A,TCGA-GV-A3JW,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-4723,24815.0,male,1943,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,87.0,TCGA-CN-4723-01A,TCGA-CN-4723,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6942,26941.0,female,1927,white,None,Primary Tumor,10.0,0.0,0.0,71.0,10.0,26.0,73.0,TCGA-CV-6942-01A,TCGA-CV-6942,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-SX-A7SO,23534.0,male,1947,white,875,Primary Tumor,0.0,1.0,0.0,80.0,1.0,0.0,100.0,TCGA-SX-A7SO-01A,TCGA-SX-A7SO,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-RS-A6TP,21393.0,male,1955,white,117,Primary Tumor,3.0,2.0,0.0,80.0,10.0,20.0,75.0,TCGA-RS-A6TP-01A,TCGA-RS-A6TP,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-EV-5901,17275.0,female,1963,white,None,Primary Tumor,None,None,0.0,80.0,None,12.0,88.0,TCGA-EV-5901-01A,TCGA-EV-5901,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5893,22320.0,male,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-BQ-5893-01A,TCGA-BQ-5893,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CN-5374,20464.0,female,1951,white,None,Primary Tumor,None,None,10.0,75.0,None,10.0,80.0,TCGA-CN-5374-01A,TCGA-CN-5374,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-A463,30095.0,female,1925,white,1772,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,80.0,TCGA-CV-A463-01A,TCGA-CV-A463,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5887,19747.0,male,1955,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-BQ-5887-01A,TCGA-BQ-5887,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-LN-A8I0,19328.0,male,1961,asian,171,Primary Tumor,3.0,3.0,0.0,65.0,20.0,60.0,25.0,TCGA-LN-A8I0-01A,TCGA-LN-A8I0,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-F7-A620,17475.0,male,1965,white,139,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-F7-A620-01A,TCGA-F7-A620,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-2H-A9GN,25664.0,male,1930,not reported,4883,Primary Tumor,2.0,1.0,0.0,90.0,6.0,20.0,77.0,TCGA-2H-A9GN-01A,TCGA-2H-A9GN,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CR-7379,28763.0,female,1931,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,90.0,TCGA-CR-7379-01A,TCGA-CR-7379,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-BA-6872,17296.0,male,1957,white,None,Primary Tumor,None,None,0.0,95.0,2.0,8.0,90.0,TCGA-BA-6872-01A,TCGA-BA-6872,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-UF-A7JO,28951.0,female,1930,white,1658,Primary Tumor,0.0,0.0,0.0,60.0,0.0,40.0,55.0,TCGA-UF-A7JO-01A,TCGA-UF-A7JO,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-A6I0,20491.0,male,1957,white,105,Primary Tumor,0.0,0.0,10.0,75.0,5.0,15.0,75.0,TCGA-HD-A6I0-01A,TCGA-HD-A6I0,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CF-A27C,19270.0,male,1959,asian,79,Primary Tumor,1.0,0.0,0.0,95.0,1.0,12.0,84.0,TCGA-CF-A27C-01A,TCGA-CF-A27C,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N7-A59B,25360.0,female,1943,white,122,Primary Tumor,40.0,20.0,0.0,90.0,20.0,0.0,90.0,TCGA-N7-A59B-01A,TCGA-N7-A59B,1.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N7-A4Y5,32058.0,female,1918,white,2744,Primary Tumor,0.0,0.0,0.0,100.0,0.0,5.0,95.0,TCGA-N7-A4Y5-01A,TCGA-N7-A4Y5,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B1-A657,19806.0,male,1958,white,355,Primary Tumor,0.0,5.0,0.0,80.0,3.0,20.0,80.0,TCGA-B1-A657-01A,TCGA-B1-A657,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6436,22885.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CV-6436-01A,TCGA-CV-6436,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-JY-A93C,17228.0,male,1964,asian,1035,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-JY-A93C-01A,TCGA-JY-A93C,3.0
UCS,Uterine Carcinosarcoma,Uterus,TCGA-N5-A4RD,25413.0,female,1938,white,2157,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,80.0,TCGA-N5-A4RD-01A,TCGA-N5-A4RD,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-A5W7,17465.0,male,1965,black or african american,215,Primary Tumor,0.0,2.0,0.0,75.0,3.0,0.0,100.0,TCGA-B9-A5W7-01A,TCGA-B9-A5W7,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-IQ-A6SH,20109.0,male,1958,black or african american,51,Primary Tumor,0.0,0.0,0.0,75.0,10.0,25.0,75.0,TCGA-IQ-A6SH-01A,TCGA-IQ-A6SH,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-Z6-AAPN,20926.0,male,1956,white,181,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-Z6-AAPN-01A,TCGA-Z6-AAPN,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-EB-A4P0,30225.0,male,1930,white,112,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,98.0,TCGA-EB-A4P0-01A,TCGA-EB-A4P0,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-18-5592,21020.0,male,1953,not reported,None,Primary Tumor,None,None,90.0,10.0,None,0.0,10.0,TCGA-18-5592-01A,TCGA-18-5592,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5491,27145.0,male,1929,white,None,Primary Tumor,1.0,1.0,13.0,80.0,10.0,0.0,74.0,TCGA-22-5491-01A,TCGA-22-5491,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-A46M,22592.0,male,1949,white,686,Primary Tumor,2.0,3.0,0.0,80.0,5.0,25.0,67.0,TCGA-58-A46M-01A,TCGA-58-A46M,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-A50M,17429.0,male,1965,asian,113,Primary Tumor,0.0,5.0,10.0,60.0,7.0,30.0,60.0,TCGA-85-A50M-01A,TCGA-85-A50M,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2704,26927.0,male,1930,white,None,Primary Tumor,None,None,2.0,60.0,None,15.0,62.0,TCGA-60-2704-01A,TCGA-60-2704,2.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-FR-A3R1,25271.0,male,1942,white,126,Primary Tumor,0.0,0.0,0.0,90.0,0.0,65.0,30.0,TCGA-FR-A3R1-01A,TCGA-FR-A3R1,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8479,24350.0,male,1946,white,None,Primary Tumor,10.0,None,0.0,75.0,10.0,15.0,80.0,TCGA-85-8479-01A,TCGA-85-8479,1.0
UVM,Uveal Melanoma,Eye,TCGA-VD-AA8N,31475.0,male,1927,not reported,118,Primary Tumor,0.0,0.0,0.0,80.0,1.0,0.0,100.0,TCGA-VD-AA8N-01A,TCGA-VD-AA8N,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-8052,19671.0,male,1958,white,None,Primary Tumor,0.0,0.0,10.0,70.0,5.0,0.0,80.0,TCGA-85-8052-01A,TCGA-85-8052,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8434,23934.0,female,1944,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-KN-8434-01A,TCGA-KN-8434,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-A56V,22475.0,male,1951,black or african american,27,Primary Tumor,1.0,5.0,0.0,80.0,10.0,30.0,67.0,TCGA-43-A56V-01A,TCGA-43-A56V,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-AASD,30623.0,male,1918,black or african american,4641,Primary Tumor,0.0,0.0,0.0,90.0,5.0,36.0,60.0,TCGA-33-AASD-01A,TCGA-33-AASD,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A036,26206.0,male,1931,not reported,2773,Primary Tumor,2.0,1.0,0.0,85.0,7.0,18.0,80.0,TCGA-AG-A036-01A,TCGA-AG-A036,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5585,18898.0,male,1952,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CW-5585-01A,TCGA-CW-5585,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5677,19849.0,female,1950,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,80.0,TCGA-CJ-5677-01A,TCGA-CJ-5677,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6093,26909.0,male,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CW-6093-01A,TCGA-CW-6093,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4787,21697.0,female,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,80.0,TCGA-BP-4787-01A,TCGA-BP-4787,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0646,22273.0,male,1947,white,None,Primary Tumor,None,None,0.0,90.0,None,30.0,60.0,TCGA-06-0646-01A,TCGA-06-0646,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4991,19739.0,male,1953,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4991-01A,TCGA-BP-4991,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5458,15790.0,male,1963,white,None,Primary Tumor,0.0,0.0,0.0,90.0,2.0,5.0,95.0,TCGA-CZ-5458-01A,TCGA-CZ-5458,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3887,24960.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,80.0,None,8.0,82.0,TCGA-AG-3887-01A,TCGA-AG-3887,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-12-3652,21920.0,male,1943,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,80.0,TCGA-12-3652-01A,TCGA-12-3652,
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3896,31046.0,female,1924,not reported,None,Primary Tumor,None,None,40.0,65.0,None,5.0,47.0,TCGA-AG-3896-01A,TCGA-AG-3896,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4882,21074.0,male,1948,black or african american,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-CJ-4882-01A,TCGA-CJ-4882,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-A01J,21581.0,female,1950,not reported,173,Primary Tumor,2.0,1.0,20.0,70.0,6.0,18.0,60.0,TCGA-AG-A01J-01A,TCGA-AG-A01J,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5075,28205.0,female,1928,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,85.0,TCGA-B0-5075-01A,TCGA-B0-5075,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-A54I,17722.0,male,1964,black or african american,138,Primary Tumor,0.0,0.0,0.0,85.0,0.0,50.0,50.0,TCGA-B8-A54I-01A,TCGA-B8-A54I,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3380,19828.0,male,1953,not reported,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-A3-3380-01A,TCGA-A3-3380,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2Z,10659.0,female,1981,white,1178,Primary Tumor,0.0,0.0,0.0,85.0,4.0,75.0,23.0,TCGA-W5-AA2Z-01A,TCGA-W5-AA2Z,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-MM-A84U,21375.0,female,1955,black or african american,178,Primary Tumor,0.0,2.0,0.0,80.0,2.0,0.0,100.0,TCGA-MM-A84U-01A,TCGA-MM-A84U,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4352,27253.0,female,1933,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-BP-4352-01A,TCGA-BP-4352,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6683,15918.0,male,1968,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,72.0,TCGA-DC-6683-01A,TCGA-DC-6683,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5469,15242.0,male,1966,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,10.0,75.0,TCGA-CZ-5469-01A,TCGA-CZ-5469,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5694,26060.0,male,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-5694-01A,TCGA-B0-5694,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5006,22324.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-5006-01A,TCGA-BP-5006,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-0645,20449.0,female,1952,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,80.0,TCGA-06-0645-01A,TCGA-06-0645,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3451,17859.0,male,1958,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-AK-3451-01A,TCGA-AK-3451,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-28-2514,16737.0,male,1964,asian,None,Primary Tumor,None,None,0.0,80.0,None,0.0,93.0,TCGA-28-2514-01A,TCGA-28-2514,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4893,27885.0,female,1929,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-CJ-4893-01A,TCGA-CJ-4893,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4700,22034.0,male,1944,white,None,Primary Tumor,None,None,0.0,70.0,None,15.0,60.0,TCGA-B0-4700-01A,TCGA-B0-4700,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4798,27335.0,male,1933,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,100.0,TCGA-BP-4798-01A,TCGA-BP-4798,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5106,23547.0,male,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,70.0,TCGA-B0-5106-01A,TCGA-B0-5106,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W6-AA0S,16951.0,female,1967,white,235,Primary Tumor,0.0,0.0,0.0,65.0,2.0,0.0,100.0,TCGA-W6-AA0S-01A,TCGA-W6-AA0S,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4899,15637.0,male,1964,asian,None,Primary Tumor,None,None,0.0,80.0,None,25.0,75.0,TCGA-CJ-4899-01A,TCGA-CJ-4899,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3306,24569.0,male,1938,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-A3-3306-01A,TCGA-A3-3306,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-3Z-A93Z,25205.0,male,1944,black or african american,134,Primary Tumor,1.0,1.0,0.0,92.0,3.0,10.0,72.0,TCGA-3Z-A93Z-01A,TCGA-3Z-A93Z,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4870,21340.0,female,1946,black or african american,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CJ-4870-01A,TCGA-CJ-4870,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4355,21642.0,female,1949,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-4355-01A,TCGA-BP-4355,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4864,31557.0,male,1916,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-CZ-4864-01A,TCGA-CZ-4864,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-EI-6885,21140.0,female,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,30.0,65.0,TCGA-EI-6885-01A,TCGA-EI-6885,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-T7-A92I,17331.0,female,1966,black or african american,112,Primary Tumor,0.0,0.0,0.0,85.0,3.0,15.0,85.0,TCGA-T7-A92I-01A,TCGA-T7-A92I,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-DV-5576,20310.0,female,1953,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,40.0,60.0,TCGA-DV-5576-01A,TCGA-DV-5576,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4863,18730.0,female,1955,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CZ-4863-01A,TCGA-CZ-4863,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3352,None,male,1931,white,None,Primary Tumor,None,None,0.0,85.0,None,30.0,70.0,TCGA-A3-3352-01A,TCGA-A3-3352,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6464,28168.0,female,1934,white,None,Primary Tumor,2.0,0.0,0.0,75.0,5.0,0.0,98.0,TCGA-F5-6464-01A,TCGA-F5-6464,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3902,22492.0,male,1946,not reported,None,Primary Tumor,None,None,15.0,70.0,None,10.0,67.0,TCGA-AG-3902-01A,TCGA-AG-3902,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-A6NN,28689.0,male,1934,black or african american,483,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-A3-A6NN-01A,TCGA-A3-A6NN,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4817,29873.0,male,1921,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,85.0,TCGA-B0-4817-01A,TCGA-B0-4817,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AH-6644,26892.0,male,1937,white,None,Primary Tumor,None,None,0.0,75.0,None,25.0,60.0,TCGA-AH-6644-01A,TCGA-AH-6644,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4876,20993.0,male,1947,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-CJ-4876-01A,TCGA-CJ-4876,2.0
GBM,Glioblastoma Multiforme,Brain,TCGA-12-0618,18071.0,male,1954,white,None,Primary Tumor,None,None,0.0,100.0,None,0.0,90.0,TCGA-12-0618-01A,TCGA-12-0618,
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZH-A8Y1,27279.0,female,1938,white,426,Primary Tumor,0.0,0.0,0.0,60.0,3.0,0.0,100.0,TCGA-ZH-A8Y1-01A,TCGA-ZH-A8Y1,4.0
GBM,Glioblastoma Multiforme,Brain,TCGA-27-2526,28977.0,female,1928,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-27-2526-01A,TCGA-27-2526,
GBM,Glioblastoma Multiforme,Brain,TCGA-06-5410,26395.0,female,1938,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,98.0,TCGA-06-5410-01A,TCGA-06-5410,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5001,15858.0,female,1964,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,90.0,TCGA-BP-5001-01A,TCGA-BP-5001,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-MM-A563,15037.0,male,1971,black or african american,137,Primary Tumor,0.0,100.0,0.0,90.0,0.0,20.0,80.0,TCGA-MM-A563-01A,TCGA-MM-A563,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5691,24120.0,female,1936,white,None,Primary Tumor,None,None,15.0,80.0,None,10.0,75.0,TCGA-B0-5691-01A,TCGA-B0-5691,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3461,26464.0,male,1935,white,None,Primary Tumor,None,None,10.0,73.0,None,5.0,85.0,TCGA-AK-3461-01A,TCGA-AK-3461,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DC-6157,17807.0,male,1961,black or african american,None,Primary Tumor,None,None,3.0,80.0,None,15.0,77.0,TCGA-DC-6157-01A,TCGA-DC-6157,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-DY-A1H8,28459.0,female,1923,white,4005,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-DY-A1H8-01A,TCGA-DY-A1H8,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3343,28930.0,male,1926,white,None,Primary Tumor,0.0,0.0,0.0,80.0,15.0,10.0,90.0,TCGA-A3-3343-01A,TCGA-A3-3343,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4860,22115.0,male,1945,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-CZ-4860-01A,TCGA-CZ-4860,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4845,25582.0,male,1933,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-B0-4845-01A,TCGA-B0-4845,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5835,23408.0,female,1946,white,None,Primary Tumor,0.0,0.0,0.0,80.0,5.0,20.0,80.0,TCGA-B4-5835-01A,TCGA-B4-5835,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3460,21281.0,male,1949,white,None,Primary Tumor,None,None,3.0,70.0,None,2.0,95.0,TCGA-AK-3460-01A,TCGA-AK-3460,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3447,30676.0,male,1923,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-AK-3447-01A,TCGA-AK-3447,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5690,19685.0,female,1951,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,90.0,TCGA-B0-5690-01A,TCGA-B0-5690,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4718,20910.0,male,1953,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-B0-4718-01A,TCGA-B0-4718,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-F5-6814,20828.0,male,1954,white,None,Primary Tumor,None,None,0.0,75.0,None,5.0,90.0,TCGA-F5-6814-01A,TCGA-F5-6814,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3307,24315.0,male,1939,not reported,None,Primary Tumor,None,None,10.0,90.0,None,5.0,85.0,TCGA-A3-3307-01A,TCGA-A3-3307,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B4-5844,22409.0,female,1949,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-B4-5844-01A,TCGA-B4-5844,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4770,26824.0,female,1932,white,None,Primary Tumor,0.0,0.0,0.0,95.0,1.0,0.0,100.0,TCGA-BP-4770-01A,TCGA-BP-4770,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-4872,18862.0,male,1953,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-CJ-4872-01A,TCGA-CJ-4872,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-5198,26360.0,male,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,45.0,45.0,TCGA-BP-5198-01A,TCGA-BP-5198,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3728,26906.0,male,1933,not reported,None,Primary Tumor,None,None,45.0,50.0,None,8.0,45.0,TCGA-AG-3728-01A,TCGA-AG-3728,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4347,27146.0,male,1932,white,None,Primary Tumor,None,None,0.0,85.0,None,5.0,95.0,TCGA-BP-4347-01A,TCGA-BP-4347,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4165,23685.0,female,1938,white,None,Primary Tumor,None,None,0.0,90.0,None,5.0,95.0,TCGA-BP-4165-01A,TCGA-BP-4165,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4993,21407.0,male,1949,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-BP-4993-01A,TCGA-BP-4993,1.0
GBM,Glioblastoma Multiforme,Brain,TCGA-06-2557,27980.0,male,1932,black or african american,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-06-2557-01A,TCGA-06-2557,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4994,19946.0,male,1953,white,None,Primary Tumor,None,None,5.0,85.0,None,10.0,85.0,TCGA-BP-4994-01A,TCGA-BP-4994,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-EU-5904,17468.0,female,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-EU-5904-01A,TCGA-EU-5904,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4766,15799.0,female,1961,white,None,Primary Tumor,None,None,None,95.0,1.0,5.0,95.0,TCGA-BP-4766-01A,TCGA-BP-4766,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-G6-A5PC,20029.0,female,1958,black or african american,295,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-G6-A5PC-01A,TCGA-G6-A5PC,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3591,24167.0,female,1941,not reported,None,Primary Tumor,None,None,0.0,85.0,None,5.0,92.0,TCGA-AG-3591-01A,TCGA-AG-3591,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-BP-4789,17540.0,male,1959,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,95.0,TCGA-BP-4789-01A,TCGA-BP-4789,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2G,22933.0,female,1946,white,2087,Primary Tumor,0.0,0.0,0.0,70.0,2.0,0.0,100.0,TCGA-W5-AA2G-01A,TCGA-W5-AA2G,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-AK-3431,22852.0,female,1942,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-AK-3431-01A,TCGA-AK-3431,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-VV-A829,16163.0,male,1967,white,720,Primary Tumor,0.0,0.0,5.0,80.0,0.0,45.0,50.0,TCGA-VV-A829-01A,TCGA-VV-A829,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A89Z,14858.0,male,1973,white,63,Primary Tumor,0.0,0.0,5.0,90.0,0.0,35.0,60.0,TCGA-S9-A89Z-01A,TCGA-S9-A89Z,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5F0,12157.0,male,1979,white,62,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-P5-A5F0-01A,TCGA-P5-A5F0,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-5305,12655.0,male,1966,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-E1-5305-01A,TCGA-E1-5305,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A61C,24276.0,male,1947,white,56,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-HT-A61C-01A,TCGA-HT-A61C,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A781,12757.0,female,1979,white,86,Primary Tumor,0.0,0.0,10.0,70.0,0.0,70.0,20.0,TCGA-P5-A781-01A,TCGA-P5-A781,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A6S2,13597.0,female,1976,black or african american,153,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-DU-A6S2-01A,TCGA-DU-A6S2,
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A40R,8963.0,female,1987,white,363,Primary Tumor,0.0,0.0,0.0,95.0,1.0,25.0,75.0,TCGA-ET-A40R-01A,TCGA-ET-A40R,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7T6,26766.0,female,1929,white,4265,Primary Tumor,0.0,0.0,30.0,60.0,0.0,40.0,30.0,TCGA-DU-A7T6-01A,TCGA-DU-A7T6,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UP,13899.0,female,1973,not reported,148,Primary Tumor,1.0,1.0,0.0,75.0,4.0,21.0,75.0,TCGA-DJ-A3UP-01A,TCGA-DJ-A3UP,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A4KQ,16685.0,female,1967,white,51,Primary Tumor,1.0,1.0,3.0,70.0,3.0,27.0,70.0,TCGA-ET-A4KQ-01A,TCGA-ET-A4KQ,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UV,6850.0,female,1992,white,475,Primary Tumor,0.0,0.0,35.0,75.0,0.0,0.0,65.0,TCGA-DJ-A3UV-01A,TCGA-DJ-A3UV,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4V0,13168.0,female,1976,asian,236,Primary Tumor,0.0,1.0,2.0,75.0,2.0,23.0,75.0,TCGA-DJ-A4V0-01A,TCGA-DJ-A4V0,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7011,9322.0,male,1975,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-DU-7011-01A,TCGA-DU-7011,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6CY,14140.0,male,1975,white,18,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-QH-A6CY-01A,TCGA-QH-A6CY,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZC,20282.0,male,1955,white,128,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-BJ-A0ZC-01A,TCGA-BJ-A0ZC,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3SX,10447.0,female,1983,not reported,183,Primary Tumor,0.0,1.0,0.0,100.0,0.0,30.0,70.0,TCGA-EM-A3SX-01A,TCGA-EM-A3SX,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13V,7915.0,female,1989,not reported,154,Primary Tumor,0.0,0.0,0.0,95.0,0.0,15.0,85.0,TCGA-DJ-A13V-01A,TCGA-DJ-A13V,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A2QD,22491.0,female,1950,black or african american,170,Primary Tumor,0.0,0.0,0.0,95.0,1.0,0.0,100.0,TCGA-FY-A2QD-01A,TCGA-FY-A2QD,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0ZJ,13149.0,male,1974,white,124,Primary Tumor,0.0,0.0,0.0,80.0,10.0,20.0,80.0,TCGA-BJ-A0ZJ-01A,TCGA-BJ-A0ZJ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-VM-A8C9,13663.0,female,1974,not reported,847,Primary Tumor,0.0,0.0,10.0,80.0,0.0,60.0,30.0,TCGA-VM-A8C9-01A,TCGA-VM-A8C9,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A4M9,10384.0,male,1984,white,43,Primary Tumor,0.0,0.0,0.0,100.0,1.0,20.0,80.0,TCGA-DE-A4M9-01A,TCGA-DE-A4M9,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FH,25500.0,male,1942,not reported,353,Primary Tumor,0.0,1.0,0.0,80.0,2.0,0.0,100.0,TCGA-EM-A4FH-01A,TCGA-EM-A4FH,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FJ,9042.0,female,1986,not reported,500,Primary Tumor,0.0,0.0,0.0,100.0,2.0,40.0,60.0,TCGA-EM-A3FJ-01A,TCGA-EM-A3FJ,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A191,18162.0,female,1961,white,30,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-BJ-A191-01A,TCGA-BJ-A191,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DQ,15871.0,female,1965,white,1351,Primary Tumor,0.0,0.0,25.0,65.0,0.0,10.0,65.0,TCGA-ET-A3DQ-01A,TCGA-ET-A3DQ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-4942,16297.0,female,1962,black or african american,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-CS-4942-01A,TCGA-CS-4942,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YD,21020.0,male,1941,white,5445,Primary Tumor,0.0,0.0,5.0,90.0,0.0,45.0,50.0,TCGA-E1-A7YD-01A,TCGA-E1-A7YD,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GW,13670.0,female,1972,white,919,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EL-A3GW-01A,TCGA-EL-A3GW,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A3YE,11446.0,female,1979,white,856,Primary Tumor,0.0,1.0,0.0,100.0,0.0,20.0,80.0,TCGA-J8-A3YE-01A,TCGA-J8-A3YE,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-6691,8403.0,female,1988,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-FG-6691-01A,TCGA-FG-6691,
LGG,Brain Lower Grade Glioma,Brain,TCGA-VM-A8CF,16334.0,female,1969,white,280,Primary Tumor,0.0,0.0,5.0,90.0,0.0,50.0,45.0,TCGA-VM-A8CF-01A,TCGA-VM-A8CF,
THCA,Thyroid Carcinoma,Thyroid,TCGA-CE-A481,15268.0,female,1970,asian,269,Primary Tumor,0.0,1.0,0.0,100.0,1.0,15.0,85.0,TCGA-CE-A481-01A,TCGA-CE-A481,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84F,17744.0,male,1961,white,1471,Primary Tumor,0.0,0.0,10.0,80.0,0.0,45.0,45.0,TCGA-TM-A84F-01A,TCGA-TM-A84F,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FN,18185.0,female,1963,not reported,241,Primary Tumor,0.0,1.0,0.0,80.0,2.0,25.0,75.0,TCGA-EM-A4FN-01A,TCGA-EM-A4FN,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7694,21930.0,male,1948,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-HT-7694-01A,TCGA-HT-7694,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-8186,15431.0,female,1969,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-FG-8186-01A,TCGA-FG-8186,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3MZ,24208.0,male,1932,white,5035,Primary Tumor,0.0,1.0,0.0,100.0,0.0,50.0,50.0,TCGA-EL-A3MZ-01A,TCGA-EL-A3MZ,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-7637,18084.0,male,1960,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-FG-7637-01A,TCGA-FG-7637,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A4FF,14796.0,female,1966,not reported,2135,Primary Tumor,0.0,2.0,0.0,75.0,4.0,40.0,60.0,TCGA-EM-A4FF-01A,TCGA-EM-A4FF,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7TG,14671.0,male,1968,white,1804,Primary Tumor,0.0,0.0,20.0,70.0,0.0,40.0,40.0,TCGA-DU-A7TG-01A,TCGA-DU-A7TG,
LGG,Brain Lower Grade Glioma,Brain,TCGA-W9-A837,None,male,1963,white,1298,Primary Tumor,0.0,0.0,10.0,85.0,0.0,45.0,45.0,TCGA-W9-A837-01A,TCGA-W9-A837,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A7UV,18161.0,male,1964,white,69,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-DH-A7UV-01A,TCGA-DH-A7UV,
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A291,20682.0,female,1954,white,380,Primary Tumor,0.0,0.0,0.0,92.0,0.0,0.0,100.0,TCGA-BJ-A291-01A,TCGA-BJ-A291,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VM,24896.0,female,1943,white,379,Primary Tumor,0.0,0.0,3.0,97.0,2.0,27.0,70.0,TCGA-DJ-A3VM-01A,TCGA-DJ-A3VM,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A39I,30349.0,female,1924,white,1442,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-ET-A39I-01A,TCGA-ET-A39I,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A25K,13351.0,female,1973,white,720,Primary Tumor,0.0,0.0,0.0,85.0,0.0,5.0,95.0,TCGA-ET-A25K-01A,TCGA-ET-A25K,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZT,13103.0,male,1973,white,1311,Primary Tumor,0.0,0.0,0.0,80.0,3.0,20.0,80.0,TCGA-EL-A3ZT-01A,TCGA-EL-A3ZT,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-5390,17460.0,female,1958,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-CS-5390-01A,TCGA-CS-5390,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4UW,12563.0,female,1978,asian,232,Primary Tumor,1.0,1.0,0.0,75.0,2.0,25.0,75.0,TCGA-DJ-A4UW-01A,TCGA-DJ-A4UW,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64W,23936.0,female,1947,white,289,Primary Tumor,0.0,0.0,10.0,80.0,0.0,5.0,75.0,TCGA-DB-A64W-01A,TCGA-DB-A64W,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A6J1,16106.0,female,1969,white,91,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-FG-A6J1-01A,TCGA-FG-A6J1,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QM,15418.0,male,1968,white,129,Primary Tumor,0.0,2.0,8.0,70.0,2.0,22.0,70.0,TCGA-DJ-A1QM-01A,TCGA-DJ-A1QM,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5280,15836.0,male,1964,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DB-5280-01A,TCGA-DB-5280,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QF,22310.0,female,1948,white,664,Primary Tumor,0.0,0.0,15.0,80.0,0.0,0.0,85.0,TCGA-DJ-A1QF-01A,TCGA-DJ-A1QF,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T9,25484.0,female,1936,white,2492,Primary Tumor,0.0,0.0,0.0,80.0,0.0,20.0,80.0,TCGA-EL-A3T9-01A,TCGA-EL-A3T9,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4IC,16671.0,female,1966,white,490,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-KS-A4IC-01A,TCGA-KS-A4IC,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A4B0,27946.0,male,1936,white,72,Primary Tumor,0.0,0.0,20.0,65.0,0.0,10.0,70.0,TCGA-FY-A4B0-01A,TCGA-FY-A4B0,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A4MA,19100.0,female,1959,black or african american,527,Primary Tumor,0.0,0.0,0.0,100.0,1.0,65.0,35.0,TCGA-DE-A4MA-01A,TCGA-DE-A4MA,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A22I,19003.0,female,1959,not reported,77,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-EM-A22I-01A,TCGA-EM-A22I,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A230,10999.0,female,1976,white,1669,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-FE-A230-01A,TCGA-FE-A230,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VG,14970.0,male,1970,white,591,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-DJ-A3VG-01A,TCGA-DJ-A3VG,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4V5,20108.0,male,1956,white,357,Primary Tumor,0.0,0.0,5.0,70.0,5.0,25.0,70.0,TCGA-DJ-A4V5-01A,TCGA-DJ-A4V5,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7681,10790.0,female,1980,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-7681-01A,TCGA-HT-7681,
LGG,Brain Lower Grade Glioma,Brain,TCGA-F6-A8O4,16202.0,male,1969,asian,100,Primary Tumor,0.0,0.0,10.0,70.0,0.0,70.0,20.0,TCGA-F6-A8O4-01A,TCGA-F6-A8O4,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A5TP,12111.0,male,1979,white,301,Primary Tumor,0.0,0.0,5.0,90.0,0.0,5.0,90.0,TCGA-DU-A5TP-01A,TCGA-DU-A5TP,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7858,10422.0,male,1979,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-7858-01A,TCGA-HT-7858,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7J2,9345.0,male,1988,white,194,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-S9-A7J2-01A,TCGA-S9-A7J2,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A235,9859.0,female,1976,white,3109,Primary Tumor,0.0,0.0,0.0,85.0,0.0,10.0,90.0,TCGA-FE-A235-01A,TCGA-FE-A235,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T1,14025.0,female,1964,black or african american,3629,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-EL-A3T1-01A,TCGA-EL-A3T1,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WO,10933.0,male,1984,white,151,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6WO-01A,TCGA-S9-A6WO,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CT,7558.0,female,1991,not reported,130,Primary Tumor,0.0,0.0,0.0,100.0,0.0,2.0,98.0,TCGA-EM-A2CT-01A,TCGA-EM-A2CT,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A713,27232.0,female,1939,white,82,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-FG-A713-01A,TCGA-FG-A713,
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A6WN,13961.0,female,1975,white,181,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A6WN-01A,TCGA-S9-A6WN,
LGG,Brain Lower Grade Glioma,Brain,TCGA-TM-A84B,14933.0,male,1972,white,417,Primary Tumor,0.0,0.0,10.0,85.0,0.0,20.0,70.0,TCGA-TM-A84B-01A,TCGA-TM-A84B,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-6690,25667.0,male,1941,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-FG-6690-01A,TCGA-FG-6690,
LGG,Brain Lower Grade Glioma,Brain,TCGA-QH-A6X9,26992.0,female,1940,white,22,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-QH-A6X9-01A,TCGA-QH-A6X9,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7688,21844.0,male,1950,white,None,Primary Tumor,None,None,30.0,75.0,None,0.0,70.0,TCGA-HT-7688-01A,TCGA-HT-7688,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7299,12266.0,male,1973,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-DU-7299-01A,TCGA-DU-7299,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5EX,15091.0,female,1971,white,65,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-P5-A5EX-01A,TCGA-P5-A5EX,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A5TS,15650.0,male,1970,black or african american,259,Primary Tumor,0.0,0.0,10.0,80.0,0.0,30.0,60.0,TCGA-DU-A5TS-01A,TCGA-DU-A5TS,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CZ,13718.0,female,1970,white,1410,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EL-A3CZ-01A,TCGA-EL-A3CZ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-CS-6668,20836.0,female,1954,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-CS-6668-01A,TCGA-CS-6668,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7472,13968.0,male,1972,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7472-01A,TCGA-HT-7472,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A5R5,12403.0,female,1979,white,194,Primary Tumor,0.0,0.0,5.0,70.0,0.0,45.0,50.0,TCGA-HT-A5R5-01A,TCGA-HT-A5R5,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T8,13290.0,male,1969,asian,2568,Primary Tumor,0.0,0.0,10.0,90.0,0.0,25.0,65.0,TCGA-EL-A3T8-01A,TCGA-EL-A3T8,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T3,23043.0,male,1939,white,3495,Primary Tumor,0.0,0.0,0.0,100.0,0.0,20.0,80.0,TCGA-EL-A3T3-01A,TCGA-EL-A3T3,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PZ,23332.0,male,1948,white,131,Primary Tumor,0.0,0.0,20.0,65.0,0.0,15.0,65.0,TCGA-DJ-A2PZ-01A,TCGA-DJ-A2PZ,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5277,12725.0,male,1973,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-DB-5277-01A,TCGA-DB-5277,
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7473,10306.0,male,1982,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-HT-7473-01A,TCGA-HT-7473,
LGG,Brain Lower Grade Glioma,Brain,TCGA-WH-A86K,24055.0,male,1948,white,112,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-WH-A86K-01A,TCGA-WH-A86K,
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YS,26159.0,male,1936,black or african american,2123,Primary Tumor,0.0,0.0,5.0,90.0,0.0,15.0,80.0,TCGA-E1-A7YS-01A,TCGA-E1-A7YS,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3MY,29706.0,male,1923,white,2828,Primary Tumor,0.0,1.0,0.0,100.0,1.0,50.0,50.0,TCGA-EL-A3MY-01A,TCGA-EL-A3MY,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3BS,15421.0,male,1968,asian,316,Primary Tumor,0.0,1.0,0.0,90.0,4.0,10.0,90.0,TCGA-ET-A3BS-01A,TCGA-ET-A3BS,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3N3,19513.0,female,1947,white,4193,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-EL-A3N3-01A,TCGA-EL-A3N3,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A233,6770.0,female,1989,white,1340,Primary Tumor,0.0,0.0,0.0,90.0,0.0,5.0,95.0,TCGA-FE-A233-01A,TCGA-FE-A233,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A414,16754.0,female,1967,asian,72,Primary Tumor,1.0,1.0,12.0,65.0,3.0,23.0,65.0,TCGA-E8-A414-01A,TCGA-E8-A414,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DE-A69K,21403.0,female,1955,black or african american,72,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-DE-A69K-01A,TCGA-DE-A69K,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FO,14864.0,male,1971,not reported,148,Primary Tumor,0.0,1.0,0.0,80.0,1.0,20.0,80.0,TCGA-EM-A3FO-01A,TCGA-EM-A3FO,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CP,9759.0,female,1985,not reported,134,Primary Tumor,0.0,0.0,0.0,85.0,5.0,15.0,85.0,TCGA-EM-A2CP-01A,TCGA-EM-A2CP,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-5964,22735.0,male,1948,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,90.0,TCGA-FG-5964-01A,TCGA-FG-5964,
LGG,Brain Lower Grade Glioma,Brain,TCGA-KT-A74X,9590.0,male,1987,white,21,Primary Tumor,0.0,0.0,10.0,80.0,0.0,40.0,50.0,TCGA-KT-A74X-01A,TCGA-KT-A74X,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H7,13407.0,female,1966,white,3506,Primary Tumor,0.0,0.0,0.0,75.0,0.0,0.0,100.0,TCGA-EL-A3H7-01A,TCGA-EL-A3H7,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-L6-A4EP,15292.0,female,1969,asian,697,Primary Tumor,0.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-L6-A4EP-01A,TCGA-L6-A4EP,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7692,15727.0,male,1966,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-HT-7692-01A,TCGA-HT-7692,
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A3U3,20117.0,female,1957,white,58,Primary Tumor,0.0,0.0,0.0,85.0,3.0,15.0,85.0,TCGA-IM-A3U3-01A,TCGA-IM-A3U3,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64U,14019.0,female,1973,white,806,Primary Tumor,0.0,0.0,15.0,80.0,0.0,20.0,65.0,TCGA-DB-A64U-01A,TCGA-DB-A64U,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6403,22031.0,female,1939,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-6403-01A,TCGA-DU-6403,
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3R7,18403.0,female,1962,white,27,Primary Tumor,0.0,0.0,0.0,80.0,2.0,0.0,100.0,TCGA-FY-A3R7-01A,TCGA-FY-A3R7,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A41I,17196.0,female,1955,white,3832,Primary Tumor,0.0,0.0,0.0,100.0,0.0,15.0,85.0,TCGA-KS-A41I-01A,TCGA-KS-A41I,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A5RB,8820.0,male,1987,white,597,Primary Tumor,0.0,0.0,5.0,80.0,0.0,45.0,50.0,TCGA-HT-A5RB-01A,TCGA-HT-A5RB,
LGG,Brain Lower Grade Glioma,Brain,TCGA-RY-A847,16732.0,male,1967,white,471,Primary Tumor,0.0,0.0,10.0,75.0,0.0,65.0,25.0,TCGA-RY-A847-01A,TCGA-RY-A847,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CM,22726.0,female,1948,not reported,176,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EM-A2CM-01A,TCGA-EM-A2CM,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-B7-A5TN,21962.0,male,1952,white,50,Primary Tumor,0.0,2.0,0.0,78.0,10.0,45.0,50.0,TCGA-B7-A5TN-01A,TCGA-B7-A5TN,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1580,29992.0,female,1925,not reported,None,Primary Tumor,None,None,0.0,70.0,None,40.0,55.0,TCGA-36-1580-01A,TCGA-36-1580,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4H6,26445.0,female,1939,asian,239,Primary Tumor,0.0,0.0,0.0,80.0,3.0,0.0,100.0,TCGA-HU-A4H6-01A,TCGA-HU-A4H6,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8291,22552.0,male,1950,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-BR-8291-01A,TCGA-BR-8291,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4371,26290.0,female,1937,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,87.0,TCGA-BR-4371-01A,TCGA-BR-4371,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3684,23741.0,female,1942,not reported,None,Primary Tumor,None,None,2.0,70.0,None,15.0,83.0,TCGA-AA-3684-01A,TCGA-AA-3684,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4370,27344.0,female,1934,white,None,Primary Tumor,None,None,25.0,65.0,None,5.0,65.0,TCGA-BR-4370-01A,TCGA-BR-4370,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1928,28126.0,female,1921,white,None,Primary Tumor,5.0,0.0,0.0,80.0,0.0,15.0,80.0,TCGA-24-1928-01A,TCGA-24-1928,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1431,24758.0,female,1932,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-24-1431-01A,TCGA-24-1431,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-3L-AA1B,22379.0,female,1952,black or african american,35,Primary Tumor,0.0,0.0,0.0,70.0,0.0,40.0,60.0,TCGA-3L-AA1B-01A,TCGA-3L-AA1B,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-B7-A5TJ,27057.0,male,1938,white,42,Primary Tumor,4.0,2.0,0.0,70.0,4.0,61.0,35.0,TCGA-B7-A5TJ-01A,TCGA-B7-A5TJ,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4305,25295.0,male,1939,not reported,None,Primary Tumor,5.0,0.0,10.0,80.0,10.0,10.0,80.0,TCGA-CG-4305-01A,TCGA-CG-4305,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8384,25281.0,male,1942,white,None,Primary Tumor,None,None,30.0,60.0,20.0,20.0,50.0,TCGA-BR-8384-01A,TCGA-BR-8384,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6929,17919.0,female,1962,white,None,Primary Tumor,None,None,None,None,None,None,None,TCGA-D5-6929-01A,TCGA-D5-6929,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0800,19087.0,female,1956,white,None,Primary Tumor,None,None,0.0,95.0,None,15.0,85.0,TCGA-13-0800-01A,TCGA-13-0800,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3685,25506.0,male,1938,not reported,None,Primary Tumor,None,None,1.0,75.0,None,10.0,84.0,TCGA-AA-3685-01A,TCGA-AA-3685,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2102,27256.0,female,1925,white,None,Primary Tumor,None,None,25.0,85.0,None,0.0,60.0,TCGA-61-2102-01A,TCGA-61-2102,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A7BS,16847.0,male,1955,white,4284,Primary Tumor,0.0,0.0,10.0,70.0,5.0,0.0,90.0,TCGA-RD-A7BS-01A,TCGA-RD-A7BS,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6924,24964.0,male,1943,white,None,Primary Tumor,2.0,1.0,0.0,45.0,30.0,74.0,25.0,TCGA-D5-6924-01A,TCGA-D5-6924,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A6RI,16788.0,male,1967,white,482,Primary Tumor,5.0,5.0,0.0,70.0,5.0,0.0,83.0,TCGA-IN-A6RI-01A,TCGA-IN-A6RI,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8525,30004.0,female,1928,asian,None,Primary Tumor,None,None,0.0,60.0,None,25.0,75.0,TCGA-CD-8525-01A,TCGA-CD-8525,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6965,22853.0,male,1949,white,None,Primary Tumor,5.0,0.0,0.0,72.0,10.0,0.0,95.0,TCGA-AD-6965-01A,TCGA-AD-6965,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3848,30194.0,female,1927,not reported,None,Primary Tumor,None,None,5.0,85.0,None,10.0,77.0,TCGA-AA-3848-01A,TCGA-AA-3848,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6677,27575.0,female,1936,white,None,Primary Tumor,None,None,0.0,65.0,None,20.0,70.0,TCGA-CM-6677-01A,TCGA-CM-6677,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2035,23855.0,female,1931,white,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,50.0,50.0,TCGA-24-2035-01A,TCGA-24-2035,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6304,24172.0,female,1940,white,None,Primary Tumor,None,None,0.0,80.0,None,30.0,65.0,TCGA-G4-6304-01A,TCGA-G4-6304,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1695,22895.0,female,1941,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,98.0,TCGA-29-1695-01A,TCGA-29-1695,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6459,22574.0,female,1950,white,None,Primary Tumor,1.0,0.0,0.0,80.0,5.0,10.0,87.0,TCGA-F4-6459-01A,TCGA-F4-6459,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A022,32446.0,female,1917,not reported,1573,Primary Tumor,2.0,1.0,0.0,90.0,4.0,5.0,85.0,TCGA-AA-A022-01A,TCGA-AA-A022,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3980,32630.0,female,1920,not reported,None,Primary Tumor,1.0,None,7.0,80.0,5.0,13.0,80.0,TCGA-AA-3980-01A,TCGA-AA-3980,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA6F,21170.0,male,1953,white,1428,Primary Tumor,20.0,20.0,20.0,60.0,40.0,20.0,60.0,TCGA-VQ-AA6F-01A,TCGA-VQ-AA6F,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3856,21670.0,male,1950,not reported,None,Primary Tumor,None,None,15.0,70.0,None,15.0,55.0,TCGA-AA-3856-01A,TCGA-AA-3856,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8PX,18902.0,male,1958,not reported,1681,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,85.0,TCGA-VQ-A8PX-01A,TCGA-VQ-A8PX,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-A54L,27074.0,female,1938,black or african american,128,Primary Tumor,3.0,3.0,0.0,75.0,10.0,20.0,60.0,TCGA-AY-A54L-01A,TCGA-AY-A54L,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-2060,18635.0,female,1958,white,None,Primary Tumor,0.0,0.0,0.0,80.0,15.0,10.0,85.0,TCGA-13-2060-01A,TCGA-13-2060,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-5664,29426.0,male,1930,black or african american,None,Primary Tumor,1.0,1.0,30.0,70.0,20.0,0.0,66.0,TCGA-A6-5664-01A,TCGA-A6-5664,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-5915,23040.0,male,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,5.0,94.0,TCGA-CK-5915-01A,TCGA-CK-5915,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A94O,27306.0,male,1938,black or african american,500,Primary Tumor,1.0,2.0,0.0,80.0,15.0,15.0,82.0,TCGA-VQ-A94O-01A,TCGA-VQ-A94O,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1711,16485.0,female,1961,black or african american,None,Primary Tumor,None,None,0.0,90.0,None,0.0,98.0,TCGA-29-1711-01A,TCGA-29-1711,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3675,30801.0,male,1922,not reported,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-AA-3675-01A,TCGA-AA-3675,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1738,21965.0,female,1945,black or african american,None,Primary Tumor,None,2.0,0.0,90.0,3.0,0.0,95.0,TCGA-61-1738-01A,TCGA-61-1738,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01K,27029.0,female,1935,not reported,173,Primary Tumor,8.0,2.0,0.0,70.0,14.0,15.0,80.0,TCGA-AA-A01K-01A,TCGA-AA-A01K,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1315,18263.0,female,1950,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-25-1315-01A,TCGA-25-1315,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8286,17966.0,male,1962,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,80.0,TCGA-BR-8286-01A,TCGA-BR-8286,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3986,26967.0,male,1934,not reported,None,Primary Tumor,None,None,18.0,86.0,None,2.0,80.0,TCGA-AA-3986-01A,TCGA-AA-3986,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-A8YK,16140.0,male,1969,black or african american,138,Primary Tumor,2.0,2.0,15.0,75.0,5.0,7.0,75.0,TCGA-AY-A8YK-01A,TCGA-AY-A8YK,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1546,17130.0,female,1951,white,None,Primary Tumor,None,None,0.0,70.0,None,40.0,60.0,TCGA-24-1546-01A,TCGA-24-1546,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6922,27771.0,male,1935,white,None,Primary Tumor,0.0,0.0,0.0,65.0,15.0,35.0,65.0,TCGA-D5-6922-01A,TCGA-D5-6922,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-A6RS,27808.0,male,1937,white,127,Primary Tumor,5.0,2.0,0.0,60.0,3.0,30.0,60.0,TCGA-IN-A6RS-01A,TCGA-IN-A6RS,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3994,25323.0,male,1939,not reported,None,Primary Tumor,None,None,40.0,70.0,None,0.0,60.0,TCGA-AA-3994-01A,TCGA-AA-3994,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1549,21432.0,female,1939,white,None,Primary Tumor,None,None,0.0,95.0,None,15.0,80.0,TCGA-24-1549-01A,TCGA-24-1549,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8679,23084.0,female,1949,white,None,Primary Tumor,20.0,0.0,17.0,65.0,10.0,0.0,68.0,TCGA-BR-8679-01A,TCGA-BR-8679,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8364,15389.0,female,1969,white,None,Primary Tumor,None,None,10.0,50.0,None,40.0,50.0,TCGA-BR-8364-01A,TCGA-BR-8364,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-0982,28201.0,female,1926,white,None,Primary Tumor,None,None,0.0,85.0,None,25.0,75.0,TCGA-24-0982-01A,TCGA-24-0982,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3542,25324.0,male,1939,not reported,None,Primary Tumor,None,None,0.0,90.0,None,13.0,80.0,TCGA-AA-3542-01A,TCGA-AA-3542,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0762,23960.0,female,1941,white,None,Primary Tumor,None,None,5.0,95.0,None,None,94.0,TCGA-13-0762-01A,TCGA-13-0762,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2293,17235.0,female,1948,white,None,Primary Tumor,None,None,58.0,66.0,None,0.0,40.0,TCGA-24-2293-01A,TCGA-24-2293,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6533,24971.0,female,1942,white,None,Primary Tumor,2.0,2.0,0.0,90.0,2.0,0.0,90.0,TCGA-D5-6533-01A,TCGA-D5-6533,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3673,19509.0,female,1953,not reported,None,Primary Tumor,None,None,0.0,60.0,None,70.0,25.0,TCGA-AA-3673-01A,TCGA-AA-3673,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1028,16018.0,female,1961,white,None,Primary Tumor,None,None,10.0,80.0,None,10.0,75.0,TCGA-23-1028-01A,TCGA-23-1028,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0720,17799.0,female,1953,white,None,Primary Tumor,20.0,None,10.0,88.0,80.0,2.0,85.0,TCGA-13-0720-01A,TCGA-13-0720,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1405,18218.0,female,1959,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,84.0,TCGA-13-1405-01A,TCGA-13-1405,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0766,15571.0,female,1964,white,None,Primary Tumor,None,None,20.0,80.0,None,None,79.0,TCGA-13-0766-01A,TCGA-13-0766,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-2084,16493.0,female,1955,white,None,Primary Tumor,None,None,1.0,90.0,None,9.0,90.0,TCGA-23-2084-01A,TCGA-23-2084,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3977,23832.0,male,1944,not reported,None,Primary Tumor,None,None,0.0,80.0,3.0,30.0,70.0,TCGA-AA-3977-01A,TCGA-AA-3977,
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1563,24274.0,female,1933,black or african american,None,Primary Tumor,None,None,0.0,70.0,None,30.0,69.0,TCGA-24-1563-01A,TCGA-24-1563,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6856,16519.0,male,1966,white,None,Primary Tumor,None,None,3.0,80.0,None,15.0,81.0,TCGA-F4-6856-01A,TCGA-F4-6856,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-ZQ-A9CR,29107.0,female,1934,white,218,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-ZQ-A9CR-01A,TCGA-ZQ-A9CR,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6625,28163.0,female,1927,white,None,Primary Tumor,None,None,10.0,60.0,None,25.0,55.0,TCGA-G4-6625-01A,TCGA-G4-6625,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3837,24655.0,male,1941,not reported,None,Primary Tumor,None,None,0.0,75.0,None,25.0,72.0,TCGA-AA-3837-01A,TCGA-AA-3837,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4253,29397.0,female,1928,white,None,Primary Tumor,None,None,5.0,70.0,None,10.0,67.0,TCGA-BR-4253-01A,TCGA-BR-4253,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A0XF,25032.0,female,1931,white,4089,Primary Tumor,2.0,1.0,0.0,65.0,6.0,20.0,76.0,TCGA-DM-A0XF-01A,TCGA-DM-A0XF,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A92D,24595.0,male,1942,white,1595,Primary Tumor,3.0,2.0,0.0,75.0,4.0,23.0,75.0,TCGA-VQ-A92D-01A,TCGA-VQ-A92D,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1YE,17297.0,female,1960,not reported,1409,Primary Tumor,0.0,0.0,5.0,95.0,0.0,5.0,90.0,TCGA-EM-A1YE-01A,TCGA-EM-A1YE,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6393,24282.0,male,1927,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-6393-01A,TCGA-DU-6393,
LGG,Brain Lower Grade Glioma,Brain,TCGA-R8-A6MK,14716.0,male,1965,white,2841,Primary Tumor,0.0,0.0,10.0,85.0,0.0,30.0,60.0,TCGA-R8-A6MK-01A,TCGA-R8-A6MK,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6401,11595.0,female,1967,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-DU-6401-01A,TCGA-DU-6401,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2QB,19601.0,female,1958,asian,148,Primary Tumor,0.0,0.0,0.0,100.0,0.0,10.0,90.0,TCGA-DJ-A2QB-01A,TCGA-DJ-A2QB,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8104,18748.0,female,1959,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-8104-01A,TCGA-HT-8104,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CL,11649.0,male,1979,not reported,164,Primary Tumor,0.0,1.0,0.0,99.0,0.0,2.0,98.0,TCGA-EM-A2CL-01A,TCGA-EM-A2CL,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-J8-A3YG,19785.0,female,1956,white,609,Primary Tumor,0.0,1.0,15.0,85.0,1.0,35.0,50.0,TCGA-J8-A3YG-01A,TCGA-J8-A3YG,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A3X7,20983.0,female,1954,white,148,Primary Tumor,0.0,1.0,0.0,100.0,1.0,55.0,45.0,TCGA-E8-A3X7-01A,TCGA-E8-A3X7,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A41F,13545.0,female,1965,white,3703,Primary Tumor,0.0,0.0,0.0,100.0,0.0,10.0,90.0,TCGA-KS-A41F-01A,TCGA-KS-A41F,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FE-A3PB,12136.0,female,1971,white,2906,Primary Tumor,0.0,1.0,0.0,100.0,8.0,50.0,50.0,TCGA-FE-A3PB-01A,TCGA-FE-A3PB,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7008,15289.0,female,1957,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7008-01A,TCGA-DU-7008,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A64O,21811.0,male,1952,white,533,Primary Tumor,0.0,0.0,5.0,85.0,0.0,20.0,75.0,TCGA-DB-A64O-01A,TCGA-DB-A64O,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-5279,21908.0,male,1948,not reported,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-DB-5279-01A,TCGA-DB-5279,
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A41Y,15694.0,female,1970,white,90,Primary Tumor,0.0,0.0,0.0,80.0,2.0,25.0,75.0,TCGA-IM-A41Y-01A,TCGA-IM-A41Y,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4JZ,20290.0,female,1954,white,1079,Primary Tumor,0.0,1.0,0.0,80.0,2.0,10.0,90.0,TCGA-EL-A4JZ-01A,TCGA-EL-A4JZ,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CN,17456.0,female,1952,white,4586,Primary Tumor,0.0,0.0,0.0,88.0,0.0,25.0,75.0,TCGA-EL-A3CN-01A,TCGA-EL-A3CN,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A40M,18722.0,female,1961,white,70,Primary Tumor,0.0,0.0,0.0,95.0,1.0,5.0,95.0,TCGA-FY-A40M-01A,TCGA-FY-A40M,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A5EY,7716.0,male,1991,white,65,Primary Tumor,0.0,0.0,5.0,70.0,0.0,75.0,20.0,TCGA-P5-A5EY-01A,TCGA-P5-A5EY,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A242,20472.0,female,1955,white,69,Primary Tumor,0.0,0.0,5.0,70.0,0.0,0.0,95.0,TCGA-E8-A242-01A,TCGA-E8-A242,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A4I1,13538.0,female,1975,asian,239,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-KS-A4I1-01A,TCGA-KS-A4I1,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QE,22645.0,female,1941,white,2945,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-DJ-A1QE-01A,TCGA-DJ-A1QE,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A0YZ,24102.0,male,1944,white,334,Primary Tumor,0.0,0.0,0.0,98.0,0.0,0.0,100.0,TCGA-BJ-A0YZ-01A,TCGA-BJ-A0YZ,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A4KD,15291.0,male,1969,white,921,Primary Tumor,0.0,1.0,0.0,100.0,0.0,10.0,90.0,TCGA-EL-A4KD-01A,TCGA-EL-A4KD,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13L,31388.0,male,1925,white,149,Primary Tumor,0.0,0.0,0.0,65.0,0.0,20.0,80.0,TCGA-DJ-A13L-01A,TCGA-DJ-A13L,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7479,16137.0,male,1967,white,None,Primary Tumor,None,None,0.0,50.0,None,0.0,100.0,TCGA-HT-7479-01A,TCGA-HT-7479,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GX,15212.0,female,1959,white,4200,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-EL-A3GX-01A,TCGA-EL-A3GX,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-A60L,12580.0,female,1978,white,121,Primary Tumor,0.0,0.0,5.0,80.0,0.0,55.0,40.0,TCGA-FG-A60L-01A,TCGA-FG-A60L,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3FR,20349.0,female,1956,not reported,95,Primary Tumor,0.0,1.0,0.0,65.0,2.0,35.0,65.0,TCGA-EM-A3FR-01A,TCGA-EM-A3FR,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7686,10724.0,female,1979,white,None,Primary Tumor,None,None,0.0,80.0,None,0.0,100.0,TCGA-HT-7686-01A,TCGA-HT-7686,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-A7TC,11884.0,male,1979,white,646,Primary Tumor,0.0,0.0,10.0,70.0,0.0,40.0,50.0,TCGA-DU-A7TC-01A,TCGA-DU-A7TC,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-7006,21990.0,female,1935,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DU-7006-01A,TCGA-DU-7006,
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-6692,23374.0,male,1948,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-FG-6692-01A,TCGA-FG-6692,
LGG,Brain Lower Grade Glioma,Brain,TCGA-P5-A737,17390.0,male,1965,white,217,Primary Tumor,0.0,0.0,10.0,70.0,0.0,50.0,40.0,TCGA-P5-A737-01A,TCGA-P5-A737,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CV,14785.0,male,1965,white,2352,Primary Tumor,0.0,0.0,0.0,70.0,10.0,30.0,70.0,TCGA-EL-A3CV-01A,TCGA-EL-A3CV,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PY,17056.0,female,1965,white,105,Primary Tumor,0.0,0.0,0.0,80.0,0.0,5.0,95.0,TCGA-DJ-A2PY-01A,TCGA-DJ-A2PY,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZM,21987.0,male,1948,not reported,1554,Primary Tumor,0.0,0.0,0.0,80.0,2.0,30.0,70.0,TCGA-EL-A3ZM-01A,TCGA-EL-A3ZM,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A13M,10530.0,female,1982,white,126,Primary Tumor,0.0,0.0,0.0,95.0,0.0,0.0,100.0,TCGA-DJ-A13M-01A,TCGA-DJ-A13M,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3RA,7900.0,female,1990,white,181,Primary Tumor,0.0,0.0,0.0,85.0,0.0,15.0,85.0,TCGA-FY-A3RA-01A,TCGA-FY-A3RA,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-S9-A7QW,19869.0,female,1959,white,78,Primary Tumor,0.0,0.0,10.0,80.0,0.0,50.0,40.0,TCGA-S9-A7QW-01A,TCGA-S9-A7QW,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-8162,22596.0,female,1950,white,None,Primary Tumor,None,None,0.0,60.0,None,0.0,100.0,TCGA-DU-8162-01A,TCGA-DU-8162,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3V4,22218.0,female,1951,white,345,Primary Tumor,1.0,1.0,10.0,70.0,3.0,20.0,70.0,TCGA-DJ-A3V4-01A,TCGA-DJ-A3V4,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2PN,25690.0,female,1940,white,237,Primary Tumor,0.0,0.0,5.0,80.0,0.0,25.0,70.0,TCGA-DJ-A2PN-01A,TCGA-DJ-A2PN,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A75K,20241.0,female,1958,white,114,Primary Tumor,0.0,0.0,10.0,90.0,0.0,40.0,50.0,TCGA-DB-A75K-01A,TCGA-DB-A75K,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4V4,17878.0,female,1964,white,215,Primary Tumor,0.0,0.0,0.0,75.0,5.0,25.0,75.0,TCGA-DJ-A4V4-01A,TCGA-DJ-A4V4,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7480,12291.0,male,1972,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7480-01A,TCGA-HT-7480,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3UU,17919.0,female,1961,white,520,Primary Tumor,1.0,1.0,0.0,80.0,3.0,20.0,80.0,TCGA-DJ-A3UU-01A,TCGA-DJ-A3UU,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A40N,20320.0,female,1957,white,55,Primary Tumor,0.0,1.0,5.0,95.0,1.0,15.0,80.0,TCGA-FY-A40N-01A,TCGA-FY-A40N,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A1QQ,15949.0,male,1967,asian,176,Primary Tumor,0.0,2.0,0.0,80.0,3.0,20.0,80.0,TCGA-DJ-A1QQ-01A,TCGA-DJ-A1QQ,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-E1-A7YH,17465.0,female,1958,white,3127,Primary Tumor,0.0,0.0,10.0,90.0,0.0,50.0,40.0,TCGA-E1-A7YH-01A,TCGA-E1-A7YH,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-5140,13943.0,female,1969,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-DH-5140-01A,TCGA-DH-5140,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A3VE,18417.0,male,1961,white,100,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-DJ-A3VE-01A,TCGA-DJ-A3VE,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H2,21266.0,male,1944,white,3292,Primary Tumor,0.0,0.0,0.0,95.0,0.0,5.0,95.0,TCGA-EL-A3H2-01A,TCGA-EL-A3H2,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A2Q1,16371.0,female,1967,white,121,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-DJ-A2Q1-01A,TCGA-DJ-A2Q1,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-8105,20041.0,male,1957,white,None,Primary Tumor,None,None,0.0,75.0,None,0.0,100.0,TCGA-HT-8105-01A,TCGA-HT-8105,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A44M,8523.0,female,1989,asian,72,Primary Tumor,0.0,0.0,0.0,90.0,30.0,10.0,90.0,TCGA-E8-A44M-01A,TCGA-E8-A44M,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-WY-A85C,13506.0,male,1974,white,1119,Primary Tumor,0.0,0.0,10.0,90.0,0.0,45.0,45.0,TCGA-WY-A85C-01A,TCGA-WY-A85C,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DB-A4XC,9705.0,male,1984,white,849,Primary Tumor,0.0,0.0,15.0,90.0,0.0,5.0,80.0,TCGA-DB-A4XC-01A,TCGA-DB-A4XC,
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4UQ,22097.0,male,1952,asian,257,Primary Tumor,0.0,2.0,10.0,90.0,1.0,30.0,60.0,TCGA-DJ-A4UQ-01A,TCGA-DJ-A4UQ,4.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-A616,13222.0,female,1977,white,70,Primary Tumor,0.0,0.0,10.0,70.0,0.0,60.0,30.0,TCGA-HT-A616-01A,TCGA-HT-A616,
THCA,Thyroid Carcinoma,Thyroid,TCGA-E3-A3E1,16895.0,female,1961,white,1737,Primary Tumor,0.0,0.0,5.0,90.0,0.0,10.0,85.0,TCGA-E3-A3E1-01A,TCGA-E3-A3E1,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-VM-A8CB,12340.0,male,1978,not reported,738,Primary Tumor,None,None,None,None,None,None,None,TCGA-VM-A8CB-01A,TCGA-VM-A8CB,
LGG,Brain Lower Grade Glioma,Brain,TCGA-DH-A66D,15866.0,female,1969,white,404,Primary Tumor,0.0,0.0,15.0,90.0,0.0,20.0,65.0,TCGA-DH-A66D-01A,TCGA-DH-A66D,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AI,24820.0,female,1943,white,294,Primary Tumor,1.0,0.0,0.0,95.0,0.0,10.0,90.0,TCGA-EM-A3AI-01A,TCGA-EM-A3AI,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-DU-6402,19207.0,male,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-DU-6402-01A,TCGA-DU-6402,
LGG,Brain Lower Grade Glioma,Brain,TCGA-EZ-7264,17432.0,female,1964,white,None,Primary Tumor,None,None,0.0,85.0,None,0.0,100.0,TCGA-EZ-7264-01A,TCGA-EZ-7264,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H3,7000.0,female,1989,white,1087,Primary Tumor,0.0,0.0,0.0,85.0,2.0,15.0,85.0,TCGA-EL-A3H3-01A,TCGA-EL-A3H3,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DJ-A4UT,11813.0,female,1980,white,222,Primary Tumor,1.0,1.0,2.0,75.0,3.0,23.0,75.0,TCGA-DJ-A4UT-01A,TCGA-DJ-A4UT,1.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-FG-6689,11312.0,male,1981,white,None,Primary Tumor,None,None,0.0,70.0,None,0.0,100.0,TCGA-FG-6689-01A,TCGA-FG-6689,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AK,22911.0,female,1949,not reported,170,Primary Tumor,0.0,1.0,0.0,95.0,1.0,10.0,90.0,TCGA-EM-A3AK-01A,TCGA-EM-A3AK,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3ST,22990.0,female,1949,not reported,224,Primary Tumor,0.0,0.0,0.0,90.0,1.0,10.0,90.0,TCGA-EM-A3ST-01A,TCGA-EM-A3ST,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3YR,23395.0,female,1948,white,122,Primary Tumor,1.0,2.0,0.0,70.0,4.0,30.0,70.0,TCGA-FY-A3YR-01A,TCGA-FY-A3YR,3.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-RY-A83Y,16470.0,male,1967,white,485,Primary Tumor,0.0,0.0,5.0,90.0,0.0,40.0,55.0,TCGA-RY-A83Y-01A,TCGA-RY-A83Y,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3D1,14245.0,male,1967,asian,2032,Primary Tumor,0.0,1.0,0.0,90.0,1.0,25.0,75.0,TCGA-EL-A3D1-01A,TCGA-EL-A3D1,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3CL,25761.0,female,1924,white,6425,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-EL-A3CL-01A,TCGA-EL-A3CL,2.0
LGG,Brain Lower Grade Glioma,Brain,TCGA-HT-7680,11970.0,female,1978,white,None,Primary Tumor,None,None,0.0,65.0,None,0.0,100.0,TCGA-HT-7680-01A,TCGA-HT-7680,
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1YD,19366.0,female,1954,not reported,1372,Primary Tumor,0.0,1.0,20.0,85.0,0.0,5.0,75.0,TCGA-EM-A1YD-01A,TCGA-EM-A1YD,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3AQ,31198.0,female,1926,not reported,128,Primary Tumor,0.0,1.0,0.0,100.0,0.0,30.0,70.0,TCGA-EM-A3AQ-01A,TCGA-EM-A3AQ,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H1,24328.0,female,1927,black or african american,6870,Primary Tumor,0.0,0.0,0.0,85.0,0.0,0.0,100.0,TCGA-EL-A3H1-01A,TCGA-EL-A3H1,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-IM-A420,14332.0,female,1973,white,56,Primary Tumor,0.0,0.0,0.0,80.0,2.0,20.0,80.0,TCGA-IM-A420-01A,TCGA-IM-A420,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A3EZ,18882.0,male,1960,white,91,Primary Tumor,0.0,0.0,0.0,90.0,0.0,0.0,100.0,TCGA-BJ-A3EZ-01A,TCGA-BJ-A3EZ,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A2CQ,14776.0,female,1971,not reported,130,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-EM-A2CQ-01A,TCGA-EM-A2CQ,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3WA,18993.0,female,1960,white,71,Primary Tumor,6.0,2.0,0.0,100.0,0.0,70.0,30.0,TCGA-FY-A3WA-01A,TCGA-FY-A3WA,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A434,20492.0,female,1956,asian,86,Primary Tumor,0.0,0.0,20.0,70.0,0.0,10.0,70.0,TCGA-E8-A434-01A,TCGA-E8-A434,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1568,19311.0,female,1955,not reported,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-36-1568-01A,TCGA-36-1568,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6527,22793.0,male,1948,white,None,Primary Tumor,None,None,5.0,75.0,None,15.0,80.0,TCGA-D7-6527-01A,TCGA-D7-6527,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-1673,18599.0,female,1958,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,87.0,TCGA-09-1673-01A,TCGA-09-1673,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-NH-A50V,25467.0,male,1943,black or african american,41,Primary Tumor,0.0,0.0,0.0,80.0,0.0,25.0,70.0,TCGA-NH-A50V-01A,TCGA-NH-A50V,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3679,21611.0,male,1947,not reported,None,Primary Tumor,None,None,5.0,70.0,None,15.0,75.0,TCGA-AA-3679-01A,TCGA-AA-3679,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-0364,29262.0,female,1918,white,None,Primary Tumor,None,None,0.0,95.0,None,10.0,90.0,TCGA-09-0364-01A,TCGA-09-0364,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1553,19393.0,female,1944,white,None,Primary Tumor,None,None,0.0,95.0,None,15.0,85.0,TCGA-24-1553-01A,TCGA-24-1553,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5720,26176.0,male,1932,not reported,None,Primary Tumor,None,None,0.0,75.0,None,15.0,80.0,TCGA-CG-5720-01A,TCGA-CG-5720,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3973,25536.0,male,1938,not reported,None,Primary Tumor,None,None,0.0,90.0,None,5.0,90.0,TCGA-AA-3973-01A,TCGA-AA-3973,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1741,27762.0,female,1928,white,None,Primary Tumor,None,None,0.0,90.0,5.0,0.0,95.0,TCGA-61-1741-01A,TCGA-61-1741,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-10-0937,16222.0,female,1961,white,None,Primary Tumor,None,None,5.0,85.0,None,15.0,80.0,TCGA-10-0937-01A,TCGA-10-0937,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3561,26420.0,male,1937,not reported,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-AA-3561-01A,TCGA-AA-3561,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1761,29337.0,female,1918,asian,None,Primary Tumor,None,None,0.0,75.0,15.0,5.0,90.0,TCGA-29-1761-01A,TCGA-29-1761,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3979,30742.0,male,1926,not reported,None,Primary Tumor,1.0,None,2.0,85.0,5.0,0.0,90.0,TCGA-AA-3979-01A,TCGA-AA-3979,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-2109,14900.0,female,1959,white,None,Primary Tumor,None,None,13.0,95.0,None,5.0,75.0,TCGA-61-2109-01A,TCGA-61-2109,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28C,27073.0,male,1927,white,3500,Primary Tumor,1.0,1.0,0.0,80.0,2.0,18.0,80.0,TCGA-DM-A28C-01A,TCGA-DM-A28C,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6163,27150.0,male,1936,white,None,Primary Tumor,None,None,20.0,60.0,None,15.0,60.0,TCGA-CM-6163-01A,TCGA-CM-6163,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-RD-A8MW,26590.0,male,1932,white,3334,Primary Tumor,0.0,0.0,0.0,70.0,5.0,0.0,100.0,TCGA-RD-A8MW-01A,TCGA-RD-A8MW,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-5914,29586.0,male,1927,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-CK-5914-01A,TCGA-CK-5914,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1576,27778.0,female,1930,not reported,None,Primary Tumor,None,None,0.0,95.0,None,10.0,88.0,TCGA-36-1576-01A,TCGA-36-1576,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6889,None,male,1929,asian,None,Primary Tumor,None,None,5.0,80.0,15.0,10.0,80.0,TCGA-AD-6889-01A,TCGA-AD-6889,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-31-1946,11146.0,female,1976,not reported,None,Primary Tumor,None,None,0.0,85.0,None,13.0,85.0,TCGA-31-1946-01A,TCGA-31-1946,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-A487,18694.0,male,1960,asian,496,Primary Tumor,0.0,0.0,20.0,80.0,1.0,0.0,80.0,TCGA-CD-A487-01A,TCGA-CD-A487,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4201,24354.0,female,1942,white,None,Primary Tumor,None,None,40.0,70.0,None,5.0,50.0,TCGA-BR-4201-01A,TCGA-BR-4201,
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-8209,18171.0,male,1956,white,None,Primary Tumor,None,None,0.0,30.0,None,70.0,30.0,TCGA-FP-8209-01A,TCGA-FP-8209,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8DV,17630.0,male,1962,white,1069,Primary Tumor,20.0,20.0,5.0,80.0,40.0,15.0,80.0,TCGA-VQ-A8DV-01A,TCGA-VQ-A8DV,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1DB,24888.0,male,1932,white,3958,Primary Tumor,0.0,0.0,0.0,70.0,0.0,0.0,100.0,TCGA-DM-A1DB-01A,TCGA-DM-A1DB,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3814,31380.0,female,1922,not reported,None,Primary Tumor,None,None,8.0,70.0,None,18.0,66.0,TCGA-AA-3814-01A,TCGA-AA-3814,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-7998,28302.0,male,1934,white,None,Primary Tumor,None,None,None,45.0,None,None,None,TCGA-FP-7998-01A,TCGA-FP-7998,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-KB-A6F7,19765.0,female,1955,not reported,1483,Primary Tumor,6.0,2.0,0.0,65.0,4.0,35.0,65.0,TCGA-KB-A6F7-01A,TCGA-KB-A6F7,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3982,27608.0,male,1934,not reported,None,Primary Tumor,None,None,0.0,80.0,5.0,10.0,88.0,TCGA-AA-3982-01A,TCGA-AA-3982,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-KB-A93J,28599.0,male,1930,white,1911,Primary Tumor,0.0,10.0,10.0,70.0,90.0,30.0,60.0,TCGA-KB-A93J-01A,TCGA-KB-A93J,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A0XD,23966.0,male,1935,white,3672,Primary Tumor,0.0,0.0,0.0,70.0,3.0,25.0,65.0,TCGA-DM-A0XD-01A,TCGA-DM-A0XD,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0920,24064.0,female,1942,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,80.0,TCGA-13-0920-01A,TCGA-13-0920,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-5538,21974.0,female,1950,white,None,Primary Tumor,2.0,1.0,0.0,80.0,10.0,0.0,95.0,TCGA-D5-5538-01A,TCGA-D5-5538,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AM-5821,24903.0,female,1942,white,None,Primary Tumor,None,None,8.0,75.0,None,10.0,77.0,TCGA-AM-5821-01A,TCGA-AM-5821,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1464,25874.0,female,1928,white,None,Primary Tumor,None,None,0.0,90.0,None,9.0,90.0,TCGA-24-1464-01A,TCGA-24-1464,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8690,19855.0,female,1958,white,None,Primary Tumor,10.0,5.0,0.0,65.0,10.0,10.0,85.0,TCGA-BR-8690-01A,TCGA-BR-8690,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1120,22148.0,female,1948,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,0.0,TCGA-23-1120-01A,TCGA-23-1120,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3552,31290.0,male,1923,not reported,None,Primary Tumor,None,None,5.0,90.0,None,5.0,90.0,TCGA-AA-3552-01A,TCGA-AA-3552,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1507,28445.0,female,1931,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,90.0,TCGA-13-1507-01A,TCGA-13-1507,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6460,18637.0,female,1960,white,None,Primary Tumor,2.0,0.0,14.0,71.0,5.0,0.0,85.0,TCGA-F4-6460-01A,TCGA-F4-6460,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6598,28182.0,female,1923,white,None,Primary Tumor,None,None,0.0,80.0,None,10.0,85.0,TCGA-AZ-6598-01A,TCGA-AZ-6598,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4357,21295.0,male,1950,white,None,Primary Tumor,None,None,0.0,70.0,None,10.0,80.0,TCGA-BR-4357-01A,TCGA-BR-4357,
STAD,Stomach Adenocarcinoma,Stomach,TCGA-B7-A5TI,19014.0,male,1960,white,58,Primary Tumor,2.0,2.0,0.0,70.0,6.0,62.0,25.0,TCGA-B7-A5TI-01A,TCGA-B7-A5TI,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-5256,19785.0,female,1956,asian,None,Primary Tumor,None,None,5.0,80.0,None,15.0,75.0,TCGA-CA-5256-01A,TCGA-CA-5256,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0923,27081.0,female,1934,white,None,Primary Tumor,None,None,0.0,85.0,None,25.0,70.0,TCGA-13-0923-01A,TCGA-13-0923,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0897,19894.0,female,1950,white,None,Primary Tumor,None,None,10.0,90.0,None,0.0,88.0,TCGA-13-0897-01A,TCGA-13-0897,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-A69D,20299.0,female,1957,black or african american,203,Primary Tumor,5.0,2.0,15.0,60.0,4.0,25.0,60.0,TCGA-AY-A69D-01A,TCGA-AY-A69D,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01V,21792.0,male,1945,not reported,2091,Primary Tumor,1.0,1.0,0.0,90.0,4.0,4.0,95.0,TCGA-AA-A01V-01A,TCGA-AA-A01V,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-5578,29390.0,male,1930,white,None,Primary Tumor,None,None,None,0.0,None,None,None,TCGA-D7-5578-01A,TCGA-D7-5578,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8578,26620.0,male,1940,white,None,Primary Tumor,3.0,0.0,25.0,62.0,20.0,0.0,75.0,TCGA-D7-8578-01A,TCGA-D7-8578,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-A48C,29203.0,female,1932,asian,398,Primary Tumor,0.0,0.0,10.0,65.0,2.0,0.0,90.0,TCGA-CD-A48C-01A,TCGA-CD-A48C,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-OY-A56Q,28623.0,female,1934,black or african american,120,Primary Tumor,0.0,0.0,0.0,85.0,1.0,0.0,100.0,TCGA-OY-A56Q-01A,TCGA-OY-A56Q,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91Y,24774.0,male,1944,white,1035,Primary Tumor,0.0,0.0,0.0,60.0,4.0,0.0,100.0,TCGA-VQ-A91Y-01A,TCGA-VQ-A91Y,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-R5-A7ZF,23908.0,female,1947,black or african american,482,Primary Tumor,10.0,2.0,1.0,80.0,5.0,25.0,70.0,TCGA-R5-A7ZF-01A,TCGA-R5-A7ZF,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1495,22046.0,female,1944,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,79.0,TCGA-13-1495-01A,TCGA-13-1495,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-2401,23711.0,female,1940,white,None,Primary Tumor,None,None,1.0,80.0,None,19.0,75.0,TCGA-25-2401-01A,TCGA-25-2401,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1910,20779.0,female,1950,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-61-1910-01A,TCGA-61-1910,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3984,22585.0,female,1948,not reported,None,Primary Tumor,5.0,None,4.0,85.0,6.0,0.0,90.0,TCGA-AA-3984-01A,TCGA-AA-3984,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6519,23413.0,female,1946,white,None,Primary Tumor,None,None,0.0,85.0,None,15.0,85.0,TCGA-D7-6519-01A,TCGA-D7-6519,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-5407,18820.0,female,1956,white,None,Primary Tumor,None,None,15.0,75.0,None,10.0,75.0,TCGA-AZ-5407-01A,TCGA-AZ-5407,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6162,17624.0,female,1962,white,None,Primary Tumor,None,None,10.0,77.0,None,15.0,74.0,TCGA-CM-6162-01A,TCGA-CM-6162,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1581,23272.0,female,1944,white,None,Primary Tumor,None,None,0.0,95.0,None,2.0,93.0,TCGA-36-1581-01A,TCGA-36-1581,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A1D7,30142.0,male,1918,white,3939,Primary Tumor,0.0,0.0,0.0,80.0,0.0,0.0,100.0,TCGA-DM-A1D7-01A,TCGA-DM-A1D7,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1866,22562.0,female,1942,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,95.0,TCGA-30-1866-01A,TCGA-30-1866,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1911,20144.0,female,1950,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,95.0,TCGA-61-1911-01A,TCGA-61-1911,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3845,31593.0,female,1923,not reported,None,Primary Tumor,None,None,15.0,80.0,None,8.0,74.0,TCGA-AA-3845-01A,TCGA-AA-3845,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-A4IV,17515.0,male,1965,asian,116,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-BR-A4IV-01A,TCGA-BR-A4IV,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-31-1956,22100.0,female,1945,white,None,Primary Tumor,None,None,0.0,90.0,None,18.0,80.0,TCGA-31-1956-01A,TCGA-31-1956,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1410,20950.0,female,1951,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-13-1410-01A,TCGA-13-1410,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-4315,22340.0,male,1945,white,None,Primary Tumor,None,None,0.0,70.0,None,20.0,75.0,TCGA-AZ-4315-01A,TCGA-AZ-4315,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-31-1944,17207.0,female,1958,white,None,Primary Tumor,None,None,0.0,90.0,None,20.0,70.0,TCGA-31-1944-01A,TCGA-31-1944,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3949,32081.0,female,1922,not reported,None,Primary Tumor,None,None,0.0,65.0,None,40.0,52.0,TCGA-AA-3949-01A,TCGA-AA-3949,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6923,21118.0,male,1954,white,None,Primary Tumor,1.0,0.0,0.0,75.0,4.0,34.0,65.0,TCGA-D5-6923-01A,TCGA-D5-6923,1.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-1670,21147.0,female,1948,white,None,Primary Tumor,None,None,0.0,99.0,None,5.0,95.0,TCGA-09-1670-01A,TCGA-09-1670,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1104,20527.0,female,1945,white,None,Primary Tumor,None,None,None,80.0,None,None,None,TCGA-24-1104-01A,TCGA-24-1104,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3562,30254.0,male,1926,not reported,None,Primary Tumor,None,None,5.0,80.0,None,25.0,70.0,TCGA-AA-3562-01A,TCGA-AA-3562,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-1501,18393.0,female,1956,white,None,Primary Tumor,None,None,0.0,70.0,None,30.0,69.0,TCGA-13-1501-01A,TCGA-13-1501,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CK-6748,16529.0,female,1963,white,None,Primary Tumor,None,None,0.0,70.0,None,25.0,75.0,TCGA-CK-6748-01A,TCGA-CK-6748,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AD-6895,30879.0,male,1927,white,None,Primary Tumor,None,None,0.0,80.0,5.0,13.0,85.0,TCGA-AD-6895-01A,TCGA-AD-6895,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6294,27755.0,male,1929,white,None,Primary Tumor,None,None,2.0,80.0,None,15.0,78.0,TCGA-G4-6294-01A,TCGA-G4-6294,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6680,28701.0,female,1933,white,None,Primary Tumor,None,None,5.0,80.0,None,12.0,83.0,TCGA-CM-6680-01A,TCGA-CM-6680,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-4615,30908.0,male,1925,white,None,Primary Tumor,None,None,0.0,75.0,None,10.0,80.0,TCGA-AZ-4615-01A,TCGA-AZ-4615,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0804,27021.0,female,1930,white,None,Primary Tumor,None,None,0.0,98.0,None,4.0,95.0,TCGA-13-0804-01A,TCGA-13-0804,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CD-8524,22445.0,female,1949,asian,None,Primary Tumor,None,None,0.0,80.0,None,15.0,85.0,TCGA-CD-8524-01A,TCGA-CD-8524,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8682,19165.0,male,1960,asian,None,Primary Tumor,5.0,0.0,35.0,80.0,5.0,0.0,65.0,TCGA-BR-8682-01A,TCGA-BR-8682,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-2054,21285.0,female,1947,black or african american,None,Primary Tumor,0.0,0.0,0.0,90.0,0.0,10.0,90.0,TCGA-09-2054-01A,TCGA-09-2054,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-25-1623,26060.0,female,1935,white,None,Primary Tumor,None,None,0.0,80.0,None,25.0,70.0,TCGA-25-1623-01A,TCGA-25-1623,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8E0,24848.0,male,1943,black or african american,942,Primary Tumor,0.0,0.0,0.0,65.0,5.0,0.0,83.0,TCGA-VQ-A8E0-01A,TCGA-VQ-A8E0,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-6141,11391.0,male,1980,black or african american,None,Primary Tumor,5.0,2.0,0.0,75.0,15.0,0.0,99.0,TCGA-A6-6141-01A,TCGA-A6-6141,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-QG-A5YX,22617.0,female,1950,black or african american,596,Primary Tumor,1.0,2.0,10.0,80.0,8.0,9.0,80.0,TCGA-QG-A5YX-01A,TCGA-QG-A5YX,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6674,14368.0,male,1972,white,None,Primary Tumor,None,None,10.0,80.0,None,15.0,65.0,TCGA-CM-6674-01A,TCGA-CM-6674,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-4308,17321.0,female,1959,white,None,Primary Tumor,None,None,15.0,85.0,2.0,5.0,80.0,TCGA-AZ-4308-01A,TCGA-AZ-4308,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-59-2351,None,female,1948,white,None,Primary Tumor,None,None,1.0,80.0,None,19.0,79.0,TCGA-59-2351-01A,TCGA-59-2351,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3841,24230.0,male,1943,not reported,None,Primary Tumor,None,None,10.0,75.0,None,10.0,72.0,TCGA-AA-3841-01A,TCGA-AA-3841,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A91Q,22303.0,male,1948,not reported,1509,Primary Tumor,20.0,20.0,0.0,80.0,40.0,20.0,80.0,TCGA-VQ-A91Q-01A,TCGA-VQ-A91Q,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4279,16065.0,male,1966,white,None,Primary Tumor,None,None,8.0,75.0,None,40.0,52.0,TCGA-BR-4279-01A,TCGA-BR-4279,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1105,13187.0,female,1965,white,None,Primary Tumor,None,None,None,90.0,None,None,None,TCGA-24-1105-01A,TCGA-24-1105,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-23-1123,21552.0,female,1939,white,None,Primary Tumor,None,None,0.0,95.0,None,0.0,0.0,TCGA-23-1123-01A,TCGA-23-1123,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-5344,14426.0,female,1971,white,None,Primary Tumor,2.0,1.0,0.0,80.0,5.0,0.0,95.0,TCGA-CM-5344-01A,TCGA-CM-5344,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-61-1907,23204.0,female,1943,white,None,Primary Tumor,None,None,0.0,95.0,None,5.0,94.0,TCGA-61-1907-01A,TCGA-61-1907,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2254,24407.0,female,1937,white,None,Primary Tumor,None,None,0.0,90.0,None,10.0,90.0,TCGA-24-2254-01A,TCGA-24-2254,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-30-1718,16400.0,female,1958,white,None,Primary Tumor,None,None,0.0,90.0,None,18.0,80.0,TCGA-30-1718-01A,TCGA-30-1718,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A0X9,26217.0,female,1930,white,3270,Primary Tumor,0.0,0.0,0.0,65.0,0.0,0.0,100.0,TCGA-DM-A0X9-01A,TCGA-DM-A0X9,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-G4-6293,18076.0,female,1953,white,None,Primary Tumor,None,None,0.0,80.0,None,20.0,80.0,TCGA-G4-6293-01A,TCGA-G4-6293,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AY-6196,17311.0,male,1963,white,None,Primary Tumor,None,None,0.0,73.0,None,60.0,40.0,TCGA-AY-6196-01A,TCGA-AY-6196,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-09-0367,24473.0,female,1934,native hawaiian or other pacific islander,None,Primary Tumor,None,None,1.0,95.0,None,9.0,90.0,TCGA-09-0367-01A,TCGA-09-0367,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CM-6167,21031.0,female,1953,black or african american,None,Primary Tumor,None,None,3.0,65.0,None,45.0,51.0,TCGA-CM-6167-01A,TCGA-CM-6167,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-B7-A5TK,18750.0,male,1961,white,51,Primary Tumor,2.0,2.0,0.0,75.0,10.0,40.0,58.0,TCGA-B7-A5TK-01A,TCGA-B7-A5TK,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-CA-5255,16743.0,male,1965,asian,None,Primary Tumor,None,None,10.0,70.0,None,30.0,53.0,TCGA-CA-5255-01A,TCGA-CA-5255,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-A01X,29281.0,female,1924,not reported,1907,Primary Tumor,0.0,0.0,0.0,80.0,2.0,17.0,80.0,TCGA-AA-A01X-01A,TCGA-AA-A01X,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A6F0,28923.0,female,1934,white,35,Primary Tumor,10.0,20.0,20.0,70.0,50.0,10.0,60.0,TCGA-D7-A6F0-01A,TCGA-D7-A6F0,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4301,27516.0,female,1931,not reported,None,Primary Tumor,2.0,0.0,22.0,77.0,1.0,0.0,78.0,TCGA-CG-4301-01A,TCGA-CG-4301,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6898,18874.0,female,1960,white,None,Primary Tumor,None,None,0.0,65.0,None,30.0,65.0,TCGA-D5-6898-01A,TCGA-D5-6898,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6707,27529.0,male,1936,white,None,Primary Tumor,None,None,0.0,80.0,None,15.0,70.0,TCGA-BR-6707-01A,TCGA-BR-6707,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2026,29050.0,female,1916,white,None,Primary Tumor,0.0,2.0,0.0,90.0,0.0,10.0,90.0,TCGA-24-2026-01A,TCGA-24-2026,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-AA6D,19090.0,female,1961,not reported,294,Primary Tumor,0.0,0.0,0.0,70.0,3.0,0.0,98.0,TCGA-VQ-AA6D-01A,TCGA-VQ-AA6D,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4361,24260.0,female,1942,white,None,Primary Tumor,None,None,5.0,80.0,None,18.0,70.0,TCGA-BR-4361-01A,TCGA-BR-4361,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-D5-6930,24764.0,male,1944,white,None,Primary Tumor,3.0,0.0,0.0,65.0,15.0,34.0,65.0,TCGA-D5-6930-01A,TCGA-D5-6930,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-4187,20635.0,male,1952,white,None,Primary Tumor,None,None,15.0,85.0,None,15.0,70.0,TCGA-BR-4187-01A,TCGA-BR-4187,
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-A6EY,26526.0,female,1941,white,63,Primary Tumor,0.0,0.0,10.0,70.0,0.0,30.0,60.0,TCGA-D7-A6EY-01A,TCGA-D7-A6EY,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-31-1959,18247.0,female,1960,white,None,Primary Tumor,None,None,0.0,75.0,2.0,37.0,60.0,TCGA-31-1959-01A,TCGA-31-1959,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-2267,21293.0,female,1935,white,None,Primary Tumor,None,None,0.0,95.0,None,4.0,95.0,TCGA-24-2267-01A,TCGA-24-2267,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-6815,25811.0,female,1940,white,None,Primary Tumor,None,None,0.0,55.0,None,20.0,70.0,TCGA-D7-6815-01A,TCGA-D7-6815,2.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1550,18049.0,female,1948,white,None,Primary Tumor,None,None,0.0,85.0,None,10.0,80.0,TCGA-24-1550-01A,TCGA-24-1550,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-13-0924,16670.0,female,1963,white,None,Primary Tumor,None,None,0.0,70.0,None,35.0,65.0,TCGA-13-0924-01A,TCGA-13-0924,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-3M-AB47,None,male,1957,white,1933,Primary Tumor,20.0,20.0,0.0,70.0,40.0,30.0,70.0,TCGA-3M-AB47-01A,TCGA-3M-AB47,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-29-1766,27359.0,female,1932,white,None,Primary Tumor,None,None,0.0,90.0,None,50.0,40.0,TCGA-29-1766-01A,TCGA-29-1766,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-4440,25171.0,female,1938,not reported,None,Primary Tumor,None,None,0.0,80.0,None,5.0,85.0,TCGA-CG-4440-01A,TCGA-CG-4440,4.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-36-1577,15804.0,female,1964,asian,None,Primary Tumor,None,None,0.0,70.0,None,50.0,45.0,TCGA-36-1577-01A,TCGA-36-1577,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-QG-A5Z2,22367.0,male,1951,black or african american,337,Primary Tumor,1.0,1.0,0.0,65.0,15.0,0.0,100.0,TCGA-QG-A5Z2-01A,TCGA-QG-A5Z2,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-D7-8576,20014.0,female,1958,white,None,Primary Tumor,5.0,5.0,0.0,75.0,5.0,0.0,100.0,TCGA-D7-8576-01A,TCGA-D7-8576,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28K,27428.0,male,1928,white,2780,Primary Tumor,0.0,0.0,0.0,75.0,10.0,22.0,75.0,TCGA-DM-A28K-01A,TCGA-DM-A28K,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-VQ-A8DT,15937.0,male,1967,not reported,1130,Primary Tumor,20.0,20.0,10.0,70.0,40.0,20.0,70.0,TCGA-VQ-A8DT-01A,TCGA-VQ-A8DT,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-DM-A28E,26602.0,female,1929,white,3454,Primary Tumor,1.0,1.0,0.0,80.0,2.0,17.0,80.0,TCGA-DM-A28E-01A,TCGA-DM-A28E,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8284,26526.0,female,1939,white,None,Primary Tumor,None,None,0.0,75.0,None,20.0,80.0,TCGA-BR-8284-01A,TCGA-BR-8284,3.0
OV,Ovarian Serous Cystadenocarcinoma,Ovary,TCGA-24-1471,22081.0,female,1949,white,None,Primary Tumor,None,None,0.0,99.0,None,1.0,98.0,TCGA-24-1471-01A,TCGA-24-1471,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7335,22863.0,female,1934,white,None,Solid Tissue Normal,0.0,14.0,None,None,2.0,None,None,TCGA-77-7335-11A,TCGA-77-7335,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8434,23934.0,female,1944,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8434-11A,TCGA-KN-8434,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5482,29657.0,male,1924,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5482-11A,TCGA-22-5482,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-6647,25378.0,female,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-43-6647-11A,TCGA-43-6647,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-51-4079,26899.0,female,1936,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-51-4079-11A,TCGA-51-4079,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8083,20696.0,male,1955,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-8083-11A,TCGA-56-8083,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8426,18345.0,male,1956,white,None,Solid Tissue Normal,0.0,0.0,None,None,5.0,None,None,TCGA-KN-8426-11A,TCGA-KN-8426,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5ED,18698.0,male,1954,white,2879,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-P4-A5ED-11A,TCGA-P4-A5ED,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6956,24720.0,male,1926,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6956-11A,TCGA-CV-6956,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7250,23489.0,male,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7250-11A,TCGA-CV-7250,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5888,27346.0,female,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5888-11A,TCGA-BQ-5888,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7255,11931.0,female,1963,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7255-11A,TCGA-CV-7255,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IC-A6RE,21640.0,male,1954,white,104,Solid Tissue Normal,0.0,0.0,15.0,0.0,5.0,85.0,0.0,TCGA-IC-A6RE-11A,TCGA-IC-A6RE,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-A6I0,20491.0,male,1957,white,105,Solid Tissue Normal,0.0,0.0,100.0,0.0,10.0,0.0,0.0,TCGA-HD-A6I0-11A,TCGA-HD-A6I0,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-V5-AASX,27081.0,male,None,white,None,Solid Tissue Normal,0.0,0.0,100.0,0.0,5.0,0.0,0.0,TCGA-V5-AASX-11A,TCGA-V5-AASX,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5894,15510.0,male,1968,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5894-11A,TCGA-BQ-5894,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7416,10936.0,female,1965,white,None,Solid Tissue Normal,0.0,1.0,None,None,1.0,None,None,TCGA-CV-7416-11A,TCGA-CV-7416,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7177,30180.0,female,1917,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7177-11A,TCGA-CV-7177,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-GL-A9DE,27330.0,male,1939,black or african american,64,Solid Tissue Normal,0.0,0.0,55.0,0.0,0.0,45.0,0.0,TCGA-GL-A9DE-11A,TCGA-GL-A9DE,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-P4-A5E8,21132.0,male,1947,white,3086,Solid Tissue Normal,0.0,0.0,80.0,0.0,0.0,20.0,0.0,TCGA-P4-A5E8-11A,TCGA-P4-A5E8,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7183,19358.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7183-11A,TCGA-CV-7183,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7235,24800.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7235-11A,TCGA-CV-7235,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7097,19382.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7097-11A,TCGA-CV-7097,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LH,21628.0,female,1943,white,2998,Solid Tissue Normal,0.0,0.0,20.0,0.0,0.0,80.0,0.0,TCGA-E2-A1LH-11A,TCGA-E2-A1LH,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DG,11204.0,female,1977,black or african american,972,Solid Tissue Normal,0.0,0.0,100.0,None,5.0,None,0.0,TCGA-BH-A0DG-11A,TCGA-BH-A0DG,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FB,21933.0,female,1940,white,3871,Solid Tissue Normal,1.0,1.0,8.0,0.0,2.0,92.0,0.0,TCGA-BH-A1FB-11A,TCGA-BH-A1FB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6985,21381.0,female,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6985-11A,TCGA-55-6985,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6776,22150.0,female,1945,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6776-11A,TCGA-44-6776,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A204,29529.0,female,1916,white,5538,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A204-11A,TCGA-BH-A204,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BJ,15027.0,female,1967,white,595,Solid Tissue Normal,0.0,1.0,100.0,None,5.0,None,0.0,TCGA-BH-A0BJ-11A,TCGA-BH-A0BJ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6968,22344.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6968-11A,TCGA-55-6968,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DH,23366.0,female,1944,white,968,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0DH-11A,TCGA-BH-A0DH,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RC,20795.0,female,1951,white,1246,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E9-A1RC-11A,TCGA-E9-A1RC,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0AY,22703.0,female,1946,white,587,Solid Tissue Normal,0.0,0.0,100.0,None,5.0,None,0.0,TCGA-BH-A0AY-11A,TCGA-BH-A0AY,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0CE,20863.0,female,1952,white,129,Solid Tissue Normal,0.0,0.0,100.0,None,3.0,None,0.0,TCGA-A7-A0CE-11A,TCGA-A7-A0CE,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6743,29807.0,female,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-49-6743-11A,TCGA-49-6743,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18N,32404.0,female,1913,white,3374,Solid Tissue Normal,None,None,100.0,None,None,None,0.0,TCGA-BH-A18N-11A,TCGA-BH-A18N,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1ND,27400.0,female,1936,white,37,Solid Tissue Normal,0.0,0.0,10.0,0.0,0.0,90.0,0.0,TCGA-E9-A1ND-11A,TCGA-E9-A1ND,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0AU,16688.0,female,1963,white,583,Solid Tissue Normal,0.0,0.0,100.0,None,3.0,None,0.0,TCGA-BH-A0AU-11A,TCGA-BH-A0AU,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18J,20678.0,female,1944,white,3948,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A18J-11A,TCGA-BH-A18J,4.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5933,26377.0,male,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-5933-11A,TCGA-50-5933,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0AZ,17465.0,female,1961,white,575,Solid Tissue Normal,0.0,2.0,100.0,None,3.0,None,0.0,TCGA-BH-A0AZ-11A,TCGA-BH-A0AZ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NF,21981.0,female,1951,white,31,Solid Tissue Normal,None,None,100.0,None,None,None,0.0,TCGA-E9-A1NF-11A,TCGA-E9-A1NF,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4627,23510.0,female,1939,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-38-4627-11A,TCGA-38-4627,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-H6-A45N,32475.0,female,1924,white,203,Solid Tissue Normal,0.0,0.0,100.0,0.0,8.0,0.0,0.0,TCGA-H6-A45N-11A,TCGA-H6-A45N,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6144,21283.0,male,1953,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6144-11A,TCGA-44-6144,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EV,16504.0,female,1954,white,4103,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A1EV-11A,TCGA-BH-A1EV,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N9,21228.0,female,1953,white,44,Solid Tissue Normal,None,None,100.0,None,None,None,0.0,TCGA-E9-A1N9-11A,TCGA-E9-A1N9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DQ,15533.0,female,1967,white,190,Solid Tissue Normal,0.0,0.0,97.0,None,20.0,None,0.0,TCGA-BH-A0DQ-11A,TCGA-BH-A0DQ,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BS,20374.0,female,1952,white,1164,Solid Tissue Normal,0.0,0.0,100.0,None,1.0,None,0.0,TCGA-BH-A0BS-11A,TCGA-BH-A0BS,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6971,21734.0,female,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6971-11A,TCGA-55-6971,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5939,31236.0,male,1923,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-5939-11A,TCGA-50-5939,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6778,21725.0,male,1948,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6778-11A,TCGA-44-6778,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7115,23986.0,male,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7115-11A,TCGA-EJ-7115,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6496,22602.0,male,1947,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6496-11A,TCGA-G9-6496,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7123,21741.0,male,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7123-11A,TCGA-EJ-7123,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A11B,26857.0,male,1932,white,1975,Solid Tissue Normal,0.0,0.0,60.0,0.0,10.0,40.0,0.0,TCGA-DD-A11B-11A,TCGA-DD-A11B,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6348,24936.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6348-11A,TCGA-G9-6348,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7737,20122.0,male,1955,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7737-11A,TCGA-HC-7737,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5761,22433.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CH-5761-11A,TCGA-CH-5761,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10T,27944.0,male,1924,white,3660,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BC-A10T-11A,TCGA-BC-A10T,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7783,25600.0,male,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7783-11A,TCGA-EJ-7783,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10W,18562.0,male,1952,asian,3100,Solid Tissue Normal,0.0,0.0,80.0,0.0,5.0,20.0,0.0,TCGA-BC-A10W-11A,TCGA-BC-A10W,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10Y,28049.0,male,1926,white,2961,Solid Tissue Normal,0.0,0.0,80.0,0.0,5.0,20.0,0.0,TCGA-BC-A10Y-11A,TCGA-BC-A10Y,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-8454,22913.0,female,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-34-8454-11A,TCGA-34-8454,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-6737,26033.0,male,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-33-6737-11A,TCGA-33-6737,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-90-6837,23511.0,male,1947,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-90-6837-11A,TCGA-90-6837,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5887,19747.0,male,1955,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5887-11A,TCGA-BQ-5887,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-A5RI,24614.0,female,1945,white,100,Solid Tissue Normal,3.0,2.0,8.0,0.0,20.0,92.0,0.0,TCGA-K4-A5RI-11A,TCGA-K4-A5RI,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5877,22095.0,male,1944,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5877-11A,TCGA-BQ-5877,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A0YN,21927.0,male,1945,white,1827,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-CU-A0YN-11A,TCGA-CU-A0YN,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7425,28368.0,female,1923,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7425-11A,TCGA-CV-7425,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7438,32021.0,female,1913,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7438-11A,TCGA-CV-7438,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20U,25761.0,female,1938,white,1174,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BT-A20U-11A,TCGA-BT-A20U,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8436,22997.0,male,1947,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8436-11A,TCGA-KN-8436,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8403,18171.0,male,1956,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-KO-8403-11A,TCGA-KO-8403,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8008,24948.0,male,1933,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-77-8008-11A,TCGA-77-8008,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5691,24120.0,female,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5691-11A,TCGA-B0-5691,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6088,22020.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-6088-11A,TCGA-CW-6088,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5706,16442.0,male,1959,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5706-11A,TCGA-B0-5706,2.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-ZU-A8S4,19264.0,male,1960,white,356,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-ZU-A8S4-11A,TCGA-ZU-A8S4,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A2QY,23398.0,female,1939,white,2957,Solid Tissue Normal,10.0,30.0,90.0,0.0,30.0,10.0,0.0,TCGA-DI-A2QY-11A,TCGA-DI-A2QY,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-EP-A3RK,26985.0,male,1939,white,14,Solid Tissue Normal,1.0,1.0,80.0,0.0,3.0,20.0,0.0,TCGA-EP-A3RK-11A,TCGA-EP-A3RK,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7328,25756.0,male,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7328-11A,TCGA-EJ-7328,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BD-A3EP,27756.0,female,1935,black or african american,398,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BD-A3EP-11A,TCGA-BD-A3EP,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A118,28406.0,female,1926,white,2854,Solid Tissue Normal,0.0,0.0,95.0,0.0,1.0,5.0,0.0,TCGA-DD-A118-11A,TCGA-DD-A118,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-3400,19826.0,male,1955,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AF-3400-11A,TCGA-AF-3400,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5451,27312.0,male,1932,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5451-11A,TCGA-CZ-5451,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-4620,25786.0,female,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B8-4620-11A,TCGA-B8-4620,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4700,22034.0,male,1944,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-4700-11A,TCGA-B0-4700,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7738,21195.0,male,1953,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7738-11A,TCGA-HC-7738,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6499,24388.0,male,1942,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6499-11A,TCGA-G9-6499,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5580,26696.0,female,1930,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-5580-11A,TCGA-CW-5580,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5672,30900.0,male,1920,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5672-11A,TCGA-CJ-5672,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3725,32872,female,1915,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AG-3725-11A,TCGA-AG-3725,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B2-5636,28901.0,male,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B2-5636-11A,TCGA-B2-5636,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5989,22170.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5989-11A,TCGA-CZ-5989,2.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2U,28552.0,female,1932,white,1430,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-W5-AA2U-11A,TCGA-W5-AA2U,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5676,17170.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5676-11A,TCGA-CJ-5676,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5712,24988.0,female,1936,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5712-11A,TCGA-B0-5712,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-4712,28095.0,male,1930,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-4712-11A,TCGA-B0-4712,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5589,19312.0,male,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-5589-11A,TCGA-CW-5589,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-2689,15082.0,female,1968,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AF-2689-11A,TCGA-AF-2689,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5549,19561.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B8-5549-11A,TCGA-B8-5549,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5587,22693.0,female,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-5587-11A,TCGA-CW-5587,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5458,15790.0,male,1963,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5458-11A,TCGA-CZ-5458,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5581,16195.0,male,1959,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-5581-11A,TCGA-CW-5581,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H2,21266.0,male,1944,white,3292,Solid Tissue Normal,0.0,5.0,100.0,0.0,2.0,0.0,0.0,TCGA-EL-A3H2-11A,TCGA-EL-A3H2,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A2N8,11024.0,female,1981,white,103,Solid Tissue Normal,0.0,0.0,100.0,0.0,5.0,0.0,0.0,TCGA-BJ-A2N8-11A,TCGA-BJ-A2N8,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T7,17302.0,female,1957,white,2718,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3T7-11A,TCGA-EL-A3T7,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A41J,10411.0,female,1972,white,4417,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-KS-A41J-11A,TCGA-KS-A41J,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A28R,14044.0,female,1972,white,205,Solid Tissue Normal,0.0,0.0,70.0,0.0,10.0,30.0,0.0,TCGA-BJ-A28R-11A,TCGA-BJ-A28R,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3MX,24178.0,female,1938,white,2906,Solid Tissue Normal,0.0,6.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3MX-11A,TCGA-EL-A3MX,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DP,15876.0,female,1964,black or african american,1632,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-ET-A3DP-11A,TCGA-ET-A3DP,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZP,7101.0,male,1989,white,1393,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3ZP-11A,TCGA-EL-A3ZP,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T3,23043.0,male,1939,white,3495,Solid Tissue Normal,0.0,2.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3T3-11A,TCGA-EL-A3T3,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T1,14025.0,female,1964,black or african american,3629,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3T1-11A,TCGA-EL-A3T1,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3712,23831.0,male,1939,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3712-11A,TCGA-AA-3712,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7704,25300.0,female,1942,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BR-7704-11A,TCGA-BR-7704,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7716,22829.0,female,1949,white,None,Solid Tissue Normal,0.0,0.0,None,None,20.0,None,None,TCGA-BR-7716-11A,TCGA-BR-7716,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3660,18932.0,female,1954,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3660-11A,TCGA-AA-3660,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2671,31329.0,male,1924,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2671-11A,TCGA-A6-2671,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-8060,27561.0,female,1936,white,None,Solid Tissue Normal,None,2.0,None,None,8.0,None,None,TCGA-BR-8060-11A,TCGA-BR-8060,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3511,23407.0,male,1941,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3511-11A,TCGA-AA-3511,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GY,28113.0,female,1936,asian,183,Solid Tissue Normal,0.0,0.0,0.0,0.0,1.0,100.0,0.0,TCGA-HU-A4GY-11A,TCGA-HU-A4GY,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3697,28367.0,male,1926,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3697-11A,TCGA-AA-3697,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-5665,30915.0,female,1926,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-5665-11A,TCGA-A6-5665,2.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3731,23923.0,male,1939,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AG-3731-11A,TCGA-AG-3731,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5452,25486.0,male,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5452-11A,TCGA-CZ-5452,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3358,21087.0,female,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A3-3358-11A,TCGA-A3-3358,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4609,29844.0,male,1922,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-4609-11A,TCGA-22-4609,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7424,24775.0,male,1930,asian,None,Solid Tissue Normal,None,None,None,None,35.0,None,None,TCGA-CV-7424-11A,TCGA-CV-7424,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A43C,29753.0,male,1928,white,1091,Solid Tissue Normal,0.0,0.0,70.0,0.0,2.0,30.0,0.0,TCGA-L5-A43C-11A,TCGA-L5-A43C,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7055,26749.0,male,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-7055-11A,TCGA-BQ-7055,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6943,27310.0,male,1925,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6943-11A,TCGA-CV-6943,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-H7-A6C4,13137.0,female,1977,white,385,Solid Tissue Normal,20.0,20.0,40.0,0.0,40.0,40.0,0.0,TCGA-H7-A6C4-11A,TCGA-H7-A6C4,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5483,27109.0,male,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5483-11A,TCGA-22-5483,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7337,24065.0,male,1935,white,None,Solid Tissue Normal,20.0,0.0,None,None,20.0,None,None,TCGA-77-7337-11A,TCGA-77-7337,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A6I3,32872,female,1923,black or african american,87,Solid Tissue Normal,1.0,1.0,12.0,0.0,65.0,88.0,0.0,TCGA-GC-A6I3-11A,TCGA-GC-A6I3,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A2LA,20032.0,male,1956,white,257,Solid Tissue Normal,0.0,0.0,0.0,0.0,0.0,100.0,0.0,TCGA-BT-A2LA-11A,TCGA-BT-A2LA,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20R,28987.0,female,1927,white,1794,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BT-A20R-11A,TCGA-BT-A20R,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-WA-A7GZ,21207.0,male,1954,white,258,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-WA-A7GZ-11A,TCGA-WA-A7GZ,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6934,24180.0,female,1932,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6934-11A,TCGA-CV-6934,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BL-A13J,23927.0,male,1945,white,246,Solid Tissue Normal,0.0,0.0,70.0,0.0,1.0,30.0,0.0,TCGA-BL-A13J-11A,TCGA-BL-A13J,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-CU-A0YR,30674.0,male,1927,white,184,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-CU-A0YR-11A,TCGA-CU-A0YR,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5985,21242.0,male,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5985-11A,TCGA-CZ-5985,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5456,21164.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5456-11A,TCGA-CZ-5456,2.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2Q,25069.0,male,1938,white,2626,Solid Tissue Normal,2.0,1.0,80.0,0.0,4.0,20.0,0.0,TCGA-W5-AA2Q-11A,TCGA-W5-AA2Q,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5988,14131.0,male,1968,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5988-11A,TCGA-CZ-5988,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-2691,17759.0,female,1961,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AF-2691-11A,TCGA-AF-2691,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5465,27838.0,female,1931,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5465-11A,TCGA-CZ-5465,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-6033,19919.0,female,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-6033-11A,TCGA-CJ-6033,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5696,25552.0,male,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5696-11A,TCGA-B0-5696,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5467,31473.0,female,1921,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5467-11A,TCGA-CZ-5467,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5689,32872,male,1915,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5689-11A,TCGA-CJ-5689,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4863,18730.0,female,1955,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-4863-11A,TCGA-CZ-4863,3.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2I,24388.0,male,1939,white,3131,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-W5-AA2I-11A,TCGA-W5-AA2I,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2R,28367.0,female,1929,white,2542,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-W5-AA2R-11A,TCGA-W5-AA2R,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5987,21928.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5987-11A,TCGA-CZ-5987,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5690,19685.0,female,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5690-11A,TCGA-B0-5690,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10Q,26400.0,female,1926,white,4437,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BC-A10Q-11A,TCGA-BC-A10Q,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39X,28528.0,female,1920,white,4705,Solid Tissue Normal,0.0,1.0,90.0,0.0,1.0,10.0,0.0,TCGA-DD-A39X-11A,TCGA-DD-A39X,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7314,22766.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7314-11A,TCGA-EJ-7314,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A0IZ,19364.0,female,1954,white,1485,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-AX-A0IZ-11A,TCGA-AX-A0IZ,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5768,26480.0,male,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CH-5768-11A,TCGA-CH-5768,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A0J0,17466.0,female,1959,white,1952,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-AX-A0J0-11A,TCGA-AX-A0J0,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6384,19620.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6384-11A,TCGA-G9-6384,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EB,26471.0,female,1929,not reported,3538,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-DD-A1EB-11A,TCGA-DD-A1EB,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-ES-A2HT,20023.0,male,1953,black or african american,1392,Solid Tissue Normal,0.0,0.0,85.0,0.0,3.0,15.0,0.0,TCGA-ES-A2HT-11A,TCGA-ES-A2HT,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6342,22472.0,male,1947,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6342-11A,TCGA-G9-6342,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CK,21200.0,female,1947,white,2115,Solid Tissue Normal,None,None,100.0,None,None,None,0.0,TCGA-AX-A1CK-11A,TCGA-AX-A1CK,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7819,19663.0,male,1958,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7819-11A,TCGA-HC-7819,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A3PP,30227.0,female,1929,white,143,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-BG-A3PP-11A,TCGA-BG-A3PP,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-2662,24014.0,male,1944,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-2662-11A,TCGA-44-2662,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BA,18839.0,female,1955,white,1266,Solid Tissue Normal,0.0,1.0,100.0,None,1.0,None,0.0,TCGA-BH-A0BA-11A,TCGA-BH-A0BA,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-2657,27298.0,female,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-2657-11A,TCGA-44-2657,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18R,18524.0,female,1951,white,3571,Solid Tissue Normal,0.0,0.0,20.0,0.0,2.0,80.0,0.0,TCGA-BH-A18R-11A,TCGA-BH-A18R,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5932,27454.0,male,1926,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-5932-11A,TCGA-50-5932,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A209,28403.0,female,1919,black or african american,5392,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A209-11A,TCGA-BH-A209,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18S,28974.0,female,1924,white,2695,Solid Tissue Normal,0.0,1.0,10.0,0.0,1.0,90.0,0.0,TCGA-BH-A18S-11A,TCGA-BH-A18S,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18P,22222.0,female,1943,white,2639,Solid Tissue Normal,10.0,10.0,90.0,0.0,70.0,0.0,0.0,TCGA-BH-A18P-11A,TCGA-BH-A18P,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HK,29751.0,female,1929,white,35,Solid Tissue Normal,5.0,3.0,100.0,None,1.0,None,0.0,TCGA-BH-A0HK-11A,TCGA-BH-A0HK,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0H9,25289.0,female,1938,white,1088,Solid Tissue Normal,0.0,0.0,100.0,None,0.0,None,0.0,TCGA-BH-A0H9-11A,TCGA-BH-A0H9,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6984,None,female,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6984-11A,TCGA-55-6984,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6829,28841.0,male,1923,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-91-6829-11A,TCGA-91-6829,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-2655,23854.0,female,1944,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-2655-11A,TCGA-44-2655,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0C0,23006.0,female,1945,white,1094,Solid Tissue Normal,0.0,1.0,100.0,None,30.0,None,0.0,TCGA-BH-A0C0-11A,TCGA-BH-A0C0,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15M,24266.0,female,1944,white,287,Solid Tissue Normal,0.0,0.0,0.0,0.0,0.0,100.0,0.0,TCGA-E2-A15M-11A,TCGA-E2-A15M,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18Q,20675.0,female,1945,white,3417,Solid Tissue Normal,0.0,0.0,5.0,0.0,0.0,95.0,0.0,TCGA-BH-A18Q-11A,TCGA-BH-A18Q,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-2661,25313.0,female,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-2661-11A,TCGA-44-2661,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RB,14755.0,female,1971,white,39,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E9-A1RB-11A,TCGA-E9-A1RB,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0CH,29104.0,female,1930,white,121,Solid Tissue Normal,0.0,0.0,10.0,0.0,1.0,90.0,0.0,TCGA-A7-A0CH-11A,TCGA-A7-A0CH,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6745,30133.0,male,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-49-6745-11A,TCGA-49-6745,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18K,16824.0,female,1953,white,4011,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A18K-11A,TCGA-BH-A18K,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6969,19270.0,male,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6969-11A,TCGA-55-6969,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BT,20625.0,female,1951,white,1167,Solid Tissue Normal,0.0,1.0,100.0,None,2.0,None,0.0,TCGA-BH-A0BT-11A,TCGA-BH-A0BT,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6981,19497.0,female,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6981-11A,TCGA-55-6981,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8324,24650.0,female,1933,white,None,Solid Tissue Normal,0.0,0.0,None,None,3.0,None,None,TCGA-KL-8324-11A,TCGA-KL-8324,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7580,30740.0,male,1927,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-7580-11A,TCGA-56-7580,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-33-4587,23062.0,female,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-33-4587-11A,TCGA-33-4587,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8435,21891.0,male,1945,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8435-11A,TCGA-KN-8435,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8433,17108.0,female,1962,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8433-11A,TCGA-KN-8433,3.0
SKCM,Skin Cutaneous Melanoma,Skin,TCGA-GN-A4U8,18953.0,male,1958,white,1293,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-GN-A4U8-11A,TCGA-GN-A4U8,
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-85-7710,21790.0,female,1952,white,None,Solid Tissue Normal,0.0,20.0,None,None,35.0,None,None,TCGA-85-7710-11A,TCGA-85-7710,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8623,26231.0,male,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-8623-11A,TCGA-56-8623,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20Q,26778.0,male,1933,white,1898,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BT-A20Q-11A,TCGA-BT-A20Q,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OF,23194.0,male,1949,white,180,Solid Tissue Normal,0.0,0.0,70.0,0.0,10.0,30.0,0.0,TCGA-L5-A4OF-11A,TCGA-L5-A4OF,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7432,28875.0,male,1919,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7432-11A,TCGA-CV-7432,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6961,22532.0,male,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6961-11A,TCGA-CV-6961,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5890,25272.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5890-11A,TCGA-BQ-5890,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-A4ZT,26058.0,female,1941,white,49,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-A4-A4ZT-11A,TCGA-A4-A4ZT,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7045,28709.0,male,1923,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-7045-11A,TCGA-BQ-7045,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6935,24799.0,male,1932,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6935-11A,TCGA-CV-6935,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DZ-6131,11487.0,male,1972,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-DZ-6131-11A,TCGA-DZ-6131,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-90-7767,20534.0,male,1955,white,None,Solid Tissue Normal,0.0,10.0,None,None,0.0,None,None,TCGA-90-7767-11A,TCGA-90-7767,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8427,19854.0,male,1952,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8427-11A,TCGA-KN-8427,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7059,26136.0,male,1939,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-7059-11A,TCGA-BQ-7059,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7434,23465.0,male,1935,white,None,Solid Tissue Normal,1.0,1.0,None,None,5.0,None,None,TCGA-CV-7434-11A,TCGA-CV-7434,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DZ-6133,24311.0,female,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-DZ-6133-11A,TCGA-DZ-6133,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3NE,16957.0,female,1965,white,134,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-AJ-A3NE-11A,TCGA-AJ-A3NE,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-EP-A26S,25677.0,male,1941,white,91,Solid Tissue Normal,0.0,1.0,85.0,0.0,2.0,15.0,0.0,TCGA-EP-A26S-11A,TCGA-EP-A26S,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3NH,32871.0,female,1921,white,67,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-AJ-A3NH-11A,TCGA-AJ-A3NH,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HC,19485.0,female,1953,black or african american,1786,Solid Tissue Normal,0.0,0.0,100.0,0.0,5.0,0.0,0.0,TCGA-AX-A2HC-11A,TCGA-AX-A2HC,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7752,22366.0,male,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7752-11A,TCGA-HC-7752,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10U,25305.0,male,1931,white,3645,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BC-A10U-11A,TCGA-BC-A10U,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7327,22475.0,male,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7327-11A,TCGA-EJ-7327,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7794,24478.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7794-11A,TCGA-EJ-7794,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A3NC,23353.0,female,1948,white,282,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-AJ-A3NC-11A,TCGA-AJ-A3NC,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7317,26064.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7317-11A,TCGA-EJ-7317,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A2QR,None,male,1931,white,1764,Solid Tissue Normal,0.0,0.0,85.0,0.0,4.0,15.0,0.0,TCGA-FV-A2QR-11A,TCGA-FV-A2QR,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8259,18309.0,male,1961,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-8259-11A,TCGA-HC-8259,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A4ZD,15536.0,female,1970,black or african american,92,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-BK-A4ZD-11A,TCGA-BK-A4ZD,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39V,28254.0,male,1923,white,4180,Solid Tissue Normal,1.0,1.0,90.0,0.0,1.0,10.0,0.0,TCGA-DD-A39V-11A,TCGA-DD-A39V,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-E8-A2JQ,6684.0,female,1993,white,107,Solid Tissue Normal,0.0,3.0,100.0,0.0,5.0,0.0,0.0,TCGA-E8-A2JQ-11A,TCGA-E8-A2JQ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LS,16887.0,female,1964,white,176,Solid Tissue Normal,0.0,0.0,0.0,0.0,2.0,100.0,0.0,TCGA-E2-A1LS-11A,TCGA-E2-A1LS,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FU,16174.0,female,1953,white,5041,Solid Tissue Normal,0.0,1.0,4.0,0.0,1.0,96.0,0.0,TCGA-BH-A1FU-11A,TCGA-BH-A1FU,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18V,17682.0,female,1953,white,3621,Solid Tissue Normal,0.0,1.0,10.0,0.0,2.0,90.0,0.0,TCGA-BH-A18V-11A,TCGA-BH-A18V,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6831,24436.0,male,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-91-6831-11A,TCGA-91-6831,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6982,None,female,1925,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6982-11A,TCGA-55-6982,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18U,26426.0,female,1931,white,2697,Solid Tissue Normal,0.0,1.0,15.0,0.0,1.0,85.0,0.0,TCGA-BH-A18U-11A,TCGA-BH-A18U,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5936,21238.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-5936-11A,TCGA-50-5936,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1CU,11470.0,male,1979,not reported,210,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EM-A1CU-11A,TCGA-EM-A1CU,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZH,15685.0,female,1964,white,2228,Solid Tissue Normal,0.0,2.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3ZH-11A,TCGA-EL-A3ZH,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H7,13407.0,female,1966,white,3506,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3H7-11A,TCGA-EL-A3H7,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZL,12649.0,female,1974,white,1595,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-EL-A3ZL-11A,TCGA-EL-A3ZL,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A41L,14440.0,female,1965,white,2800,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-KS-A41L-11A,TCGA-KS-A41L,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZM,21987.0,male,1948,not reported,1554,Solid Tissue Normal,0.0,5.0,100.0,0.0,1.0,0.0,0.0,TCGA-EL-A3ZM-11A,TCGA-EL-A3ZM,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZR,16852.0,female,1962,white,1332,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3ZR-11A,TCGA-EL-A3ZR,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZO,28924.0,female,1929,white,1492,Solid Tissue Normal,2.0,2.0,35.0,0.0,3.0,65.0,0.0,TCGA-EL-A3ZO-11A,TCGA-EL-A3ZO,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3N3,19513.0,female,1947,white,4193,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3N3-11A,TCGA-EL-A3N3,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A290,25803.0,male,1940,white,486,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BJ-A290-11A,TCGA-BJ-A290,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-5662,16873.0,male,1964,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-5662-11A,TCGA-A6-5662,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2685,17757.0,female,1961,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2685-11A,TCGA-A6-2685,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3520,31531.0,female,1921,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3520-11A,TCGA-AA-3520,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-5667,14756.0,female,1970,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-5667-11A,TCGA-A6-5667,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6600,23581.0,male,1937,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AZ-6600-11A,TCGA-AZ-6600,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GC,27267.0,male,1937,asian,288,Solid Tissue Normal,1.0,1.0,0.0,0.0,2.0,100.0,0.0,TCGA-HU-A4GC-11A,TCGA-HU-A4GC,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4HB,25131.0,male,1944,asian,111,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-HU-A4HB-11A,TCGA-HU-A4HB,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-8238,20708.0,male,1955,asian,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HU-8238-11A,TCGA-HU-8238,
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3496,30438.0,female,1919,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3496-11A,TCGA-AA-3496,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5733,30650.0,female,1920,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CG-5733-11A,TCGA-CG-5733,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7851,27091.0,male,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BR-7851-11A,TCGA-BR-7851,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3489,27606.0,male,1927,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3489-11A,TCGA-AA-3489,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-5659,30028.0,male,1928,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-5659-11A,TCGA-A6-5659,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2683,20871.0,female,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2683-11A,TCGA-A6-2683,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6960,18194.0,male,1950,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6960-11A,TCGA-CV-6960,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-A54R,21601.0,male,1953,white,224,Solid Tissue Normal,1.0,1.0,25.0,0.0,3.0,75.0,0.0,TCGA-K4-A54R-11A,TCGA-K4-A54R,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OG,29105.0,female,1933,white,184,Solid Tissue Normal,0.0,0.0,50.0,0.0,10.0,50.0,0.0,TCGA-L5-A4OG-11A,TCGA-L5-A4OG,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EH,8499.0,male,1985,white,933,Solid Tissue Normal,0.0,0.0,75.0,0.0,8.0,25.0,0.0,TCGA-DD-A1EH-11A,TCGA-DD-A1EH,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CI,22582.0,female,1943,white,2222,Solid Tissue Normal,None,None,100.0,None,None,None,0.0,TCGA-AX-A1CI-11A,TCGA-AX-A1CI,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10X,19140.0,female,1950,white,3080,Solid Tissue Normal,0.0,0.0,80.0,0.0,3.0,20.0,0.0,TCGA-BC-A10X-11A,TCGA-BC-A10X,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8262,20946.0,male,1954,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-8262-11A,TCGA-HC-8262,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7789,24107.0,male,1945,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7789-11A,TCGA-EJ-7789,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5402,23477.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5402-11A,TCGA-B0-5402,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5984,18775.0,male,1954,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5984-11A,TCGA-CZ-5984,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-5654,26738.0,female,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AF-5654-11A,TCGA-AF-5654,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5461,19030.0,male,1954,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5461-11A,TCGA-CZ-5461,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5453,24640.0,male,1939,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5453-11A,TCGA-CZ-5453,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4864,31557.0,male,1916,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-4864-11A,TCGA-CZ-4864,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-4619,21206.0,male,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B8-4619-11A,TCGA-B8-4619,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5679,26858.0,male,1930,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5679-11A,TCGA-CJ-5679,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5466,24669.0,male,1940,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5466-11A,TCGA-CZ-5466,3.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3732,28521.0,female,1927,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AG-3732-11A,TCGA-AG-3732,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EE,26858.0,male,1933,white,1521,Solid Tissue Normal,0.0,0.0,90.0,0.0,0.0,10.0,0.0,TCGA-DD-A1EE-11A,TCGA-DD-A1EE,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A110,18951.0,female,1952,black or african american,2629,Solid Tissue Normal,0.0,0.0,70.0,0.0,5.0,30.0,0.0,TCGA-BC-A110-11A,TCGA-BC-A110,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39W,10699.0,female,1966,white,6014,Solid Tissue Normal,0.0,1.0,85.0,0.0,2.0,15.0,0.0,TCGA-DD-A39W-11A,TCGA-DD-A39W,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A3R2,27530.0,male,1930,white,2555,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-FV-A3R2-11A,TCGA-FV-A3R2,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AJ-A2QL,22057.0,female,1951,white,138,Solid Tissue Normal,0.0,0.0,5.0,0.0,8.0,95.0,0.0,TCGA-AJ-A2QL-11A,TCGA-AJ-A2QL,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5878,29010.0,female,1926,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5878-11A,TCGA-BQ-5878,3.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OR,30417.0,male,1927,white,924,Solid Tissue Normal,0.0,0.0,100.0,0.0,3.0,0.0,0.0,TCGA-L5-A4OR-11A,TCGA-L5-A4OR,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7091,19938.0,male,1947,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7091-11A,TCGA-CV-7091,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7101,29550.0,male,1919,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7101-11A,TCGA-CV-7101,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-Y8-A8RY,23192.0,male,1949,white,434,Solid Tissue Normal,1.0,1.0,35.0,0.0,10.0,65.0,0.0,TCGA-Y8-A8RY-11A,TCGA-Y8-A8RY,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-IC-A6RF,25417.0,female,1944,white,113,Solid Tissue Normal,1.0,1.0,6.0,0.0,15.0,94.0,0.0,TCGA-IC-A6RF-11A,TCGA-IC-A6RF,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7044,26831.0,male,1927,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-7044-11A,TCGA-BQ-7044,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6938,31825.0,male,1909,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6938-11A,TCGA-CV-6938,2.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OQ,27565.0,male,1935,white,934,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-L5-A4OQ-11A,TCGA-L5-A4OQ,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5879,11862.0,female,1973,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5879-11A,TCGA-BQ-5879,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7103,18219.0,male,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7103-11A,TCGA-CV-7103,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6959,17679.0,male,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6959-11A,TCGA-CV-6959,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7051,27120.0,male,1933,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-7051-11A,TCGA-BQ-7051,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7242,22136.0,female,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7242-11A,TCGA-CV-7242,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5882,20042.0,male,1953,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5882-11A,TCGA-BQ-5882,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7238,25471.0,female,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7238-11A,TCGA-CV-7238,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A2LB,26846.0,female,1937,white,317,Solid Tissue Normal,0.0,0.0,20.0,0.0,0.0,80.0,0.0,TCGA-BT-A2LB-11A,TCGA-BT-A2LB,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-GL-7966,10428.0,female,1983,white,None,Solid Tissue Normal,0.0,0.0,None,None,5.0,None,None,TCGA-GL-7966-11A,TCGA-GL-7966,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7245,22646.0,male,1947,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7245-11A,TCGA-CV-7245,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7440,13992.0,male,1962,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7440-11A,TCGA-CV-7440,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6962,24103.0,male,1934,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6962-11A,TCGA-CV-6962,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7423,24071.0,male,1932,white,None,Solid Tissue Normal,3.0,None,None,None,10.0,None,None,TCGA-CV-7423-11A,TCGA-CV-7423,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-H7-A6C5,23808.0,male,1947,white,230,Solid Tissue Normal,20.0,20.0,70.0,0.0,40.0,30.0,0.0,TCGA-H7-A6C5-11A,TCGA-H7-A6C5,2.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A2AD,23064.0,female,1948,white,45,Solid Tissue Normal,30.0,20.0,100.0,0.0,30.0,0.0,0.0,TCGA-BG-A2AD-11A,TCGA-BG-A2AD,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A3I1,None,female,1930,white,76,Solid Tissue Normal,1.0,1.0,90.0,0.0,1.0,10.0,0.0,TCGA-FV-A3I1-11A,TCGA-FV-A3I1,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7786,22793.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7786-11A,TCGA-EJ-7786,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7747,19188.0,male,1959,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7747-11A,TCGA-HC-7747,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A05Y,20904.0,female,1947,white,2391,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-AX-A05Y-11A,TCGA-AX-A05Y,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-J4-A83J,24960.0,male,1945,not reported,272,Solid Tissue Normal,0.0,0.0,40.0,0.0,0.0,60.0,0.0,TCGA-J4-A83J-11A,TCGA-J4-A83J,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-EP-A12J,22997.0,male,1948,black or african american,59,Solid Tissue Normal,0.0,1.0,95.0,0.0,3.0,5.0,0.0,TCGA-EP-A12J-11A,TCGA-EP-A12J,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A113,20188.0,female,1951,white,1650,Solid Tissue Normal,0.0,0.0,95.0,0.0,1.0,5.0,0.0,TCGA-DD-A113-11A,TCGA-DD-A113,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7321,21108.0,male,1954,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7321-11A,TCGA-EJ-7321,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A4,13739.0,male,1961,white,4776,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-DD-A3A4-11A,TCGA-DD-A3A4,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8258,20703.0,male,1955,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-8258-11A,TCGA-HC-8258,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A116,24934.0,male,1934,asian,3208,Solid Tissue Normal,0.0,0.0,90.0,0.0,1.0,10.0,0.0,TCGA-DD-A116-11A,TCGA-DD-A116,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7742,21323.0,male,1953,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7742-11A,TCGA-HC-7742,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6365,26207.0,male,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6365-11A,TCGA-G9-6365,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7781,23937.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7781-11A,TCGA-EJ-7781,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EL,8573.0,male,1986,black or african american,577,Solid Tissue Normal,0.0,0.0,90.0,0.0,3.0,10.0,0.0,TCGA-DD-A1EL-11A,TCGA-DD-A1EL,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A1,24046.0,male,1936,not reported,3753,Solid Tissue Normal,0.0,0.0,80.0,0.0,2.0,20.0,0.0,TCGA-DD-A3A1-11A,TCGA-DD-A3A1,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-6773,28036.0,male,1932,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-43-6773-11A,TCGA-43-6773,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KO-8415,16395.0,female,1963,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-KO-8415-11A,TCGA-KO-8415,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8309,24382.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-8309-11A,TCGA-56-8309,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-GL-A59R,29046.0,male,1933,white,76,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-GL-A59R-11A,TCGA-GL-A59R,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7406,18250.0,male,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7406-11A,TCGA-CV-7406,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-7657,25042.0,female,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-43-7657-11A,TCGA-43-7657,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5491,27145.0,male,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5491-11A,TCGA-22-5491,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7222,22097.0,male,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-7222-11A,TCGA-56-7222,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8424,15384.0,female,1963,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8424-11A,TCGA-KN-8424,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8326,25267.0,male,1932,white,None,Solid Tissue Normal,0.0,0.0,None,None,4.0,None,None,TCGA-KL-8326-11A,TCGA-KL-8326,3.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8339,24545.0,male,1939,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-KL-8339-11A,TCGA-KL-8339,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-92-7340,16447.0,female,1966,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-92-7340-11A,TCGA-92-7340,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5471,27749.0,male,1930,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5471-11A,TCGA-22-5471,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5472,24482.0,male,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5472-11A,TCGA-22-5472,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-8007,25102.0,male,1933,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-77-8007-11A,TCGA-77-8007,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A3ST,22990.0,female,1949,not reported,281,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EM-A3ST-11A,TCGA-EM-A3ST,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1CT,27944.0,male,1934,not reported,113,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EM-A1CT-11A,TCGA-EM-A1CT,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A3PU,19007.0,male,1959,white,168,Solid Tissue Normal,1.0,2.0,60.0,0.0,2.0,40.0,0.0,TCGA-BJ-A3PU-11A,TCGA-BJ-A3PU,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZS,8076.0,female,1986,white,1315,Solid Tissue Normal,0.0,0.0,0.0,0.0,50.0,100.0,0.0,TCGA-EL-A3ZS-11A,TCGA-EL-A3ZS,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3H1,24328.0,female,1927,black or african american,6870,Solid Tissue Normal,0.0,3.0,100.0,0.0,8.0,0.0,0.0,TCGA-EL-A3H1-11A,TCGA-EL-A3H1,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8429,13903.0,female,1968,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8429-11A,TCGA-KN-8429,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5457,22763.0,male,1944,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5457-11A,TCGA-CZ-5457,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5469,15242.0,male,1966,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5469-11A,TCGA-CZ-5469,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5701,23915.0,male,1942,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5701-11A,TCGA-B0-5701,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A208,17715.0,female,1947,white,5893,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A208-11A,TCGA-BH-A208,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0H5,16719.0,female,1963,white,815,Solid Tissue Normal,0.0,0.0,100.0,None,0.0,None,0.0,TCGA-BH-A0H5-11A,TCGA-BH-A0H5,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-2668,18856.0,male,1958,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-2668-11A,TCGA-44-2668,1.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-YB-A89D,21792.0,male,1954,white,48,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-YB-A89D-11A,TCGA-YB-A89D,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BV,28699.0,female,1928,white,1328,Solid Tissue Normal,0.0,0.0,35.0,None,5.0,None,0.0,TCGA-BH-A0BV-11A,TCGA-BH-A0BV,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18L,18519.0,female,1953,white,2669,Solid Tissue Normal,0.0,0.0,25.0,0.0,1.0,75.0,0.0,TCGA-BH-A18L-11A,TCGA-BH-A18L,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1BC,23168.0,female,1947,not reported,275,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E2-A1BC-11A,TCGA-E2-A1BC,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6148,22138.0,male,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6148-11A,TCGA-44-6148,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A203,28609.0,female,1918,white,5418,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A203-11A,TCGA-BH-A203,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1LB,15283.0,female,1967,black or african american,909,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E2-A1LB-11A,TCGA-E2-A1LB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6744,23484.0,female,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-49-6744-11A,TCGA-49-6744,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4626,20903.0,female,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-38-4626-11A,TCGA-38-4626,
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0H7,23972.0,female,1943,white,542,Solid Tissue Normal,0.0,0.0,100.0,None,2.0,None,0.0,TCGA-BH-A0H7-11A,TCGA-BH-A0H7,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4632,15418.0,male,1956,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-38-4632-11A,TCGA-38-4632,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0E0,14175.0,female,1971,white,136,Solid Tissue Normal,0.0,0.0,100.0,None,1.0,None,0.0,TCGA-BH-A0E0-11A,TCGA-BH-A0E0,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N4,15055.0,female,1969,white,65,Solid Tissue Normal,0.0,0.0,6.0,0.0,0.0,94.0,0.0,TCGA-E9-A1N4-11A,TCGA-E9-A1N4,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6835,29887.0,female,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-91-6835-11A,TCGA-91-6835,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A18M,14532.0,female,1962,white,3629,Solid Tissue Normal,0.0,0.0,15.0,0.0,1.0,85.0,0.0,TCGA-BH-A18M-11A,TCGA-BH-A18M,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-3396,27073.0,female,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-3396-11A,TCGA-44-3396,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DO,28529.0,female,1931,white,287,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0DO-11A,TCGA-BH-A0DO,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6980,None,male,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6980-11A,TCGA-55-6980,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-5645,22471.0,female,1949,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-5645-11A,TCGA-44-5645,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FF,None,female,1966,asian,1904,Solid Tissue Normal,0.0,0.0,20.0,0.0,1.0,80.0,0.0,TCGA-AC-A2FF-11A,TCGA-AC-A2FF,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A13E,22690.0,female,1948,white,220,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-A7-A13E-11A,TCGA-A7-A13E,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RI,15942.0,female,1968,white,64,Solid Tissue Normal,0.0,0.0,0.0,0.0,0.0,100.0,0.0,TCGA-E9-A1RI-11A,TCGA-E9-A1RI,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0E1,19192.0,female,1957,white,301,Solid Tissue Normal,0.0,0.0,100.0,None,6.0,None,0.0,TCGA-BH-A0E1-11A,TCGA-BH-A0E1,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-HV-A5A3,18475.0,male,1962,asian,226,Solid Tissue Normal,0.0,3.0,100.0,0.0,8.0,0.0,0.0,TCGA-HV-A5A3-11A,TCGA-HV-A5A3,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4512,25502.0,female,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-49-4512-11A,TCGA-49-4512,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NA,21397.0,female,1953,white,42,Solid Tissue Normal,0.0,0.0,0.0,0.0,2.0,100.0,0.0,TCGA-E9-A1NA-11A,TCGA-E9-A1NA,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-FY-A3TY,22556.0,female,1951,white,49,Solid Tissue Normal,1.0,1.0,80.0,0.0,2.0,20.0,0.0,TCGA-FY-A3TY-11A,TCGA-FY-A3TY,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZT,13103.0,male,1973,white,1311,Solid Tissue Normal,0.0,1.0,100.0,0.0,1.0,0.0,0.0,TCGA-EL-A3ZT-11A,TCGA-EL-A3ZT,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1CS,20284.0,female,1954,not reported,527,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EM-A1CS-11A,TCGA-EM-A1CS,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6454,21501.0,male,1953,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BR-6454-11A,TCGA-BR-6454,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A2NA,28147.0,male,1934,white,148,Solid Tissue Normal,0.0,0.0,70.0,0.0,1.0,30.0,0.0,TCGA-BJ-A2NA-11A,TCGA-BJ-A2NA,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-KS-A41I,17196.0,female,1955,white,3832,Solid Tissue Normal,0.0,4.0,100.0,0.0,10.0,0.0,0.0,TCGA-KS-A41I-11A,TCGA-KS-A41I,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1CW,14263.0,female,1971,not reported,249,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EM-A1CW-11A,TCGA-EM-A1CW,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A28X,11735.0,female,1978,white,161,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BJ-A28X-11A,TCGA-BJ-A28X,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2678,16030.0,female,1966,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2678-11A,TCGA-A6-2678,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3525,32871.0,male,1917,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3525-11A,TCGA-AA-3525,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-AB1V,23030.0,male,1950,white,152,Solid Tissue Normal,0.0,0.0,100.0,0.0,3.0,0.0,0.0,TCGA-IN-AB1V-11A,TCGA-IN-AB1V,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5728,32293.0,female,1915,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CG-5728-11A,TCGA-CG-5728,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3522,24653.0,male,1940,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3522-11A,TCGA-AA-3522,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3527,32871.0,female,1917,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3527-11A,TCGA-AA-3527,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-8663,25172.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-IN-8663-11A,TCGA-IN-8663,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5721,21244.0,male,1947,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CG-5721-11A,TCGA-CG-5721,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3713,24927.0,male,1937,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3713-11A,TCGA-AA-3713,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2679,26820.0,female,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2679-11A,TCGA-A6-2679,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6453,20061.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BR-6453-11A,TCGA-BR-6453,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7717,23102.0,male,1948,white,None,Solid Tissue Normal,5.0,0.0,None,None,50.0,None,None,TCGA-BR-7717-11A,TCGA-BR-7717,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3655,24896.0,male,1937,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3655-11A,TCGA-AA-3655,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2682,25683.0,male,1939,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2682-11A,TCGA-A6-2682,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7823,21344.0,female,1953,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-7823-11A,TCGA-56-7823,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8329,20972.0,female,1946,asian,None,Solid Tissue Normal,0.0,0.0,None,None,3.0,None,None,TCGA-KL-8329-11A,TCGA-KL-8329,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8425,19692.0,male,1952,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8425-11A,TCGA-KN-8425,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7338,23480.0,male,1931,white,None,Solid Tissue Normal,0.0,15.0,None,None,2.0,None,None,TCGA-77-7338-11A,TCGA-77-7338,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5489,23618.0,male,1939,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5489-11A,TCGA-22-5489,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6090,24909.0,male,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-6090-11A,TCGA-CW-6090,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5470,26494.0,female,1936,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5470-11A,TCGA-CZ-5470,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5709,22843.0,female,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5709-11A,TCGA-B0-5709,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-H2-A2K9,9221.0,male,1986,white,127,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-H2-A2K9-11A,TCGA-H2-A2K9,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-DO-A1JZ,8551.0,female,1984,black or african american,1386,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-DO-A1JZ-11A,TCGA-DO-A1JZ,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3TA,15366.0,male,1963,white,2457,Solid Tissue Normal,0.0,53.0,100.0,0.0,1.0,0.0,0.0,TCGA-EL-A3TA-11A,TCGA-EL-A3TA,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3MW,20186.0,female,1948,white,3067,Solid Tissue Normal,0.0,4.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3MW-11A,TCGA-EL-A3MW,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-38-4625,24241.0,female,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-38-4625-11A,TCGA-38-4625,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EN,28724.0,female,1921,white,4343,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A1EN-11A,TCGA-BH-A1EN,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3516,27303.0,female,1933,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3516-11A,TCGA-AA-3516,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IP-7968,27114.0,male,1937,white,None,Solid Tissue Normal,0.0,0.0,None,None,2.0,None,None,TCGA-IP-7968-11A,TCGA-IP-7968,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3662,29554.0,female,1925,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3662-11A,TCGA-AA-3662,4.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-7806,18404.0,male,1961,white,None,Solid Tissue Normal,0.0,0.0,None,None,2.0,None,None,TCGA-IN-7806-11A,TCGA-IN-7806,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6599,26438.0,male,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AZ-6599-11A,TCGA-AZ-6599,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-60-2709,25453.0,male,1935,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-60-2709-11A,TCGA-60-2709,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20N,26456.0,male,1931,not reported,2955,Solid Tissue Normal,0.0,0.0,0.0,0.0,5.0,100.0,0.0,TCGA-BT-A20N-11A,TCGA-BT-A20N,3.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-K4-A3WV,28444.0,female,1934,white,143,Solid Tissue Normal,0.0,0.0,0.0,0.0,1.0,100.0,0.0,TCGA-K4-A3WV-11A,TCGA-K4-A3WV,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7178,23430.0,female,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7178-11A,TCGA-CV-7178,4.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1IG,16757.0,female,1964,white,679,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E2-A1IG-11A,TCGA-E2-A1IG,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-4490,16634.0,female,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-49-4490-11A,TCGA-49-4490,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EO,25136.0,female,1931,white,4330,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A1EO-11A,TCGA-BH-A1EO,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GD-A3OP,30956.0,female,1927,white,133,Solid Tissue Normal,0.0,0.0,10.0,0.0,0.0,90.0,0.0,TCGA-GD-A3OP-11A,TCGA-GD-A3OP,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-BT-A20W,26078.0,male,1938,white,751,Solid Tissue Normal,0.0,0.0,0.0,0.0,3.0,100.0,0.0,TCGA-BT-A20W-11A,TCGA-BT-A20W,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-A4-A57E,21885.0,male,1952,white,588,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-A4-A57E-11A,TCGA-A4-A57E,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-8635,22340.0,female,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HD-8635-11A,TCGA-HD-8635,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6933,19518.0,male,1945,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6933-11A,TCGA-CV-6933,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HD-A6HZ,29045.0,female,1933,white,167,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-HD-A6HZ-11A,TCGA-HD-A6HZ,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-B9-4115,19571.0,male,1956,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B9-4115-11A,TCGA-B9-4115,1.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BG-A3EW,22705.0,female,1949,white,24,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-BG-A3EW-11A,TCGA-BG-A3EW,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A0CB,21930.0,female,1950,white,64,Solid Tissue Normal,0.0,0.0,100.0,None,5.0,None,0.0,TCGA-BK-A0CB-11A,TCGA-BK-A0CB,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7331,23458.0,male,1947,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7331-11A,TCGA-EJ-7331,
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5681,16121.0,female,1959,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5681-11A,TCGA-CJ-5681,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5468,30729.0,male,1923,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5468-11A,TCGA-CZ-5468,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AG-3742,31078.0,female,1919,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AG-3742-11A,TCGA-AG-3742,1.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA34,27535.0,female,1937,white,461,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-W5-AA34-11A,TCGA-W5-AA34,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5584,27352.0,male,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-5584-11A,TCGA-CW-5584,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5585,18898.0,male,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-5585-11A,TCGA-CW-5585,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5454,23083.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5454-11A,TCGA-CZ-5454,4.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA31,26139.0,male,1939,white,1079,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-W5-AA31-11A,TCGA-W5-AA31,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5462,30659.0,male,1924,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5462-11A,TCGA-CZ-5462,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-A3-3387,17920.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A3-3387-11A,TCGA-A3-3387,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5703,26897.0,male,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5703-11A,TCGA-B0-5703,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5982,21592.0,female,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5982-11A,TCGA-CZ-5982,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5678,22944.0,male,1941,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5678-11A,TCGA-CJ-5678,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-5591,20712.0,male,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-5591-11A,TCGA-CW-5591,4.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA30,30039.0,male,1928,white,1134,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-W5-AA30-11A,TCGA-W5-AA30,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5986,22456.0,male,1945,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5986-11A,TCGA-CZ-5986,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1NG,22896.0,female,1949,white,30,Solid Tissue Normal,0.0,0.0,0.0,0.0,0.0,100.0,0.0,TCGA-E9-A1NG-11A,TCGA-E9-A1NG,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6828,25870.0,male,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-91-6828-11A,TCGA-91-6828,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0DB,20570.0,female,1953,white,167,Solid Tissue Normal,0.0,0.0,0.0,0.0,1.0,100.0,0.0,TCGA-A7-A0DB-11A,TCGA-A7-A0DB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6847,22862.0,female,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-91-6847-11A,TCGA-91-6847,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A158,15903.0,female,1966,white,436,Solid Tissue Normal,1.0,1.0,0.0,0.0,1.0,100.0,0.0,TCGA-E2-A158-11A,TCGA-E2-A158,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DL,23628.0,female,1943,white,1074,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0DL-11A,TCGA-BH-A0DL,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1F2,19701.0,female,1946,white,4147,Solid Tissue Normal,0.0,0.0,80.0,0.0,5.0,20.0,0.0,TCGA-BH-A1F2-11A,TCGA-BH-A1F2,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6975,None,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6975-11A,TCGA-55-6975,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A23H,32872,female,1919,white,478,Solid Tissue Normal,0.0,0.0,22.0,0.0,2.0,78.0,0.0,TCGA-AC-A23H-11A,TCGA-AC-A23H,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1R7,23397.0,female,1947,white,51,Solid Tissue Normal,0.0,0.0,100.0,0.0,5.0,0.0,0.0,TCGA-E9-A1R7-11A,TCGA-E9-A1R7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B5,14920.0,female,1967,white,1008,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0B5-11A,TCGA-BH-A0B5,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-AC-A2FB,23851.0,female,1944,white,576,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-AC-A2FB-11A,TCGA-AC-A2FB,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6146,23378.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6146-11A,TCGA-44-6146,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DK,18237.0,female,1960,white,254,Solid Tissue Normal,0.0,1.0,97.0,None,2.0,None,100.0,TCGA-BH-A0DK-11A,TCGA-BH-A0DK,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BC,21949.0,female,1947,white,1098,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0BC-11A,TCGA-BH-A0BC,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6978,None,male,1929,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6978-11A,TCGA-55-6978,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0HA,11379.0,female,1977,white,675,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0HA-11A,TCGA-BH-A0HA,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5935,31610.0,female,1920,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-5935-11A,TCGA-50-5935,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GI-A2C8,23103.0,female,1941,white,2429,Solid Tissue Normal,0.0,0.0,0.0,0.0,0.0,100.0,0.0,TCGA-GI-A2C8-11A,TCGA-GI-A2C8,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A153,18875.0,female,1958,white,475,Solid Tissue Normal,1.0,3.0,20.0,0.0,2.0,80.0,0.0,TCGA-E2-A153-11A,TCGA-E2-A153,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A13G,28969.0,female,1931,white,69,Solid Tissue Normal,None,None,100.0,None,None,None,0.0,TCGA-A7-A13G-11A,TCGA-A7-A13G,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6970,24773.0,female,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6970-11A,TCGA-55-6970,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RF,25119.0,female,1943,white,56,Solid Tissue Normal,0.0,1.0,0.0,0.0,2.0,100.0,0.0,TCGA-E9-A1RF-11A,TCGA-E9-A1RF,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BM,20049.0,female,1953,white,1080,Solid Tissue Normal,None,None,70.0,None,None,None,0.0,TCGA-BH-A0BM-11A,TCGA-BH-A0BM,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A1L7,14854.0,female,1969,white,548,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E2-A1L7-11A,TCGA-E2-A1L7,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1EU,30339.0,female,1916,white,4106,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A1EU-11A,TCGA-BH-A1EU,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0DC,23294.0,female,1946,white,238,Solid Tissue Normal,0.0,0.0,0.0,0.0,1.0,100.0,0.0,TCGA-A7-A0DC-11A,TCGA-A7-A0DC,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-GI-A2C9,21534.0,female,1945,black or african american,2979,Solid Tissue Normal,0.0,0.0,15.0,0.0,1.0,85.0,0.0,TCGA-GI-A2C9-11A,TCGA-GI-A2C9,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10Z,22913.0,female,1941,white,2652,Solid Tissue Normal,0.0,0.0,70.0,0.0,7.0,30.0,0.0,TCGA-BC-A10Z-11A,TCGA-BC-A10Z,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A3,16708.0,male,1954,asian,4397,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-DD-A3A3-11A,TCGA-DD-A3A3,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-CH-5769,17807.0,male,1959,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CH-5769-11A,TCGA-CH-5769,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-A8FO,18875.0,male,1962,not reported,177,Solid Tissue Normal,0.0,0.0,25.0,0.0,0.0,75.0,0.0,TCGA-EJ-A8FO-11A,TCGA-EJ-A8FO,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A11C,25403.0,male,1937,white,1703,Solid Tissue Normal,0.0,2.0,75.0,0.0,5.0,25.0,0.0,TCGA-DD-A11C-11A,TCGA-DD-A11C,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A11A,24646.0,male,1937,black or african american,2184,Solid Tissue Normal,0.0,0.0,70.0,0.0,5.0,30.0,0.0,TCGA-DD-A11A-11A,TCGA-DD-A11A,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A5,24288.0,female,1930,white,5538,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-DD-A3A5-11A,TCGA-DD-A3A5,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7782,25965.0,male,1939,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7782-11A,TCGA-EJ-7782,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6351,18723.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6351-11A,TCGA-G9-6351,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EC,7363.0,female,1984,white,2254,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-DD-A1EC-11A,TCGA-DD-A1EC,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6333,24249.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6333-11A,TCGA-G9-6333,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A216,22968.0,female,1946,white,1052,Solid Tissue Normal,0.0,3.0,97.0,0.0,5.0,3.0,0.0,TCGA-BC-A216-11A,TCGA-BC-A216,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A119,14613.0,male,1963,asian,2738,Solid Tissue Normal,0.0,0.0,95.0,0.0,1.0,5.0,0.0,TCGA-DD-A119-11A,TCGA-DD-A119,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-E6-A1M0,20629.0,female,1954,white,360,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E6-A1M0-11A,TCGA-E6-A1M0,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HA,13142.0,female,1970,white,2188,Solid Tissue Normal,0.0,0.0,99.0,0.0,1.0,0.0,0.0,TCGA-AX-A2HA-11A,TCGA-AX-A2HA,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7797,19616.0,male,1958,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7797-11A,TCGA-EJ-7797,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A6,26319.0,female,1925,white,5304,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-DD-A3A6-11A,TCGA-DD-A3A6,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EJ,26009.0,female,1937,white,909,Solid Tissue Normal,0.0,0.0,85.0,0.0,5.0,15.0,0.0,TCGA-DD-A1EJ-11A,TCGA-DD-A1EJ,3.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A2,27930.0,female,1922,white,4962,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-DD-A3A2-11A,TCGA-DD-A3A2,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-8260,15884.0,male,1968,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-8260-11A,TCGA-HC-8260,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6356,22010.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6356-11A,TCGA-G9-6356,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2HD,25499.0,female,1939,white,1175,Solid Tissue Normal,0.0,0.0,97.0,0.0,0.0,0.0,0.0,TCGA-AX-A2HD-11A,TCGA-AX-A2HD,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7784,23183.0,male,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7784-11A,TCGA-EJ-7784,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7315,25154.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7315-11A,TCGA-EJ-7315,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EI,17097.0,male,1962,asian,926,Solid Tissue Normal,0.0,0.0,70.0,0.0,10.0,30.0,0.0,TCGA-DD-A1EI-11A,TCGA-DD-A1EI,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A23B,25788.0,female,1935,white,2030,Solid Tissue Normal,0.0,0.0,92.0,0.0,3.0,8.0,0.0,TCGA-FV-A23B-11A,TCGA-FV-A23B,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A1EG,28108.0,male,1931,white,1386,Solid Tissue Normal,0.0,0.0,70.0,0.0,10.0,30.0,0.0,TCGA-DD-A1EG-11A,TCGA-DD-A1EG,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-6143,25820.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-43-6143-11A,TCGA-43-6143,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8201,27211.0,male,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-8201-11A,TCGA-56-8201,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5478,28978.0,male,1925,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5478-11A,TCGA-22-5478,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-39-5040,21790.0,male,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-39-5040-11A,TCGA-39-5040,3.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7731,24441.0,female,1945,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-7731-11A,TCGA-56-7731,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-34-7107,25677.0,male,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-34-7107-11A,TCGA-34-7107,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-7658,27734.0,female,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-43-7658-11A,TCGA-43-7658,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8423,16335.0,male,1961,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8423-11A,TCGA-KN-8423,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-8082,29440.0,female,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-8082-11A,TCGA-56-8082,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-5481,26419.0,female,1930,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-5481-11A,TCGA-22-5481,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7142,21796.0,female,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-77-7142-11A,TCGA-77-7142,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OO,27757.0,male,1935,white,901,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-L5-A4OO-11A,TCGA-L5-A4OO,3.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7252,22934.0,female,1932,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7252-11A,TCGA-CV-7252,4.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6936,25020.0,male,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6936-11A,TCGA-CV-6936,4.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-L5-A4OJ,25657.0,female,1942,white,266,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-L5-A4OJ-11A,TCGA-L5-A4OJ,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8422,10303.0,female,1977,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8422-11A,TCGA-KN-8422,1.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8431,13043.0,female,1972,not reported,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8431-11A,TCGA-KN-8431,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-58-8386,27455.0,male,1933,not reported,None,Solid Tissue Normal,None,10.0,None,None,5.0,None,None,TCGA-58-8386-11A,TCGA-58-8386,4.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8437,15475.0,female,1964,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8437-11A,TCGA-KN-8437,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7579,22632.0,male,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-7579-11A,TCGA-56-7579,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZG,5612.0,male,1991,asian,2291,Solid Tissue Normal,0.0,1.0,60.0,0.0,4.0,40.0,0.0,TCGA-EL-A3ZG-11A,TCGA-EL-A3ZG,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3N2,8989.0,female,1987,white,92,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3N2-11A,TCGA-EL-A3N2,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-ET-A3DW,23603.0,male,1939,asian,3138,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-ET-A3DW-11A,TCGA-ET-A3DW,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A2N9,15411.0,female,1969,white,97,Solid Tissue Normal,0.0,0.0,60.0,0.0,5.0,40.0,0.0,TCGA-BJ-A2N9-11A,TCGA-BJ-A2N9,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3534,28489.0,female,1929,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3534-11A,TCGA-AA-3534,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2686,29623.0,female,1928,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2686-11A,TCGA-A6-2686,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5720,26176.0,male,1932,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CG-5720-11A,TCGA-CG-5720,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GH,27473.0,male,1936,asian,547,Solid Tissue Normal,1.0,1.0,100.0,0.0,20.0,0.0,0.0,TCGA-HU-A4GH-11A,TCGA-HU-A4GH,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GP,22711.0,female,1949,asian,476,Solid Tissue Normal,0.0,0.0,15.0,0.0,0.0,85.0,0.0,TCGA-HU-A4GP-11A,TCGA-HU-A4GP,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2680,26533.0,female,1937,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2680-11A,TCGA-A6-2680,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-7735,28232.0,male,1934,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-FP-7735-11A,TCGA-FP-7735,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6802,23915.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BR-6802-11A,TCGA-BR-6802,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7703,29711.0,male,1930,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BR-7703-11A,TCGA-BR-7703,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-FP-7829,25534.0,male,1942,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-FP-7829-11A,TCGA-FP-7829,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2684,27708.0,female,1934,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2684-11A,TCGA-A6-2684,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3518,29769.0,female,1926,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3518-11A,TCGA-AA-3518,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-IN-AB1X,28493.0,female,1935,white,96,Solid Tissue Normal,0.0,0.0,100.0,0.0,2.0,0.0,0.0,TCGA-IN-AB1X-11A,TCGA-IN-AB1X,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-6457,25396.0,male,1942,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BR-6457-11A,TCGA-BR-6457,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6603,28424.0,female,1925,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AZ-6603-11A,TCGA-AZ-6603,
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6979,21780.0,female,1947,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6979-11A,TCGA-55-6979,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8428,26252.0,male,1935,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8428-11A,TCGA-KN-8428,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-GL-6846,19012.0,male,1944,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-GL-6846-11A,TCGA-GL-6846,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GD-A3OQ,17682.0,male,1963,white,297,Solid Tissue Normal,0.0,0.0,10.0,0.0,0.0,90.0,0.0,TCGA-GD-A3OQ-11A,TCGA-GD-A3OQ,4.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DZ-6134,25529.0,male,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-DZ-6134-11A,TCGA-DZ-6134,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5875,24153.0,female,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5875-11A,TCGA-BQ-5875,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-DZ-6132,25417.0,male,1934,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-DZ-6132-11A,TCGA-DZ-6132,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6939,21947.0,male,1934,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6939-11A,TCGA-CV-6939,4.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3WC,29295.0,female,1931,white,119,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-GC-A3WC-11A,TCGA-GC-A3WC,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7061,30662.0,female,1928,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-7061-11A,TCGA-BQ-7061,1.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7437,28221.0,male,1919,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7437-11A,TCGA-CV-7437,2.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GC-A3BM,25609.0,male,1940,white,276,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-GC-A3BM-11A,TCGA-GC-A3BM,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-6955,27261.0,female,1926,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-6955-11A,TCGA-CV-6955,2.0
HNSC,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-CV-7261,20992.0,male,1951,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CV-7261-11A,TCGA-CV-7261,4.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7125,16425.0,male,1961,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7125-11A,TCGA-EJ-7125,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-G3-A3CH,19473.0,male,1957,asian,444,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-G3-A3CH-11A,TCGA-G3-A3CH,3.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A1CF,25300.0,female,1935,white,2284,Solid Tissue Normal,None,None,100.0,None,None,None,0.0,TCGA-AX-A1CF-11A,TCGA-AX-A1CF,4.0
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-DI-A2QU,24488.0,female,1938,white,2296,Solid Tissue Normal,0.0,0.0,0.0,0.0,5.0,100.0,0.0,TCGA-DI-A2QU-11A,TCGA-DI-A2QU,4.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A3A8,27524.0,male,1926,white,3708,Solid Tissue Normal,0.0,0.0,70.0,0.0,0.0,30.0,0.0,TCGA-DD-A3A8-11A,TCGA-DD-A3A8,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-FV-A3I0,28101.0,female,1935,white,70,Solid Tissue Normal,1.0,1.0,90.0,0.0,1.0,10.0,0.0,TCGA-FV-A3I0-11A,TCGA-FV-A3I0,2.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A114,15410.0,male,1963,black or african american,2063,Solid Tissue Normal,0.0,0.0,90.0,0.0,1.0,10.0,0.0,TCGA-DD-A114-11A,TCGA-DD-A114,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-4865,25709.0,female,1936,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-4865-11A,TCGA-CZ-4865,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CW-6087,22438.0,male,1942,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CW-6087-11A,TCGA-CW-6087,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5697,18486.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5697-11A,TCGA-B0-5697,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5699,19647.0,male,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5699-11A,TCGA-B0-5699,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B2-5641,28953.0,male,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B2-5641-11A,TCGA-B2-5641,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B7,15593.0,female,1964,white,1391,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0B7-11A,TCGA-BH-A0B7,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DP,22199.0,female,1949,white,293,Solid Tissue Normal,0.0,0.0,71.0,None,10.0,None,0.0,TCGA-BH-A0DP-11A,TCGA-BH-A0DP,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8430,27467.0,male,1932,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8430-11A,TCGA-KN-8430,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7730,26699.0,male,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-7730-11A,TCGA-56-7730,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-5670,25652.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-43-5670-11A,TCGA-43-5670,2.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-51-4081,20261.0,male,1954,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-51-4081-11A,TCGA-51-4081,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8419,15769.0,male,1961,black or african american,None,Solid Tissue Normal,0.0,0.0,None,None,2.0,None,None,TCGA-KN-8419-11A,TCGA-KN-8419,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KN-8432,31591.0,female,1924,white,None,Solid Tissue Normal,0.0,0.0,None,None,0.0,None,None,TCGA-KN-8432-11A,TCGA-KN-8432,2.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5884,21730.0,female,1949,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5884-11A,TCGA-BQ-5884,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-77-7138,24594.0,male,1932,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-77-7138-11A,TCGA-77-7138,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-22-4593,28385.0,male,1925,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-22-4593-11A,TCGA-22-4593,2.0
KICH,Kidney Chromophobe,Kidney,TCGA-KL-8336,18821.0,female,1955,white,None,Solid Tissue Normal,0.0,0.0,None,None,5.0,None,None,TCGA-KL-8336-11A,TCGA-KL-8336,4.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-43-6771,31052.0,male,1921,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-43-6771-11A,TCGA-43-6771,1.0
LUSC,Lung Squamous Cell Carcinoma,Lung,TCGA-56-7582,30678.0,male,1928,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-56-7582-11A,TCGA-56-7582,1.0
ESCA,Esophageal Carcinoma,Esophagus,TCGA-V5-A7RE,16643.0,male,None,white,None,Solid Tissue Normal,1.0,4.0,100.0,0.0,5.0,0.0,0.0,TCGA-V5-A7RE-11A,TCGA-V5-A7RE,1.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-5891,20945.0,female,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-5891-11A,TCGA-BQ-5891,3.0
KIRP,Kidney Renal Papillary Cell Carcinoma,Kidney,TCGA-BQ-7046,22337.0,male,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-BQ-7046-11A,TCGA-BQ-7046,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-5552,15219.0,female,1969,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B8-5552-11A,TCGA-B8-5552,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-6030,24096.0,male,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-6030-11A,TCGA-CJ-6030,1.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5677,19849.0,female,1950,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5677-11A,TCGA-CJ-5677,4.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AF-2692,19830.0,female,1955,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AF-2692-11A,TCGA-AF-2692,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5705,23746.0,female,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5705-11A,TCGA-B0-5705,1.0
READ,Rectum Adenocarcinoma,Colorectal,TCGA-AH-6643,18273.0,male,1960,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AH-6643-11A,TCGA-AH-6643,3.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7211,22768.0,male,1948,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7211-11A,TCGA-HC-7211,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6362,21149.0,male,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6362-11A,TCGA-G9-6362,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-G9-6363,23480.0,male,1945,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-G9-6363-11A,TCGA-G9-6363,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BD-A2L6,25489.0,male,1942,white,148,Solid Tissue Normal,0.0,0.0,90.0,0.0,25.0,10.0,0.0,TCGA-BD-A2L6-11A,TCGA-BD-A2L6,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7330,25050.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7330-11A,TCGA-EJ-7330,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A11D,21003.0,female,1949,white,1731,Solid Tissue Normal,0.0,0.0,80.0,0.0,7.0,20.0,0.0,TCGA-DD-A11D-11A,TCGA-DD-A11D,1.0
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-BC-A10R,24274.0,female,1933,white,4316,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BC-A10R-11A,TCGA-BC-A10R,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-BK-A13C,17317.0,female,1963,black or african american,146,Solid Tissue Normal,0.0,0.0,100.0,0.0,10.0,0.0,0.0,TCGA-BK-A13C-11A,TCGA-BK-A13C,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7740,21883.0,male,1952,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7740-11A,TCGA-HC-7740,
LIHC,Liver Hepatocellular Carcinoma,Liver,TCGA-DD-A39Z,15930.0,female,1953,not reported,5728,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-DD-A39Z-11A,TCGA-DD-A39Z,2.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-HC-7745,24078.0,male,1946,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-HC-7745-11A,TCGA-HC-7745,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7793,17982.0,male,1962,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7793-11A,TCGA-EJ-7793,
UCEC,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-AX-A2H8,23448.0,female,1942,white,1974,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-AX-A2H8-11A,TCGA-AX-A2H8,1.0
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7785,19939.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7785-11A,TCGA-EJ-7785,
PRAD,Prostate Adenocarcinoma,Prostate,TCGA-EJ-7792,19454.0,male,1957,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-EJ-7792-11A,TCGA-EJ-7792,
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6849,27676.0,female,1934,black or african american,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-91-6849-11A,TCGA-91-6849,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A0D9,13836.0,female,1972,white,173,Solid Tissue Normal,0.0,5.0,0.0,0.0,1.0,100.0,0.0,TCGA-A7-A0D9-11A,TCGA-A7-A0D9,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DT,15078.0,female,1966,white,1044,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0DT-11A,TCGA-BH-A0DT,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N6,19327.0,female,1958,white,63,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E9-A1N6-11A,TCGA-E9-A1N6,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RD,24719.0,female,1944,white,38,Solid Tissue Normal,0.0,1.0,0.0,0.0,1.0,100.0,0.0,TCGA-E9-A1RD-11A,TCGA-E9-A1RD,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5930,17238.0,male,1954,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-5930-11A,TCGA-50-5930,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6742,25839.0,male,1940,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-49-6742-11A,TCGA-49-6742,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1N5,16736.0,female,1965,white,63,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-E9-A1N5-11A,TCGA-E9-A1N5,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0C3,17221.0,female,1959,white,1335,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0C3-11A,TCGA-BH-A0C3,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6983,None,male,1924,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6983-11A,TCGA-55-6983,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FN,12525.0,female,1963,white,4838,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A1FN-11A,TCGA-BH-A1FN,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DZ,15980.0,female,1966,white,308,Solid Tissue Normal,0.0,0.0,100.0,None,0.0,None,0.0,TCGA-BH-A0DZ-11A,TCGA-BH-A0DZ,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-6595,27197.0,female,1935,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-6595-11A,TCGA-50-6595,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-A7-A13F,16363.0,female,1966,white,121,Solid Tissue Normal,0.0,0.0,30.0,0.0,0.0,70.0,0.0,TCGA-A7-A13F-11A,TCGA-A7-A13F,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-50-5931,27733.0,female,1926,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-50-5931-11A,TCGA-50-5931,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DV,19781.0,female,1953,white,975,Solid Tissue Normal,0.0,0.0,100.0,None,1.0,None,0.0,TCGA-BH-A0DV-11A,TCGA-BH-A0DV,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-49-6761,24849.0,female,1941,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-49-6761-11A,TCGA-49-6761,3.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6777,31234.0,female,1921,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6777-11A,TCGA-44-6777,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-91-6836,19216.0,female,1958,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-91-6836-11A,TCGA-91-6836,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0DD,21386.0,male,1948,white,1248,Solid Tissue Normal,0.0,0.0,100.0,None,0.0,None,0.0,TCGA-BH-A0DD-11A,TCGA-BH-A0DD,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6145,22745.0,female,1949,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6145-11A,TCGA-44-6145,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-73-4676,16746.0,male,1965,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-73-4676-11A,TCGA-73-4676,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15K,21514.0,female,1952,white,309,Solid Tissue Normal,0.0,0.0,2.0,0.0,2.0,98.0,0.0,TCGA-E2-A15K-11A,TCGA-E2-A15K,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0B8,23380.0,female,1942,white,1401,Solid Tissue Normal,0.0,5.0,0.0,None,2.0,None,0.0,TCGA-BH-A0B8-11A,TCGA-BH-A0B8,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A1FC,28706.0,female,1920,black or african american,4456,Solid Tissue Normal,0.0,1.0,4.0,0.0,1.0,96.0,0.0,TCGA-BH-A1FC-11A,TCGA-BH-A1FC,2.0
PAAD,Pancreatic Adenocarcinoma,Pancreas,TCGA-H6-8124,20741.0,female,1955,white,None,Solid Tissue Normal,0.0,0.0,None,None,10.0,None,None,TCGA-H6-8124-11A,TCGA-H6-8124,2.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BW,25974.0,female,1935,black or african american,1344,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0BW-11A,TCGA-BH-A0BW,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BZ,21856.0,female,1948,white,1084,Solid Tissue Normal,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCGA-BH-A0BZ-11A,TCGA-BH-A0BZ,3.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-BH-A0BQ,14494.0,female,1968,white,1197,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-BH-A0BQ-11A,TCGA-BH-A0BQ,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E2-A15I,16163.0,female,1965,white,344,Solid Tissue Normal,0.0,0.0,0.0,0.0,1.0,100.0,0.0,TCGA-E2-A15I-11A,TCGA-E2-A15I,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-6147,24631.0,female,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-6147-11A,TCGA-44-6147,1.0
BRCA,Breast Invasive Carcinoma,Breast,TCGA-E9-A1RH,23224.0,female,1948,white,32,Solid Tissue Normal,0.0,0.0,1.0,0.0,0.0,99.0,0.0,TCGA-E9-A1RH-11A,TCGA-E9-A1RH,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6972,26625.0,male,1933,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6972-11A,TCGA-55-6972,1.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-44-2665,20349.0,female,1954,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-44-2665-11A,TCGA-44-2665,2.0
LUAD,Lung Adenocarcinoma,Lung,TCGA-55-6986,None,female,1930,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-55-6986-11A,TCGA-55-6986,1.0
BLCA,Bladder Urothelial Carcinoma,Bladder,TCGA-GD-A2C5,19498.0,female,1958,white,76,Solid Tissue Normal,1.0,0.0,20.0,0.0,20.0,80.0,0.0,TCGA-GD-A2C5-11A,TCGA-GD-A2C5,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B8-4622,21135.0,male,1953,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B8-4622-11A,TCGA-B8-4622,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5455,23150.0,male,1943,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5455-11A,TCGA-CZ-5455,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CZ-5463,27911.0,male,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CZ-5463-11A,TCGA-CZ-5463,2.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5711,18444.0,male,1954,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5711-11A,TCGA-B0-5711,3.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-CJ-5680,23778.0,female,1938,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CJ-5680-11A,TCGA-CJ-5680,4.0
CHOL,Cholangiocarcinoma,Bile Duct,TCGA-W5-AA2X,24797.0,male,1943,white,1238,Solid Tissue Normal,0.0,1.0,94.0,0.0,4.0,6.0,0.0,TCGA-W5-AA2X-11A,TCGA-W5-AA2X,4.0
KIRC,Kidney Renal Clear Cell Carcinoma,Kidney,TCGA-B0-5694,26060.0,male,1937,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-B0-5694-11A,TCGA-B0-5694,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZQ,28783.0,female,1930,white,1360,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3ZQ-11A,TCGA-EL-A3ZQ,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T0,16798.0,female,1956,white,3923,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3T0-11A,TCGA-EL-A3T0,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A28W,11999.0,female,1979,white,105,Solid Tissue Normal,0.0,0.0,90.0,0.0,3.0,10.0,0.0,TCGA-BJ-A28W-11A,TCGA-BJ-A28W,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3GZ,12665.0,female,1967,white,3741,Solid Tissue Normal,1.0,1.0,100.0,0.0,2.0,0.0,0.0,TCGA-EL-A3GZ-11A,TCGA-EL-A3GZ,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A3PR,25565.0,female,1942,white,204,Solid Tissue Normal,0.0,0.0,90.0,0.0,20.0,10.0,0.0,TCGA-BJ-A3PR-11A,TCGA-BJ-A3PR,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1YC,26143.0,female,1936,not reported,1326,Solid Tissue Normal,0.0,2.0,100.0,0.0,0.0,0.0,0.0,TCGA-EM-A1YC-11A,TCGA-EM-A1YC,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3MY,29706.0,male,1923,white,2828,Solid Tissue Normal,0.0,2.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3MY-11A,TCGA-EL-A3MY,4.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-GE-A2C6,12068.0,female,1978,white,57,Solid Tissue Normal,0.0,0.0,70.0,0.0,20.0,30.0,0.0,TCGA-GE-A2C6-11A,TCGA-GE-A2C6,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T6,12777.0,female,1969,white,3292,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3T6-11A,TCGA-EL-A3T6,1.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6598,28182.0,female,1923,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AZ-6598-11A,TCGA-AZ-6598,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-F4-6704,21949.0,male,1951,american indian or alaska native,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-F4-6704-11A,TCGA-F4-6704,3.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5722,24472.0,female,1938,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CG-5722-11A,TCGA-CG-5722,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3517,22099.0,male,1947,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3517-11A,TCGA-AA-3517,2.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3TB,17195.0,female,1958,white,2443,Solid Tissue Normal,0.0,0.0,100.0,0.0,1.0,0.0,0.0,TCGA-EL-A3TB-11A,TCGA-EL-A3TB,3.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-BJ-A2N7,11188.0,female,1981,white,141,Solid Tissue Normal,0.0,0.0,100.0,0.0,10.0,0.0,0.0,TCGA-BJ-A2N7-11A,TCGA-BJ-A2N7,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T8,13290.0,male,1969,asian,2568,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EL-A3T8-11A,TCGA-EL-A3T8,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3ZK,15121.0,female,1966,white,1646,Solid Tissue Normal,0.0,1.0,100.0,0.0,8.0,0.0,0.0,TCGA-EL-A3ZK-11A,TCGA-EL-A3ZK,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EM-A1CV,11932.0,female,1978,not reported,54,Solid Tissue Normal,0.0,0.0,100.0,0.0,0.0,0.0,0.0,TCGA-EM-A1CV-11A,TCGA-EM-A1CV,1.0
THCA,Thyroid Carcinoma,Thyroid,TCGA-EL-A3T2,20403.0,female,1947,white,3565,Solid Tissue Normal,0.0,1.0,100.0,0.0,4.0,0.0,0.0,TCGA-EL-A3T2-11A,TCGA-EL-A3T2,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3531,27514.0,female,1932,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3531-11A,TCGA-AA-3531,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-A6-2675,28813.0,male,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-A6-2675-11A,TCGA-A6-2675,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6605,28485.0,male,1931,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AZ-6605-11A,TCGA-AZ-6605,3.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3514,29738.0,female,1925,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3514-11A,TCGA-AA-3514,1.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-BR-7715,23861.0,male,1946,white,None,Solid Tissue Normal,5.0,0.0,None,None,30.0,None,None,TCGA-BR-7715-11A,TCGA-BR-7715,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5730,29432.0,female,1925,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CG-5730-11A,TCGA-CG-5730,4.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AA-3663,15675.0,male,1963,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AA-3663-11A,TCGA-AA-3663,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-HU-A4GN,22288.0,male,1950,asian,483,Solid Tissue Normal,2.0,1.0,100.0,0.0,15.0,0.0,0.0,TCGA-HU-A4GN-11A,TCGA-HU-A4GN,2.0
COAD,Colon Adenocarcinoma,Colorectal,TCGA-AZ-6601,25082.0,male,1933,white,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-AZ-6601-11A,TCGA-AZ-6601,2.0
STAD,Stomach Adenocarcinoma,Stomach,TCGA-CG-5734,25079.0,male,1937,not reported,None,Solid Tissue Normal,None,None,None,None,None,None,None,TCGA-CG-5734-11A,TCGA-CG-5734,3.0
